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Minimising prescribing errors in the ICU
DJ Melia, S Saha
Queen’s Hospital, Romford, UK
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Introduction We aimed to audit the prescribing practice on a busy 
14-bedd general ICU, and develop standardised practices and tools 
to improve safety. Prescribing errors occur as commonly as in 10% of 
UK hospital admissions, costing 8.5 extra bed days per admission, and 
costing the National Health Service an estimated £1 billion per annum 
[1]. The majority of these mistakes are avoidable [2].
Methods We audited the daily infusion charts of all patients in 
three separate spot checks, over 1  week. We assessed all aspects of 
prescriptions that make them legal and valid, in accordance with 
national guidance [3]. New procedures were introduced, which 
included a standardised prescription sticker, with common, pre-
printed, infusion prescriptions on (noradrenaline, propofol, and so 
forth), and education on using the new prescription stickers. A month 
later the audit process was repeated.
Results We assessed 129 prescriptions in the fi rst round, and 111 after 
intervention, demonstrating a 70% improvement in safe prescribing. 
Only 24% of prescriptions initially fulfi lled best practice criteria, 
improving to 94% afterwards. We also reduced the number of infusions 
running without prescription, 7 (6%) versus 24 (19%). See Figures 1 and 2.
Conclusion Our audit supports the need for standardised prescribing 
practices within critical care, especially when dealing with potentially 
harmful vasoactive/sedative drugs. With a small, cost-eff ective 
intervention (£20 for 6,200 stickers), we improved prescribing accuracy, 
and thus patient safety in intensive care.
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Introduction The theft and tampering of controlled drugs (CDs) remains 
a prevalent patient safety issue. Sadly there are numerous reports of 
critical care staff  stealing CDs for personal use or fi nancial gain and 
notably there have been some cases where CDs have been substituted 
for other medications in order to delay detection of the theft. This 
creates both the hazard of medication errors and potentially exposes 
patients to opioid intoxicated healthcare workers. As most critical care 
staff  have access to CDs, when drugs are found to be missing it can be 
diffi  cult to identify the perpetrators. Therefore the implementation of a 
deterrent which also improves the methods of detection is warranted.
Methods The Limpet, a device which incorporates a proximity sensor 
and a camera unit, was installed within the CD cupboard of the 
critical care unit. Whenever the cupboard was accessed the date and 
time were recorded and a photograph was taken to identify the staff  
member. Mock thefts were subsequently undertaken by a designated 
staff  member at random times. This allowed testing of the product to 
determine the number of times the ‘thief’ was correctly identifi ed.
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Figure 1 (abstract P1). Accuracy of prescriptions before intervention.
Figure 2 (abstract P1). Accuracy of prescriptions after intervention.
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Results Mock thefts were successfully accomplished on six occasions 
over a 4-week period. On each occasion the Limpet photographed the 
‘thief’ and recorded the date and time of access. Therefore, in the event 
of a real theft it would be possible to quickly and easily indentify the 
culprit.
Conclusion When CDs are missing it can be extremely stressful for 
the staff  involved. Those who have access to CDs may feel unfairly 
scrutinised and the potential for false accusation exists. Investigating 
the theft of CDs is costly and usually involves pharmacists, managers 
and the police. Until the issue is resolved, potential suspects are usually 
suspended from work, leading to disruptions in patient care. The utility 
of the Limpet in modifying staff  behaviour by reducing the number of 
occasions and the duration of time that open drug cupboards are left 
unattended, has previously been demonstrated [1]. By providing the 
facility to determine exactly who accessed each CD cupboard at which 
time, this initial study has shown the benefi ts of the Limpet as a tool for 
detecting theft. Therefore the installation of the Limpet mitigates the 
diffi  culties of investigating CD theft and is likely to prove an eff ective 
deterrent.
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Introduction Multidisciplinary rounding practices in the ICU have now 
become the standard of care in most institutions. Few objective data are 
available, however, on the value each individual member of the team 
brings to the patient care. In our institution, pediatric pharmacists have 
been an integral part of the PICU rounds since 2002, although their role 
has evolved over the course of years. This study was undertaken with 
the primary aim of identifying the impact of pharmacist involvement in 
PICU rounds, with respect to changes in therapy.
Methods Since January 2003, pharmacists have recorded their clinical 
interventions and outcomes of those interventions in an institutionally 
developed Pharmaceutical Care database (P-Care). An intervention is 
defi ned as any recommendation the pharmacist makes to the patient 
care team regarding a change in the patient management or medication 
therapy. P-Care is designed to assist the pharmacist to optimize 
medication therapy, identify medication-related problems, decrease 
medication costs, improve pharmacist effi  ciency and document 
pharmacist workload. Data concerning pharmacists’ interventions 
were extracted from the P-Care database in yearly increments via a 
reporting functionality that is available in the P-Care system. This study 
was exempted for review by the Mayo Clinic IRB.
Results From 1 January 2003 through 31 December 2012 pharmacists 
made 24,207 clinical interventions in the PICU and 19,252 of those 
interventions resulted in changes in medication therapy or therapy 
monitoring. Interventions that were accepted by the team involved 
10,361 (53.8%) drug dosing regimen changes, 292 (1.5%) drug 
interactions or incompatibility, 969 (5%) drug monitoring suggestions, 
1,665 (8.7%) drug routes/methods of administration, 3,895 (20.2%) drug 
selections, and 2,070 (10.8%) medication profi le/order clarifi cations. As 
the pharmacist role on the PICU multidisciplinary rounds has evolved, 
the number of interventions has increased from 1,643 in 2003 to 3,799 
in 2012. Of the 19,252 interventions that were implemented, 304 were 
deemed to be of potentially life-threatening consequences, 10,767 had 
a moderate impact, and 8,181 had minimal impact on patient outcome.
Conclusion To our knowledge this is the largest reported data on 
pharmacist’s involvement in pediatric intensive care. This can serve 
as background knowledge on implementing measures on novel 
methodologies to integrate pharmacists in intensive care practice.
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Introduction The purpose of this study was to assess our practice in 
identifying and managing inadvertent hypothermia and whether 
this could be improved by education and introduction of a protocol. 
Hypothermia is associated with multiple physiological abnormalities 
including reduced myocardial contractility, peripheral vasoconstriction, 
increased infection risk and impaired coagulation [1]. Inadvertent 
hypothermia may therefore be an avoidable risk factor in the critically 
ill. The UK National Institute of Clinical Excellence has issued guidance 
for avoidance of inadvertent hypothermia (temperature <36°C) 
during the perioperative period. We audited our practice against 
three standards from these guidelines: all patients should have at 
least 4-hourly temperature observations; no patient should become 
inadvertently hypothermic; and all inadvertently hypothermic patients 
should be rewarmed.
Methods Data were collected prospectively. Body temperature was 
recorded routinely by nursing staff  using a tympanic thermometer. We 
noted any occasion where the body temperature dropped below 36°C 
along with any associated interventions – such as the use of additional 
bed sheets or a forced air warming device. After the fi rst audit period 
a simple education programme was delivered. We also introduced 
a departmental protocol for the prevention and management of 
inadvertent hypothermia. Six months later we re-audited our practice.
Results Data were collected from 130 patients (2,931 patient-hours) 
in the fi rst audit period and from 87 patients (2,070 patient-hours) 
in the second audit period. In the fi rst period 29% of patients had at 
least 4-hourly temperature measurements compared with 40% in the 
second period (P <0.01). The average number of overdue temperature 
observations per day was 1.4 in the fi rst period and 0.9 in the second 
(P <0.01). Twenty-four per cent of patients became hypothermic in the 
fi rst period compared with 22% in the second (P = 0.07); however, the 
time these patients remained hypothermic reduced from an average 
of 7.9  hours to 6.1  hours (P  <0.01). An intervention was made and 
documented in 15% of cases in the fi rst period and 46% in the second 
(P <0.001).
Conclusion We saw some improvement following an education 
programme and introduction of a clinical protocol although there 
remains room for further improvement.
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Introduction Security policies for the patient are an interest to any 
health professional. The rates of adverse events in hospitals reach 
values ranging between 3.7 and 16.6%, being the highest range (40 
to 70%) considered preventable or avoidable [1]. The objective of this 
study is to analyze the incidence of adverse events and their severity in 
a Brazilian coronary ICU (CICU).
Methods Research conducted from database analysis regarding 
hospitalizations from 1 May 2012 until 31 October 2013 in a coronary 
care unit of the city of Presidente Prudente, Brazil. Statistical analysis 
was performed using EPI INFO, version 3.5.2 software, which was 
considered signifi cant at P  <0.05 two-tailed and CIs at 95% (CI) were 
used for the odds ratios (OR) estimated in the sample. Demographics 
(gender and average age) and aspects related to adverse events were 
analyzed, the latter being under the impact and probability of death.
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Results A total of 1,067 admissions were analyzed in the period, with 
57.38% male and 42.63% female. The average age was 67.7 ± 13.2 years. 
The average CICU length of stay was 3.74 ± 5.51 days. A total of 211 
adverse events occurring in 140 diff erent admissions were recorded. 
The most frequent were drug administration errors (24.3%), pressure 
ulcer (24.3%), phlebitis (22.1%), loss of enteric tube (13.6%) and central 
venous cannulation accident (7.1%). The statistical analysis shows that 
hospitalization time longer than 2 days are related to the occurrence of 
the events (OR: 8.08 CI: 4.95 to 13.2) and that the presence of the fi rst 
occurrence is signifi cant to increase the probability of death in the unit 
(OR = 5.33, CI: 3.49 to 8.12). Pressure ulcer (OR = 16.73, CI: 8.04 to 34.81), 
enteral tube loss (OR 3.64, CI: 1.36 to 9.75) and drug administration 
errors (OR = 2.87, CI: 1.31 to 6.31) were also related to higher mortality.
Conclusion The research draws attention to a signifi cant incidence of 
adverse events and shows that their occurrence implies an increase of 
death in the unit. Therefore, security measures should be employed 
for the reduction, and thus enhance the quality of service provided by 
health professionals to patients admitted to a coronary care unit.
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Introduction Ventilator-associated pneumonia (VAP) is the leading 
cause of death amongst hospital-acquired infections and is also 
linked to an increased length of stay and cost of care. The Institute for 
Healthcare Improvement ventilator bundle is comprised of a series of 
interventions, which, when implemented together, have been shown 
to decrease the incidence of VAP. The aim of this study was to determine 
the compliance of the bundle and if <95% [1] devise strategies to 
improve compliance.
Methods A retrospective review of the compliance of an existing VAP 
bundle was conducted for all adult patients ventilated in the ICU of 
a large district general hospital in 2011. The bundle comprised four 
elements: head up 30°, peptic ulcer prophylaxis, deep vein thrombosis 
(DVT) prophylaxis and sedation hold. The bundle was considered 
compliant if all four were performed. The fi ndings of the audit were 
presented to the department and, through subsequent discussions, 
barriers to noncompliance were identifi ed. Following a period of 
education, a revised and updated bundle was implemented. A repeat 
audit covering 3 months was subsequently conducted.
Results Pre-intervention, overall compliance of the bundle stood at 
32% and subsequently increased to 63% post intervention (P  <0.05). 
Compliance at the level of individual elements varied: head up 30°, 
94%; ulcer prophylaxis, 91%; DVT prophylaxis, 85%; sedation hold, 
37%. Post intervention, a statistically signifi cant increase in compliance 
with regard to sedation hold was observed; 72% (P <0.05). The other 
individual elements did not show a statistical change. However, the 
new elements that were introduced demonstrated high levels of 
compliance; cuff  pressure 20 to 30 cm H2O 83% and oral hygiene with 
chlorhexidine 90%.
Conclusion Post intervention, a statistically signifi cant improvement 
in overall bundle compliance was found. Thereby highlighting that 
through engaging all members of the multidisciplinary team in 
identifying barriers to noncompliance and delivering education, 
it is possible to improve compliance. While total compliance was 
suboptimal as the target was 95%, the bundle redesign has given a 
tool that records compliance with greater clarity due to the presence 
of clearly defi ned exclusion criteria. It has also been a signifi cant step 
in the right direction to improving the reliability of care delivered to 
patient and reinforces the concept that quality improvement is a 
continuous cycle.
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Introduction The report of the National Confi dential Enquiry 
into Patient Outcome and Death (NCEPOD) 2005 [1] provides 
recommendations to reduce morbidity and mortality among acutely 
ill patients. It highlights the importance for involvement of consultants 
in the referral process, clear physiological monitoring plans for each 
patient, and review by a consultant intensivist within 12  hours of 
admission to critical care. The objective of the audit was to assess 
compliance with these recommendations, ensuring safe management 
of acutely unwell patients and appropriate utilisation of scarce critical 
care resources.
Methods Prospective data on referrals to adult critical care in a 20-
bed unit in a teaching hospital were collected over 8 weeks. Collected 
data included: source, time, seniority of doctor referring and receiving 
referral, outcome of referral, involvement of team consultant prior to 
referral, documented management plan and review by a critical care 
consultant within 12 hours of referral.
Results Seventy-three referrals were analysed, the majority of which 
were medical. One-half of referrals came out of hours; 24% of referrals 
were made by a consultant; 51% were seen by a consultant prior to 
referral; 73% of referrals were admitted; likelihood of admission 
increased from 63% to 83% if the patient was reviewed by home 
consultant prior to referral. In 56% of cases the referral was received 
by a foundation doctor (all referrals were discussed with a consultant 
intensivist). Among the rejected referrals (maximal ward therapy not 
reached), 54% were from a trainee below registrar grade. Twenty-fi ve 
per cent of patients were not seen by a consultant intensivist within 
12 hours of referral.
Conclusion Acutely unwell patients require the expertise of the most 
senior clinicians regarding further management, including planning 
for end-of-life care. Our audit demonstrated poor adherence to 
NCEPOD [1] and Department of Health [2] recommendations. The 
majority of referrals to critical care were made by nonconsultants and 
for patients who had not been reviewed by a team consultant, prior to 
referral. The workload in critical care demonstrated that almost one-
half of the referrals happen out of hours. These fi ndings have resulted 
in signifi cant changes to working practice, including the presence of an 
onsite consultant intensivist for a minimum of 13 hours daily.
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Introduction Demand for critical care (CC) resources is constantly 
increasing in the face of limited availability. Guidance for triage 
exists but may no longer refl ect current practice [1,2]. We previously 
identifi ed nonmedical and medical factors (comorbidities, 
physiological derangement and functional status) as predicting 
likelihood of admission of referred patients to CC [3-5]. Reduction in 
UK doctors’ working hours and numbers has resulted in new ways of 
multidisciplinary teams working the hospital at night (H@N), which 
may have an impact on CC referral. We aimed to establish any eff ect of 
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hospital changes in service provision outside CC on the referral pattern 
and admissions.
Methods Data from prospectively enrolled urgent patient referrals 
were analysed comparing two periods: before (period 1: 2011/12) and 
after (period 2: 2013) the introduction of H@N. We collected data on 
acute physiological parameters, hospital length of stay, demographic 
and functional status, dependency and comorbidities. STATA was used 
for these preliminary analyses.
Results Comparing the two periods we found no signifi cant 
diff erences in age, gender distribution, degree of acute physiological 
derangement, comorbidities, specialty of origin, time spent in hospital 
prior to referral and grade of referrer. By contrast, the proportion of out-
of-hours referrals greatly increased (from 49.3% to 69.7%) along with 
the proportion of referrals deemed inappropriate for CC (from 37.3% to 
54.8%); the proportion of patients accepted increased only marginally 
(from 46.7 to 50%) in the second period, compared with the fi rst. Neither 
the number of beds available within the critical care department 
(P  =  0.59) nor receiving the referral out of hours (P  =  0.8) infl uenced 
the likelihood of admission. The factors predicting admission to CC 
(functional status, acute physiological derangement) did not diff er 
signifi cantly between the two periods examined. Housebound status 
was consistently found to be an independent predictor of admission 
refusal (OR 0.11, 95% CI 0.05 to 0.23, P <0.001).
Conclusion Decision-making about admission to CC is based mainly on 
the assessment of patients’ functional status. Organisational changes in 
the provision of healthcare services outside CC, such as H@N, have had 
a signifi cant infl uence on CC workload and patterns of referrals.
References
1. ACCCM Guidelines for ICU admission, discharge, and triage. Crit Care Med 
1999, 27:633-638.
2. ATS. Fair allocation of intensive care unit resources. Am J Respir Crit Care 
Med 1997, 156:1282-1301.
3. Tridente A, Chick A, Keep S, Furmanova S, Webber S, Bryden DC: Factors 
aff ecting critical care admission to a UK University Hospital [Poster P508]. 
Presented at 32nd International Symposium on Intensive Care and Emergency 
Medicine; March 19-23 2012; Brussels.
4. Tridente A, Chick A, Keep S, Furmanova S, Webber S, Bryden DC: Functional 
status as a predictor of admission to critical care in acutely unwell patients 
[Abstract 0424]. Presented at 25th Annual Congress of the European Society of 
Intensive Care Medicine; October 13-17 2012; Lisbon.
5. Tridente A, Chick A, Keep S, Furmanova S, Webber S, Bryden DC: Non medical 
factors infl uence likelihood of admission to critical care of acutely unwell 
patients [Abstract A-570-0025-00363]. Presented at 26th Annual Congress of 
the European Society of Intensive Care Medicine; October 5-7 2013; Paris.
P9
Demand versus supply in intensive care: an ever-growing problem
M Tanaka Gutiez, R Ramaiah
East Kent Hospitals University NHS Foundation Trust, Ashford, UK
Critical Care 2014, 18(Suppl 1):P9 (doi: 10.1186/cc13199)
Introduction The demand for intensive care has reached new heights, 
where medical advancement and aging populations have increased 
the proportion of patients with multi comorbidities. Ideally, bed 
occupancy on the ICU should be around 70% whereas beyond 80% has 
been associated with increased mortality. William Harvey Hospital is a 
district general hospital with nine ICU beds where the ICNARC national 
database suggested a consistently high occupancy. The purpose of this 
study was to assess bed occupancy and its impact on service delivery.
Methods Data were collected between 2005 and 2013 to analyse trends 
in ICU bed occupancy, overnight discharges, surgical cancellations, and 
nonclinical transfers. Data were gathered from April 2012 to March 
2013 using quality indicators (Intensive Care Society): readmissions; 
premature discharges; discharges at night; cancelled planned surgery; 
and nonclinical transfers. Regression analysis was conducted to assess: 
correlation between mortality and eff ects of excess occupancy; and 
causality of increasing demand for ICU beds.
Results Bed occupancy remained high between 2005 and 2013 with a 
15% increase. This was associated with increased overnight discharges 
(29%), surgical cancellations (90%), and nonclinical transfers (88%). 
Between 2012 and 2013, the calculated demand for beds was 174. 
There were 1.8 ICU to 100 hospital beds and 4.5 ICU beds per 100,000 
population, which dropped signifi cantly when including regional 
specialty services. A persistent gap between ICU bed supply and 
demand was associated with increased unfavourable outcomes in all 
quality indicators.
Conclusion A steady increase in occupancy over the last 8 years was 
due to multiple factors, including an increase in clinical services such 
as in the coronary care centre, head and neck unit, and trauma centre. 
Presentation of our results to managerial level facilitated increased bed 
capacity by 22%.
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Introduction Physicians have an intense and irregular workday life. 
Thus, they need to use their time for continuing education in the most 
effi  cient way. This presents a major challenge to suppliers of continuing 
study programs. Our online master program Physico-Technical Medicine 
(PTM) addresses working physicians who want to acquire knowledge in 
the fi elds of biomedical engineering and medical physics [1]. We attach 
great importance to the special needs of our participants. Therefore, 
we investigated which general conditions are most important for the 
working physician regarding qualifying continuing education.
Methods The general conditions of our continuing education program 
(PTM) were examined on the basis of evaluation questionnaires. 
Additionally, students were asked in interviews about their demands, 
and they could give anonymous feedback on feedback cards.
Results Flexibility: students appreciated fl exibility regarding time and 
environment of their learning activities. This fl exibility enables the 
students to use even small time frames or traveling times for learning. 
Students can choose their preferred time and place for their learning 
activities. Security in planning: students have to organize their time 
frames for learning besides their daily work, their family life, and 
possibly their academic career. Especially phases of attendance should 
be planned and communicated as early as possible. Transparency of 
structure: participants ask for transparency in terms of the expected 
workload and expenditure of time to plan their studies and get 
focused. Relation to previous knowledge: learning success is supported 
by relating new contents to previous knowledge from the student’s 
fi rst medical degree. Mainly clinical examples illustrate abstract topics, 
which also helps students to recognize the relevance of the content. 
Individual support: students need contact persons in terms of learning 
organization, technical support, and for questions regarding the course 
material.
Conclusion We could show that an extra-occupational continuing 
study program for physicians should be adjusted to their special 
situation and therefore has to comply with particular requirements. As 
such we could identify fi ve main requirements which are continuously 
fulfi lled by the online master program PTM and regularly surveyed by 
evaluations.
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Introduction We examined the extent to which the two generic health-
related quality of life (HRQL) measures recommended for use in adult, 
general critical care [1]  – the SF-36 and EQ-5D  – captured survivors’ 
HRQL, which is important in assessing the eff ectiveness of critical care. 
Unlike other fi elds of healthcare that employ both generic and specifi c 
HRQL measures, most recent studies in critical care have used only 
generic measures, despite uncertainty as to their appropriateness.
Methods A patient-based conceptual framework for survivors’ HRQL 
was built using: a systematic review of the literature; secondary analysis 
of 40 in-depth interviews with adult critical care survivors; and primary 
analysis of in-depth interviews with a maximum variation sample of 25 
white critical care survivors in England. Two methods were then used 
to assess the extent to which the SF-36 and EQ-5D captured their HRQL, 
as detailed in the framework: the content of both instruments was 
examined, alongside data collected from the in-depth interviews; and 
the opinions that survivors expressed about how accurately the SF-36 
and EQ-5D refl ected their ideas on health and HRQL were analysed and 
taken into account.
Results The patient-based framework was in two parts: the fi rst 
covered survivors’ personal status which consisted of their physical 
status, emotional/psychological status and cognitive status; and the 
second comprised nine subdomains aff ected by their personal status. 
The latter were: activities and behaviours; physical zone of comfort 
and/or activity; interactions and relationships with others; perception 
of, interpretation of, and responses to life; personality; external 
appearance; suitability and availability of clothes; place of residence; 
and fi nances. The current generic measures recommended on the basis 
of expert consensus for use with survivors of adult, general critical care 
have substantial gaps in their coverage of this conceptual framework 
for survivors’ HRQL, particularly in relation to their cognitive status and 
its subsequent impact.
Conclusion The two most commonly used generic HRQL measures in 
adult, general critical care have signifi cant gaps in their coverage of 
survivors’ HRQL. Any (new) critical care-specifi c HRQL measure should 
be designed specifi cally to capture the impact of critical illness on 
survivors’ cognitive status and its subsequent eff ects.
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Introduction The aim was to explore the HDU booking process, 
organ support requirements and fi nancial implications as the current 
approach to booking surgical cases for HDU has somewhat been based 
on a ‘just in case’ principle.
Methods The booking and admission details from October 2012 to 
July 2013 were gathered from the HDU log-book and Ward Watcher 
software. The cost of HDU beds and staff  were provided by the fi nance 
department. Data were analysed using MS Excel and SPSS software.
Results There were 105 handwritten bookings over 10 months, several 
missing essential data. Only 89 admissions actually took place; 61 were 
elective, 66 colorectal, six urgent, 19 scheduled and three unspecifi ed 
(Figure 1). Most patients required basic cardiovascular and respiratory 
support (Figure  2). Data revealed 16 cancellations. Each booking 
requires allocated nursing staff  which bears a basic cost of £23/hour 
(estimated annual loss >£10.000). If we add the daily cost of basic 
HDU care (approximately £1,000 for single organ support), the losses 
rise rapidly. We also registered 38 days in delayed discharges. This was 
predominantly due to ward bed shortages. In fi nancial terms there is at 
least £500/day diff erence between surgical and HDU (potential annual 
loss >£22,000). In addition there were 13 patients who spent a total of 
37 days on the HDU but did not require an HDU level of care.
Conclusion The currently limited resource is not being utilised 
eff ectively with implications on both staff  deployment and fi nances. A 
more holistic approach is needed where all requests are reviewed by 
a consultant anaesthetist in conjunction with preadmission data. This 
could better identify patients for HDU care and potentially decrease 
cancellations. We have developed an improved booking form for this 
purpose.
P13
Convalescence via critical care collaboration
C Shute, A Saayman
University Hospital Wales, Cardiff , UK
Critical Care 2014, 18(Suppl 1):P13 (doi: 10.1186/cc13203)
Introduction A collaborative approach to patient management has 
been shown to improve patient outcomes. In a resource-limited NHS, 
critical care beds are at a premium, therefore preventing unnecessary 
admissions by optimising ward-based management is essential. The 
objective of this service quality improvement project was to improve 
collaboration between the critical care directorate and neurosurgical 
high care unit at a tertiary university teaching hospital. We proposed 
that the use of a simple ward round tool on collaborative rounds would 
facilitate systematic patient review, prompt early recognition of those 
critically unwell and improve patient outcomes.
Methods An initial observation period of behaviours and practice on 
the neurosurgical unit was conducted with qualitative and quantitative 
data collection. Following analysis of these outcome measures a 
simple ward round tool was constructed, with the mnemonic ‘DON’T 
FORGET’, and we devised a programme for collaborative ward rounds 
to take place three times per week over a 1-month period. During this 
Figure 1 (abstract P12). Admissions per speciality.
Figure 2 (abstract P12). Organ support requirements.
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time further data were collected to assess whether our interventions 
resulted in modifi ed behaviours and to document the number of 
changes made to patient management as a consequence of the 
collaborative approach to care.
Results Our results showed that improvements were made in all 
assessed domains. Consultant-led ward rounds increased, attendance 
by members of the multidisciplinary team (MDT) dramatically 
improved and as a result MDT discussion was enhanced. In addition, 
documentation of structured plans improved and review of prescription 
charts signifi cantly increased. As a consequence of collaborative 
rounds, a total of 343 changes were made to patient management 
under the domains of the ward round tool. This was an average of 21.4 
changes per collaborative round, with most changes being made to 
medication charts or decisions regarding thromboprophylaxis.
Conclusion The use of a simple ward round tool combined with a 
collaborative approach to ward rounds improved MDT involvement and 
discussion, promoted structured patient review and resulted in positive 
changes to multiple areas of patient management. In conclusion, 
structured collaborative rounds result in signifi cant changes to patient 
management that may prevent admission, or readmission, to critical 
care which has the potential to reduce healthcare costs and morbidity.
P14
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Hospital, Kolding, Denmark; 3Danish Building Research Institute/Aalborg 
University, Copenhagen, Denmark
Critical Care 2014, 18(Suppl 1):P14 (doi: 10.1186/cc13204)
Introduction Hospital lighting may cause disruption in the circadian 
rhythm, partly due to suppression of melatonin production. This may 
create sleep diffi  culties and delirium for ICU patients and health issues 
such as fatigue, poor sleep quality and chronic diseases for ICU staff . 
Dynamic RGB coloured light which changes colour and intensity in 
correlation with the time of day has been installed in a Danish ICU, 
aiming to create lighting conditions being close to daylight variations 
and supporting patient and staff  rhythms. As the eff ect of dynamic 
light on patients may be biased by illness, organ failure, and so forth, 
the aim was to examine the infl uence of dynamic light on ICU nurses’ 
melatonin production, quality of sleep, and well-being.
Methods An intervention study examining the impact of dynamic light 
regarding the impact on the circadian rhythm (measured by melatonin 
profi les from saliva samples), quality of sleep (sleep effi  ciency, number 
of awakenings and subjective assessment of sleep; measured by sleep 
monitors and sleep diary), and subjective experiences of well-being, 
health, and sleep quality (measured by a questionnaire survey). Results 
from the intervention group were compared with a control group of 
nurses from a similar ICU without dynamic light. Light conditions were 
documented by measurements. Data collection was from February to 
May 2013.
Results A total of 55 nurses (89%) from the intervention ICU (ICU1) and 
58 nurses (88%) from the control ICU (ICU2) participated. No signifi cant 
diff erences were found between the two groups regarding personal 
characteristics. The nurses from ICU1 described their work light as 
comfortable, relaxing and natural compared with artifi cial, institutional 
and gloomy in ICU2. Preliminary analyses did not shown any signifi cant 
diff erences in melatonin level. During a 10-day period, the nurses from 
ICU2 assessed their actual sleep as less eff ective (OR 2.17; P = 0.03) and 
felt less rested (OR 1.89; P = 0.006) compared with nurses from ICU1. 
The nurses in ICU2 had 16% more awakenings (P = 0.05) during sleep, 
but there were no signifi cant diff erences in duration of awakenings or 
in total sleep effi  ciency between the two groups.
Conclusion Most participants from the intervention ICU found the 
dynamic light agreeable and assessed their sleep more positively than 
participants from the control ICU. No signifi cant diff erences were found 
between monitored sleep effi  ciency and melatonin level.
P15
Targeting blood tests in the ICU may lead to a signifi cant cost 
reduction
R Gray, F Baldwin
BSUH, Brighton, UK
Critical Care 2014, 18(Suppl 1):P15 (doi: 10.1186/cc13205)
Introduction Daily blood tests are an essential diagnostic tool and 
routine practice in the management of ICU patients, but are associated 
with cost and a risk of anaemia. There is no evidence for the frequency 
or breadth of blood testing but there is evidence that by rationalising 
blood tests, signifi cant cost saving can be made without a negative 
eff ect on mortality or length of ICU stay [1]. Blood tests in our ICU are 
requested by nurses, this is a unique practice to the ICU compared with 
other hospital departments.
Methods We had previously carried out a survey to assess blood 
requesting practise in UK ICUs. This demonstrated that routine tests 
were, as in our ICU, nurse led and the majority of staff  underestimated 
the costs of tests. Using the results of this survey and a literature review 
we developed routine blood test guidelines for our general mixed 26-
bed ICU/HDU. Following a period of staff  education, we audited our 
blood requesting practice over 28 days.
Results Our blood testing did not comply with our guidelines. Over the 
28-day period, €12,849.96 was spent on all blood tests. According to 
our guidelines, €2,914.96 was spent on inappropriate tests (€37,998.63 
per year) (Table 1). Over 40% of this cost was spent on the coagulation 
screen.
Table 1 (abstract P15)
 Number of 28-day cost Annual cost
Test inappropriate requests (€) (€)
Full blood count 4 21.82 284.44
Urea and electrolytes 6 29.44 383.77
Liver function tests 95 583.18 7,602.1
Coagulation screen 117 1,276.86 16,644.78
C-reactive protein 45 245.55 3,200.91
Bone profi le 112 274.75 3,581.56
Magnesium 88 483.35 6,300.81
Conclusion In our ICU, unnecessary blood tests have a signifi cant 
cost burden of approximately €38,000 per year. To limit unnecessary 
costs, consultants now lead requesting by completing a blood test pro 
forma on the evening ICU ward round indicating which blood tests are 
clinically needed the following day.
Reference
1. Seguin P, et al.: Intensive Care Med 2002, 28:332-335.
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Analysis of the acoustic environment in an ICU using patient 
information as a covariate
M Park1, P Vos2, A Kohlrausch1, B Vlaskamp1, AW Oldenbeuving2
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Critical Care 2014, 18(Suppl 1):P16 (doi: 10.1186/cc13206)
Introduction Noise levels in ICUs are often very high, potentially 
aff ecting patient health outcome, which are also considered to be 
among the risk factors contributing to ICU delirium [1]. In the current 
study, multivariate linear regression models were established to relate 
the acoustic data to the indicators of patient status.
Methods Acoustic measurements were taken in eight single-bed 
patient rooms in a level 3 ICU, while patient information was also 
collected, including APACHE IV score and mortality rate together 
with other potentially relevant variables; for example, the usage of 
mechanical ventilators, and so on. The hourly and daily trends of the 
acoustic data were obtained, and an analysis of variance was carried 
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out to investigate the eff ect of relevant factors (for example, the time of 
day). Furthermore, multiple linear regression models were established 
to relate the diff erent types of patient-related data (as independent 
variables) to each type of the acoustic data (as dependent variable), 
where independent variables were selected based on an exhaustive 
search method.
Results Data were collected for 3 months for 106 patients. The 24-hour 
trends of acoustic parameters corresponded well to the daily routine 
events in the ICU. The analyses for the fi rst 4 days of the patients’ ICU stay 
showed that the average SPL varied depending on the day (P = 0.023) 
and on the time of the day (day/night) (P <0.001). The average noise 
level decreased from day  1 to day  2 with a signifi cant reduction at 
night (P = 0.008), but it was found to rebound from day 2 where the 
increase of the daytime noise level from day 2 to day 4 was signifi cant 
(P  =  0.005). The results of the multiple linear regression showed that 
various patient conditions infl uenced diff erent types of noise-level 
parameters. For example, the location of the patient room, the usage of 
mechanical ventilators and the mortality rate were found to correlate 
to the 10th-percentile SPL (L90) in the fi rst 48 hours (adjusted R2 = 0.58; 
P <0.001). Also, the room location, gender and the usage of mechanical 
ventilators were found to be related to the 50th-percentile SPL (L50) in 
the same period (adjusted R2 = 0.54; P <0.001).
Conclusion Noise-level parameters were found to vary depending 
on the day of ICU stay, the time of day, and other indicators of the 
patient’s status. For a rigorous analysis of the infl uence of noise on 
patients’ outcome, the eff ects of these factors must fi rst be controlled 
or corrected.
Reference
1. Van Rompaey et al.: Crit Care 2012, 16:R73.
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Introduction Sepsis has high incidence around the world, approximately 
400,000 new cases occur annually in Brazil. In developing countries, 
it is still an important cause of death due to poor adherence to best-
practice medicine protocols. The Brazilian mortality rate of septic shock 
is around 60%. The aim of this study is to describe the initial results 
for the implementation of the Brazilian initiative of a Telemedicine 
(TM) Project for therapeutic support of septic patients in a community 
hospital in São Paulo, Brazil.
Methods Since May 2012, a TM Program has been implemented at 
two hospitals in São Paulo  – Hospital Municipal Dr. Moysés Deutsch 
(HMMD), a public, secondary hospital, and Hospital Israelita Albert 
Einstein (HIAE), a tertiary private philanthropic entity  – due to a 
partnership with Brazilian Health Ministry. A TM Central Command was 
located at HIAE with Endpoint 97 MXP Cisco® Solution and Medigraf 
Gowireless® technology. Mobile Intern MXP ISDN/IP Cisco® and 
Medigraf Gowireless® for the remote hospital (HMMD) via a dedicated 
connection. At HMMD, the sepsis protocol, based on the Surviving 
Sepsis Campaign, has been started for every recruited patient admitted 
to the emergency department (ED) or the ICU, and assessed by the 
Central Command through TM with an experienced consultant of HIAE. 
We compared the results of this group of patients with the group of 
patients with diagnosis of severe sepsis and septic shock, admitted to 
HMMD during 2011, who were not assisted with TM resources.
Results From January to December 2011, 283 septic patients 
were treated at HMMD, 161 (56.8%) patients were male, mean age 
was 53.7  years and the hospital mortality was 65.3%. After the 
implementation of the TM Program, 189 septic patients were admitted 
to the hospital and evaluated by skilled doctors of HIAE via TM, with the 
institution of the Surviving Sepsis Campaign protocol. In total, 68.9% of 
the consultations originated from the ICU and 31.1% from the ED; 111 
patients were male (58.4%), mean age was 54.1 years and the hospital 
mortality was 32.9% (P <0.05).
Conclusion Use of the TM Program for the implementation of 
the Surviving Sepsis Campaign Protocol at a community Brazilian 
hospital improved compliance with recommended care bundles and 
signifi cantly decreased the hospital mortality of septic patients.
P18
ICU nursing connectivity and the quality of care in an academic 
medical center: a network analysis
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Introduction A collaborative nurse work environment is associated 
with ICU quality, yet collaborative interaction is diffi  cult to measure. 
Network analysis may be an innovative tool to measure interactions. 
We sought to determine the feasibility of network analysis to measure 
ICU nurse connectivity and test whether key network measures were 
associated with the ICU quality of care.
Methods We performed a network analysis in eight ICUs within an 
urban academic medical center in the United States during 2011. 
Using scheduling data, we defi ned network ties as instances when 
two ICU nurses worked together in the same ICU for 4 hours or more. 
We examined each ICU’s network by visualizing sociograms and by 
measuring two network properties: density and clustering. Density 
measures the cohesion within a network on a scale from 0 to 100, with 
a higher score indicating more cohesion. Clustering assesses the local 
neighborhoods on a scale from 0 to 100, with a higher score indicating 
a more decentralized network. We examined variation in network 
measures across ICUs and tested the correlation between network 
measures and the proportion of patients receiving daily interruption 
of sedation (DIS).
Results There was wide variation in the networks, with density ranging 
from 79 to 96 and clustering ranging from 88 to 97. Two sample 
sociograms are shown in Figure 1: ICU A had a very high density (96) 
and clustering coeffi  cient (97) suggesting a cohesive and decentralized 
network, contrasting with ICU H that had the lowest density (79) and 
clustering coeffi  cient (88). Greater density and clustering was positively 
associated with DIS (B = 0.02 (–0.10, 0.14); B = 0.003 (–0.07, 0.07)) but 
did not achieve statistical signifi cance in our small sample.
Conclusion We found substantial variation in ICU nursing networks 
across eight ICUs in one academic medical center. These patterns may 
have implications for evidence-based practice implementation. More 
work is needed to understand the role of network analysis as a reliable 
tool for improving and understanding ICU organization.
P19
Compassion fatigue and burnout among healthcare professionals 
in the ICU
M Van Mol1, E Kompanje1, J Bakker1, M Nijkamp2
1Erasmus MC, Rotterdam, the Netherlands; 2Open University, Heerlen, the 
Netherlands
Critical Care 2014, 18(Suppl 1):P19 (doi: 10.1186/cc13209)
Introduction This study comprises a systematic review of studies 
focusing on the prevalence of compassion fatigue (CF) and burnout 
Figure 1 (abstract P18). Sociograms of ICU A and ICU H.
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(BO) among professionals in the ICU, to indicate the size of this 
problem. Both CF and BO have an important impact on daily quality of 
life of professionals and may threaten patient care. A growing body of 
research suggests that BO appears to be common among ICU nurses [1] 
and physicians [2] due to a highly stressful work environment. However, 
BO might be overestimated and seen as a fashionable diagnosis [3]. The 
overlap of BO with CF, secondary traumatic stress (STS) and vicarious 
traumatisation has recently been explored [4]; CF seems to apply more 
to ICU staff  and might be a lead in future preventive strategies.
Methods A review of the literature between 1998 and December 2013 
was conducted using eight databases, and included the keywords CF, 
STS, BO, ICU, nurses and physicians. The references were screened for 
relevancy at title/abstract using predefi ned inclusion and exclusion 
criteria. Studies were limited to original and review articles in the English 
language. Two independent researchers assessed the methodological 
soundness of each article.
Results All references, retrieved from electronically database search (n = 
1,432) and manual search (n = 3), resulted in 100 relevant publications 
for full-text screening. Subsequently, articles with only an abstract 
available (n = 28), a language barrier (n = 27), or prevalence not shown 
in percentages (n = 23) were removed. Finally, a sample of 22 eligible 
articles were appraised as methodologically sound and systematically 
analysed for this review. The prevalence of BO in the ICU varied from 
1.2 to 49% and diff ered in defi ning a severe BO. Two studies reported 
the prevalence of CF, 7.3% and 40%, and fi ve studies described the 
prevalence of STS in a range from 21 to 44%.
Conclusion The emotional price of working at the ICU can become a 
burden in personal life, but the size of the problem in ICU staff  remains 
unclear. Because the decreased well-being of the professionals might 
negatively infl uence the quality of care, preventive strategies should be 
developed in order to alleviate the distressed. Further exploration of CF 
might provide suffi  cient starting points.
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Introduction There is an actual discussion about the best way to 
provide medical care for critically ill patients, particularly between 
the classical opened versus closed ICU models [1,2]. In Brazil, all ICUs 
have to have a full-time and dedicated physician at the unit but the 
primary physician also can visit his patient every day and, most of the 
time, participates in the patient’s care plan. This hybrid model creates 
opportunity for patient’s care plan divergences between the ICU staff  
and the primary physician. The objective of this study is to evaluate 
the eff ect of divergences about patient’s care plan on the outcome of 
critically ill patients.
Methods A prospective court study was conducted (from January 
to May 2013) to point out the patient’s care divergences (blood 
transfusion, diuretics, antibiotics, vasopressors, mechanical ventilation, 
and so forth) that happened in the fi rst 72 hours of ICU admission in a 
30-bed adult Brazilian ICU. We enrolled only patients that stayed more 
than 48 hours in the ICU.
Results In a court of 357 patients at least one divergence between the 
ICU medical staff  and the primary(s) physician(s) were identifi ed in 31 
cases (8.6%  – divergence group (DG)). The age (67.9  years), gender 
(55.2% of male), SAPS3 score (45.7) and reasons for ICU admission 
(emergency surgery 7.6%, nonemergency surgery 30%, clinical 62.4%) 
were similar in DG and nondivergence (NDG); however, the ICU length 
of stay (6.2 vs. 3.9  days, P  =  0.023), use of mechanical ventilation 
(48.4% vs. 27%, P = 0.012), vasopressors (77.4% vs. 46%, P = 0.001) and 
blood transfusion (41.9% vs. 27.6%, P = 0.073) were higher in the DG 
compared with NDG. Discordance was associated with higher ICU and 
hospital mortality (35.5 vs. 11%; OR = 4.09; P <0.001 and 45.2 vs. 20.1%; 
OR = 2.77; P = 0.02 respectively).
Conclusion The occurrence of divergences, even during the fi rst days 
of ICU admission, about medical plans of care for critically ill patients is 
frequent and is associated with higher ICU and hospital mortality and 
more use of medical resources.
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Introduction The ICU is a stressful place with several sources of confl icts. 
Among ICU workers, confl icts lead to burnout, loss of psychological 
well-being, and deterioration of the work performance. Intra-team 
confl icts (confl icts that occur among members of the intensive care 
team) are one of the most frequent types of confl icts in the ICU. The 
objectives of this study were to determine the prevalence, risk factors 
and consequences associated with intra-team confl icts in the ICU.
Methods A survey was conducted in 12 Uruguayan adult ICUs in 2009. 
ICUs and clinician’s characteristics were assessed for their association 
with the prevalence of confl icts. All factors associated with confl icts 
were introduced into a multivariable model.
Results A total of 384 questionnaires were collected, 74.5% (n = 286) 
were nurses and 23.2% (n = 89) were intensivists. From the 384 forms, 
45.8% perceived at least one confl ict in the past year. Confl icts were 
perceived more frequently by intensivists (61.8%) than nurses (40.9%) 
(P = 0.001). A worse relationship with intensivists (OR 1.3; 95% CI 1.09 
to 1.59; P = 0.004) is independently associated with confl icts. However, 
lower grade of irritability (OR 0.8, 95% CI 0.73 to 0.97; P = 0.01) and a 
higher position in the ICU (OR 0.57 95% CI 0.36 to 0.92; P = 0.02) are 
factors independently associated with a lower incidence of intra-team 
confl icts. Interestingly, this study confi rms that workers with at least 
one confl ict had more frequently: libido disturbances (56% vs. 40%; 
P = 0.002), eating problems (52% vs. 40%; P = 0.02), as well as the wish 
to leave the ICU (53% vs. 39%; P = 0.005).
Conclusion The prevalence of confl icts is very high among ICU workers 
in Uruguay. We have identifi ed diff erent risk factors associated with the 
development of confl icts. These results confi rm previous fi ndings and 
highlights that strategies to decrease intra-team confl icts in the ICU are 
urgently warranted.
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Hospital Moinhos de Vento, Porto Alegre, Brazil
Critical Care 2014, 18(Suppl 1):P22 (doi: 10.1186/cc13212)
Introduction The Therapeutic Intervention Scoring System (TISS-28) 
quantifi es the type and number of intensive care treatments; therefore, 
it indicates the workload of ICU and may be used for calculating costs 
[1]. A previous cohort study [2] demonstrated that seriously ill older 
patients receive fewer invasive procedures and less resource-intensive 
hospital care, showing a preferential allocation of hospital services to 
younger patients regardless of severity of illness. The objective of this 
study is also to compare resource utilization across diff erent ages of 
critically ill patients in an open model, mixed ICU.
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Methods During 7  years (2007 to 2013), TISS-28 was prospectively 
applied to all consecutive adult critically ill patients at 24 and 72 hours 
of ICU admission in a private hospital in Brazil. Demographic data, 
diagnoses on admission, comorbidities, ICU length of stay and mortality 
were recorded. Patients were stratifi ed according to their ages.
Results TISS-28 scores at 24 and 72  hours of ICU admission were 
analyzed for 4,128 patients. Mean patient age was 68.3 (SD  ±  17.6), 
46.8% were female and 37% were surgically ill. The mean APACHE II 
score was 16 (SD ± 8) and 40% were submitted to mechanical ventilation 
at any time of the stay. Overall mortality was 14.4%. Neither APACHE 
II score adjusted for age nor TISS-28 in 24 and 72 hours of admission 
diff ers among age groups. However, mortality was signifi cantly higher 
in patients aged 70 years or older (P <0.001).
Conclusion Mortality remained higher in older patients despite an 
absence of age-related diff erences in resource use at ICU. Comparing 
our results to a previous prospective cohort study [2], we emphasize the 
lower overall mortality of our population (14.4% vs. 50%). Limitations of 
our analysis include our unicenter design and lack of data for a closed 
model ICU.
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Introduction ICU visits are generally limited to 2  hours per day 
selected at any time during the 24 hours. At our institution we abide 
to the international regulations which were recently modifi ed allowing 
family members and signifi cant others to be present throughout 
the day accompanying their ICU-admitted relatives, participating in 
an uninterrupted timely fashion and no time limits with their daily 
activities.
Methods From January 2012 through April 2012, 200 questionnaires 
were fi lled by families of ICU-admitted patients; each questionnaire 
includes 13 questions concerning their overall degree of satisfaction 
at our unit and evaluating the quality. Accommodating spaces were 
off ered for families of ICU patients, off ering them a state of freedom 
within the ICU premises surrounding their beloved sick relatives; 
additionally they were constantly advised by a designated secretary to 
share their experience and any possible insight to improve the overall 
polity of our service.
Results Two hundred patients were included in the study, the average 
age of patients was 68.55 years and the average length of ICU stay was 
5.2 days. Most family (85%) desired their presence accompanying their 
related patients within the ICU premises when meals were served. 
Those families expressed satisfaction while off ering psychological 
support to their beloved ill ones. Fifteen per cent of the families argued 
about the permitted number of visitors (one person) per visit and 
12% addressed lack of communication between the medical staff  and 
patient’s families.
Conclusion Compared with the limited visit status within the ICU ward 
in the past, the majority of families expressed general acceptance 
and satisfaction toward the newly adopted policy. Additionally and 
by this new policy, patients displayed marked improvement at the 
psychological level, being more cooperative and experiencing less 
episodes of agitation. Even the medical team elaborated their interest 
towards this policy as being a more profound and comprehensive way 
of supporting the ICU patients. Further investigations are currently 
being employed to strengthen the outcome of the study.
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Introduction Studies have shown that communication in the ICU 
is related to the cultural background of all involved actors. As a 
consequence, hospitals in multiethnic areas in western countries are 
currently forced to rethink their models of communication as they are 
increasingly transformed into spaces of cultural encounter. During this 
process one needs to be aware of the cultural diff erences in attitudes 
and experiences towards communication in critical medical situations. 
However, the growing academic interest in intercultural relations 
in the critical care has not yet led to the construction of cumulative 
knowledge. The aim of this study is to review the experiences of the 
involved actors, namely the care providers, the patients and their family 
members, with cultural diversity during the process of communication 
and decision-making in the ICU.
Methods A literature review was conducted. PubMed was searched. 
The following combinations of Mesh terms were used: [(decision-
making) OR (communication)] AND (intensive care) OR (intensive care 
units)] AND [(cultural diversity) OR (multiculturalism) OR (migrants) 
OR (culture) OR (ethnicity)]. A total of 111 studies were retrieved. We 
excluded nonempirical studies, studies not written in English and 
articles published before 2003. After screening the titles and abstracts 
12 articles were selected. The full text of these articles was analyzed 
and synthesized with a thematic-synthesis approach. During the 
process we performed additional searches based on the bibliographies 
of all the relevant articles.
Results Culturally specifi c expectations about communication and 
decision-making, diff erent views on gender roles, organization of the 
care and expression and resolving emotional and social crises may 
cause extra stress. The communication becomes more complex when 
the language of the care providers diff ers from the language of the 
patient and family. Intercultural communication can be improved by 
specifi c actions such as ethnic matching, using an interpreter and the 
formation of cultural-competent healthcare professionals.
Conclusion There is a lack of knowledge regarding the specifi c 
experiences of patients, families and care providers with communi-
cation and especially decision-making in multicultural ICUs in Western 
Europe.
P25
Symptoms of anxiety, depression and post-traumatic stress in pairs 
of patients and their family members during and following ICU stay: 
who suff ers most?
R Fumis1, O Ranzani2, P Martins1, G Schettino1
1Hospital Sírio Libabês, São Paulo, Brazil; 2Hospital das Clínicas, Universidade 
de São Paulo, Brazil
Critical Care 2014, 18(Suppl 1):P25 (doi: 10.1186/cc13215)
Introduction To compare the incidence of anxiety, depression and 
post-traumatic stress symptoms in pairs of patients and respective 
family members during the ICU stay and at 30 and 90 days post ICU 
discharge. According to the literature, both patients and family 
members suff er from psychological distress during and following an 
ICU stay [1]. Although these issues have been discussed, to date few 
studies have addressed the pairs at three times.
Methods A prospective study conducted in a 22-bed adult general 
ICU including patients staying >48  hours. The Hospital Anxiety and 
Depression Scale (HADS) was completed by pairs (patients/respective 
family members). They were interviewed by telephone at 30 and 
90  days after ICU discharge with the Impact of Event Scale (IES) and 
the HADS. We separated them into three diff erent groups (patients – 
group A, family member of patient who survived – group B and family 
member of patient who deceased – group C).
Results A total of 184 pairs were interviewed at the ICU. Mean 
patient age was 59.33  ±  15.5  years. The admission SAPS III was 
47.6 ± 15.7 points. Median ICU LOS was 4 days (2 to 47). Family’s age 
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was 51.79 ± 13.47 and 64% were spouses. Patients had symptoms of 
anxiety (26.1%), depression (12%) or both (8.7%) during the ICU stay. 
Regarding family members, the incidence of anxiety, depression or 
both during the ICU was 33.2%, 9.8% and 8.2% respectively. Symptoms 
of PTSD within patients were found in 6.9% at 30 days and disappeared 
at 90 days. Diff erently, these symptoms in family members were found 
in 6.2% at 30 days and 9.0% at 90 days. There was a positive correlation 
between HADS at ICU and IES at 30 days for family members (r = 0.527, 
P <0.001). The HADS score over time between patients, family members 
of patients who deceased and who survived were diff erent (P = 0.002). 
In post-hoc analysis, group A presented less symptoms than group C at 
30 days (P = 0.001) and less than groups B and C at 90 days (P <0.001 
for both). At 90  days, group B showed less symptoms than group C 
(P = 0.039).
Conclusion Family members of ICU patients suff er more than the 
patients principally when their loved one died. Patients’ symptoms 
of anxiety, depression and PTSD decrease with time but in family 
members these symptoms continue along the 90 days.
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Introduction A series of studies have shown an association between the 
ICU environment and symptoms of psychological distress in critically ill 
patients’ relatives [1-3]. The aim of this study was to investigate the risk 
of cardiophobia and panic attack crisis on ICU patients’ family members.
Methods In the period from March 2012 to July 2013, we studied 223 
family members (81 men and 142 women, mean age 41.5 ± 11.0 years) 
of critically ill patients. These patients were admitted to the intensive 
care department with various medical and surgical conditions (147 
patients, 103 men and 44 women, mean age 58.3  ±  18.6  years). We 
used a questionnaire in which were included: social–demographic 
characteristics of the patients’ family environment, and the Cardiac 
Anxiety Questionnaire (CAQ). The results from the CAQ [4] were 
compared with those of the general population of Greece (GGP).
Results In comparison with the general Greek population, the relatives 
of critically ill patients demonstrate statistically signifi cant higher scores 
(P <0.001) on the scales of fear and anxiety in regards of thoracic and 
heart sensations (1.1 ± 0.9 vs. 0.9 ± 0.9 in GGP), avoidance of activities 
considered to reproduce cardiac symptoms (1.3 ± 1.0 vs. 1.1 ± 0.9 in 
GGP), heart-focused attention and self-monitoring of cardiac activity 
(0.9  ±  0.7 vs. 0.7  ±  0.6 in GGP), and at total CAQ score (1.1  ±  0.6 vs. 
0.9 ± 0.6 in GGP). Analysis of variance among family members on heart-
focused attention and self-monitoring of cardiac activity showed that 
hospitalization provoked heart-focused attention (that is, the main 
factor of perceived panic crisis risk). In accordance with the Bonferroni 
criterion, we found that patients’ siblings demonstrated statistically 
signifi cant diff erence compared with patients’ children (P = 0.015), with 
the latter showing lower levels of heart-focused attention and self-
monitoring of cardiac activity. Further MANCOVA analysis showed a 
statistically signifi cant correlation between age and cardiophobia, and 
also between education level and heart-focused anxiety (P = 0.041 and 
P = 0.044 respectively).
Conclusion The hospitalization of a patient in the ICU is considered to 
be a factor that is aff ecting the mental health of patients’ relatives. Our 
results highlight a risk for psychologically induced symptoms on ICU 
relatives and underline the need for a psychosocial support system for 
them. The cardiophobia and self-monitoring of heart activity which 
infl icts the patients’ relatives appears to be more intense in the siblings, 
parents and partners of patients.
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Introduction The aim of the study was to prospectively assess family 
satisfaction in the intensive care setting and identify fi elds of possible 
improvement.
Methods The study was performed over a 6-month period in a 10-bed 
ICU. A properly translated and validated Family Satisfaction in the ICU 
(FS-ICU 24) questionnaire was used. A total of 126 questionnaires were 
handed out to family members upon patient discharge. The number of 
questionnaires returned for evaluation was 120 (91.5% participation). 
Five-point Likert scale responses were transformed to percentage 
scores, higher values representing better satisfaction.
Results Overall satisfaction with care was reported as very good or 
excellent by 81% of family members (32% and 49% respectively) both 
for ICU staff  concern and caring as well as symptom management. 
Favorable scores were also noted in terms of decision-making, 89% of 
relatives reporting very good and excellent rates as regards information 
needs. On the other hand, most of the family members (73%) felt 
neither included nor excluded from the decision-making process. 
Moreover, a small number of them (6%) answered that they received 
poor emotional support. Finally, the frequency of communication with 
ICU nurses and the atmosphere in the waiting room were noted as fair 
by 28% and 47% of subjects respectively.
Conclusion Most family members were highly satisfi ed with ICU 
care their patients received. Nevertheless, our study showed that 
the fi elds of communication with the nurses as well as the waiting 
room atmosphere defi nitely need further improvement. Concerning 
emotional support and decision-making, the study revealed that 
currently used measures in our ICU still do not apply to all families and 
probably require a few changes.
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Introduction Patient satisfaction is a key determinant of the quality 
of care within the hospital environment. Critically ill patients often 
lack capacity. Under such circumstances, family members are often 
main decision-makers and their satisfaction about the ICU experience 
resembles an important surrogate in evaluating the quality of care. We 
aimed to measure family satisfaction with diff erent aspects of medical 
care.
Methods In February 2013, surveys, including 24 qualitative questions, 
were sent out to relatives of 50 patients 1 month after their discharge 
from ICU St George’s, UK. Responses were graded 1 to 5, with higher 
values representing a greater degree of satisfaction.
Results Most respondents were satisfi ed with the overall performance 
and the respect received (mean  ±  SD score 4.7  ±  0.68). Skills and 
competency of doctors (4.38  ±  0.67) and nurses (4.57  ±  0.68) was 
also perceived very positive. However, family satisfaction with 
communication with doctors (3.52  ±  1.47) and nurses (3.71  ±  0.96), 
as well as inclusion in decision-making (3.39  ±  1.24), resulted in 
somewhat lower scores. In particular, ease, clarity, consistency, 
honesty, and completeness of information given by doctors resulted in 
inhomogeneous perceptions between relatives (Figure 1). Additionally, 
the majority of responders felt only moderately satisfi ed with time and 
support to make a decision.
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Conclusion In general, relatives felt very satisfi ed with the ICU, 
especially with the care of the patients and the professional workforce. 
The complete decision-making process was rated moderately good, 
which highlights some areas of improvement in involving relatives in 
the care of their beloved by providing regular, clear, easy to understand 
and consistent information.
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Introduction Patients with acute respiratory distress syndrome (ARDS) 
have a high mortality rate. Whether this excess mortality is contributed 
by ARDS or is a consequence of prolonged mechanical ventilation is 
unclear.
Methods A longitudinal retrospective study focusing on noncardiac 
ICU patients who required mechanical ventilation. Patients were 
classifi ed as having ARDS on admission, late-onset ARDS or no ARDS. 
The analysis included patients ventilated for longer than 48  hours. 
Primary outcomes were mortality at 28 days, 1 year and 2 years from 
ICU admission.
Results A total of 1,396 patients were enrolled between 2001 and 
2008: 485 (34.7%) had ARDS on admission (early-onset ARDS), 219 
(15.6%) developed ARDS during their ICU stay (late-onset ARDS) and 
692 (49.5%) did not meet ARDS criteria prior to ICU discharge or death. 
Twenty-eight-day mortality rates were 23.7%, 25.6% and 25.7% for 
early, late and non-ARDS respectively. After adjusting for age, weight 
on admission, unit of admission (MICU vs. SICU), severity of disease 
score, comorbidity score, and primary diagnosis on admission, and 
mortality risk at 28  days, 1  year and 2  years were not signifi cantly 
diff erent between the three study groups. Neither severity of ARDS 
or timing of ARDS (early versus late) was associated with mortality. 
Sensitivity analysis, analyzing all ventilated patients, including those 
who were ventilated less than 48 hours, showed the same results.
Conclusion Neither the presence of ARDS or the severity or timing 
contribute independently to the short and long mortality risk after 
adjustment for age, severity of disease, comorbidity score and 
diagnosis on presentation in patients hospitalized in a noncardiac ICU 
with acute respiratory failure.
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Introduction Signifi cant improvements in chemotherapy, haemato-
poietic stem cell transplantation and general intensive care mean 
that more patients are now living longer and often present to the 
ICU at various stages of their disease [1,2]. Encouraging patients with 
haematological malignancy (HM) to express their wishes and values 
on end of life (EoL) prior to ICU admission would ensure that their 
autonomy is respected. The aim of our study was to determine whether 
patients with HM that were admitted and died in the ICU had any form 
of advance care planning (ACP) documented prior to their admission.
Methods Data were collected on all adult patients with HM that were 
admitted and died in the ICU of a tertiary haematology referral centre 
in London during the period of 1 year.
Results Information was collected for 34 patients and their charac-
teristics are shown in Table 1. In 62% of the patients EoL decisions were 
made, and do-not-attempt-resuscitation documentation was found 
in 65% of the cases. Documentation on information exchange, and 
participation in the deliberation or the decision-making process was 
found in only 30% of the patients, even though more than 75% of the 
haematology physicians estimated the prognosis of these patients as 
moderate (17%) or poor (59%). In the vast majority of cases (31/34) the 
deaths occurred after withholding or withdrawal of treatment in ICU.
Table 1 (abstract P30). Patient characteristics
Mean age  30
Median APACHE II score 26
>3 organ support 60%
Leukaemias >50%
Conclusion Only a small number of patients with HM that die in the 
ICU have documented ACP prior to admission. Since the majority of 
ICU patients lack personal decision-making capacity, ACP would ensure 
that care is consistent with patients’ wishes, EoL actions are congruent 
with their values, the burden on family and healthcare providers is 
alleviated and cost is decreased.
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Introduction Perceived futility of care may jeopardize patient quality 
of care and increase ICU staff  turnover. It is related to workload and 
interdisciplinary collaboration. Our aim was to evaluate concepts 
from team science, namely inclusive leadership (a style that invites 
and appreciates others’ contributions) and psychological safety (a key 
antecedent of speaking up and learning behavior), and to determine 
their eff ect on perceived futility and intention to quit.
Methods A staff  survey in four interdisciplinary ICUs and two 
intermediate care units of two tertiary care hospitals. The questionnaire 
contained validated scales to assess inclusive leadership of head nurses 
and attending physicians, nurse–physician collaboration, collaborative 
Figure 1 (abstract P28). Team performance.
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decision-making, psychological safety, workload, intention to quit and 
a newly developed scale for perceived futile care. English questions 
were translated into German by state-of-the art forward and backward 
translations. Reliability  – that is, internal consistency and inter-rater 
reliability of scales – was evaluated. Predictors of perceived futile care 
and intention to quit were identifi ed by multiple regressions.
Results A total of 220 nurses and 55 physicians participated. Scales 
showed good reliability with all Cronbach’s alpha ≥0.8 and signifi cant 
between unit variability (all P ≤0.011). On a scale from 0 (‘never’) to 5 
(‘very often’), ICU staff  rated frequency of futile care as median 3.6 (IQR: 
3 to 4). On a seven-point Likert scale with 7 denoting maximal values, 
intention to quit was rated as 2.3 (1 to 4). Nurses gave signifi cantly 
lower ratings of job satisfaction than physicians (4 (3 to 5) vs. 5 (4 to 
6), P ≤0.001), perceived futility more often than physicians (P ≤0.001), 
and rated all aspects of nurse–physician collaboration worse than 
physicians, including attendings’ inclusive leadership, collaboration, 
decision-making and psychological safety (all P  ≤0.001). Futility and 
intention to quit were each predicted by high workload and low 
psychological safety (all P ≤0.009). Among nurses, inclusive leadership 
by the head nurse prevented intention to quit (P  =  0.001) and a 
composite score of good nurse–physician interactions predicted less 
perception of futile care (P ≤0.001).
Conclusion The scales of the new questionnaire showed good reliability 
and diff erentiated between nurses and physicians. Psychological safety 
and inclusive leadership proved to be important concepts.
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Introduction Many scoring systems have been designed to predict 
mortality in surgical patients; however, these systems require the 
collection of several parameters that may not be available at ICU 
admission. As a result, these classifi cation systems are not used as a 
routine part of clinical practice. The aim of this study was to evaluate 
the prognostic value of ASA classifi cation predicting ICU and hospital 
mortality.
Methods We analyzed the records of 11,230 ICU admissions. ASA and 
elective/nonelective nature of the admission were combined into 
eight categories. We used the chi-square test and accepted the null 
hypothesis if P >0.05. Areas under the ROC curve using ASA and ASA/
admission categories were constructed.
Results We included 5,998 patients admitted to the ICU immediately 
after surgery. Forty-one percent were older than 65 years and 51% were 
female. Length of stay previous to ICU admission was 2.5 ± 6.1 days and 
duration of ICU stay was 1.9  ±  2.4  days. Elective hospital admission 
occurred in 65% of the patients. Neurosurgery with 21% of the 
procedures was followed by abdominal surgery (20%), and orthopedic 
surgery (15%). The death rate at the hospital was 6.9% (2.8% in ASA I 
patients and 31% in ASA IV/E). Higher ASA classifi cation was signifi cantly 
associated with the death rate both in the ICU and at the hospital 
(P <0.00001). The nonelective nature of the hospital admission was also 
associated with higher risk of death at the ICU (P <0.0001) and in the 
hospital (P <0.0001). Gender and hour of admission was not associated 
with the death rate. The combination of ASA classifi cation with the 
nonelective nature of the hospital admission produced an eight-
category index signifi cantly associated with mortality (P  <0.00001). 
Analyzing hospital mortality, the area under the ROC curve was 0.77 
(95% CI 0.74 to 0.79) for this index and was 0.72 (95% CI 0.69 to 0.75) for 
ASA. When analyzed for death at the ICU the AUROC was 0.71 (95% CI 
0.69 to 0.75, P <0.0001) for ASA and 0.75 (95% CI 0.71 to 0.78, P <0.0001) 
for ASA nonelective admission index.
Conclusion These results show that the ASA index can be used, 
preferably in combination with other data from electronic records, to 
predict mortality for surgical ICU patients.
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Introduction The aim of the ICU is to give the best life care to the 
admitted patients in order to preserve and restore the patients’ quality 
of life. In some critical patients, life-supporting therapies become 
actions to support the end stage of their life [1]. This is the paradox 
of the ICU. Patients aff ected by amyotrophic lateral sclerosis (ALS) 
belong to this category: for these patients, all medical actions do not 
improve the quality of life but just prolong it. ALS or Charcot’s disease 
is the most common motor neuron disease which causes severe motor 
disability and evolves in a few years to death [2]. We want to present 
our experience in patients aff ected by ALS in the ICU.
Methods We collected data about patients aff ected by ALS admitted 
to the ICU from 1 January 2010 to 31 October 2013. We considered 
entry diagnosis, mean age, need to perform tracheostomy and/or 
percutaneous endoscopic gastrostomy (PEG), and mortality in the ICU.
Results Sixty patients were admitted for neuromuscular respiratory 
failure complicated by aspiration pneumonia. Mean age was 43 years. 
The male to female ratio was 3:1. All patients underwent percutaneous 
tracheostomy and PEG. One of them died in the ICU because of septic 
shock. In every case we honestly communicated the worsening of the 
disease and we perceived the awareness of it by the patients and/or 
their family. In no case did patients ask us to withdraw the necessary 
cures such as percutaneous tracheostomy and PEG. In no case did they 
ask us to die. In Europe the ‘end of life care’ law is very dyshomogeneous 
because of diff erent cultures, traditions, religions, and beliefs. In Italy 
euthanasia is not allowed by law. It is the physician often by himself 
that has to make the fi nal decision according to the patient’s mind.
Conclusion Our experience shows that patients aff ected by severe 
motor disability are not always willing to die. It is essential that decisions 
should be patient-centered and taken multidisciplinarily, based on 
open and emphatic communication, involving family and caregivers.
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Introduction Several studies conducted in a number of diff erent 
populations indicate that patients admitted to hospitals on weekends 
have a higher mortality rate. Many factors have been proposed to 
explain these observations and in most studies, however, this eff ect 
disappeared after controlling for illness severity. We undertook the 
present study to explore the eff ect that day of ICU admission may have 
on death rate.
Methods We analyzed 11,230 electronic records from patients admitted 
from 1 January 2006 to 30 June 2013. The ICU admission dates were 
categorized as normal weekdays and as weekends and holidays. The 
dependent variables were ICU mortality and hospital mortality. The chi-
square test and Student t test were used as appropriate and signifi cant 
association was accepted when P  <0.05. Multiple logistic regression 
(backward conditional) was used accepting a variable when P  <0.05 
and rejecting a variable with P >0.1. SPSS version 19.0 was used.
Results Forty-nine percent of these patients were female, 53% was 
admitted immediately after surgery, 56% had <2  days of previous 
hospital admission, and 19.2% were admitted during weekends and 
holidays. Mortality in the ICU for admissions on weekends and holidays 
was 24% and was 13% for those admitted on weekdays (OR = 2.23, 95% 
CI 2.02 to 2.47; P <0.0001). The hospital mortality was respectively 35% 
and 20% (OR = 2.23, 95% CI 2.02 to 2.47; P <0.0001). Diff erences between 
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patients admitted on weekends and on weekdays were found in the 
group admitted after surgery (respectively 10% and 30%, P <0.0001), 
originating from the emergency unit (respectively 30% and 16%; 
P  <0.0001), originating from step-down units (respectively 31% and 
17%; P <0.0001), patients from clinical teams compared with surgical 
teams (respectively 28% and 13%; P <0.0001), previous hospital length 
of stay lower versus higher than 2 days (respectively 15% and 25%; 
P <0.0001) and age ≥65 years (respectively 21% and 18%; P <0.0001). 
The mortality ratios were signifi cantly diff erent between these groups. 
Multiple logistic regression showed that the inclusion of other variables 
reduces the odds ratio associated with admission on weekends and 
holidays to 1.22 (95% CI 1.08 to 1.39, P <0.002) for ICU mortality and to 
1.23 (95% CI 1.09 to 1.38, P <0.001).
Conclusion The higher death rate on weekends and holidays may be 
related to case mix. The interplay of other variables possibly related 
either to admission on weekends or higher death rate should be sought.
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Introduction Although avoidance of death is a key goal of critical care, 
so too is provision of high-quality end-of-life care when life-prolonging 
therapy is not desired. One often-used measure of ICU performance is 
risk-adjusted mortality, yet this measure treats all deaths equally and 
thus is fl awed. In this work, we identify diff erent death typologies using 
cluster analysis, with the ultimate goal of more narrowly targeted ICU 
quality improvement measures and eff orts.
Methods We performed k-means cluster analysis in 2,047 ICU 
decedents admitted to a university medical center in 2011/12. 
Variables for the analysis included ICU length of stay (LOS), mechanical 
ventilation, tracheostomy, gastrostomy tube insertion, dialysis, enteral 
or parenteral nutrition, and cardiopulmonary resuscitation (CPR).
Results Four clusters were identifi ed. Short ICU LOS and low life-
sustaining therapy utilization but relatively frequent CPR characterized 
Cluster 1. Intermediate ICU LOS and moderate life-sustaining therapy 
utilization characterized Clusters 2 and 3. Prolonged ICU LOS and high 
life-sustaining therapy utilization (except CPR) characterized Cluster 4. 
Age and severity of illness decreased across clusters with the oldest, 
sickest patients in Cluster  1 and the youngest, least sick patients in 
Cluster 4. See Table 1.
Table 1 (abstract P35).
 Cluster 1 Cluster 2 Cluster 3 Cluster 4
 (n = 353) (n = 755) (n = 667) (n = 272)
ICU LOS, mean ± SD (days) 0.5 ± 0.2 2.0 ± 0.8 7.2 ± 2.8 25.6 ± 15.2
Mechanical ventilation 282 (79.9%) 631 (83.6%) 604 (90.6%) 269 (98.9%)
Tracheostomy 3 (0.9%) 13 (1.7%) 14 (2.1%) 127 (46.7%)
CPR 20 (5.7%) 19 (2.5%) 16 (2.4%) 8 (2.9%)
Conclusion Cluster analysis can identify unique typologies of death 
within ICUs. This approach may be a novel method to more specifi cally 
target ICU eff orts to reduce mortality and improve the quality of death.
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Introduction The decision to withhold therapeutic intervention in a 
patient is a complex decision, wrapped in profound ethical debates. The 
role of the physician is to cure, treat and alleviate suff ering. When the 
fi rst two goals are not possible the medical role should be dedicated to 
end-of-life treatments adjusted to the patient’s benefi t [1,2].
Methods A retrospective cohort study including all adult patients 
with sepsis admitted to the emergency room (ER) at a tertiary care, 
university hospital between 1 July 2011 and 30 June 2012.
Results During the study period 162 patients with sepsis were admitted 
to the ER, of which 40 (25%) had withheld therapeutic decisions. 
Comparing this group with the group without therapeutic limitations, 
patients in the fi rst group were older (81 ± 13 vs. 68 ± 14, P <0.001), with 
more comorbidities (90% vs. 66%, P = 0.004) and a higher proportion 
needing help in daily activities (Karnofsky performance status (KPS) 
<70% = 55% vs. 8%, P <0.001). The hospital mortality in patients with 
a decision to limit the therapeutic intervention was signifi cantly higher 
(83% vs. 43%, P <0.001). Variables independently associated with the 
withholding therapy decision were age (adjusted OR per year = 1.078, 
P <0.001), presence of comorbidities (adjusted OR = 4.632, P = 0.030), 
chronic wounds (adjusted OR = 5.965, P = 0.005) and patient’s needed 
of help in daily activities (KPS <70%, adjusted OR = 5.391, P = 0.012). In 
the fi rst group a lower proportion received antibiotics (70% vs. 99%, 
P <0.001) and when those were considered inadequate for the agent 
responsible for the sepsis episode it was less frequently changed (15% 
vs. 50%, P = 0.028). However, no diff erences were found regarding the 
elapsed time from admission to the ER until the fi rst medical contact or 
the time since the recognition of sepsis and antibiotic administration, 
although the group with withholding decisions had less specimens 
collected for microbiology: blood cultures (68% vs. 91%, P <0.001) or 
other specimens (58% vs. 96%, P <0.001).
Conclusion In this study the decision to withhold therapy was 
independently associated with increasing age, the presence of 
comorbidities and loss of functional autonomy. For the same level of 
intervention such as antibiotic administration, the decision to withhold 
therapy did not infl uence the effi  cacy of therapeutic attitudes.
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Introduction Even with the availability of new and more eff ective 
diagnostic procedures over the past decades, autopsy remains one of 
the most reliable methods to validate clinical diagnoses. The aim of this 
review was to determine whether autopsy plays a role in extending 
knowledge about the cause of death in patients with cirrhosis who 
died in the ICU.
Methods We conducted a retrospective review of medical records and 
postmortem fi ndings in critically ill patients with cirrhosis who were 
admitted to a major university teaching medical ICU (MICU) between 
August 2007 and August 2013. Agreement between diagnoses before 
death and postmortem fi ndings were compared using the Goldman 
system [1]. Review was independently performed by a fellow in critical 
care medicine and a board-certifi ed attending. Autopsy diagnoses 
included histologic and microbiological fi ndings. The records were 
also reviewed for demographics, APACHE II score and all performed 
diagnostic procedures.
Results Of 641 patients admitted with diagnosis of cirrhosis, 86 (13%) 
died in the MICU. Forty-fi ve (52%) patients underwent an autopsy. 
Forty-two autopsy reports were available for review, three histologic 
and microbiological reports were missing. Major missed diagnoses 
(principal underlying disease related to death and primary cause 
of death itself ) were present in seven patients (17%), four in class I 
(10%) and three in class II (7%) (Table 1). Minor missed diagnoses were 
present in 13 patients (31%) (class III and IV). Postmortem fi ndings were 
in complete agreement (class V) with clinical cause of death in almost 
one-half of the patients (n = 19, 45%).
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Table 1 (abstract P37). Major missed diagnosis
Class I (n = 11) Class II (n = 3)
1. Metastatic linitis plastica 1. Acute pancreatitis
2. Oesophageal variceal bleeding 2. Necrotizing mucor mycosis pneumonia
3. Disseminated mucor mycosis  3. Focal aspergillosis (myocardial)
4,5,6. Invasive aspergillosis (n = 3) 
7. Invasive candidiasis 
8. Herpes simplex pneumonia 
9. Pneumocystis pneumonia 
10. Gastric rupture 
11. Disseminated HCC, vs. porta thrombosis 
Class I = missed major diagnosis that would have changed management and 
might have resulted in cure or prolonged survival. Class II = missed major 
diagnosis that would not have modifi ed ongoing patient care.
Conclusion Despite declining rates worldwide, autopsy remains an 
important tool for quality and safety assurance. In this retrospective 
study, autopsy showed that knowledge of the correct premortem 
diagnosis would have altered therapy in 10% of critically ill cirrhotic 
patients.
Reference
1. Goldman et al.: The value of autopsy in three medical eras. N Engl J Med 
1983, 308:1000-1005.
P38
Profi le, outcomes, and predictors of mortality of abdomino-pelvic 
trauma patients in a tertiary ICU in Saudi Arabia
S Haddad, Z Youssef, S Azzam, A Aldawood, A Al-Zahrani, H Al-Zamel, 
H Tamim, A Deeb, Y Arabi
King Abdulaziz Medical City, Riyadh, Saudi Arabia
Critical Care 2014, 18(Suppl 1):P38 (doi: 10.1186/cc13228)
Introduction Saudi Arabia (KSA) has the world’s highest number 
of deaths from motor vehicle accidents (MVAs). Numerous trauma 
victims sustain abdomino-pelvic injuries which are associated with 
considerable morbidity and mortality. The purpose of this study is to 
describe the profi le, outcomes and predictors of mortality of patients 
with abdomino-pelvic trauma admitted to the ICU in a tertiary care 
trauma center in Riyadh, KSA.
Methods This is a retrospective analysis of a prospectively collected 
ICU database. All consecutive patients older than 14  years with 
abdomino-pelvic trauma from March 1999 to June 2013 were 
included. The followings were extracted: demographics, injury severity, 
mechanism and type of injury, associated injuries, use of vasopressors 
and mechanical ventilation, and worse laboratory results in the fi rst 
24  hours. The primary outcome was hospital mortality. Secondary 
outcomes were ICU mortality, mechanical ventilation duration, need 
for tracheotomy, and ICU and hospital length of stay. We compared the 
profi le, outcomes, and the predictors of mortality between survivors 
and nonsurvivors.
Results Of 9,974 trauma patients during the study period, 702 patients 
with abdomino-pelvic trauma were admitted to the ICU. The average 
age was 30.7  ±  14.4  years and the majority was male (89.5%). MVA 
was the most common cause of abdomino-pelvic trauma (86%). Pelvis 
(46.2%), liver (25.8%), and spleen (23.1%) were the most frequent 
injuries; and chest (55.6%), head (41.9%), and lower extremities (27.5%) 
were the most commonly associated injuries. Mechanical ventilation 
was required in 89.6%, emergency surgery was performed in 45% 
and vasopressors were used in 46.6% of patients. The most commonly 
performed interventions during the ICU stay were surgery (39.5%) and 
chest tube insertion (33.3%). Of the 702 patients with abdomino-pelvic 
trauma, 115 (16.4%) patients did not survive. Associated head trauma 
and retroperitoneal hematoma, higher level of lactic acid on admission 
and ISS, and advanced age were independent risk factors for fatality. 
Compared with survivors, nonsurvivors were older in age; had higher 
ISS, APACHE II, BMI, lactic acid, INR and creatinine, and lower GCS, PaO2/
FiO2 and platelet count; were more likely to be mechanically ventilated 
and on vasopressors; and were associated with more head injuries.
Conclusion In KSA, abdomino-pelvic traumas are serious injuries 
aff ecting mainly young male victims; however, with a lower mortality 
than predicted.
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Introduction Trauma patients are subjected to higher radiation 
exposure (RE) as a function of Injury Severity Score (ISS) [1]. Analysis of 
this dataset was done to ascertain if RE varied with patient age.
Methods Data collection was as previously described [1]. RE was 
measured in milliSieverts (mSv). RE as a function of the ISS and age was 
explored for 7,661 trauma patients. The ISS groupings were as follows: 
ISS 1 to 8, ISS 9 to 15, ISS 16 to 25, and ISS >25. Age groupings were 19 
to 39, 40 to 59, 60 to 79, and >80 years.
Results The data were analyzed in a hierarchical fashion: the mean 
exposure by age group was compared by one-sided, two-sample 
t tests. Diff erences were set up to test if mean exposure decreased 
with increasing age. Bonferroni adjustment was used for all multiple 
comparisons to maintain the overall error rate at 0.05. Of the six 
independent diff erence tests conducted, fi ve were signifi cant: 19 to 39 
versus 60 to 79; 19 to 39 versus >79; 40 to 59 versus 60 to 79; 40 to 59 
versus >79; and 60 to 79 versus >79 (P <0.01). Analysis was done for 
ISS categories: ISS 1 to 8, ISS 9 to 15, ISS 16 to 25, and ISS >25. For ISS 
1 to 8, fi ve diff erences were signifi cant: 19 to 39 versus 60 to 79; 19 to 
39 versus >79; 40 to 59 versus 60 to 79; 40 to 59 versus >79; and 60 to 
79 versus >79 (P <0.01). For ISS 9 to 15, all diff erences were signifi cant: 
19 to 39 versus 40 to 59; 19 to 39 versus 60 to 79; 19 to 39 versus >79; 
40 to 59 versus 60 to 79; 40 to 59 versus >79; and 60 to 79 versus >79 
(P  <0.01). For ISS 16 to 25, four diff erences were signifi cant: 19 to 39 
versus 60 to 79; 19 to 39 versus >79; 40 to 59 versus 60 to 79; and 40 
to 59 versus >79 (P <0.01). For ISS > 25, none of the diff erences were 
signifi cant.
Conclusion Previous studies show signifi cant RE in trauma patients [1]. 
We demonstrated the signifi cance of RE to trauma patients, that the 
amount of RE has gone up chronologically over time, and that patients 
with an increasing ISS have a higher RE. We sought to determine 
whether age played a factor in RE. Based on our statistical analyses, 
older patients receive less RE for a given ISS. Although this is a large 
assessment of RE and trauma patients broken down by ISS and patient 
age, data analysis by year was limited by the small number of patients 
in high ISS groups at higher ages.
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Introduction The admission of patients with haematological 
malignancies to the ICU is associated with high mortality, especially 
when mechanical ventilation is required [1,2]. The purpose of the 
present study was to explore survival rates and the predictors of 
survival in this group of patients.
Methods A retrospective study of intubated patients with haemato-
logical malignancies, admitted to a general ICU in central Greece, due 
to any cause.
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Results During a 10-year period (2003 to 2013), 16 patients with 
haematological malignancies (nine with acute myelogenous leukaemia, 
four with non-Hodgkin lymphoma, one with Hodgkin lymphoma 
and two with multiple myeloma, mean age 50.75  ±  16.59) (male/
female 3/13, mean APACHE II score 23.18  ±  6.67, mean SOFA score 
12.50 ± 2.82, CRP 16.00 ± 10.13, WBC 2.055 ± 30.053) were admitted 
to the ICU. The majority of patients were admitted due to ARDS (PO2/
FiO2 164  ±  109), one patient was admitted due to intestinal rupture 
and peritonitis and the other one due to intracerebral haemorrhage. 
In the majority of the patients (13/16) diagnosis of the malignancy was 
made during the present admission and only three had the malignancy 
for a longer period (5 months to 3 years). The mean ICU length of stay 
was 10.56  ±  16.19  days. A total 68.75% (11/16) of the patients were 
intubated upon admission, whereas the mean time to intubation for 
the rest of the patients was 6.37 ± 4.16 hours. Neither intubation upon 
admission nor time to intubation was correlated with survival. Type 
of haematological malignancy, duration of immunosuppression and 
preceding length of stay in the general ward did not correlate with 
survival either. The survival rate was 18.7% and in linear regression 
analysis, duration of treatment with NIV in the general ward, increased 
SOFA score and the number of platelets (<50.000) upon admission to 
the ICU were independent predictors of survival (R2 = 0.77, P = 0.017).
Conclusion The present retrospective study indicates that patients 
with haematological malignancies have poor survival when they are 
admitted to the ICU. Longstanding treatment with NIV before ICU 
admission, high SOFA scores and low platelet levels upon admission 
negatively aff ect survival.
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Introduction Critical care (CC) admission has traditionally been 
viewed as likely to result in a poor outcome for immune-compromised 
haemato-oncological (HO) patients [1,2]. Recent studies have 
challenged such views [3,4]. We recently reported results from a cohort 
of HO patients admitted to CC, showing the pAO2/FiO2 (P/F) ratio to be 
the only independent predictor of mortality [5]. We report analyses of a 
larger cohort of HO patients admitted to CC.
Methods We assessed outcome for HO patients at CC (primary 
outcome) and hospital discharge, and at 6-month and 1-year follow-
up. Single variable logistic regression analyses, adjusted by age, 
gender and haematological diagnosis, and multivariate analyses were 
performed to identify independent predictors of outcome using STATA.
Results A total of 225 HO patients were admitted to CC. Median age 
was 59 (interquartile range (IQR) 46 to 66) years. The most common 
haematological diagnoses on admission were acute myeloid 
leukaemia in 57 (25.3%) cases, non-Hodgkin lymphoma in 54 (24%) 
cases and multiple myeloma in 42 (18.7%) patients. Median APACHE II 
score was 21 (IQR 17 to 26). A total of 164 patients (72.9%) had at least 
one organ supported. Unit and hospital mortality rates were 34.7% (78 
patients) and 49.3% (111 patients), respectively. At 6-month and 1-year 
follow-up, mortality increased to 63.1% (142 patients) and 70.5% (153 
patients), respectively. The APACHE II score (OR = 0.93, 95% CI = 0.89 to 
0.97, P <0.001), number of organs supported (OR = 0.34, 95% CI = 0.23 
to 0.48, P <0.001), P/F ratio (OR = 1.06, 95% CI = 1.03 to 1.09, P <0.001), 
inotropic requirement (OR = 0.27, 95% CI = 0.15 to 0.49, P <0.001), and 
IMV status (OR = 0.06, 95% CI = 0.03 to 0.14, P <0.001) infl uenced unit 
survival at single variable analyses. At multivariate analysis, the P/F ratio 
(OR = 1.05, 95% CI = 1.02 to 1.09, P = 0.002) and IMV status (OR = 0.12, 
95% CI = 0.04 to 0.35, P <0.001) independently predicted outcome.
Conclusion Organ failures and need for organ support correlated with 
outcome. P/F ratio and need for IMV were independent predictors of 
mortality, in agreement with previously published data [6]. The CC 
mortality rate was 34.7%; at 1 year, mortality had risen to 70.5%.
Acknowledgement AT and KB are joint fi rst authors.
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Introduction There are no well-validated risk scores for patients 
with oncological and hematological malignancies presenting to the 
emergency department (ED). Previous research found the prognostic 
blood biomarker pro-adrenomedullin (proADM) to be associated with 
infection-related complications and mortality and thus may be helpful 
in managing febrile patients with malignancies. Yet the prognostic 
value of proADM in general oncological patients presenting to the 
ED remains unclear. Herein, the objective of this study is to evaluate 
the prognostic potential of proADM and clinical parameters in a 
consecutive cohort of patients with oncological and hematological 
malignancies with regard to ICU admission and 30-day mortality.
Methods We enrolled all consecutive patients with oncological and 
hematological malignancies seeking ED care at a tertiary care hospital 
from February 2013 to October 2013. We prospectively collected 
various clinical features, and measured blood parameters including 
proADM upon admission. To assess outcomes, data from electronic 
medical records – that is, ICU admission, length of stay (LOS), and post-
acute care location – were used and we contacted all patients 30 days 
after hospital admission. Logistic regression models with area under 
the receiver operating curve (AUC) were used to assess association of 
baseline parameters and outcomes.
Results We included a total of 469 patients with oncological and 
hematological malignancies, of whom 8.9% (n  = 42) were admitted 
to the ICU and 18.7% (n = 88) did not survive until the 30-day follow-
up. There was a strong association of initial proADM levels and 30-day 
mortality risk (odds ratio (OR) per 10-fold increase 9.9, 95% CI 4.3, 22.9) 
with an AUC of 0.67 (95% CI 0.60, 0.74). This association remained 
signifi cant after multivariate adjustment for initial vital signs (blood 
pressure, pulse, temperature) and comorbidities (chronic heart failure, 
chronic obstructive pulmonary disease, diabetes, coronary heart 
disease) with an adjusted OR of 9.0 (95% CI 3.1, 26.4). There was also 
a signifi cant association of proADM and LOS (adjusted regression 
coeffi  cient per 10-fold increase: 6.6, 95% CI 2.0, 11.2).
Conclusion This study including consecutive patients with oncological 
and hematological malignancies found a moderate association of 
proADM with 30-day mortality and LOS. proADM in combination with 
clinical parameters may help to improve site-of-care decisions for these 
patients in the future.
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Introduction We studied radiation exposure (RE) in trauma patients [1]. 
To adjust for injury severity the New Injury Severity Score (NISS) or the 
Injury Severity Score (ISS) can be used to group patients. We sought to 
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determine whether there is a diff erence in the calculated RE per group 
when the patients are grouped using either the NISS or ISS.
Methods Data collection was as previously described [1]. RE was 
measured in milliSieverts (mSv). Group analysis was done for both ISS 
and NISS using the following severity score ranges (SSR) 1 to 8, 9 to 15, 
16 to 25, and >25.
Results The analysis conducted in previous research [1] was repeated 
for the data recategorized by NISS. The conclusions were identical; 
increased NISS is associated with increased radiation exposure. A 
total of 465 patients fell into diff erent SSR when classifi ed by NISS. The 
distribution of exposure for each SSR, NISS versus ISS, was compared 
using Wilcoxon’s test. For the range 1 to 8, there was no detectable 
diff erence. There was a signifi cant shift in the distribution of exposures 
for the remaining three ranges (P  <0.02). The exposure shift was 
downward for NISS compared with ISS.
Conclusion In this analysis, with the exception of patients in groups 
1 to 8 there was a signifi cant decrease in RE in the NISS groups when 
compared with the compared ISS group. Further analysis is needed to 
determine the cause for this change and whether this diff erence will be 
clinically signifi cant.
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Introduction A prospective multicentre observational study was 
carried out to assess the extent to which critical care teams manage 
patients in hospital who are cared for outside the critical care unit. 
The Health Service Executive (HSE) in Ireland is in the process of 
implementing a national Early Warning Score (EWS) and, at an EWS of 7 
or above, a referral to critical care is recommended. This study recorded 
the EWS of patients referred to the critical care team and describes the 
subsequent interventions made by the critical care team and patient 
outcomes.
Methods Six critical care departments in university-affi  liated hospitals 
across Ireland collected data on all referrals to the critical care team over 
a 6-week period. Data were anonymised, coded and analysed centrally.
Results A cumulative total of 399 calls were made to the critical care 
teams in the six hospitals. The most common reason for referral was to 
request a critical care review of a patient (n = 319, 79.9%). Other reasons 
for referral included cardiac arrest, request to transfer patients from 
other hospitals and requests for vascular access. The average duration 
spent by the critical care team reviewing patients on the wards was 
57 minutes. This increased up to 67 minutes for cardiac arrest calls. Of 
the 319 critical care reviews, 160 (50.2%) patients were subsequently 
admitted to critical care. A total 118 of this 160 had EWS of 7 or above, 
while 42 scored less than 7 but were still deemed to require admission 
to critical care.
Conclusion Regardless of the EWS, critical care teams are heavily 
involved in the management of patients outside critical care units. Fifty 
per cent of patients reviewed by the critical care team subsequently 
required admission to a critical care unit. The trigger threshold (7 and 
above) for referral to a critical care team currently recommended by 
the EWS escalation protocol is more likely to predict need for critical 
care admission. However, one in four patients referred below the 
threshold also required admission to a critical care environment. This 
study questions the safety of introducing such a protocol into acute 
hospitals. Will noncritical care staff  be forced to wait until patients 
deteriorate further and reach the trigger threshold for referral or will 
the role of the critical care team expand further to look after all patients 
with abnormal EWS in hospital?
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Introduction We aimed to assess actions taken in response to variations 
in the National Early Warning (NEW) score and to identify factors 
associated with a poor response. The NEW score is a physiological score, 
which prescribes an appropriate response for the deteriorating patient 
in need of urgent medical care. This allows enhanced observation and 
clinical review of patients, identifying patients at risk of acute mortality.
Methods We performed a prospective observational study of adult 
patients admitted to an acute medical ward in a London district general 
hospital over a 2-week period. Patient characteristics, NEW score, time 
of day, day of week and clinical response data were collected for the 
fi rst 24 hours of admission. Patients with less than a 12-hour hospital 
stay were excluded. The primary outcome measure was the quality of 
clinical response. Data were analysed with univariate and multivariate 
logistic regression.
Results During the study period 200 patients were included with a 
median age of 70 (20 to 102) years. NEW scores were evenly distributed 
between day and night (52% vs. 48%) with a greater proportion on 
weekdays compared with weekend days (82% vs. 18%). The majority 
of patients scored <5 (93% vs. 7%). Forty-seven (27%) patients 
received an inadequate clinical response. Univariate analysis showed 
no association with time of day (night 34% vs. day 38%, OR 0.83 
(0.47 to 1.49), P  =  0.556). However, day of the week (weekend 56% 
vs. weekday 32%, OR 2.8 (1.30 to 5.84), P = 0.01) and increasing score 
(NEWS ≥5 100% vs. NEWS <5 31%, OR 65 (3.8 to 1100), P  < 0.0001) 
were signifi cantly associated with an inadequate response. Day of the 
week was independently associated with an inadequate response after 
adjusting for confounders (OR 3.08 (1.27 to 7.46), P = 0.013).
Conclusion Clinical response to NEW score triggers is signifi cantly 
worse at weekends, highlighting an important patient safety concern.
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Introduction The purpose of this study was to evaluate the impact of 
obesity on outcomes in patients with severe sepsis. Since obesity is 
considered an infl ammatory disease and is associated with elevations 
in several infl ammatory mediators important in the outcome of sepsis, 
the relationship between obesity and outcome in septic patients was 
studied.
Methods This retrospective cohort study included all patients over the 
age of 40 with a confi rmed diagnosis of severe sepsis and an ICU stay 
at our academic medical center from 1 January 2005 to 31 March 2011. 
Obesity was defi ned as a body mass index of 30 or greater. Data on 
other patient demographics and APACHE II score at the time of sepsis 
were collected from patient charts. Outcomes measured included in-
hospital mortality, development of acute respiratory distress syndrome 
(ARDS), days on mechanical ventilation, hospital cost, and length of 
stay.
Results We identifi ed 824 patients who met the inclusion criteria for 
this study. Of these patients, 257 (31.2%) were classifi ed as obese. 
The mean APACHE II score was similar between obese and nonobese 
patients (23.3 vs. 22.4; P  =  0.068). Obese patients had a similar rate 
of in-hospital mortality (31.9% vs. 33.7%; P  =  0.810) compared with 
nonobese patients, but a signifi cantly higher rate of development of 
ARDS (49.4% vs. 34.4%; P <0.001). Obese patients also had signifi cantly 
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more days on mechanical ventilation (6.2 days vs. 5.0 days; P = 0.005). 
There was no relationship between mortality in obese patients on 
mechanical ventilation (34.4% vs. 39.5%; P = 0.26) or ARDS (33.9% vs. 
42.6%; P = 0.13) compared with nonobese patients. Hospital costs and 
length of stay did not diff er between the groups.
Conclusion Obesity signifi cantly increased the incidence of ARDS and 
days on mechanical ventilation in patients with sepsis. Previous work 
has reported that obesity is associated with elevations in infl ammatory 
cytokines and adipokines, particularly IL-6, which is a known risk factor 
for ARDS. The higher rate of ARDS in obese patients with sepsis identifi es 
a high-risk group where new therapies may be most benefi cial and 
where new methods of preventing ARDS can be targeted.
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Introduction Studies suggest that obesity may infl uence mortality 
in patients who develop sepsis. However, the mechanisms linked to 
improved outcomes are unclear. Our aim was to assess the impact of 
obesity on mortality at 30 and 180 days and cytokine expression.
Methods We used a platform of a negative randomized control trial in 
subjects (n = 51) with a diagnosis of severe sepsis with ≥1 organ failure. 
The cohort of severe septic subjects was stratifi ed by obesity status 
based on the body mass index (BMI >30). Primary outcomes: 30-day 
and 180-day mortality; secondary outcome: diff erence in median (IQR) 
of fi ve infl ammatory cytokines including tumor necrosis factor alpha 
(TNFα), TNFα-receptor 2, interleukin (IL)-6, IL-1-receptor-antagonist (IL-
1ra) and IL-10. The measurement of median baseline cytokine levels 
was done in serum by Luminex technology. Statistical signifi cance was 
defi ned as P <0.05.
Results Fifty-one subjects with severe sepsis were included in the 
study; 37% of the patients were obese (BMI >30). Paradoxically, obese 
severe septic patients had lower 30-day mortality (n = 1 (5%) vs. n = 
9 (28%), P = 0.069) and 180-day mortality (n = 1 (5%) vs. n = 13 (41%), 
P  =  0.008), when compared with nonobese. The expression of TNFα, 
TNFα-receptor 2, IL-6, IL-1ra and IL-10 was not statistically signifi cant 
diff erent among obese versus nonobese severe septic patients.
Conclusion Obesity is associated with lower mortality rates at 30 
and 180  days in patients diagnosed with severe sepsis. This survival 
benefi t was not associated with lower cytokine production among 
obese patients. Further studies are needed to assess the mechanisms 
associated with the survival benefi t related to obesity in patients with 
severe sepsis.
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nonpneumonic exacerbation: a 6-year prospective follow-up study
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Introduction Predicting long-term outcome in patients surviving a 
pneumonic or nonpneumonic COPD exacerbation remains challenging. 
This study investigates the association of clinical parameters and the 
prognostic blood marker pro-adrenomedullin (proADM) measured 
upon hospital discharge with 6-year mortality in well-defi ned cohort 
of COPD patients.
Methods We prospectively followed consecutive COPD patients from a 
previous Swiss multicenter trial (2006 to 2008) [1] over a 6-year follow-
up and investigated all-cause mortality following hospital discharge. 
Patients and/or treating general practitioners were contacted by 
telephone interview to assess the vital status of patients. We used 
Cox regression models and the area under the receiver operating 
characteristics curve (AUC) to investigate associations of baseline 
predictors and mortality.
Results Overall mortality in the 469 included COPD patients was 55% 
(95% CI 0.5 to 0.6) with a 14% (95% CI 0.1 to 0.2) mortality incidence 
rate per year. Patients with pneumonic COPD exacerbation had a 
more pronounced infl ammatory response compared with patients 
with nonpneumonic exacerbation with regard to levels of initial 
C-reactive protein levels (median 158 mg/dl vs. 39 mg/dl, P <0.0001), 
procalctionin (median 0.4  μg/l vs. 0.1  μg/l, P  <0.0001) and proADM 
(median 1.3  nmol/l vs. 0.9  nmol/l, P  <0.0001), but long-term survival 
was similar (HR 1.0, 95% CI 0.8 to 1.2). In univariate regression models, 
proADM was signifi cantly associated with mortality after 1, 3 and 
6 years (HR 16.1 (95% CI 6.9 to 37.7), 10.5 (95% CI 5.7 to 19.6) and 10.4 
(95% CI 6.2 to 17.7), respectively). There was no eff ect modifi cation 
by type of exacerbation. A model including clinical parameters (age, 
coronary heart disease, heart failure, diabetes mellitus, chronic renal 
failure, neoplastic disease, pneumonia, smokers) and proADM showed 
good discrimination of long-term survivors from nonsurvivors with 
AUC of 0.74 (95% CI 0.6 to 0.7).
Conclusion Clinical parameters and discharge levels of proADM allow 
accurate long-term prognostication in COPD patients independent 
of initial type of exacerbation. The focus on the best use of long-term 
prognostic information to improve patient care and clinical outcomes 
seems promising/rational.
Reference
1. Schuetz P, et al.: Eff ect of procalcitonin-based guidelines vs standard 
guidelines on antibiotic use in lower respiratory tract infections: the 
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Introduction Based on expert opinion and case note review, the 
UK National Confi dential Enquiry into Peri-operative Outcome has 
recommended provision of perioperative level 2 and 3 care to support 
major surgery in older people, and particularly those with comorbidity 
[1]. We wished to identify whether we could predict if the need was 
uniform and whether any factors could predict the degree of organ 
supports needed.
Methods A retrospective note review of all patients admitted to 
a level  2 critical care unit in the 12-month period from 1  January 
2012 to 31  December 2012 undergoing revision hip surgery either 
as a two-stage or single-stage process. Surgery was undertaken at a 
national referral unit and chosen to represent an appropriate group of 
older, comorbid patients. Predefi ned preoperative and perioperative 
data were collected from chart review, along with postoperative 
physiological data whilst the patient was in critical care. This included 
frailty, comorbidities, operative blood loss, anaesthetic technique and 
level and duration or organ supports including the need for additional 
medical review whilst on the unit. Frailty was assessed preoperatively 
Figure 1 (abstract P49). Proportion of patients requiring additional 
medical review on critical care by degree of frailty.
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using the Rockwood assessment tool by trained staff  [2]. Data were 
analysed using Microsoft Excel for Mac 2011 and Stata/IC 11.2 for Mac.
Results A total of 182 patients with a mean age of 69.8 years (range 29 
to 92) were identifi ed. Frail patients were signifi cantly more likely to need 
additional medical input in the postoperative period whilst on critical 
care (Figure 1, P = 0.002) but this was not signifi cantly linked to need for 
vasopressors, evidence of sepsis or choice of anaesthetic technique.
Conclusion In complex revision orthopaedic surgery, the need 
for postoperative level 2/3 support cannot be predicted from any 
preoperative or intraoperative factors but patient frailty does indicate 
the need for medical input in the postoperative period.
References
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Introduction As the general population ages, the proportion of critically 
ill patients in whom frailty may adversely aff ect outcome is likely to 
rise. The aim of this systematic review was to evaluate performance of 
frailty measures in predicting ICU, hospital and long-term outcomes 
following intensive care admission.
Methods We performed a literature search for original studies 
in: EMBASE, MEDLINE, Web of Knowledge, Cochrane database of 
systematic reviews, and Database of Abstracts of Reviews of Eff ects, 
using the terms ‘frailty’, ‘frail elderly’, ‘critical care’, ‘critically ill’, ‘critical 
illness’ and ‘intensive care’. Our study inclusion criteria were that the 
study: included patients cared for in intensive care, captured data 
relating to premorbid frailty, and reported ICU, hospital and/or long-
term outcome data.
Results Initial searches identifi ed 606 reports, of which, following 
review of abstracts and removal of duplicates, 66 full-text papers were 
evaluated. Of these, 11 met inclusion criteria. A further 19 papers that 
met inclusion criteria were identifi ed from relevant review articles 
and reference lists. There was huge variation in populations studied, 
methodology, frailty measures utilised and reported outcome 
measures. Of the 30 included studies, 11 studies evaluated patients 
undergoing major (including cardiothoracic) surgery, two studies 
specifi cally assessed patients with pneumonia, one study investigated 
patients in a burns ICU and one study restricted its investigation to 
former nursing home residents. The most commonly used measures 
of frailty were: measures of Activities of Daily Living (n  = 9), which 
predicted need for long-term institutional care, 30-day, 90-day, 
6-month and 12-month mortality; Clinical Frailty Score [1] (n = 5), which 
predicted ICU mortality, hospital mortality, 12-month mortality, quality 
of life and functional dependence; and Knaus score [2] (n = 4), which 
predicted ICU mortality, hospital and 12-month mortality.
Conclusion Measures of frailty appear to predict mortality and 
functional dependence following critical admission across a wide 
range of clinical conditions. However, comparative data regarding the 
relative accuracy and reliability of frailty measures in the intensive care 
population are currently defi cient.
References
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Introduction ICU or hospital mortality rates have been reported as the 
endpoint of ICU therapy for many years. The aim of this study was to 
determine the 1-year mortality after discharge from the ICU in patients 
who were treated in the ICU for more than 72  hours and to identify 
predictors for 1-year mortality.
Methods This study was conducted in a 20-bed mixed ICU of a teaching 
hospital. The study sample was extracted from a dataset of all ICU 
patients treated for more than 72 hours between 1 January 2007 and 1 
October 2012. Demographic characteristics and clinical characteristics 
at admission and during the ICU stay were collected. Characteristics of 
patients alive 1 year after ICU discharge were compared with patients 
who died within the fi rst year after ICU discharge. Descriptive statistics 
were calculated. Multivariate analysis of 1-year mortality was performed 
using a logistic regression model with backward elimination. Survival 
was analysed by the Kaplan–Meier method using the time interval from 
day of ICU discharge until death.
Results During the study period, 740 patients were treated for more 
than 72  hours in the ICU. The ICU mortality was 106/740 (14%). The 
data of 617 ICU survivors were further analysed (17 patients were 
lost to follow up). One-year mortality was 175/617 (28%), of which 
85/175 (49%) patients died during hospital stay after ICU discharge. 
Independent predicting factors of 1-year mortality were: age at ICU 
admission (OR: 1.03; 95% CI: 1.01 to 1.05), APACHE IV predicted mortality 
score (OR: 1.02; 95% CI: 1.02 to 1.03), number of comorbidities (one or 
two co morbidities OR: 2.14; 95% CI: 1.42 to 3.23) (>3 comorbidities OR: 
2.56; 95% CI: 1.16 to 5.62), readmission after ICU discharge within the 
same period of hospital stay (OR: 1.98; 95% CI: 1.13 to 3.46) and the 
diagnosis at admission (cardiovascular OR: 4.31; 95% CI: 1.73 to 10.76) 
(sepsis OR: 2.67; 95% CI: 1.50 to 4.77).
Conclusion Of patients being treated for more than 72  hours in 
the ICU, 28% died within 1  year after ICU discharge. One-half of 
them within the hospital stay after ICU discharge. High age at ICU 
admission, high APACHE IV predicted mortality score, high number 
of comorbidities, readmission and an admission diagnosis within the 
categories ‘cardiovascular’ and ‘sepsis’ are associated with an increased 
1-year mortality after ICU discharge in this population. The burden of 
patients dying after ICU discharge underlines the necessity for clear ICU 
discharge criteria and post-ICU care.
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Introduction The long-term impact of critical illness on survivors’ 
physical and mental health remains unknown. Our aim was to create a 
follow-up clinic for survivors of critical illness in order to quantitatively 
examine muscle weakness, physical functioning and mental health and 
relate these fi ndings to health-related quality of life (HRQL) and ICU risk 
factors.
Methods Study patients were selected from a 24-bed multidisciplinary 
ICU. Fifty-six patients who were ≥18 years old, stayed longer than 4 days 
in the ICU and did not have an acute brain injury were followed-up at 2 
and 4 months post hospital discharge. Peripheral muscle strength (grip, 
triceps, biceps, hamstrings, quadriceps and dorsifl exors) and physical 
functioning were objectively assessed using hand-held dynamometry 
and the six-minute walk test (6MWT); both were compared with age/
sex normative data. HRQL and mental health were assessed using the 
Short Form-36 (SF-36), EuroQol-5D (EQ-5D) and Hospital Anxiety and 
Depression Scale.
Results The median age of patients was 60 years, 68% were admitted 
for respiratory illnesses, they were severely ill (median APACHE II, 19) 
and had long ICU lengths of stay (median, 11 days). Muscle strength 
was signifi cantly reduced when compared with normative data in all 
muscle groups at the 2-month and 4-month visits (2-month average 
indexed overall strength, 72%, P <0.05). The median distance walked 
during the 6MWT was 382 m at 2 months (median percent predicted, 
72%) and it did not signifi cantly change at the 4-month visit. Reduced 
peripheral muscle strength was signifi cantly correlated with lower 
distance walked during the 6MWT. Reported HRQL by the SF-36 was 
below national averages at both 2-month and 4-month visits (2-month 
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physical composite score (PCS) 36.2, mental composite score 48.1; 50 = 
national average). Reduced muscle strength was associated with low 
scores on the SF-36 physical function and general health domains. 
Performance on the 6MWT correlated with the SF-36 including the 
PCS (P  =  0.001). Screening positive for anxiety was associated with 
both poor 6MWT performance and reporting dysfunction on the EQ-
5D domains. ICU/hospital length of stay, number of days ventilated, 
severity of illness and organ dysfunction were not found to be 
predictive of muscle strength or physical functioning.
Conclusion Our study gives qualitative evidence that survivors of 
critical illness have reduced muscle strength, physical functioning and 
HRQL after hospital discharge. Also, we have shown muscle weakness is 
predictive of overall physical functioning, which in turn impacted HRQL 
and mental health. No ICU risk factors were identifi ed that predicted 
defi cits in muscle strength or physical functioning.
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Introduction The aim of this study was to determine an appropriate 
risk model to identify patients at high risk of prolonged ICU stay and to 
aid patient consent prior to cardiac surgery.
Methods Data were prospectively collected on 5,440 consecutive 
cardiac surgery cases between April 2009 and March 2012. The primary 
outcome measure was the combined outcome of prolonged ICU stay 
(length of stay greater than 20  days) and/or in-hospital mortality. 
Logistic regression was performed to assess the predictability of 
logistic EuroSCORE against the primary outcome. Low-risk, medium-
risk and high-risk groups were identifi ed and subsequent risk of 1-year 
mortality assessed. Survival status was determined at 1 year.
Results A total of 192 (3.5%) patients had a prolonged ICU stay and 
187 (3.4%) in-hospital deaths occurred, resulting in a combined 
primary outcome of 349 (6.4%). At 1 year, 371 (6.8%) deaths occurred. 
The risk of death in-hospital and at 1 year was signifi cantly higher in 
patients with prolonged ICU stay (in-hospital mortality, 15.6% vs. 
3.0%; P  <0.001/1  year, 27.6% vs. 6.1%; P  <0.001). The mean logistic 
EuroSCORE for all patients was 10.9. Patients with prolonged ICU stay 
had a signifi cantly higher logistic EuroSCORE (20.3 vs. 10.6; P <0.001). 
The logistic EuroSCORE was a reasonable predictor of prolonged ICU/
in-hospital mortality (OR 1.04, 95% CI 1.04 to 1.05, P  <0.001) with a 
receiver operating characteristic (ROC) curve of 0.72. The relationship 
between a patient’s logistic EuroSCORE and predicted risk of prolonged 
ICU is shown in the fi gure; including low-risk, medium-risk and high 
risk groups. Around 50% of the entire cohort of patients had a logistic 
EuroSCORE of 10 or less and an associated risk of prolonged ICU stay of 
5% or less. See Figure 1.
Conclusion Using an existing risk prediction model, a patient’s risk of 
prolonged ICU stay can be calculated using contemporaneous data. 
This information could be relevant for aiding in providing informed 
consent for cardiac surgery patients.
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Introduction Information about lung cancer patients surviving critical 
illnesses is very scarce. Our aim was to evaluate the outcomes and 
continuing of anticancer treatments in lung cancer patients surviving 
ICU admission.
Methods Secondary analysis of a prospective multicenter study 
including patients admitted for >24 hours to 22 ICUs in six countries 
from Europe and South America during 2011. Readmissions and 
patients in cancer remission >5 years were excluded. Logistic regression 
was used to identify predictors for hospital mortality.
Results A total of 449 patients (small-cell (SCLC)  = 55; non-SCLC  = 
394)) were admitted to ICUs, and out of them 275 (SCLC = 29; NSCLC = 
246) were discharged alive from the hospital. Among them, 200 
(73%) patients were alive and 72 (26%) had died at 6  months; three 
Figure 1 (abstract P53). Risk of long stay versus 1-year mortality.
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(1%) patients were lost to follow-up. Mortality rates were far lower 
in the patient subset with nonrecurrent/progressive cancer and a 
good performance status (PS), even those with sepsis, multiple organ 
dysfunctions, and need for ventilatory support. Cancer recurrence 
or progression occurred in 53 (26%) hospital survivors. Anticancer 
treatments were recommended for 108 (39%) hospital survivors and 
administered to 102. Treatments used were variable combinations of 
surgical resection (7%), radiation therapy (34%), and chemotherapy 
(80%). The initial treatment plan required reduction or modifi cation in 
35 (34%) patients. Post-hospital mortality was nonsignifi cantly lower in 
the patients given the initial treatment plan than in the other patients 
(17% vs. 32%, P = 0.065). Poor PS was the only factor associated with a 
lower probability of receiving the initial treatment plan (OR = 0.20; 95% 
CI, 0.05 to 0.87; P = 0.032). At 6 months, 71% patients were at home, 
15% were hospitalized, and 7% were in hospice care; the location 
was unknown for 6% patients. PS at 6 months was 3 to 4 in 19 (9.5%) 
survivors.
Conclusion Post-hospital mortality in critically ill lung cancer patients 
is relatively high and many patients require anticancer treatments after 
discharge. PS before ICU admission is a major determinant of both 
mortality and ability to receive optimal anticancer treatment in these 
patients.
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in the fi rst 24 hours of ICU admission
I Soliman, L Peelen, D De Lange, D Van Dijk
University Medical Center, Utrecht, the Netherlands
Critical Care 2014, 18(Suppl 1):P55 (doi: 10.1186/cc13245)
Introduction Survival and quality of life (QoL) in ICU patients with 
acute kidney injury (AKI) have been repeatedly reported as poor [1-3]. 
It is unknown whether early AKI, occurring during the fi rst 24 hours of 
ICU treatment, is also a strong predictor of poor long-term outcome. 
Our aim was to describe the long-term outcomes of this specifi c group 
of ICU patients.
Methods All patients admitted to our mixed ICU from July 2009 to May 
2012 with early AKI were included. All survivors received the EuroQoL 
EQ-6D-3L questionnaire. Early AKI was defi ned as creatinine >1.5 mg/
dl and urine output <150 ml/8 hours. Poor ICU outcome was defi ned as 
either death or EuroQoL index <0.4 at 1-year follow-up.
Results Out of 5,934 admissions, 269 patients were identifi ed with early 
AKI. After ICU discharge a large and signifi cant diff erence in survival 
between included patients and the Dutch population, matched for age 
and gender, was seen (P <0.001). The median QoL index in surviving 
patients was 0.65 (interquartile range (IQR) 0.45 to 1.00), versus 0.86 
(IQR 0.84 to 0.89) in the Dutch population (P  <0.001). Low QoL was 
found in 11/59 (18.6%) survivors. In total, poor ICU outcome was seen 
in 171/269 (63.6%) patients. See Figure 1.
Conclusion Patients developing AKI in the fi rst 24 hours of ICU stay are 
prone to poor outcome. Future research into prognostic factors for ICU 
patients should include early AKI in their models.
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Introduction The population of the UK is ageing, with the fastest 
increase in those ≥85  years. Increased age has been repeatedly 
associated with adverse outcome and it is uncertain to what extent 
this relates to the changes of ageing in themselves, or due to other 
considerations. Age is a key variable in the majority of scoring systems 
that relate patient characteristics to adverse outcome. We aimed 
to assess change in age distribution of patients admitted to our ICU 
over 20  years and examine the relationship between age of patient, 
mortality and length of stay (LOS).
Methods Data were extracted from electronic records (WardWatcher) 
and analysed using SPSS 20, GraphPad Prism 5.0 and Excel 2007.
Results ICU patients have become older by 4.4 months/year. By 2013 
the median age was 66 and 15% of all patients are now ≥80  years  – 
a 36% increase since 1993. Compared with the reference group (61 
to 70 years), those in the older deciles have increased risk of ICU and 
hospital mortality (P <0.01). Fifteen per cent of all those 81 to 90 years 
old and 20% of those >91 years old who do not die on the ICU go on 
to die on the ward. It is unknown what proportion of these post-ICU 
deaths was unexpected. Older patients had prolonged hospital LOS 
(P <0.01) but not ICU LOS. See Figures 1 and 2.
Conclusion There are increasing numbers of older patients on ICUs in 
the UK. In analyses uncorrected for severity of illness or comorbidities, 
older patients are more likely to die on the ICU, and on the ward after 
ICU. They also spend longer in hospital prior to discharge.
Figure 1 (abstract P55). Survival.
Figure 1 (abstract P56). Proportion of patients admitted to ICU aged 
>80 years, over time.
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Introduction UK military personnel injured overseas are repatriated 
to the Royal Centre for Defence Medicine (RCDM) based at the Queen 
Elizabeth Hospital Birmingham (QEHB) in Birmingham UK. We report 
the demographics and outcomes of military patients treated on the 
ICU at RCDM using data from the Intensive Care National Audit and 
Research Centre over a 6.5-year period.
Methods Data on 570 admissions of 527 patients to the ICU at RCDM/
QEHB were analysed by ICNARC using standard methodology.
Results Some physiology and CCMDS data were missing for 175 
patients. Age, sex and mortality are described in Table  1. A total of 
90.9% of patients had traumatic injuries, 2.1% received CPR prior to 
ICU admission, 1.5% prehospital. A total of 20.6% had head, neck or 
spinal trauma. A total of 85.7% were transferred directly to the ICU from 
a military hospital overseas, others coming to the ICU following surgery 
at RCDM. Of the 382 patients with APACHE II score data the mean score 
was 11.0 (SD 4.9), probably refl ecting stabilisation in military hospitals 
overseas or during aeromedical critical care transfer. The mean number 
of ICU days was Level 3: 7.6 (SD 11.6); Level 2: 2.0 (SD 2.8). A total of 
70.4% of patients required advanced respiratory support for a mean 
of 7.5 days, and 33% required advanced cardiovascular support for a 
mean of 3.7 days.
Table 1 (abstract P57). Case mix, demographics and outcome
n 570
Male (%) 97.9
Age 25.7
Trauma (%) 90.9
Died (%) 6.8
LOS 8.8
MV (%) 70.4
CRRT (%) 10.9
Neuro (%) 24.8
CV (%) 33.2
Conclusion The data on resource utilisation for this group of patients 
may inform planning of critical care support for military operations 
overseas.
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Introduction The rate of very old patients (≥80 years old) admitted to 
intensive care has increased in the last years. Older age is associated 
with a higher prevalence of chronic diseases, including cancer [1]. The 
aim of the present study was to describe characteristics, outcomes and 
predictive factors of mortality in very old patients admitted to the ICU.
Methods We performed a retrospective analysis of all cancer patients 
who were 80 years or older admitted to the ICU between January 2009 
and December 2012 in a tertiary reference cancer center. Data were 
collected from medical records.
Results A total of 597 patients with cancer were included in the analysis. 
Hospital mortality was 28.5%. These patients were more likely to have a 
solid tumor, a localized disease and underwent surgery, chemotherapy 
or radiotherapy recently. Variables associated with hospital mortality 
in these patients were: lung cancer, metastatic cancer and at ICU 
admission vasopressor requirements, acute respiratory failure, low 
hemoglobin levels, elevated creatinine levels, elevated bilirubin 
levels, acidosis and hyperlactatemia. By the multivariate analysis, the 
following factors were independent factors associated with hospital 
mortality: lung cancer (odds ratio (OR)  = 6.3, 95% CI  = 2.6 to 15.0, 
P <0.001), lactate levels on ICU admission (OR = 1.03, 95% CI = 1.02 to 
1.04), P <0.001), bilirubin levels on ICU admission (OR = 1.16, 95% CI = 
1.04 to 1.30, P = 0.007) and creatinine levels on ICU admission (OR = 
1.58, 95% CI = 1.35 to 1.85, P <0.001).
Conclusion Very old patients with cancer present acceptable rates 
of survival after ICU admission. Similarly to younger patients, organ 
function evaluation in the fi rst hours of ICU can predict outcomes in 
this specifi c population.
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Introduction Just over 1,200 curative oesophagectomies are carried out 
in the UK annually. Although in-hospital mortality rates have fallen (12 
to 13% in 1998 to 2.5% 2013), complication rates remain high [1] with 
anastomotic failure and respiratory failure common postoperatively 
[2]. The aim of this retrospective review was to examine the outcomes 
in patients who underwent oesophagectomies in our unit between 
January 2010 and October 2012.
Methods We examined demographic data, survival (30  day and 
1 year) and length of ICU and hospital stay. Case notes were reviewed 
to identify postoperative complications including anastomotic 
breakdown, reintubation and respiratory failure. Data were analysed 
to examine the relationship between the use of postoperative non-
invasive ventilation and intraoperative fl uid volume and the incidence 
of postoperative complications.
Results Seventy-two patients were identifi ed as having undergone an 
oesophagectomy between January 2010 and October 2012. Median 
age was 65 and 82% were male. One patient died within 30 days (1.39%) 
Figure 2 (abstract P56). Post-ICU in-hospital mortality, by age.
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and nine patients had died by 1  year (12.5%). The median length of 
ICU and hospital stay was 4 days and 14 days respectively. Six patients 
had an anastomotic leak (of which two were chyle leaks). Use of non-
invasive ventilation (in 23.1% of patients) was not associated with an 
anastomotic leak (chi-square P  =  0.53), nor was the amount of fl uid 
given intraoperatively (Mann–Whitney U P = 0.410). Six patients had to 
be reintubated and this was associated with a signifi cantly increased 
length of both ICU and hospital stay (Mann–Whitney U P = 0.01 and 0.03 
respectively). Lower P/F ratios were also associated with a signifi cant 
increase in length of both ICU and hospital stay (P = 0.007 and 0.043).
Conclusion The overall mortality and morbidity rate was comparable 
with that seen nationally. Our data suggest that the use of non-invasive 
ventilation was not associated with anastomotic breakdown. A lower 
P/F ratio in the postoperative period was associated with prolonged 
ICU and hospital stay.
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Introduction The fi rst description of SAPS II dates back to 1993 [1], but 
little is known about the scoring accuracy in daily practice and factors 
possibly aff ecting it. The purpose of this study was to evaluate accuracy 
of SAPS II scoring by means of a nationwide survey.
Methods Twenty clinical scenarios, covering a broad range of illness 
severity, were randomly assigned to a convenience sample of clinicians 
or nurses of Swiss adult ICUs. They were asked to assign a SAPS II score 
(including details for each item of the score) for one scenario. Results 
were compared with a reference, as defi ned by fi ve experienced 
researchers using a Delphi method, and cross-matched with data 
related to training and quality control for scoring, information on daily 
practice of scoring, and structural and organizational properties of 
each participating ICU.
Results Sixty-three (81%) of 78 adult ICUs participated in this survey. A 
perfect match with each single reference item was found in 27 (7.8%) 
of 345 scorings. The participants’ mean SAPS II scoring was 42.6 ± 23.4, 
with a bias of +5.7 (95% CI 2.0 to 9.5) as compared with the reference 
score. There was no evidence of variation of the bias according to 
case severity, number of beds in the unit, number of residents during 
workshifts, linguistic area, profession (physician vs. nurse), experience, 
initial SAPS II training, and presence of a quality control system. The 
items with highest scoring accuracy were bilirubin, temperature and 
chronic disease (93%, 93% and 91% respectively), whereas the lowest 
agreement was found for urinary output and for the Glasgow Coma 
Scale (63% and 64%).
Conclusion This nationwide survey suggests a wide variability of SAPS 
II scoring results. On average, SAPS II was overestimated by more than 
10%, irrespective of the profession or experience of the scorer or the 
structural characteristics of the ICUs. At least one person per unit 
involved in the scoring should be trained by the national society and 
should be responsible for the scoring quality.
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Introduction Early Warning Scores (EWS) are used in UK hospitals to 
identify patients who are acutely unwell or needing urgent review. The 
National EWS (NEWS) [1] was implemented in our institution and led 
to a noticeable increase in the numbers of patients being triggered 
for escalation of medical care, although clinically this was thought 
unwarranted. This led to a potentially dangerous lack of faith in the 
NEWS by clinical staff . We assessed whether it was safe to move to 
VitalPAC™ EWS (ViEWS), a commercially available electronic EWS [2].
Methods All patients scored as ‘high risk’ by NEWS (with a score of 6 
or more) in a snapshot audit of patients in our 500-bed acute district 
general hospital were identifi ed and reviewed clinically. All of these 
patients were then recategorised using ViEWS. The clinical safety of this 
recategorisation was then assessed.
Results Forty-six patients were identifi ed in our hospital at the time of 
the snapshot as being high risk according to NEWS. After recategorising 
this cohort of patients using ViEWS, 36 were classifi ed as high risk (in 
this instance meaning a score of 5 or more). Subjectively the authors 
did not have any clinical concerns created by moving 10 patients out of 
the high-risk classifi cation.
Conclusion ViEWS is more specifi c without being less sensitive. We 
have replaced NEWS with ViEWS and feel that this is clinically safe.
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Introduction There is an unknown role for macrocirculation and 
microcirculation endpoint resuscitation, which are combined as the 
component of a prediction model for early mortality of patients with 
severe sepsis and septic shock [1,2]. The aim of this study is to develop 
a prediction model for early mortality (fi rst 120 hours after onset [3]) of 
patients with severe sepsis and septic shock based on macrocirculation 
and microcirculation endpoint resuscitation.
Methods A retrospective cohort study was conducted in adult patients 
with severe sepsis and septic shock hospitalized in the ICU, Cipto 
Mangunkusumo Hospital, Indonesia. Patients’ outcome and time to 
outcome were observed during the fi rst 120 hours after severe sepsis 
and/or septic shock onset. Independent predictors for early mortality 
were identifi ed by Cox’s proportional hazard regression analysis and 
each was quantifi ed to develop an early mortality prediction model. The 
calibration and discrimination abilities of the model were determined.
Results Subjects consisted of 268 patients. Early mortality developed 
in 70 patients. Two independent predictors for early mortality were: 
lactate clearance <10% (adjusted hazard ratio (HR) 11.81 (95% CI 6.50 
to 21.46)) and number of organ dysfunctions (two organs, adjusted HR 
1.47 (95% CI 0.58 to 3.72); >2 organs, adjusted HR 3.79 (95% CI 1.65 
to 8.69)). A scoring system as the predictive model was performed by 
assigning 1 point for two organ dysfunctions, 6.5 points for >2 organ 
dysfunctions, and 12 points for lactate clearance <10%. This scoring 
system was stratifi ed into two levels: low-risk (score <12, probability 
for early mortality 7.8%) and high-risk (score ≥12, probability for 
early mortality 72.3%) groups. The Hosmer–Lemeshow test revealed 
good precision (P = 0.745) and the area under the receiver operating 
characteristic curve showed very good discrimination ability (0.91 (95% 
CI 0.87 to 0.97)).
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Conclusion A prediction model for early mortality of patients with 
severe sepsis and septic shock can be developed based on two 
parameters, lactate clearance and number of organ dysfunctions. A 
model has been developed to predict and classify mortality risk.
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Introduction The Golden hour (GH) complies the concept that 
defi nitive trauma care must be initiated within 60 minutes in order to 
improve outcome, but evidence is confl icting [1,2]. A variety of injury 
and health loss scores are used in post-impact care for assessing the 
injury severity, probability of survival and long-term loss of health [3]. 
The aim of this study is to establish a relationship between the concept 
of GH and disability or health-related quality of life (HRQoL) in trauma 
patients and to compare injury scores and health loss scores in this 
population.
Methods We analyzed patients from a trauma registry of a 700-bed 
university hospital between January 2003 and December 2007 who 
were alive 6 months after injury. A follow-up interview with the EQ-5D 
questionnaire was conducted. Data included patient demographics, 
type of injury, ISS, RTS and TRISS scores, ICU and hospital length of stay 
(LOS), mortality and EQ-5D domains.
Results There were 78% (n  = 589) males and the average age was 
44 ± 20 years. Most trauma cases originated from metropolitan areas 
and 91% (n = 688) of patients were managed within the GH. There was 
an association of mortality with older age and penetrating trauma. 
Mortality was higher for those with shorter length of stay. Those 
treated within the GH were less likely to die. In the HRQoL analysis, over 
one-half of the patients had moderate to severe problems in the Usual 
Activities domain. The median EQ-5D Index was 0.66 (0.47 to 0.98). 
There was no association of GH with HRQoL domains 6 months after 
discharge from the ICU. For the TRISS there was a lower probability of 
survival for the patients with severe problems in the physical health 
domains. The same results were obtained for association with age and 
LOS.
Conclusion The GH may be important as a survival outcome but not 
as a HRQoL outcome. Patients with severe problems in EQ-5D physical 
health domains showed lower probability of survival, were older and 
had a longer ICU LOS.
References
1. Orwelius L, et al.: J Trauma Acute Care Surg 2012, 72:504-512.
2. Aitken LM, et al.: J Trauma Acute Care Surg 2012, 72:1702-1708.
3. European Commission Mobility and Transport Road Safety [http://
ec.europa.eu/transport/road_safety/specialist/knowledge/postimpact/
data_and_information_systems/impairment_disability_and_loss_of_
function_scales_and_scores.htm]
P64
Predicting outcomes after blunt chest wall trauma: development 
and external validation of a new prognostic model
C Battle1, S Lovett1, H Hutchings2, PA Evans1
1Morriston Hospital, ABMU Health Board, Swansea, UK; 2Swansea University, 
Swansea, UK
Critical Care 2014, 18(Suppl 1):P64 (doi: 10.1186/cc13254)
Introduction Blunt chest wall trauma accounts for over 15% of 
all trauma admissions to emergency departments worldwide [1]. 
Reported mortality rates vary between 4 and 60% [2]. Management 
of this patient group is challenging as a result of the delayed onset 
of complications. The aim of this study was to develop and validate 
a prognostic model that can be used to assist in the management of 
blunt chest wall trauma.
Methods There were two distinct phases to the overall study; the 
development and the validation phases. In the fi rst study phase, the 
prognostic model was developed through the retrospective analysis 
of all blunt chest wall trauma patients (n  = 274) presenting to the 
emergency department of a regional trauma centre in Wales (2009 
to 2011). Multivariable logistic regression was used to develop the 
model and identify the signifi cant predictors for the development of 
complications. The model’s accuracy and predictive capabilities were 
assessed. In the second study phase, external validation of the model 
was completed in a multicentre prospective study (n  = 237) in 2012. 
The model’s accuracy and predictive capabilities were re-assessed for 
the validation sample. A risk score was developed for use in the clinical 
setting.
Results Signifi cant predictors of the development of complications 
were age, number of rib fractures, chronic lung disease, use of pre-
injury anticoagulants and oxygen saturation levels. The fi nal model 
demonstrated an excellent c-index of 0.97.
Conclusion In our two-phase study, we have developed and validated 
a prognostic model that can be used to assist in the management 
of blunt chest wall trauma patients. The fi nal risk score provides the 
clinician with the probability of the development of complications for 
each individual patient.
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Introduction Crush syndrome is often encountered in natural 
disasters. It is a critical condition leading to multiple organ failure. 
However, the mechanisms by which the local traumatic injuries 
aff ect distant organs remain unknown. We paid attention to bone 
marrow-derived mononuclear cells (BMMNCs) as therapeutic strategy 
against crush injury. Transplantation of BMMNCs can elicit protection 
and regeneration against damaged organs through their paracrine 
properties and its clinical application has been realized to treat ischemia 
reperfusion-related various diseases. We have previously reported that 
multiple organ damage based on systemic infl ammatory response is 
induced in crush injury and the pathogenesis is largely dependent 
on massive ischemia–reperfusion. We investigated whether BMMNCs 
could suppress systemic infl ammation and improve mortality in a rat 
model of crush injury.
Methods To develop crush syndrome, both hind limbs of rats were 
compressed for 6 hours under weights (3.0 kg each). Rats in the treated 
group were intravenously administrated BMMNCs (1×107 cells in 1 ml 
phosphate-buff ered saline (PBS)) immediately after weight removal 
(BMMNC group) and PBS alone was administered in the control 
group (CR group). The sham group underwent the same procedure 
without compression of hind limbs (SH group). The rats were observed 
over 7  days after the injury to evaluate survival. To estimate anti-
infl ammatory eff ects of BMMNCs, sera were collected 3 hours, 6 hours 
and 24 hours after the injury. The levels of interleukin 6 (IL-6) and tumor 
necrosis factor alpha (TNFα) were measured by ELISA and statistically 
analyzed.
Results The survival rate at day 7 in the BMMNC group was 80.0%, 
and that in the CR group was 47.6%, revealing that the 7-day survival 
Critical Care 2014, Volume 18 Suppl 1 
http://ccforum.com/supplements/18/S1
S23
was signifi cantly improved by the BMMNC injection (P  <0.05). Crush 
injury-induced upregulation of serum IL-6 was signifi cantly reduced by 
the BMMNC treatment at all time points (P  <0.05). The level of TNFα 
decreased signifi cantly in the BMMNC group compared with that in 
the CR group 24 hours after the compression release (P <0.05). These 
fi ndings suggest that transplantation of BMMNCs has an ability to 
evade the devastating condition following crush injury by suppressing 
systemic infl ammation.
Conclusion The administration of BMMNCs reduced production of 
infl ammatory cytokines and improved survival rate in a rat model 
of crush injury. Cell therapy using BMMNCs might become a novel 
therapy against crush injury.
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Introduction In this study we determine the impact of a dedicated 
trauma desk on the identifi cation of patients suff ering from major 
trauma and on time to allocate critical care resources. Trauma is 
increasingly recognised as a serious global health problem and is 
the leading cause of death in those under the age of 45, accounting 
for 1,300 deaths in Scotland each year [1]. In addition, trauma 
causes considerable short-term and long-term morbidity and has 
personal, social and fi nancial impact on the population [2]. Evidence 
and expert opinion strongly support the presence of appropriately 
trained, clinically active, personnel integrated and fundamental to the 
command and control structure in order to optimise the right resource 
being dispatched to the right patient at the right time.
Methods From October 2012 to April 2013 a trauma desk, staff ed by 
experienced paramedics, was created in ambulance control with access 
to all emergency calls across Scotland. The operational hours of the desk 
were 08:00 to 18:00, 7 days a week. A customised database provided 
a data entry portal. Retrospective data were collated for comparison. 
Primary outcome measures were the number of emergency calls 
identifi ed as potential major trauma and the time to allocation of 
critical care resources. Secondary outcome measures were the eff ects 
on stand-down rates of prehospital critical care teams.
Results There were 190 activations of critical care teams during the study 
period compared with 73 from the historical data from the same time 
frame in the previous year, representing a 160% increase in activations. 
The mean time from emergency call to allocation of critical care resource 
was 6  minutes compared with 19  minutes from historical data. The 
stand-down rate for prehospital critical care resource from emergency 
calls identifi ed by trauma desk clinicians was 31.5% compared with 56% 
for those by nontrauma desk clinicians or dispatchers.
Conclusion A clinician focusing on major trauma in the ambulance 
control room improves activation times of prehospital critical care 
teams. The number of patients receiving life-saving and limb-saving 
interventions has substantially increased. The stand-down rate of 
teams following activation by the trauma desk is considerably reduced.
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Introduction Some patients presenting to the emergency department 
(ED) currently face inacceptable delays in initial treatment due to 
suboptimal initial triage. Triage scores, such as the Manchester Triage 
System (MTS), have not been well validated in unselected medical 
patients. Herein, we performed a prospective cohort study to assess 
the prognostic potential of the MTS and the prognostic biomarker pro-
adrenomedullin (ProADM) to identify patients at high initial treatment 
priority, patients with admission to the ICU, and patients who die 
within a 30-day follow-up.
Methods This is a prospective, observational cohort study including all 
consecutive medical patients seeking ED care between June 2013 and 
October 2013, except nonadult and nonmedical patients. We collected 
detailed clinical information including the initial MTS and measured 
ProADM levels on admission in all patients. Initial treatment priority 
was adjudicated by two independent, blinded physicians based on 
all available results at the time of ED discharge to the medical ward. 
To assess outcomes, data from electronic medical records were used 
and all patients were contacted by telephone 30  days after hospital 
admission. The prognostic performance of MTS and ProADM was 
assessed in multivariate regression models with area under the receiver 
operating curve (AUC) as an overall measure of discrimination.
Results We included a total of 1,452 patients (58% males, mean age 
66.6 years). A total of 20.1% (n = 292) were classifi ed as high treatment 
priority, 5.4% (n = 79) were admitted to the ICU and 4.4% (n = 64) died 
within 30 days. The initial MTS showed a good prognostic accuracy to 
predict treatment priority (AUC 0.75) and ICU admission (AUC 0.76), 
but not for mortality prediction (AUC 0.58). Initial ProADM levels 
were independent predictors for all three outcomes and signifi cantly 
improved the MTS score to AUCs of 0.78 for treatment priority, 0.80 for 
ICU admission and 0.84 for mortality.
Conclusion Within this large cohort of consecutive unselected 
medical patients seeking ED care, the MTS instrument in combination 
with a prognostic biomarker (ProADM) allowed accurate initial 
risk assessment in regard to treatment priority, ICU admission and 
mortality. A combined score has the potential to signifi cantly improve 
initial risk assessment in patients, which may translate into faster and 
more targeted care and better clinical patient outcomes.
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Introduction Our hospital has introduced the telemedicine system for 
emergency medicine (k-support) using a smart device to rectify health 
disparity and reduce the burden to general physicians since February 
2013. We have expanded to the ambulance services’ k-support toward 
further survival rate improvement.
Methods The registration device, patient information and image 
information such as magnetic resonance imaging and computed 
tomography taken in the hospital were transferred in real time to 
k-support using the smart device. Since September 2013, we newly 
developed k-support to the Kainan Fire Department Mugi branch 
offi  ce, Kainan Fire Department Hiwasa branch offi  ce, Kaifu Fire-fi ghting 
Union Kainan fi re department, and Muroto Fire-Fighting Headquarters 
Touyou branch offi  ce, and reviewed our experience of this approach 
in the use of k-support during the fi rst 3 months of the introduction.
Results k-support was used for 62 patients, and 13 (21.0%) of them 
were categorized as neurosurgical diseases. The detail of neurosurgical 
diseases consisted of six patients (46.1%) with head injury, followed 
by fi ve patients (38.5%) with cerebral infarction, one patient (7.7%) 
with cerebral hemorrhage and one patient (7.7%) with miscellaneous 
diseases. We shared the information by ambulance services to tweet the 
patient information or transmit vital signs and electrocardiograms. We 
experienced a case that was diagnosed with cardiogenic embolism and 
tried the ‘drip and ship’ method of rt-PA. The outcomes were as follows: 
hospitalization, 28 (45.2%); discharge, 18 (29.0%); and transfer, 16 (25.8%).
Conclusion Introduction of k-support is the fi rst trial in Japan. For 
emergency diseases such as ischemic heart diseases and stroke, we 
could perform responses earlier than ever by providing this system.
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Introduction Japanese emergency medical technicians are not allowed 
to perform some advanced medical practices such as a tracheal 
intubation, establishment of an intravenous line, administration of a 
drug to a patient who retains their own circulation. So medical staff  
have to be dispatched to the accident scene to give a patient such 
medical practices. In Japan, we have developed and dispersed the 
educational course of the Disaster Medical Assistance Team since 2005. 
But the role of medical teams at the scene is not widely known among 
rescue workers. It is also distant for medical staff  to coordinate rescue 
teams, because most of them do not work with rescue workers in their 
daily work. We have felt a need for practical training to achieve the 
coordination of rescue and medical teams.
Methods We held a disaster-relief training workshop from 2010 to 
2013. Prior to starting the drill, we gave two lectures about the role of a 
medical team in a rescue site and the basic knowledge of rescue skills. 
The drill was organized for 1 to 1.5 hours. The scenario was secret for 
participants. Before and after the workshop, we had a questionnaire 
survey for attitude changes about a collaborative work between a 
rescue team and a medical team.
Results A total of 160 people participated in the workshop (63 rescue 
workers, 27 ambulance workers, 33 paramedics, 37 medical staff ). At 
fi rst, rescue workers tended to downplay the importance about the 
division of roles or the establishment of command and control system 
between rescue teams and medical teams, but their attitude changed 
after the drill (P <0.05). They also understood the need to know about 
basic trauma survey skills and some medical terms.
Conclusion To achieve mutual understanding, it is important to have 
drills in which both rescue teams and medical teams participate.
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Introduction Recently, the dispatch system with a medical doctor in 
pre-hospital care has made rapid progress in Japan. We usually use 
an ambulance helicopter or an ambulance car/rapid response car for 
dispatch. In this report, we analyzed the cases in which the medical 
doctors were dispatched using both means at the same time.
Methods We analyzed 29 cases with simultaneous dispatch with the 
medical doctors using ambulance helicopter and car during October 
2012 to September 2013.
Results The average distance of dispatch was 25.6  km. The corres-
pondence to the plural patients was three trauma cases. In nine cases, 
the ambulance car was fi rst selected for the dispatch vehicle and 
the ambulance helicopter was added. In three cases, both devices 
were canceled on the dispatch way to the scene. In seven cases, the 
ambulance car was canceled. In 10 cases, the patients were transferred 
by the ambulance helicopter.
Conclusion In the selection of the dispatch means, the time to contact 
with the patient is the most important factor. However, the decision of 
the suitable means is occasionally quite diffi  cult at the moment of fi rst 
information. The ambulance helicopter and car were complementary 
to each other in the dispatch mean of the medical doctors.
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Introduction At the hospital we are faced with situations of violence, 
whether verbal or physical, especially in the emergency department 
(ED) [1]. The objective of this study is to evaluate the phenomenon 
of violence at hospitals in Lebanon, especially in the ED, and to 
recommend techniques to prevent it.
Methods A questionnaire consisting of 18 questions was sent to the 
caregivers in the ED of three randomly selected hospitals in Beirut, 
Lebanon in 2012. A total of 111 people (nurses, aides, doctors, interns, 
residents, social workers and security guards) responded to the survey 
questionnaire.
Results The majority of the surveyed people are young women (62%) 
aged between 20 and 40 years (78%) with a nursing degree (74%) and 
professional experience <5  years (48%). In total, 59% of respondents 
have experienced violence in the ED during the night (58%) from 
the patients (31%) or their companions (68%). The caregivers most 
aff ected by the violence are nurses (54%) and employees of reception 
(46%). Violence can be verbal (threats 47%, insults 36%, criticism 
18%) or physical (hitting 43%, slapping 40%, stabbing 17%). The 
dissatisfaction of the patient in his care (42%) and his anxiety (33%) are 
the most important factors in the generation of violence that may have 
repercussions on the care workers and their psychological status.
Conclusion Violence in the ED may be due to the heavy workload of 
the caregivers causing a delay in care. Secondly, patients in the ED may 
feel insuffi  ciently informed and heard by the nursing staff . The priority 
given to emergencies depending on the severity and not the order 
of arrival can be misunderstood [2]. Therefore, we recommend the 
following actions: encourage caregivers to improve their knowledge 
and training on the management of patients in emergency situations; 
train emergency caregivers to mediation, nonviolent communication 
and managing stressful situations; and increase the number of nurses 
and security guards in the ED and motivate them to ensure a better 
quality of care and minimize the delay in their care.
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Introduction Intentional self-poisoning is one of the most common 
presentations to acute medical units across the UK [1]. To our 
knowledge no studies have been published on incidence of admissions 
to critical care in England after overdose. Our aim was to investigate 
the epidemiology, clinical features and outcomes of patients admitted 
to critical care after intentional self-poisoning to establish patterns in 
our community.
Methods We performed a retrospective data collection using our 
critical care database ‘Metavision’ to select all patients admitted with a 
diagnosis of ‘overdose’. Records were scrutinised to collect information 
on patient demographics, clinical features and medical management.
Results Thirty-eight patients (male:female ratio 1:1.53) were admitted 
to critical care over a 1-year period (September 2011 to 2012). This 
represented 2.45% of the total admissions to critical care during the 
same period. The sample had a signifi cantly younger median age 
(45 years) than the standard patient population in critical care (68 years) 
during the same period (P <0.0001). Despite the young age and paucity 
of comorbidities, there was no diff erence in length of stay between 
overdose patients (2.0  days) and all other patients on critical care 
(1.58 days, P = 0.3). The median number of agents ingested was three 
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(1 to 7) with 84.2% ingesting ≥2 agents. Hypnotics and antidepressants 
made up 45% of the agents ingested. A total 92.1% of the sample 
was admitted out-of-hours or at weekends. Fifty per cent had a past 
history of overdose, 25% had a history of alcohol misuse. A total of 79% 
of patients were referred to critical care due to a low conscious level 
but only 50% required IPPV and 20% received vasopressors/inotropes. 
The mortality rate was 2.6%, with one further death 6  months after 
discharge due to alcoholic liver disease. Estimated fi nancial cost was 
£80,555 or £2,119 per patient (57 level 3 bed-days, 35 level 2 bed-days).
Conclusion Intentional self-poisoning mortality rates are low in spite 
of the number of patients admitted. Despite the young age of patients 
and lack of comorbidities, their length of stay is similar to the average 
length of stay for all patients admitted to the unit, representing a 
signifi cant fi nancial cost. Self-poisoning requiring critical care support 
is more common out-of-hours when less senior expertise is available. 
Education of junior doctors into management of overdose is therefore 
vital to ensure the early identifi cation and appropriate treatment of 
these patients.
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Introduction A number of studies have demonstrated the signifi cant 
and increasing morbidity and mortality associated with alcohol-related 
disease in the UK, and the corresponding impact this has on critical care 
services [1]. This study was designed to similarly evaluate the current 
burden of alcohol-related disease on admission rates to a regional ICU, 
but also to calculate the fi nancial costs of such admissions.
Methods Data-entry fi elds derived from recommendations in a public 
heath publication [2] were introduced to the local electronic records 
system to enable prospective data collection for all admissions that 
were either wholly or partially attributable to alcohol consumption. 
Using locally defi ned values for the cost per day of an admission to 
the ICU, depending on the maximum level of organ support required 
during the admission, it was possible to calculate the total expense 
incurred by the unit for each alcohol-related admission.
Results In 1  year from December 2012 to November 2013 inclusive, 
the ICU recorded 84 alcohol-related admissions, accounting for 
approximately 9% of annual unplanned admissions. With an average 
length of stay (5.8  days) similar to that of all other unplanned 
admissions, this totalled 534 ICU bed-days. A total of 86% of patients 
with alcohol-related conditions were male with an average age of 
46.4 years (range 15 to 83 years), and the majority (42%) presented with 
chronic conditions partially attributable to alcohol consumption. The 
number of admissions per month varied from zero in May to a peak 
of 14 in November, with the majority (40%) of admissions occurring 
over the autumn months (Figure  1). Eighty-nine per cent of patients 
with alcohol-related conditions required support for at least two organ 
failures, which subsequently equated to an overall cost to the unit of 
£725,308 and 12% of an approximate £6 million annual budget.
Conclusion The results of this study support the hypothesis that 
alcohol-related disease contributes considerably to admissions to 
this ICU. Furthermore, they have shown that the fi nancial impact was 
proportionally greater than the percentage number of admissions 
attributable to alcohol consumption, refl ecting the high frequency of 
multiorgan failure in this patient cohort.
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Introduction The objective was to analyze the clinical features of 
multiple organ dysfunction syndrome (MODS) induced by severe heat 
stroke, and to investigate the pathogenesis, diagnosis and prevention 
strategies in patients with MODS caused by severe heat stroke.
Methods We retrospectively studied nine cases of MODS caused by 
severe heat stroke, and systemically reviewed the relevant literature.
Results (1) Nine patients with MODS caused by severe heat stroke were 
all exposed in hot and humid environments. All nine patients are severe 
heat stroke, including seven cases of classic heat stroke (77.8%) and two 
cases of exertional heat stroke (22.2%). (2) Among nine cases of MODS 
caused by severe heat stroke, eight patients met the diagnostic criteria 
for SIRS. In addition, there was a signifi cant increase in blood PMN 
proportion and serum CRP of all nine patients. Of note, there was also a 
marked increase in serum IL-6 (average (36 ± 19) pg/ml; reference range 
(0 to 5.9  pg/ml)); and TNFα level (average (21  ±  10) pg/ml; reference 
range (0 to 8.1 pg/ml)), while IL-8 was normal (average (22 ± 25) pg/
ml; reference range (0 to 62 pg/ml)). (3) There were 34 organ damages 
involved in all nine patients with MODS induced by severe heat stroke. 
The kidney, circulatory and liver accounted for 58.8% of all these 
organ dysfunctions. The incidence of severe heatstroke-induced organ 
dysfunction in turn was the kidney, circulation, liver, blood coagulation, 
metabolism, brain, lungs, and gastrointestinal tract. (4)  During 
hospitalization, the common complication was pulmonary infection in 
patients with MODS caused by heat stroke. (5) After early intensive care 
of organ supportive treatment, there was a quick improvement and 
recovery in most cases in several days. Seven patients survived, and the 
average length of stay in hospital was 9.5 days.
Conclusion Severe heat stroke results in signifi cant abnormal changes 
in infl ammatory markers in patients with MODS induced by heat stroke. 
The types of organ dysfunction in heat stroke-induced MODS are 
usually distinct from those of infection and trauma. After active cooling 
and intensive organ function supportive treatment, most patients 
recovered in a relatively short period.
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Introduction The systemic eff ect of infl ammatory mediators released 
after severe burn is a severe cardiovascular dysfunction called burn 
Figure 1 (abstract P73).
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shock. Patients need vasopressor infusion to maintain adequate 
delivery of oxygen but it could have deleterious eff ects on skin perfusion 
and worsen the burn depth. This shock could result from the interplay 
of the initial hypovolemia and the release of multiple infl ammatory 
mediators [1]. It has been shown that a low-dose of hydrocortisone 
could reduce the shock duration but the mechanisms involved remain 
unclear. We investigated the systemic genomic response after severe 
burn injuries and determine whether patterns of gene expression 
could be associated with a low dose of glucocorticoids.
Methods Thirty burn patients with over 30% of total body surface 
area were enrolled into a randomized double-blind clinical study. 
Fifteen patients were treated with a low dose of hydrocortisone and 
15 patients were treated with placebo. Whole blood samples were 
collected after shock onset (S1) before any treatment, 1  day after 
treatment beginning (S2), and 120 hours and 168 hours after the burn 
injury (S3/S4). Blood samples of 13 healthy volunteers were collected. 
Pangenomic expression was evaluated with Aff ymetrix HG-U133plus 
2.0 microarrays. Moderated t tests and F test were used to compare 
burn patients with controls and gene expression profi les between the 
two groups (B–H correction, P <0.05).
Results Severe burn injury induced the deregulation of a considerable 
number of genes (n  >2,200 at S1) in comparison with controls with 
an increased number of deregulated genes over time. Within burn 
patients, more than 300 genes were deregulated by hydrocortisone 
over time. The treatment had a rapid eff ect on gene expression, 339 
and 627 genes were diff erentially expressed at S2 and S3 respectively. 
However, the number of these genes decreased drastically at S4 (only 
24 genes signifi cant). The genes identifi ed at S2 were mostly related to 
the decrease of growth, development and quantity of leukocytes but 
these biological processes were not found signifi cant at S3, indicating 
that the action of glucocorticoid in the response to burn injury is short 
lived and time dependent.
Conclusion This study is an informative overview of the genomic 
responses after burn injuries. More importantly, it is the fi rst study 
providing information about mechanisms involved in glucocorticoid’s 
reduced shock duration after burn.
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Introduction The Managed Clinical Network for Care of Burns in 
Scotland (COBIS) was launched in April 2007. Primary aims included 
establishing and maintaining a registry of complex burn injury in 
Scotland and setting mechanisms to regularly audit outcome of burn 
treatment against nationally agreed standards of care. On behalf of 
COBIS, we present 3-year incidence and mortality data of Scottish 
patients admitted with a complex burn injury in this abstract.
Methods From January 2010 onwards, data were prospectively 
collected for all patients in Scotland with complex burn injury admitted 
to Scottish burns units. Data collection was initially on a paper pro 
forma, but subsequently evolved into a web-based audit data capture 
system to securely link hospital sites involved in the delivery of care of 
complex burns. Data collected included extent and mechanism of burn, 
presence of airway burn or smoke inhalational injury, comorbidities, 
complications, length of stay, interventions and mortality. Quality, 
completeness and consistency of data collection are audited with 
feedback to the individual units.
Results In a population of approximately 5.3 million, the annual 
incidence of complex burn injury is 499 to 537 (9 to 10 per 100,000). 
The incidence of a major burn is 5% of burn admissions. The hospital 
mortality from a burn is 1 to 2.2%. See Table 1.
Conclusion From these data, Scotland now has comprehensive national 
fi gures for complex burn injury. This allows for benchmarking against 
other international indices, few of which provide comprehensive 
data. COBIS data can now also be correlated with other mortality data 
sources. As data quality improves, detailed analysis of mortality data 
will allow COBIS to identify contributing issues aff ecting burns patients. 
Some issues identifi ed already are that patients with burns often die 
soon after their discharge from hospital of other related and unrelated 
causes. Subsequent analysis of this will allow COBIS to identify and 
address issues that may be contributing to these statistics.
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Introduction The majority of burns injuries are considered accidental, 
although previous studies have identifi ed demographic factors 
associated with higher risk of burns such as socioeconomic deprivation 
[1] and being from ethnic minority groups [2]. This study aims to 
identify population subgroups in London at high risk of burns injuries 
requiring admission to a burns centre through geographic mapping 
and socioeconomic statistics.
Methods Records of all paediatric and adult inpatients admitted to the 
burns centre at Chelsea and Westminster Hospital were retrospectively 
reviewed for age, ethnic group and deprivation score of residence, 
as measured by the English Index of Multiple Deprivation 2010. 
Corresponding population data for London were obtained.
Results In total, 2,195 patients from London were admitted between 
January 2009 and August 2013, with 1,963 (89.4%) classifi ed as having 
accidental injuries. A total 1,725 (87.8%) of accidental burn injuries 
occurred in the patients’ own homes. Patients from ethnic minorities 
have the highest rate of burn injury at 7.1 per 100,000 population per 
annum (P  <0.0001). Patients below the median for socioeconomic 
deprivation in London are more likely to suff er burn injuries (P <0.0001). 
Patients from the most deprived quartile are more likely to suff er burns 
injuries of >10% TBSA (P = 0.04), and have a trend towards higher rates 
of ICU admission (P = 0.144). Domestic accidental burns were mapped 
to their respective administrative wards, and the rate of burns per 
100,000 was calculated and divided into quintiles. The areas with the 
top quintile of burn injury rate, of up to 18.8 per 100,000 population per 
year, were almost four times the national average.
Conclusion Ethnicity, socioeconomic deprivation and geographical 
location appear to be risk factors for burn injuries. Identifying such 
groups may allow the development of targeted preventative strategies.
References
1. Mistry RM, Pasisi L, Chong S, Stewart J, She RB: Socioeconomic deprivation 
and burns, Burns 2010, 36:403-408.
2. Tan KT, Prowse PM, Falder S: Ethnic diff erences in burn mechanism and 
severity in a UK paediatric population, Burns 2012, 38:551-555.
P78
Eff ectiveness of noncontrast abdominal multidetector CT for 
evaluating the patient with renal insuffi  ciency in the emergency 
department
HJ Lee, E Kang, JH Shin
SMG-SNU Boramae Medical Center, Seoul, South Korea
Critical Care 2014, 18(Suppl 1):P78 (doi: 10.1186/cc13268)
Introduction Contrast-enhanced abdominal multidetector CT (MDCT) 
is an important and accurate diagnostic approach for acute abdominal 
Table 1 (abstract P76). Numbers of complex burns in Scotland 2010 to 2012
 2010 2011 2012
Adult 304 392 399
Paediatric 195 185 138
Adult >15% 27 28 26
Paediatric >15% 0 2 4
Mortality 5 7 13
Critical Care 2014, Volume 18 Suppl 1 
http://ccforum.com/supplements/18/S1
S27
symptoms or searching for an infection focus such as sepsis. But 
contrast dye can cause renal damage especially in critically ill patients. 
Noncontrast CT can be alternative options but few studies have 
shown the eff ectiveness of noncontrast MDCT. We want to evaluate 
the eff ectiveness of noncontrast abdominal MDCT in the emergency 
department.
Methods This is a retrospective chart review study conducted in a 
single tertiary academic hospital from January 2011 to April 2012. 
Patients were enrolled if they visited the emergency department with 
acute abdominal symptoms or infection signs, had elevated serum 
creatinine level, and received noncontrast 16-channel MDCT.
Results During study period, 78 patients with renal insuffi  ciency 
received noncontrast abdominal CT. Causes of CT were infection 
focus (48, 61.5%), abdominal pain (21, 26.9%), GI bleeding (4, 5.2%), 
abnormal labs (3, 3.9%), ureter stone (1, 1.3%) and abdominal 
distension evaluation (1, 1.3%). Any abnormal CT fi ndings were 
detected in 61 (78.2%) patients. For 42 (53.8%) patients, noncontrast 
CT fi ndings showed diagnostic abnormal fi ndings. For excluding 
abdominal pathology, 35 (44.9%) were helpful. In one (1.6%) case with 
hematochezia, noncontrast CT showed no benefi t for patient diagnosis. 
Additional contrast-enhanced CTs were performed in 32 (41%) and 
additional fi ndings were found in fi ve cases (6.4%). There were 40 
patients with severe sepsis or septic shock. Abnormal CT fi ndings were 
found in 30 (75%) cases. Additional contrast enhanced CT was done for 
13 (32.5%) patients but no additional information was detected.
Conclusion Performing noncontrast abdominal MDCT to the patient 
with renal insuffi  ciency for evaluating acute abdominal symptoms, 
severe sepsis or septic shock in the emergency department was 
feasible and eff ective.
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Introduction Fever is a common problem in adults visiting the 
emergency department (ED) [1]. Although it is important to treat the 
cause of fever, symptomatic management of fever is also necessary. 
Multiple studies are available on the effi  cacy of various antipyretics in 
children, but very little has been done in adults [1,2]. Hence we aimed 
to compare the antipyretic effi  cacy of intravenous (i.v.) paracetamol 
and intramuscular (i.m.) diclofenac in adult patients presenting with 
fever to the ED.
Methods In this parallel-group, open-label trial, participants aged 14 
to 75  years who had a temperature more than 38.5°C were enrolled 
and treated in the ED, Alkhor, Hamad Medical Corporation, during the 
period June 2008 to December 2011. Patients were randomly assigned 
to receive either 1,000 mg i.v. paracetamol or 75 mg i.m. diclofenac. The 
primary outcome was degree of reduction in mean oral temperature 
at 90 minutes and the secondary outcomes were degree of reduction 
at 30, 60 and 120  minutes. The effi  cacy of drugs was assessed by a 
superiority comparison. Analysis was done using intention-to-treat 
(ITT) principles.
Results In total, 139 patients received i.v. paracetamol and 150 received 
i.m. diclofenac. The mean age was 35.5 ± 14.24 and 36.4 ± 14.98 years 
in the i.m. diclofenac and i.v. paracetamol groups respectively. The 
majority of the patients were males in both groups. After 90 minutes 
both groups showed a signifi cant reduction in mean temperature, i.m. 
diclofenac showing a greater reduction (–1.44 ± 0.43(95% CI –1.4, –2.5)) 
than i.v. paracetamol (–1.35 ± 0.46 (95% CI –1.3, –3.1) P <0.0001). After 
120 minutes, a signifi cant diff erence was observed in the mean change 
from the baseline temperature between the groups, –1.81 ± 0.46 (95% CI 
–1.7, –2.9) in i.m. diclofenac versus –1.63 ± 0.55 (95% CI –1.5, –4.1) in the 
i.v. paracetamol group (P <0.0001). Signifi cant changes in temperature 
were observed in favor of i.m. diclofenac over i.v. paracetamol at each 
time point from 60 minutes through 120 minutes inclusive.
Conclusion Both i.m. diclofenac and i.v. paracetamol showed signifi cant 
antipyretic activity, with diclofenac having a greater eff ect. In view of 
ease of administration, i.m. diclofenac can be used as a fi rst-choice 
antipyretic in febrile adults in the ED.
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Introduction A pragmatic survey of shock management in Thai 
physicians is unavailable. The objective of this study is to identify shock 
management patterns for severe sepsis and septic shock in Thailand.
Methods Two thousand questionnaires were sent to physicians 
involved in caring for shock patients across Thailand. The frequency 
scale was defi ned as fi ve levels by patient proportion estimation at 
routine practice.
Results Between April and August 2013, a total of 533 questionnaires 
(26.7%) were returned. For severe sepsis and septic shock management, 
a total of 406 physicians (76.2%) reported their routine usage of 
quantitative resuscitation protocols. Urine output, mean arterial 
pressure and central venous pressure are more frequently used than 
central venous oxygen saturation and lactate as the resuscitation 
endpoint. Nearly 80% of these had an ‘often and always’ resuscitation 
goal within 6 hours. Most physicians (65.3%) never used procalcitonin. 
The antimicrobial empirical treatments were started within 1 hour for 
87.7% and these were continued less than 5 days in 67.3% before de-
escalation. Crystalloid was the common initial fl uid therapy in 98.9%. 
The most common used vasopressor was norepinephrine (69.6%). 
The median of cortisol threshold level for steroid replacement therapy 
was 15 (interquartile range, 5 to 19) mg/dl. Almost all of the physicians 
used hydrocortisone (96.4%). The median daily dose of hydrocortisone 
was 300 mg (interquartile range, 200 to 300). Nearly 50% divided the 
dose every 8 hours and 31.8% infused continuously. The duration for 
tapering was varied (33.6% in 2 to 3  days). Central venous pressure 
(CVP) and fl uid challenge test were more frequently used for preload 
evaluation than new fl uid responsiveness methods. Less than 15% still 
used a pulmonary artery catheter in their routine practice.
Conclusion Most physicians manage shock with protocols. 
Hemodynamic endpoints are preferred to tissue perfusion targets. Early 
antimicrobial therapy and de-escalation are routine practices without 
use of infective biomarkers. Crystalloid is preferred rather than colloid 
at initial resuscitation. CVP and fl uid challenge are still more popular 
than new fl uid responsiveness methods on preload assessment. 
Hydrocortisone is the most common steroid prescription in septic 
shock but the threshold of initiation, frequency and discontinuation 
are varied.
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Introduction NCEPOD reported in 2012 that 75% of patients had 
warning signs for cardiac arrest present prior to their arrest [1]. NICE 
recommends a vital sign-based early warning score (EWS) to identify 
patients at risk of deterioration or death [2]. In our trust, audit has 
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shown that only 20 to 35% of patients trigger the clinical EWS prior to 
cardiac arrest. Jarvis and colleagues proposed that an EWS based on 
common laboratory fi ndings can predict patient mortality [3]. The aim 
of this study, as part of a wider review of cardiac arrests in our hospital, 
was to determine whether the laboratory early warning score (LEWS) 
might be of use identifying patients at risk of cardiac arrest in our trust.
Methods Retrospective data collected identifi ed cardiac arrest calls that 
lead to CPR or defi brillation over 6 months. The LEWS was calculated 
according to the formula devised by Jarvis and colleagues [3]. LEWS ≥4 
for males and ≥5 for females was taken as being a ‘trigger’ as suggested 
by Jarvis and colleagues [3].
Results Eighty-nine cardiac arrest calls lead to CPR and/or defi brillation 
in this time period. Of these, 65 patients had had blood tests within the 
last 24 hours. Median LEWS was 6 for females and 7 for males (range 1 
to 12). Most patients (77%) had a LEWS trigger (≥4 for females and ≥5 
for males).
Conclusion The collected data suggest that more patients at risk 
of cardiac arrest in our hospital might be identifi ed using a LEWS 
rather than a clinical EWS. It is evident that for a clinical EWS regular 
observations need to be taken and are subject to user error. Clinical EWS 
could also not be sensitive enough or there is a failure to implement it 
successfully. LEWS can be generated automatically when bloods are 
taken. The downside is that it relies on bloods being done. It is beyond 
the scope of this study to examine the sensitivity/specifi city of LEWS 
or suggest that LEWS should replace EWS. We suggest that LEWS may 
compliment EWS by identifying a diff erent group of patients. The 
ongoing data collection aims to correlate the clinical EWS for each 
patient directly with their LEWS to confi rm the initial fi ndings.
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Introduction The Rapid Response Team (RRT) represents an important 
advance in the management of deteriorating ward patients and 
is recommended as a patient safety measure. Most studies on RRT 
evaluate the eff ects of its implementation on rate reduction of 
cardiopulmonary arrest outside the ICU and hospital mortality, with 
limited information on the criteria for RRT calls and predictive factors 
associated with hospital mortality [1,2]. Therefore, our objective was 
to determine what factors are associated with hospital mortality for 
patients seen by the RRT at the Hospital Israelita Albert Einstein (HIAE).
Methods A total of 1,051 patients assessed by RRT between January 
and December 2012 at the HIAE, a general hospital with 650 beds, were 
included in this study. Multivariate analysis was used to evaluate what 
variables were associated with hospital mortality. Early RRT call was 
defi ned as RRT activation <48 hours from hospital admission and late 
RRT call if it happened >48 hours from hospital admission.
Results The mean age was 64 ± 19.8 years and 48% (n = 513) were male. 
There were 513 (48.9%) early calls and 537 (51.1%) late calls. The main 
reasons for RRT activation were respiratory failure in 18.2% (n = 191) 
and severe sepsis/septic shock in 13.1% (n = 138). The distribution of 
RRT activation was uniform over the 24-hour period, with 50.5% (n = 
531) of calls during the day (7:00  a.m. through 7:00  p.m.) and 49.5% 
(n = 520) overnight (7:00 p.m. through 7:00 a.m.). A total of 460 patients 
(43.7%) were admitted to the ICU. The multivariate analysis showed the 
following variables as signifi cantly associated with hospital mortality: 
age (OR 1.03; 95% CI 1.01 to 1.04), late (>48 hours) RRT call (OR 2.73; 
95% CI 1.79 to 4.71), acute change in oximetry saturation to <90% (OR 
1.94; 95% CI 1.28 to 2.95) and acute change in respiratory rate to <8 or 
>28 breaths/minute (OR 1.79 95% CI 1.09 to 2.94).
Conclusion In this study, hospital mortality predictive factors for 
patients seen by the RRT were: age, acute respiratory failure and late 
RRT call.
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Introduction To improve early detection and the mortality rate of in-
hospital cardiac arrest, the Emergency Response Team (ERT) system 
was planned and implemented since June 2009 to detect pre-arrest 
conditions and for any concerns. The ERT consisted of on-duty 
physicians and nurses from emergency department. ERT calling criteria 
[1,2] consisted of acute change of HR <40 or >130 beats per minute, 
systolic blood pressure <90 mmHg, respiratory rate <8 or >28 breaths 
per minute, O2 saturation <90%, acute change in conscious state, acute 
chest pain or worried about the patients. From the data on ERT system 
implementation in our hospital in the early phase (during June 2009 to 
2011), there was no statistical signifi cance in diff erence in in-hospital 
cardiac arrest incidence and overall hospital mortality rate. Since the 
introduction of the ERT service in our hospital, we have conducted a 
continuous educational campaign to improve awareness in an attempt 
to increase use of the service.
Methods To investigate the outcome of the ERT system in in-hospital 
cardiac arrest and the overall hospital mortality rate, we conducted 
a prospective, controlled before and after examination of the long-
term eff ect of an ERT system on the incidence of cardiac arrest. We 
performed chi-square analysis to fi nd statistical signifi cance.
Results Of a total 623 ERT cases from June 2009 until December 
2012, there were 72 calls in 2009, 196 calls in 2010, 139 calls in 2011 
and 245 calls in 2012.The number of ERT calls per 1,000 admissions in 
year 2009 to 2010 was 7.69, 5.61 in 2011 and 9.38 in 2013. The number 
of Code Blue calls per 1,000 admissions decreased signifi cantly from 
2.28 to 0.99 per 1,000 admissions (P <0.001). The incidence of cardiac 
arrest decreased progressively from 1.19 to 0.34 per 1,000 admissions 
and was signifi cant in diff erence in year 2012 (P  <0.001). The overall 
hospital mortality rate decreased by 8% from 15.43 to 14.43 per 1,000 
admissions (P = 0.095).
Conclusion ERT system implementation was associated with 
pro gressive reduction in cardiac arrests over the 3-year period, 
especially statistically signifi cant in diff erence in the fourth year 
after implementation. We also found an inverse association between 
number of ERT use and the risk of occurrence of cardiac arrests, but we 
found no diff erence in overall hospital mortality rate.
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Introduction The provision of intensive care has lagged behind 
demand [1]. Intensive care services in the UK have signifi cant resource 
restriction. Although rationing of beds has been a priority, equally 
important is to establish patient safety and also identify strategies 
to prevent admissions [2], which echoes the importance of early 
recognition of deteriorating patients and prompt intervention. This 
study evaluates the epidemiology of unplanned admissions to the ICU 
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in order to identify the associative trends that led to the admission and 
hence to mitigate the processes of interventional strategies.
Methods A prospective observational evaluation of ICU unplanned 
admission through in-hospital ward referral over a 3-month duration. 
Anonymised data collection included baseline demographics, timing 
and grade of referral, Modifi ed Early Warning Score (MEWS) at time 
of referral, clinical reason for referral, senior review prior to referral, 
MEWS trend 24 hours prior to referral, if appropriate basic intervention 
commenced, time delay between referral and assessment by the ICU 
team, organ failure score, length of stay (LOS) and survival status.
Results So far 22 patients have been enrolled, of which 60% of the 
unplanned admissions were ‘out of  hours’, 60% of admissions were 
from medical wards and 33% from surgical wards. Pneumonia was the 
main reason for referral and admissions were due to respiratory failure 
requiring advanced ventilator care. Twenty per cent of the patients 
did not have senior medical review for at least 4 hours prior to the ICU 
referral. Basic interventions such as antibiotics and intravenous fl uids 
were not started in a few patients (13%) prior to admission. The mean 
ICU review time from referral was 70 minutes and the mean MEWS at 
the time of referral was 8.
Conclusion The study is due to be completed by mid-January 2014. 
With the limitation of incompleteness, the fi ndings so far have 
alluded that there is a necessitation for change and education for 
early identifi cation and intervention in deteriorating patients. The 
completed study with outcomes (that is, survival rates and ICU LOS) will 
help us identify whether delay or defi ciency in the early management 
had a causal relationship.
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Introduction In 1995, Smith and colleagues fi rst proposed the use 
of low-dose CT KUB for the diagnosis of ureteric colic [1]. Since then, 
popularity of this imaging modality has increased due to a number 
of reasons: a sensitivity of 94 to 97%, a specifi city of 96 to 99%, lack 
of intravenous contrast injection and speed of examination. The UK 
College of Emergency Medicine considers CT KUB as best practice 
for radiological investigation of renal colic. A review of the literature 
suggests that the true positive rate (number of patients diagnosed 
with an obstructing or symptom causing calculus) should be between 
47.5 and 67% and alternative diagnoses should be confi rmed in 
approximately 10% of patients imaged [2].
Methods All patients over the age of 18  years who had a CT KUB 
requested from the emergency department of the Homerton University 
Hospital, London over a period of 3 months, between May 2012 and 
July 2012, were identifi ed. Individual case notes were examined and 
data were collected on an Excel spreadsheet. Data were analysed and 
results were divided into positive for renal colic (true positive), positive 
for other pathology (other signifi cant diagnoses) and negative results.
Results A similar previous audit carried out in 2009 at the same hospital 
demonstrated a true positive rate of 48.5%. The 2012 audit examined 
the outcome of 124 consecutive scans and a true positive rate of 29% 
(P  =  0.0006) was identifi ed. Alternative diagnoses were 10% in 2009 
compared with 17% in 2012 (P = 0.02).
Conclusion The true positive rate of CT KUB for renal colic has decreased 
signifi cantly. We are getting more negative scan results and more scans 
diagnosing other signifi cant pathology. The authors believe clinicians’ 
thresholds for imaging may have decreased due to the apparent low-
dose radiation of CT KUBs. Furthermore, there is a perceived ease of 
access to CT KUB imaging and hence this modality appears to be being 
used to identify other signifi cant pathology.
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Introduction The aim of this audit was to evaluate whether guidelines 
produced in a local intensive therapy unit (ITU) with regard to blood 
sampling practices were being adhered to. The volume of blood taken 
and cost was also evaluated.
Methods A retrospective audit investigating the number of routine 
blood tests ordered on an ITU in January 2013 was performed. There 
were no exclusion criteria. Computer-based data collection systems 
were used to gather data with regard to patient details and when blood 
tests were processed. The collection bottles used were examined to see 
how much blood was needed to fi ll them. Thirty nurses were asked how 
much ‘dead space’ blood they discarded, and an average was recorded. 
The cost of the blood tests was also calculated. Following a period of 
education regarding the contents of the guidelines, this was re-audited 
in July 2013 retrospectively.
Results The initial audit examined 901 patient-days. Urea and 
electrolytes (U&Es) and full blood counts (FBC) were requested in line 
with the guidelines. Liver function tests (LFTs), bone profi le, magnesium 
and a clotting screen were ordered approximately four times more 
than advocated. It was shown that many bone profi les and magnesium 
tests were probably inappropriate requests. Moreover, twice as much 
blood was taken from patients compared with that recommended by 
guidelines (almost 16 litres in total in January). The cost of the routine 
blood tests in January was €11,019. If guidelines had been followed, 
the estimated yearly saving would be €65,588. During the repeat audit, 
731 patient-days were examined. The amount of times a U&E or FBC 
were requested was largely unchanged, but the amount of times a LFT, 
bone profi le, magnesium and clotting screen were ordered reduced 
by approximately 50%. Almost one-third more blood was taken from 
patients when compared with the suggested volume in the guidelines. 
The cost of the blood tests done in July was €5,423. Despite an 
improvement in the frequency of blood testing, an estimated €21,907 
per year could still be saved.
Conclusion The results underline that the unit’s guidelines were not 
being followed. The re-audit does show an improvement in adherence. 
Patients are being exposed to unnecessary blood tests, which not 
only is implicated in iatrogenic anaemia, but also places a signifi cant 
fi nancial burden on the department. Continued staff  education and 
encouragement are required in order to aid the transition from current 
to recommended practice.
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Introduction The direct central line entry rate is believed to be a major 
contributor to the risk of central line infections. At Mayo Clinic there was 
historically no schedule for obtaining blood for analysis in the pediatric 
ICU. A policy was implemented in May 2013 to restrict blood draws to 
three times daily for nonemergent blood draws only. We subsequently 
conducted this study to determine whether implementation of this 
policy was associated with a reduction of blood draws as well as 
central-line unique entries.
Methods Data from the laboratory as well as database for Central Line 
Unique Entry were analyzed at baseline and after implementation of 
the policy change for identifi cation of any decrease in line entry/blood 
draw rate. As per Mayo Clinic policy, IRB approval was not required for 
a QI project.
Results In the pre-implementation phase there were a total of 4,602 
blood draws in 5,227 total patient-days, (0.88 blood draws/patient-
days). After consolidation, there were 1,095 blood draws in 1,491 
patient-days (0.73 blood draws/patient-day; 17% reduction). Of these 
line entries, 24.7% were arterial line entry, 50.5% central line entry and 
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12.5% were by peripheral venipuncture. After policy implementation, 
these numbers were 10.9%, 49.7%, and 23.8%, respectively. The 
average central line unique entry after blood draw consolidation 
decreased from 10 to 6 line entries/central line-day. Consolidation of 
blood draws was associated with a cost saving of $7,200/year.
Conclusion Consolidating time frames for blood draws in the PICU was 
associated with decreased central line entries, decreased utilization of 
vascular access teams, and decreased phlebotomy cost. We hypothesize 
that this policy will be associated with a decreased incidence of CLABSI 
when more patients are included for analysis.
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Introduction The standard arterial system for blood withdrawal 
provides no impediment to intra-arterial injection [1] and bacterial 
contamination. We assessed the probability of inadvertent intra-arterial 
injection, transmission of bacterial contamination and surveyed the 
nursing staff  following introduction of a non-injectable connector 
(NIC).
Methods The simulation study data were descriptive. Fifteen junior 
doctors managed a case of bradycardia. A simulated patient had a 
peripheral intravenous cannula, central venous catheter and brachial 
arterial cannula. Atropine was available on request. A laboratory 
controlled trial compared a transmission of bacteria through standard 
arterial ports against the NIC when attached to an arterial sampling 
hub. The colonization rates were compared using a two-tailed Fisher’s 
exact test. A closed-circuit arterial sampling system was designed. A 
contaminated syringe tip was inserted into the conventional arterial 
hub or the NIC to take an arterial sample. Transducer fl ush fl uid fl owing 
to the patient bloodstream was cultured. In a survey the nursing staff  
were asked questions regarding the NIC system, including its manual 
handling, sampling of the blood and its durability.
Results In the simulation study 10/15 clinicians (67%) injected atropine 
directly into arterial cannula via a three-way tap. Five of 15 doctors 
(34%) injected safely. In the laboratory study, swabbing of the arterial 
hubs showed bacterial contamination of all of the samples in the 
standard group (20/20) and no contamination in the NIC group (0/20), 
P  <0.0001. Eighty-fi ve per cent (17/20) of samples in the standard 
arterial group showed onward transmission of pathogens to the 
patient circulation, and none of the patient samples taken from the NIC 
group were contaminated (0/20), P <0.0001. In the survey, 80% of the 
nurses found manual handling of a new device equally simple and 20% 
even simpler. Sampling of the blood was equally challenging for 87% 
participants. Ninety-four per cent found similar durability of the new 
device and better protection against accidental intra-arterial injection. 
Sixty-six per cent of the nursing staff  would replace the standard 
system with a NIC.
Conclusion Most of the doctors would inject the drug intra-arterially. 
Currently, no other device is available to eliminate accidental intra-
arterial injection or bacterial transmission. The nursing staff  found the 
management of the NIC equally challenging.
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Introduction The purpose of this study is to demonstrate the effi  cacy 
of our novel hemostatic technique for burn surgery. Signifi cant 
bleeding remains a challenge in tangential excision of the burn wound. 
Although various techniques to reduce intraoperative blood loss have 
been described, there is an absence of uniformity and consistency in 
their application. In the literature, the blood loss in burn surgery is 
estimated to be at least 123  ±  106 ml per percentage body surface 
area excised [1]. Recently we developed a novel hemostatic technique 
using a silicone gel dressing (SI-AID®; ALCARE Co., Ltd, Tokyo, Japan) 
to stop intraoperative bleeding. Briefl y, soon after tangential excision 
with the Humby knife, the wounds were sprayed with thrombin and 
with 1:100,000 adrenalin solution and wrapped tightly with SI-AID® 
for a full 10 minutes. Burn wounds on limbs were tangentially excised 
under tourniquet control and wrapped with SI-AID® before defl ation of 
the tourniquet. After defl ation of the tourniquets, we waited for a full 
10 minutes. When the SI-AID® was removed, any major bleeders were 
cauterized, and the grafts were applied after rinsing the wounds with 
warm saline.
Methods This is a prospective observational study. From 1 January to 
31 October 2013 we collected preoperative and 24-hour postoperative 
hemoglobin levels from the patients who underwent tangential 
excision for burn injury, and calculated blood loss in the perioperative 
period. The data for amounts of blood transfusion, excised area, and 
harvest area were also collected.
Results Nine patients, 13 operations were included. The mean excised 
area was 8.3  ±  4.6% body surface area. Estimated blood loss was 
35.3 ± 38.3 ml per percentage body surface area excised. Intraoperative 
transfusion requirements were 86.2 ± 134.5 ml per case. The mean skin 
graft take rate was 4.5 ± 2.2%.
Conclusion The application of our new technique during burn excision 
and grafting resulted in a remarkable reduction in blood loss and 
transfusion requirements.
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Introduction Patients with cancer now live longer due to advances 
in oncologic treatment. ICU admission is progressively more frequent 
in this population due to complications of both disease and therapy. 
Pericardial eff usion leading to tamponade and hemodynamic 
compromise is a common fi nding in the advanced stages of disease 
and results in death if not treated on an urgent basis. However, we 
do not know midterm outcomes of these patients after pericardial 
drainage. The aim of this study was to evaluate prospectively cancer 
patients with pericardial tamponade regarding mortality in 6 months.
Methods We evaluated consecutively 105 patients with cardiac 
tamponade consecutively admitted to the ICU of the Cancer 
Institute, a reference cancer hospital, during a 3-year period. Baseline 
characteristics and clinical data were collected prospectively. Patients 
were followed during a 6-month period.
Results Fifty-three patients (50%) were female. Most patients had 
a previous diagnosis of lung neoplasia (46%), followed by breast 
neoplasia (15%) and hematological neoplasia (15%). The mean 
Karnofsky performance status of patients was 70. All these patients 
underwent surgical drainage in a mean time of 1.5  hours since ICU 
admission until surgery. Length of ICU stay was 8 days (2 to 15) and of 
hospital stay was 16 days (8 to 31). ICU mortality was 75.2%, hospital 
mortality was 83% and at 3 months 92% of patients were dead.
Conclusion Cardiac tamponade is a serious complication in cancer 
patients. Despite adequate treatment, high rates of mortality are 
observed. Prospective studies are needed to better defi ne whether in 
these patients end-of-life discussion should be implemented early in 
the diagnosis, avoiding futility.
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Introduction Massive bleeding remains a leading cause of potentially 
preventable death after cardiovascular surgery [1]. Conventional 
coagulation tests (CCT) fail to characterize the multiple hemostatic 
abnormalities observed in surgical patients and are further limited by 
their slow results and poor correlation with transfusion requirements. 
We assessed the clinical impact of goal-directed coagulation manage-
ment based on rotational thromboelastometry (ROTEM) in patients 
undergoing an emergent cardiovascular surgical procedure.
Methods Over a 2-year period, data from 71 patients were collected 
prospectively and blood samples were obtained for coagulation 
testing. Administration of packed red blood cells (PRBC) and 
hemostatic products was guided by an algorithm using ROTEM-
derived information and hemoglobin level. Based on the amount of 
PRBC transfused, two groups were considered: high bleeders (≥5 PRBC; 
HB) and low bleeders (<5 PRBC; LB). Data were analyzed using the chi-
square test, unpaired t test and ANOVA as appropriate.
Results Preoperatively, the HB group (n  = 31) was characterized by 
lower blood fi brinogen and decreased clot amplitude at ROTEM 
compared with the LB group (n = 40). Intraoperatively, larger amounts 
of fi brinogen, fresh frozen plasma and platelets were deemed 
necessary to normalize the coagulation parameters in the HB group. 
Postoperatively, the incidence of major thromboembolic and ischemic 
events did not diff er between the two groups (<10%) and the observed 
in-hospital mortality was signifi cantly less than expected by the 
POSSUM score (22% vs. 35% in HB group and 5% vs. 13% in LB group).
Conclusion ROTEM-derived information is helpful to detect early 
coagulation abnormalities and to monitor the response to hemostatic 
therapy. Early goal-directed management of coagulopathy may 
contribute to improve outcome after cardiovascular surgery.
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Introduction In critically ill patients a number of elective procedures 
with a potential risk of bleeding are performed. In this population, 
coagulation disorder is frequently observed according to the commonly 
used laboratory parameters of APTT (activated partial thromboplastin 
time), INR (international normalized ratio) or platelet count. 
Thromboelastometric examination (ROTEM) evaluates coagulation 
of whole blood and thus allows the testing of all components of 
secondary hemostasis.
Methods Identifi cation of patients with pathological values of INR, 
APTT and platelet count before the planned intervention. Through a 
questionnaire we found a potential correction of coagulopathy carried 
out by the physician. Performed ROTEM methodology: ExTEM (external 
pathway thromboelastometry). Inclusion criteria: normal curves and 
values, CT (clotting time), MCF (maximum clot fi rmness). In those 
patients with normal values according to ExTEM examination, no blood 
products were administered.
Results During March 2013 to November 2013, 40 patients were 
identifi ed as relevant, 26 men of average age 53 years and 14 women 
of average age 59 years. Central venous cannulation, 12 cases; surgical 
revision, nine cases; thoracic drainage, six cases; percutaneous 
endoscopic gastrostomy, fi ve cases; nephrostomy, two cases; epidural 
catheter, two cases; tracheostomy, two cases; permanent pacemaker, 
one case; and bronchoscopy, one case. INR normal values were 0.8 to 
1.2. The average measured value of INR in men was 1.50, and in women 
was 1.35. APTT normal values were 0.8 to 1.2. The average measured 
value of APTT in men was 1.09, and in women was 1.14. Platelet count 
was 150×109/l to 300×109/l level of platelets; in men was 252.57, 
in women was 226.78. ExTEM CT normal values at 41 to 74 seconds: 
measured value of CT in men was 62.58 and in women was 62.07. 
MCF normal values were 50 to 72 mm; the measured value of MCF in 
men was 69.88, and in women was 73.28. Considered administration 
of blood derivatives: fresh frozen plasma, 123 transfusion units 
(TU); platelets, 4 TU. In the examined cases no blood products 
were administered to avoid the risk of bleeding before the elective 
procedure. No periprocedural bleeding was observed.
Conclusion Examination EXTEM in these patients proved to be 
eff ective and effi  cient in predicting bleeding complications in relation 
with interventions routinely performed on the ICU. Also, these specifi c 
cases proved not indicated and thus ineff ective administration of 
blood products.
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Introduction Hemostatic disorders are common in intensive care 
patients and can be used as prognostic markers. The aim of this 
prospective clinical study was to study platelet function in intensive care 
patients using point-of-care viscoelastic and platelet aggregometry 
instruments and platelet count (PLC). Our hypothesis was that 
measurement of platelet function would give more information about 
disseminated intravascular coagulation (DIC), morbidity and mortality 
than PLC alone.
Methods Patients admitted to the ICU were monitored with ROTEM 
viscoelasticity and a new Multiplate platelet aggregometer; routine 
coagulation analyses; International Society of Thrombosis and 
Haemostasis and Japanese Association for Acute Medicine DIC 
calculated scores; Sequential Organ Failure Assessment scores, 
Simplifi ed Acute Physiology Score III  – Expected Mortality Rate; and 
real in-hospital mortality. Nonparametric tests were chosen for all 
statistical evaluation. P <0.05 was considered signifi cant.
Results A total of 128 patients with diff erent diagnoses were studied, 
with 330 sampling events. Multiplate analyses correlated signifi cantly 
with PLC and ROTEM. However, there were more test results below 
normal limits for Multiplate analyses than for ROTEM in patients with 
thrombocytopenia. Multiplate, ROTEM and PLC results were low in 
patients with high SOFA scores and in patients with overt DIC scores. 
These test results at admission to the ICU did not diff er between 
survivors and nonsurvivors, and did not correlate with the length of 
stay in the ICU. Only EMR diff ered between survivors and nonsurvivors 
and correlated with ICU length of stay.
Conclusion In this study, Multiplate and ROTEM did not provide any 
more information than PLC about DIC, morbidity and mortality. 
Multiplate showed lower platelet function in more patients with 
low platelets than ROTEM. In patients without thrombocytopenia, 
all patients had normal ROTEM results, but 36% of Multiplate 
measurements were low. This higher sensitivity of the Multiplate to 
measure lowered platelet function needs to be linked to real bleeding 
in larger patient series to defi ne its clinical signifi cance.
P94
Retrospective observational study of interventional radiology and 
critical care coagulopathy
SP Hibbs, S McKechnie, M Little, M Desborough
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Introduction Estimation of bleeding risk in critical care patients 
undergoing interventional radiological procedures is often made on 
the basis of coagulation tests. If these tests are abnormal, fresh frozen 
plasma (FFP) is often given to reduce the risk of bleeding, despite 
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a poor evidence base for this practice [1]. There is a relatively better 
evidence base for prophylactic platelet transfusion [2] but clinical 
practice is inconsistent. Through a retrospective study we aimed to 
establish the thresholds triggering use of FFP and platelet transfusion 
prior to percutaneous drain insertion in critical care patients.
Methods We identifi ed 68 consecutive chest, abdominal or pelvic drain 
insertions in 54 critical care patients between 1 January 2008 and 11 
October 2012 at the John Radcliff e Hospital, Oxford. The prothrombin 
time (PT), activated partial thromboplastin time (APTT) and platelet 
counts prior to each procedure were recorded to demonstrate triggers 
used for FFP and platelet transfusion. In patients who underwent 
transfusion, the next PT, APTT and platelet count post transfusion were 
recorded.
Results Patients who received FFP had a mean PT of 18.5  seconds 
while those who did not receive FFP had a mean PT of 16.7 seconds 
(unpaired t  test, P  =  0.275). In the nine patients given FFP, the pre-
transfusion mean PT was 18.5  seconds whereas the post-transfusion 
mean PT was 17.1 seconds (paired t test, P = 0.235). The pre-transfusion 
mean APTT was 41.6 seconds compared with a post-transfusion mean 
APTT of 38.1 seconds (paired t test, P = 0.127). No patient had platelet 
levels below the recommended transfusion threshold [2], but one 
patient nevertheless received a double-dose platelet transfusion. One 
patient had a recorded immediate bleeding complication. Their PT was 
15.6 seconds and APTT was 40.9 seconds and they did not receive FFP. 
One patient had an anaphylactic reaction whilst receiving FFP.
Conclusion This study demonstrates inconsistent use of FFP, with no 
signifi cant diff erence in PT between patients who were transfused 
and those that were not. The lack of eff ect of FFP transfusion on PT 
and APTT creates additional confusion for its prophylactic usage. 
There is a need for further clarifi cation around coagulopathy and 
interventional radiology in the critical care setting. The low absolute 
incidence of bleeding complications and risk of complications from 
transfusion lends further support to the view that FFP should be used 
therapeutically rather than as prophylactic ‘cover’ [1].
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Introduction Few studies have investigated the use of viscoelastic 
devices for monitoring of treatment with LMWHs and to our knowledge 
there are no studies comparing diff erent LMWHs or diff erent 
visocoelastic methods.
Methods Enoxaparin (Klexane) and tinzaparin (Innohep) were added 
to 2 ml citrated blood from 10 intensive care patients to obtain plasma 
concentrations of 0, 0.5, 1.0 and 1.5 IU/ml enoxaparin and tinzaparin, 
respectively. The study was approved by the local ethics committee 
and with written consent (relatives). Clot formation and clot retraction 
was studied using ROTEM and ReoRox.
Results ROTEM analysis showed prolonged clot formation (CT) with 
increasing concentrations of enoxaparin and tinzaparin (more so). 
ReoRox analysis showed that the initiation of clot formation (COT1) 
increased with increasing doses of enoxaparin and tinzaparin (more so), 
as did the progression of clot formation (COT2 – COT1), thus resulting in 
a prolongation until complete clot formation (COT2). See Table 1.
Conclusion Clot initiation was prolonged with both drugs and detected 
by both ROTEM and ReoRox. Clot formation was more decreased with 
tinzaparin than enozaparin and only detected by ReoRox.
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Introduction Heparin is commonly given in our neonatal ICU (NICU) 
by continuous intravenous infusion. Heparin is diluted in parenteral 
nutrition bags and administered over a period of 24 hours with in-line 
fi ltration. However, there are no data on heparin stability in parenteral 
nutrition bags, especially on its compatibility with 50% dextrose mainly 
present in bags. The aim of our in vitro study was to determine heparin 
stability in parenteral nutrition bags prepared in a NICU after 24-hour 
infusion and to assess its interaction or not with 50% dextrose.
Methods We prepared both types of bag: parenteral nutrition bags 
whose composition was defi ned in the unit, including sodium heparin 
(77 UI/ml); and bags containing only sodium heparin diluted in 50% 
dextrose (193 UI/ml). These bags (n = 6 per type) were infused over a 
period of 24 hours with and without in-line fi ltration. Heparin activity 
was measured using a chromogenic anti-Xa method in bags just being 
prepared (references for other measures) and after 24-hour infusion 
and in effl  uents at the end of infusion line after 24 hours.
Results Our results show values of heparin activity measured in bags 
and effl  uents with and without in-line fi ltration after 24-hour infusion 
for both types of bag assessed (Tables 1 and 2). Results are expressed as 
median values (minimum to maximum) in percent.
Table 1 (abstract P95). ROTEM and FOR variables for enoxaparin and tinzaparin
 Enoxaparin Tinzaparin
  0 IU/ml 0.5 IU/ml 1.0 IU/ml 1.5 IU/ml 0.5 IU/ml 1.0 IU/ml 1.5 IU/ml
ROTEM
 CT (seconds) 175 ± 38 191 ± 89* 214 ± 109 249 ± 94* 223 ± 53* 289 ± 84* 326 ± 125*
 CFT (seconds) 77 ± 23 87 ± 21 85 ± 16 83 ± 22 74 ± 27 84 ± 45 80 ± 21
 Angle (°) 75 ± 4 74 ± 4 75 ± 3 74 ± 4 75 ± 5 73 ± 5 73 ± 4
 MCF (mm) 62 ± 5 61 ± 7 63 ± 5 63 ± 6 68 ± 7* 64 ± 8 65 ± 6*
 MCL (%) 8 ± 4 6 ± 3+ 5 ± 4 2 ± 5* 5 ± 4* 6 ± 4 2 ± 4*
ReoRox
 COT1 (seconds) 30 ± 5 35 ± 7* 39 ± 8* 38 ± 11* 36 ± 4* 45 ± 9* 48 ± 15*
 COT2 (seconds) 65 ± 11 76 ± 13* 82 ± 14* 85 ± 20* 74 ± 5* 91 ± 16* 108 ± 29*
 COT2 – COT1 (seconds) 34 ± 10 41 ± 8* 43 ± 9* 46 ± 10* 37 ± 4 46 ± 11* 51 ± 15*
Data presented as median (SD). *P <0.05 compared with 0 IU/ml LMWH.
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Table 1 (abstract P96). Results of heparin activity in parenteral nutrition 
bags
  Bags at T0 +  Effl  uent at T0 + 
 Bags at T0 24 hours 24 hours
With fi ltration 100 95.45 97.73
 (84.09 to 109.09) (79.55 to 102.27) (75.00 to 104.55)
Without fi ltration 100 97.62 97.62
 (90.48 to 114.29) (83.33 to 107.14) (83.33 to 114.29)
Table 2 (abstract P96). Results of heparin activity in bags with sodium 
heparin in 50% dextrose
  Bags at T0 +  Effl  uent at T0 + 
 Bags at T0 24 hours 24 hours
With fi ltration 100 95.10 98.04
 (77.45 to 108.82) (90.20 to 109.80) (95.10 to 100.98)
Without fi ltration 100 92.23 94.17
 (85.44 to 107.77) (88.35 to 100.00) (86.41 to 108.74)
Conclusion We conclude that there is no loss of heparin activity 
when drug is infused over 24  hours for both types of bag prepared, 
with and without in-line fi ltration, showing heparin activity remains 
stable during this period and there is no interaction of drug with other 
nutrient components of bags, especially 50% dextrose.
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Introduction Anticoagulation with unfractionated heparin in cardiac 
surgery patients has several limitations, and above all the risk of 
heparin-induced thrombocytopenia. Bivalirudin is a direct thrombin 
inhibitor, use of which in cardiac surgery patients has expanded in 
recent years. The aim of the study was to analyze two strategies for 
introducing bivalirudin in this setting (as secondary drug switching 
from heparin or as primary anticoagulant) and to evaluate clinical 
outcomes.
Methods Data from 100 propensity matched patients who received 
heparin (Group H, n = 50) or bivalirudin (Group B, n = 50), from January 
2009 to January 2012, in a cardiac surgery ICU of a university hospital 
were analyzed. Bivalirudin was administered as either fi rst-line or 
second-line drug after heparin discontinuation if heparin-induced 
thrombocytopenia was presumed.
Results Bivalirudin treatment was associated with a reduction of major 
bleeding (P = 0.05) compared with the control group. Interestingly, in 
an intention-to-treat analysis, patients receiving primary bivalirudin 
showed a signifi cant reduction in minor bleeding (P  =  0.04), and 
mortality (P  =  0.01) compared with the secondary bivalirudin group, 
and similarly if compared with UFH and secondary bivalirudin patients 
(P = 0.01 and P = 0.05 respectively). Predictors of hospital mortality at 
multivariate analysis included urgent admission (OR = 2.7; 95% CI, 1.03 
to 7.2; P = 0.04), septic shock (OR = 8.0; 95% CI, 2.26 to 28.7; P <0.005) and 
primary therapy with UFH (OR = 19.2; 95% CI, 2.2 to 163.9; P = 0.007).
Conclusion Novel anticoagulant strategies might play a crucial role 
in critically ill cardiac surgery patients. In a propensity-matched 
population, our study showed that primary bivalirudin anticoagulation 
may reduce bleeding complications and mortality. Further studies are 
therefore warranted.
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Introduction The oral direct and selective factor Xa inhibitor edoxaban 
(Daiichi Sankyo) is currently available in Japan for the prophylaxis 
of venous thromboembolism (VTE) in patients undergoing major 
orthopedic surgery and is undergoing investigation in phase III trials 
for the prevention of stroke in patients with atrial fi brillation and the 
treatment and secondary prevention of VTE. The primary complication 
of any available anticoagulant therapy is the risk of bleeding. Rapid 
reversal of anticoagulation may be necessary in patients requiring 
emergency treatment due to uncontrolled bleeding. Prothrombin 
complex concentrates (PCC) are frequently used to reverse the eff ect of 
vitamin K antagonists such as warfarin and have also been suggested 
to be potentially eff ective in reversing the eff ects of the new oral 
anticoagulants. The present study was therefore designed to determine 
whether the four-factor PCC Beriplex® can eff ectively reverse bleeding 
and normalize coagulation following edoxaban administration in a 
rabbit kidney injury model.
Methods Rabbits were treated with a high intravenous bolus dose of 
edoxaban (1,200 μg/kg) followed by the administration of Beriplex® (25 
to 75 IU/kg). Bleeding was assessed based on the time to hemostasis 
and the total blood loss after induction of a standardized kidney injury. 
In parallel, the following biomarkers of hemostasis were determined: 
factor Xa inhibition, prothrombin time (PT), activated partial thrombo-
plastin time (aPTT), whole blood clotting time (WBCT), and thrombin 
generation (TGA).
Results The results confi rmed increased and prolonged bleeding 
of edoxaban-treated animals following standardized kidney injury 
compared with vehicle administration. Parallel monitoring of 
biomarkers of hemostasis showed a prolongation of PT, aPTT, WBCT, 
and changes in thrombin generation parameters. Subsequent 
administration of Beriplex® resulted in a dose-dependent reversal 
of edoxaban-induced bleeding as indicated by reduced time to 
hemostasis and total blood loss. Both parameters achieved statistical 
signifi cance compared with placebo at the Beriplex® dose of 50 IU/kg 
under fully blinded study conditions. The biomarkers correlating best 
with Beriplex®-mediated edoxaban anticoagulation reversal included 
PT, WBCT and endogenous thrombin potential.
Conclusion In summary, Beriplex® treatment eff ectively reversed 
edoxaban-induced anticoagulation in an animal model of acute 
bleeding at clinically relevant dose levels.
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Use of a specifi c antidote to dabigatran (idarucizumab) 
reduces blood loss and mortality in dabigatran-induced and 
trauma-induced bleeding in pigs
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Introduction The reversal of the anticoagulant eff ects of the new 
oral anticoagulants in severely bleeding patients requires new 
therapeutic strategies. This study investigated the eff ectiveness of a 
specifi c antidote for idarucizumab to reverse bleeding in a dabigatran 
anticoagulated pig trauma model.
Methods After ethical approval, male pigs (n  = 30) were given 
dabigatran etexilate for 3 days (30 mg/kg bid p.o.), and the sham group 
(n = 6) received placebo. To achieve supra-therapeutic anticoagulation, 
dabigatran was infused prior to injury on day 4 in anesthetized pigs, and 
the sham group received placebo. A standardized blunt liver injury was 
infl icted and blood loss (BL) was recorded 10 minutes post trauma. The 
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dabigatran-treated animals were randomized (n = 6/group) to a single 
injection of idarucizumab at 30, 60 or 120 mg/kg i.v. or vehicle (control 
animals). Blood loss and hemodynamic variables were monitored over 
4 hours or until time of death. Data were analyzed by ANOVA (± SD) and 
by the log-rank test.
Results Dabigatran levels were 1,147 ± 370 ng/ml with no diff erences 
between groups prior to injury. BL in sham animals was 409 ± 53 ml 
10  minutes after injury and 700  ±  107  ml after 4  hours (survival rate 
100%). Anticoagulation with dabigatran (control animals) resulted in 
signifi cantly higher BL 10 minutes after injury (801 ± 66 ml, P <0.05). 
Mortality in these animals was 100%, with a mean survival time 
of 121  minutes (range: 90 to 153  minutes; P  <0.05 vs. sham and 
idarucizumab-treated animals). Total BL in dabigatran-treated animals 
was 2,977  ±  316 ml. In contrast, treatment with idarucizumab was 
associated with a dose-dependent reduction in BL. The lowest dose of 
30 mg/kg resulted in 17% mortality (1/6 animals) and BL was reduced 
by 50% (1,586 ± 619 ml). BL was further reduced in animals receiving 
60 (1,077 ± 103 ml) or 120 mg/kg idarucizumab (1,137 ± 121 ml; both 
100% survival). Hemodynamic parameters and markers of shock were 
similar to pre-trauma levels in latter groups receiving idarucizumab.
Conclusion This study demonstrates for the fi rst time that 
anticoagulation with dabigatran can be reversed eff ectively and 
safely by idarucizumab. Even under supra-therapeutic dabigatran 
concentrations, the antidote decreased blood loss and mortality in this 
lethal pig animal model. Thus, data from clinical studies are warranted 
to confi rm the fi ndings of this study.
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Introduction Bivalirudin is a direct thrombin inhibitor that is 
increasingly used in patients undergoing mechanical circulatory 
support as it presents many advantages compared with heparin. The 
aim of this study was to describe our experience with bivalirudin as 
primary anticoagulant in patients undergoing ventricular assist device 
(VAD) implantation.
Methods An observational study on the 12 consecutive patients 
undergoing VAD implantation from October 2011 at out institution. 
Five patients were implanted the Heart Mate II LVAD (Thoratec Corp., 
Pleasanton, CA, USA), six patients the Heartware HVAD (HeartWare 
Inc., Miramar, FL, USA), and one patient a Cardiowest Total Artifi cial 
Heart (Syncardia Systems Inc., Tucson, AZ, USA). Patients received a 
continuous infusion of bivalirudin, with a starting dose of 0.025  μg/
kg/hour. The target activated partial thromboplastin time (aPTT) was 
between 45 and 60 seconds.
Results Patients never received heparin during hospitalization 
nor had a prior diagnosis of HIT. Preoperative platelets count 
was 134,000  ±  64,000  platelets/mm3. The bivalirudin dose was 
0.040  ±  0.026  mg/kg/hour, and the duration of therapy was 5 
(5 to 12) days. The lowest platelet count during treatment was 
73,000  ±  23,000  platelets/mm3. No thromboembolic complications 
occurred. Two episodes of minor bleeding from chest tubes which 
subsided after reduction or temporary suspension of bivalirudin 
infusion were observed. Six patients required blood red cell 
transfusions, and one patient had one fresh frozen plasma transfusion. 
No platelet transfusions were performed during treatment. The ICU 
stay was 8 (7 to 17) days, and the hospital stay 25 (21 to 33) days.
Conclusion Bivalirudin is a valuable option for anticoagulation in 
patients with VAD, and can be easily monitored with aPTT. The use of 
a bivalirudin-based anticoagulation strategy in the early postoperative 
period may overcome many limitations of heparin, and above all the 
risk of HIT which is higher in patients undergoing cardiac surgery. 
Bivalirudin should no longer be regarded as a second-line therapy for 
anticoagulation in patients with VAD.
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Introduction Free hemoglobin (fHb) can scavenge nitric oxide and 
induce vasoconstriction [1]. The fHb content may be higher in older 
blood bags. We studied whether old red blood cell (RBC) transfusion 
increases plasma fHb in septic patients and if this aff ects the 
microvascular response.
Methods Twenty septic patients randomly received either fresh 
(<10  days storage) or old (>15  days) RBC transfusion. Plasma fHb 
was measured before and 1  hour after transfusion; the sublingual 
microcirculation was assessed with sidestream dark-fi eld imaging. 
The perfused boundary region (PBR) was measured as an index of 
glycocalyx damage [2]. The thenar Tissue Hb index (THI) was measured 
(near-infrared spectroscopy).
Results fHb increased in the old RBC group (Figure  1). THI increased 
in both groups, while SDF parameters were unaltered. Negative 
correlations were found between ΔfHb and changes in total vessel 
density (r = –0.57, P <0.01; Figure 2) and THI (r = –0.71, P <0.001). These 
relations were lacking in patients with PBR <2.68 μm.
Figure 1 (abstract P101). Changes in fHb.
Figure 2 (abstract P101). Relation between changes in fHb and TVD.
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Conclusion Old RBC transfusion increased plasma fHb in septic 
patients. Increasing plasma fHb levels after transfusion were associated 
with decreased microvascular density and lower increase in tissue 
Hb content. This relation might be blunted when the glycocalyx is 
preserved.
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Introduction The aim of study was to assess the fatty acid (FA) 
composition of blood plasma in multiple organ dysfunction syndrome 
(MODS).
Methods The objects of the study were 18 people with multiple organ 
failure (35.6  ±  8.7  years) of various etiologies. The blood of 16 healthy 
volunteers aged 37.7  ±  3.2  years served as control. There were also 
analyzed blood plasma and fragments of artery luminal part from patients 
who died from diff erent causes. Analysis of FA was conducted using 
capillary gas–liquid chromatography. Quantitative evaluation of individual 
FA content was made as a mass percentage of their total. Statistical analysis 
was performed using the Mann–Whitney U test (P <0.05).
Results Normalized contents of oleic and palmitoleic monounsaturated 
FA increase in patients with MODS, while the levels of stearic saturated 
FA and polyunsaturated FA decrease, as compared with the control. 
Considering these results, we conclude that blood plasma FA 
composition in MODS biased towards composition of FA characteristic 
of adipose and muscle tissue triglycerides, which quantitatively 
predominant monounsaturated FA, and stearic and polyunsaturated 
FA have a signifi cantly lower level [1,2]. Thus, the composition of the 
FA in MODS refl ects the degree of lipolysis activation in fat depots. As 
a result of these processes there should occur an imbalance in vascular 
endothelial cells between monounsaturated and polyunsaturated FA 
and, as a consequence, changes in metabolism of eicosanoids and 
other lipid vasoactive mediators should develop. One should note that 
in plasma of people who died in a hospital environment due to various 
reasons, similar changes in FA blood composition are observed. The 
degree of change of FA composition in postmortem blood samples 
presumably primarily depends on severity and duration of a previous 
critical and serious condition. Postmortem changes presumably exert 
some infl uence on blood plasma FA composition. Moreover, the 
composition of FA in blood plasma in the case of MODS is similar to 
that of FA in the luminal part of the artery wall. This suggests a decrease 
in the infl uence of intertissue diff erences in lipid composition on 
metabolic processes.
Conclusion Given that the monounsaturated FAs in the case of MODS 
enter the bloodstream primarily from adipose and muscle tissues, 
one can assume that their blood plasma level refl ects the degree of 
hypermetabolism processes in the organism.
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Introduction The present study investigated the relationship between 
age [1] and biomarkers of coagulation and fi brinolysis [2] and their 
impact on outcome in severe sepsis patients.
Methods A prospective observational study of adult patients with 
severe sepsis was conducted in a single academic hospital. Plasma was 
analyzed for coagulation and fi brinolysis markers on days 1, 2, and 3. 
Patients were stratifi ed according to the age 67 years, which was the 
point of the Youden index (maximum sensitivity + specifi city – 1) in a 
receiver operation characteristics plot for a logistic regression model of 
in-hospital mortality.
Results For the in-hospital survival rate, that of older sepsis patients 
was signifi cantly lower than younger patients, 9/15 (60.0%) versus 
27/28 (96.4%), P  <0.05. Older patients had markedly higher total 
plasmin activator inhibitor-1 (TPAI-1) on day 1, thrombin–antithrombin 
complex (TAT) on days 2 and 3, and fi brin monomer complex on day 2, 
and markedly lower plasminogen (PMG) on day 3 and alpha-plasmin 
inhibitor (αPI) on days 2 and 3 compared with younger patients (all 
P <0.05). Age was an independent predictor of high TAT on days 2 and 
3, high fi brin monomer complex on day 2, low PMG on day 3, and low 
αPI on days 2 and 3 after adjusting for some cofactors and covariables. 
TPAI-1 on day 2, TAT on day 2, and PMG on day 3 were risk factors of in-
hospital mortality in older sepsis patients (Table 1).
Table 1 (abstract P103). Univariate analysis of logistic regression for 
in-hospital mortality
 HR 95% CI P
PAI-1 day 2 1.02 1.0 to 1.06 <0.01
TAT day 2 1.49 1.02 to 19 <0.05
PMG day 3 0.64 0.1 to 0.95 <0.01
SOFA day 1 1.2 0.9 to 1.69 0.21
IL-6 day 1 0.99 0.9 to 1.00 0.21
Conclusion In severe sepsis, older patients displayed a biomarker 
profi le suggestive of enhanced response of coagulation and fi brinolysis 
system compared with younger patients. Change of some markers 
depended on age and may contribute to the poor outcome in older 
patients.
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Introduction Antifi brinolytic drugs recently have been associated 
with adverse outcomes in patients undergoing cardiac surgery. We 
reviewed our experience with prophylatic ε-aminocaproic acid in 
patients undergoing cardiac surgery at InCor – Heart Institute.
Methods We retrieved data on 2,852 consecutive patients undergoing 
cardiac surgery at revascularization at Duke between 1 January 
2004 and 31 December 2008. We compared patients receiving or 
not prophylatic ε-aminocaproic acid in coronary artery bypass graft 
surgery, or valve procedures or combined ones. We evaluated baseline 
characteristics, intraoperative data and severe clinical endpoints 
during 30 days.
Results A total of 2,852 patients were included in the analysis and 1,389 
(48.7%) received prophylactic ε-aminocaproic acid. The others did not 
receive any antifi brinolytic. In the risk-adjusted model, survival was 
similar among patients treated with aminocaproic acid or not treated 
(1.9 vs. 1.6%, P = 0.48). Bleeding in 24 hours was reduced in the treated 
group as compared with the nontreated (391 vs. 472  ml, P  =  0.012). 
There were no diff erences regarding acute renal failure, stroke and 
infection in 30 days.
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Conclusion In cardiac surgery, prophylactic use of aminocaproic acid 
reduces bleeding and does not result in higher incidence of acute 
complications.
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Introduction Atypical haemolytic uraemic syndrome (aHUS) is 
a rare, life-threatening disease in which patients experience un-
controlled complement activation leading to systemic thrombotic 
microangiopathy (TMA). We report on the eff ect of eculizumab (Ecu), a 
terminal complement inhibitor approved for the treatment of aHUS, in 
the largest prospective clinical trial in aHUS.
Methods Adult aHUS patients (≥18 years) with platelets <150×109/l and 
LDH ≥1.5 ULN were recruited into a 26-week single-arm, phase 2 study 
evaluating Ecu treatment. Patients with STEC-HUS (Shiga toxin and E. 
coli) and severe ADAMTS13 defi ciency (activity <5%) were excluded. 
Identifi cation of complement mutation was not required for enrolment. 
The primary endpoint was complete TMA response (platelet and LDH 
normalisation (>150×109/l and <ULN, respectively) and <25% increase 
in serum creatinine from baseline (BL)). Other effi  cacy evaluations 
measured platelet counts and eGFR improvement (by MDRD).
Results Forty-one patients were enrolled (mean (SD) age 40.3 (15.3) 
years; 28 (68%) females), 30 (73%) of whom with fi rst presentation of 
aHUS (median 2 weeks before Ecu). BL mean (SD) platelets and eGFR 
were 119 (66.1) ×109/l and 17.3 (12.1) ml/minute/1.73 m2, respectively. 
Thirty-eight (93%) patients received Ecu for 26  weeks. Table  1 shows 
improvements in outcomes. Dialysis was discontinued in 20 (83%) 
among the 24 patients requiring dialysis at inclusion. Ecu was generally 
well tolerated, with no deaths or unexpected safety concerns. 
Meningococcal infections occurred in two patients, one of whom 
continued treatment.
Table 1 (abstract P105). Outcomes at 26 weeks in adult aHUS patients 
receiving Ecu
Complete TMA response, n (%) patients 30 (73); 95% CI 57 to 86
Platelet count normalisation, n (%) patients 40 (98); 95% CI 87 to 100
Mean (SD) platelet count increase from baseline, ×109/l 135 (114); P <0.0001
Mean (SD) eGFR increase from baseline ml/minute/1.73 m2 29.3 (23.6); P <0.0001
Conclusion Results from this large prospective clinical trial in adult 
patients with aHUS confi rm prior trials with Ecu to inhibit complement-
mediated TMA, improve renal and haematological outcomes and show 
the benefi t of early diagnosis and treatment. There were no unexpected 
safety concerns. The trial is ongoing.
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Introduction Restrictive transfusion practice in recent randomized 
trials and systematic reviews continues to have favorable outcomes [1]. 
Despite this, substantial variability in transfusion practice persists [2]. 
It is important to identify contemporary variability, and which patient, 
provider, and institutional factors drive this variability. Therefore, we 
performed a retrospective analysis hypothesizing that red blood cell 
(RBC) transfusion practice remains variable and is infl uenced by patient 
characteristics and institutional transfusion culture.
Methods We performed a multicenter retrospective analysis within the 
ongoing prospective randomized, Age of Blood Evaluation (ABLE) trial. 
The patient population included patients admitted to the ICU with an 
anticipated length of invasive or non-invasive mechanical ventilation 
>48  hours and who required a fi rst RBC transfusion during the fi rst 
7 days of ICU admission. As of March 2013, completed and verifi ed data 
from 45 sites in Canada, France, and the UK were included. Sites with at 
least 12 patients were included in site analysis. The primary outcome is 
the association of enrolling centers on the median hemoglobin prior 
to transfusion.
Results As of March 2013, there were 1,288 patients randomized 
in the ABLE study. The median patient age was 63  years (IQR 50 to 
74). The majority of patients were emergent admissions (97%) with 
nonoperative diagnoses (85%), including respiratory illness (27%) and 
sepsis (18%). Bleeding was infrequent (0.4%). At least one comorbidity 
was common (43%), frequently signifi cant cardiac disease (14%) and 
diabetes (12%). There is signifi cant variability in the median pre-
transfusion hemoglobin across diff erent sites (P  <0.05). The median 
pre-transfusion hemoglobin by site was 75  g/l (IQR 71 to 77). Six of 
24 sites had a signifi cantly higher, and four had a signifi cantly lower, 
median transfusion threshold compared with the median. Signifi cant 
variability in the median pre-transfusion hemoglobin remained in 
multivariate analysis, after adjustment for age and type of ICU.
Conclusion There was a 16  g/l diff erence in median hemoglobin 
between the lowest and highest site and wide inter-site variation. 
These diff erences may be due to transfusion education, monitoring 
and blood-bank enforcement practices. Site, not country, remains a 
signifi cant predictor of transfusion. Future directions in transfusion 
best practices should focus on local transfusion culture. Signifi cant and 
nonevidence-based variability persists in transfusion thresholds for 
critically ill patients.
References
1. Carson, et al.: Cochrane Database 2012, 4:CD002042.
2. Barr PJ, et al.: Transfusion 2011, 51:1684-1694.
P107
A liberal strategy of red blood cell transfusion reduces 
cardiovascular complications in older patients undergoing cardiac 
surgery
R Nakamura1, JL Vincent2, J Fukushima1, J Almeida1, F Bergamin1, C Park1, 
E Osawa1, M Sundin1, A Muller1, F Galas1, L Hajjar1
1Instituto do Cancer do Estado de São Paulo, Brazil; 2Erasme Hospital, 
Université libre de Bruxelles, Brussels, Belgium
Critical Care 2014, 18(Suppl 1):P107 (doi: 10.1186/cc13297)
Introduction Owing to their high risk in cardiac surgery, it is essential 
to defi ne which transfusion strategy results in a lower rate of cardio-
vascular complications in older patients [1]. The aim of this study was 
to compare clinical outcomes after the implementation of either a 
restrictive or a liberal transfusion strategy in patients aged 60 years and 
above.
Methods This study was a substudy of the Transfusion Requirements 
After Cardiac Surgery study. In this subgroup analysis we included all 
patients aged 60 years and above randomized to a restrictive or a liberal 
strategy of RBC transfusion. A composite endpoint for cardiovascular 
complications was used and defi ned as a combination of 30-day all-
cause mortality and severe cardiovascular morbidity.
Results The primary composite endpoint – all-cause 30-day mortality, 
cardiogenic shock, or myocardial infarction  – occurred in 9.6% of 
patients in the liberal strategy group and in 18.4% in the restrictive 
strategy group (P  =  0.041). The incidence of cardiogenic shock was 
5.2% in the liberal group and 12.8% in the restrictive group (P = 0.031) 
and of myocardial infarction was 2.2% in the liberal group and 5.6% 
in the restrictive group (P = 0.203). There was no signifi cant diff erence 
between transfusion strategies in 30-day mortality rates (4.4% vs. 8%, 
respectively; P = 0.23).
Conclusion In this prospective, randomized clinical trial, older patients 
submitted to a restrictive strategy of RBC transfusion had a rate of 
cardiovascular complications in 30  days after cardiac surgery twice 
as high than a liberal strategy. In this group of patients, probably 
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untreated anemia would be more harmful than in a younger or 
healthier population undergoing cardiac surgery.
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Introduction Anemia and its association with mortality among 
emergency department (ED) patients with suspected infection has to 
our knowledge never been investigated. We hypothesize that anemia 
as well as high hematocrit increases the risk of in-hospital death among 
these patients.
Methods A prospective observational study of adult ED patients with 
suspected infection presenting to an urban, academic medical center 
ED at Beth Israel Deaconess Medical Center, Boston, MA, USA. Inclusion 
criterion was clinically suspected infection at ED presentation. Patients 
were enrolled over a 1-year period. Laboratory and clinical data were 
collected at enrollment. Primary outcome was in-hospital mortality. 
Logistic regression was performed determining the independent 
mortality odds adjusting for confounders.
Results A total of 4,952 patients were enrolled with an in-hospital 
mortality rate of 4% and a mean age of 58 ± 21 years. In total, 4,683 
(95%) patients had their hematocrit measured: 3,857 (82%) patients 
had a normal hematocrit (30 to 44%), 413 (8.8%) patients had 25 to 
29% hematocrit, and 66 (1.4%) patients ≤24% hematocrit. A total of 248 
(5.3%) had a high hematocrit (≥45%). After adjusting for age, present 
or prior cancer, diabetes I and II, end-stage renal disease, AIDS and liver 
disease, anemia remained an independent predictor of in-hospital 
mortality with odds ratios of respectively 1.7 and 2.5 with worsening 
anemia as well as high hematocrit, with odds ratio 2.3 (Table  1). The 
AUC for the model was 0.78.
Table 1 (abstract P108). Eff ect of severity of anemia or high hematocrit on 
in-hospital mortality
Hematocrit Mortality OR P value
≥45% 2.3(1.3 to 4.1) 0.007
30 to 44%, ref. 1.0 
25 to 29% 1.7(1.1 to 2.6) 0.019
< 20% 2.5(1.1 to 5.8) 0.032
Conclusion Anemia and elevated hematocrit seem to be associated 
with in-hospital mortality among patients with suspected infection. 
Treatment of high or low hematocrit as a part of the ED resuscitation 
could be a subject for further investigation.
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Introduction Several predicting models have been described to 
identify the necessity for massive transfusion (MT) for trauma patients 
[1]. The purpose of this study is to validate the simplifi ed scoring 
systems reported previously and establish new criteria at emergency 
and in the ICU in Japan.
Methods We retrospectively analyzed trauma patients transported 
to our center for the recent 2  years. Patients transferred from other 
hospitals with minor injuries or confi rmed cardiac arrest at the scene 
were excluded.
Results A total of 297 trauma patients were included in this study. 
Thirty-one (10.4%) patients required MT. Sensitivity and specifi city 
for the Assessment of Blood Consumption (ABC) score were 48% and 
99%, respectively. Because blunt injuries account for most trauma 
patients in Japan, we established new simple criteria using signifi cant 
factors that were derived from the examination on arrival. If trauma 
patients met any of the following conditions – that is, shock index (SI) 
>1, base excess (BE) <–3 mmol/l, and positive focused assessment of 
sonography for trauma (FAST) – sensitivity and specifi city was 97% and 
80%, respectively. The area under the receiver operating characteristic 
curve of ABC and the new criteria was 0.889 (95% CI, 0.815 to 0.963) and 
0.927 (95% CI, 0.881 to 0.974), respectively.
Conclusion We suggest new criteria for early predicting MT in trauma 
using SI, BE, and FAST. This method may be valid especially in such 
areas because blunt injuries are the major cause of trauma in Japan.
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Introduction A massive transfusion protocol (MTP) aims to provide 
standardized and early delivery of blood products and prohemostatic 
agents by keeping pre-thawed fresh frozen plasma (FFP) available. 
Implementation of MTP is assumed to result in transfusion with higher 
ratios of FFPs and platelets to red blood cells (RBCs). Pre-thawing may 
also result in waste of FFPs. These MTP benefi ts or disadvantages have 
not yet been demonstrated. The aim of this study was to evaluate 
effi  cacy of a MTP 1  year after implementation in our level I trauma 
center in an academic hospital.
Methods A retrospective analysis of an electronic blood bank 
transfusion database comparing massive transfusion before (January to 
December 2011) and after (January to December 2012) implementation 
of MTP. Activation of MTP consists of delivery of packages of 6 units of 
RBC, 6 units of pre-thawed FFP and 2 units of platelets collected from 
fi ve donors. Massive bleeding was defi ned as transfusion ≥10 units of 
RBCs. Statistics by t test and Mann–Whitney U test.
Results In 2012, a total of 101 MTP activations was registered. Accurate 
prediction of massively bleeding patients (n = 30) was 29.7% of MTP 
activations. Of all massively bleeding patients in 2012, MTP was 
not activated in 55.2%. In patients for whom MTP was activated, the 
RBC:FFP ratio was 1:0.9. In patients for whom MTP was activated and 
who were massively bleeding, the RBC:FFP ratio was 1:0.9, which was 
signifi cantly higher compared with 1:0.6 in massive bleeders in 2011 
(n = 70) (P = 0.001). The median of blood products administered was 
12.5 (6 to 21) in massive bleeding after MTP implementation, compared 
with 8 (3 to 13) in 2011 (P  <0.001). In patients for whom MTP was 
activated, 9.7% of thawed FFPs were not transfused and wasted. When 
massive transfusion was accurately predicted, the waste of FFPs was 
4.8% versus a waste of 16.2% in the group of unjustifi ed MTP activation.
Conclusion Implementation of MTP is associated with an increase of 
blood products transfused and a signifi cant shift of RBC:FFP ratio to 1:1. 
However, MTP is also associated with a 9.7% waste of FFP. Improving 
prediction for massive bleeding patients may result in a decrease of 
wasted, costly blood products.
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Introduction The objective of this study was to determine whether 
septic patients requiring blood product transfusions have worse 
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outcomes compared with those who do not require transfusions. It 
is not uncommon for patients with sepsis to require blood product 
transfusions. The need for transfusions may be indicative of infl ammatory 
consumption of blood cells, active blood loss, or impaired hematopoiesis. 
Regardless of the etiology, need for transfusion may be an indicator of a 
more severely ill patient and a valuable prognostic factor.
Methods This retrospective cohort study included all patients over 
the age of 40  years with a confi rmed diagnosis of sepsis and an ICU 
stay at our academic medical center from 1 January 2005 to 31 March 
2011. Use of blood product transfusion, patient demographics, and 
APACHE II score at the time of sepsis were collected from patient charts. 
Outcomes of interest were in-hospital mortality, development of acute 
respiratory distress syndrome (ARDS), days on mechanical ventilation, 
hospital cost, and length of stay.
Results We identifi ed 824 patients who met the inclusion criteria 
for this study. Of those patients, 543 (66%) received at least 1 unit 
of blood products during hospitalization. Patients receiving blood 
products had signifi cantly higher in-hospital mortality (36.1% vs. 
26.9%; P  =  0.003) and a higher rate of development of ARDS (45.3% 
vs. 27.1%; P  <0.001) compared with patients not receiving blood 
products. Patients receiving packed red blood cells (PRBCs) (60%) did 
not demonstrate a signifi cant increase in mortality (35.1% vs. 28.8%; 
P  =  0.058), while patients receiving platelets (20%) did have higher 
mortality (45.1% vs. 29.5%; P <0.001). Transfusions of PRBCs or platelets 
were both associated with a higher development of ARDS (P  <0.001 
for both). There was a signifi cant increase in days on mechanical 
ventilation (7.0 days vs. 2.3 days; P <0.001), hospital cost ($88,331 vs. 
$35,047; P <0.001), and length of stay (17.3 days vs. 9.7 days; P <0.001) 
for patients receiving blood products, regardless of the type. These 
diff erences were seen despite the mean APACHE II score being similar 
(22.8 vs. 22.5; P = 0.645).
Conclusion Patients with sepsis receiving blood products, particularly 
platelets, were signifi cantly more likely to develop ARDS, had more 
days on mechanical ventilation, and had higher mortality. The lack of 
an increase in mortality associated with PRBC transfusion may be due 
to the benefi t in oxygen delivery or sample size.
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Introduction Perioperative red blood cell transfusion is commonly 
used to address anemia, an independent risk factor for morbidity 
and mortality in critically ill patients [1]; however, evidence regarding 
optimal blood transfusion practice in septic shock is lacking. The aim of 
this study was to defi ne which is the best transfusion strategy in septic 
shock patients regarding 28-day mortality and clinical outcomes: 
restrictive or liberal.
Methods The Transfusion Requirements After Cardiac Surgery (TRACS) 
study is a prospective, randomized, controlled clinical noninferiority 
trial conducted between February 2009 and February 2010 in an 
ICU at a university hospital cardiac surgery referral center in Brazil. 
Consecutive adult patients (n = 502) who underwent cardiac surgery 
with cardiopulmonary bypass were eligible; analysis was by intention 
to treat.
This is a randomized controlled parallel-group trial, which included 
300 patients admitted to a cancer ICU with diagnosis of septic 
shock. Patients were randomly assigned to a liberal strategy of blood 
transfusion (to maintain hemoglobin >9 g/dl) or to a restrictive 
strategy (hemoglobin >7  g/dl). Mortality in 28  days was the main 
outcome. Secondary outcomes were clinical complications days free of 
organ dysfunction, ICU and hospital length of stay, adverse eff ects of 
transfusion and 60-day mortality.
Results A total of 136 patients were included in the fi rst part of the 
trial. Mean age was 62 ± 14 years, SAPS 3 at admission was 65 ± 15 and 
all patients had the diagnosis of solid neoplasm. Sixty-three patients 
(46.3%) were included in the liberal strategy and 73 patients (53.7%) 
in the restrictive strategy. Occurrence of 28-day mortality was similar 
between groups (54% in liberal group vs. 56.2% in restrictive group; 
P = 0.395).
Conclusion Among cancer patients with septic shock, the use of a 
restrictive perioperative transfusion strategy compared with a more 
liberal strategy resulted in similar rates of 28-day-mortality.
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Introduction Blood transfusion is associated with increased morbidity 
and mortality in the critically ill [1]. Adverse eff ects of transfusion may 
be mediated by changes in the blood product that accumulate with 
storage time [2]. The mechanisms, however, are largely unknown. 
Erythrocyte-derived microparticles (MPs) have been found in 
transfusion bags [3,4] and their concentration increases with storage 
duration [5]. We hypothesize that accumulation of MPs during storage 
induces a proinfl ammatory state in the recipient.
Methods Microparticles were isolated by high-speed centrifugation 
from red blood cell transfusion bags stored for 41 or 42  days. Whole 
blood from healthy volunteers was incubated for 24  hours with 
supernatant from the bags either containing MPs or depleted from 
MPs. Controls were incubated with medium or LPS (10 ng/ml). TNFα, IL-
10 and IL-6 were measured in supernatant by ELISA. Data are expressed 
as median and range.
Results MP-depleted supernatant induced a modest increase in 
median levels of TNFα (9.2 (2.3 to 22.2) pg/ml) and IL-6 (2,140.7 (1,507 to 
2,199) pg/ml) compared with the negative controls (2.3 (2.3 to 2.3) pg/
ml and 94.4 (64.7 to 124.1) pg/ml, respectively), while IL-10 levels were 
not aff ected. Addition of MP-containing supernatant resulted in highly 
increased levels of TNFα (699 (687 to 742) pg/ml), IL-6 (37,443 (26,493 to 
40,967) pg/ml) and IL-10 (1,201 (1,178 to 1,533) pg/ml) compared with 
negative controls. This MP-induced increase in cytokine production 
was comparable with the increase observed after the addition of LPS.
Conclusion Erythrocyte-derived MPs from aged red blood cell 
transfusion bags induce a strong infl ammatory response in vitro, which 
is largely negated when MPs are removed. Whether MPs mediate 
adverse eff ects of blood transfusion in the critically ill remains to be 
determined.
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Introduction Transfusion-related acute lung injury (TRALI) is the 
leading cause of transfusion-related fatalities [1]. A two-hit hypothesis 
has been proposed for TRALI. The fi rst hit is underlying patient factors, 
resulting in adherence of primed neutrophils to the pulmonary 
endothelium, such as severe pneumonia due to infl uenza A H1N1. 
The second hit is caused by mediators in the blood transfusion that 
activate the endothelial cells and pulmonary neutrophils, resulting 
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in capillary leakage and subsequent pulmonary edema [2]. TRALI is a 
clinical diagnosis with the following criteria: acute onset within 6 hours 
of blood transfusion, PaO2/FIO2 ratio <300 mmHg, or worsening of the 
P:F ratio, bilateral infi ltrative changes on chest radiograph, no sign of 
hydrostatic pulmonary edema (pulmonary arterial occlusion pressure 
≤18 mmHg or central venous pressure ≤15 mmHg) and no other risk 
factor for acute lung injury [2].
Methods We describe a fatal TRALI in a patient with infl uenza A (H1N1), 
suggesting a relationship between a fi rst-hit lung injury followed by 
the second lung impairment after blood transfusions.
Results We report a 57-year-old female, without a previous medical 
record. She had an acute onset of fever, cough, muscle pain and 
progressive dyspnea leading to acute respiratory distress syndrome. 
The test for infl uenza A H1N1 was positive. She was recovering, but on 
day 12 of admission, after 1  hour of platelet transfusion, she started 
with intensive tachycardia, dyspnea and hypoxemia. Her mechanical 
ventilation parameters increased dramatically. She was in plan for 
extubation with FiO2 of 30% and positive end-expiratory pressure of 
8, which became 100% and 14 respectively. The P:F ratio dropped to 
62. Her leukocytes were 10.6×109/l a few hours earlier and went down 
to 1.5×109/l after the onset. Previous lactate was normal, but jumped 
to 42  mg/dl. She was free of vasopressors and after the off ending 
transfusion went through refractory shock and died approximately 
24 hours after the blood transfusion.
Conclusion For our knowledge this is the fi rst case reported of TRALI in 
an infl uenza A (H1N1) patient. Although blood transfusion can be life 
saving, it also can be a life-threatening intervention. Prevention is still 
the best hit.
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Introduction Prothrombin complex concentrate (PCC) has been 
suggested as a measure to terminate trauma and dabigatran-induced 
bleeding. Owing to the confl icting data concerning such therapy, we 
investigated the impact of a four-factor PCC to terminate massive 
bleeding following the infl iction of multiple trauma in dabigatran 
anticoagulated pigs.
Methods After ethical approval, 24 male pigs were administered 
dabigatran etexilate (30 mg/kg bid p.o.) for 3 days. On day 4, dabigatran 
in anaesthetised animals was infused prior to injury to achieve supra-
therapeutic levels. Twelve minutes after infl iction of bilateral femur 
fractures and standardised blunt liver injury, animals randomly received 
PCC (25, 50 or 100 IU/kg; n = 6) or placebo (n = 6). Time-adjusted blood 
loss as primary endpoint (observation period 300 minutes) and a 
panel of coagulation variables were continually measured. Data were 
analysed by two-way ANOVA. Data are mean ± SEM.
Results Concentrations of dabigatran prior to infl iction of trauma 
was comparable between groups (590  ±  40 ng/ml). Anticoagulation 
with dabigatran and trauma caused severe coagulopathy as shown 
by prolonged TEM variables (CT, CFT), PT and aPTT. Following PCC 
application these eff ects were partially reversed. Due to ongoing blood 
loss both PT and TEM variables prolonged over time in PCC 25  IU/kg 
substituted animals. Accordingly, no-PCC (38.5  ±  4.7  ml/minute) and 
PCC 25 IU/kg (22.6 ± 5.5 ml/minute) animals showed highest blood loss 
(P <0.05 vs. PCC 50 IU/kg and PCC 100 IU/kg) with a mean survival time 
of 106 minutes (no-PCC animals) and 204 minutes for PCC 25  IU/kg 
animals, respectively. All animals of the PCC 50 IU/kg and PCC 100 IU/kg 
group survived. Blood loss in both groups was comparable (PCC 50 IU/
kg: 5.9 ± 0.2 ml/minute; PCC 100 IU/kg 6.0 ± 0.3 ml/minute).
Conclusion The use of high doses of PCC reversed the anticoagulant 
eff ects of dabigatran, which was associated with a signifi cant reduction 
of blood loss. However, the results of this study show that suffi  cient 
concentrations of PCC are necessary to overcome thrombin inhibition.
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Introduction Fresh frozen plasma (FFP) is associated with onset of 
acute lung injury [1], the mechanism of which is largely unknown. 
On the other hand, FFP may be benefi cial, as a higher ratio of FFP to 
red blood cells decreases mortality in bleeding trauma patients [2] 
and is associated with an endothelial stabilizing eff ect in vitro [3]. We 
investigated the eff ect of transfusion with FFP on host response and 
markers of endothelial damage in nonbleeding critically ill patients.
Methods This was a substudy of a multicenter trial in which nonbleeding 
critically ill patients with an increased International Normalized Ratio 
(1.5 to 3.0) were randomized to omitting or administering a prophylactic 
transfusion of FFP (12  ml/kg) prior to an invasive procedure. In 38 
patients randomized to receive FFP transfusion, we measured levels 
of factor VIII, von Willebrand factor, and markers of proinfl ammatory 
response before and after transfusion. Data are presented as medians.
Results FFP transfusion resulted in a signifi cant decrease of TNFα (from 
12.3 to 3.1 pg/ml, P = 0.01), von Willebrand factor (from 475 to 424%, 
P <0.01) and factor VIII (from 246 to 244%, P <0.01). FFP did not alter 
levels of IL-1β, IL1-RA, IL-8, IL-10, MCP1, MIP1A or sCD40L. Patients had 
some degree of lung injury at baseline as refl ected by a lung injury 
score of 2 (0.8 to 2.5), which did not change following transfusion. None 
of the patients developed TRALI.
Conclusion FFP transfusion is not associated with a proinfl ammatory 
response in the critically ill. Rather, FFP seemed to have an endothelial 
stabilizing eff ect.
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Introduction When treating trauma patients with severe hemorrhage, 
massive blood transfusions are often needed. Damage control 
resuscitation strategies can be used for such patients, but an adequate 
fresh frozen plasma:packed red blood cell (FFP:PRBC) administration 
ratio must be established.
Methods We retrospectively reviewed the medical records of 100 
trauma patients treated with massive transfusions from March 2010 
to October 2012. We divided the patients into two groups according 
to the FFP:PRBC ratio: a high-ratio group (≥0.5) and a low-ratio group 
(<0.5). The patient demographics, fl uid and transfusion quantities, 
laboratory values, complications, and outcomes of both groups were 
analyzed and compared.
Results There were 68 patients in the high-ratio group and 32 in the 
low-ratio group. There were statistically signifi cant diff erences between 
groups in the quantities of FFP, FFP:PRBC, platelets, and crystalloids 
administered, as well as the initial diastolic blood pressure. When 
comparing the incidence of complications, bloodstream infections 
were noted only in the high-ratio group, and the diff erence was 
statistically signifi cant (P = 0.028). Kaplan–Meier plots revealed that the 
24-hour survival rate was signifi cantly higher in the high-ratio group 
(71.9% vs. 97.1%, P  <0.001). The 30-day survival rate was also higher 
in the high-ratio group (56.2% vs. 67.6%), but the diff erence was not 
statistically signifi cant (P = 0.117).
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Conclusion For treating patients with severe hemorrhagic trauma, 
raising the FFP:PRBC ratio to 0.5 or higher may increase the chances 
of survival (especially the 24-hour survival rate). Eff orts to minimize 
bloodstream infections during the resuscitation process must be 
increased.
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Introduction Strategies to reverse the anticoagulant eff ects of the new 
oral anticoagulants in severely bleeding patients remain challenging 
and confl icting results have been presented regarding the effi  cacy 
of PCCs to alter dabigatran-induced coagulopathy. Thus, this study 
assessed the ability of PCC, activated PCC (aPCC), recombinant FVII 
(rFVIIa) and idarucizumab to reverse the anticoagulant eff ects of 
dabigatran in a porcine model of trauma.
Methods Studies were performed in fi ve pigs. Dabigatran etexilate (DE) was 
given orally for 3 days (30 mg/kg bid) and on the 4th day dabigatran was 
infused 90 minutes (30 minutes: 0.77 mg/kg/hour; 60 minutes 0.52 mg/kg/
minute) prior to blunt liver injury. Blood samples were taken before and 
after dabigatran infusion and 60 minutes post injury. Two doses of PCC (30, 
60 IU/kg), aPCC (30, 60 IU/kg), rVIIa (90, 180 μg/kg) and idarucizumab (30, 
60 mg/kg) were added to blood samples ex vivo. Coagulation was assessed 
by thromboelastometry, PT and diluted TT. One-way analysis of variance 
with the Dunnett post-hoc test for multiple comparisons was used for 
statistical analysis. Data are presented as mean ± SD.
Results Oral DE prolonged clot formation (CFT: 159 ± 39 seconds) and 
PT (27 ± 9 seconds). Following the 90-minute infusion of dabigatran, 
the mean plasma levels of dabigatran increased to 1,423  ±  432  ng/
ml. This supra-therapeutic level was associated with a further 
prolongation of PT, aPTT, and the EXTEM variables CT and CFT. These 
changes in coagulation parameters were compounded by blood loss 
following trauma (total blood loss at 60 minutes: 1,978 ± 265 ml). Sixty 
minutes after trauma, four out of fi ve animals had no measurable clot 
formation (EXTEM CFT ≥4,000  seconds) and clot strength (EXTEM 
MCF) had reduced to 11  ±  7  mm. Both PCCs and aDabi-Fab, but not 
rFVIIa, reversed the eff ects of dabigatran on thromboelastometry 
parameters (clotting time and clot formation time) and PT at all time 
points. In contrast, aPTT was only normalised by idarucizumab. Plasma 
concentrations of dabigatran remained elevated after PCC therapy, but 
were not measureable after idarucizumab.
Conclusion Both PCC and aPCC are eff ective in reducing coagulopathy 
in a porcine trauma model with dabigatran anticoagulation. The ex 
vivo addition of idarucizumab fully corrected all coagulation measures 
and signifi cantly decreased plasma concentrations of dabigatran. No 
signifi cant eff ects on haemostasis were observed after the application 
of rFVIIa.
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Introduction Fluid resuscitation of hemorrhagic shock is frequently 
associated with reperfusion injury and secondary organ damage. 
Studies suggest that low doses of both nitrite and carbon monoxide 
may protect tissues and organs from this reperfusion injury by limiting 
mitochondrial free radical production. We explored the eff ects of very 
small doses of nitrite and carbon monoxide on tissue injury in a porcine 
model of hemorrhagic shock.
Methods Fluid resuscitation of hemorrhagic shock is frequently 
associated with reperfusion injury and secondary organ damage. 
Studies suggest that low doses of both nitrite and carbon monoxide 
may protect tissues and organs from this reperfusion injury by limiting 
mitochondrial free radical production. We explored the eff ects of very 
small doses of nitrite and carbon monoxide on tissue injury in a porcine 
model of hemorrhagic shock.
Results Although no increase in blood nitrite concentrations was 
observed after inhalation, nitrite was associated with signifi cant 
decreases in blood, muscle, and peritoneal fl uid lactate concentrations 
(P <0.05), whereas both nitrite and carbon monoxide were associated 
with signifi cant decreases in glycerol in peritoneal fl uid (P  <0.05). 
Following resuscitation, the muscle mitochondrial respiratory control 
ratio was preserved in the nitrite and carbon monoxide groups and 
reduced in the control group. Adjuvant drugs had no eff ects on any 
gross hemodynamic parameters.
Conclusion We conclude that at low doses, nebulized sodium nitrite 
and inhaled carbon monoxide are associated with tissue protection 
during resuscitation from severe hemorrhagic shock.
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Introduction Currently, most non-invasive blood pressure (NIBP) 
monitoring is based on the oscillometric method and determines 
the blood pressure during cuff  defl ation [1]. On the other hand, a 
measurement during cuff  infl ation may be advantageous, as cuff 
infl ation requires lower cuff  pressure and shorter duration than 
defl ation. In surgical patients during anesthesia, the infl ationary NIBP 
has reasonable accuracy compared with conventional defl ationary NIBP 
[2]. Few studies have reported NIBP monitoring using the infl ationary 
NIBP in ER patients with various unstable conditions. A purpose of this 
study is to verify the usefulness of the infl ationary NIBP monitoring in 
the emergency department.
Methods A total of 2,981 NIBP data were collected from 174 patients 
(age; 56.5 ± 22.2 (7 to 92) years) who have been accommodated in the 
resuscitation area of the ER at Keio University Hospital, using alternately 
two algorithms with a standard monitor (BSM-6000; Nihon Kohden 
Inc., Tokyo, Japan). One algorithm consists of continuous infl ationary 
and defl ationary measurement in a single cycle (dual algorithm, 1,502 
data) performed in order to verify a success rate and a precision of data. 
The defl ationary algorithm (1,479 data) consists of only conventional 
defl ationary measurement performed in order to verify the duration of 
the measurement cycle.
Results The success rate of the infl ationary NIBP (completed only by 
infl ationary method) was 69.0%. The bias and precision of systolic 
pressure and diastolic pressure (diff erence of systolic and diastolic 
pressure between infl ationary and defl ationary NIBP) were –0.6 ± 8.8 
and 3.5  ±  7.5  mmHg, respectively (Figure  1). Infl ationary NIBP could 
also determine NIBP more quickly compared with defl ationary NIBP 
(16.8 vs. 29.1 seconds, median) (Figure 2).
Conclusion These data suggest that infl ationary NIBP has reasonable 
accuracy and suffi  cient rapidity compared with defl ationary NIBP in 
emergency room patients.
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Introduction The CNAP™ system (CNSystems Medizintechnik AG, 
Graz, Austria) provides continuous non-invasive arterial pressure (AP) 
measurements based on the volume clamp method using a fi nger 
cuff . Finger AP values are calibrated to oscillometric upper-arm AP 
measurements. In the present study we investigated the infl uence 
of the calibration approach based on oscillometric upper-arm cuff 
measurements on the accuracy and precision of the CNAP™ device in 
comparison with invasively obtained AP measurements.
Methods The datasets of simultaneously recorded invasive (via arterial 
catheter) and non-invasive (using the CNAP™ system) AP measurements 
in 43 patients treated in the medical ICU of a university hospital were 
analyzed in this study. The following comparative analyses between 
the two AP measurement techniques were performed: (1) comparison 
of CNAP™-derived AP values with invasive AP (IAP) measurements; 
(2)  comparison of the CNAP™ oscillometric AP values used for the 
calibration of fi nger AP with IAP measurements; and (3)  computer-
aided calibration (CAC) of the CNAP™ fi nger AP values to IAP values 
instead of calibration to oscillometric upper-arm AP measurements 
with IAP measurements.
Results (1)  The comparison of CNAP™-derived AP values with IAP 
measurements revealed a mean diff erence (± standard deviation) for 
mean AP, systolic AP, and diastolic AP of +0.6  mmHg (±10  mmHg), 
+11  mmHg (±17  mmHg), and –6  mmHg (±9  mmHg), respectively. 
(2)  The comparison between the oscillometric AP values used for 
calibration of the CNAP™ device and the corresponding IAP values 
resulted in a mean diff erence (±  standard deviation) of –0.8  mmHg 
(±8  mmHg), –5  mmHg (±14  mmHg), and +10  mmHg (±9  mmHg), 
respectively. (3)  CAC of the CNAP™ fi nger AP values to IAP values 
instead of calibration to oscillometric upper-arm AP measurements 
resulted in a mean diff erence (±  standard deviation) of +4  mmHg 
(±8  mmHg), +5.5  mmHg (±14  mmHg), and +3  mmHg (±7  mmHg), 
respectively. The accuracy of CAC-CNAP™-derived systolic and diastolic 
AP compared with the CNAP™-derived AP calibrated to oscillometric 
AP was signifi cantly higher (P = 0.004 and P <0.001, respectively).
Conclusion When using the CNAP™ system, calibration to oscillometric 
upper-arm AP values integrated into the CNAP™ system is a relevant 
source of diff erence between CNAP™-derived continuous non-invasive 
AP measurements and invasively assessed AP values.
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Introduction The time profi le of the arterial pulse is known to have 
features such as the dicrotic notch and subsidiary peaks. Such features 
may provide useful information about the vascular system and are 
traditionally explained in terms of aortic valve closure or multiple 
refl ections from impedance mismatches within the arterial system. 
However, experimental evidence of such refl ections has been elusive. 
It has been proposed that arterial dynamics may obey a nonlinear 
equation [1]. This model predicts the existence of multipeaked solitons 
which can travel long distances without dissipation. We demonstrate 
that within the soliton model it is not necessary to model valve closure 
or wave refl ection: single or multiple notches arise de novo even from 
featureless theoretical LV pressure pulse profi les. We show that a 
number of clinically relevant features of the invasive blood pressure 
are reproduced by the soliton model and examine the role of LV pulse 
energy on pulse wave shape and progression.
Methods A model for the arterial pressure is given by solutions to a 
KdV equation with constants depending on the properties of the 
artery [1]. This can be solved with the initial condition of a parabolic left 
ventricular pressure pulse.
Results The evolution of the arterial pulse along the arterial tree is 
shown in Figure  1. We also predict arterial pulses for increasing left 
ventricular ejection energies.
Conclusion Our simple model explains many features of the arterial 
pulse observed in clinical practice such as the development of the 
dicrotic notch, the change in shape along the arterial tree and the 
steepening and acceleration with hypertension. Some phenomena 
that have traditionally been attributed to arterial wave refl ections or 
resonance of the invasive arterial pressure measurement can instead 
be explained by intrinsic properties of the arterial pulse.
Figure 1 (abstract P120). Precision of measurements between infl ationary and defl ationary NIBP.
Figure 2 (abstract P120). Frequency histogram of measurement time.
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Introduction Pay-for-performance programs and economic constraints 
call for solutions improving the quality of healthcare without increasing 
costs. Many studies have shown decreased morbidity in major surgery 
when perioperative goal-directed therapy (PGDT) is used. We assessed 
the clinical and economic burden of postsurgical complications in 
the University HealthSystem Consortium (UHC) in order to predict 
potential savings with PGDT.
Methods Data from adults who had 10 major surgical procedures 
in 2011 were screened in the UHC database. Thirteen postsurgical 
complications were tabulated. In-hospital mortality, hospital length 
of stay and costs from patients with and without complications were 
compared. The risk ratios reported by the most recent meta-analysis 
were used to estimate the potential reduction in postsurgical morbidity 
with PGDT. Potential cost savings were calculated from the actual and 
anticipated morbidity rates.
Results A total of 75,140 patients met the search criteria. In total, 
8,421 patients developed one or more postsurgical complications 
(morbidity rate 11.2%). In-hospital mortality was 12.42% and 1.39% 
(P  <0.001), mean hospital length of stay was 20.48  ±  20.09  days and 
8.05 ± 7.11 days (P <0.001), and mean direct cost was $47,284 ± 49,170 
and $17,408  ±  15,612 (P  <0.001) in patients with and without 
complications, respectively. With PGDT, morbidity rate was projected 
to decrease to 6.5 to 9.0%, yielding gross costs savings of $50 million 
to 151 million for the study population or $670 to $1,406 per patient.
Conclusion Postsurgical complications have a dramatic impact on 
mortality, hospital length of stay and costs. Potential cost savings 
resulting from PGDT are substantial. PGDT may be recommended to 
improve quality of care and decrease costs.
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Introduction The placement of a central venous catheter (CVC) is now 
common practice. Control of the seat of the tip occurs through the 
antero-posterior radiograph of the chest (RX). New techniques have 
been developed to control the seat of the CVC, to avoid complications 
during the procedure and the RX control post insertion. The aim of this 
study is to demonstrate the ECG’s P-wave amplitude (PWA) increases 
as we approach the atrio-caval junction (ACJ) by recording the intra-
cavity and show that this method is more sensitive and specifi c 
compared with RX control. To confi rm this, we use the direct view of 
the tip by transesophageal echocardiography (TEE), a method which 
has the most recognized high sensitivity and specifi city [1].
Methods In 55 adult patients, hospitalized in the ICU, a CVC was placed. 
We excluded patients with cardiac arrhythmias or pacemaker wearers. 
All CVCs were placed with an ultrasound-guided puncture technique 
of the internal jugular vein (IJV) or subclavian vein (SV). The CVC was 
introduced by the Seldinger technique. Introducing the CVC along the 
Seldinger guide links to the same terminal on the cable connection 
as the intra-cavity derivation ECG (set CVC Certofi x B; Braun), in turn 
connected to the adapter for ECG (Certodyn Universaladapter B; Braun). 
Then the detection mode of the adapter is converted by the ECG trace 
outside (through surface electrodes) to the ECG mode intra-cavity 
and an increase of PWA confi rmed the CVC in the vicinity of the ACJ. 
Through the TEE with esophageal average scan at 120° we measured 
the distance between the tip and the ACJ. The results were expressed 
as mean with standard deviation.
Results Forty-fi ve CVCs were placed in the IJV while 10 were in the SV. 
No complications or arrhythmias were detected during the procedure. 
All CVCs produced an increase in PWA. Where the PWA increased by 
25% compared with normal, the TEE scanning tip was 2.5  ±  1.3  cm 
from the ACJ. Where the PWA increased by 33%, the TEE scanning tip 
was 1.9 ± 1.1 cm from the ACJ. Where the PWA increased by 50%, the 
TEE scanning tip was 1.3 ± 0.6 cm from the ACJ. The RX reports have 
described briefl y the presence of the catheter in the superior vena cava 
without making explicit the exact position relative to the ACJ.
Conclusion We have shown the increase in PWA by detecting that the 
endo-cavity, as we proceed with the insertion of the CVC, corresponds 
to higher proximity to the ACJ. These results canceled the need for RX 
control in the future.
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Introduction In internal jugular vein (IJV) catheterization, neck 
rotation may enhance the visibility of anatomical landmarks; however, 
it may increase the risk of carotid artery (CA) puncture by replacing 
the position of the IJV in relation to the CA. In our study, during US-
guided IJV catheterizations, we investigated the eff ects of changing the 
position of the IJV by the CA depending on the neutral position and 
45° rotation of the head on duration of procedure and complications.
Methods After obtaining hospital ethics committee approval, 100 
intensive care patients aged >18  years were included in the study. 
Patients were randomly selected and catheterization was performed in 
a neutral position of the head (n = 50) and by turning the head 45° to 
the opposite side (n  =  50). The US-guided catheterization procedure 
was performed in accordance with general principles. Once the needle 
entered the IJV and blood was aspirated, the US probe was released 
from the hand, and the catheter was placed and fi xed according to the 
Seldinger technique. The data of the intervention side for each process, 
the count number of successful catheter insertion, whether there is 
arterial access or not and the duration of procedure (from skin contact 
of the needle to catheter insertion) were recorded.
Results The localization of the IJV in relation to the CA is 66% 
anterolateral, 4% anterior and 30% lateral in a neutral position, and 
62% anterolateral, 28% anterior, 10% lateral position in 45° rotation. 
So while there is no change in a signifi cant proportion of patients in 
Figure 1 (abstract P122).
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the localization of the IJV in relation to the CA, the anterior placement 
rate increasing the risk of CA puncture was signifi cantly higher in a 
position of rotation compared with the neutral position (P  =  0.001). 
No signifi cant diff erence was found between procedure durations. 
Complications were recorded when observed.
Conclusion In our study, it has been shown that anterior placement 
of the IJV in the neutral position is less but this has no advantage in 
avoiding arterial puncture. The smaller area of procedure in a neutral 
position can cause diffi  culties in practice. However, the processing 
times between each head position were not diff erent. Nevertheless, 
further studies evaluating whether there are comparable complication 
rates and the same duration of procedure in emergency and trauma 
patients in whom head rotation cannot be possible are needed.
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Introduction Peres [1] and more recently Lum [2] developed some 
anthropometric formulas to correlate patient’s height (H) and ideal 
length of central venous catheter (CVC) in order to identify optimal 
tip position. The aim of this study is to compare the reliability of the 
anthropometric formulas with the method based on intracavitary ECG.
Methods We enrolled patients admitted to our ICU candidate to 
elective CVC insertion, who had a detectable P wave on surface ECG. 
Intracavitary ECG was used to identify the optimum tip location since 
a maximal P wave indicates the cavo-atrial junction [3]. Post-insertion 
chest X-ray (CXR) was performed in all patients to verify the tip position. 
Assuming that the cavo-atrial junction is about 3 cm from the carina [4], 
the tip position was considered correct between 1 and 5 cm from the 
carina (between the lower 1/3 of the superior vena cava and the upper 
1/3 of the right atrium). For each patient we retrospectively evaluated 
whether the catheter length calculated with Lum’s and Peres’ formulas 
on an estimated height would have been acceptable.
Results Sixty-fi ve CVCs were placed: 51 in the right internal jugular vein 
(IJV), 14 in the left IJV. The mean catheter length by intracavitary ECG 
was signifi cantly deeper than predicted by Lum’s formulas (18.2 ± 1.9 
vs. 16.7  ±  1.7  cm, P  <0.001) and not diff erent from Peres’ formulas 
(18.2 ± 1.9 vs. 18.2 ± 1.7 cm, P = 0.8).
At post-procedural CXR, 88% of the tips were in the target zone. In 
three cases (5%) the catheter went in the wrong direction but was 
immediately corrected during the procedure since the intracavitary P 
wave did not change its amplitude. Compared with the intracavitary 
ECG, the incidence of malposition would have been signifi cantly higher 
with Lum’s formulas (48% vs. 12%, P <0.001) and Peres’ formulas (51% 
vs. 12%, P <0.001).
Conclusion The intracavitary ECG was associated with a lower incidence 
of tip malposition than Peres’ and Lum’s formulas. It is also the only 
technique allowing one to immediately correct a primary malposition 
during catheter insertion.
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Introduction An ultrasound-guided (UG) technique is the recom men-
ded procedure for central venous catheterization (CVC). But ultrasound 
may not be available in emergency situations, and therefore guidelines 
also propose that physicians remained skilled in landmark (LM) 
placement. We conducted this prospective observational study to 
determine the learning curve of the LM technique in residents only 
learning the UG technique.
Methods During the fi rst 3 months of their rotation in our ICU, residents 
inexperienced in CVC used only the real-time UG technique. During the 
following 3 months, residents were allowed to place CVC by means of 
the LM technique when authorized by the attending physician.
Results A total of 172 procedures (84 UG and 88 LM) were performed 
by the inexperienced residents during the study. The success rate 
was lower (72% vs. 84%; P  =  0.05) and the complication rate was 
higher (22% vs. 10%; P = 0.04) for LM compared with UG procedures. 
Comparison between the fi ve last UG procedures and the fi rst fi ve LM 
procedures performed demonstrated that the transition between the 
two techniques was associated with a marked decrease of the success 
rate (65% vs. 93%; P = 0.01) and an increase of the complication rate 
(33% vs. 8%; P  =  0.01). After 10 LM procedures, residents achieved a 
success rate and a complication rate of 81% and 6%, respectively.
Conclusion Residents who only learn the UG technique will not be 
immediately able to perform the LM technique, but require specifi c 
training based on at least 10 LM procedures. Whether the LM technique 
should still be taught when an ultrasound device is not available must 
therefore be addressed.
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Introduction Bedside insertion of peripherally inserted central 
catheters (PICCs) results in tip malposition in up to 48% [1], with 
catheters frequently terminating in the internal jugular vein (IJV) or 
in peripheral veins [2]. In an attempt to reduce tip malposition, we 
developed a standardized approach to PICC installation. This study 
aims to validate that method.
Methods From a 34-bed adult ICU, we retrospectively reviewed PICC 
insertions over a 6-month period before the intervention program 
(control group). We designed a prospective interventional pilot study 
on 40 consecutive patients (intervention group). Patients in the 
intervention group were positioned in a standardized fashion and the 
PICC length was measured from easily identifi ed anatomic landmarks. 
During PICC insertion, the patient’s head was either rotated ipsilaterally 
to the site of PICC insertion or the ipsilateral IJV was manually 
compressed, depending on the patient’s capacity to collaborate. Once 
the PICC was inserted, an ultrasound survey was conducted to identify 
the catheter in the subclavian vein (SC) and ensure its absence in the 
ipsilateral IJV. The primary endpoint was defi ned as PICC tip position, 
obtained from the post-procedural chest X-ray. A catheter was 
considered to be in an optimal position if the tip resided in the distal 
third of the superior vena cava (SVC), adequate if it resided between 
the subclavian vein (SC) and the distal third of the SVC, and aberrant if 
in any other location.
Results In the retrospective control arm, 105 PICCs were reviewed for 
tip position. Optimal, adequate, and aberrant positions were found in 
22 (21%), 49 (47%), and 34 (32%) respectively, in comparison with 17 
(43%), 15 (38%), and eight (20%) in the intervention group (P  <0.05 
between both groups). In the control arm, 11 (10%) PICCs terminated 
outside the central venous system, whereas none failed to achieve 
central venous access in the intervention arm.
Conclusion Using the standardized method described above, PICC 
tip positioning can be greatly improved. In our results, 100% of 
catheters placed using the standardized method allowed for central 
venous access. This pilot study paves the way for a larger, multicentric 
evaluation of the bedside installation method of PICC.
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Introduction According to the European Society of Parenteral and 
Enteral Nutrition guidelines [1], post-insertion chest X-ray (CXR) is 
not necessary if the location of the tip has been verifi ed during the 
procedure and if pleura-pulmonary damage has been ruled out by 
other methods. The aim of this study is to assess feasibility and safety 
of an echo-ECG-guided method of central venous catheter (CVC) 
insertion and to evaluate whether post-insertion CXR can be avoided.
Methods We enrolled only patients admitted to our ICU and candidate 
to elective CVC insertion, who had a detectable P wave on surface ECG. 
Our insertion protocol included: preliminary ultrasound (US) scan of 
central veins and pleural space; US-guided puncture and US control 
of the correct direction of the guidewire; intracavitary ECG method for 
tip location (cavo-atrial junction (CAJ) = maximal P wave); and US scan 
of pleural space to rule out pneumothorax (PNX). Post-insertion CXR 
was performed in all patients to rule out PNX and verify tip location 
close to the CAJ (CAJ = 3 cm below the carina [2]). Tip location between 
1 and 5 cm below the carina – in the lower 1/3 of the superior vena 
cava (SVC) or in the higher 1/3 of the right atrium (RA) – was considered 
acceptable [1].
Results Eighty CVCs were placed in 78 patients, either by residents in 
training or by attending doctors. The vein was selected by US scan: right 
internal jugular (IJ) 64%, left IJ 17%, right axillary 11%, left axillary 4%, 
right innominate 4%. One pre-existing PNX was identifi ed by US before 
the procedure. Accidental arterial puncture occurred in three cases 
(two by residents). In fi ve cases, the wrong direction of the wire was 
detected by US and corrected during the procedure. The mean number 
of attempts was 1.65 (1.35 for attending vs. 1.95 for residents, P <0.02) 
and mean insertion time was 10.4 minutes (8.72 for attending vs. 12.11 
for residents, P <0.005). Pleural US scan ruled out puncture-related PNX 
in all patients. At post-procedural CXR: no PNX was detected, 90% of 
tips were in the target zone, 5% were in the middle 1/3 of SVC and 5% 
were in the middle 1/3 of RA (all CVC with tips out of the target zone 
were inserted by residents).
Conclusion Our insertion protocol was safe and eff ective, with minor 
diff erences between experienced versus nonexperienced operators. 
Our data suggest that immediate CXR is not necessary soon after CVC 
insertion, since PNX can be ruled out by US and since the intracavitary 
ECG method allows tip location in the SVC and RA in all cases.
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Introduction Chest auscultation and chest X-ray are commonly used 
to detect postoperative abnormalities and complications in patients 
admitted to intensive care after cardiac surgery [1,2]. The aim of the 
study was to evaluate whether chest ultrasound represents an eff ective 
alternative to bedside chest X-ray to identify early postoperative 
abnormalities.
Methods A total of 151 consecutive patients (103 male and 47 female) 
were studied by chest auscultation, ultrasound and X-ray upon 
admission to intensive care after cardiac surgery. Six pathologic entities 
were explored by each method: postero-lateral pleural eff usion and/
or alveolar consolidation (PLAPS), alveolar-interstitial syndrome (AIS), 
alveolar consolidation (AC), pneumothorax (PTX), pleural eff usion (PE), 
and pericardial eff usion with or without cardiac tamponade. Positions 
of the endotracheal tube and central venous catheter were also 
checked.
Results Ninety-four of the 151 patients included (62%) showed 
abnormalities on chest X-ray (AC 9%, AIS 25%, PLAPS 42%, PE 3.3%, PTX 
2%). Compared with chest X-ray, chest ultrasound had a sensitivity of 
86% and a specifi city of 99% for AC, a sensitivity of 95% and a specifi city 
of 100% for AIS, a sensitivity of 97% and a specifi city of 98% for PLAPS, 
a sensitivity of 99% and a specifi city of 100% for PE, and a sensitivity 
and specifi city of 100% for PTX. Furthermore, chest ultrasound 
detected all pericardial eff usions while neither chest X-ray nor chest 
auscultation were able to identify them. Chest ultrasound identifi ed all 
cases of endotracheal tube (two patients) and central venous catheter 
(two patients). There was a highly signifi cant correlation between 
abnormalities detected by chest ultrasound and X-ray (k = 0.90), but a 
poor correlation between chest auscultation and X-ray abnormalities 
(k = 0.15).
Conclusion Chest auscultation may help identify endotracheal 
misplacement and tension pneumothorax but it may miss most of major 
abnormalities. Chest ultrasound represents a valid alternative to chest 
X-ray to detect all postoperative abnormalities and misplacements.
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Introduction Assessment of volume status and responsiveness guides 
resuscitation strategy. Non-invasive techniques are desirable. Changes 
in carotid fl ow time have been proposed as a marker of volume status, 
but few data support their use. We sought to determine whether carotid 
fl ow time decreased in the volume-depleted state of acute blood loss, 
and whether volume-depleted individuals would demonstrate an 
increase in carotid fl ow time after a passive leg raise (PLR) maneuver.
Methods Volunteers aged 18 to 55 presenting to the hospital’s blood 
donor center for whole blood donation were eligible to participate. 
Individuals with a history of aortic or carotid artery disease, atrial 
fi brillation, or a contraindication to blood donation were excluded. 
Prior to blood donation, an investigator performed an ultrasound of the 
right common carotid artery with a high-frequency linear transducer, 
obtaining a Doppler tracing of carotid artery fl ow. Measurements of 
peak velocity, systole time, and carotid fl ow time were obtained. A 
PLR was performed for 30 seconds, followed by repeat measurements 
of carotid velocity and fl ow time. Whole blood was then collected 
according to the blood donor center’s protocol. Immediately after 
blood donation, repeat measurements of carotid fl ow and velocity 
were obtained in the supine position and after a PLR. Carotid fl ow times 
corrected for heart rate (FTc) were analyzed with Student’s t test. The 
institutional review board approved the study.
Results Eighty donors were screened for participation by two 
investigators; 68 consented and completed donation (60.3% female, 
mean age 31). Donors had mean blood loss of 450 ml. The mean FTc 
supine after blood donation was 296 ms; this was signifi cantly diff erent 
from the FTc prior to donation (supine  = 320  ms, PLR  = 323  ms; 
P  <0.0001). The mean FTc following blood donation and PLR was 
321 ms, signifi cantly diff erent from the supine position after donation 
(P <0.0001), but not pre-donation measurements.
Conclusion Ultrasound measurement of carotid fl ow time was 
signifi cantly decreased in the setting of acute blood loss. An auto-
bolus by PLR after blood loss restored FTc to pre-donation levels. 
Further investigation of FTc as a non-invasive predictor of volume 
responsiveness is warranted.
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Introduction Central venous catheters play an important role in patient 
care; however, their use is associated with various complications and 
more frequently through the subclavian vein (SCV) route. A previous 
study showed that ultrasound-guided cannulation of the SCV in critical 
care patients is superior to the landmark method and should be the 
method of choice in these patients [1]. The aim of this study was to 
compare short-axis and long-axis approaches for ultrasound-guided 
subclavian vein cannulation with respect to indicators of success.
Methods Eighty-three patients undergoing cardiac surgery and 
requiring central venous cannulation were randomized to receive long-
axis or short-axis ultrasound-guided cannulation of the subclavian 
vein by a skilled anesthesiologist. First-pass success, unsuccessful 
placement, number of attempts, number of needle passes, skin and 
vessel puncture, time to successful catheterization and complications 
were considered as outcomes.
Results The subclavian vein was successfully cannulated by ultrasound-
guided techniques in all patients. Central venous cannulation failed 
in two and 10 cases respectively with short-axis and long-axis view 
and the other view was used successfully. The fi rst-pass success rate 
was signifi cantly higher in the short-axis group (73%) compared with 
the long-axis group (40%) (P  =  0.005). The procedure time, number 
of attempts, needle redirection, and skin and vessel punctures were 
signifi cantly lower in the short-axis than long-axis group (P <0.05). The 
overall number of complications did not diff er signifi cantly between 
groups even if artery puncture and hematoma occurred more frequently 
in the long-axis group. Moreover, the need to change the ultrasound-
guided insertion technique was more frequent in the long-axis group.
Conclusion Ultrasound-guided subclavian vein cannulation by an 
experienced operator has a higher fi rst-pass success rate and lower 
access time using the short-axis than long-axis approach.
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Introduction During passive leg raising (PLR), we need a real-time 
device to demonstrate the hemodynamic change [1-3]. This study 
investigates the ability of transthoracic echocardiography (TTE) to 
predict fl uid responsiveness (FR) in terms of detecting change of 
stroke volume (ΔSV) after PLR compared with the transpulmonary 
thermodilution technique (TPTD) ΔSV after volume expansion (VE).
Methods A prospective study was carried out in a medical ICU. Eligible 
patients were age ≥18 years without necessarily full adaptation to the 
ventilator with hemodynamic instability who were considered for VE. 
SV assessment using the subaortic velocity–time measurement was 
obtained by TTE simultaneously with other hemodynamic parameters 
derived from TPTD at baseline, within 2 minutes of PLR and following 
VE (250 ml fl uid in 10 minutes). A fl uid responder was defi ned by ΔSV 
≥15% after VE by TPTD.
Results Preliminary reports on 16 patients with satisfactory cardiac 
windows were analyzed. ΔSV-TTE after PLR ≥13.6% predicts FR with 
sensitivity of 83.33%, specifi city of 70% and AUC of 0.78 (95% CI: 0.54 
to 1.00). Initial PPV ≥11% predicted FR with sensitivity of 83.33% with 
lower specifi city of 60% and AUC of 0.64 (95% CI: 0.35 to 0.93) (Figure 1). 
The Bland–Altman plot showed 95% limits of agreement from –8.96 to 
+8.83% and mean diff erence (bias) of –0.07% (Figure 2).
Conclusion We may use %ΔSV measured by TTE after PLR to predict 
FR, which is noninvasive and less time-consuming than other invasive 
techniques.
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Introduction Echocardiography is commonly used during both veno-
arterial (V-A) and venovenous extracorporeal membrane oxygenation 
Figure 1 (abstract P133). ΔSV-TTE after PLR≥13.6% may predict fl uid 
responsiveness with sensitivity of 83.33%, specifi city of 70% and AUC of 
0.78 (95% CI: 0.54 to 1.00). Initial PPV ≥11% predicted fl uid responsiveness 
with sensitivity of 83.33%, lower specifi city of 60% and AUC of 0.64 (95% 
CI: 0.35 to 0.93). 
Figure 2 (abstract P133). Bland–Altman plot, comparing two methods, 
showing 95% limits of agreement from –8.96 to +8.83%ΔSV and the mean 
diff erence (bias) of measurement is –0.07%ΔSV. Dashed lines, upper and 
lower limits of agreement (95% CI for repeated measurements).
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(ECMO). In many circumstances, transoesophageal echocardiography 
(TOE) is the preferred monitoring tool. It can aid in cannula positioning, 
especially during double-lumen cannula placement for V-V ECMO, 
weaning of V-A ECMO and diagnose causes of high-access pressures 
and circuit fl ow problems. We use TOE as our preferred monitoring 
equipment before, during and after establishing ECMO. We sought 
to investigate how often information gained from TOE imaging had a 
major impact on management decisions.
Methods A single-centre observational study at a tertiary referral 
institution. All patients supported with V-A or V-V ECMO during an 
18-month period were included. Routine procedures such as wire 
position checks during cannulation or information gained to assist 
weaning from V-A support were not included.
Results Twenty patients were supported with either V-A (all peripheral) 
or V-V ECMO during the observation period. In 12 patients (60%) TOE 
was instrumental in diagnosing potentially fatal complications or 
altered clinical management. In three patients on V-A support, afterload 
reduction and modulation of inotropic support was necessary due to 
extensive spontaneous echo contrast formation in the left ventricle 
and stagnant pulmonary blood fl ow; two out of these three patients, 
immediately after establishing support, required intra-aortic balloon 
counterpulsation to reverse clot formation around the aortic valve 
and root. Further diagnosis were Avalon cannula misplacement in the 
blind end of a piggyback cava following liver transplant, collapsing 
right atrial free wall with ‘sucking down’ into the access cannula (n = 3), 
pericardial clot formation and tamponade (n  =  1), persistent left 
superior vena cava making planned cannula placement into the right 
atrium impossible or potentially fatal, diagnosis of patent foraminae 
ovale providing left atrial decompression and appropriate drainage 
cannula positioning during liver transplantation on ECMO.
Conclusion In our practice, TOE is an indispensable tool for safe ECMO 
practice, both during V-A and V-V support.
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Introduction Right-sided precordial leads (V3R to V5R) and posterior 
chest leads (V7 to V9) provide important information for the right 
ventricle and posterior wall. These additional lead electrocardiograms 
(ECGs) improve diagnostic value in acute coronary syndrome patients 
[1]. However, these additional electrocardiograms are not routinely 
recorded due to the time-consuming procedure involved. Recently 
these synthesized six additional lead ECGs using the standard 12-lead 
ECG system (Nihonkoden Co. Ltd) have been developed [2,3]. But the 
accuracy is not clear. The purpose of the present study was to evaluate 
the accuracy of synthesized ECGs at the ST part.
Methods Standard 12-lead and actual V3R to V5R, V7 to V9 lead ECGs 
at Tokyo Medical University Hospital were successfully recorded and 
compared with synthesized ECGs at the J point, M point that was 
defi ned for the point after 1/16 RR interval and T wave amplitude. ECGs 
of the complete right branch block, complete left branch block and 
pacing rhythm were excluded.
Results A total of 1,216 ECGs were correctly recorded. The diff erences 
of actual and synthesized at the J point, M point and T wave amplitude 
were very small. Means of the diff erence ± 2SD were V3R/V4R/V5R/V7/
V8/V9: J point, 17 ± 1/14 ± 1/13 ± 1/12 ± 1/15 ± 1/18 ± 1 μV; M point, 
15 ± 1/13 ± 1/12 ± 1/12 ± 1/12 ± 1/13 ± 1 μV; and T wave amplitude, 
20  ± 3/32  ± 2/16  ± 2/37  ± 2/39  ± 2/43  ± 3  μV. There were positive 
correlations between all actual and synthesized ECGs of J point, M 
point and T wave amplitude (Figure 1).
Conclusion The ST part of synthesized V3R to V5R and V7 to V9 lead 
ECGs appears to be highly reliable. Synthesized additional lead ECGs 
might be useful to diagnose ischemic heart disease.
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Introduction Acute and chronic systemic infl ammatory conditions 
are associated with aortic stiff ening. Carotid–femoral pulse wave 
velocity (PWV), a marker of aortic stiff ness, increases in patients with 
infl ammatory diseases and independently correlates to levels of 
C-reactive protein (CRP). The eff ects of massive infl ammatory response 
in early sepsis on mechanical properties of the aorta have not been 
investigated. The objective of the current study was to prospectively 
assess aortic stiff ness in patients with early severe sepsis and septic 
shock and relate it to infl ammatory and haemodynamic variables and 
outcome.
Methods We recruited patients meeting criteria for severe sepsis and 
septic shock within 24 hours of admission to ICU. After haemodynamic 
stabilisation, PWV was recorded at inclusion and after 48 hours using 
dual-channel plethysmography. Severity of illness was assessed with 
APACHE II and serial SOFA scores, haemodynamic and infl ammatory 
parameters (CRP, procalcitonin and fi brinogen) recorded. A 28-day 
follow-up was performed to distinguish between survivors and 
nonsurvivors.
Results Twenty consecutive general ICU patients (six with severe sepsis 
and 14 with septic shock) were enrolled in the study; median age 
59 years (IQR 56.5 to 72), APACHE II score 17 (13 to 20.5), SOFA score 5 
(IQR 4 to 9). At 28 days, six patients had died. Median initial PWV was 
10.4 (IQR 6.9 to 12.1) m/second in patients with severe sepsis, and 6.8 
(IQR 5.3 to 7.5) m/second in patients with septic shock (P = 0.13). After 
48 hours, PWV in the severe sepsis and septic shock groups had become 
similar, 9.3 (IQR 7.3 to 11.1) m/second and 9.2 (IQR 7.8 to 13) m/second 
respectively (P = 0.96). PWV had signifi cantly increased in survivors (7.8 
to 12.3 m/second) (P = 0.04) versus nonsurvivors (6 to 7.8 m/second) 
(P = 0.69). Higher PWV correlated with increasing systolic pressure and 
lower CRP levels (r = 0.73, P = 0.01).
Conclusion In early sepsis, aortic stiff ness is decreased in patients 
with greater disease severity, and in survivors increases to median 
levels within 48  hours. The main factors associated with lower pulse 
wave velocity are lower systolic pressure and higher CRP levels. The 
association of high serum CRP levels with low aortic stiff ness in patients 
with sepsis does not match data described in the literature [1].
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Figure 1 (abstract P135). Correlation between actual and synthesized 
ECG at V7.
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Introduction Approximately 15 million people worldwide suff er from 
congestive heart failure (CHF). The most severe symptom of CHF is 
pulmonary congestion – an acute increase in extravascular lung fl uid 
due to acute decompensation of heart failure. To date, no direct, 
reliable, simple and non-invasive method is available for assessment 
of thoracic fl uids. Continuous dependable monitoring of pulmonary 
edema for hospital patients can improve management and reduce 
duration of hospitalization. KYMA’s solution is based on a matchbox-
sized monitoring device, which monitors thoracic fl uid content and 
trends. The μCor monitor transmits and receives electromagnetic 
signals that are propagated through tissue layers. Conduction is 
highly related to the amount of accumulated fl uids in tissues. This trial 
investigated the correlation between KYMA’s lung water index (LWI) 
and directly assessed extravascular lung water (EVLW) in the scenario 
of acute pulmonary edema induced in seven sheep.
Methods Acute pulmonary edema was induced by intravenous infusion 
of noradrenaline and dextrane, with stepwise increased dosage. KYMA 
measurements of LWI were compared with PiCCO extravascular lung 
volume as the reference gold standard. The experiment continued until 
maximum increase of EVLW and complete heart failure were reached.
Results All seven sheep developed pulmonary edema, which was 
validated by increased LVEDP and EVLW. A linear correlation was found 
between invasive measurements of EVLW (PiCCO) and non-invasive 
KLWI.
Conclusion KYMA’s fl uid index demonstrated excellent correlation with 
invasive lung water measurement (R2 = 0.96; P <0.0001) and was able 
to detect dynamic accumulation of EVLW in a range of 40 to 50  cm3 
increments (Figure  1). Since the change in fl uid content between a 
normal and congested lung ranges between 250 and 500  cm3, the 
demonstrated sensitivity as refl ected in this study, supports its use for 
high-resolution and accurate thoracic fl uid monitoring.
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Introduction The aim of this work is to verify that low incidence of 
hemodynamic interventions in hemodynamically monitored patients 
in our postoperative ICU is not caused by insuffi  cient attention being 
paid to the drop of noncalibrated cardiac index (nCI). In the last 
2  years there was a need for hemodynamic intervention in 92% of 
patients with perioperative cardiac output monitoring, while only 
31% of these patients needed at least one hemodynamic intervention 
postoperatively in the ICU.
Methods High-risk patients planned to undergo elective major 
abdominal surgery were routinely monitored with LiDCOrapid; the 
monitoring continues overnight after surgery. The target nCI for the 
postoperative monitoring, as well as hemodynamic interventions in 
case of its drop, were prescribed by the anesthetist in the protocol upon 
handover of the patient to the postoperative ICU. The hemodynamic 
protocol in the ICU was then nurse driven with compulsory recording 
of patient’s hemodynamic data into the patient’s documentation every 
2 hours and at the time of each intervention. Data from the memory of 
the LiDCOrapid monitor were analyzed using LiDCOview software and 
compared with patients’ documentation.
Results A total 649  hours of hemodynamic record were analyzed in 
40 patients chosen at random from 121 patients monitored in the last 
2 years. We found 22 drops in nCI that were noticed by the nursing staff  
and led to volume challenge in accordance with the protocol. One-half 
of these interventions was carried out outside the 2-hour interval of 
protocol-required monitoring and documentation entry. We identifi ed 
nine drops in nCI that were not reacted to. None of them happened 
within the fi rst 4 hours postoperatively and all of them were outside 
the 2-hour interval of protocol-required monitoring. In fi ve of these 
episodes the pulse pressure also dropped, suggesting impairment of 
the reading of the waveform from the arterial line.
Conclusion The need for hemodynamic intervention in postoperative 
care was quite rare in our patients. The drop in nCI was noticed in most 
of the cases and the patient was treated according to the protocol. 
However, isolated episodes of nCI drop were missed during the night 
after the operation. The results were pointed out to the nursing staff  
and a comparative survey will be conducted. As with any monitoring 
modality, (non)adherence to the protocol may become the limiting 
issue to the benefi t for the patient.
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Introduction The aim of this work is to evaluate perioperative 
hemodynamic monitoring for major abdominal surgery using the 
estimated continuous cardiac output (esCCO) technique available with 
the NIHON KOHDEN Vismo monitor as compared with the LiDCOrapid 
hemodynamic monitoring system.
Methods The esCCO technique is a novel noncalibrated non-invasive 
method of cardiac output monitoring. It is based on the estimation 
of pulse pressure from the speed of pulse wave propagation, which 
is measured as a time delay between the ECG R-wave and the 
corresponding peripheral pulse wave detected by pulse oximetry – the 
delay being called the pulse wave transit time (PWTT) [1]. LiDCOrapid 
estimates noncalibrated cardiac output (nCO) by pulse wave contour 
analysis from an arterial line and is a well-established monitoring 
modality in our department. The patients planned for elective major 
abdominal surgery with ASA score of III and expected operation 
duration over 90 minutes are routinely monitored by LiDCOrapid with 
a perioperative hemodynamic optimalization protocol. In accordance 
with the protocol, an arterial line was inserted and LiDCOrapid 
monitoring was started before the induction of anesthesia. At the same 
time, non-invasive esCCO monitoring was started.
Results Ten patients were monitored with a total of 141 esCCO–nCO 
measurement pairs. The correlation coeffi  cient between esCCO and 
nCO was 0.65 and in the Bland–Altman diff erence analysis bias was 
+1.2  l/minute and 95% limits of agreement were ±  2.6  l/minute. The 
change of cardiac output between two consecutive measurements 
detected by LiDCOrapid was detected by esCCO in 80% of cases.
Conclusion Hemodynamic monitoring with esCCO yields cardiac 
output values diff erent from those measured by LiDCOrapid. The 
reliability of PWTT is questionable when systemic vascular resistance 
Figure 1 (abstract P137). Pooled correlation between EVLW and KYMA 
LWI.
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changes (as with any other noncalibrated cardiac output monitor), but 
it can still trace the trends of CO changes. Due to its non-invasiveness, 
esCCO might be the monitoring of choice for high-risk patients 
undergoing low-risk surgery.
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Introduction The Mostcare monitor is a non-invasive cardiac output 
monitor. It has been well validated in cardiac surgical patients but there 
is limited evidence on its use in patients with severe sepsis and septic 
shock [1].
Methods The fi rst 22 consecutive patients with severe sepsis and 
septic shock in whom the fl oatation of a pulmonary artery catheter 
was deemed necessary to guide clinical management were included. 
Cardiac output measurements were simultaneously calculated and 
recorded from a thermodilution pulmonary artery catheter and from 
the Mostcare monitor respectively. The two methods of measuring 
cardiac output were compared by Bland–Altman statistics and linear 
regression analysis. A percentage error less than 30% was defi ned as 
acceptable for this study.
Results Bland–Altman analysis for cardiac output showed a bias of 
0.31 l/minute, precision (=SD) of 1.97 l/minute and a percentage error 
of 62.54%. Linear regression produced a correlation coeffi  cient r2 for 
cardiac output of 0.403. See Figure 1.
Conclusion Compared with thermodilution cardiac output, cardiac 
output studies obtained from the Mostcare monitor have an 
unacceptably high error rate. The Mostcare monitor is not a reliable 
monitoring device to measure cardiac output in patients with severe 
sepsis and septic shock on an ICU.
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Introduction The aim of this animal study was to determine the 
feasibility and accuracy of a new non-invasive system for determination 
of cardiac output (CO) compared with a known device (PiCCO; Pulsion 
Medical). In ICUs and ORs, hemodynamic management using goal-
directed therapy has been shown to improve patient outcomes 
[1,2]. The invasiveness of current technology may prevent clinicians 
from obtaining hemodynamic information. We developed a non-
invasive system for detection of hemodynamic variables utilizing a 
photo-acoustic sensor (PA-S) and indicator dilution. The PA-S utilizes 
a combination of a miniature ultrasound sensor, a laser diode and an 
optical detector to accomplish the measurement.
Methods Five pigs weighing 25 to 29  kg were used in the study 
approved by the local animal use and care committee. The animals 
were anesthetized, medically paralyzed, intubated and mechanically 
ventilated. Central venous and arterial catheters were placed for 
injection of the indicator and connection to the PiCCO system. The 
PA-S was placed in contact with the skin over the saphenous artery 
on the animal and adjusted to receive the maximum acoustic signal. 
The adjustment included the depth of ultrasonic penetration and the 
exact location on top of the blood vessel. Each indicator dilution was 
accomplished using three central venous injections of 15  ml normal 
saline at room temperature. Variation in CO was accomplished by 
removing up to 50% of the blood volume after splenectomy. The PA-S 
results were obtained using the empirical regression method. The 
resulting cardiac output readings from the PA-S were compared with 
the PiCCO readings.
Results The correlation between the PA-S and the PiCCO system was 
(R2 = 0.746) over a range of CO from 1 to 6 l/minute. The Bland–Altman 
analysis demonstrated a bias of –0.05 l/minute and precision of 0.50 l/
minute.
Conclusion This animal study demonstrated the feasibility of the new 
PA-S for determination of indicator dilution CO in a limited range. The 
system showed good correlation with the PiCCO system even in the 
case of vasoconstriction as a result of blood loss. Since the PA-S utilizes 
transpulmonary indicator dilution, other variables such as intrathoracic 
blood volume, global end-diastolic volume and extravascular lung 
water can be calculated. Additionally, continuous CO can be obtained 
from the optical sensor signal utilizing arterial waveform analysis.
References
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Figure 1 (abstract P140). Cardiac output Bland–Altman analysis.
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Introduction The aim was to evaluate the performance of arterial 
pressure-based cardiac output (APCO) [1] and pulse wave transit time-
based cardiac output (esCCO) [2] monitors in Thai patients undergoing 
coronary artery bypass graft surgery (CABG) with cardiopulmonary 
bypass.
Methods We studied 50 Thai surgical patients undergoing CABG with 
cardiopulmonary bypass and requiring pulmonary artery catheter 
and radial artery catheter placement as a standard of clinical care. All 
patients were measured for APCO using the Vigileo/FloTrac and for 
esCCO using the esCCO monitoring system. The data were compared 
with thermodilution cardiac output (TDCO) monitoring as a reference 
method, simultaneously at pre-induction, post-induction, and every 
30 minutes thereafter until the completion of the surgery. The bias and 
precision were assessed using Bland–Altman analysis.
Results In total, 310 pairs of simultaneous measurements of APCO 
versus TDCO and 303 pairs of esCCO versus TDCO were obtained from 
50 patients. Both APCO (R = 0.53, P <0.0001) and esCCO values (R = 0.56, 
P <0.0001) were correlated with TDCO values. Either of the changes in 
APCO (R = 0.63, P <0.0001) or any changes in esCCO (R = 0.60, P <0.0001) 
were correlated with changes in TDCO. For APCO relative to TDCO, the 
bias, precision, and the limits of agreement were 0.70, 1.63, and –2.5 
to 3.9 l/minute, while those of esCCO were 1.20, 1.59, and –1.9 to 4.3 l/
minute, respectively. Comparisons of the bias of APCO and esCCO 
revealed a level of signifi cance of P <0.001.
Conclusion Despite the overestimation of cardiac output measure-
ments, APCO and esCCO calibrated with patient information has 
shown an acceptable trend as compared with TDCO in Thai patients 
undergoing CABG with cardiopulmonary bypass. Compared with 
esCCO, APCO demonstrated no signifi cant diff erences of precision; 
however, a lower mean bias was exhibited.
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Introduction Transpulmonary thermodilution is useful in the critical 
care. Following PiCCO, VolumeView is now available. Although previous 
studies concluded that signifi cant correlation was found between 
VolumeView and PiCCO [1,2], all experiments and data analysis were 
done by Edwards Lifescience. The aim of the present study was to 
compare the new VolumeView with PiCCO to clarify their compatibility 
and to give a neutral answer.
Methods Six pigs (about 10 kg) were used and we made sepsis models 
by LPS administration. All pigs were instrumented with a right (Pulsio-
Cath) and a left (VolumeView) thermomistor-tipped femoral arterial 
catheter. The central venous catheter was inserted through the right 
jugular vein. CO, GEDV and EVLW were measured by the two systems.
Results We performed measurements at 57 points. There was a good 
correlation between the two devices regarding CO and GEDV, but 
VolumeView showed higher GEDV than PiCCO. Regarding EVLW, there 
was no signifi cant correlation between two systems. VolumeView 
showed signifi cantly higher EVLW than PiCCO (Figure 1 and Table 1).
Figure 1 (abstract P143). CO, GEDV, EVLW correlation and Bland–Altman analysis.
Table 1 (abstract P143). Explanation of abbreviations
 CO GEDV EVLW
PiCCO PCO PGEDV PEVLW
VolumeView ECO EGEDV EEVLW
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Conclusion Our data analysis showed that PiCCO and VolumeView were 
not the same. Neither the normal values of two devices nor the rates of 
change were same. Careful attention should be paid to interpret the 
data obtained from two systems.
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Introduction Goal-directed therapy used in the perioperative period 
of patients undergoing cardiac surgery shortens the length of ICU 
stay [1]. We aimed to compare the postoperative results of the liberal 
and restrictive fl uid strategy used in patients undergoing pulmonary 
resection surgery (PRC).
Methods We have been using the restrictive fl uid strategy since March 
2013 in our institute. Patients who were on the liberal fl uid regime were 
analyzed retrospectively. From March 2013 until today, patients who 
were on restrictive fl uid strategy were analyzed prospectively. A total 
of 125 patients were included in the study. Age, duration of anesthesia, 
type of fl uids given intraoperatively, fl uid index (ml/kg/hour), fl uid 
intake/output balance, creatinine and lactate levels were compared 
with pulmonary and renal morbidity, and length of stay in ICU, using 
multivariate analysis.
Results A signifi cant correlation (P  <0.05) was established between 
the amount of crystalloid given intraoperatively, fl uid index and fl uid 
balance with pulmonary morbidity (n = 52). The fl uid index and inotropes 
usage were correlated with the postoperative creatinine levels (P <0.05). 
There was no correlation between perioperative lactate levels with fl uid 
balance and fl uid index. Intraoperative blood loss, the amount of given 
crystalloid, colloid, blood and FFP, fl uid balance, duration of anesthesia 
and postoperative blood transfusion were found to be related (P <0.05) 
with the length of ICU stay. Four percent of the patients required renal 
replacement therapy and the overall mortality was 0.8%.
Conclusion To reduce the morbidity of patients undergoing major 
surgery, the protocols of using the restrictive fl uid strategy in the 
perioperative period and simultaneous protection of end organs, 
especially the kidneys, is currently the subject of this discussion. We 
observed that the restrictive fl uid strategy did not lead to global organ 
hypoperfusion, which was monitored by lactate. Even though there was 
a negative correlation between the fl uid index with creatinine levels and 
renal failure, the need for renal replacement therapy was observed only 
in one case. As a conclusion, the postoperative pulmonary morbidity and 
length of ICU stay can be reduced in patients who undergo PRC by using 
the restrictive fl uid strategy (4.2 ± 0.3 ml/kg/hour), without causing any 
vital organ dysfunction.
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Introduction The rationale for perioperative fl uid therapy has been 
to preserve organ perfusion. However, conservative postoperative 
fl uid balance (FB) is now encouraged to avoid the eff ects of iatrogenic 
fl uid overload. In addition, fl uid expansion has been described as a 
confounder of acute kidney injury (AKI) diagnosis by dilution serum 
creatinine (SCr).
Methods We conducted a prospective audit of FB and renal function 
in patients undergoing major elective surgery admitted to critical care 
over a 28-day period. Fluid overload was defi ned as: (positive FB) / 
(weight × 0.6) × 100%.
Results Thirty-two patients (56% female, median age 64) were studied 
over a median of 3 critical care days (range 1 to 7). Total FB was +3.9 l 
at discharge; however, 75% of this occurred intraoperatively so that 
positive FB in critical care was only +390 ml/day. Patients had median 
9% fl uid overload at discharge. Two patients had transient AKI stage 
1. Overall SCr decreased signifi cantly from preoperatively to discharge 
(P  =  0.003), median 73 to 55  μmol/l, with decreases occurring both 
postoperatively and during critical care stay (Figure 1).
Conclusion We achieved near-neutral fl uid balances after admission, 
but did not resolve intraoperative fl uid accumulation. SCr fell 
signifi cantly, even after there was no further net fl uid accumulation. 
This suggests a decrease in creatinine generation after major surgery, 
rather than fl uid expansion, may largely account for sCr decreases in 
these patients.
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Introduction The aims of the study are to assess the usefulness of pulse 
pressure variation (PPV) as a predictive marker of fl uid responsiveness 
and to estimate the value of central venous–arterial diff erence of 
carbon dioxide (PCO2cv-a) to predict the outcome of critically ill 
septic patients. The question of whether a septic patient needs fl uids 
or not is crucial. Although PPV is a very reliable predictor of volume 
responsiveness, there are many limitations for its application. Cardiac 
arrhythmia, spontaneous breathing and low tidal volume ventilation 
prevent the extended use of this index.
Methods This is a post-hoc analysis of data from a prospective 
observational study [1], which included a population of patients with 
severe sepsis or septic shock as the main reason for ICU admittance. 
After an echo for the assessment of the cardiac systolic performance, 
we measured PPV, central venous oxygen saturation, blood gases from 
arterial and central venous lines, central venous pressure, systolic, 
diastolic, mean and pulse pressures, before and after volume challenge. 
We calculated changes in pulse pressure before and after volume 
challenge, and an increase of 9% was used as criterion to defi ne volume 
responsiveness [2].
Figure 1 (abstract P145). Serum creatinine changes after major surgery.
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Results Among 72 patients (71% men, APACHE II score 23.2) included 
in this study, 41 (57%) were responders. Due to spontaneous breathing 
and cardiac arrhythmia we were able to calculate PPV only in 18 
patients (25%). Moreover, only eight (11%) calculations of PPV proved 
useful because of the application of low tidal ventilation (4 to 6 ml/kg 
ideal body weight) in the remaining 10 patients. We did not fi nd any 
value of the PCO2cv-a to predict the outcome of the patients (mortality 
26.3%), since the diff erence between survivors and nonsurvivors was 
not statistically signifi cant (7.7 vs. 7.9, P >0.05).
Conclusion The usefulness of PPV, the marker with the best 
performance in the prediction of volume responsiveness, due to its 
limitations, is very limited.
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Introduction The renal resistive index (RI) determined by Doppler 
ultrasonography allows a semiquantitative evaluation of kidney 
vasculature at the bedside. Interpretation of the RI in clinical practice 
is diffi  cult due to interaction with cardiac output, heart rate (HR) and 
blood pressure [1,2]. The impact of global hemodynamics on the RI 
remains to be evaluated. This study aims to investigate the relationship 
between the RI and changes in central hemodynamic during a central 
hypovolemia model in healthy volunteers (HV).
Methods Eleven healthy volunteers (27  ±  8  years; eight male) 
participated in this study. Two diff erent models were performed: the 
fi rst model was performed by applying the head-up tilt (HUT) test. 
The complete maneuver was done by a 10-minute step that consisted 
of tilting the table from a supine position (Sup) to an angle of 70° 
(HUT) and back to supine (Sup’). The second model was performed by 
applying three consecutive valsalva maneuvers. Global hemodynamics 
included stroke volume (SV), HR, and mean arterial pressure, which 
were continuously measured non-invasively with a Finometer. At least 
three RI readings were obtained and averaged from the right and left 
kidneys in all HV.
Results All HV had a signifi cant decrease of SV from 83  ±  17  ml to 
63 ± 14 ml and an increase in HR from 67 ± 10 bpm to 88 ± 13 bpm 
during the HUT. Figure  1 shows the temporal changes of mean RI in 
both kidneys. A signifi cant decrease in the RI in both kidneys was seen 
during HUT. After the move back to supine, RI returned to baseline 
values, with a signifi cant variation of RI in the early measurements on 
the right kidney compared with late measurements on the left kidney 
(0.67 ± 0.05 vs. 0.61 ± 0.05, P <0.05). Valsalva maneuvers signifi cantly 
increased the RI in the right and left kidneys, from 0.6  ±  0.04 and 
0.6 ± 0.05 to 0.7 ± 0.1 and 0.68 ± 0.15 (P <0.05), respectively.
Conclusion These preliminary results showed that Doppler renal RI was 
aff ected equally in both kidneys during HUT, suggesting an eff ect of 
hemodynamic alterations during our model of central hypovolemia.
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Introduction Tissue hypoxia occurs frequently during surgery and may 
contribute to postoperative organ dysfunction [1]. We hypothesised 
that intraoperative optimisation of tissue oxygenation reduces 
postoperative complications and evaluated the feasibility of the 
optimisation protocol used.
Methods We randomised 50 high-risk patients who underwent 
major abdominal surgery. Tissue oxygenation was monitored at the 
thenar eminence using near-infrared spectroscopy. All patients were 
treated according to a standard care algorithm. In addition, patients 
in the intervention group received dobutamine if necessary to keep 
tissue oxygenation ≥80%. Data were recorded continuously and 
complications were recorded during the hospital stay with a maximum 
of 28 days.
Results The number of complications tended to be lower in the 
intervention group (11 vs. 20). Eleven patients in the intervention 
group had no complication, versus seven in the control group. There 
was no signifi cant diff erence between groups in length of stay in 
ICU or in hospital. Administration resulted in a 5% increase of tissue 
oxygenation. The cardiac index increased 0.3 (0.0 to 0.6) l/minute/m2 
(Figure 1). The overall protocol adherence was 94%.
Conclusion Intraoperative optimisation of tissue oxygenation will 
potentially result in better outcome after high-risk abdominal surgery. 
The protocol used may be considered feasible for clinical practice.
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Figure 1 (abstract P147). Doppler-based renal resistive index in both 
kidneys during HUT.
Figure 1 (abstract P148). Evolution of individual patient values (thin 
lines) and the average values (thick lines) of the tissue oxygenation 
(StO2) and the relative change of cardiac index (CI), delta CI. All graphs 
are synchronised at the moment of the fi rst dobutamine administration 
(time = 0; arrow). Values are shown from 10 minutes before dobutamine 
administration until 45 minutes after.
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Introduction Passive leg raising (PLR) has been suggested as a simple 
diagnostic tool to guide fl uid administration in critically ill patients [1]. 
Although the basic principles of PLR have been well studied, little is 
known about the impact of the introduction of this technique in daily 
clinical practice. The aim of the study was to describe the changes in 
fl uid balance of ICU patients before and after the introduction of PLR, 
and to determine the compliance of medical personnel with a PLR-
driven protocol of fl uid administration.
Methods In this single-centre prospective study, mixed ICU patients 
equipped with a PiCCO system received fl uid therapy on the basis of PLR 
test results in the fi rst 48 hours of treatment, after careful introduction of 
a new PLR-driven protocol. Exclusion criteria were increased abdominal 
pressure, fracture of leg or pelvis, deep vein thrombosis, head trauma 
and pregnancy. The control group existed of patients admitted to the 
ICU 1 year prior to the introduction of the protocol.
Results We included 21 patients in each group. There was no signifi cant 
diff erences in the fl uid balance between the control and study group 
after 24 hours (5.0 ± 2.9 l vs. 3.6 ± 2.7 l, P = 0.11) and 48 hours (5.7 ± 3.5 l 
vs. 4.8  ±  3.7  l, P  =  0.39). However, compliance with the protocol was 
poor (56%). After 2/11 positive tests, fl uid was not administered; and 
after 21/39 tests, fl uid was administered despite a negative test result 
(Figure 1).
Conclusion The implementation of a PLR-driven protocol of fl uid 
administration did not change mean fl uid balances after the fi rst 
48  hours. Noncompliance with the protocol was an important 
confounder.
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Introduction The correct assessment of volume status and prediction 
of response to fi lling fl uid challenge is of crucial importance in the 
patient with septic shock. A patient is a fl uid responder if there is an 
increase in cardiac index (CI) >15% in response to the fl uid challenge. 
Identifying which patient will be a fl uid responder is crucial. The aim of 
this prospective study is to evaluate which patient is a fl uid responder in 
septic shock using dynamics echocardiography with the distensibility 
index of the inferior vena cava (DIIVC), which has been shown to be 
predictive of an increase in CI [1].
Methods In a period of 1  year, 42 adult patients were admitted to 
the ICU in septic shock. All patients were treated according to the 
guidelines of the Surviving Sepsis Campaign International Guidelines 
for Management of Severe Sepsis and Septic Shock 2012 [2]. All patients 
were mechanically ventilated and subjected to transesophageal 
echocardiography in bicavale projection, calculating the DIIVC through 
the M-mode by measuring the change in diameter with the acts of 
positive pressure ventilation and using the formula: (100 × (maximum 
diameter – minimum diameter)) / minimum diameter. A value >18% was 
considered a predictor of an increase in CI >15%. The CI was measured 
continuously through use of the pressure recording analytical method 
on a Mostcare Vytech monitor. All patients were subjected to a bolus of 
500 ml crystalloid through a central venous catheter only after reaching 
central venous pressure (CVP) ≥10 mmHg during treatment. The results 
were expressed as the mean with standard deviation and percentage.
Results Sixteen patients (38%) had a change in DIIVC <18%, on average 
11 ± 5%, and when subjected to fl uid challenge did not have an increase 
in CI >15%, average 8 ± 3%, not proving to be a fl uid responder. Twenty-
six patients (62%) had a change in DIIVC >18%, on average 45 ± 22%, 
and when subjected to fl uid challenge had an increase of the CI >15%, 
on average 31 ± 8%, proving to be a fl uid responder.
Conclusion We have shown that the DIIVC can predict the response 
of patients to fl uid challenge regardless of the values of CVP and then 
distinguish fl uid responders from nonresponder patients. This can help 
us in the choice of treatment for patients in septic shock.
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Introduction Dynamic arterial elastance (Eadyn), defi ned as the pulse 
pressure variation (PPV) to stroke volume variation (SVV) ratio, has 
been suggested as a predictor of the arterial pressure response to 
fl uid administration. Rather than a steady-state assessment, Eadyn 
depicts the actual slope of the pressure–volume relationship providing 
a dynamic evaluation of the arterial load. So the higher the Eadyn 
value, the more likely arterial blood pressure is to improve after fl uid 
challenge (FC). The aim of this study was to assess the eff ectiveness of 
Eadyn, measured non-invasively in preload-dependent, spontaneously 
breathing patients.
Methods Patients admitted postoperatively and monitored with the 
Nexfi n monitor were enrolled in the study. Patients were included 
if they were spontaneously breathing and had an increase in cardiac 
output ≥10% after a FC. They were classifi ed according to the increase 
in mean arterial pressure (MAP) after FC into MAP-responders (MAP 
increase ≥10%) and MAP-nonresponders (MAP increase <10%). Eadyn 
was calculated from the PPV and SVV values obtained from the monitor.
Results A total of 34 FCs from 26 patients were studied. Seventeen 
FCs (50%) induced a positive MAP response. Preinfusion Eadyn was 
signifi cantly higher in MAP-responders (1.39  ±  0.41 vs. 0.85  ±  0.23; 
P  =  0.0001) (Figure  1). Preinfusion Eadyn predicted a positive MAP 
response to FC with an area under the ROC curve of 0.92 ± 0.04 of SE 
(95% CI: 0.78 to 0.99; P <0.0001). A preinfusion Eadyn value ≥1.06 (grey 
zone: 0.9 to 1.15) discriminated MAP-responders with a sensitivity and 
specifi city of 88.2% (95% CI: 64 to 99%).
Conclusion Non-invasive dynamic arterial elastance, defi ned as the 
PPV to SVV ratio, predicted the arterial pressure increase to fl uid 
administration in spontaneously, preload-dependent patients.
Figure 1 (abstract P149). SVI, stroke volume index; –, negative PLR; 
+, positive PLR; fl uid 250 cm3 RL solution.
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Introduction Recent studies showed that the plethysmographic 
variability index (PVI), a dynamic index resulting from cardiopulmonary 
interactions, could predict fl uid responsiveness (FR) in mechanically 
ventilated patients during general anesthesia and in the ICU [1,2]. In 
this study, we aimed to compare, in patients after cardiac surgery, the 
clinical utility of the PVI versus traditional statics and dynamics indices 
to predict FR.
Methods We prospectively enrolled 52 consecutive adult patients 
in sinus rhythm and mechanically ventilated (tidal volume of 8 
(7.5 to 8.5) ml/kg ideal body weight) admitted to the ICU of CHU de 
Charleroi (Belgium) after scheduled cardiac surgery. Before and after 
fl uid challenge (FC), we measured: heart rate (HR), BP, PVI (Masimo 
Corporation, Irvine, CA, USA) and PPV. PAOP and cardiac index (CI) 
were estimated by Swan–Ganz catheter (Edwards Lifesciences LLC, 
Irvine, CA, USA). Patients with an increase in CI of at least 15% after 
FC and subsequently were considered responders (R). Continuous 
variables were analyzed with Mann–Whitney U  tests. Categoric 
variables were analyzed with the Fisher’s exact test. Correlations were 
assessed by Spearman’s correlation. The discriminatory ability of each 
haemodynamic parameter to determine FR was assessed by area 
under the receiver operating characteristic curve (AUC), between R and 
nonresponders (NR). P <0.05 was considered statistically signifi cant.
Results Twenty-fi ve (48%) patients were classifi ed as R. Before FC, R and 
NR patients were comparable except for HR (91 (83 to 108) for R vs. 
80 beats/minute (72 to 89) for NR; P = 0.009), PVI (18 (12 to 26) for R 
vs. 12% (9 to 15) for NR; P = 0.003), PAOP (8 (6 to 9) for R vs. 11 mmHg 
(8 to 12) for NR; P  = 0.001), and PPV (13 (8 to 19) for R vs. 10% (4 to 
13) for NR; P = 0.086). PVI and delta PP before FC were correlated (r = 
0.53, P <0.0001). AUC showed a better prediction of FR for PVI (AUC = 
0.74, P <0.001) than for PPV (AUC = 0.64, P = 0.05). Nevertheless, the 
sensitivity (Se) and specifi city (Sp) of both indices were low: for a PPV 
over 13%, Se = 48% (0.301 to 0.665),and Sp = 82% (0.627 to 0.921); for a 
PVI over 12%, Se = 68% (0.482 to 0.828) and Sp = 69% (0.498 to 0.835). 
As for PAOP, increasing values are associated with NR (AUC  = 0.22, 
P <0.0001).
Conclusion The PVI appears to be useful to predict FR in mechanically 
ventilated patients after cardiac surgery. However, Se and Sp remain low 
in the type of patients with relative euvolemia and cardiac dysfunction.
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Introduction According to Guyton and colleagues [1], expansion of 
blood volume can increase cardiac output (CO) in so far as the change 
in volume aff ects the mean systemic fi lling pressure (Pmsf ). However, 
rapid stress relaxation occurs after acute intravascular volume 
expansion so that the eff ect of volume on Pmsf and CO may disappear 
after a few minutes. The objective of the present study is to describe the 
extent of the haemodynamic changes generated by a fl uid challenge 
during 10 minutes on critically ill patients.
Methods Patients admitted to the ICU were monitored with a calibrated 
LiDCOplus (LiDCO, UK) and Navigator (Applied Physiology, Australia) to 
estimate Pmsf analogue (Pmsa). Then 250  ml Hartmann’s solution or 
Volplex was infused over 5 minutes. Data were recorded automatically 
from baseline to 10 minutes after the end of fl uid infusion. The time to 
maximum response and percentage change between baseline and last 
value of diff erent haemodynamic parameters are also reported.
Results Sixty fl uid challenges were studied in 34 patients, with a mean 
duration of 5.3 minutes (± 2.5). In 22 events (37%), CO increased more 
than 10% (responders). The change between baseline and last value 
was greater in nonresponders for heart effi  ciency (Eh) (–9.2% ± 9.7 vs. 
–3.1% ± 13.9, P = 0.05) but not in other haemodynamic variables. Time 
to maximal response on CO was 2 minutes after the end of the infusion 
(Figure 1).
Conclusion Stress relaxation damps down the eff ect of a fl uid challenge 
after 10 minutes except in terms of heart effi  ciency. The eff ect of a fl uid 
challenge should be assessed up to 2  minutes after the end of fl uid 
infusion. Failure to do so may mislead clinicians about the patient’s 
fl uid responsiveness.
Figure 1 (abstract P151). Distribution of individual arterial load parameters at preinfusion time.
Figure 1 (abstract P153). Change of CO during and after a fl uid 
challenge. BL, baseline; end, end of fl uid infusion.
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Introduction The latest sepsis guideline has emphasized early 
resuscitative fl uid management [1]. Early goal-directed therapy (EGDT) 
has been shown to improve 28-day mortality in recent studies [2,3]. This 
strategy was based on improving tissue perfusion and oxygenation in 
spite of other supportive and therapeutic measures. Technically and 
historically, central venous pressure (CVP) measurement is one of 
the most dependent methods to estimate fl uid responsiveness and 
intravascular volume status on resuscitation. The Surviving Sepsis 
Campaign (SSC) guidelines recommended goal levels of CVP 8 to 
12  mmHg in order to obtain appropriate tissue perfusion [1]. In this 
study, we objected to re-evaluate eff ectiveness of a fl uid resuscitation 
strategy in sepsis, comparing the eff ect of patients’ daily fl uid balances 
(DFB) and CVP on patients’ survival.
Methods Patient records (APACHE II, length of stay (LOS), CVP, DFB, 
vasopressor and ventilator needs) were retrospectively collaborated, 
and a randomly-assigned 100 (63 men and 37 women, age 
64.2 ± 15.5 years) were statistically analyzed for survival function.
Results The mean APACHE II score was 23.6  ±  7.7, LOS was 
9.7 ± 10.0 days, intubated period was 6.4 ± 8.6 days, vasopressor period 
was 4.7 ± 5.5 days, CVP was 10.5 ± 5.5 mmHg, DFB was 1,147.9 ± 1,157.6 
ml, and 42 survived. Kaplan–Meier survival and COX regression analysis 
showed that CVP levels of 6 to 9  mmHg and DFB +800 to +900 ml, 
but not above, signifi cantly predicted survival, and also shorter LOS, 
intubated days and lower vasopressor needs with earlier discharge 
possibility. On the other hand, over-increased DFB and CVP levels 
strictly correlated with longer LOS and higher mortality rates, and the 
fi rst 24-hour mean fl uid balance alone was surprisingly not predictive.
Conclusion Fluid resuscitation therapy is a double-edge-sword. (1) 
Despite lower volumes, higher volumes also increase mortality. (2) 
Overall, DFB seemed more important than the fi rst 24-hour DFB.
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Introduction Previous in vitro studies have shown that photometric 
assays may overestimate fi brinogen levels after hemodilution with HES. 
The in vivo eff ect of HES on fi brinogen assays was therefore studied.
Methods Forty patients with intracranial tumor gave their consent 
to participate in this ethical approved study. Plasma fi brinogen 
levels were analyzed with ELISA, two photometric assays (Dade and 
Multifi bren) and one mechanical (Hook). In addition, ROTEM FibTEM-
MCF was analyzed.
Results Twenty-fi ve of the 40 patients received 1 l HES. Mean reduction 
of hematocrit was 17%. ELISA was lower than Hook and Multifi bren. 
The FibTEM relative decrease of 43% diff ered signifi cantly from the 
other assays. See Figure 1.
Conclusion After in vivo hemodilution with HES, some assays 
overestimated fi brinogen levels. An overestimation of around 0.3  g/l 
may lead to undercorrection of fi brinogen in critical bleeding situations. 
The aggravated response on the FibTEM-MCF may better refl ect HES 
eff ects on clot structure.
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Introduction Lactated Ringer (L/R) for resuscitation of hemorrhagic 
shock is suggested by the ATLS program. However, prior studies 
showed that resuscitation with L/R was associated with more kidney 
damage in rats with severe hemorrhagic shock. The direct eff ects of L/R 
on human renal tubule cells have not been reported.
Methods Human proximal renal tubular cell line HK-2 was used. Viability 
was examined by MTT assay. An additional equal volume of phosphate-
buff ered saline (PBS) served as control. Addition of 200  nM dipyridyl 
and 1 mM H2O2 served as conditions of hypoxia and oxidative stress, 
respectively. Patterns of cell death were observed by fl ow cytometry.
Results To imitate early resuscitation in hypovolemic shock, medium 
was replaced with 40% v/v of L/R with dipyridyl plus H2O2 for 4 hours, 
followed by replacing with complete medium for 44  hours. In such 
Figure 1 (abstract P155). Relative change of P-fi brinogen compared with 
preoperative values.
Figure 1 (abstract P156). Cell death of HK-2 cells after lactated Ringer 
administration in a hypovolemia mimic model.
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conditions, L/R augmented cytotoxicity, and more annexin V (+) cells 
were observed. Co-treatment or post-treatment with BXL 628, a novel 
VDR agonist, reversed L/R-induced cytotoxicity. See Figures 1 and 2.
Conclusion BXL 628 rescued L/R-induced apoptosis in human renal 
proximal tubule cells in a hypovolemia mimicking model.
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Introduction Morbidity after liver transplantation has been linked 
with preoperative MELD scores and transfusion volumes [1]. We 
hypothesized that in the immediate post-transplant period there may 
be modifi able risk factors associated with prolonged ICU stays.
Methods In a retrospective, case–control study, we reviewed all liver 
transplant adult recipients over a 33-month period, January 2010 
to September 2013. Recipients were divided into two groups based 
on a priori determined cutoff  value of 8  days after transplantation. 
Signifi cant associations for prolonged ICU admission were identifi ed 
using chi-square analysis for categorical and ANOVA for continuous 
variables. P  <0.05 was considered signifi cant. SPSS version 22.0 was 
used for all analyses.
Results Total numbers of transplants performed were 162. Mean pre-
transplant MELD score was 19.5  ±  7.7; viral hepatitis was the most 
common indication for transplant, 44 (27%). Living-related donor 
transplants were carried out in 87 (54%) cases. Median ICU length of 
stay was 4  ±  11.9  days and ICU mortality was 15 (9%). Acute kidney 
injury developed in 30 (19%) with 5% needing renal replacement 
therapy. Early complications developed in 33%. Prolonged ICU stay 
was related to: a higher pre-transplant INR (P = 0.000), larger volumes of 
RBC (2,064 ± 1,701 vs. 1,176 ± 1,454 ml, P = 0.000), platelets (453 ± 271 
vs. 365 ± 276 ml, P = 0.046) and cryoprecipitate transfusions (47 ± 98 
vs. 23  ±  85  ml, P  =  0.037) received in the OR and mean volumes of 
hypotonic crystalloids administered in the fi rst 24  hours (P  =  0.002), 
48 hours (P = 0.010) and 72 hours (P = 0.007) of ICU admission. Serum 
sodium, chloride, lactate or creatinine levels were not signifi cantly 
diff erent between the two groups.
Conclusion The administration of hypotonic fl uids in the fi rst 72 hours 
of liver transplantation may be a risk factor for prolonged ICU 
admission. This eff ect appears independent of serum electrolyte levels 
or renal dysfunction.
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Introduction Vasopressin is frequently used to maintain blood pressure 
in refractory septic shock [1]. This study is looking into the hypothesis 
that vasopressin compared with norepinephrine would decrease the 
severity of septic status, evolution to multiple organ dysfunction, 
length of hospitalization, and mortality among patients with septic 
shock.
Methods In this randomized, double-blind study, we assigned patients 
who still needed vasopressor to restore tissue perfusion after fl uid 
resuscitation to receive norepinephrine (0.05 to 2.0 μg/kg/minute) or 
vasopressin (0.01 to 0.03 U/minute) with low doses of norepinephrine. 
Both groups had the vasoactive drug infusions titrated and tapered 
to maintain a target mean blood pressure. The analysis included the 
total time of use and dosage of vasopressors every 6 hours, the move 
to single organ dysfunction and multiple organ failure, length of ICU 
stay and hospitalization, and mortality 7, 14 and 28 days after the start 
of infusions.
Results A total of 407 patients underwent randomization but 387 
patients were included in this study (191 patients received vasopressin, 
and 196 received norepinephrine only). The total time for vasopressors 
was 37  hours and 68  hours in the vasopressin and norepinephrine 
groups with P  =  0.02. Single organ dysfunction and multiple organ 
dysfunction using vasopressin and norepinephrine were respectively: 
37.7% vs. 49.2%, P = 0.02; and 17.8% vs. 26%; P = 0.05. Length of stay 
in the ICU was 14 and 17 days (P = 0.29) and the time of hospitalization 
was 23 and 28  days (P  =  0.11) respectively. There was a signifi cant 
diff erence between the vasopressin and norepinephrine groups in the 
mortality rate at 14 and 28 days (29.3% vs. 36.7%, P = 0.05; 34% and 
42.3%, P = 0.03), but there were no signifi cant diff erences in the overall 
rates for 7-day mortality (21.2% vs. 23.9%, respectively; P = 1.1).
Conclusion Early application of vasopressin reduced the time of 
vasopressor use, progression to multiple organ dysfunction, length 
of stay in the ICU, and mortality rates at 14 and 28 days as compared 
with norepinephrine only. This observed diff erence can be attributed 
to early restoration of tissue perfusion in the control group making the 
state of septic shock shorter and reducing the potential for multiple 
organ dysfunction, which directly infl uenced patient survival.
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Introduction Terlipressin is a vasopressin (V1 receptor) agonist that 
causes splanchnic constriction and is used in the management 
of variceal bleeding. This case report demonstrates the profound 
hyponatraemia, suffi  cient to cause a fall in conscious level, developing 
following terlipressin administration for variceal gastrointestinal 
bleeding.
Figure 2 (abstract P156). Elocalcitol (BXL 628) ameliorates toxicity of 
lactated Ringer in HK-2 human renal tubule cells.
Critical Care 2014, Volume 18 Suppl 1 
http://ccforum.com/supplements/18/S1
S56
Methods A 28-year-old man was admitted to the ICU following 
intubation and sedation for seizures due to acute alcohol withdrawal. 
A CT scan of the brain was normal. In the ICU the patient became 
haemodynamically unstable and fresh blood was aspirated from the 
nasogastric tube. Gastroscopy showed bleeding oesphageal varicies 
and hypertensive portal gastropathy. The patient was treated with 
variceal banding, tazobactam/pipacillin (4.5  g three times daily) and 
terlipressin (2 g four times daily) as per protocol for variceal bleeding. 
He was successfully extubated 48 hours later.
Results On admission the patient’s serum sodium was 139 mmol/l. The 
patient received terlipressin for 4  days in the following regimen: 2  g 
four times daily for 48 hours, then 1 mg four times daily for 24 hours 
and then 0.5 mg four times daily for a further 24 hours before stopping. 
On the last day of his terlipressin therapy, the patient’s GCS dropped 
from 15 to 11. Serum sodium had fallen acutely to 116 mmol/l. The 
last two doses of terlipressin were cancelled and no other treatment 
for hyponatraemia was administered. His serum sodium and GCS 
returned to normal limits within 13 hours of terlipressin cessation with 
no neurological consequences.
Conclusion There are few case reports of terlipressin-induced 
hyponatraemia [1]. Hyponatraemia is considered a rare side eff ect 
brought about by the partial agonist eff ect of terlipressin on renal 
vasopressin V2 receptors. Sola and colleagues monitored serum sodium 
concentrations in patients with acute variceal bleeding. They found that 
rapid reduction in serum sodium was common (up to 36%) and one 
patient developed osmotic demyelination syndrome. Hyponatraemia 
resolved on cessation of terlipressin [2]. Close monitoring of serum 
sodium levels is essential in patients on terlipressin therapy so rapid 
drops in sodium can be identifi ed and managed to stop associated 
neurological complications.
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Introduction Patients with distributive shock who require high-dose 
vasopressors have a high mortality. Vasopressors belong to two classes: 
catecholamines and vasopressin analogs. Each class has limitations. 
Patients receiving catecholamines often develop tachyphylaxis and 
metabolic complications (for example, lactic acidosis). Vasopressin 
analogs can cause mesenteric or myocardial ischemia and oliguria. 
Angiotensin II (ATII) is an endogenous peptide that increases blood 
pressure and aldosterone production. Preclinical data suggest a role 
for ATII in the treatment of sepsis-associated acute kidney injury. 
ATII may prove useful in patients who remain hypotensive despite 
catecholamine and vasopressin therapy. This is the fi rst randomized 
clinical trial to date which seeks to evaluate ATII for use in distributive 
shock.
Methods Twenty patients with distributive shock and a cardiovascular 
Sequential Organ Failure Assessment score ≥4 were randomized 
to either ATII infusion (n  =  10) or placebo (n  =  10) plus standard of 
care. ATII was started at a dose of 20  ng/kg/minute, and titrated per 
a protocolized schedule for a goal of maintaining a mean arterial 
pressure (MAP) of 65 mmHg. The infusion (either ATII or placebo) was 
continued for 6 hours and then titrated off . The primary endpoint was 
the eff ect of ATII on the standing dose of norepinephrine required to 
maintain a MAP of 65 mmHg. Secondary endpoints included the eff ect 
of ATII on urine output, serum lactate and creatinine clearance, as well 
as 30-day mortality.
Results The mean age was 62.9  ±  15.8  years. Of the patients, 75% 
were male, 45% were Caucasian and 40% were African American. 
The 30-day mortality for the two groups were similar for the ATII 
cohort and the placebo cohort (50% vs. 60%, P  =  1.00). ATII resulted 
in marked reduction in norepinephrine dosing in all patients. The 
mean norepinephrine dose for the placebo cohort was 20.1 ± 16.8 μg/
minute vs. 7.3 ± 11.9 μg/minute for the ATII cohort (P = 0.022). The most 
common adverse event was hypertension, which occurred in 20% of 
patients receiving ATII.
Conclusion ATII is an eff ective vasopressor agent in patients with 
distributive shock requiring multiple vasopressors. The initial dose 
range of ATII that appears to be appropriate for patients with 
distributive shock is 2 to 10 ng/kg/minute. Further studies to assess the 
use of ATII in patients with distributive shock are warranted.
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Introduction Patients with septic shock die mainly due to refractory 
shock. Vasopressin is commonly used as an adjunct to catecholamines 
to support blood pressure in refractory septic shock, but its eff ect on 
mortality is unknown. We hypothesized that vasopressin as compared 
with norepinephrine would decrease mortality among cancer patients 
with septic shock.
Methods In this, randomized, double-blind trial, we assigned patients 
who had cancer and septic shock and needed a vasopressor to receive 
norepinephrine or vasopressin in addition to open-label vasopressors. 
All vasopressor infusions were titrated and tapered according to 
protocols to maintain a target blood pressure. The primary endpoint 
was the mortality rate 28 days after the start of infusions.
Results A total of 107 patients underwent randomization in this fi rst 
part of trial, and were infused with the study drug (53 patients received 
vasopressin, and 54 norepinephrine), and were included in the analysis. 
There was no signifi cant diff erence between the vasopressin and 
norepinephrine groups in the 28-day mortality rate (67.9 and 58.5%, 
respectively; P  =  0.31). There were no signifi cant diff erences in the 
overall rates of serious adverse events (5.3% and 5.5%, respectively; 
P = 1.00).
Conclusion Vasopressin did not reduce mortality rates as compared 
with norepinephrine among patients with cancer and septic shock who 
were treated with catecholamine vasopressors.
Acknowledgement Clinical Trials number: NCT 01718613.
P162
Heart rate reduction with esmolol in septic shock: eff ects on 
myocardial performance
A Morelli1, A D’Egidio1, A Orecchioni1, E Maraff a1, S Romano2
1University of Rome La Sapienza, Rome, Italy; 2University of Florence, Italy
Critical Care 2014, 18(Suppl 1):P162 (doi: 10.1186/cc13352)
Introduction Clinical study suggests that beta-blockers, by decreasing 
the heart rate (HR) together with an increase in stroke volume (SV), do 
not negatively aff ect cardiac output (CO), allowing an economization 
of cardiac work and oxygen consumption in patients with septic shock 
[1]. Whether this hemodynamic profi le leads to an amelioration of 
myocardial performance is still unclear. The objective of the present 
study was therefore to elucidate whether a reduction in HR with esmolol 
is associated with an improvement of cardiac effi  ciency in patients 
with septic shock who remained tachycardic after hemodynamic 
optimization.
Methods After 24 to 36 hours of initial hemodynamic stabilization, 24 
septic shock patients with HR >95 bpm and requiring norepinephrine 
(NE) to maintain mean arterial pressure (MAP) between 65 and 75 mmHg 
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despite adequate volume resuscitation received a continuous esmolol 
infusion to maintain the HR between 94 and 80 bpm. NE was titrated 
to achieve a MAP between 65 and 75 mmHg. To investigate myocardial 
performance, we simultaneously assessed LV ejection fraction (LVEF), 
tricuspidal annular plane solid excursion (TAPSE) by echocardiography, 
the dP/dt MAX and the cardiac cycle effi  ciency (CCE) both estimated 
from the arterial pressure waveform. Data were obtained at baseline 
and after achieving the predefi ned HR threshold (T1).
Results For a MAP between 65 and 75 mmHg, esmolol administration 
signifi cantly decreased HR (115 ± 10 to 91 ± 7 bpm), NE (0.7 ± 0.4 to 
0.5  ±  0.3  μg/kg/minute), and dP/dt MAX (1.1  ±  0.3 to 0.8  ±  0.3  ms/
mmHg). Conversely, TAPSE (15 ± 3 to 20 ± 3 mm), CCE (–0.2 ± 0.4 to 
–0.03 ± 0.4 units) and SV (37 ± 8 to 42 ± 10 ml) signifi cantly increased 
at the end of the study period (all P <0.05). CO (4.1 ± 0.8 to 3.9 ± 0.8 l/
minute) and LVEF (46 ± 10 to 48 ± 10%) did not change.
Conclusion In patients with established septic shock who remained 
tachycardic after hemodynamic optimization, titration of esmolol to 
reduce the HR to a predefi ned threshold economized cardiac function, 
resulting in a maintained CO with a lower HR and a higher stroke 
volume. Such a hemodynamic profi le was characterized by an improved 
cardiac effi  ciency, as indicated by the decrease in dP/dt MAX associated 
with an increase in CCE. Finally, echocardiographic data suggest that 
reducing HR with esmolol positively aff ects right ventricular function.
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Introduction In the intensive care setting, most physiologic 
parameters are monitored automatically. However, urine output (UO) 
is still monitored hourly by manually handled urinometers. This study 
evaluated an automatic urinometer (AU) and compared it with a 
manual urinometer (MU).
Methods This was a prospective study in the ICU of a cardio-thoracic 
surgical clinic. In postoperative patients (n  =  36) with indwelling 
urinary catheters and an expected stay of 24  hours or more, hourly 
UO samples were measured with an AU (n  =  220, Sippi®; Observe 
Medical, Gothenburg, Sweden) or a MU (n  =  188, UnoMeter™ 500; 
Unomedical a/s, Birkeroed, Denmark), and thereafter validated 
by cylinder measurements. Malposition of instrument at reading 
excluded measurement. Data were analyzed with the Bland–Altman 
method. The performance of the MU was used as minimum criteria of 
acceptance when the AU was evaluated. The loss of precision with the 
MU due to temporal deviation from fi xed hourly measurements was 
recorded (n = 108). A questionnaire, fi lled out by the ward staff  (n = 28), 
evaluated the ease of use of the AU compared with the MU.
Results Analysis according to Bland–Altman showed a smaller mean 
bias for the AU, +1.9  ml, compared with the MU, +5.3  ml (P  <0.001). 
There was no statistical diff erence in measurement precision between 
the two urinometers, defi ned by their limits of agreement (±15.2  ml 
vs. ±16.6 ml, P = 0.11). The mean temporal variation with the MU was 
±7.4  minutes (±12.4%), limits of agreement ±23.9  minutes (±39.8%), 
compared with no temporal variation with the AU (P <0.001). A total 
86% of the ward staff  considered the AU superior to the MU (P <0.001).
Conclusion The AU had a signifi cantly lower bias than the MU and the 
loss of precision of hourly UO due to temporal deviations using the MU 
was avoided with the AU. The AU was also evaluated higher by the ward 
staff , refl ecting perception of higher reliability, easier use, less contact 
with urine bags and less time usage for measurements. The features of 
the AU may also indicate a favorable clinical impact in the normal ward, 
when staffi  ng does not allow hourly measurements with a MU.
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Introduction Fall in mean arterial blood pressure (MAP) during 
anaesthetic induction is common and may result in profound hypo-
tension. Using the LiDCORapid (LiDCO Ltd, UK), we previously 
demonstrated that the fall in MAP is usually driven by a reduction in 
stroke volume (SV) that was presumed due to venodilation. Low-
dose phenylephrine (PE), a venoconstrictor, commenced immediately 
prior to induction ameliorated these eff ects to a signifi cant degree 
[1]. However, it is important that the pre-induction administration 
of PE should not cause any marked changes in MAP and CO. We 
retrospectively studied a group of 40 high-risk patients about to 
undergo major peripheral vascular surgery where PE was commenced 
immediately pre-induction. The haemodynamic eff ects of this dose of 
PE on MAP, SV and CO were analysed.
Methods A radial artery line was inserted prior to induction of 
anaesthesia, and baseline MAP, CO and SV were obtained using the 
LiDCORapid. The PE infusion was commenced at a rate of 1 to 2 mg/
hour. Remifentanil was then administered using a target-controlled 
infusion pump until a 2 ng/ml predicted eff ect site concentration (Ceff ) 
was reached. Propofol was then administered to induce anaesthesia. 
Haemodynamic changes from the pre-PE baseline to commencement 
of propofol were recorded at 5-second intervals. The changes in MAP, 
SV and CO were assessed as the percent change in values obtained 
immediately prior to PE and followed for at least 5  minutes until 
commencement of propofol.
Results Patient demographics, mean (range): age 71 (46 to 89) years, 
31 male, weight 80 (55 to 115) kg, ASA 3 (2 to 4). The changes in MAP 
and CO were not clinically or statistically signifi cant. MAP increased by 
an average of only 2%, range –25 to +12; CO by 0%, range –23 to +16 
(P = 0.35 and P = 0.36 respectively).
Conclusion In a previous study [1], PE administered prospectively prior 
to induction markedly reduced the haemodynamic changes following 
induction of anaesthesia in high-risk patients using remifentanil and 
propofol. This eff ect was achieved without signifi cant changes in MAP 
and CO in the 5-minute to 10-minute period between commencement 
of PE and induction of anaesthesia.
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Introduction Acetaminophen (APAP) is commonly administered in the 
surgical ICU (SICU) for its analgesic and antipyretic eff ects. Case reports 
have described the potential for APAP to cause allergic reactions with 
and without hypotension. Furthermore, there have been case reports 
of APAP causing isolated hypotension in the absence of other allergic 
responses [1]. This has been well described following intravenous 
administration [2]. However, other routes of administration causing 
hypotension and associated diagnoses remain to be elucidated. 
The present case series describes 11 patients with APAP-induced 
hypotension in the SICU at a Level I trauma center.
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Methods Patients admitted to the SICU over a 7-month time frame who 
were reported by the nursing staff  to have experienced hypotension 
following the oral or rectal administration of APAP were included. Their 
electronic medical records were retrospectively reviewed to describe 
the change in systolic blood pressure (SBP) and mean arterial pressure 
(MAP) within the fi rst hour following all administrations of APAP. 
Additional data collected consisted of patient age, sex, admission 
diagnoses and formulation/route of APAP administration.
Results Of the 11 patients included, six had spontaneous intracranial 
hemorrhage (ICH), four had traumatic ICH and one was free of 
neurologic injury. Following administration of 393 doses of APAP, the 
average change in MAP for all patients was –7.52 mmHg and SBP was 
–12.04  mmHg. When evaluated on an individual basis, patients with 
ICH had an average change in MAP of –10.64 (–5.2 to –19.08) and SBP 
of –17.81 (–7.54 to –35.75). The patient without neurologic injury had 
an average change in MAP and SBP of –3.01 and –2.42. The average 
change in MAP and SBP following administration of oral APAP solution 
(n  =  357) was –7.84 and –12.39 while the change following rectal 
administration (n  =  3) was –4.22 and –8 and tablet administration 
(n = 33) was –4.4 and –8.61.
Conclusion It appears from this small case series that patients with ICH 
may experience more isolated hypotension following administration 
of APAP when compared with others. These changes seemed to be 
greater than previously reported for intravenous administration. It may 
also be possible that APAP solution exudes hypotensive eff ects more 
commonly when compared with tablet or rectal formulations.
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Introduction Profound myocardial depression can occur after cardiac 
surgery. Use of ventricular assist support through venoarterial 
extracorporeal membrane oxygenation (ECMO) has been positively 
reported. This study will focus on the outcomes of patients who, upon 
suff ering hemodynamic failure after cardiac surgery, were supported 
by the use of ECMO during their stay in the surgical ICU of Incor FMUSP.
Methods This was a retrospective, single-center and observational 
study. The records of 48 patients who underwent cardiac surgery 
and, subsequently, needed percutaneous or surgical implantation of 
ventricular assist devices were evaluated. The evaluation considered 
the following criteria: basal characteristics, indications for ventricular 
assistance, duration, length of ICU and hospital stay, and hospital 
mortality, through data collection forms.
Results Of the 48 patients included on the study, 26 (54%) were 
males, and 31 (64%) were younger than 18  years old. These patients 
developed cardiogenic shock during 72 hours after cardiac surgery. In 
all cases, ECMO was inserted after cardiac surgery. Of all patients, 32 
(66%) were central ECMO, inserted in the operative room, and 16 were 
percutaneous, inserted in the ICU. The median duration of ventricular 
assistance was 6 days (IQR 0 to 41), the length of ICU stay was 16 days 
(IQR 1 to 111), and hospital stay was 29  days (IQR 1 to 198). Twenty 
patients survived (41%) and were discharged from our hospital.
Conclusion The use of mechanical circulatory assists devices is an 
effi  cient tool to manage seriously ill patients after cardiac surgery. This 
tool should be considered early in the diagnosis of cardiogenic shock 
after cardiac surgery.
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Introduction Mortality from cardiogenic shock remains high [1] and, 
despite a physiological rationale, intra-aortic balloon counterpulsation 
(IABP) has recently been shown to be ineff ective in reducing mortality 
[2,3]. Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) 
may off er a survival advantage over IABP. The objective of this study 
was to describe the characteristics and outcomes of patients supported 
with IABP or Impella and to identify the characteristics of patients who 
die, despite mechanical assistance, for whom a proposed V-A ECMO 
programme may be benefi cial.
Methods A retrospective cohort study in a 30-bed, medical–surgical 
ICU. All adult patients supported with IABP or Impella over 2  years 
to March 2013 were identifi ed and data were extracted by case-note 
review. Subgroup analysis was carried out for patients aged ≤65 and 
for those who fulfi lled the modifi ed Melbourne criteria for V-A ECMO 
[4]. Data collected included demographic data, physiology and organ 
support at baseline and at 6, 12, and 24  hours, ICU and hospital 
outcomes and cause of death. Comparisons between survivors and 
nonsurvivors were made with t test/chi-squared tests as appropriate.
Results A total of 129 patients were identifi ed: 78% were male, mean 
age was 70 years (SD ±11.8), mean APACHE II score was 20 (±5) and ICU 
mortality was 44%. Comparing survivors with nonsurvivors the only 
statistically signifi cant diff erence was metabolic acidosis (–6.8 ± 5.3 vs. 
–10.9 ± 7.0 mEq/l; P <0.05). Heart rate, mean arterial pressure, lactate, 
central venous oxygen saturation, cardiac index, arterial blood pH and 
mechanical ventilation failed to show a signifi cant diff erence. Eleven of 
these patients would have fulfi lled the proposed criteria for V-A ECMO, 
with an ICU mortality of 36%.
Conclusion Only metabolic acidosis was associated with mortality in 
patients supported with mechanical assist devices. Our data do not 
allow discrimination of survivors from nonsurvivors. Patients who 
fulfi lled the proposed criteria for V-A ECMO showed a similar mortality 
to a recent series treated with V-A ECMO [4]. The proposed criteria do 
not identify a cohort, in this population, that would expect a mortality 
benefi t from V-A ECMO.
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Introduction The normobaric oxygen paradox (NOP) is a recent 
concept that postulates the use of intermittent hyperoxia to stimulate 
erythropoietin (EPO) production [1]. Hyperoxia increases oxygen free 
radicals and may lead to endothelial damage and vasoconstriction [2]. 
We evaluated the microvascular response to transient hyperoxia and its 
eff ects on EPO production.
Methods Six patients with hemodynamic stability and mechanically 
ventilated with FiO2 <50% were included in this prospective 
observational study. Patients underwent a 2-hour period of hyperoxia 
(FiO2 100%). The sublingual microcirculation (sidestream dark-fi eld 
imaging (SDF)) was evaluated at baseline (t0), 2 hours after hyperoxia 
(t1), and 2  hours after return to basal FiO2 (t2). SDF monitoring was 
continuously performed also during the variation of FiO2 for 2 minutes. 
EPO levels were assayed at baseline and for 2 days.
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Results An early vasoconstriction and a trend towards total vessel 
density (TVD) reduction were observed at t1 (Figure 1). The TVD tended 
to increase without returning to baseline levels at t2. EPO increased 
in four patients out of 6 (P  =  NS). A negative correlation was found 
between the change in TVD after hyperoxia (t1 – t0) and the change in 
EPO (r = –0.88, P = 0.03).
Conclusion Hyperoxia leads to vasoconstriction that seems to be 
reversible at hyperoxia cessation. Further data are needed to verify 
the effi  cacy of the NOP in stimulating erythropoiesis in the critically 
ill. There might be a relation between hyperoxia-induced reduction in 
vessel density and the EPO increase.
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Introduction This study aims to develop predictive criteria to identify 
which patients are at risk of developing intra-abdominal hypertension 
(IAH) and abdominal compartment syndrome (ACS) upon admission to 
the ICU.
Methods This is a prospective, observational study of 403 consecutively 
admitted ICU patients in a 3-month period, requiring the insertion of an 
indwelling urinary catheter. Intra-abdominal pressure was measured at 
least twice daily in all patients.
Results Thirty-nine and 2% of patients developed IAH and ACS as per 
consensus defi nitions. Upon ICU admission, patients that would go on 
to develop IAH had a signifi cantly higher APACHE III score (62 (44 to 
81) vs. 50 (37 to 68); P <0.001), abbreviated SOFA score (6 (4 to 8) vs. 4 
(2 to 6); P <0.001), CVP (17 (13 to 20) vs. 15 (12 to 17) mmHg; P <0.001), 
lactate (2.2 (1.4 to 3.8) vs. 1.5 (1.1 to 2.4) mmol/l; P <0.001), INR (1.3 (1.1 
to 1.5) vs. 1.2 (1.1 to 1.3); P <0.001), bilirubin (11 (7 to 19) vs. 10 (6 to 15) 
μmol/l; P  =  0.027), creatinine (108 (76.8 to 175) vs. 84.0 (66.0 to 118) 
μmol/l; P <0.001), 24-hour fl uid balance (2.47 (0.95 to 4.05) vs. 1.23 (0.29 
to 2.27)  l; P  <0.001), vasopressor requirement (60 vs. 39%; P  <0.001), 
mechanical ventilation requirement (71 vs. 58%; P = 0.011), PEEP (8.00 
(5.00 to 10.00) vs. 5.50 (5.00 to 8.00) cmH2O; P <0.001), and peak airway 
pressure (24 (21 to 30) vs. 22 (19 to 24) cmH2O; P <0.001). These patients 
also had a signifi cantly lower abdominal perfusion pressure (61 (55 to 
71) vs. 69 (60 to 77) mmHg; P <0.001), pH (7.29 (7.22 to 7.35) vs. 7.33 
(7.28 to 7.37); P <0.001) and PaO2:FiO2 ratio (182 (100 to 263) vs. (264 
(168 to 371); P  <0.001) upon ICU admission. Abdominal distension 
(odds ratio, 4.95; 95% CI, 1.19 to 7.24; P  <0.001), hemoperitoneum/
pneumoperitoneum/intraperitoneal fl uid collection (odds ratio, 3.61; 
95% CI, 1.29 to 10.12; P = 0.014), obesity (odds ratio, 3.41; 95% CI 1.97 
to 5.90; P <0.001), fl uid received >2.3 l (odds ratio, 2.68; 95% CI, 1.48 to 
4.84; P = 0.001), abbreviated SOFA score >4 points (odds ratio, 2.49; 95% 
CI, 1.49 to 4.15; P <0.001) and lactate >1.4 mmol/l (odds ratio, 2.28; 95% 
CI, 1.33 to 3.91; P <0.001) were identifi ed as independent predictors of 
IAH upon admission to ICU. The presence of three or more of these risk 
factors at admission predicted the onset of IAH with sensitivity of 75% 
and a specifi city of 76%, and the onset of grade II, III and IV IAH with a 
sensitivity of 91% and a specifi city of 62%.
Conclusion IAH is a common clinical entity in the intensive care setting. 
Predictive criteria, based on data readily available upon a patient’s 
admission to ICU, were developed and eff ectively predicted the risk of 
developing IAH.
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Introduction It is unknown whether lactate monitoring aimed to 
decrease levels during the fi rst  hours in patients undergoing cardiac 
surgery improves outcome. The aim of this study was to evaluate the 
eff ect of lactate monitoring and resuscitation directed at decreasing 
lactate levels in patients admitted to the ICU in the fi rst 8 hours with 
lactate level ≥3.0 mEq/l.
Methods Patients were randomly allocated to two groups. In the lactate 
group, treatment was guided by lactate levels with the objective to 
decrease lactate by 20% or more per 2 hours for the initial 8 hours of 
ICU stay. In the control group, the treatment team had no knowledge 
of lactate levels (except for the admission value) during this period. 
The primary outcome measure was the incidence of complications in 
28 days.
Results The lactate group received more fl uids and dobutamine. 
However, there were no signifi cant diff erences in lactate levels between 
the groups. The rate of complications was similar between groups (11% 
vs. 7%, P = 0.087). Length of ICU stay was higher in the lactate group 
(3.5 vs. 2.4 days, P = 0.047) when compared with the control group.
Conclusion In patients with hyperlactatemia on ICU admission, 
lactate-guided therapy did not reduce complications and was related 
to a longer ICU length of stay. This study suggests that goal-directed 
therapy aiming to decrease initial lactate levels does not result in 
clinical benefi t.
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Introduction The use of serum lactate level to risk-stratify emergency 
department (ED) patients with sepsis is widely used. Studies in 
nonsepsis populations also suggest its utility in predicting adverse 
outcomes. Whether lactate prognosticates equally across disease 
states is not clearly defi ned. This study compares the ability of 
lactate to identify patients at risk for deterioration (intubation, acute 
renal dysfunction, vasopressor use, or death) and mortality during 
hospitalization in infected and non-infected populations.
Methods A prospective, observational cohort study of ED adult patients 
presenting from 11 November 2012 to 1 February 2013 who had lactate 
measured and abnormal vital signs (hearth rate ≥130, respiratory rate 
≥24, shock index ≥1, systolic blood pressure <90 mmHg). Patients with 
isolated atrial tachycardia, seizure, intoxication, or psychiatric agitation 
Figure 1 (abstract P168). TVD and NOP.
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were excluded. Patients were stratifi ed into three groups by lactate 
<2.5 (low), 2.5 to 4 (intermediate), and >4 mmol/l (high). Chi-square test 
for trend was used to compare outcome rates between lactate levels 
for each diagnostic category.
Results Of 1,152 patients identifi ed, 366 were excluded and 298 did 
not have lactate measurements, leaving 488 for the analysis: 289 sepsis 
patients and 202 nonsepsis patients. Of these, 168 (34.4%) met the 
deterioration outcome, and there were 61 (12.5%) deaths. For infected 
patients, 46/342 (13.5%; 95% CI 10.2 to 17.5) low, 34/100 (34.0%; 95% CI 
25.4 to 43.7) intermediate, and 20/46 (43.5%; 95% CI 30.2 to 57.8) high 
lactate patients suff ered deterioration (P <0.01). Likewise, 6/342 (1.6%; 
95% CI 0.7 to 3.9) low, 19/100 (19.0%; 95% CI 12.4 to 27.9) intermediate, 
and 11/46 (23.9%; 95% CI 13.8 to 38.0) high lactate patients died during 
hospitalization (P <0.01). For non-infected patients, 42/342 (12.3%; 95% 
CI 9.2 to 16.2) low, 13/100 (15.1%; 95% CI 7.6 to 21.1) intermediate, 
and 13/46 (28.2%; 95% CI 17.2 to 42.7) high lactate patients suff ered 
deterioration (P = 0.01). In the regression models, lactate was strongly 
associated with deterioration for both infected (odds ratio (OR)  = 
1.94; 95% CI 1.4 to 2.3) and non-infected (OR  = 1.48; 95% CI 1.14 to 
1.91) groups. In regression models for mortality, lactate had better 
discrimination ability in infected (OR = 1.8; 95% CI 1.4 to 2.3) patients 
than in the non-infected (OR = 1.11; 95% CI 0.85 to 1.47) patients.
Conclusion Lactate levels can be used to identify patients who are at 
increased risk of deterioration regardless of infection status. Lactate 
identifi es high-risk patients for mortality in infected patients more 
strongly than in non-infected patients.
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Adipose tissue lactate clearance but not blood lactate clearance is 
associated with clinical outcome in severe sepsis or septic shock 
during the post-resuscitation period
M Theodorakopoulou, S Orfanos, N Nikitas, D Vasilliadi, S Apolonatou, 
A Diamantakis, G Karkouli, C Diakaki, A Armaganidis, I Dimopoulou
University Hospital of Athens Greece ‘ATTIKON’, Attiki, Greece
Critical Care 2014, 18(Suppl 1):P172 (doi: 10.1186/cc13362)
Introduction Blood lactate clearance, a surrogate of tissue hypoxia, 
is associated with increased mortality in septic patients. However, no 
study has directly measured lactate clearance at the tissue level in 
the post-resuscitation period of sepsis. This study aimed to examine 
the relative kinetics of blood and tissue lactate clearances and to 
investigate whether these are associated with outcome in ICU patients 
having severe sepsis or septic shock during the post-resuscitation 
phase.
Methods A microdialysis catheter was inserted in the subcutaneous 
adipose tissue of the upper thigh and interstitial fl uid samples were 
collected. Serial measurements of blood and interstitial fl uid lactate 
levels were performed over a 48-hour period. Lactate clearance was 
calculated according to the formula: (lactate (initial) – lactate (delayed) / 
lactate (initial)) × 100%. Lactate (initial) is blood or tissue lactate within 
the fi rst 24 hours after ICU admission (H0). Lactate (delayed) is blood or 
tissue lactate at H4, H8, H12, H16, H20, H24 and H48 (H = hours).
Results A total of 112 patients having septic shock (n = 79) or severe 
sepsis (n  =  33) were examined. Tissue lactate clearance was higher 
compared with blood lactate clearance at H0 to H8 (P  =  0.02), H0 to 
H12 (P = 008), H0 to H16 (P = 0.01), H0 to H20 (P = 0.01), and H0 to H24 
(P  = 0.02). Tissue lactate clearance was higher in survivors compared 
with nonsurvivors at H0 to H12, H0 to H20 and H0 to H24 (P  =  0.02, 
for all). Multivariate analysis showed that ARACHE II along with 
tissue clearances at H0 to H12, H0 to H20 and H0 to H24 <30% were 
independent outcome predictors. Blood lactate clearance was not 
related to survival.
Conclusion In critically ill septic patients, after the initial resuscitation 
phase, adipose tissue clears lactate earlier than blood. High tissue 
lactate clearance, but not blood lactate clearance, is associated with a 
favorable clinical outcome.
P173
Correlation between conventional and advanced hemodynamic 
parameters versus serum lactate in patients with severe sepsis
M Kok1, A Oei2, A Karakus3, H Endeman4
1UMC Utrecht, the Netherlands; 2AMC, Amsterdam, the Netherlands; 
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Introduction The aim of this study was to determine the correlation 
between levels of serum lactate (SL) and conventional hemodynamic 
parameters (HPs) (mean arterial pressure (MAP), heart rate (HR), central 
venous pressure (CVP), urinary output (UP)) in patients with severe 
sepsis. In a subgroup, advanced HPs (central venous saturation (SvO2), 
peripheral temperature (PT), cardiac index (CI), global end-diastolic 
volume index (GEDI) and extravascular lung water (ELWI)) were 
compared with levels of SL.
Methods An observational prospective, single-center, pilot study 
was performed in intensive care (IC) of a medium-sized teaching 
hospital. Adult patients with severe sepsis were included and received 
standard goal-directed therapy (Surviving Sepsis Guidelines). Every 
patient received an arterial line and a central venous line in the upper 
diaphragm position. A subgroup received pulse contour cardiac 
output (PiCCO)-guided resuscitation and PT measurements. Pearson 
correlation coeffi  cients (PCCs) were calculated between HPs and SL, 
which were measured every 4 hours for the fi rst 48 hours after inclusion. 
P <0.05 was considered statistically signifi cant.
Results Twenty-fi ve patients (12 men) were included. Mean age was 
68  years (30 to 93), mean APACHE II score 31 (20 to 42). The most 
frequent reasons for IC admission were abdominal sepsis (n = 11) and 
pneumosepsis (n = 7). Mean HPs (with SD and range) were respectively: 
Figure 1 (abstract P173). Scatterplot of (a) MAP and SL and (b) PT and SL.
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MAP 73 mmHg (13, 37 to 120), HR 101 beats/minute (22, 51 to 172), CVP 
12 mmHg (5, 1 to 29), UP 55 ml/hour (62, 0 to 500), SL 3.2 mmol/l (3, 1 
to 18.6), CI 4.1 ml/kg/minute (1.1, 1.6 to 6.7), GEDI 871 ml/m2 (210, 500 
to 1,691), ELWI 11 ml/kg (5, 4 to 23), PT 32.1 C (2.8, 26.4 to 38), and SvO2 
75% (8, 39 to 93). Relevant and signifi cant (P <0.005) PCCs between HPs 
and SL were respectively: MAP –0.417, HR 0.195, UP –0.237, SvO2 –0.204 
and PT –0.569. Figure 1 shows the relation between two HPs with the 
highest correlation with SL.
Conclusion The conventional HPs MAP, HR, UP and SvO2 are signifi cantly 
correlated to levels of SL, but clinical value might be limited due to the 
relatively low correlation coeffi  cients. In a small subgroup, PT is better 
correlated to the level of SL.
P174
Delayed assessment of serum lactate in sepsis is associated with an 
increased mortality rate
R Arnold1, Z Zhang1, S Patel2, S Smola1, J Isserman1, E Jackson1
1Christiana Care Health System, Newark, DE, USA; 2Cooper University Hospital, 
Camden, NJ, USA
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Introduction Lactate assessment early in the resuscitation of sepsis has 
been recommended as a diagnostic biomarker. An abnormal lactate, 
independent of blood pressure, is an indication for aggressive fl uid 
resuscitation and its normalization is a recommended endpoint of 
resuscitation. The objective of this study was to evaluate the eff ect of 
the timing of lactate assessment on patient outcomes in sepsis.
Methods Data were compiled using the Clinical Vigilance for Sepsis 
electronic health record (EHR) screening tool, which identifi ed 
consecutive patients from two hospital systems over 12  months at a 
300-bed community hospital and over 24  months from a 500-bed 
academic tertiary care center. CV Sepsis alert screens the EHR to identify 
the presence of infection based on a multifactor alert system including 
labs, vital signs, and treatment team documentation. A physician order 
for intravenous antibiotics was used as a surrogate for suspected 
infection. The database identifi ed 37,160 consecutive patients treated 
for infection from a total of 216,550. Patients with a measured lactate 
were divided relative to its measurement within 3  hours (eLac) or 
greater than 3 hours (dLac) of sepsis identifi cation as recommended by 
the Surviving Sepsis Campaign. The CV Sepsis alert was the reference 
standard for time zero. Patients were compared in each group for the 
occurrence of the primary outcome of in-hospital mortality.
Results A total 5,072 of 37,160 consecutive patients (13%) had 
a measured lactate. Sepsis patients experienced an overall 3% 
(1,186/37,160) mortality rate. In total, 4,153 (82%) patients had 
measured lactate within 3 hours, and 919 (18%) were delayed, with a 
decreased morality rate (eLac 6.8 vs. dLac 24.7, P <0.0001). There was no 
diff erence in average lactate levels between the groups (eLac: 2.1 ± 2.6, 
dLac: 2.3 ± 3.0, P = NS). A larger ratio of delayed-lactate patients had a 
lactate ≥4 mmol/l (dLac 12.6% vs. eLac 8.7%).
Conclusion The delay in lactate assessment relative to clinical evidence 
of infection was associated with an increased mortality rate. The average 
lactate level in each group did not account for this eff ect. The timing of 
the assessment, not the lactate level, was prognostic of outcome. The 
mortality benefi t associated with lactate assessment within the 3-hour 
guideline suggests that an increased clinical awareness may lead 
to early initiation of time-sensitive interventions known to improve 
outcomes.
P175
Lactate clearance as a predictor of mortality in colonic perforation
R Egashira, T Kobayashi
Osaki Citizen Hospital, Miyagi, Japan
Critical Care 2014, 18(Suppl 1):P175 (doi: 10.1186/cc13365)
Introduction The objective of this study was to determine whether 
lactate clearance (LC) is a signifi cant indicator of mortality in patients 
with colorectal perforation. LC has been associated with mortality in 
heterogeneous critically ill patients, but its role as a predictor of mortality 
in homogeneous patients with colorectal perforation is unclear.
Methods We retrospectively analyzed the clinical data of patients who 
underwent emergency surgery for colorectal perforation and were 
admitted to the ICU of our hospital from January 2003 to August 2013. 
Patients with traumatic, iatrogenic, and appendicitis perforations were 
excluded. The primary endpoint was survival to hospital discharge. 
The modifi ed Sequential Organ Failure Assessment (mSOFA) score, 
a customized SOFA score excluding the central nervous system 
component [1], was used for prognostic scoring. The mSOFA score and 
several clinical factors were analyzed by univariate analysis as possible 
predictors of survival. We collected lactate levels and base excess (BE) 
measured during surgery and at 6, 12, and 24  hours after the fi rst 
measurement and calculated the respective LC values. The associations 
of initial blood lactate level, LC, and BE with mortality were assessed by 
receiver operating characteristics (ROC) curve and logistic regression 
analyses.
Results Of the 61 patients identifi ed, fi ve were excluded as their ICU 
stay was <24 hours. The overall mortality in the remaining 56 patients 
(mean age of 76.7 ± 10.4 (SD) years) was 21.4%. In univariate analysis, 
mSOFA and several other variables correlated signifi cantly (P  <0.05) 
with mortality. The area under the ROC curve for LC at 6, 12, and 
24 hours was 0.601, 0.719, and 0.731, respectively. LC at 24 hours was 
the most accurate, and its optimum cutoff  value was 37.5%. LC, lactate 
level, and BE at 24 hours, as well as the signifi cant factors in univariate 
analysis, were entered into a stepwise logistic regression model, which 
revealed 24-hour LC ≤37.5% (odds ratio (OR), 23.0) and mSOFA score 
(OR, 2.1) as independent predictive values of mortality.
Conclusion In patients with colorectal perforation, 24-hour LC is more 
accurate than LC measured at earlier time points. Patients with 24-
hour LC ≤37.5% and a high mSOFA score have a high risk of in-hospital 
mortality.
Reference
1. Nates JL, et al.: Automating and simplifying the SOFA score in critically ill 
patients with cancer. Health Informatics J 2010, 16:35-47.
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Introduction The Surviving Sepsis Campaign (SSC) indicates that 
a lactate (LT) concentration greater than 4  mmol/l indicates early 
resuscitation bundles. However, several recent studies have suggested 
that LT values lower than 4  mmol/l may be a prognostic marker of 
adverse outcome. The aim of this study was to identify clinical and 
analytical prognostic parameters in severe sepsis (SS) or septic shock 
(ShS) according to quartiles of blood LT concentration.
Methods A cohort study was designed in a polyvalent ICU. We studied 
demographic, clinical and analytical parameters in 148 critically ill 
adults, within 24 hours from SS or ShS onset according to SSC criteria. 
We tested for diff erences in baseline characteristics by lactate interval 
using a Kruskal–Wallis test for continuous data or a chi-square test for 
categorical data and reported the median and interquartile ranges; 
SPSS version 15.0 (SPSS Inc., Chicago, IL, USA).
Results We analyzed 148 consecutive episodes of SS (16%) or ShS 
(84%). The median age was 64 (interquartile range, 48.7 to 71) years; 
male: 60%. The main sources of infection were respiratory tract 38% 
and intra-abdomen 45%; 70.7% had medical pathology. Mortality at 
28 days was 22.7%. Quartiles of blood LT concentration were quartile 
1 (Q1): 1.87 mmol/l or less, quartile 2 (Q2): 1.88 to 2.69 mmol/l, quartile 
3 (Q3): 2.7 to 4.06 mmol/l, and quartile 4 (Q4): 4.07 mmol/l or greater 
(Table  1). The median LT concentrations of each quartile were 1.43 
(Q1), 2.2 (Q2), 3.34 (Q3), and 5.1 (Q4) mmol/l (P <0.001). The diff erences 
between these quartiles were that the patients in Q1 had signifi cantly 
lower APACHE II scores (P  =  0.04), SOFA score (P  =  0.024), number of 
organ failures (NOF) (P <0.001) and ICU mortality (P = 0.028), compared 
with patients in Q2, Q3 and Q4. Patients in Q1 had signifi cantly higher 
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cholesterol (P = 0.06) and lower procalcitonin (P = 0.05) at enrolment. At 
the extremes, patients in Q1 had decreased 28-day mortality (P = 0.023) 
and, patients in Q4 had increased 28-day mortality, compared with 
the other quartiles of patients (P  =  0.009). Interestingly, patients in 
Q2 had signifi cant increased mortality compared with patients in Q1 
(P = 0.043), whereas the patients in Q2 had no signifi cant diff erence in 
28-day mortality compared with patients in Q3.
Conclusion Adverse outcomes and several potential risk factors, 
including organ failure, are signifi cantly associated with higher 
quartiles of LT concentrations. It may be useful to revise the cutoff  value 
of lactate according to the SSC (4 mmol/l).
P177
Correlation between arterial lactate and venous lactate in patients 
with sepsis and septic shock
P Theerawit, C Na Petvicharn
Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Critical Care 2014, 18(Suppl 1):P177 (doi: 10.1186/cc13367)
Introduction Measurement of arterial lactate (A-LACT) levels has 
been used to monitor poor tissue perfusion, predicting mortality and 
guiding resuscitation. Peripheral venous lactate (V-LACT) has been 
regarded as an unreliable test, but a less invasive approach. We aimed 
to determine correlation between A-LACT and V-LACT and agreement 
of both in order to determine the usefulness of V-LACT as a biomarker 
for assessment in sepsis.
Methods We conduct a prospective, cross-sectional study during June 
to December 2011 at a university hospital. Septic patients in the ICU 
were enrolled in this research. Sepsis was defi ned according to the 
Surviving Sepsis Campaign: International Guidelines for Management 
of Severe Sepsis and Septic Shock: 2008. The exclusion criteria were: 
contraindication for arterial puncture; and denying inform consent. The 
venous lactate would be sampled at the same point in time as arterial 
lactate measurement. The correlation and agreement between arterial 
and venous lactate was the primary outcome.
Results A total of 73 pair-samples in 45 intensive care patients 
were collected. Mean age was 68.33  ±  14.5  years. Fifty percent of all 
patients received the vasopressors to stabilize hemodynamics. The 
mean serum creatinine level was 2.78  mg/dl and the mean anion 
gap was 13.55  mmol/l. The mean arterial lactate (A-LACT) level was 
3.73  ±  4.0  mmol/l, and the mean venous lactate (V-LACT) level was 
4.6 ± 4.2 mmol/l. The A-LACT and V-LACT were strongly correlated as 
shown in Figure 1 (r = 0.927, P <0.0001, r2 = 0.859). The mean diff erence 
between V-LACT and A-LACT was 0.889  mmol/l. The 95% limits of 
the V-A diff erence in the individual patients were between –2.3 and 
4.1 mmol/l. However, the agreement looks very good at lactate levels 
not higher than 4  mmol/l (Figure  2). The regression equation was: 
A-LACT = (0.877 × V-LACT) – 0.320.
Conclusion The arterial lactate and venous lactate levels were strongly 
correlated in the condition of sepsis or septic shock. Consequently, 
V-LACT may be used in substitution for A-LACT particularly in lactate 
levels not higher than 4 mmol/l. However, trending should be generally 
applied instead of the absolute value.
Table 1 (abstract P176). Baseline characteristics in SS and ShS patients by quartiles of blood LT
 Lactate <1.87 (n = 33) Lactate 1.88 to 2.69 (n = 41) Lactate 2.7 to 4.06 (n = 34) Lactate>4.07 (n = 37) P 
value
Age (years) 57 (45 to 71) 64 (51.5 to 74.5) 65 (48 to 69) 60 (48.5 to 71) NS
APACHE II 25 (18.5 to 30) 25 (19.5 to 27) 25 (21.5 to 29.5) 27 (22 to 33) 0.04
SOFA 9 (7 to 10.5) 9 (7 to 11) 9 (8 to 11) 11(8 to 13) 0.024
NOF 3 (3 to 4) 3 (3 to 4) 4 (3 to 5) 5 (3.5 to 5) <0.001
LT (mmol/l) 1.43 (1.16 to 1.56) 2.2 (1.99 to 2.47) 3.34 (3 to 3.72) 5.1 (4.4 to 7.34) <0.001
Procalcitonin (ng/ml) 2.81 (0.76 to 20.7) 11.5 (2.88 to 37.15) 13.47 (1.91 to 42.1) 21.6 (5.2 to 5.8) 0.05
Cholesterol (mg/dl) 127 (97.5 to 165) 130 (95.5 to 152.5) 100 (72 to 128) 91 (79 to 116.7) 0.06
28-day mortality (%) 10.8 21.2 24.4 35.1 0.029
ShS (%) 83.8 85.4 81.1 87.9 NS
Figure 1 (abstract P177).
Figure 2 (abstract P177).
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solution and crystalloid cardioplegia on myocardial protection 
during pediatric cardiac surgery
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Introduction The major components of myocardial protection during 
cardiac surgery are the combination of cardioplegia solutions with 
hypothermia. The primary endpoint of this study is to compare the 
eff ects of histidine–triptophan–ketoglutarate (HTK) solution and 
crystalloid cardioplegia on release of cardiac troponin-I (cTn-I) and 
creatine kinase-myocardial band (CK-MB), which are perioperative 
determinants of myocardial protection; the secondary endpoint is to 
evaluate the intraoperative and postoperative hemodynamic variables 
and clinical outcome parameters.
Methods A total of 66 children aged 1 month to 6 years undergoing 
elective congenital heart surgery were randomly allocated to HTK 
solution (Group H, n = 32) or crystalloid cardioplegia (Group C, n = 34) 
after aortic cross-clamping. Blood samples for cTn-I and CK-MB levels 
were measured before the surgical incision, at the end of surgery and 
at 4, 16, 24 and 48 hours postoperatively.
Results Demographic features were similar in both groups. Duration 
of surgery, aortic clamp and cardiopulmonary bypass times, amounts 
of intraoperative fl uids used and urine outputs were similar between 
the groups. The groups were not signifi cantly diff erent in terms 
of cTn-I and CK-MB levels at the intraoperative and postoperative 
period (P  >0.05 for all). The dose of positive inotropic drug at the 
end of surgery was signifi cantly high in Group H (P  =  0.01). The 
requirements for defi brillation were similar in both groups. There were 
no signifi cant diff erences between the groups regarding postoperative 
hemodynamic parameters, positive inotropic requirements, amounts 
of fl uids and blood given and pacemaker requirements (P >0.05 for all). 
Duration of mechanical ventilation, lengths of ICU and hospital stay 
were similar in both groups.
Conclusion The present study demonstrated that there is no 
superiority of HTK solution and crystalloid cardioplegia to each other 
for myocardial protection during pediatric cardiac surgery.
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Hyperdynamic ejection fraction in the critically ill patient
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Introduction The hyperdynamic left ventricular ejection fraction 
(HDLVEF) in the ICU is a common fi nding thought to be associated with 
critical illness and possibly sepsis. The exact etiology of hyperdynamic 
ejection fraction has yet to be determined, and the prognosis of these 
patients has not been well defi ned.
Methods The cohort consisted of 2,632 adults admitted to the ICU with 
echocardiogram reports using the MIMIC-II database, and was divided 
into those with HDLVEF and those with normal left ventricular ejection 
fraction (NLVEF). Those with impaired ejection fraction were excluded 
from the analysis. Baseline comparisons were performed using chi-
squared tests for equal proportion with results reported as numbers, 
percentages, and 95% CIs. Continuous variables were compared 
using t tests and reported as means with 95% CIs, while non-normally 
distributed data were compared using Wilcoxon rank-sum tests and 
reported as medians.
Results Patients with HDLVEF had increased mortality in hospital, 
at 28  days and at 1  year when compared with patients with NLVEF. 
HDLVEF patients more frequently required renal replacement therapy 
(RRT), vasopressors and mechanical ventilation. Of the 2,632 patients, 
1,220 were septic. There was an increased proportion of HDLVEF in the 
septic compared with the nonseptic groups (11.2% vs. 8.6%, P = 0.026). 
Interestingly, other statistically signifi cant associated comorbidities 
were cancer, CHF, arrhythmias, and hypertension, which were more 
commonly seen in the HDLVEF group. See Table 1.
Table 1 (abstract P179)
  Normal Hyperdynamic 
  (n = 2,373, 90%) (n = 259, 10%) P value
Male 1,159 (49) 98 (38) <0.001
Service type   
 MICU 1,234 (52) 138 (53) 0.695
 CCU 364 (15) 28 (11) 0.052
 SICU 572 (24) 69 (27) 0.367
 CSRU 188 (8) 23 (9) 0.590
Primary outcome   
 Twenty-eight-day mortality 458 (19) 79 (31) <0.001
 One-year mortality 892 (38) 129 (50) <0.001
 ICU mortality 296 (12) 60 (23) <0.001
 Hospital mortality 433 (18) 80 (31) <0.001
Treatment   
 RRT 363 (15) 55 (21) 0.013
 Vasopressor 1,063 (45) 139 (54) 0.006
 Ventilated 1,453 (61) 186 (72) <0.001
Conclusion Patients with hyperdynamic LVEF in the ICU clearly 
have increased mortality. Hyperdynamic LVEF may be a result of 
increased catecholamines during cytokine storm. It is unclear whether 
hyperdynamic LVEF itself worsens outcomes. Further investigation is 
needed.
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Impact of nitric oxide on pulmonary regurgitation and cardiac 
function in the acute stage after right ventricular outfl ow surgery
Y Ko, K Morita, R Nagahori, T Abe, K Hashimoto
Jikei University School of Medicine, Tokyo, Japan
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Introduction Pulmonary regurgitation (PR) that develops after 
right ventricular (RV) outfl ow reconstruction including the Rastelli 
and Norwood procedure may often result in serious cardiac events 
early after surgery. We hypothesized that PR may be associated with 
pulmonary vascular resistance (PVR) and RV contraction. Accordingly, 
we assessed the impact of PVR on PR and RV function using a swine 
model.
Methods Eight pigs (14  ±  2  kg) underwent total resection of the 
pulmonary valve cusps under cardiopulmonary bypass (PR group). 
This was compared with a control group (n = 6) that underwent only 
bypass. In both groups, the pulmonary regurgitant fraction (PRF) and 
cardiac output were measured by a pulsed Doppler fl ow meter, and 
the percent segmental shortening of RV (%RVSS) and RV end-diastolic 
dimension (RVDd) were measured by sonomicrometry. We also 
performed dobutamine stress evaluation as well as changing the PVR 
by carbon dioxide (PaCO2) and inhaled nitric oxide (NO).
Results All bypass time was 18 ± 3 minutes. In the PR group, the PRF was 
40 ± 4% and the RVDd was 53 ± 9 mm* (vs. control 34 ± 6 mm). *P <0.05. 
A signifi cant reduction in the %RVSS (18 ± 1%* vs. control 22 ± 1%) and 
the cardiac output (2.1 ± 0.2  l/minute* vs. control 2.5 ± 0.3  l/minute) 
were observed. The PRFs were 60 ± 5% (PaCO2 >80 mmHg), 37 ± 2% 
(PaCO2 <20 mmHg), 24 ± 2% (NO 20 ppm; PaCO2 40 mmHg), and were 
positively correlated with the PVR (Figure 1A). During the dobutamine 
stress, the %RVSS was increased (baseline 18  ±  1%, 5γ 21  ±  2%, 10γ 
26 ± 3%), and was negatively correlated with the PRFs (Figure 1B).
Conclusion These results indicated that massive PR resulted in marked 
deterioration of RV performance; however, low PVR and high RV 
contractility may contribute to reduce the severity of PR and improve 
cardiac function. Nitric oxide may be a useful treatment modality the 
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same as catecholamine during the acute stage after RV outfl ow surgery 
with PR.
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Introduction Cardiogenic oscillation is the fl uctuation in fl ow tracing 
in mechanically ventilated patients. Large cardiogenic oscillation 
may cause autotriggering in adult patients after cardiac surgery [1] 
and inaccurate volume monitoring [2]. However, it is unknown how 
cardiogenic oscillation is problematic in pediatric patients. Therefore, 
we prospectively surveyed cardiogenic oscillation in pediatric patients 
after cardiac surgery.
Methods We enrolled 17 pediatric patients who underwent cardiac 
surgery using cardiopulmonary bypass. They were mechanically 
ventilated with pressure-controlled ventilation. We measured the 
amplitude in cardiogenic oscillation and compared them between their 
admission to the ICU and before extubation. We performed statistical 
analysis with the t test and considered P <0.05 signifi cant.
Results Cardiogenic oscillation was 2.1  ±  0.6  l/minute just after the 
surgery (Figure  1). Autotriggering occurred in seven of 17 patients 
when triggering sensitivity was set at 1 l/minute. Before the extubation, 
cardiogenic oscillation signifi cantly decreased to 1.4  ±  0.4  l/minute 
when autotriggering disappeared. Intensive care including adjustment 
of inotropes and intravascular volume might have contributed to the 
decrease in cardiogenic oscillation.
Conclusion In pediatric patients after cardiac surgery, cardiogenic 
oscillation was initially large but was decreasing at the extubation.
References
1. Crit Care Med 2000, 28:402.
2. Crit Care Med 2004, 32:1546.
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Introduction Postoperative new-onset atrial fi brillation (PNAF) is very 
common after cardiac surgery. The infl ammatory response due to 
surgery and cardiopulmonary bypass (CPB) may contribute to PNAF by 
inducing atrial dysfunction [1]. Corticosteroids reduce the infl ammatory 
response and may thus reduce atrial dysfunction and PNAF [2]. The aim 
of this study was to determine whether dexamethasone protects from 
left atrial dysfunction and PNAF in cardiac surgical patients.
Methods Patients undergoing cardiac surgery were randomized to a 
single dose of dexamethasone (1 mg/kg) or placebo after inducing 
anesthesia. Transesophageal echocardiography was performed in 
patients after CPB. The primary outcome was left atrial total ejection 
fraction (LA-TEF) after sternal closure; secondary outcomes included 
left atrial diameter and PNAF, detected by Holter monitoring.
Results Sixty-two patients were included. Baseline characteristics were 
well balanced. Postoperative LA-TEF was 36.4% in the dexamethasone 
group and 40.2% in the placebo group (P = 0.15) (Figure 1). Secondary 
echocardiographic outcomes were also insignifi cant (Table  1). The 
incidence of PNAF was 30% in the dexamethasone group and 39% in 
the placebo group (P = 0.47).
Table 1 (abstract P182). Secondary postoperative echocardiographic 
parameters in both groups
Parameter Dexamethasone Placebo P value
LA-TEF 36.4 40.2 0.15
LA diameter 4.6 4.3 0.19
LA area 16.0 16.4 0.81
Conclusion Intraoperative high-dose dexamethasone did not have any 
protective eff ect on postoperative LA-TEF or dimension and did not 
reduce the risk of PNAF in cardiac surgical patients.
Figure 1 (abstract P180).
Figure 1 (abstract P181). Cardiogenic oscillation.
Figure 1 (abstract P182). Primary outcome preoperatively and 
postoperatively in dexamethasone and placebo groups.
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Introduction Postoperative new-onset atrial fi brillation (PNAF) is the 
most common complication after cardiac surgery. Infl ammation as 
an underlying mechanism has been studied by various infl ammatory 
markers, and white blood cell count (WBC) is the only present consequent 
infl ammatory marker predicting PNAF [1]. This study aimed to determine 
the association between perioperative WBC and PNAF.
Methods Patients >18 years undergoing elective cardiac surgery with 
a sinus rhythm preoperatively were recruited from the Dexamethasone 
for Cardiac Surgery-PNAF trial for this post-hoc cohort study. The 
WBC was prospectively measured preoperatively and once during 
each of the fi rst four postoperative days. Development of PNAF was 
evaluated with continuous 12-lead ECG monitoring the fi rst 5  days 
postoperatively.
Results A total of 657 patients were included in this trial, 277 developed 
PNAF. The WBC was signifi cantly higher in the PNAF group on day 2 
and day 4 (Figure  1). However, multivariate analysis showed that 
preoperative and postoperative WBC, days 1 to 3, were not associated 
with PNAF (Table  1). Older age (OR: 1.05; CI: 1.03 to 1.07; P  <0.001), 
CABG plus valve surgery (OR: 2.95; CI: 1.78 to 4.88), single valve surgery 
(OR: 3.09; CI: 2.03 to 4.69; P <0.001) and other surgery (OR: 2.21; CI: 1.23 
to 3.97; P <0.001) were correlated with the occurrence of PNAF.
Table 1 (abstract P183). Multiple regression analysis of association between 
high WBC and developing PNAF
Time point OR 95% CI
Baseline 1.04 0.96 to 1.13
Day 1 1.03 0.98 to 1.08
Day 2 1.03 0.99 to 1.08
Day 3 1.03 0.96 to 1.11
Day 4 1.09 1.01 to 1.16
Conclusion Preoperative and postoperative WBC were not associated 
with development of PNAF.
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Introduction Ranolazine, a piperazine derivative, is used as an anti-
anginal drug to treat patients with chronic angina in clinical practice [1] 
and may improve coronary blood fl ow by reducing compression eff ects 
of ischemic contracture, and by improving endothelial function [2,3]. 
In the present study we investigate the vascular eff ects of ranolazine 
on the endothelium, adrenergic system and Ca2+ in isolated rat aorta.
Methods Rat aortic segments (3  mm long) with and without 
endothelium were mounted for isometric tension recording in organ 
baths containing Krebs–Henseleit solution. Electrical fi eld stimulation 
(2, 4 and 8  Hz, 20 V, 0.25  ms duration for 30  seconds) was provided 
by a Grass S88 stimulator via two platinum electrodes positioned on 
each side and parallel to the axis of the aortic segment. Concentration–
response curves of ranolazine (10–7 to 10–4  M) were obtained in a 
cumulative manner using endothelin-1, noradrenaline, thromboxane 
A2 and KCl as constrictor agents.
Results The contractile responses to electrical fi eld stimulation were 
abolished by tetrodotoxin, guanethidine and prazosin, indicating 
that the contractile eff ect is due to the action of noradrenaline on 
alpha adrenoreceptors. Ranolazine diminished (P  <0.05) neurogenic 
adrenergic contractions induced by electrical fi eld stimulation in 
aortic rings with and without endothelium. Ranolazine produced 
concentration-dependent relaxation in rings precontracted with 
noradrenaline (Emax 86  ±  6%, n  =  10; P  <0.05) but not in rings 
precontracted with endothelin-1, thromboxane A2 and KCl. Neither 
L-NAME (10–4 M), an inhibitor of nitric oxide synthase, nor indomethacin 
(10–5  M), an inhibitor of cyclooxygenase, modifi ed the relaxation 
induced by ranolazine. The calcium antagonist nifedipine (10–6  M) 
reduced the relaxation induced by ranolazine.
Conclusion These results indicate that ranolazine diminished the 
contractile response induced by adrenergic stimulation, suggesting an 
eff ect as an adrenergic blocker. The relaxant eff ects of ranolazine on 
rat aortic vessels is not dependent on the endothelium-derived factors 
(nitric oxide or dilator prostanoids) but involves an interference with 
the entry of calcium through dihydropyridine calcium channels.
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Introduction Early extubation post coronary artery bypass grafting 
does not increase perioperative morbidity and reduces the length 
of stay (LOS) in the ICU and in hospital [1]. Use of low-dose opioid-
based general anaesthesia and time-directed protocols for fast-
track interventions does not increase mortality or postoperative 
complications in low–moderate-risk patients and has been found to 
have a reduced time to extubation and shortened ICU stay [2]. Our mean 
time to extubation is 6 hours, although patients are assessed to be safe 
to be weaned from mechanical ventilation at 2 hours following arrival 
in the ICU. This study aims to identify factors that delay extubation in 
patients undergoing routine cardiac surgery at our institution.
Methods A prospective analysis was performed on all patients post 
adult cardiac surgery from 14 May 2013 to 10 July 2013. Emergency 
surgical patients and those with intraoperative complications were 
excluded.
Results A two-sample t  test was used to analyse the data. Patient 
demographics are presented in Table 1. There were signifi cant delays in 
time of extubation in those who received morphine prior to extubation 
compared with those that did not (P = 0.0184) (Table 2). There were no 
Figure 1 (abstract P183). WBC at baseline (t = 0) and in the four 
postoperative days (t = 1 to 4), PNAF versus no PNAF.
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signifi cant diff erences in LOS in ICU or hospital. Factors such as age, 
EUROSCORE and type of operation did not have an infl uence on time 
to extubation.
Conclusion Administering morphine prior to extubation causes 
signifi cant delays in weaning from mechanical ventilation. We plan 
to introduce intraoperative and postoperative protocols to facilitate 
rapid weaning from mechanical ventilation for elective cardiac surgical 
patients.
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Introduction No randomized trial has assessed the eff ects of diff erent 
mean arterial pressure (MAP) targets in postcardiac surgery intensive 
care. We investigated the short-term eff ects of MAP of 65 or 85 mmHg 
on splanchnic oxygen fl ux, metabolic function, mucosal perfusion and 
cytokine regulation.
Methods A single-center, randomized controlled, double cross-over 
trial was performed. Patients were randomized to: HLH (high–low–
high) where MAP targets were 85–65–85 mmHg in sequence, with each 
lasting 2  hours, or LHL (low–high–low) where MAP targets were 65–
85–65 mmHg. Blood pressure was adjusted with noradrenalin infusion.
Results Six + six patients were included in the study. MAP targets were 
achieved in all patients at all time points (64 ± 3, 84 ± 4; 65 ± 5 mmHg 
in the LHL group and 84 ± 3; 66 ± 2; 85 ± 5 mmHg in the HLH group at 
the fi rst, second and third time points), with corresponding changes 
in fi lling pressures. Cardiac output did not change over time. Hepatic 
venous saturation was 41 ± 15; 58 ± 24; 56 ± 21% in the LHL group and 
50 ± 19; 43 ± 20; 41 ± 18% in the HLH group at the fi rst, second and 
third time points, with a signifi cant time group interaction (P <0.05). No 
changes were observed in global or trans-splanchnic lactate levels and 
cytokine levels or in gastric tonometry CO2.
Conclusion Increasing MAP with norepinephrine has some eff ects 
splanchnic oxygenation, but has no impact on metabolic or 
biochemical function and key cytokine removal or release. MAP targets 
of 60 to 65 mmHg or 80 to 85 mmHg appear physiologically equivalent 
for the splanchnic circulation.
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Introduction Tako-tsubo cardiomyopathy (TCM) is an acute cardiac 
syndrome with regional hypokinesia in the left ventricle (LV), often 
aff ecting the apex causing apical ballooning. TCM is frequent in 
patients with adrenergic overstimulation and is probably common in 
ICU patients [1]. In a TCM rat model we evaluated whether diff erent 
anesthetic agents could attenuate LV akinesia in TCM.
Methods Isoprenaline was intraperitoneal (i.p.) injected, which 
induces LV akinesia and apical ballooning within 90  minutes [2]. We 
performed the study in two diff erent settings. In the fi rst setting, 
spontaneously breathing rats (n = 12 in each group) were sedated with 
either pentobarbital, ketamine, isofl urane or no anesthetic before i.p. 
isoprenaline. One additional group received the K-ATP blocker glyburide 
before sedation with isofl urane. In the second setting, rats were 
anaesthetized with ketamine + midazolam, mechanically ventilated 
and the carotid artery was cannulated. Before i.p. isoprenaline, animals 
were randomized to either no isofl urane (0 MAC), isofl urane 0.5 MAC 
or isofl urane 1.0  MAC (n  =  12 in each group). Arterial blood gas was 
obtained before isoprenaline and 60  minutes after isoprenaline. The 
heart rate (HR), systolic blood pressure (SBP) and body temperature 
(BT) were recorded continuously. After 90 minutes, echocardiography 
was performed. Extent of akinesia was expressed as the percentage of 
total LV endocardial length. End-diastolic and end-systolic LV volumes 
were measured, and stroke volume (SV) and cardiac output (CO) were 
calculated.
Results In spontaneously breathing rats, the degree of akinesia was 
signifi cantly lower with pentobarbital and isofl urane (± glyburide) but 
not with ketamine compared with controls. The degree of akinesia was 
lowest with isofl urane. In ventilated rats, the degree of apical akinesia 
(%) was signifi cantly lower at 0.5 MAC (8.7 ± 7.3) and 1 MAC (5.7 ± 7.4) 
versus 0 MAC (17.7 ± 8.0). This was accompanied by a higher CO and 
SV. HR was lower at 1 MAC (6%) and SBP was lower at 0.5 MAC (106 ± 7) 
and 1 MAC (98 ± 7) versus 0 MAC (126 ± 8). BT and pH was lower in 
both isofl urane groups. In a multivariate model, isofl urane was the 
only variable that was independently associated with the degree of LV 
akinesia.
Conclusion Isofl urane prevents experimental TCM and preserves LV 
function, an eff ect not mediated via opening of K-ATP channels. The 
eff ect cannot be explained entirely by attenuation of myocardial 
stress. Isofl urane sedation in the ICU might be an interesting approach 
for patients suff ering from hyperadrenergic conditions at risk of 
developing TCM.
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Introduction Preoperative therapy with angiotensin-converting 
enzyme inhibitors (ACEI) is common in patients undergoing cardiac 
surgery. The aim of this study was to evaluate the still-debated impact 
of preoperative use of ACEI on postoperative renal function in cardiac 
surgery patients [1,2].
Methods A total of 624 consecutive patients, who underwent cardiac 
surgery from July 2012 to October 2013, were evaluated. Data were 
prospectively collected in our clinic’s electronic database and were 
retrospectively analyzed as to preoperative ACEI therapy. The chi-
square test was used for correlations. Endpoints of the study were 
the development of postoperative acute kidney injury (AKI) and the 
diff erence between hospital admission and discharge glomerular 
fi ltration rate (GFR). The AKI defi nition was based on modifi ed RIFLE 
classifi cation. GFR values were estimated by the MDRD formula.
Results A total of 354 patients (56.7%) were treated with ACEI 
preoperatively. Overall, 95 patients (15.3%) developed postoperative 
AKI. Preoperative use of ACEI was not associated with the development 
Table 1 (abstract P185). Patient demographics
Age (years) 66 (10.1)
EUROSCORE (%) 2.90 (1.84)
Table 2 (abstract P185). Morphine versus no morphine
 Morphine No morphine
Patient number 51 20
Time to extubation (hours) 7:48 (4:42) 4:48 (2:19)
LOS ICU (hours) 51:21 (55:16) 40:06 (28:47)
LOS hospital (days) 9.83 (5.01) 10.8 (13.5)
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of postoperative AKI (P  =  0.981). Mean GFR values on admission day 
were 65.23 ± 16.89 for ACEI users, and 65.06 ± 19.62 for the rest of the 
cohort. Mean GFR values on discharge day were 66.77  ±  21.25 and 
67.35 ± 25.64 respectively. The diff erence in GFR at the time of hospital 
admission and on discharge day had no statistical diff erence, P = 0.511 
(Table 1). Overall, 25 patients (4%) needed dialysis.
Conclusion The impact of preoperative ACEI treatment on 
postoperative renal function after cardiac surgery is still debated. 
We found no association, neither protective nor harmful, between 
preoperative ACEI therapy and renal function impairment.
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Introduction Cardiovascular disease is the leading cause of death 
worldwide and the outlook for 2020 data is even more alarming [1,2]. 
In this context, the coronary ICUs (CICUs) have become increasingly 
numerous. However, data concerning this are still very limited in the 
literature. This study aims to characterize the profi le of CICU admissions 
in Brazil and the main clinical variables associated with increased 
mortality.
Methods To conduct the study we analyzed the database of a CICU 
of a medium-sized hospital in the city of Presidente Prudente, Brazil. 
Admissions that occurred during the period 1 September 2010 to 31 
August 2013 were analyzed. The information was collected from the 
EPIMED MONITOR system and statistically analyzed using EPI INFO, 
version 3.5.2 software. P  <0.05 two-tailed was considered signifi cant, 
and confi dence intervals at 95% (95% CI) were used for the logistic 
regression multivariate estimated in the sample.
Results A total of 2,098 admissions were recorded, of which 42.1% were 
female and 57.9% male. The average age was 66.99 ± 13.30 years. The 
prognosis for SAPS 3 admission score averaged 40.8 ± 15.48 points and 
the mean unit length of stay was 3.5 ± 5.01 days. The main admission 
diagnoses were unstable angina (13.06%), non-ST-segment elevation 
myocardial infarction (8.29%), ST-segment elevation myocardial 
infarction (8.10%) and supraventricular cardiac tachyarrhythmia 
(6.91%). We observed a higher risk of death among patients who had, 
at admission, congestive heart failure NYHA 2, 3 or 4 (odds ratio (OR) = 
2.81, 95% CI: 2.07 to 3.83, P = 0.001), chronic renal failure (OR = 2.48, 
95% CI: 1.68 to 3.67, P  = 0.001), peripheral artery disease (OR  = 1.93, 
95% CI: 1.04 to 3.58, P = 0.033), severe chronic obstructive pulmonary 
disease (OR  = 3.17, 95% CI: 1.82 to 5.51, P  =  0.002), and infection at 
admission (OR = 7.88, 95% CI: 5.27 to 11.78, P = 0.001).
Conclusion The results reported may direct healthcare professionals to 
profi le the patient hospitalized in a CICU, paying attention to the most 
disturbing and lethal comorbidities present on admission.
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Introduction The reperfusion time is critical in ST-segment elevation 
myocardial infarction (STEMI), and it makes a diff erence to clinical 
outcomes. This study was designed to investigate the hospital visit 
pattern and its eff ect on reperfusion time and clinical outcomes of 
STEMI patients.
Methods A total of 199 STEMI patients were registered in this study 
from three university hospitals in Kyungsang-do area, Korea, and were 
divided into two groups; group  1 (n  =  69) who directly visited the 
hospitals capable of percutaneous coronary intervention (PCI), and 
group 2 (n = 130) who fi rst visited local hospitals and then transferred 
to PCI-capable hospitals. We analyzed the estimated distance and time 
to the hospitals using a driving navigation system, elapsed time from 
chest pain to primary PCI hospitals, chest pain to reperfusion time, and 
in-hospital outcomes.
Results There was no diff erence in fi rst medical contact time between 
groups 1 and 2. But the time from chest pain to PCI hospital was shorter 
in group 1 (206.2 ± 268.5 vs. 370.3 ± 415.2 minutes, P = 0.001). Sixty 
patients in group 1 and 108 patients in group 2 underwent reperfusion 
therapy (P = 0.473). The chest pain to reperfusion time was shorter in 
group 1 (294.6 ± 255 vs. 397.2 ± 341.9 minutes, P = 0.045). The diff erence 
in estimated time by navigator and actual hospital visit time was also 
shorter in group 1 (194.2 ± 269.9 vs. 321.6 ± 411.0 minutes, P = 0.009). 
In-hospital mortality was higher in group 2 (0 vs. 4.6%, P = 0.094).
Conclusion A primary visit to a local hospital was associated with 
longer reperfusion time and was associated with higher mortality. 
Therefore, the reperfusion time could be reduced by patient education 
and management of the community healthcare system.
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Introduction A potential measure of post-ischemic milieu in 
myocardium subject to acute ischemic injury is to assess the so-
called myocardial salvage index (SI) by relating the fi nal infarct size 
to the initial myocardium at risk (MaR). Cardiac magnetic resonance 
(CMR) has previously been shown to enable determination of both 
infarct size using late gadolinium enhancement and MaR using T2-
weighted imaging. This technique could thus potentially be used to 
identify infl ammatory responses that could be targeted to accomplish 
cardioprotection. The aim of this study was to relate SI, as determined 
by CMR, to the infl ammatory response in patients with acute myocardial 
infarction.
Methods Fifteen patients with fi rst-time ST-elevation myocardial 
infarction were included in the study. All patients underwent primary 
PCI due to an acute occlusion in one branch of the left coronary artery. 
Final infarct size and MaR was determined by CMR performed 1 week 
after the acute event. The ischemic time was defi ned as the time from 
pain onset to opening of the occluded vessel. Blood samples were 
taken for assessment of infl ammatory response. Infl ammatory cells 
were analyzed by fl ow cytometry in a BD FACS Aria. Parameters were 
gated against control antibody and fl uorescence minus one strategy. 
Cytokine patterns were analyzed by BioRad BioPlex multiplex protein 
analysis technology.
Results The SI did not correlate with MaR (P  = 0.2720, R2  = 0.09191). 
The population was divided into the lowest half of the SI (representing 
the most hostile milieu; SI: 23 to 57%) and the upper half of the SI 
(representing the friendliest post-infarction milieu; SI: 71 to 95%). The 
patients’ profi le of adaptive infl ammatory response was characterized 
by fl ow cytometry. The two groups did not diff er with regard to their 
T-regulatory response (CD25+FoxP3+, P = 0.7203) or NK-cell (CD3–CD56+, 
Table 1 (abstract P188). AKI and GFR diff erence
 ACEI users (n = 354) ACEI nonusers (n = 270) P value
AKI 54 (15.3%) 41 (15.2%) 0.981
GFR diff erence (mean) +1.43 +2.3 0.511
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P  =  0.5742) response. However, the proportion of TH1 (CD4+ IFNγ+) 
cells was higher in the group with the lowest SI (57.47  ±  4.805 vs. 
38.10 ± 6.514, P = 0.0349).
Conclusion This is the fi rst study that identifi es infl ammatory cell 
patterns which infl uence the hostility of the infarction milieu in 
vivo. The study indicates that SI can be used as an evaluator of post-
ischemic milieu and that TH1 response is associated with unfavorable 
post-infarction injury and could therefore be a possible target for 
future studies to limit infarction size. The current study is, by its size 
and observational character, important; an argument for rather than a 
substitute for future interventional studies in this area.
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Introduction The management of ICU patients following heart 
surgery can be hustling when coping with severe left ventricular 
(LV) dysfunction. Single beat (Sb) measurements of ventriculo-
arterial coupling (VAc) can be used by the intensivist when dealing 
with altered hemodynamic states [1]. LV elastance (Ees) and arterial 
elastance (Ea) can be measured by trasthoracic echocardiography 
(TTE) in a Sb fashion [2], so allowing quick assessment of VAc. PEEP 
application is common practice in the ICU but can have hemodynamic 
consequences and lead to instability. Speckle tracking analysis by TTE 
has been recently reported to help titrating PEEP in critically ill patients 
[3]. However, this can be demanding and require specifi c ultrasound 
tools. In this study we aimed to assess whether standard TTE can be 
useful in evaluating the eff ect of respiratory treatment with PEEP on 
cardiovascular effi  ciency by measuring VAc after coronary artery 
bypass surgery (CABG).
Methods TTE was performed before anesthesia induction and upon 
ICU arrival in 15 patients with preoperative diagnosis of LV dysfunction 
defi ned as an EF <35%. In-ICU measurements of Ees, Ea and VAc were 
taken at diff erent steps of PEEP application lasting 3 minutes as follows: 
0 cmH2O PEEP (ZEEP), 5 cmH2O PEEP, 10 cmH2O PEEP and 15 cmH2O 
PEEP. TTE and hemodynamic parameters were recorded and analyzed.
Results All patients were uncoupled preoperatively (VAc >1.31, average 
VAc (AVAc) = 1.56) before anesthesia induction and showed worsened 
uncoupling postoperatively at ZEEP. PEEP application altered VAc by 
modifying both Ees and Ea at all steps and all patients showed further 
uncoupling at any level of PEEP application (AVAc at ZEEP  = 1.97, at 
5 cmH2O PEEP = 1.61, at 10 cmH2O PEEP = 1.87, at 15 cmH2O PEEP = 
2.23) A PEEP of 5 cmH2O provided the more favorable VAc.
Conclusion Sb evaluation of Ea/Ees shows that following CABG the 
patients with depressed LV remain uncoupled, and that in such patients 
the application of PEEP leads to further decoupling. In this preliminary 
experience, 5  cmH2O PEEP seems to be the most appropriate in 
preventing further worsening of the VAc. A large RCT is needed to draw 
conclusions on the PEEP eff ect on VAc following CABG in a depressed 
heart.
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Introduction Elevated cardiac troponin levels are common in ICU 
patients even in the absence of acute coronary syndromes and may be 
predictive of mortality. The recently introduced high-sensitivity cardiac 
troponin T (HS cTnT) assay has resulted in an increased detection of 
elevated cTnT in ICU patients [1]. The aim of this study was to determine 
the prevalence of elevated cTnT using the HS assay and its relationship 
with mortality.
Methods A retrospective observational study was performed on all 
ICU admissions over a 12-month period. Data were obtained from the 
clinical information system (ICIP; Philips) and the ICU audit databases 
(AcuBase). Data collected included patient demographics, peak cTnT 
value, APACHE II score, requirement for organ support and mortality. 
The primary outcome measure was hospital mortality. Data were 
analysed using SPSS v.17.0. cTnT levels were divided into categories 
for analysis: normal (<14 ng/l) and elevated. The elevated category was 
further subdivided into quartiles. Univariate analysis was performed 
between potential risk factors and mortality followed by multivariate 
regression analysis to ascertain independent predictors of mortality.
Results There were 417 admissions to the ICU during the study period, 
89 of whom were excluded because of an absent cTnT value, leaving 328 
patients included in the analysis. cTnT was elevated in 85% of patients. 
ICU mortality was 19% and hospital mortality was 28%. Hospital 
mortality (%) per cTnT category was: <14  ng/l  = 2%; 14 to 38  ng/l  = 
19%; 39 to 90 ng/l = 26%; 91 to 252 ng/l = 39%; >252 ng/l = 43%. On 
univariate analysis, cTnT levels, age, ventilation and APACHE II score 
were signifi cantly associated with mortality. cTnT levels were signifi cant 
in multivariate regression independent of age and ventilation but did 
not reach signifi cance (P = 0.06) in a multivariate analysis that included 
the APACHE II score.
Conclusion In 85% of general ICU patients, troponin measured by 
HS cTnT assay was elevated. cTnT levels were signifi cantly associated 
with mortality and are predictive of mortality independent of age and 
mechanical ventilation, but not independently of APACHE II score. There 
was a high correlation between troponin levels and APACHE II scores.
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Introduction In the view of robust consequences following 
cardiac surgery, acute kidney injury (AKI) remains a major concern. 
Rhabdomyolysis (RML) following cardiac surgery and its relation to 
AKI need to be investigated. We aim to study the prevalence of RML 
development following cardiac surgery and the perioperative risk 
factors that may expedite the occurrence of RML.
Methods All patients undergoing cardiac surgeries in our hospital 
were enrolled in the study during the period of 1 year in a prospective 
descriptive study measuring the occurrence of RML and its association 
with AKI, where all patients in the study underwent serial assessment 
of serum creatinine kinase (CK) and serum myoglobin. Serial renal 
function, prior statin treatment, cardiac injury, lengths of ventilation, 
and lengths of stay in the ICU and hospital were monitored.
Results We recruited 202 patients in our study, 185 males and 17 females 
with mean age 52 ± 12.4 years. According to the existence of RML (CK 
2,500  U/ml or more) [1], patients were divided into group  1 where 
RML was identifi ed in 17 patients (8.4%), which was associated with 
AKI in seven patients (41%), and group 2 without RML (185 patients), 
where AKI occurred in 34 patients (18.4%) (P = 0.025). We observed a 
signifi cantly longer duration of ventilation and lengths of stay in the 
ICU and in hospital in the RML group (P <0.01 for all observations).
Conclusion Early increase in the serum CK and myoglobin in 
postoperative high-risk cardiac surgeries may predict the concomitance 
of early AKI, where proper intervention may prevent the sequelae of 
logistic organ dysfunction.
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Introduction This review was undertaken to establish the ICU and 
hospital mortality rates in patients aged 80 and over admitted to 
our ICU following abdominal cavity surgery. Intensive care mortality 
increases progressively with age [1] and as the population changes 
we are likely to see increasing numbers of patients over the age of 80 
admitted to critical care units.
Methods We searched the ICNARC database from 2006 to 2013 for 
patients aged 80 years or over, admitted from theatre or after surgery. 
Data were referenced against the electronic theatre management 
system, and patients not undergoing abdominal cavity surgery 
were excluded. The data were analysed using an Excel spreadsheet 
(Microsoft) and Medcalc software.
Results Eighty-fi ve patients were included, with ages ranging from 80 
to 99 years. Fifty-one (60%) patients were male and 79 (93%) patients 
were categorized as having an emergency operation. ICU mortality was 
34/85 (40%) and hospital mortality was 48/85 (56%). Variables assessed 
for association with hospital mortality can be seen in Table  1. Only 
invasive ventilation and time (days) from hospital admission to ICU 
admission were signifi cant predictors of hospital mortality.
Table 1 (abstract P195). Survivors versus nonsurvivors
 Survivors Nonsurvivors P value
Age 83 83 0.82
Time 1, 1 to 8 4.5, 1 to 8 0.004
APACHE II 17, 14 to 20 17, 14 to 21 0.96
Sex (%) M57, F43 M63, F37 0.65
Ventilation (n, %) 31, 83 48, 100 0.005
RRT (n, %) 6, 16 11, 23 0.58
Data presented as median, IQR or n, %.
Conclusion ICU and hospital mortality rates were high at 40% and 56% 
respectively. Increasing age did not correlate with mortality. However, 
invasive ventilation and time between hospital and ICU admission 
were associated with a higher mortality. This may be due to a delay in 
diagnosis or surgical intervention. We suggest that one considers early 
intervention in patients aged over 80. A functional outcome measure at 
discharge may be a more clinically relevant endpoint.
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Introduction The aim of this study was to clarify the risk factors for 
acute renal impairment (ARI) in patients with severe acute pancreatitis 
(SAP).
Methods We conducted a retrospective observational case–control 
study. The data of all patients admitted to the ICU at a university 
hospital with the diagnosis of SAP from January 2008 to December 
2012 were abstracted from the hospital database. ARI was defi ned 
according to RIFLE criteria. Patients with any signs of renal impairment 
(serum creatinine value ≥1.5-fold from the estimated baseline) on 
admission or history of kidney disease were excluded. A control group 
was composed of randomly selected patients with SAP who did not 
develop ARI.
Results Of 145 patients, 24 patients who developed ARI at any time 
during hospitalization (ARI group) were contrasted with 24 patients 
without ARI (control group). The patients were older in the ARI group: 
age 57 ± 13 versus 49 ± 16, P = 0.046. Although none of the patients 
in the ARI group had creatinine values ≥1.5-fold from the estimated 
baseline, the creatinine values on admission were higher in this group: 
100  ±  38 versus 68  ±  16, P  =  0.001. The severity of pancreatitis was 
similar. On admission, the APACHE II and SOFA scores were higher in the 
ARI group (12.7 ± 3.7 vs. 8.6 ± 3.4, P = 0.001 and 5.6 ± 3.4 vs. 2.8 ± 1.9, 
P = 0.002, respectively). The patients in the ARI group had higher intra-
abdominal pressure and SOFA respiratory score on admission and after 
72  hours (P  <0.01). Although on admission the cardiovascular SOFA 
score was similar in both groups, it increased signifi cantly after 72 hours 
in the ARI group from 1.1 ± 1.7 to 2.1 ± 1.8, P = 0.012 and became higher 
compared with the control group: 2.1 ± 1.8 versus 0.6 ± 1.2, P = 0.001. 
Lactate was higher in the ARI group on admission and after 72 hours 
(P  <0.05). The percentage of patients requiring vasopressors over 
72 hours was greater in the ARI group: 66.7% versus 29.2%, P = 0.01. 
Positive fl uid balance after 72 hours in ICU was higher in the ARI group: 
8,594  ±  7,044  ml versus 4,192  ±  4,467  ml, P  =  0.004; however, the 
infused volume of crystalloids did not diff er between groups. Central 
venous pressure was higher on admission (P = 0.036) and after 72 hours 
(P = 0.001) in the ARI group. Multivariable logistic regression analysis 
revealed that development of ARI was independently associated with 
cardiovascular SOFA score after 72  hours: odds ratio  = 1.475, 95% CI 
1.049 to 2.073, P = 0.025.
Conclusion The development of ARI in SAP was associated with 
hemodynamic instability, whereas excessive volume expansion does 
not prevent ARI.
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Introduction Severe acute pancreatitis (SAP) is associated with 
signifi cant mortality and morbidity. The objective of this study is to 
examine the profi le, outcome and resource utilization for patients with 
SAP admitted to the ICU in a university teaching hospital over a 5-year 
period.
Methods A retrospective observational study was carried out of all 
patients admitted to the ICU from 1  January 2008 to 31  December 
2012 with SAP. Data were collected from the ICU database (AcuBase), 
the medical records and the ICU clinical information system. Data 
collected included patient demographics, etiology of SAP, data for 
APACHE II, Imrie, Ranson and Acute Kidney Injury Network (AKIN) 
scores, and requirement for organ support. Outcomes recorded were 
length of stay, ICU mortality and hospital mortality. Cost of ICU care was 
calculated based on previously reported methodology.
Results Thirty-eight eligible patients were identifi ed. Mean age was 
51.4 years (range 24 to 86), 68% were male. The commonest etiologies 
were alcohol (53%) and gallstone pancreatitis (24%). The mean APACHE 
II score was 18.5 (IQR 14 to 23). Twenty-eight patients (74%) required 
mechanical ventilation, three of whom required high-frequency 
oscillation (all three survived). Twenty-two patients (58%) had evidence 
of an acute kidney injury on admission (AKIN criteria). Eighteen (47%) 
required renal replacement therapy and 60% required inotropes. 
The ICU mortality and the hospital mortality were 26%. There was 
no signifi cant diff erence in age, APACHE II, Imrie, or Ranson scores 
between survivors and nonsurvivors. The median length of stay in the 
ICU was 11 days (IQR 5.25 to 28.5) and the median hospital stay was 
45.4 days (IQR 22.25 to 104.5). Nine patients (24%) required multiple 
ICU admissions and the mortality was signifi cantly higher in this group 
(P <0.05, chi-square test). In total, 834 ICU bed-days were taken up by 
38 patients. Based on a median cost for an ICU bed-day of €2,205 [1], 
the total cost of ICU care for these patients is estimated at €1,838,970 or 
almost €50,000 per patient.
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Conclusion A hospital mortality rate of 26% is similar to that reported 
recently from a specialist unit in the UK [2] but less than the 42% 
reported in the UK in 2007 [1], suggesting some improvement in recent 
years. SAP is associated with prolonged ICU and hospital stay and 
signifi cant resource utilization.
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Introduction Controversy surrounds the empirical use of antibiotics in 
severe acute pancreatitis (SAP). There are concerns that the widespread 
use of antibiotic therapy in the absence of documented infection may 
lead to selection of drug-resistant organisms [1]. The aim of this study 
was to review the profi le of pancreatic fl uid isolates in patients with 
SAP admitted to the ICU.
Methods Data were reviewed for 38 patients admitted to the ICU over 
a 5-year period. We evaluated organisms cultured from pancreatic 
specimens, as well as the prevalence of drug-resistant organisms in this 
group of patients.
Results Aspirate of pancreatic material for culture was obtained in 
55% of patients (n = 21). The mean time to acquisition of samples for 
culture from admission to ICU was 15.5 days. Fluid was sterile in 67% 
(n = 14) of initial samples. Gram-positive organisms were cultured from 
43% (n = 9) of samples, Gram-negative organisms from 5% (n = 1) and 
yeasts from 5% (n = 1). Antibiotic therapy was administered in 95% of 
patients prior to samples being obtained for culture. On review of all 
samples received from patients (including nonpancreatic specimens), 
vancomycin-resistant enterococci (VRE) were isolated in 13 patients. 
Linezolid-resistant enterococci (LRE) were isolated in six patients, 
fi ve of whom had VRE isolated prior to the culture of LRE. Extended-
spectrum beta-lactamase organisms were isolated in two patients, 
and carbapenem nonsusceptible Gram-negative organisms in three 
patients. The mean APACHE II score was 18.5 and overall hospital 
mortality was 26%.
Conclusion In the majority of patients, initial aspirates of pancreatic 
material were sterile. This may be a result of prior antibiotic usage. 
Where organisms were cultured from initial aspirates, Gram-positive 
organisms predominated, possibly as a result of prior anti-Gram-
negative antibiotic use. Therefore, in patients with ongoing sepsis who 
are receiving broad-spectrum antibiotic therapy, consideration needs 
to be given to the empiric treatment of Gram-positive infection, and 
in particular drug-resistant organisms such as VRE. Local epidemiology 
should be taken into account. Rationale use of antibiotics, in 
accordance with best-practice guidelines, may limit development of 
drug resistance; however, other risk factors for resistance may exist in 
this group and this would need to be further evaluated.
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Introduction Liver transplantation (LT) in acetaminophen-induced 
acute liver failure (APAP-ALF) patients often presents signifi cant 
challenges. The King’s College Criteria (KCC) have been validated on 
admission but not in later phases of illness. The aim was to improve 
determinations of prognosis on and after admission in APAP-
ALF patients using the classifi cation and regression tree (CART) 
methodology to construct optimal binary splits on independent 
variables to predict outcome.
Methods CART models were applied to US ALFSG registry data for 
prediction of 21-day spontaneous survival on admission and late stage 
(days 3 to 7). Analyses were carried out using R software (package rpart) 
for all (n = 803) APAP-ALF patients enrolled between January 1998 and 
September 2013 with complete outcome data. Training data were used 
to build CART trees and test data were used to evaluate prediction 
accuracy (AC), sensitivity (Sn) and specifi city (Sp).
Results Of the 803 APAP-ALF patients, the median age was 37 (29 to 
47) years and 76% were female. A total of 238 (30%) patients were listed 
for and 87 (11%) received LT. A total of 531 (66%) patients recovered 
without LT at 21 days. Using standard logistic regression methods for 
all patients with complete data (n  =  679), KCC (INR, creatinine, coma 
grade 3/4, pH) yielded an AC of 69% (Sn 90%, Sp 27%) at admission. 
For late-stage data (n  =  341), KCC provided similar AC (70%) and Sn 
(97%), but suff ered poor Sp (15%). CART analysis using the KCC 
variables on admission off ered predictive AC (66%) and Sn (65%), with 
increased Sp (67%). Using day  3 to 7 data, the KCC-CART model had 
increased AC (82%) and Sn (86%), with improved Sp (46%) compared 
with logistic KCC. New CART models were developed with 18 variables 
based on previous literature. A new CART model on admission (MELD, 
lactate and MV: test AC 72%, Sn 71%, Sp 77%) performed better than 
KCC-CART. For days 3 to 7, a CART model (MELD, lactate, coma grade) 
off ered superior prediction (test AC 86%, Sn 91%, Sp 46%) compared 
with days 3 to 7 KCC-CART.
Conclusion CART analysis increased predictive performance compared 
with traditional KCC. KCC-CART trees have higher Sp and similar 
predictive AC compared with traditional KCC, with newer CART trees 
providing marginal improvement over KCC-CART models.
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Introduction Cerebral edema is a severe and life-threatening 
complication in acute liver failure (ALF). Concerns exist that therapeutic 
hypothermia (TH) may increase the risk of infection, worsen 
coagulopathy and inhibit hepatic regeneration. We therefore reviewed 
the experience in use of TH in participating US Acute Liver Failure Study 
Group (ALFSG) centers. The aims were to determine utilization of TH 
in ALF patients at high risk for cerebral edema (grade III or IV hepatic 
encephalopathy (HE)) and to determine its eff ect on survival and 
complication rates.
Methods A retrospective cohort study of all ALF patients enrolled in 
the US ALFSG registry between January 1998 and September 2013 with 
grade III or IV HE. TH using an external cooling device was used in 97 
(8%) patients while in 1,135 (92%) patients it was not (controls).
Results TH ALF patients were younger (36 vs. 40, P  =  0.03) and had 
acetaminophen etiology (63 vs. 47%, P  =  0.04). Admission MELD (32 
vs. 34) and lactate (5.4 vs. 5.0 mmol/l, P >0.2 for all) were similar. More 
TH ALF patients received renal replacement therapy (63 vs. 40%), 
vasopressors (61 vs. 43%) and ICP monitoring (40 vs. 22%, P <0.0002 for 
all). Overall (38% vs. 40%, P = 0.7) and 21-day transplant survival (45 vs. 
49%, P = 0.5) were similar. There were no diff erences in bleeding (12% 
vs. 12%) or bloodstream infections (17 vs. 18%, P >0.7 for both). More 
TH ALF patients had arrhythmias (38 vs. 27%, P = 0.03). There were no 
diff erences in listing (43 vs. 40%, P  = 0.5) or receipt of transplant (18 
vs. 25%, P  =  0.1). After controlling for MELD, requirement for organ 
support on multivariable analysis, hypothermia was not independently 
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associated with 21-day spontaneous survival (P  =  0.93) while MELD 
(P <0.0001) and vasopressors (P <0.02) were.
Conclusion TH was not associated with increased bleeding/infection 
rates nor diff erences in survival in ALF patients with high-grade HE. ICP 
monitoring was not universally used in TH ALF patients (~40%). There is 
a need for a prospective trial to clarify the use of TH in patients with ALF.
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Introduction Cirrhotic patients with Model for End-stage Liver Disease 
(MELD) score ≥40 have high risk of death without liver transplant 
(LT) [1]. This study aimed to evaluate these patients’ outcomes after 
transplant.
Methods The retrospective cohort included 519 adult cirrhotic patients 
who underwent LT at one Canadian center between 2002 and 2012. 
Primary exposure was severity of end-stage liver disease measured by 
MELD score at transplant (≥40 vs. <40) [2]. The primary outcome was 
duration of fi rst ICU stay after LT [3]. Secondary outcomes were duration 
of fi rst hospital stay after LT, rate of ICU readmission, re-transplant rate, 
and survival rates.
Results On the day of LT, 5% (28/519) of patients had a MELD score ≥40. 
These patients had longer fi rst ICU stay after LT (14 vs. 2 days; P <0.001). 
MELD score ≥40 at transplant was independently associated with fi rst 
ICU stay after transplant ≥10 days (OR, 3.21). These patients had longer 
fi rst hospital stay after LT (45 vs. 18 days; P <0.001); however, there was 
no signifi cant diff erence in the rate of ICU readmission (18% vs. 22%; 
P = 0.58) or re-transplant rate (4% vs. 4%; P = 1.00). Cumulative survival 
at 1  month, 3  months, 1  year, 3  years, and 5  years was 98%, 96%, 
90%, 79%, and 72%, respectively. There was no signifi cant diff erence 
in cumulative survival stratifi ed by MELD score ≥40 versus <40 at 
transplant (P = 0.59).
Conclusion Cirrhotic patients with MELD score ≥40 at transplant utilize 
greater postoperative health resources; however, they derive similar 
long-term survival benefi t with LT.
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Introduction Patients with liver transplantation suff er a major 
risk of infections immediately after the surgery due to heavy 
immunosuppression, severe stress and underlying pathology. The aim 
of this study is to fi nd their causes and consequences in our ICU.
Methods We studied 72 cirrhotic patients who were transplanted 
in our hospital during the years 2011 and 2012. The cases that 
developed intrahospital infection, its source and microbiology, the 
surgical complications, the function of the transplant, the duration of 
mechanical ventilation and their outcome were fully examined.
Results Twenty patients (27.1%) developed 33 episodes of infection. 
Among them 35% suff ered from liver dysfunction, 40% took large 
doses of immunosuppression and 50% were re-operated. Five out 
of them showed signs of infection promptly after transplantation. 
Medium duration of mechanical ventilation was 16.5 ± 12.75 days (vs. 
3.24 ± 5.5 of those without an infection) and medium length of stay was 
22.14 ± 18.35 days (vs. 6.79 ± 8.86). The medium APACHE II score was 
17.8 ± 5.5 (vs. 16.4 ± 4.37, P = 0.256) and medium SOFA was 11.32 ± 2.62 
(vs. 9.9 ± 2.62, P = 0.054). The majority of patients was transfused with 
many blood units, FFP and cryoprecipitates and was hemodynamically 
unstable (56.3%). MELD score and MELD-Na were higher (22.57 and 
27.5 relatively vs. 19.02 and 22.5). Eight cases had VAP from Gram-
negative bacteria, 15 had bacteraemia (mainly Gram-negative, but 
also fungaemia), 10 had intraabdominal infection (most of them 
with two or three re-operations) and urine infection. The majority of 
pathogens were multidrug resistant. Regarding Klebsiella pneumoniae 
Carbapenemase, 60% was sensitive to colimycine, 20% to tobramycin, 
70% to gentamycin and 40% to tygecycline. In four cases the donors 
had an infection that was transmitted to the recipient as much as 75%. 
Fourteen patients died (10 in ICU and four in the transplantation clinic) 
soon after with multiorgan failure.
Conclusion Patients after liver transplantation with organ dysfunction 
and multiple transfusions, due to surgical complications, have a major 
risk of developing an infection inside the ICU that aff ects their survival.
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Introduction Extracorporeal membrane oxygenation (ECMO) is 
increasingly used for the treatment of refractory but potentially 
reversible respiratory and/or cardiac failure. Data on perioperative 
support with veno-arterial (V-A) and veno-venous (V-V) ECMO for adult 
liver transplant recipients are scarce [1,2]. We report our experience of 
ECMO support in patients with acute liver failure (ALF) as a bridge to 
transplant and postoperative ECMO use following complications after 
surgery.
Methods A retrospective study in a specialist tertiary referral ICU. 
Patients supported with V-V or V-A ECMO before, during, or after 
orthotopic liver transplant (OLT) were identifi ed.
Results In total, four patients were supported during a 12-month 
period. Two patients required V-V and two patients V-A support. Two 
patients with ALF were bridged to OLT, one patient V-V ECMO for 
refractory respiratory failure and the other patient required emergency 
V-A support for treatment of intraoperative arrest. Both patients 
were successfully transplanted but died subsequently on ECMO: 
disseminated aspergillosis and haemophagocytic syndrome, and 
anoxic brain injury respectively. Two patients received postoperative 
ECMO support. The fi rst was treated with V-V ECMO for refractory 
persistent hypoxaemia following OLT for hepato-pulmonary syndrome, 
the second received emergency V-A support (eCPR) following cardiac 
tamponade and arrest on postoperative day 2. Both patients made a 
full recovery.
Conclusion Emergency ECMO support before and after liver transplant 
is feasible. Despite the poor outcome in patients with ALF, we consider 
ECMO a valuable option to bridge selected patients to transplant.
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Introduction A period of hemodynamic instability following 
revascularization of the liver graft during liver transplantation is 
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frequently observed and is termed post-reperfusion syndrome. Recent 
studies showed the existence of a specifi c heart disease associated 
with cirrhosis termed cirrhotic cardiomyopathy (CCM). The aim of this 
study was to investigate whether the CCM has an infl uence on the 
development or the severity of post-reperfusion syndrome.
Methods Fifty-two consecutive liver transplant patients were included 
in a retrospective observational study. The variables recorded were: 
age, etiology of the liver disease, MELD and MELD Na scores, the 
associated pathologies, the length of the QT interval, and plasma 
levels of brain natriuretic peptide (BNP). The patients with known renal 
or heart disease and the recipients of organs from extended criteria 
donors were excluded from the study. The QT interval was corrected 
for the heart rate using Bazett’s formula (QTc). Statistical analysis was 
performed using SPSS Statistics v.19.1.
Results In our study the criteria used to defi ne post-reperfusion 
syndrome relied on the hemodynamic changes that occurred at 
reperfusion. Preoperative echocardiography showed normal systolic 
and diastolic function at rest in all of the patients. For the identifi cation 
of patients at risk for CCM we used two of the supportive criteria from 
the recent defi nition of CCM: prolonged QTc interval and increased 
BNP levels. The study group included 28 men (53.8%) and 24 women. 
Mean (± SD) age was 50.5 (± 11.4). Mean MELD and MELD Na scores 
were respectively 15.51 (±  5.43) and 18.9(±  6.22). The value of BNP 
correlated well with the length of the QTc interval (P  =  0.005), and 
with MELD and MELD Na scores (P = 0.025 and P = 0.001). In our study, 
post-reperfusion syndrome occurred in 63.4% of the patients. We 
could not fi nd a correlation between post-reperfusion syndrome and 
the BNP levels (P = 0.85) or the prolonged QTc interval (P = 0.38). The 
post-reperfusion syndrome did not correlate with the severity of the 
liver disease as assessed by MELD and MELD Na scores. The severity of 
post-reperfusion syndrome did not correlate with QTc prolongation or 
BNP levels.
Conclusion Reperfusion is a critical time during liver transplantation. 
The clinical predictors of post-reperfusion syndrome are still under 
debate [1]. Our study showed that the post-reperfusion syndrome is 
not correlated with the severity of the liver disease or with the presence 
of risk factors indicating CCM.
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Introduction Combined heart–liver transplantation (CHLT) is an 
uncommonly performed procedure for patients with coexisting cardiac 
and liver disease [1]. The purpose of this study was to examine and 
describe the perioperative management of patients undergoing CHLT.
Methods A retrospective review was performed of patients undergoing 
CHLT at our institution from 1999 to 2013.
Results Twenty-seven CHLTs were performed, with 4/27 including 
simultaneous kidney transplantation. Familial amyloidosis was 
the indication for 21 CHLTs (78%), and 12 of these explanted livers 
were used for domino transplantations. Nineteen patients (70%) 
were receiving inotropic infusions at the time of organ availability. 
The median preoperative MELD score was 12, and elevations in 
preoperative international normalized ratio were due to warfarin in all 
but one patient. Liver transplantation immediately preceded cardiac 
transplantation in 2/27 cases to reduce high-titer donor-specifi c 
antibodies. Venovenous bypass was utilized in 14 operations (52%) 
performed with the caval interposition liver transplantation approach, 
cardiopulmonary bypass during liver transplantation in two cases (7%), 
and no bypass in 11 operations (41%) performed with a caval sparing 
(piggyback) surgical technique. Postoperatively, the median duration 
of mechanical ventilation, ICU stay, and hospital stay until discharge 
were 1  day, 5.5  days, and 15  days, respectively. Transfusions in the 
fi rst 48  hours following CHLT were not substantial in the majority of 
patients. One patient died within 30 days of CHLT.
Conclusion CHLT is a life-saving operation that is performed with 
relatively low mortality and can be successfully performed in select 
patients with congenital heart disease. Patients undergoing CHLT at our 
institution had relatively preserved hepatic function but limited cardiac 
function often requiring inotropic support. Cardiac transplantation 
typically precedes liver transplantation during CHLT given the 
decreased ischemic tolerance of the cardiac graft [2]. However, liver 
transplantation prior to cardiac transplantation may serve to mitigate 
high-titer donor-specifi c antibodies. Various aforementioned operative 
approaches may be successfully utilized for the liver transplantation 
portion of these procedures. We attribute the favorable outcomes and 
perioperative courses to the multidisciplinary approach to care that 
CHLT patients receive at our institution.
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Introduction The balance between coagulation and fi brinolysis was a 
prominent factor in the pathophysiology of sepsis, but this mechanism 
has been poorly understood. We aimed to determine whether 
collapsing this balance during the fi rst  day of sepsis correlates with 
progression of organ dysfunction and subsequent death.
Methods This study included all patients with sepsis admitted to 
a tertiary referral hospital in Japan. Global coagulation tests and 
hemostatic molecular markers such as fi brin/fi brinogen degradation 
products (FDP), D-dimer, thrombin–antithrombin complex (TAT) and 
plasmin-alpha 2 plasmin inhibitor complex (PIC) were measured within 
12  hours after admission, and then SOFA and APACHE II scores and 
in-hospital mortality were evaluated. Patients were divided into three 
groups based on the levels of TAT/PIC and FDP/D-dimer and diff erences 
of clinical outcome between groups were assessed by chi-square 
analysis and ANOVA.
Results We enrolled 101 patients; 87 patients survived, and 14 died. 
Mortality was signifi cantly higher in the high TAT/PIC group (0%, 
19% and 24% for low, middle and high TAT/PIC groups, respectively; 
P  =  0.011). In addition, SOFA and APACHE II scores were signifi cantly 
higher in the low FDP/D-dimer group (APACHE II = 22.3, 18.9 and 15.3; 
P <0.01, SOFA = 8.6, 6.5 and 5.1; P <0.01, for low, middle and high FDP/
D-dimer groups, respectively). See Figure 1.
Conclusion We demonstrated that the balance between coagulation 
and fi brinolysis, assessed with FDP/D-dimer and TAT/PIC ratios, was 
correlated with disease severity and clinical outcomes in sepsis, 
suggesting that impaired balance of the hemostatic system might play 
a pivotal role in progression of sepsis pathophysiology.
Figure 1 (abstract P206). Comparison of the characteristics between the 
three groups.
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Introduction The soluble fi brin monomer fi brinogen complex (SF) 
is a complex coupling fi brin monomer and fi brinogen molecules. As 
the level of SF refl ects the thrombin generation activity in plasma, we 
may estimate the early-activated state of blood coagulation by the 
measurement of SF. The aim of this study is to evaluate the clinical 
usefulness of SF for the hypercoagulated state.
Methods We measured the plasma level of SF in 63 patients within 
48  hours after admission and on the 1st, 3rd, 5th and 7th  days after 
admission. Underlying disease mainly includes sepsis, shock, and so 
on. According to the disseminated intravascular coagulation diagnostic 
criteria established by the Japanese Association of Acute Medicine, we 
defi ned the DIC group as JAAM-DIC score more than 3 within 48 hours 
after admission, the Subclinical DIC group as score more than 3 within 
7 days beyond 48 hours after admission, and the No DIC group as score 
less than 4 during the entire study period. The SF value of each group 
was compared with the Mann–Whitney U test.
Results The SF values in the DIC and the Subclinical DIC groups were 
signifi cantly higher than in the No DIC group. We created the receiver 
operating characteristic curve of SF value for DIC onset (JAAM-DIC score 
≥4) and the SF value of 35 μg/ml was set as the cutoff  SF value. The high 
SF group (SF ≥35 μg/ml) had signifi cantly higher JAAM-DIC score, SOFA 
score and APACHE II score than the low SF group (SF <35 μg/ml). Mainly 
in the high SF group except DIC patients on admission, we found that 
SF increased before the JAAM-DIC score changed. See Figures 1 and 2.
Conclusion We think measurement of the plasma SF level may be 
clinically useful in evaluating the severity of critically ill patients such 
as those with sepsis.
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Introduction Hemodynamic disorders in critically ill patients are often 
connected with bacterial load. Bacterial load is usually associated with 
bacteremia, LPS, high level of IL-6, PCT and also with aromatic microbial 
metabolites [1-3], and so forth. In our opinion, microbial metabolites can 
participate in hemodynamic disorders in critically ill patients, particularly 
due to their infl uence on NO production [4] and intestinal permeability.
Methods In a prospective study we observed critically ill patients on 
the day of admission to a polyvalent ICU, severe cardiac pathology 
was excluded. The level of phenylpropionic, phenyllactic, p-OH-
phenyllactic, p-OH-phenylacetic acids and total phenylcarboxylic acids 
(PhCAs) were measured in blood serum using gas chromatography 
(GC-FID). The level of PCT and NT-proBNP were measured using Elecsys 
2010. Comparison between patients with hypotension (on vasopressor 
support) (group A) and without (group B) was performed.
Results We studied 50 ICU patients with diff erent diseases: pneumonia 
(n = 15), severe kidney failure (n = 13), abdominal surgical pathology 
(n  =  10), alcoholic cirrhosis (n  =  5), soft-tissue infection (n  =  7). In 
group A (24/50) the median of PhCAs was 17.8 (IR 11.4 to 30.0) μmol/l, 
and in group B (26/50) it was 7.2 (IR 3.7 to 13.2) μmol/l, P = 0.003 (t test). 
In group A, all patients (with or without documented infections) had 
symptoms of infection manifestation [5], 20/24 (83.3%) of them died. 
In group  B, the symptoms of infection manifestation were revealed 
in 12/26 (46%) cases, and the mortality was signifi cantly lower, 3/26 
(11.5%) (P  <0.05). General mortality was 23/50 (46%). The profi le of 
PhCAs diff ered in groups A versus B.
Conclusion The total level of PhCAs in critically ill patients with 
hypotension was considerably higher than in hemodynamically stable 
patients. The participation of microbial factor in pathogenesis of 
hemodynamic disorders in the presence of systemic infl ammation may 
be validated with the load of microbial metabolites (PhCAs).
Acknowledgement This work was supported by the Russian 
Foundation for Basic Research (project number 13-04-01758/13).
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Introduction Coagulation abnormalities are common in severe sepsis 
or septic shock [1].
Methods A prospective observational cohort study of 100 patients 
above 18  years of age diagnosed with severe sepsis or septic shock 
on admission. The fi rst blood sample collected on admission was 
analyzed. Data were collected through a predesigned pro forma. Those 
with previous history of any coagulation disorders were excluded.
Figure 1 (abstract P207). SF values of the DIC, Subclinical DIC and No 
DIC groups.
Figure 2 (abstract P207). ROC curve of the SF value for DIC.
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Results Univariate analysis showed signifi cant correlation of APACHE 
II, platelet, PT, aPTT, fi brinogen and D-dimer with mortality in patients 
with severe sepsis or septic shock. Multivariate analysis showed APACHE 
II >20 (P = 0.001), fi brinogen <2 (P = 0.019) and D-dimer >1(P = 0.06) are 
independent predictors of mortality in severe sepsis or septic shock. 
See Table 1.
Table 1 (abstract P209).
 Died Survived  95% CI
Variable (n = 65) (n = 35) ARR of ARR P value
Platelet <150 33 (50.8) 10 (28.6) 1.37 0.03, 1.84 0.03
PT >16 41 (63.1) 14 (40) 1.40 1.02, 1.91 0.027
aPTT >40 41 (63.1) 14 (40) 1.40 1.02, 1.91 0.027
Fibrinogen <2 40 (61.5) 15 (42.9) 1.31 0.96, 1.70 0.07
D-dimer >1 64 (98.5) 31 (88.6) 3.37 0.48, 19.5 0.03
APACHE II >20 53 (81.5) 18 (51.4) 1.80 1.15, 2.84 0.002
Age >65 27 (41.5) 8 (22.9) 1.60 1.04, 2.46 0.02
Conclusion The fi brinogen level at admission is an independent 
predictor of mortality in patients with sepsis or septic shock. It also 
confi rms correlation of other coagulation abnormalities with the 
outcome.
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Introduction While the crosstalk between coagulopathy and 
infl ammation plays a key role in the development of multiple organ 
dysfunction in critically ill patients, the mechanisms governing this 
crosstalk have yet to be established. Microparticles (MPs) are submicron 
vesicles shed from a variety of cells that are considered to have 
proinfl ammatory and prothrombotic properties. Although platelet-
derived MPs (PDMPs) are the main form of MPs, the role of PDMPs in 
critically ill patients remains unclear [1]. The aims of this study were 
to investigate serum PDMP levels in critically ill patients and to assess 
their prognostic value.
Methods This study comprised 119 critically ill patients who were 
admitted to the ICU. PDMPs were measured by ELISA three times a 
week, and 372 samples were obtained. We calculated both the mean 
PDMP value and the mean PDMP/platelet (PDMP/PLT) ratio (converted 
to plasma PDMP levels per 104 platelets) during the course of the ICU 
stay. Baseline patient data, including APACHE II score, SOFA score, 
Japanese Association for Acute Medicine DIC score, International 
Society for Thrombosis and Haemostasis overt DIC score, blood 
coagulation parameters, C-reactive protein and lactate, were collected 
at the time of admission to the ICU. The primary outcome was in-
hospital mortality. Potential predictors were analyzed for possible 
association with outcomes.
Results The mean PDMP/PLT ratio was signifi cantly diff erent when 
comparing hospital survivors (n = 98; median, 1.95) and nonsurvivors 
(n  =  21; median 8.40; P  =  0.00). The mean PDMP/PLT ratio was 
signifi cantly higher in patients with (median, 4.28) than in those 
without DIC (median, 1.57; P = 0.00). In DIC patients, the mean PDMP/
PLT ratio was signifi cantly higher in nonsurvivors (median, 9.39) than 
in survivors (median, 3.65; P  =  0.02). Multivariate logistic regression 
analysis revealed that both the mean PDMP/PLT ratio (P  =  0.04) 
and APACHE II score (P  =  0.00) were independently associated with 
in-hospital mortality. The AUCs were calculated as 0.768 ± 0.073 for the 
mean PDMP/PLT ratio (P  = 0.00) and 0.811  ±  0.048 for the APACHE II 
score (P = 0.00).
Conclusion The PDMP/PLT ratio is a good predictor of in-hospital 
mortality in critically ill patients, especially in patients with DIC.
Reference
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Introduction Systemic infl ammation caused by infection or trauma 
often leads to adverse outcome in critically ill patients. Binding of ligands 
to the receptor for advanced glycation end products (RAGE) activates 
several pathways, including the nuclear factor-kappa B pathway, which 
generates infl ammatory cytokines, proteases and oxidative stress. RAGE 
activation has been suggested to link amplifi cation and perpetuation 
of infl ammation to subsequent organ damage and adverse outcome 
in sepsis, acute lung injury and myocardial dysfunction [1]. The soluble 
receptor, sRAGE, is thought to act as a decoy, thus protecting against 
further RAGE activation. High mobility group box 1 (HMGB1) is a nuclear 
protein that is released during cellular stress and damage. S100A12 is 
a neutrophil-derived protein that acts as a proinfl ammatory danger 
signal. Both are ligands for RAGE. We hypothesized that excessive RAGE 
activation is linked to adverse outcome in critically ill patients and 
that a diff erent pattern of RAGE activation and infl ammation may be 
present in patients according to underlying pathology.
Methods We measured sRAGE, HMGB1 and S100A12 serum levels 
upon admission, day  7 and the last day in the ICU in 405 critically ill 
surgical patients who needed intensive care for at least 7  days and 
in 69 matched healthy controls. We assessed the relation of these 
levels with clinical complications and outcome, in comparison with 
C-reactive protein (CRP) as a routinely measured clinical parameter of 
infl ammation.
Results Upon ICU admission, levels of sRAGE, HMGB1, S100A12 and 
CRP were higher as compared with healthy levels. HMGB1, S100A12 
and CRP remained elevated throughout the ICU stay but sRAGE 
decreased to levels lower than in healthy volunteers by day 7. sRAGE 
and CRP showed distinct time profi les during the ICU stay in patients 
undergoing cardiac versus other surgery and in patients with versus 
without sepsis upon admission. Elevated sRAGE upon admission, 
unlike CRP, was associated with need for renal replacement therapy, 
liver dysfunction, circulatory failure and mortality. Except for mortality, 
these associations remained in multivariate logistic regression analysis 
correcting for baseline risk factors.
Conclusion Critical illness alters several components of the RAGE axis. 
Elevated sRAGE levels upon admission to the ICU were associated with 
adverse outcome, independent of baseline pathology.
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Introduction Endotoxin is a component of the membrane of Gram-
negative bacteria and plays a key role in the pathogenesis of sepsis 
[1]. Measurement of endotoxin levels in patient blood is important 
for the early diagnosis of and appropriate determination of the 
treatment strategy for sepsis. The aim of this study was to investigate 
the prevalence of endotoxemia in Japanese critically ill patients using 
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the endotoxin activity assay (EAA), a newly developed rapid assay of 
endotoxin. Blood endotoxin levels (EA levels) of 314 patients admitted 
to our university hospital ICU were measured within 24  hours from 
admission, and their correlation with disease severity and outcome 
was examined.
Methods The study is a single-center retrospective analysis of critically 
ill patients admitted to our university hospital ICU from November 
2006 to March 2012. All patients whose EA and procalcitonin levels 
were measured and severity criteria of disease recorded were enrolled. 
A total of 314 patients were analyzed.
Results The mean  ±  SD of all ICU-admitted patients (n  =  314) was 
0.39 ± 0.25, and that of healthy volunteers (n = 61) was 0.10 ± 0.09. The 
mean APACHE II score at admission increased in parallel with increased 
EA levels. The mean (±  SD) APACHE II score in the very low group of 
patients (EA <0.2) was 17.3 ± 8.9, while that in the low group (0.2 ≤EA 
<0.4) was 20.6 ± 9.2; it was 22.6 ± 8.1 in the intermediate group (0.4 
≤EA <0.6) and 25.3  ±  8.5 in the high group (0.6 ≤EA). The diff erence 
between the groups was statistically signifi cant. The diff erence 
between the groups was statistically signifi cant. The percentages of 
patients diagnosed with severe sepsis or septic shock were 19.3%, 
34.5%, 50.0% and 81.3% in the very low, low, intermediate and high 
groups, respectively.
Conclusion Our patients’ EA levels were signifi cantly correlated with 
disease severity criteria and 28-day mortality of the patients. When 
the EA level and procalcitonin level were used concomitantly, disease 
severity could be assessed more precisely than when either marker was 
used alone. These results suggest that the EA level is a useful marker 
for disease severity assessment and outcome prediction in critically ill 
patients.
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Introduction The presepsin (PSEP) and procalcitonin (PCT) levels 
are useful biomarkers for diff erentiating between sepsis and non-
infectious systemic infl ammatory response syndrome (SIRS). The PSEP 
and PCT levels have been reported to be abnormally high in patients 
with chronic renal failure. However, there have been no signifi cant 
investigations regarding the relationships between these biomarkers 
and the presence of acute kidney injury (AKI) in the diagnosis of sepsis. 
The purpose of this study was to clarify the diagnostic accuracy of PSEP 
and PCT levels in patients with AKI.
Methods This study was conducted as a single-center retrospective 
study. Blood samples were collected from patients immediately after 
admission to the Department of Emergency and Critical Care Medicine, 
Fukuoka University Hospital between June 2010 and August 2013. 
We enrolled 629 patients in whom both the PSEP and PCT levels were 
measured on admission. We classifi ed the patients into two groups 
according to the RIFLE criteria (Risk, Injury, Failure, Loss of kidney 
function and End-stage kidney disease: Loss and ESKD): the AKI group 
and the non-AKI group. The patients in the AKI group were further 
classifi ed into the sepsis group and the nonsepsis group according 
to each stage of AKI. We subsequently investigated the diagnostic 
accuracy of the PSEP and PCT levels for detecting sepsis in these groups.
Results We evaluated 254 patients with AKI and 375 patients without 
AKI. The AKI group included 103 patients who met the Risk criteria, 
65 who met the Injury criteria, 66 who met the Failure criteria and 18 
who met the Loss and ESKD criteria. The mean PSEP and PCT levels 
were signifi cantly higher in the sepsis group than in the nonsepsis 
group among the non-AKI patients and those meeting the Risk, Injury 
and Failure criteria (P <0.01). The diagnostic accuracy of the PSEP and 
PCT levels for detecting sepsis was determined according to a ROC 
analysis; the area under the curve (AUC) for the PSEP and PCT levels 
was 0.883 and 0.870, respectively, in the non-AKI group. In addition, 
the AUC values for the PSEP and PCT levels in the Risk, Injury and 
Failure groups were 0.843 and 0.843, 0.818 and 0.922 and 0.669 and 
0.804, respectively. In the Failure group, the AUC for the PSEP and 
PCT levels was 0.828 and 0.852, respectively, after dividing the PSEP 
and PCT levels by the creatinine (Cr) level. The optimal cutoff  values 
for the PSEP and PCT levels for diagnosing sepsis were 409 pg/ml/Cr 
(sensitivity: 66.0%, specifi city: 91.7%) and 1.5  ng/ml/Cr (sensitivity: 
63.6%, specifi city: 95.8%), respectively.
Conclusion The diagnostic accuracy of PSEP and PCT levels for 
detecting sepsis decreased in the Failure group; however, the value of 
these parameters for diagnosing sepsis in patients meeting the Failure 
criteria increased after dividing them by the Cr level.
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Introduction Diff erentiation of sepsis from non-infectious SIRS is 
important in improving sepsis outcome. We intended in this study 
to evaluate the role of serum leptin and to compare it with CRP in 
diff erentiating sepsis from non-infectious SIRS.
Methods We included 30 patients with SIRS. According to the presence 
or absence of infection, our patients were classifi ed into the SIRS group 
and the sepsis group. Leptin and CRP were evaluated in all patients on 
admission, day 2 and day 4.
Results Our patients had mean age of 52.3  ±  18.6  years, 10 males 
(33.3%). There were no signifi cant diff erences regarding baseline 
demographic and clinical data apart from blood pressures, which were 
lower in sepsis group. Serum leptin on day  2 only was higher in the 
sepsis group (44.2  ±  17.7  μg/l vs. 31.1  ±  2.1  μg/l, P  =  0.008) with no 
diff erence on days 0 and 4 of admission. We detected a serum leptin 
level of 38.05 μg/l on day 2 to be 93% sensitive and 100% specifi c to 
diagnose sepsis. The three serum CRP levels were higher in the sepsis 
group compared with the SIRS group (61.2 ± 9 mg/l vs. 48.9 ± 7.1 mg/l, 
P <0.001 on day 0, 71.5 ± 9.6 mg/l and 196.8 ± 39.8 mg/l in the sepsis 
group vs. 56.9 ± 8 mg/l and 73.7 ± 32.5 mg/l in the SIRS group for days 2 
and 4 respectively, P <0.001 for both). We found a CRP of 67.5 mg/l on 
day 2 having 87% sensitivity and 93% specifi city for the diagnosis of 
sepsis.
Conclusion We concluded that although serum leptin may not be 
benefi cial in early diff erentiation between sepsis and non-infectious 
SIRS on admission, it may be highly specifi c on the second day.
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E Tamayo1, S Gutierrez1, E Alvarez1
1Hospital Clínico Universitario de Valladolid, Spain; 2Hospital Río Hortega, 
Valladolid, Spain
Critical Care 2014, 18(Suppl 1):P215 (doi: 10.1186/cc13405)
Introduction The aim of this study is to identify a marker able to 
predict sepsis in cardiac surgery patients and to diff erentiate SIRS from 
infectious and non-infectious origin. The occurrence of sepsis after 
cardiac surgery increases the mortality risk. Sepsis may be mistaken 
for the cardiac surgery-associated systemic infl ammatory response 
syndrome (SIRS) [1].
Methods A prospective, observational study was carried out to 
compare procalcitonin (PCT), C-reactive protein (CRP) and white 
blood cells (WBCs) during the fi rst 10 postoperative days after cardiac 
surgery with cardiopulmonary bypass (CPB) between 122 patients with 
infection (Infection group) and 301 without (Control group) to identify 
predictors of infection.
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Results The WBC and PCT median values were signifi cantly (P <0.05) 
higher in infected than control patients, during 10 postoperative days 
and on the third and fourth postoperative day, respectively, both 
variables showing a peak at 3  days in infected patients. The number 
of times that the WBC count surpassed its second postoperative 
median value (13,000 cells/mm3) during the fi rst 3 postoperative 
days plus the number of times that PCT surpassed its own (1.7  ng/
ml) was a parameter (ranging from 1 to 6) with three categories (R1= 
surpassed zero to one time; R2 = two to three times; R3 = four to six 
times) signifi cantly associated with risk of infection, which increased 
with increasing number of times (R2: OR = 2.48 (1.32 to 4.65) and R3: 
OR = 7.06 (3.17 to 15.71)).
Conclusion Daily assessment of WBC and PCT during the fi rst 3 
postoperative days may be of value to diagnose and predict infection 
in cardiac surgery patients.
Reference
1. Sablotzki A, Friedrich I, Muhling J, Dehne MG, Spillner J, Silber RE, et al.: The 
systemic infl ammatory response syndrome following cardiac surgery: 
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Introduction The early phase of septic shock is dominated by severe 
alterations of the cardiovascular system. The prognostic value of pro-
adrenomedullin (pADM), a vasoactive pro-hormone, measured within 
24 hours from septic shock onset was assessed.
Methods A prospective, observational study in 100 patients >18 years with 
septic shock in a polyvalent ICU of a university hospital. Demographic, 
clinical parameters and pADM, C-reactive protein (CRP) and procalcitonin 
(PCT) were studied during the fi rst 24  hours after admission in 2011. 
Descriptive and comparative statistical analysis was performed using the 
statistical software packages StatSoft STATISTICA 7.1 and MedCalc 9.2.1.0.
Results We analyzed 100 consecutive episodes of septic shock in the 
ICU. The median age of the study sample was 64  years, interquartile 
range 16.8  years, 59% were men; the main sources of infection were 
respiratory tract (48%) and intra-abdominal (24%). The 28-day mortality 
was 36%. The profi le of dead patients showed signifi cantly higher 
clinical severity scores, APACHE II (27 vs. 25; P <0.001) and SOFA (12 vs. 
10; P <0.001). The area under the curve was 0.72 for pADM, signifi cantly 
higher than those for CRP (0.62) and PCT (0.65), but similar to those 
for APACHE II score (0.69) and SOFA score (0.78). Kaplan–Meier survival 
analysis was signifi cant (P = 0.0012) for patients with pADM <1.2 nmol/l. 
Cox regression analysis also showed statistical signifi cance (P = 0.0004) 
and a likelihood ratio =1.26 per each 1 nmol/l increase in pADM.
Conclusion Pro-adrenomedullin is an important prognostic biomarker 
of survival when measured on admission of septic shock patients to 
the ICU.
P217
Surfactant protein A: a candidate predictive biomarker of mortality 
in acute respiratory distress syndrome in sepsis
V Moroz, A Kuzovlev, A Goloubev
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Moscow, Russia
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Introduction Prediction of mortality in septic acute respiratory distress 
syndrome (ARDS) is a problem of great signifi cance. The aim of this 
study was to investigate the role of surfactant protein A (SPA) as a 
candidate predictive biomarker of mortality in ARDS.
Methods The observational study in ICU ventilated septic patients 
with peritonitis (65%), pancreonecrosis (20%) and mediastinitis (15%) 
was performed in 2010 and 2013. ARDS was diagnosed and staged 
according to the V.A. Negovsky Research Institute criteria [1,2] and the 
Berlin defi nition. Plasma SPA was measured on ARDS diagnosis (day 
0) and days 3 and 5 by the immunoenzyme essay (BioVendor, USA). 
Patients were treated according to the international guidelines. Data 
were statistically analyzed by STATISTICA 7.0, ANOVA method, and 
presented as median and 25th to 75th percentiles, ng/ml; P <0.05 was 
considered statistically signifi cant. Areas under the receiver operating 
curves were calculated.
Results Eighty-fi ve patients (out of 300 screened) were enrolled in 
the study according to the inclusion/exclusion criteria. Patients were 
assigned into groups: ARDS (n  =  50, 48  ±  5.7  years old, M/F 35/15, 
mortality 26%) and noARDS (n  =  35, 46  ±  8.7  years old, M/F 30/5, 
mortality 23%). Groups were comparable in APACHE II scores. In the 
ARDS group SPA was higher at all points than in the noARDS group 
(day 0: 32.6, 25 to 75 IQR 18.2 to 60.7 vs. 23.4, 25 to 75 IQR 17.8 to 28.6; 
day 3: 31.5, 25 to 75 IQR 20.9 to 31.5 vs. 24.6, 25 to 75 IQR 19.7 to 24.6; 
day 5: 32.5, 25 to 75 IQR 17.3 to 66.4 vs. 22.5, 25 to 75 IQR 13.4 to 29.5, 
P  <0.05). The plasma SPA was signifi cantly lower in surviving versus 
dead patients with ARDS (day 0: 20.9, 25 to 75 IQR 13.0 to 35.7 vs. 45.7, 
25 to 75 IQR 23.5 to 67.9; day 3: 25.5, 25 to 75 IQR 11.8 to 35.5 vs. 45.0, 25 
to 75 IQR 29.6 to 68.4; day 5: 24.5, 25 to 75 IQR 11.4 to 33.6 vs. 49.6, 25 to 
75 IQR 31.3 to 79.0, P <0.05). Plasma SPA on day 0 had a good capacity 
for prediction of mortality in ARDS patients: SPA on day 0 ≥38.8 ng/ml 
yielded a sensitivity of 65% and specifi city of 80% (AUC 0.74; 95% CI 
0.577 to 0.866; P = 0.0026).
Conclusion Plasma SPA level ≥38.8 ng/ml on the day of ARDS diagnosis 
is a sensitive and specifi c candidate biomarker of mortality prediction 
in ARDS septic patients.
References
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Introduction Early etiological diagnosis of nosocomial pneumonia (NP) 
determines prompt targeted treatment. The aim of this study was to 
investigate the role of Club Cell protein (CCP) as a candidate diagnostic 
biomarker of Pseudomonas aeruginosa (PA) NP.
Methods The observational study in ICU ventilated septic patients with 
peritonitis (65%), pancreonecrosis (20%) and mediastinitis (15%) was 
performed in 2010 and 2013. Diagnosis of NP was made according 
to the standard clinical criteria. Associations of multiresistant Gram-
negative bacteria were detected in sputum of all patients. PA was 
detected in 75% of patients. Plasma CCP was measured on the day of 
NP diagnosis (day 0) and days 3, 5 and 7 by the immunoenzyme essay 
(BioVendor, USA). Data were statistically analyzed by STATISTICA 7.0, 
ANOVA method, and presented as Me and 25 to 75 percentiles, ng/ml; 
P <0.05 was considered signifi cant. Areas under the receiver operating 
curves (ROC) were calculated.
Results Ninety patients (out of 350 screened) were enrolled in the study 
according to the inclusion/exclusion criteria. Patients were assigned to 
groups: NP (n = 50, 45 ± 4.3 years old, M/F 36/14) and noNP (n = 40, 
48  ±  7.2  years old, M/F 30/10). Groups were comparable in APACHE 
II and CPIS scores. In patients with PA NP (n  = 30), plasma CCP was 
signifi cantly lower at all points than in the patients with no PA detected 
(n  =  20; Figure  1). Plasma CCP on day 0 had a good capacity for the 
diagnosis of PA NP: CCP on day 0 ≤17.5  ng/ml yielded a sensitivity 
of 86.5% and specifi city of 66.7% (AUC 0.74; 95% CI 0.630 to 0.829; 
P = 0.0001; Figure 2).
Conclusion Plasma CCP level ≤17.5 ng/ml is a sensitive and specifi c 
candidate diagnostic biomarker of PA NP.
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Plasma cholinesterase activity as diagnostic marker for systemic 
infl ammation
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Introduction Systemic infl ammation is a generalized response to 
internal or external infl ammatory stimuli often resulting in multiple 
organ failure. Therefore, early diagnosis of systemic infl ammation 
would be of great therapeutic and prognostic importance. Various 
infl ammation biomarkers have been used in clinical and experimental 
practice, but a defi nitive diagnostic tool for an early detection of 
systemic infl ammation remains to be identifi ed. The neurotransmitter 
acetylcholine (Ach) has been shown to play an important role in the 
infl ammatory response. Serum cholinesterase (butyrylcholinesterase 
(BChE)) is synthesized in the liver and acts as the major Ach hydrolyzing 
enzyme in plasma. Hence, BChE activity has been widely used as a 
biomarker for liver function. However, the role of this enzyme in the 
infl ammatory pathomechanism has not yet been fully understood. 
Here, we describe a strong correlation between the BChE activity and 
the systemic infl ammatory response.
Methods In this study we measured BChE activity in healthy subjects 
and in critically ill patients, clinically diagnosed with systemic 
infl ammation or sepsis. Furthermore, we measured the levels of routine 
infl ammation biomarkers and liver function parameters in blood of 
critically ill patients. Data were statistically analyzed using unpaired 
Student t test, Pearson correlation or ANOVA followed by Dunnett’s 
post hoc analysis. P <0.05 was considered statistically signifi cant.
Results We found that the activity of BChE in patients with systemic 
infl ammation was dramatically reduced in comparison with 
healthy subjects and negatively correlated with the serum levels of 
conventional infl ammatory biomarkers. BChE synthesis depends on 
hepatic function. Surprisingly, the observed reduction in the BChE 
activity during systemic infl ammation does not correlate with liver 
failure.
Conclusion Our results suggest that BchE activity might play an 
important role in the diagnosis of systemic infl ammation independent 
of overall hepatic function.
P220
Lymphopenia as a predictor of bacteremia in the emergency 
department
R Lowsby1, C Gomes1, I Jarman2, P Nee1
1St Helens and Knowsley Teaching Hospital NHS Trust, Liverpool, UK; 
2Liverpool John Moores University, Liverpool, UK
Critical Care 2014, 18(Suppl 1):P220 (doi: 10.1186/cc13410)
Introduction Bloodstream infection (BSI) is associated with a reduction 
in circulating lymphocytes. Lymphopenia has been proposed as an 
early marker of BSI in pyrexial adults in the emergency department 
(ED) setting [1]. The aim of this study was to compare lymphocyte 
Figure 1 (abstract P218). Club Cell protein concentration in patients 
with Pseudomonas aeruginosa NP.
Figure 2 (abstract P218). ROC curve for Club Cell protein (day 0) for the 
diagnosis of Pseudomonas aeruginosa NP.
Figure 1 (abstract P220). ROC curve comparing blood test parameters in 
predicting bacteremia.
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count with conventional markers in patients presenting to the ED of a 
UK hospital with suspected sepsis.
Methods A retrospective review was undertaken of adult patients 
presenting to the ED (annual census 90,000) with pyrexial illness over a 
12-month period, 2011 to 2012. Data included white cell count (WCC), 
neutrophil count (NC), lymphocyte count (LC) and C-reactive protein 
(CRP). The results were compared. Sensitivity and specifi city were 
calculated for each parameter and receiver operating characteristic 
(ROC) curves were constructed.
Results A total of 2,515 patient records were screened. Patients on 
chemotherapy were excluded, as were those under 18  years old. In 
total, 1,954 patients (53% female, median age 66 years) were included 
in the analysis. Blood cultures were positive in 13.7% of cases. There 
were signifi cant diff erences between all variables measured, with the 
exception of WCC, between bacteremic and nonbacteremic patients. The 
area under the curve of 70.8 was best for lymphocyte count (Figure 1).
Conclusion In adult patients presenting to the ED with pyrexial illness, 
lymphopenia predicts bacteremia better than the usual markers of 
infection.
Reference
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Introduction Blood biomarkers are increasingly used to diagnose, 
guide therapy in, and risk-stratify community-acquired pneumonia 
(CAP) patients in emergency departments (EDs). How pre-analytic 
factors aff ect these markers’ initial levels in this population is unknown.
Methods In this secondary analysis of consecutive ED patients 
with CAP from a large multicentre antibiotic stewardship trial [1], 
we used adjusted multivariate regression models to determine the 
magnitude and statistical signifi cance of diff erences in mean baseline 
concentrations of fi ve biomarkers (procalcitonin (PCT), C-reactive 
protein (CRP), white blood cell count, proadrenomedullin (ProADM), 
copeptin) associated with six pre-analytic factors (antibiotic or 
corticosteroid pretreatment, age, gender, chronic renal failure or liver 
insuffi  ciency).
Results Of 925 CAP patients (median age 73 years, 58.8% male), 25.5% 
had antibiotic pretreatment, 2.4%, corticosteroid pretreatment, 22.3% 
chronic renal failure, and 2.4% chronic liver insuffi  ciency. Diff erences 
associated with pre-analytic factors averaged 6.1  ±  4.6%; the three 
largest statistically signifi cant changes (95% CI) were: PCT, +14.2% 
(+2.1 to +26.4%, P = 0.02) in patients with liver insuffi  ciency; ProADM, 
+13.2% (+10.2 to +16.1%, P <0.01) in patients with age above median; 
and CRP, –12.8% (–25.4 to –0.2%, P = 0.05) with steroid pretreatment.
Conclusion The infl uence of pre-analytic factors on the examined 
biomarkers is marginal and not clinically relevant. Our observations 
reinforce the concept of using biomarkers in algorithms with widely-
separated cutoff  values and overruling criteria considering the entire 
clinical picture, without adjustment for pre-analytic factors.
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Introduction The values of C-reactive protein (CRP) and procalcitonin 
(PCT) were investigated to determine their eff ects on postoperative 
complications in patients with or without systemic infl ammatory 
response syndrome (SIRS).
Methods In 183 patients, in a prospective observational study, serum 
CRP and PCT values were collected every day starting on postoperative 
day 1 through day 5. The defi nition of SIRS includes two or more of the 
following: temperature >38 or <36°C; heart rate >90 beats/minute; 
respiratory rate >20/minute; arterial carbon dioxide pressure <32 mmHg; 
white blood cell count >12,000/mm3 and <4.00/mm3. The ability of PCT to 
predict sepsis and other postoperative complications were determined 
by performing receiver operative characteristic curve analysis.
Results All patients were divided post hoc into patients with SIRS 
(Group 1, n = 83) and patients without SIRS (Group 2, n = 100). A PCT 
threshold value of 2.79  ng/ml on postoperative day 1 was able to 
discriminate postoperative complications in patients with or without 
SIRS with a sensitivity of 82.5% and a specifi city of 70% (area under 
curve: 0.76, P <0.01).
Conclusion (1) Serum PCT values increased signifi cantly after 
cardiopulmonary bypass in the SIRS group in comparison with patients 
without SIRS on postoperative day 1 and remain elevated until 
postoperative day 5. (2) Serum CRP values also follow a similar pattern, 
but a CRP threshold value was not obtained to diff erentiate between 
postoperative complications in patients with or without SIRS. A PCT 
threshold value of 2.79  ng/ml on postoperative day 1 is a valuable 
marker to discriminate between patients with or without SIRS.
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Introduction The occurrence of sepsis-induced immune suppression is 
associated with multiple organ dysfunctions, although the exact role of 
T-cell malfunction is obscure. We investigated the impact of sepsis on the 
adaptive immune system and to monitor T-cell receptor (TCR) diversity.
Methods TCR diversity was analyzed in peripheral blood mononuclear 
cells (PBMCs) isolated from septic shock patients at three time points 
(days 1, 3 and 7 after diagnosis of septic shock). TCR diversity was 
measured in genomic DNA isolated from PBMCs using the Human 
Immun TraCkeRb test (ImmunID Technologies, Grenoble, France) 
[1]. Multi-N-plex PCR was performed using a primer specifi c to a V 
gene family and several primers specifi c to J segments. The signal is 
measured as a function of the fl uorescence intensity of the reference 
marker. Rearrangement validation and map generation were detected 
and analyzed using the Constel’ID software (ImmunID Technologies). 
HLA-DR expression on CD14 cells was measured by fl ow cytometry.
Results TCR diversity was markedly decreased in septic patients at 
day 1 compared with healthy volunteers. A recovery of TCR diversity 
was observed at days 3 and 7 except for dead patients. HLA-DR 
expression was signifi cantly decreased in septic patients at day 1. The 
total lymphocyte count reduced in septic patients at day 1, but the 
lymphocyte count recovered at days 3 and 7 except for dead patients.
Conclusion We observed a lower TCR diversity and lymphopenia in 
the early stages of septic shock. A quick recovery of TCR diversity and 
lymphocyte count was observed in live patients. On the other hand, 
dead patients stayed on the lower level over the course of the study. 
These results suggest that altered TCR diversity and lymphopenia 
might participate in increased mortality and susceptibility to secondary 
nosocomial infections.
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Introduction The aim of this study was to analyze whether 
mitochondrial DNA haplogroups are associated with severe sepsis and 
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mortality after major surgery in European populations. Mitochondrial 
DNA (mtDNA) variants may play an important role for predicting 
clinical outcome in sepsis [1].
Methods We carried out a case–control study on 240 septic patients 
(severe sepsis or septic shock; Case group) and 267 patients with 
systemic infl ammatory response syndrome (SIRS; Control group). 
Furthermore, a longitudinal substudy for analyzing survival was 
performed in septic patients. mtDNA genotyping was performed by 
Sequenom’s MassARRAY platform.
Results Regarding cardiac surgery, patients with clusters JT and 
haplogroup J had higher likelihoods of sepsis than patients with 
clusters HV (OR = 2.76 (95% CI = 1.27; 6.02); P = 0.010) and haplogroup H 
(OR = 3.68 (95% CI = 1.17; 11.54); P = 0.026), respectively. No signifi cant 
association was found for abdominal surgery. When analyzing 
survival, 45.4% patients died with a survival median of 39 (95% CI  = 
31.4; 46.62) days. When the clusters were analyzed for all patients, 
41% (55/134) of patients within cluster HV died versus 71.4% (10/14) 
patients within cluster IWX (P  =  0.018). The adjusted Cox regression 
showed that patients within cluster IWX had a higher risk of dying 
than patients within cluster HV (hazard ratio (HR)  = 2.24 (95% CI  = 
1.10; 4.56); P = 0.027). No signifi cant association between haplogroups 
and mortality was found when patients were stratifi ed by the type of 
surgery.
Conclusion European mitochondrial haplogroups are associated with 
sepsis development in patients who underwent major cardiac surgery, 
but not in patients who underwent major abdominal surgery. Besides, 
mtDNA haplogroups also infl uence mortality. Haplogroups HV and H 
were related to low risk of sepsis and death, while JT and J were related 
to high risk of sepsis, and IWX was associated with death.
Reference
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Introduction Sepsis is associated with immune hyporesponsiveness 
but the immunological processes behind this are ill defi ned.
Methods This study quantifi ed diff erences in plasma concentrations 
of cytokines between septic patients with faecal peritonitis, age 
and gender-matched surgical patients (without sepsis) and age and 
gender-matched healthy participants. In addition, cytokine levels 
were measured in supernatant from peripheral blood mononuclear 
cells stimulated with anti-CD3 and anti-CD3+anti-CD28, incubated 
for 4 days. Cytokine concentrations of IL-1β, IL-5, IL-6, IL-8, IL-10, IL-13, 
IL-17A, IFNγ and TNFα were determined by multiplex cytometric bead 
array.
Results Plasma levels of IFNγ and IL-13 were lower in septic patients 
compared with healthy participants. In contrast, plasma levels of IL-6 
(see Figure  1) and IL-8 were increased in septic patients compared 
with both surgical patients and healthy participants. Plasma levels 
of IL-10 were signifi cantly higher only in comparison with surgical 
patients. Following incubation with anti-CD3 and anti-CD3+anti-CD28, 
concentrations of IL-1β, IL-5, IL-6 (see Figure  1), IL-13, IL-17A, IFNγ 
and TNFα were markedly decreased in samples from septic patients. 
In addition, stimulation with anti-CD3+anti-CD28 resulted in lower 
production of IL-10 in septic patients. Lower concentrations of IL-8 
were detected in septic patient samples stimulated with only anti-CD3. 
We found cytokine levels of IL-12p70 remained unaff ected across all 
groups and stimuli.
Conclusion We demonstrated a proinfl ammatory cytokine profi le 
in blood from septic patients, preceding a pan downregulation of 
all assessed cytokines following in vitro T-cell stimulation. To our 
knowledge, this study is the fi rst to perform an immune functional 
assay across these three groups.
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Introduction Activated protein C (APC) defi ciency is prevalent in severe 
sepsis and septic shock patients. The aim of the study was to relate 
the anticoagulation activity evaluated by APC with other coagulation 
parameters adjusted to 28-day mortality.
Methods A cohort study of 150 critically ill adults. Age, sex, sources 
of infection and coagulation markers within 24  hours from severe 
sepsis or septic shock onset, defi ned according to Surviving Sepsis 
Campaign (SSC) criteria, were studied. We analyzed APC activity using 
a hemostasis laboratory analyzer (BCS® XP; Siemens). A descriptive and 
comparative statistical analysis was performed using SPSS version 15.0 
(SPSS Inc., Chicago, IL, USA).
Results We analyzed 150 consecutive episodes of severe sepsis (16%) 
or septic shock (84%) admitted to the UCI. The median age of the study 
sample was 64 (interquartile range (IQR): 22.3  years; male: 60%). The 
main sources of infection were: respiratory tract 38%, intra-abdomen 
Figure 1 (abstract P225). Concentration of IL-6 in plasma on day 0 (a) and supernatant on day 4 (b).
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45%, and 70.7% had medical pathology. The 28-day mortality was 
22.7%. Nonsurvivors had a signifi cantly higher consumption of APC 
than survivors, 56% (IQR: 38.5) versus 68.6 (IQR: 41.4); P  =  0.023. The 
profi le of lower levels of APC was a surgery patient with septic shock, 
neurological focus or catheter-related infection and Gram-negative 
pathogens from blood cultures. Spearman’s showed relationship with 
antithrombin III, r = 0.674 (P <0.001) and International Normalized Ratio 
(INR), r = –0.611 (P >0.001). See Figure 1.
Conclusion Low levels of PC are associated with poor outcome and 
severity in severe sepsis, and it is well correlated with antithrombin III 
and INR.
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Introduction Flow-cytometric analysis is still restricted to cancer and 
immunocompromised patients. There are no clinical studies that 
evaluate the immunological changes in traumatic brain injury (TBI) 
patients. The objective of this study is to determine whether patients 
with severe TBI (GCS <9) manifest early (<48 hours after injury) signs 
of immunosuppression and whether this condition increases the 
incidence of infection during the ICU stay.
Methods We retrospectively analyzed data from 54 patients, including 
10 patients with isolated brain injury and 44 patients with brain and 
extracranial injuries. The fl ow-cytometric analysis was performed 
within 48 hours of trauma. Collected data are shown in Table 1.
Results Preliminary analysis is limited to descriptive statistics that show 
an immediate immunosuppression condition after TBI, as established 
by reduction of CD4+ T lymphocytes and CD8+ T lymphocytes. 
Signifi cant data are collected in Table 2.
Conclusion In severe TBI patients, an immunosuppression state is early 
developed. It is relevant to establish whether this condition could 
aff ect the course and prognosis of ICU patients.
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Introduction Each cell of the immune system shows a characteristic 
expression of cell surface molecules depending on the grade of 
activation or suppression. We examined the cell surface profi le on 
polymorphonuclear cells (PMN) of polytraumatized patients and 
compared them with those of healthy controls and furthermore with 
patients with severe sepsis or septic shock. Moreover, we wanted to 
fi nd out in the polytraumatized patients whether there are associations 
of PMN surface marker patterns with severity of injury, of disease and 
of organ dysfunctions.
Methods In a prospective observational study, cell surface expression 
of CD16, CD88, CD64, CD66b, CD11b, CD95, CD33, CD39, IL-17RA, TLR-
2, TLR-4 and HLA-DR on PMN was determined using fl ow cytometry. 
Thirteen healthy volunteers, eight patients with severe sepsis and 
Figure 1 (abstract P226). Relationship between activated protein C and antithrombin III and INR.
Table 1 (abstract P227). Collected data
Age (years), mean ± SD 55.43 ± 23.12
Sex (M/F) 44/10
Body mass index, mean ± SD 25.51 ± 2.69
ISS, mean ± SD 29.04 ± 26.57
RTS, mean ± SD 5.76 ± 1.53
TRISS, mean ± SD 68.73 ± 28.77
Admission SAPS II, mean ± SD 44.96 ± 14.87
Admission GCS, mean ± SD 7.63 ± 3.88
Flow-cytometric analysis day (days), mean ± SD 1.69 ± 3.34
Discharge GCS, mean ± SD 10.48 ± 3.19
ICU LOS, mean ± SD 10.67 ± 8.08
Table 2 (abstract P227). Flow-cytometric data
  Normal value
WBC (×109/l) 10.67 ± 4.82 4 to 10
Total lymphocytes (×106/l) 1,123.15 ± 547.02 1,200 to 3,000
CD3+ lymphocytes (×106/l) 67.11 ± 11.86 1,100 to 1,700
CD3+CD4+ lymphocytes (×106/l) 493.07 ± 313.92 600 to 1,400
CD3+CD8+ lymphocytes (×106/l) 250.65 ± 171.94 300 to 900
CD4+DR+ lymphocytes (×106/l) 23.19 ± 15.09 
CD8+DR+ lymphocytes (×106/l) 16.26 ± 20.83 
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septic shock, and longitudinally, on admission (0  hours), and 4, 12, 
24, 48, 120 and 240  hours thereafter, eight polytraumatized patients 
were monitored. ISS, SAPS3 and SOFA score refl ect severity of injury, of 
disease and of organ dysfunctions.
Results In polytraumatized patients (24  hours measurement), but also 
in septic patients, CD88+ expression and CD33+/CD66b– expression were 
signifi cantly lower and CD33–/CD66b+ higher than in healthy controls.
Especially, the lowest values of CD88+ occurred in patients with 
polytrauma developing septic complications.
Furthermore, the polytraumatized patients revealed higher levels of 
CD66b, CD11b and CD16, whereas CD16+ was lower. Considering the 
post-traumatic course, polytraumatized patients with better prognostic 
evaluation in SOFA and SAPS3 initially expressed higher levels of TLR-2. 
Polytrauma patients could be divided into two subgroups, one with and 
the other without septic complications. The septic subgroup presented 
predominantly higher values in SOFA, SAPS3 and ISS scoring.
Conclusion Cell surface molecules on PMN of polytraumatized patients 
diff er from those of healthy volunteers. Besides, distinct expression 
patterns resemble those of patients with sepsis. Patents with higher ISS 
values go along with higher scores in SOFA and SAPS3, and are at risk 
to develop septic complications.
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Introduction Lymphocytes show diff erent cell surface molecules 
depending on the degree of their activation or suppression. We used 
this surface expression to look at infl ammatory or infectious states in 
patients with polytrauma and patients with sepsis. The present study was 
performed to clarify: what is the expression profi le of lymphocyte surface 
markers in polytraumatized patients over time; and are there diff erences 
in the expression patterns of polytraumatized patients compared with 
healthy controls and with patients with severe sepsis and septic shock?
Methods In a prospective observational study in a surgical ICU, 
surface expression of CD3, CD4, CD8, IL7R, CD4/25, CD8/25, CD2/86, 
CD28, CD3/56, CD2, CD39, CD244, CD11b, and CD56 on lymphocytes 
was measured by fl ow cytometry. We collected data from six healthy 
controls, from eight patients with severe sepsis or septic shock, and, 
longitudinally from eight polytraumatized patients on admission 
(0 hours), and at 4, 12, 24, 48, 120, and 240 hours. ISS, SAPS 3 and SOFA 
score refl ect severity of injury, of disease and of organ dysfunctions of 
the polytraumatized patients.
Results In septic and polytraumatized patients, the expression 
of CD3, CD28 and CD2 was signifi cantly lower than in controls. 
In polytraumatized patients, surface expression of CD244, CD39 
and CD8/25 was signifi cantly higher than in controls. Within the 
polytraumatized patients, we found two diff erent subgroups, group 
A with septic progression and Group B without septic progression of 
disease. Especially, the septic polytraumatized patients revealed very 
low levels of CD3, CD2 and CD28. Moreover, their levels of CD39 and 
CD8/25 were less increased and their ISS higher than those of the 
nonseptic subgroup.
Conclusion Surface expression molecules of polytraumatized patients 
diff er from those of the healthy controls and within the group. The 
more heavily injured polytraumatized patients are more likely to 
develop severe sepsis and septic shock with surface expression profi les 
on lymphocytes comparable with those of septic patients.
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Introduction The aim of the study is to investigate the relationship 
between Cl:Na ratio disturbances and mortality in sepsis patients. 
Stewart’s strong ion theory can be used in the interpretations of acid–
base abnormalities [1]. The Cl:Na ratio is a simple alternative test that 
obviates the need to solve the complex strong ion gap (SIG) equations 
[2].
Methods A total of 434 sepsis and severe sepsis patients hospitalized 
in the ICU of two centers between 2006 and 2012 were included in 
the study. Three groups were formed as patients having low (<0.75), 
normal (>0.75 to <0.80) and high (>0.80) Cl:Na ratio within the fi rst 
24 hours in the ICU. Patients’ age, gender, APACHE II score, SOFA score, 
pH, PaCO2, HCO3, base excess, Na, K, Cl, Ca, lactate, strong ion diff erence, 
anion gap, length of ICU stay and mortality were recorded. Logistic 
regression analysis was used to calculate odd ratios and 95% CIs for the 
association of Cl:Na with mortality. In the fully adjusted model, pH, BE, 
AG, lactate and Cl:Na ratio were entered into the model. P <0.05 was 
considered statistically signifi cant.
Results The distribution of the patients was as follows: low Cl:Na (75, 
17%), normal Cl:Na (243, 56%), high Cl:Na (116, 27%). Univariate analysis 
revealed that in low and high Cl:Na ratio patients, mortality was higher 
by 1.56-fold (0.87 to 2.81) and 2.22-fold (1.36 to 3.61) (P  = 0.135 and 
P <0.01). In multivariate analysis, increased mortality by 1.95-fold (0.92 
to 4.12) and 2.02-fold (1.01 to 4.03) was found in low and high Cl:Na 
ratios (P = 0.081 and P = 0.046) (Figure 1).
Conclusion Stewart’s strong ion theory provides assessment for the 
etiology of acid–base disturbances. This evaluation can be performed 
easier and faster with the Cl:Na ratio. This study demonstrates that the 
disturbed Cl:Na ratio is associated with increased mortality in sepsis 
and severe sepsis patient groups.
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Introduction This study demonstrates that low level of plasmalogens 
(Pls) is an important marker of peroxisomal dysfunction. The primary-
OH group in glycerol Pls was not substituted by the acyl group (fatty 
acid) as in diacylphospholipids but by the aldehydogenic alkenyl group 
(fatty aldehyde) found in the form of vinyl ether [1]. It is known that 
there is disruption of several organ systems in diseases connected with 
peroxisomal dysfunction, as in the case of multiple organ failure.
Methods The objects of study were 18 people with multiple organ 
failure (35.6 ± 8.7 years) of various etiologies. The blood of 16 healthy 
Figure 1 (abstract P230). In the multivariate model, eff ect of Cl:Na ratio 
group was adjusted for pH, lactate, anion gap and base excess.
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volunteers aged 37.7  ±  3.2  years served as control. The preanalytical 
phase was to prepare a solution of ethyl esters of fatty acids (FAc) and 
diethylacetals of fatty aldehydes (FAl) of blood plasma samples by 
acidic ethanolysis. Analysis of FAl and FAc in plasma was carried out 
using capillary gas–liquid chromatography. Quantitative evaluation of 
the analytes was performed as a mass percentage of the FA and FAl 
amount. Statistical analysis was performed using the Mann–Whitney 
U test (P <0.05).
Results In contradistinction to triglycerides, diacylphospholipids and 
Pls participate in exchange of polyunsaturated fatty acids (PUFA) with 
a large number of double bonds, such as primarily arachidonic and 
docosahexaenoic PUFA, acting as an intermediate station, through 
which these fatty acids are transported to cell membranes [1]. Thus, the 
ratio of level of FAl to the level of aforementioned blood plasma PUFA 
may refl ect a change in the share of Pls relative to diacylphospholipids. 
According to our data, at MODS the ratio of fatty aldehydes to amount 
of arachidonic and docosahexaenoic PUFA is 0.16, while in the control 
group the fi gure is 0.27 (P <0.001). Thus, we can conclude that the level 
of Pls towards diacylphospholipid plasma levels of the experimental 
group decreased by approximately 40%. Currently, there is evidence 
that there is a reduction of cholesterol levels in blood plasma of patients 
with the diseases associated with peroxisome biogenesis disorders 
[2]. In our study, patients had low levels of plasma total cholesterol 
(124.6 ± 28.7 mg/dl), which may also indicate peroxisome dysfunction 
in MODS patients.
Conclusion On the basis of determined defi ciency of analyzed 
compound levels, we concluded the possibility of peroxysomal 
dysfunction in MODS.
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Introduction Acute alcohol exposure suppresses proinfl ammatory 
response, which may be related to increased susceptibility to 
infections [1].The purpose of the study was to investigate the eff ect 
of acute exposure to alcohol on TNFα production capacity and TNFα 
receptors (TNFRs) in an ex vivo model of whole-blood stimulation with 
lipopolysaccharide (LPS).
Methods Whole blood was taken from healthy volunteers and was 
placed in tubes containing EDTA and immediately transferred to the 
laboratory. Heparinized blood samples were diluted 1:10 in RPMI 1640 
culture medium (100  μl whole blood added in 900  μl RPMI 1640). 
Samples were preincubated with 0‚ 5‚ 12.5‚ 25‚ 50‚ 100 and 200  mM 
alcohol (EtOH) for 10 minutes at room temperature. After incubation, 
500  pg LPS was added to each sample for 4  hours at 37°C. At the 
end of the process, samples were centrifuged (1,800 rpm, 5 minutes, 
r.t.). Culture supernatants were collected and stored at –70°C until 
measurements. TNFα and TNFR levels were determined in culture 
supernatant using the ELISA method [2].
Results We studied 24 healthy males volunteers aged 36.5  ±  1.4 
(X ± SEM). TNFα was not detected in samples treated without alcohol 
in the absence of LPS stimulation (control) or in the presence of alcohol 
alone (data not shown). TNFα production was signifi cantly decreased 
at a dose of 25 mM alcohol after LPS stimulation (P <0.0001) compared 
with LPS-challenged samples (Figure  1A). Alcohol had no eff ect on 
TNFR I production when incubated with or without LPS (data not 
shown). Alcohol at lower doses (<50 mM) seemed to decrease TNFR II 
levels, but an increase in TNFR II levels was observed at higher doses 
(>50 mM) of alcohol, which was statistically signifi cant at doses of 100 
and 200 mM alcohol after LPS stimulation ex vivo (P <0.001) (Figure 1B).
Conclusion Our observations indicate a suppression of pro infl am-
matory response, but also a diff erential eff ect of alcohol on TNFR II 
production of whole blood in the presence of LPS challenge depending 
on the degree of alcohol intoxication.
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Introduction Neutrophils play a central role in eliminating bacterial 
pathogens, but may also contribute to end-organ damage. 
Interleukin-8 (IL-8), a key modulator of neutrophil function, signals 
through neutrophil specifi c surface receptors CXCR-1 and CXCR-2. 
Expression of these surface receptors can be altered by perfusion 
through an extracorporeal device. Extracorporeal methods of immune 
modulation have shown promise for treatment of sepsis; however, 
achieving an appropriate response is a major challenge [1]. In this study 
a mechanistic mathematical model was used to evaluate and deploy an 
extracorporeal sepsis treatment that modulates CXCR-1/2 levels.
Figure 1 (abstract P232).
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Methods A simplifi ed mechanistic mathematical model of IL-8-
mediated activation of CXCR-1/2 receptors was developed. 
Receptor-level dynamics and systemic parameters are coupled with 
multiple neutrophil phenotypes to generate dynamic populations 
of activated neutrophils that reduce pathogen load, and/or primed 
neutrophils that cause adverse tissue damage when misdirected. The 
mathematical model was calibrated using experimental data from 
baboons administered a 2-hour infusion of E. coli and followed for a 
maximum of 28 days. An extracorporeal intervention was implemented 
by introducing a trapped receptor state that limits IL-8 signaling 
through CXCR-1/2. Time of onset, duration, and capture effi  cacy of 
the extracorporeal device were explored to provide probabilistic 
predictions of the impact on mortality.
Results Of 16 baboons, 11 (69%) died, six (38%) within 1  day of 
bacterial infusion. The model was well calibrated to the data from 
survivors and nonsurvivors. Sensitivity analysis identifi ed six model 
parameters, out of 21, as key determinants of mortality. Predictions 
indicate best eff ect with introduction of the proposed extracorporeal 
intervention within 1 hour of infection for a 72-hour duration, results 
in the survivor population increasing from 31% to 61%. The treatment 
can result in harm if initiated <10 hours from infection and continued 
<24  hours. A delay of 10  hours increases survival by 7% on average. 
Treatment effi  cacy quickly diminishes if not introduced within 15 hours 
of infection.
Conclusion These fi ndings support the continued development of 
an extracorporeal treatment that modulates CXCR-1/2 levels. Further 
development of the mathematical model will help guide device 
development and determine which patient populations should be 
targeted by treatment.
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Introduction Besides cortisol, prolactin might also be important in 
maintaining normal immune response in stress states. Its role in the 
hypothalamus–pituitary–adrenal axis hormonal and immune stress 
response in sepsis has hardly been investigated in a critically ill setting. 
The aims of the study were to evaluate the early (fi rst 48 hours) ACTH, 
cortisol and prolactin plasma levels in ICU patients with severe sepsis/
septic shock (SS) or systemic infl ammatory response syndrome (SIRS) 
compared with healthy control subjects (C) and to correlate their 
expression with heat shock proteins (HSPs), interleukins (ILs) and 
outcome.
Methods Thirty consecutively admitted patients with SS, 22 with SIRS, 
and 15 C were enrolled in the study. Patients’ demographics, laboratory 
examinations, and APACHE II, SOFA and SAPS III scores were recorded 
on ICU admission. Blood sampling was performed between 9:00 and 
10:00  a.m. Prolactin and cortisol were measured using the ADVIA 
centaur system, ACTH using the Immulite 2000. Intracellular monocyte 
HSP (iHSP) was determined after staining with surface antigens CD33– 
PE/Cy5 and CD45 PE/Cy7 followed by either HSP72-FITC or HSP90a-PE 
intracellular staining (four-color fl ow cytometry). Mean fl uorescence 
intensity values for each HSP were noted and analyzed. ELISA was used 
to determine extracellular (e) HSP, IL-6 and IL-10 levels.
Results Prolactin (P  <0.034), cortisol (P  <0.0001), and ACTH (P  <0.02) 
levels diff ered among groups. Prolactin, cortisol, IL-6, and eHSP90 were 
higher in SS (P  <0.03) and SIRS (P  <0.04) compared with C. Cortisol 
and eHSP90 were higher in SS compared with SIRS (P <0.005; P <0.03); 
iHSP72 and iHSP90 were higher in SIRS compared with SS (P  <0.05; 
P <0.05) or C (iHSP72, P <0.02). Cortisol related with eHSP90 (r = 0.45, 
P <0.02), lactate (r = 0.33, P <0.02) and HCO3 (r = –0.45), and prolactin 
with SAPS III (r = 0.34, P <0.02), but not with mortality or LOS.
Conclusion Prolactin seems to be a stress hormone, probably related to 
the severity of illness, increased along with IL-6 and eHSP90 levels in SS. 
Also in these patients, cortisol correlates to lactate and eHSP90, but in 
contrast to SIRS the iHSP72 and iHSP90 immune response is depressed.
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Introduction Organ injury is a hallmark of sepsis, in particular acute 
kidney injury (AKI). Yet the mechanisms involved in sepsis-induced 
AKI are not well understood. Energy prioritization is an important 
cell defense mechanism, and thus we hypothesized that exogenous 
activation of AMP-protein kinase (AMPK), a master regulator of cellular 
energy metabolism, protects against sepsis-induced AKI.
Methods Sixty C57BL/6 male mice, 6 to 8 weeks of age, weighing 20 to 
25 g were divided into six groups: 1, cecal ligation and puncture (CLP); 
2, CLP+AICAR (AI, AMPK activator, 100 mg/kg 24 hours before CLP); 3, 
CLP+compound C (AMPK inhibitor, 30 mg/kg; CoC); 4, sham; 5, sham+AI; 
6, sham+CoC. Blood/tissue samples were collected 8 hours after CLP. 
Renal function (creatinine (Cr, mg/dl), BUN (mg/dl) and cystatin C (CysC, 
ng/ml)), cytokine expression (ELISA), endothelial activation (ICAM-
1 expression), neutrophil adhesion (PMN, fl uorescence, anti-CD11b 
mAb-tagged PMNs) and vascular leak (Evan’s blue) were assessed. 
The eff ect of AI given 4 hours (n = 12) before and 2 hours after (n = 11) 
CLP was also evaluated. The experiment was reproduced in vitro using 
cell culture (renal epithelial, endothelial cells and macrophages), with 
similar groups: 1, control; 2, control+AI (1 mM/1 hour pre LPS); 3, LPS 
(100  ng/ml for 4  hours); 4, LPS+AI; 5, control+CoC (10  μM/1  hour 
pre LPS); 6, LPS+CoC. Cytokines were measured with ELISA. Data are 
presented as mean ± SD and as LPS/CLP and LPS/CLP+AI.
Results AI prevented Cr, BUN and CysC from increasing after CLP 
(0.43 ± 0.18, 0.2 ± 0.02, P = 0.0003; 62.2 ± 10.8, 43.7 ± 17.7, P = 0.01; 
103.9  ±  54.8, 49.3  ±  30.8, P  =  0.01, respectively). AICAR decreased 
cytokine release after CLP (IL-6: 1,818 ± 344 vs. 1,374 ± 268, P = 0.04; IL-
10: 7,592 ± 5,038 vs. 2,245 ± 2,668, P = 0.05; TNFα: 213 ± 172 vs. 39 ± 16, 
P = 0.03) and LPS in macrophage culture (IL-6: 241.7 ± 1.5 vs. 7.2 ± 1.5, 
P = 0.055; TNF: 1,882 ± 583 vs. 82 ± 28, P = 0.04). However, AI lost its 
protective signal when administered 4 hours pre or 2 hours after CLP 
(Cr CLP vs. CLP+AI: 0.2 vs. 0.2, P = 0.1 and 0.45 ± 0.3 vs. 0.56 ± 0.3, P = 0.5, 
respectively). AI also decreased ICAM-1 expression in vivo and in vitro, 
vascular leak (0.09 ± 0.01 vs. 0.06 ± 0.008, P = 0.003) and PMN adhesion 
(1,055 ± 179 vs. 751 ± 242, P = 0.04).
Conclusion AMPK activation by AICAR prevented sepsis-induced AKI. 
AICAR decreased cytokine release, endothelial activation and vascular 
leak, suggesting that organ protection may be mediated by modulation 
of the infl ammatory response and protection of the microvasculature. 
However, AICAR’s protective eff ect may be conditional to timing of 
administration.
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Introduction Immunological status is diff erentiated with age, 
infl uencing treatment and outcome [1]. The aim is to determine the 
immune response of severely traumatized older patients compared 
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with a group with arterial disease, expressed by proinfl ammatory 
cytokine release after ex vivo whole-blood LPS stimulation [2].
Methods The study comprised 16 polytrauma patients admitted to 
the ICU, aged 78 ± 8 (Group I) and 16 with arterial disease, aged 74 ± 5 
(Group II). Ten milliliters of peripheral blood were collected from each 
patient, divided into two tubes with/without anticoagulant. Diluted 
1:10 whole-blood samples were stimulated with 500  pg/ml LPS, at 
37°C, for 4  hours. Serum and cell culture supernatants (CCSP) were 
removed and stored at –70°C. TNFα and IL-6 were measured in serum 
and CCSP by ELISA.
Results Serum proinfl ammatory cytokines were signifi cantly elevated 
after severe trauma against control group (TNFα, P  <0.001 and IL-6, 
P  <0.001). Ex vivo cytokine release showed the opposite direction. 
There was a signifi cantly lower TNFα and IL-6 release for Group I (TNFα, 
P <0.05 and IL-6, P <0.01) compared with Group II. TNFα ex vivo release 
from the samples of Group II was >300 pg/ml. See Figures 1 and 2.
Conclusion Older patients showed adequate immunological 
response, considering the limit of 300 pg/ml. The incidence of severe 
trauma was involved in the downregulation of immune activity and 
should be considered. Group I patients do not have the opportunity 
to precondition their immune status. Group II patients can better 
compensate operative therapies.
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Introduction Patients with multiple injuries are prone to hospital-
acquired infections. We hypothesized that exposure to multiple injuries 
may modulate the innate immune response and the subsequent 
outcome of infections.
Methods Ninety-seven C56Bl6 male mice were subject to multitrauma 
after crush of the femur and chemical pneumothorax by turpentine. 
Mice surviving 72  hours after the injuries were challenged 
intravenously with one 7log10 log-phase inoculum of P. aeruginosa and 
survival was recorded. In separate experiments, mice were sacrifi ced 
post injury; splenocytes were isolated and stimulated with 10  ng/
ml LPS and cytokines were measured in supernatants by an enzyme 
immunoassay. Quantitative cultures of the right lung, kidney and liver 
were performed. The same procedures were done for sham-operated 
mice and for mice subject only to femur crush and to pneumothorax.
Results Initial experiments with 21 mice showed that the overall 
death rate for this model of multitrauma was 66.7% with most deaths 
occurring in the fi rst 48  hours. In the second set of experiments, 
12 mice remaining alive 72  hours post injury were challenged with 
P.  aeruginosa; mortality was 37.5% compared with 75% of 12 non-
injured and infected mice (log-rank: 5.77, P = 0.016). Respective mean 
production of TNFα from splenocytes isolated at sacrifi ce 24 hours and 
96 hours post sham injury was 651 and 523 pg/ml (P = NS); post femur 
crush 217 and 916  pg/ml (P  =  0.010); post pneumothorax 286 and 
1,056 pg/ml (P = 0.018); and post both femur crush and pneumothorax 
207 and 1,011 pg/ml (P = 0.019). Respective mean production of IFNγ 
from splenocytes isolated at sacrifi ce 24  hours and 96  hours post 
sham injury was 324 and 230 pg/ml (P  =  NS); post femur crush 278 
and 840 pg/ml (P = 0.021); post pneumothorax 377 and 2,356 pg/ml 
(P  =  0.025); and post both femur crush and pneumothorax 252 and 
908 pg/ml (P = 0.019). Mean production of TNFα from splenocytes of 
injured mice sacrifi ced 24 hours after bacterial challenge was 1,184 pg/
ml compared with 484 pg/ml non-injured and infected mice (P = 0.024). 
Similar diff erences were not found for IFNγ or for quantitative tissue 
cultures. See Figure 1.
Conclusion Mice survivors from multiple trauma become resistant 
to subsequent infection. This is probably linked with the induction of 
tolerance of the innate immunity to substances released after sterile 
tissue injury.
P238
Does clopidogrel change morbidity and mortality in ICU sepsis 
patients?
DG Klepser, PP Dobesh, TR McGuire, DA Roberts, AL Himmelberg, 
KM Olsen
University of Nebraska Medical Center College of Pharmacy, Omaha, NE, USA
Critical Care 2014, 18(Suppl 1):P238 (doi: 10.1186/cc13428)
Introduction The purpose of this study was to evaluate whether 
patients with sepsis exposed to clopidogrel have lower mortality and 
fewer days on mechanical ventilation compared with patients not 
exposed to clopidogrel. A recent post-hoc analysis of the PLATO trial 
suggests that the antiplatelet agent ticagrelor provided a signifi cant 
Figure 1 (abstract P236). Serum proinfl ammatory cytokines in older 
patients.
Figure 2 (abstract P236). Ex vivo proinfl ammatory cytokine release after 
whole-blood LPS stimulation in older patients.
Figure 1 (abstract P237). Cytokine stimulations after sterile injury.
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reduction in sepsis-related mortality and pulmonary adverse events 
compared with clopidogrel. It is unknown whether clopidogrel 
also provides benefi t in patients with sepsis compared with no 
therapy. Knowing this information may help focus future research on 
determining the mechanism of ticagrelor’s benefi t.
Methods This retrospective cohort study included all patients over 
the age of 40 with a confi rmed diagnosis of severe sepsis and an ICU 
stay at our academic medical center from 1 January 2005 to 31 March 
2011. Clopidogrel use, patient demographics, and APACHE II score at 
the time of sepsis were collected from patient charts. Clinical outcomes 
included in hospital mortality, development of acute respiratory 
distress syndrome (ARDS), days on mechanical ventilation, in-hospital 
cardiac events, hospital cost, and length of stay.
Results We identifi ed 824 patients who met the inclusion criteria for this 
study. Of these patients, 76 (9.2%) had been exposed to clopidogrel. 
The mean APACHE II score was similar for patients receiving clopidogrel 
and those who did not (23.4 vs. 22.6; P = 0.426). Patients exposed to 
clopidogrel had a similar rate of in-hospital mortality (26.3% vs. 33.2%; 
P = 0.223) and ARDS (43.4% vs. 38.6%; P = 0.415). While mortality was 
also similar between the groups for patients with a low APACHE II 
score (<25), mortality was lower in clopidogrel-exposed patients with 
an APACHE II score ≥25 (27.3% vs. 45.6%; P = 0.045). Patients exposed 
to clopidogrel did not have a higher use of blood products (65.8% 
vs. 65.9%; P  =  0.983). Patients exposed to clopidogrel did not have 
signifi cantly more days on mechanical ventilation, or ventilation-free 
days. Cardiac events during the hospital stay were not lower in patients 
on clopidogrel (4.0 vs. 2.4; P = 0.432). Hospital costs and length of stay 
did not diff er between the groups.
Conclusion While clopidogrel may not increase the risk of bleeding in 
these patients, these data suggest that clopidogrel does not reduce 
adverse outcomes in patients with sepsis. A potential benefi t in patients 
with APACHE II scores ≥25 may need further study. Future research into 
the mechanism of ticagrelor’s benefi t reported in the PLATO trial may 
be directed at the non-P2Y12 receptor mechanism.
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Continuous administration of corticosteroids in septic shock can 
reduce risk of hypernatremia
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Institute of Endocrinology, Bucharest, Romania; 3Elias University Emergency 
Hospital, Bucharest, Romania
Critical Care 2014, 18(Suppl 1):P239 (doi: 10.1186/cc13429)
Introduction Although the administration of hydrocortisone in septic 
shock generates adverse eff ects, the risk of corticosteroid-induced 
hypernatremia may be reduced by continuous administration of the 
drug [1,2].
Methods A total of 171 patients with septic shock were randomized 
into three study groups: group A (n = 58), 200 mg/day hydrocortisone 
hemisuccinate in four doses; group B (n  = 59), same dose of 
hydrocortisone hemisuccinate in continuous administration; group C 
(n = 54), no hydrocortisone hemisuccinate. Mean serum sodium values, 
the number of hypernatremia episodes and variations in serum sodium 
(Na var) were investigated for 7  days. The local ethics committee 
approved the study.
Results There were no diff erences between the three groups at 
the beginning of the study regarding demographic data and the 
clinical characteristics. Mean values of natremia were normal in 
group C (140.35  ±  7.390  mEq/l to 144.79  ±  8.338  mEq/l) during 
the study period. High mean values appeared on day 4 in group A 
(147.21 ± 8.470 mEq/l to 149.37 ± 8.973 mEq/l on day 7) and on day 5 
in group B (146.36 ± 8.272 mEq/l to 147.70 ± 8.865 mEq/l). Na var was 
8.59 ± 5.960 mEq/l (–8 and 21 mEq/l) in group A, 6.63 ± 7.609 mEq/l (–17 
and 23 mEq/l) in group B and 4.54 ± 7.455 mEq/l (–12 and 22 mEq/l) 
in group C. This variation is statistically signifi cant when groups A and 
B are compared with group C (P  =  0.012) and when only group A is 
compared with group C (P  = 0.0019). The risk of hypernatremia after 
hydrocortisone hemisuccinate was almost three times higher than 
that of patients who did not receive this drug (RR 2.82, 1.35 <OR <5.90, 
P = 0.0041) and slightly higher when HHS was delivered as a bolus (RR 
3.08, 1.32 <OR <7.25, P = 0.0071).
Conclusion Continuous administration of hydrocortisone hemi-
succinate in septic shock is associated with a lower risk of hypernatremia 
than bolus administration.
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Introduction The aim of this study was to determine the correlation 
between regional tissue oxygenation (SrO2) measured by near-infrared 
spectroscopy (NIRS), central venous oxygen saturation (SvO2) and 
levels of serum lactate (SL) in patients with severe sepsis.
Methods An observational pilot study was performed in an ICU of a 
medium-sized teaching hospital. Adult patients admitted with severe 
sepsis were included and three NIRS electrodes were attached: on the 
left side of the forehead (LF), the right side of the forehead (RF) and 
the right forearm (RA). SL and SvO2 measured in a jugular or subclavian 
central venous line sample were determined every 4 hours. Descriptive 
statistics were calculated. Pearson correlation coeffi  cients (PCC) were 
calculated between SrO2, SvO2 and SL. Normal values for SrO2 were 
defi ned as the median  ±  1 interquartile range in patients with SL 
<1.7 mmol/l. Diff erences between groups were calculated by Pearson 
chi-square tests. P <0.05 was considered statistically signifi cant.
Results Twenty-fi ve patients (12 men) were included. Mean age was 
68  years, mean APACHE score 31. The most frequent reasons for ICU 
admission were abdominal sepsis (n = 11) and pneumosepsis (n = 7). 
Statistically signifi cant correlations were found between SvO2 and SrO2: 
PCC SrO2 LF, 0.46; PCC SrO2 RF, 0.50; PCC SrO2 RA, 0.21. Low, although 
statistically signifi cant, correlations were found between SrO2 and 
SL: PCC SrO2 LF, –0.16; PCC SrO2 RF, –0.15; and PCC SrO2 RA, –0.20. 
Calculated normal values for SrO2 LF were 60 to 80%, for SrO2 RF were 
60 to 76% and for SrO2 RA were 64 to 84%. An out-of-range SrO2 had 
a high positive predictive value (PPV) for an increased SL. The PPV for 
out-of-range SrO2 LF was 85% versus 58% for normal SrO2 LF (OR 4.27; 
95% CI 2.09 to 8.72), the PPV for out-of-range SrO2 RF was 77% versus 
60% for normal SrO2 RF (OR 2.32; 95% CI 1.25 to 4.31) and the PPV for 
out-of-range SrO2 RA 75% versus 60% for normal SrO2 RA (OR 1.94; 95% 
CI 0.95 to 4.00).
Conclusion This pilot study shows a statistically signifi cant correlation 
between SvO2 and SrO2 in patients with severe sepsis. An out-of-range 
SrO2 LF or RF had a high predictive value for increased serum lactate. 
We therefore conclude that NIRS could have a role in goal-directed 
therapy of patients with severe sepsis.
P241
Delayed admission to the ICU is associated with increased 
in-hospital mortality in patients with community-acquired severe 
sepsis or shock
A Schnegelsberg, J Mackenhauer, M Pedersen, H Nibro, H Kirkegaard
Aarhus University Hospital, Aarhus C, Denmark
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Introduction The aim of this study is to determine whether ward 
transfers causing delayed ICU admission are associated with increased 
in-hospital mortality in patients with community-acquired severe 
sepsis or shock. Community-acquired infections are among the leading 
causes of ICU admission [1]. The 30-day mortality for adult emergency 
department (ED) patients with a delay in ICU admission of up to 
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24  hours has been found to be signifi cantly higher compared with 
patients admitted directly to the ICU from the ED [2].
Methods A retrospective cohort study of patients admitted with 
community-acquired sepsis to a 12-bed, tertiary ICU at a university-
affi  liated teaching hospital, November 2008 to October 2010. Patients 
were divided into two groups based on their ICU admission pattern: 
direct transfer from the ED (direct group); and one or more ward 
transfers between the ED and ICU within 48 hours (delayed group). Our 
primary outcome measure was mortality.
Results We identifi ed 277 patients admitted to the ICU within 48 hours 
from arrival in the ED. Of these, 186 were admitted directly from the 
ED, and 91 patients had more than one ward transfer between the 
ED and the ICU. In-hospital mortality in the delayed group was 32% 
compared with 21% in the direct group (P  =  0.0477). Patients with 
delayed admission had signifi cantly lower APACHE II scores: 21 (16; 26) 
and 24 (18.75; 31) respectively (P  =  0.0016). The in-hospital LOS was 
similar in the two groups. For patients in the delayed group, we found a 
trend toward increased 30-day mortality (P = 0.0723), 90-day mortality 
(P = 0.0838) and higher Charlson Comorbidity Index (P = 0.0609).
Conclusion We found that patients admitted with community-
acquired severe sepsis or shock are more likely to die in-hospital if they 
experience redundant ward transfers within 48  hours of admission. 
However, the delayed group was signifi cantly lower risk stratifi ed in the 
ICU based on their APACHE II score. Identifi cation of severe sepsis and 
risk assessment in the ED is crucial for patient outcome.
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Introduction A recent randomized trial of our group showed that 
blind treatment with clarithromycin decreased mortality from septic 
shock and multiple organ dysfunction, shortened time until resolution 
of infection in patients with severe sepsis/shock and decreased 
hospitalization costs [1]. The effi  cacy of clarithromycin in relation with 
the type of failing organs is analyzed.
Methods Six hundred patients with systemic infl ammatory response 
syndrome due to primary Gram-negative bacteremia or acute 
pyelonephritis or intraabdominal infection were blindly assigned to 
placebo or clarithromycin for four consecutive days as adjunctive 
treatment to standard of care. Clarithromycin was administered at a 
dose of 1 g once daily in 1 hour of continuous infusion. Organ failures 
before allocation to blind treatment were defi ned according to the 
Surviving Sepsis Campaign 2003 defi nitions. Cox regression analysis 
was done to verify the eff ect of clarithromycin as a moderator. Hazard 
ratios (HRs) and 95% confi dence intervals (CIs) were calculated.
Results Forty-nine patients of the placebo arm and 55 patients of the 
clarithromycin arm had acute lung injury (ALI); mortality was 51.0% 
and 30.9% respectively (P = 0.046). Forty-seven patients of the placebo 
arm and 54 patients of the clarithromycin arm had acute coagulopathy; 
mortality was 44.7% and 44.4% respectively (P  =  1.000). Twenty 
patients of the placebo arm and 19 patients of the clarithromycin arm 
had metabolic acidosis; mortality was 55.0% and 52.6% respectively 
(P = 1.000). Twenty-nine patients of the placebo arm and 39 patients 
of the clarithromycin arm had acute oliguria; mortality was 55.2% 
and 48.7% respectively (P  =  0.631). ALI (HR  = 2.42; 95% CI  = 1.45 to 
4.03, P = 0.001), acute coagulopathy (HR = 2.65; CI = 1.69 to 4.16) and 
cardiovascular failure (HR = 3.36, CI = 2.09 to 5.39) were independently 
associated with unfavorable outcome. Adding treatment with 
clarithromycin in the equation reduced the risk for death by ALI by 
1.86-fold (HR = 0.54; CI = 0.29 to 0.99, P = 0.049).
Conclusion Clarithromycin is a major moderator of the physical course 
of Gram-negative sepsis complicated with ALI.
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Introduction Recombinant human soluble thrombomodulin (rhTM) 
demonstrated promising evidence suggestive of effi  cacy in a phase 
IIb, randomized, controlled trial [1] and is currently under evaluation 
in a phase III trial. However, the benefi t profi les of rhTM have not been 
elucidated. The purpose of this study was to explore whether patients 
with a high disease severity (according to Acute Physiology and 
Chronic Health Evaluation (APACHE) II and Sequential Organ Failure 
Assessment (SOFA) scores) might have a treatment benefi t from rhTM 
administration.
Figure 1 (abstract P243). Estimated survival curves for each of three disease severities.
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Methods This was a post-hoc, subgroup analysis of a multicenter 
retrospective cohort study [2] conducted in three tertiary referral 
hospitals in Japan. All patients with sepsis-induced DIC who required 
ventilator management were included. We stratifi ed all patients with 
diff erent disease severity, as defi ned by APACHE II and SOFA scores 
to three strata. Intervention eff ects estimated as hazard ratios were 
analyzed by Cox regression analysis adjusted for propensity model to 
detect subgroup heterogeneity of the eff ects of rhTM on in-hospital 
mortality.
Results Eligible were 162 patients with sepsis-induced DIC; 68 patients 
received rhTM and 94 did not. After adjusting for imbalances, rhTM 
administration was signifi cantly associated with reduced mortality only 
in patents in the stratum II group (APACHE II, 22 to 27) (adjusted hazard 
ratio, 0.20; 95% confi dence interval, 0.05 to 0.74; P = 0.016), while not 
signifi cant in stratum I and stratum III (Figure 1). A similar tendency was 
observed in analysis for SOFA score (stratum I (SOFA, –10), P = 0.368; 
stratum II (SOFA, 11 to 12), P = 0.012; stratum III (SOFA, 13–), P = 0.673).
Conclusion A survival benefi t with rhTM treatment was observed 
in sepsis-induced DIC and a high risk of death according to baseline 
APACHE II and SOFA scores.
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Introduction Interventional trials for sepsis have not shown an 
improvement in patient outcomes, often due to the lack of a diagnostic 
gold standard resulting in large heterogeneity of the patients enrolled. 
Electronic health record (EHR) screening tools have been applied to 
the sepsis population but limited to vital sign and laboratory data to 
identify target patients. Our objective was to describe an investigational 
database created through the application of a new EHR screening tool 
that applies natural language processing (NLP) analysis to clinical 
documentation to augment the identifi cation of infection.
Methods We acquired data from the Clinical Vigilance for Sepsis 
EHR screen on consecutive patients from two hospital systems over 
12 months at a 300-bed community hospital and 24 months from a 500-
bed academic tertiary care center. A physician order for intravenous 
antibiotics was used as a surrogate for suspected infection, removing 
patients receiving a single dose of antibiotics without subsequent 
administration. Each patient’s in-hospital course was tracked from 
arrival to fi nal disposition, identifying vital signs, laboratory values, 
radiological results, and interventions as they occurred. Patients 
were followed for the primary outcome of mortality, with secondary 
outcomes of transfer to the ICU, vasopressor initiation and mechanical 
ventilation.
Results The EHR screen identifi ed 216,550 patients over a total of 
36  months from the two hospitals. A total of 37,160 (17%) patients 
were treated with i.v. antibiotics. Sepsis patients experienced a 3% 
(1,186/37,160) mortality rate relative to 0.5% (448/216,550) in patients 
without infection at any time. Sepsis at any time represented 73% 
(1,186/1,634) of all in-hospital deaths. ICU transfer occurred in 18% 
(6,865/37,160) of patients, with septic shock (vasopressor requirement) 
occurring in 10% (3,837), and 13% (5,072) requiring mechanical 
ventilation.
Conclusion Application of this novel EHR screening tool to identify 
sepsis patients utilizes NLP applied to clinical documentation, providing 
greater clinical context than laboratory and vital sign screening alone. 
This database represents the entire sepsis acuity spectrum, allowing 
for a more granular description of the infectious process as well as 
subgroups with adequate sample size. The dataset collected as a 
patient-centered time series will enable future studies to focus on the 
trajectory of clinical deterioration and shock before its occurrence.
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Introduction The hospital survival rate for patients with septic shock 
remains at approximately 50% [1]. Critically ill cancer patients have 
often been considered poor candidates for ICU management due to 
the perception of poor outcomes for this group, in particular in the 
presence of neutropenia. There is a paucity of data supporting this. The 
objective of this study was to describe clinical outcomes for a group of 
septic neutropenic patients admitted to a cancer ICU.
Methods All neutropenic patients (neutrophils <1,000/mm3) admitted 
to the ICU at the Royal Marsden hospital (London, UK) between October 
2010 and December 2012 with a diagnosis of severe sepsis/septic 
shock were included retrospectively. Data were collated from patients’ 
electronic records after approval by the hospital audit committee. Data 
are presented as the absolute value (%) or median (IQR). Fisher’s exact 
test or the Mann–Whitney U test was used as appropriate.
Results Sixty-four neutropenic patients were admitted to the ICU 
during this period. Forty-seven (73%) patients survived to ICU discharge 
and 34 (53%) patients to hospital discharge. Twenty-two (34%) patients 
were alive at 6 months and 18 (28%) patients were alive at 12 months. 
Seventy-seven percent of patients had microbiologically documented 
infections. There was no signifi cant diff erence between ICU survivors 
and nonsurvivors in duration of neutropenia, the presence of, or 
removal of, indwelling catheters, or the source of sepsis. Mechanical 
ventilation and need for vasopressors were associated with worse 
outcomes. Patient characteristics are presented in Tables 1 and 2.
Table 1 (abstract P245). Patient characteristics
 ICU survivors ICU nonsurvivors
n 47 (73%) 17 (27%)
Age (years) 53 (38 to 65) 49 (33 to 62)
BM transplant 24 (51%) 7 (41%)
Table 2 (abstract P245). Characteristics on admission to the ICU
 ICU survivors ICU nonsurvivors
Neutrophil count 0.5 (0.3) 0.2 (0.3)*
Days of neutropenia 3 (0 to 8) 6 (0 to 19)
*P <0.05.
Conclusion In a group of oncology patients admitted to the ICU with 
neutropenia and severe sepsis/septic shock, we found an in-hospital 
mortality of less than 50%. This is similar to the general population.
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Introduction Vitamin D, a secosteroid hormone, has roles in the 
optimal functioning of many organ systems and illnesses [1]. Recent 
reports show that most patients admitted to the ICU are vitamin D 
insuffi  cient [2].
Methods In a 10-bed general ICU at the emergency department of a 
tertiary teaching hospital in Florence (Italy), 71 medical patients with 
severe sepsis or septic shock (51% men, 40% women) admitted to the 
ICU between January 2013 and September 2013 were studied. Vitamin 
D levels were measured by radioimmunoassay at admission, as well 
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as demographic data (Table  1) and the Simplifi ed Acute Physiology 
Score II (SAPS II). Exclusion criteria were: age <18  years, malnutrition 
state (body mass index (BMI) <18 kg/m2), pregnancy. Statistical analysis 
was carried out by linear regression and t test with SPSS 13. This study 
was approved by the Internal Review Board. Informed consent was 
obtained.
Results Most patients showed vitamin D levels below 20  ng/ml, and 
we have not demonstrated a statistical signifi cance correlation in 
the univariate regression between vitamin D level and both SAPS 
(P = 0.300) or length of stay in hospital (P = 0.154). Also our data do not 
demonstrate a statistical signifi cance diff erence at t test between the 
value of vitamin D in the dead group and the alive group.
Conclusion Several groups have reported an inverse association 
between vitamin D levels in critically ill patients, severity of disease, 
outcome length of ICU stay and mortality [3,4]. In our experience we 
have not found an evident correlation between low vitamin levels and 
ICU outcomes. However, considering the prevalence of low vitamin D 
levels among the medical patients admitted to the ICU, further studies 
should be performed.
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Introduction Benefi cial eff ects of 3-hydroxy-3-methylglutaryl 
coenzyme A (HMG-CoA) reductase inhibitors (statins) on vascular 
diseases have been demonstrated in several clinical trials. Recently 
discovered anti-infl ammatory eff ects of statins seem to have an 
important role in counteracting the harmful eff ects of sepsis on the 
coagulation system. Many epidemiologic studies evidence that statin 
treatment may be associated with a better prognosis in severe bacterial 
infections, and a recent randomized trial found a reduced mortality 
in the statin group. We decided to perform a meta-analysis of all 
randomized controlled trials ever performed on statin therapy in septic 
patients to evaluate their eff ect on survival.
Methods Four trained investigators searched and assessed pertinent 
studies in BioMed Central, PubMed, Embase and the Cochrane Central 
Register (divergences resolved by consensus). Inclusion criteria 
were: random allocation to treatment; comparison of statins versus 
any comparator in septic patients. Exclusion criteria were: duplicate 
publications; nonadult studies; no data on main outcomes.
Results Data from 650 patients in fi ve randomized controlled studies 
were analyzed. Overall analysis showed no diff erence in mortality 
between patients receiving statins (44/322 (14%)) versus control 
(50/328 (15%)), RR = 0.90 (95% CI 0.65 to 1.26), P = 0.6.
Conclusion Scientifi c evidence for the role of statins in septic patients 
is still limited and larger randomized trials should be performed on this 
topic. Published data, summarized by this meta-analysis of randomized 
trials, show that statin therapy has no detrimental eff ect on survival in 
the overall population of adult septic patients.
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Introduction We hypothesize that the early administration of thrombo-
modulin alfa (TM-alfa) (Recomodulin® injection; Asahi Kasei Pharma 
Corporation, Tokyo, Japan) could improve mortality in patients with 
sepsis-induced disseminated intravascular coagulation (DIC). TM-alfa 
has been approved for use as a curative medicine for DIC in Japan from 
2008 that was examined in a multicenter, randomized, clinical trial [1].
Methods DIC was diagnosed based on the Japanese Association 
for Acute Medicine (JAAM) criteria. From May 2008 to April 2010, a 
total of 1,787 patients with sepsis-induced DIC from post-marketing 
surveillance data [2] were analyzed. The survival rates on day 28 after 
the last TM-alfa administration were evaluated.
Results The 28-day survival rate was 64.5%. Use of other anticoagulants 
before and after TM-alfa administration did not aff ect the survival rate 
(present vs. absent: 63.8% vs. 65.2% (P  =  0.782) and 62.5% vs. 65.3% 
(P  =  0.606) respectively). The survival rate decreased signifi cantly 
in proportion to the duration of DIC before TM-alfa administration 
(P <0.001). More precisely, the 28-day survival rate was 66.4% when TM-
alfa was injected on the same day that DIC was diagnosed, whereas it 
was 48.5% and 31.1% when TM-alfa was started 4 days later and 7 days 
or more after DIC was diagnosed, respectively. These diff erences were 
signifi cant (P = 0.033 and P <0.001, respectively).
Conclusion The early administration of TM-alfa may be eff ective for 
patients with sepsis-induced DIC diagnosed based on the JAAM criteria.
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Introduction Depression of left ventricular contractility appears in 
many diseases resulting from various etiology factors. One of the most 
interesting features of septic cardiomyopathy is the signifi cant dynamic 
myocardial depression that is commonly observed. In this context, the 
objective of the present work is to characterize clinically, by laboratory, 
by echocardiography, and by invasive measures the patients with 
septic cardiomyopathy.
Methods A single-center database investigates all patients who were 
admitted and treated for severe sepsis or septic shock in the ICU over 
a period of 2 years (November 2011 to October 2013), and who were 
discharged with a diagnosis of septic cardiomyopathy or new left 
ventricular dysfunction. The clinical, laboratory, echocardiography, and 
invasive measures, and clinical outcome were recorded.
Results From the 105 patients that were investigated, 15 patients were 
found with septic cardiomyopathy. Septic cardiomyopathy is more 
prevalent among men (60%). Patients with septic cardiomyopathy 
have an increased prevalence of immune compromised disease (46%), 
and hypertension (40%). There was a need for mechanical respiratory 
support for 86% of patients. The improvement in cardiac function 
Table 1 (abstract P246).
   Length Length  
   of stay of stay in Vitamin 
   ICU hospital D 
 Age SAPS (days) (days) (ng/ml) BMI
Mean 62.59 52.48 10.14 24.90 11.35 26.38
Median 67.00 54.00 6.00 20.00 9.60 24.83
Mode 77.00 40.00 3.00 8.00 4.00 24.69
Standard deviation 17.85 18.35 10.17 20.70 7.16 8.33
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occurred at an average of 6.9 days. E. coli is the commonest bacterial 
pathogen (33%). Laboratory fi ndings show elevated liver enzyme and 
kidney function impairment in all patients. Thirty-three percent of 
patients were treated with N-acetyl cysteine, and 46% were treated 
with renal replacement therapy. High CRP was observed in all patients. 
Paroxysmal atrial fi brillation was diagnosed in 46%. Invasive measures 
in 50% of the patients have demonstrated high cardiac index (CI) and 
low systemic vascular resistant index (SVRI) on their admission, and 93% 
demonstrate low CI and high SVRI a few hours later. Hospitalization stay 
was between 3 and 42 days with an average of 14.6 days.
Conclusion Septic cardiomyopathy is more common among immune 
compromised patients. It is characterized by dynamic changes in the 
cardiac function based on echocardiography and invasive measures. A 
persistent hyperkinetic state was associated with high mortality rate. In 
addition to echocardiography follow-up, invasive monitoring even in 
their admission is of great importance for more eff ective and adequate 
treatment.
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Introduction We performed a survey under Dutch intensivists on 
the current practice of chest radiography in their departments. Chest 
radiographs (CXRs) are obtained frequently in ICU patients, despite the 
diagnostic and therapeutic effi  cacy of routine CXRs being known to be 
low. The discussion regarding specifi c indications for CXRs in critically ill 
patients and the safety of abandoning routine CXRs is still continuing [1].
Methods A web-based questionnaire was sent to the medical director 
of all adult ICUs in the Netherlands. This survey contained questions 
regarding ICU characteristics, ICU patients, daily CXR strategies, 
indications for routine CXRs and the practice of radiologic evaluation.
Results Of the 83 ICUs that were contacted, 69 (83%) responded to the 
survey. Only 7% of ICUs still perform daily routine CXRs for all patients 
while 65% of ICUs say never to perform CXRs on a routine basis. A daily 
meeting with a radiologist is established in the majority of ICUs and is 
judged to be important or even essential. The therapeutic effi  cacy of 
routine CXRs was assumed by intensivists to be lower than 10% or to 
be between 10 and 20%. The effi  cacy of on-demand CXRs was assumed 
to be between 10 and 60%. There is consensus between intensivists 
to perform a routine CXR after endotrachial intubation, chest tube 
placement or central venous catheterization.
Conclusion The strategy of daily routine CXRs for critically ill patients 
has developed from a common practice (63%) in 2006 [2] to a rare 
practice (7%) nowadays. Intensivists still assume the value of routine 
CXRs to be higher than the effi  cacy that is reported in the literature. 
This might be due to the clinical value of negative fi ndings, which has 
not been studied before.
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Introduction We investigated the effi  cacy and safety of chest 
radiographs (CXRs) performed on specifi ed indications only, directly 
after cardiac surgery. CXRs in the ICU are frequently obtained routinely 
for postoperative cardiosurgical patients, despite the fact that the 
diagnostic and therapeutic effi  cacy of these CXRs is now known to be 
low [1]. Routine CXRs may only be benefi cial for certain indications 
and the discussion regarding these indications and the safety of 
abandoning routine CXRs is still continuing [2].
Methods We prospectively included all patients who underwent 
major cardiac surgery in the year 2012. A direct postoperative CXR was 
performed only for certain specifi ed indications. An on-demand CXR 
could be obtained during the postoperative period according to other 
specifi ed indications. For all patients who did not have a CXR taken 
before the morning of the fi rst postoperative day, a control CXR was 
then performed. All CXR fi ndings were noted and classifi ed, including 
whether or not they led to an intervention. Diagnostic and therapeutic 
effi  cacy values were calculated.
Results A total of 1,351 patients were included who mainly underwent 
coronary artery bypass grafting, valve surgery or a combination of 
both. Eighteen percent of patients underwent a minimally invasive 
cardiac surgery. The diagnostic effi  cacy for major abnormalities was 
clearly higher for the postoperative and on-demand CXRs, performed 
on indication, when compared with the next-morning routine CXR 
(6.7% and 6.9% vs. 2.9%) (P = 0.002). The therapeutic effi  cacy was also 
clearly higher for the postoperative and on-demand CXRs (2.9% and 
4.1%), while the need for intervention after the morning control CXR 
was now reduced to be minimal (0.6%) (P = 0.002).
Conclusion Stating clear indications for CXRs following cardiac surgery 
increases the effi  cacy of these CXRs and safely reduces the total number 
of CXRs signifi cantly.
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Introduction The aim of the study was to investigate early graft 
function in terms of biological and radiological variables in a case series 
of lung transplant (Ltx).
Methods We performed a prospective analysis of patients that 
underwent Ltx at Fondazione IRCCS Cà Granda Policlinico of Milan 
from 1 December 2012 to 10 December 2013. Donors’ lung parameters 
were recorded. Recipients’ clinical data were collected daily and lung 
computed tomography (CT) at end expiration was performed within 
7 days after Ltx. On the same day, bronchoalveolar lavage was collected 
[1]. Quantitative CT analysis was run on separate lungs for each patient.
Results Out of 25 LTx, 12 paired data for donors and recipients were 
analyzed. Lung donors’ PaO2/FiO2 was 392 ± 118, Oto score was 5 ± 3, 
and ICU length of stay was 2 ± 1 days. Recipients’ age was 56 ± 11 years, 
and body mass index was 24 ± 4 kg/m2. Four patients received double 
Ltx, and the warm ischemia time was 85 ± 16 and 94 ± 14 respectively 
for right lung and left lung. When the CT scan was performed (on 
Table 1 (abstract P252). Quantitative CT scan analysis on transplanted lungs
Lung CT Mean ± SD (n = 16)
Volume (ml) 1,639 ± 437
Weight (g) 761 ± 175
Hyper infl ated (%) 0.0 ± 0.0
Normal (%) 38.9 ± 17.1
Poorly (%) 29.4 ± 8.4
Not infl ated (%) 31.7 ± 14.9
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day 4 ± 1), four patients were mechanically ventilated, PaO2/FiO2 was 
270 ± 93 and PaCO2 was 44.6 ± 10.0 mmHg. Primary graft dysfunction 
grade 2 or 3 at 72  hours post Ltx was diagnosed in six patients. All 
patients were discharged from ICU. Table  1 presents quantitative 
analysis of transplanted lungs. The alveolar protein concentration and 
not aerated tissue weight are signifi cantly related (R2 =0.69; P = 0.001).
Conclusion Alveolar protein concentration is related to morphological 
features of lungs early after Ltx.
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Introduction Our objective was to determine whether an Early 
Warning Score (EWS) based on laboratory tests could risk stratify 
patients admitted to the Norfolk & Norwich University Hospitals 
NHS Foundation Trust with pneumonia. Physiological EWS systems 
producing an escalated response to an increasing score are used 
eff ectively within the Trust, yet mortality is high in patients admitted 
with a diagnosis of pneumonia. The CURB-65 score may not be an 
eff ective risk stratifi cation tool for predicting mortality in the older 
patient nor to guide intensive care admission [1]. Jarvis and colleagues 
developed an EWS based on laboratory blood tests and used it in 
conjunction with physiological EWS to eff ectively risk stratify all 
medical patients [2].
Methods Of 2,158 patients admitted with pneumonia during 
12 months from August 2012, data were collected for 1,598 who had 
received the required blood tests. Data included dates of admission, 
discharge and death if appropriate, gender, haemoglobin (g/dl), white 
cell count (109/l), sodium (mmol/l), potassium (mmol/l), urea (mmol/l), 
creatinine (mmol/l) and albumin (g/l) on admission. A composite EWS 
was calculated and measured against outcome.
Results Of 1,598 patients, 538 died during this admission. It is uncertain 
whether death was due to pneumonia as only admission diagnosis is 
recorded but overall mortality was 35%. Analysis of data showed a 
strongly positive relationship between increasing EWS and increased 
risk of mortality with a correlation coeffi  cient of 0.97.
Conclusion Observational results suggest an EWS based on laboratory 
tests can be used to risk stratify patients with pneumonia and could 
be used to treat those with higher scores more aggressively earlier in 
their illness. Further analysis is required to determine whether age is 
a contributing factor and how this may modify the EWS. We need to 
determine whether laboratory-based EWS risk stratifi cation can be 
used in isolation, or whether it contributes suffi  ciently to an existing 
physiological EWS that a combined system would improve outcome 
in our patients.
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Introduction Previous studies reported that video-assisted thoraco-
scopic surgery (VATS) is more benefi cial for pulmonary lobectomy 
concerning the late postoperative period than open thoracotomy [1,2]. 
However, the early postoperative period when the rate of complications 
is highest has been scarcely examined. Our study aimed to compare 
the residual pulmonary function of pulmonary lobectomy patients 
after VATS and the standard thoracotomy approach in the immediate 
postoperative period.
Methods This prospective study included 14 VATS and 13 thoracotomy 
lobectomy (THOR) patients (age 58.8 ± 10.9 vs. 59 ± 8.9 years, P = 0.96; 
preoperative FVC 3.4  ±  1 vs. 3.4  ±  0.95  l, P  = 0.98 and preoperative 
FEV1 2.7  ±  0.96 vs. 2.7  ±  0.6  l, P  = 0.9, respectively). All patients 
received standard surgical and postoperative care with standardized 
pain management including i.v. diclofenac combined with epidural 
administration of bupivacaine and fentanyl. Spirometry was performed 
with a bedside MIR Spirolab II spirometer (Rome, Italy) preoperatively 
and 4, 8, 24, 48 and 72 hours after the surgery. FVC, FEV1, PaO2, PaCO2, 
complication rate, and length of ICU and hospital stay were recorded. 
Postoperatively measured FVC and FEV1 values were divided by 
preoperatively predicted values and multiplied by 100 to give the 
normalized FVC (nFVC) and FEV1 (nFEV1) [3].
Results The nFVC and nFEV1 values were signifi cantly higher in the 
VATS group in the fourth and eighth postoperative hours compared 
with the THOR group (84.3 ± 14.4 vs. 64.3 ± 23.4, P = 0.013 and 84 ± 18.8 
vs. 64 ± 22, P = 0.017, respectively). There was no statistically signifi cant 
diff erence between the groups in the 24th, 48th and 72nd hours, 
although VATS patients showed higher values at each time points. The 
length of ICU stay was similarly 1 day, but the length of hospital stay 
was signifi cantly longer in the THOR group (5 (3 to 6) vs. 7 (3 to 42) days 
(median and range) (P = 0.011)).
Conclusion Preoperative lung function prediction severely over-
estimates the real lung capacity of lobectomy patients in the immediate 
postoperative period. VATS lobectomy seems more benefi cial from the 
point of early postoperative lung function. VATS lobectomy should be 
considered in patients with poor preoperative spirometry results to 
ensure better postoperative outcome.
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Introduction The aim of our study is to evaluate the lung ultrasound 
(LUS) reaeration score (ReS) as a predictive tool for non-invasive 
ventilation (NIV) effi  cacy in general wards for acute respiratory failure 
(ARF) treatment. Even if ICUs are considered the safest place to perform 
NIV, a shortage of intensive beds has lead to NIV application outside 
the ICU. With appropriate patient selection, treatment-timing choice, 
adequate monitoring and staff  training, NIV application in general 
wards can allow one to safely treat patients at an early stage with better 
cost-eff ectiveness [1]. Few data assessing the right tool to evaluate NIV 
treatment effi  cacy are available.
Methods We present preliminary data of a prospective observational 
ongoing study. Sixteen patients undergoing NIV treatment outside the 
ICU for ARF of any origin were evaluated with LUS at three times: before 
NIV application (T0), and at 5 minutes (T5) and 60 minutes (T60) of NIV 
treatment. US scan was performed in six regions for each emithorax. 
LUS patterns were defi ned as: consolidation (C); multiple coalescent 
B-lines (B+); multiple irregularly spaced B-lines (B) and normal aeration 
(A). A LUS-ReS [2] was calculated detecting changes in the US pattern 
when comparing T0 to T5 and T0 to T60 assessments. Outcome was 
defi ned as NIV failure in the case of tracheal intubation or death within 
1 week from ARF outset, otherwise NIV success.
Results NIV treatment failed in fi ve patients. Eleven patients have been 
successfully treated with NIV. Mean LUS-ReS (SD) at T0 to T5 was 0 
(± 3.1) in group 0 and 2.5 (± 2.5) in group 1 (P = 0.15). Mean LUS-ReS 
(SD) at T0 to T60 was –1.2 (± 3.9) in group 0 and 4.2 (± 3.4) in group 
1 (P  = 0.03). ROC curves were obtained for the two LUS-ReS at T0 to 
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T5 (AUC 0.72) and T0 to T60 (AUC 0.83) (Figure  1). A LUS-ReS cutoff  
value of 0 can predict NIV eff ectiveness, with a sensibility of 91% and a 
specifi city of 80%.
Conclusion If confi rmed, our preliminary results suggest that LUS-ReS 
could be a useful tool in predicting NIV eff ectiveness for ARF treatment. 
Caution has to be applied when interpreting our results considered the 
small amount of patients enrolled.
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Introduction The purpose of this study was to survey current practice 
for the use of lung ultrasound (LUS) in the diagnosis of pneumothorax.
Methods Physician sonographers accredited by the German Medical 
Ultrasound Society (DEGUM) for ultrasonography in surgery, 
anaesthesia or medicine were invited to participate in an online survey. 
Frequency of exposure to patients with suspected pneumothorax, 
frequency of LUS use, assessment of diagnostic accuracy of LUS for 
ruling-out or ruling-in pneumothorax and preferences regarding 
technical aspects were enquired about.
Results Eighty-nine physicians responded. Average exposure to 
pneumothorax cases was 1/week. Fifty-fi ve per cent of respondents 
used LUS ‘always’ or ‘frequently’. Thirty-four per cent of physicians rated 
LUS as ‘always accurate’, and a further 54% as ‘accurate in a majority 
of cases’ in ruling out pneumothorax. Twenty-one per cent rated 
LUS as ‘always accurate’ and 69% as ‘accurate in a majority of cases’ 
in ruling in pneumothorax. Physicians reporting frequent exposure 
to pneumothorax patients used LUS in a higher proportion of cases 
(‘high caseload sonographers’) and were more confi dent to rule 
out pneumothorax (Figure  1). In total, 16 diff erent combinations of 
transducers, probe orientations and scanning modes were reported. 
Linear transducers, sagittal probe-orientation, and B-mode and 
M-mode scanning were most often selected (38%).
Conclusion Physicians’ use of LUS in the diagnosis of pneumothorax 
was modest. Assessment of diagnostic accuracy gave markedly lower 
scores than reported in clinical trials [1]. Correlation between frequency 
of exposure, likelihood of LUS usage and confi dence in diagnostic 
accuracy warrants further research into the nature of the learning 
curve. Considerable variations regarding technical aspects of LUS 
refl ect the ambiguity of current recommendations [2]. More research 
is required to establish the most effi  cient way of performing LUS for 
suspected pneumothorax and eff orts need to be made to promote its 
use in these scenarios.
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Introduction Smoke inhalation injury (SII) is progress to pulmonary 
edema, pneumonia, and acute respiratory distress syndrome. SII may 
cause bronchial mucosal edema; we hypothesized that narrowing 
of luminal air bronchus due to bronchial wall edema correlated with 
respiratory deterioration of SII patients.
Figure 1 (abstract P255).
Figure 1 (abstract P256). Accuracy of LUS in pneumothorax.
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Methods We prospectively studied 42 patients with a diagnosis of 
SII, according to visualized bronchoscopic fi ndings at admission, 
and 15 control subjects. The thoracic high-resolution computed 
tomography (HRCT) scan was obtained within a few hours of admission 
to our hospital. Airway wall dimensions were calculated using a 
validated method. The images were viewed on a workstation using a 
magnifi cation of ×5, and measurements of overall (D) and internal (L) 
diameter of the bronchi were made using electronic calipers, with wall 
thickness (T) being derived from these measurements (T = (D – L) / 2). 
Luminal area (Ai, mm2) and total airway wall area (Ao) were calculated 
from L and D, respectively, using the formula: A  = r2. We used both 
the ratio of airway wall thickness to total diameter (T/D ratio) and the 
percentage luminal area (LA% = (Ai / Ao + Ai) × 100).
Results The mean age of the patients was 59 years, 32 of the patients 
were men. The mean (SD) diameter of the bronchi in SII patients 
measured was 3.9 (1.5) mm (range 0.9 to 9.0  mm). There were 
statistically signifi cant positive associations between wall thickening 
(expressed as T/D ratio) and luminal narrow (expressed as LA%) and 
the developed pneumonia (T/D ratio: R2 = 0.56, P <0.01 and LA%: R2 = 
0.19, P = 0.005) and mechanical ventilation days (T/D ratio: R2 = 0.37, 
P  <0.0001 and LA%: R2  = 0.32, P  <0.001, respectively). No statistically 
signifi cant associations were identifi ed between T/D ratio or LA% and 
initial P/F ratio, infusion volume initial 24  hours, ICU stay days, and 
outcome. The mean T/D ratio and LA% were 0.25 (0.04) and 25.9% (7.6) 
for patients with SII and 0.35 (0.04) and 44.7% (5.6) for controls.
Conclusion We have shown with the use of HRCT scanning on admission 
that patients with SII have airway wall thickening compared with 
normal controls. Furthermore, airfl ow obstruction due to bronchial wall 
edema related with developed pneumonia and mechanical ventilation 
days in SII patients.
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Introduction A semi-upright position (45° position) in ventilated 
patients is recommended to prevent ventilator-associated pneumonia 
(VAP) and is one of the fi rst steps in progressive early mobility. We 
studied ventilated intensive care patients in a semi-upright position 
compared with a supine position to explore whether there was an 
improvement of oxygenation and ventilation.
Methods We retrospectively studied 60 patients in a mixed medical, 
surgical, neurological ICU during 2003 and 2007 [1-3]. In this study the 
eff ects of 45° position on the peripheral oxygen saturation (SpO2) and 
the end-tidal carbon dioxide (ETCO2) were measured. Body position was 
changed with a Total Care® bed (Hill-Rom) after results for the supine 
position (10°) were obtained. Half an hour after the body position was 
changed, measurements were taken, which included SpO2 and ETCO2. 
The results of body position change in the individual patients were 
analysed with paired-samples t test. A signifi cance level <0.05 was 
considered signifi cant.
Results Mean SpO2 supine was 96.55%  ±  SD 2.404 versus mean 
SpO2 semi-upright 97.4%  ±  SD 2.423, and mean ET-CO2 supine was 
4.62% ± SD 1.988 versus mean ET-CO2 semi-upright 4.31% ± SD 1.060. 
The SpO2 (P <0.0001) and the ETCO2 (P <0.0001) improved signifi cantly 
for the 45° position compared with <10° position.
Conclusion We demonstrated a signifi cant increase in oxygen 
saturation and a signifi cant decrease in end-tidal CO2 when the head 
of the bed was elevated during mechanical ventilation. We believe 
positional therapy in intensive care patients is very important. The 
semi-upright position is an easy, eff ective and safe treatment in ICU 
patients. This position is eff ective in the bundle prevention of VAP, 
is the fi rst step in progressive early mobility and is also eff ective in 
oxygenation and ventilation in mechanically ventilated patients. This 
clinical benefi t of head-of-bed elevation >30° must lead to a standard 
of care in mechanically ventilated patients. Since 2009 the semi-upright 
position is a standard of care in our hospital.
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Introduction The eff ect of sitting in an armchair on mechanically 
ventilated patients has not been studied enough. We study a group 
of patients ready for weaning for the respiratory pattern, mechanics 
and work of breathing during reclining in bed and after sitting in an 
armchair.
Methods Thirteen patients who needed mechanical ventilation after 
18 days (1 to 60) were studied during volume assist-control mechanical 
ventilation and spontaneous breathing (O2T, CPAP or PSV) in both 
positions. Airways, esophageal pressures and fl ow were registered for 
posterior analysis. Passive respiratory mechanics were measured by 
multiple linear regression methods, respiratory drive in esophageal 
pressure (P01) and respiratory eff ort using the pressure time product 
(PTP).
Results On controlled mechanical ventilation the respiratory system 
and chest wall elastance were signifi cantly higher in sitting compared 
with reclining positions (Ers 39  ±  24 vs. 33  ±  25  cmH2O/l and 10  ±  3 
vs. 7  ±  3  cmH2O/l), respiratory resistances were similar (15  ±  3 vs. 
14  ±  5  cmH2O/l/second) in both positions. Breathing pattern did not 
change signifi cantly: tidal volume (0.406  ±  0.108 vs. 0.394  ±  0.118  l), 
inspiratory fl ow (0.74  ±  0.27 vs. 0.69  ±  0.23 l/second), inspiratory 
(0.97  ±  0.23 vs. 0.97  ±  0.28  seconds) and expiratory (1.43  ±  0.55 vs. 
1.39  ±  0.44 seconds) times and respiratory frequency (27  ±  7 vs. 
26 ± 7 bpm). Respiratory drive and eff ort tend to be higher in the sitting 
position, but not signifi cantly. P01: 3.7  ±  1.9 versus 3.0  ±  1.4  cmH2O, 
Δpes: 19  ±  10 versus 15  ±  8 cmH2O, PTPmin: 373  ±  192 versus 
284 ± 162 cmH2O/second*minute.
Conclusion A sitting position for mechanically ventilated patients 
increased the rigidity of chest wall and the respiratory system. The 
eff ects of this mobilization must be evaluated because some patients 
show higher respiratory drive and eff ort in this position.
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Introduction Development of novel antibiotics for VAP is hampered 
by the need for large phase 3 trials with mortality endpoints. With all-
cause mortality rates decreasing, the large sample size for these trials, 
in particular for non-inferiority trials, has become a barrier to rapid drug 
development. Recently, a hierarchical approach to defi ning a composite 
endpoint for CV trials (win ratio method) has been described [1].
Methods We have adapted this approach in an ongoing superiority 
trial (Clinicaltrials.gov NCT01969799) comparing adjuvant use of a 
combination of fosfomycin and amikacin aerosol delivered by the PARI 
eFlow® Inline nebulizer in patients with Gram-negative pneumonia 
who are on mechanical ventilation. Both groups are receiving standard-
of-care i.v. antibiotics. Patients from the active and placebo groups are 
matched in pairs based on presence of MDR Gram-negative bacteria, 
and disease severity by APACHE II score. Each pair has a winner and a 
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loser, or is a draw. The pair is fi rst compared on mortality; if no diff erence, 
then ventilator-free days (VFD) are compared. If the outcomes are the 
same for both endpoints, a draw results. Active versus placebo groups 
will then be compared using the win ratio, defi ned as the number of 
pairs in which the active group was the winner divided by the number 
of pairs that did not result in a draw. We examined sample size and 
power characteristics of the win ratio endpoint using trial simulations.
Results Assuming a 15% 28-day mortality rate in the active arm and 
20% in the control arm, to have 80% power with a two-tailed 0.05-level 
test for mortality would require 906 subjects per arm. Under the same 
assumptions with a diff erence in mean VFDs of 3 favoring the active 
arm (with common SD of 6), 130 subjects per arm provides 80% power. 
In approximately 32% of simulations, the win ratio result for each 
pair was determined by mortality. These simulation results assumed 
results within pairs were uncorrelated. If a positive correlation for each 
endpoint within pairs is assumed, power for the win ratio endpoint 
increases.
Conclusion The win ratio method is both clinically meaningful and 
straightforward to explain. This method could provide a new approach 
to powering both superiority and non-inferiority trials of novel 
antibiotics. In particular, this method allows for well-powered phase 2 
trials, and potentially decreases the required size of phase 3 trials.
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Introduction The primary objective was to assess the impact of failure 
to obtain sputum culture (SC) among patients requiring intubation for 
pneumonia. For patients admitted to an ICU with severe pneumonia, 
guidelines recommend obtaining a lower respiratory tract sample 
for culture. Our experience suggested this is rarely ordered from the 
emergency department (ED).
Methods We retrospectively reviewed charts of all patients admitted 
through the ED with a diagnosis of pneumonia requiring intubation 
in the fi rst 24  hours between January 2011 and November 2012. 
Patients were classifi ed as SC collected or not collected. We recorded 
demographic data, SC results, antibiotic choice and de-escalation, 
ventilator-free days (up to day 14), and mortality in ICU and hospital. 
Inferential statistics were performed using SPSS version 20.0, with 
P <0.05 considered signifi cant.
Results Of 50 patients we reviewed, 43 (86%) were intubated in the ED, 
45 had SC ordered (only eight (18%) by ED physicians), and 37 (74%) 
had SC collected. There was no diff erence in age, gender or severity 
of illness as measured by APACHE score between the two groups. ICU 
mortality was lower in the SC collected group (24% vs. 69%, P = 0.007), 
as was hospital mortality (30% vs. 77%, P  = 0.007) and antibiotics 
were de-escalated more often (89% vs. 8%, P <0.001). Patient with SC 
collected showed a trend toward signifi cantly more ventilator-free days 
(6.5 vs. 0, P = 0.053).
Conclusion Sputum cultures were rarely ordered by ED physicians, and 
when not obtained in intubated patients with pneumonia, ICU and 
hospital mortality was higher, there was less antibiotic de-escalation, 
and a trend toward fewer ventilator-free days. Eff orts to improve 
collection of sputum cultures in these patients are warranted.
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Nonventilatory factors aff ecting noninvasive mechanical ventilation 
success in hypercapnic critical care patients
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Introduction The aim was to determine the nonventilatory factors 
that aff ect the noninvasive mechanical ventilation (NIMV) success in 
patients with hypercapnic respiratory failure.
Methods A total of 41 patients were included in this prospective cohort 
study, who were followed for at least 96 hours in the ICU between 
January 2010 and November 2012 with the diagnosis of hypercapnic 
respiratory failure. Patients with ≥10 mmHg decrease in PaCO2 in the 
fi rst 72 hours were accepted as successful (Group 1) and those without 
this decrease were accepted as unsuccessful (Group  2). Among the 
patients with similar NIMV application characteristics, the eff ect of age, 
APACHE II score, infection, bronchospasm (daily respiratory function 
tests were performed with portable spirometry), heart failure, thyroid 
dysfunction and physiologic dead space ventilation (VD/VT) on success 
were evaluated. In statistical analysis, t test, Mann–Whitney U test and 
regression analysis were used.
Results Among the 41 patients, 28 (68%) were classifi ed as Group  1 
and 13 (32%) as Group  2. No diff erences were identifi ed among the 
ventilatory parameters of the two groups (P >0.05). Patients in Group 1 
were younger, had higher admission PaCO2 levels, higher free T3 levels 
and ejection fraction in echocardiography (P  <0.05). VD/VT values of 
Group 1 measured at admission and on the second and third days 
of NIMV were lower than Group 2 (P <0.05). Similarly, they had lower 
FEV1 percent predicted values in the stable period and on the fi rst and 
second days of NIMV (P <0.05). FEV1/FVC was lower in Group 1 when 
measured in the stable period and on the third and fourth days of NIMV. 
In Group 2, CRP values measured during the fi rst day (P = 0.014) and 
third day (P = 0.031) of NIMV were identifi ed as higher. In multivariate 
regression analysis, admission PaCO2 (OR: 1.59, 95% CI: 1.1 to 2.3, P = 
0.014), free T3 (OR: 12, 95% CI: 1.51 to 101, P = 0.019), and VD/VT (OR: 
1.23, 95% CI: 1.01 to 1.52, P = 0.048) were identifi ed as independent risk 
factors aff ecting NIMV success.
Conclusion The results of this study revealed that among the NIMV 
nonresponsive hypercapnic patients, nonventilatory factors such as 
thyroid dysfunction and increased dead space ventilation should be 
considered.
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Introduction The aim of the present study was to compare, in a group 
of diffi  cult to wean critically ill patients, the short-term eff ects of PSV, 
PAV+ and NAVA on breathing pattern, patient eff ort and patient–
ventilator interaction.
Methods Seventeen patients were studied during NAVA, PAV+ and PSV 
with and without artifi cial increase in ventilator demands (challenge) 
using either dead space (DS, n  = 10) or chest elastic load (CL, n  = 7) 
application. Airway and transdiaphragmatic (Pdi) pressures, electrical 
activity of the diaphragm (EAdi), volume and fl ow were measured 
breath by breath, while inspiratory integral of Pdi (PTPPdi) and EAdi 
(EAdi) were calculated.
Results At resting conditions all modes provided equal support as 
indicated by a similar PTPPdi per breath, per minute and per liter of 
ventilation. Apart from triggering delay, which with and without the 
challenge was signifi cantly higher with PAV+ than that with NAVA 
and PSV, patient–ventilatory synchrony did not diff er among modes. 
Independent of challenging conditions, inspiratory eff ort to trigger the 
ventilator was signifi cantly higher with PAV+ than with NAVA and PSV. 
Compared with PSV, PAV+ and NAVA favored a more variable breathing 
pattern as indicated by the signifi cantly higher coeffi  cient of variation 
of tidal volume (VT). CL increased PTPPdi signifi cantly less with PAV+ 
than with PSV and NAVA, while the increase of PTPPdi after DS did 
not diff er among modes. The relationship between VT and PTPPdi 
was weaker with NAVA (median (IQR) r2 = 25.6% (2.7 to 58.1%)) than 
with PAV+ (55.6% (34.4 to 61.6%)) and PSV (53.9% (23.2 to 77.4%)) on 
account of a poor EAdi–PTPPdi relationship (r2 = 16.2% (1.4 to 30.9%)) 
during NAVA.
Conclusion Compared with PSV proportional modes favored breathing 
variability, while in the face of changing respiratory system mechanics 
PAV+ might be superior. However, signifi cant drawbacks of both NAVA 
and PAV+ limit the eff ectiveness of these modes to proportionally assist 
the inspiratory eff ort.
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Does average volume-assured pressure support make any 
diff erence compared with BIPAP?
G Canpolat, A Ozgultekin, G Turan, A Iskender, E Adıyeke, O Ekinci
Haydarpasa Numune Teaching and Research Hospital, Istanbul, Turkey
Critical Care 2014, 18(Suppl 1):P265 (doi: 10.1186/cc13455)
Introduction Average volume-assured pressure support (AVAPS) has 
been developed to ensure a more fi xed tidal volume along with the 
convenience and advantages of pressure support ventilation. In this 
study we compared the AVAPS with the BIPAP.
Methods Approval was obtained from the hospital’s ethics committee 
for the study. Thirty-three patients over 18 years of age with acute 
respiratory failure as a result of either internal or surgical reasons 
were included in the study. This study was conducted with the Philips 
V 60 ventilator, which includes both BIPAP and AVAPS mode. The 
implementation protocol for non-invasive ventilation (NIV) included, 
fi rstly, a 2-hour BIPAP application (Period Bi) and then, without inter-
ruption, a 2-hour AVAPS application (Period AV). After measuring the 
basal blood gas analysis, patients were informed of how NIV would be 
practiced and what function it would have. In BIPAP mode, the ventilator 
parameters were adjusted as follows; EPAP: 5 to 7 cmH2O, IPAP: 15 to 
20 cmH2O. Patient comfort was analyzed with a scale ranging from 0 
to 2 (0: compatible, 1: medium-compatible, 2: noncompatible). During 
BIPAP ventilation, levels of arterial blood gases (pH, pO2, pCO2 and 
SPO2), comfort scale and hemodynamic data were recorded at the 30th 
minute, fi rst hour and second hour. After the patient was monitored 
for 2  hours in BIPAP mode, the mode was changed to the AVAPS by 
setting the required rates without removing the mask. EPAP settings 
were adjusted as follows for AVAPS: 5 to 7 cmH2O, Pmin to max: 10 to 25 
cmH2O, tidal volume: 6 to 8 ml/kg. As in the BIPAP mode, we analyzed 
and recorded the rates of arterial blood gases, comfort scale and 
hemodynamic parameters at the 30th minute, fi rst hour and second 
hour. In case of agitation that prevents NIV, patients were sedated by 
dexmedetomidine.
Results When we analyzed patients according to their body mass 
indexes (BMI), pH and pCO2 values of the patients with BMI ≤30 
showed a greater improvement at all three measurements in the 
AVAPS compared with BIPAP (P <0.001). When patient compliance was 
examined, the number of patients regarded as comfortable in the BIPAP 
period was 20 (66.7%), but this fi gure was 25 (83.3%) for the AVAPS.
Conclusion Patient comfort was higher and need for sedation was 
lower in AVAPS. According to the results obtained from this study, the 
AVAPS had positive eff ects on pH, gas variation and patient comfort; 
therefore, it can be confi dently used in clinical practice.
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Oxygenation index outperforms the P/F ratio for mortality 
prediction
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Introduction The P/F ratio is widely used clinically and as part of 
research to categorise severity of respiratory failure [1]. However, no 
account is made of an important determinant of oxygenation; mean 
airway pressure (MAP). The oxygenation index (OI) incorporates the 
MAP and has been suggested as a more accurate means of determining 
severity of respiratory failure [2]. In addition, the optimal time for 
this assessment is unclear. We sought to answer these questions by 
analysing a large database of patient and ventilator data.
Methods The ICU of the Bristol Royal Infi rmary has used an electronic 
clinical information system (CIS) since 2008, with every hour of care 
available for analysis as a result. Ventilated patients were identifi ed, 
the P/F ratio and OI were calculated and the worst values for these 
determined for four time periods (fi rst 12, 24, 36 and 48  hours of 
ventilation). Logistic regression analysis was used to create models to 
predict unit and hospital mortality.
Results Data for over 150,000 hours of care in 4,886 patients was 
available for analysis. Excluding nonventilated patients and those 
transferred ventilated from another ICU, 2,156 patients provided data. 
In comparison with survivors, nonsurvivors were older, with higher OI 
and 24-hour SOFA scores and lower P/F ratios. The optimal time for 
calculation of both OI and P/F ratio for mortality prediction is the fi rst 
12 hours of ventilation. The models using worst OI are better predictors 
of ICU and hospital mortality than those using worst P/F ratio (area 
under receiver operating curve 0.840 vs. 0.822).
Conclusion Our analysis suggests that the OI is a more sensitive 
descriptor of the severity of respiratory failure than the P/F ratio and 
that this calculation should be performed using data from the fi rst 12 
hours of ventilation.
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Introduction Weaning from the mechanical ventilation (MV) composes 
about 40 to 50% of the total length of MV. Besides, there is no single 
reliable parameter indicating that patient will tolerate extubation safely. 
The rapid shallow breathing index (RSBI) is relatively the best predictive 
parameter for the initial assessment of readiness for discontinuation 
of MV support. But evaluation of the RSBI is valuable during T-tube 
ventilation; and in clinical practice it is not always possible to perform 
this assessment. In this study, we aimed to determine the best MV 
mode and pressure combinations that can predict successful RSBI 
closest to values calculated in spontaneous ventilation and estimate 
the patients’ readiness for weaning.
Methods In this prospective cohort study, 25 mechanically ventilated 
patients were included. After 24  hours of MV, if the patients can 
successfully pass the daily screening test a spontaneous breathing trial 
(SBT) was initiated. RSBI and other weaning parameters were calculated in 
diff erent combinations (PS:5 PEEP:5, PS:0 PEEP:5, PS:5 PEEP:0, PS:0 PEEP:0) 
before T-tube trial in all patients. Measurements in the spontaneous 
ventilation was performed with the COSMOPLUS Novometrix device that 
has both capnography and respiratory monitorisation function; other 
measurements were performed with ventilators.
Results The mean age of the study group was 73  ±  10  years; 11 
of them were female and mean APACHE II score was 19  ±  6. RSBI 
did not diff er signifi cantly between spontaneous mode and other 
combinations, but the best correlation with spontaneous mode was 
found with PS:5 PEEP:0 (P = 0.0001, r = 0.719), and the worst with PS:0 
PEEP:5 combination. RSBI calculated in each combination showed no 
predictive value for weaning success. Respiration rate (f) was higher in 
the SBT failure group than the SBT success group. When measured at 
PS:0 PEEP:5 and PS:5 PEEP:0 combinations, the threshold value of f was 
found to be 27/minute (P = 0.03).
Conclusion Although there was a correlation between RSBI measured 
in the T-tube and RSBI measured in diff erent mode and pressure 
combinations, especially with the combination of PS:5 PEEP:0, a threshold 
value for RSBI cannot be detected during MV to predict SBT success.
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Introduction Noninvasive ventilation through a mask is commonly 
applied in pressure support ventilation (nPSV). Recent studies 
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showed that noninvasive neurally adjusted ventilatory assist (nNAVA) 
improves patient–ventilator interaction and synchrony. More recently 
we described a new setting for nNAVA (nNAVA15) able to reduce the 
peak of electrical activity of the diaphragm (EAdipeak) and dyspnea 
(assessed by a visual analogue scale, VASd), compared with both nPSV 
and nNAVA, in patients undergoing NIV through a helmet, by improving 
the rate pressurization. We therefore designed a physiological study to 
evaluate and compare the eff ects of nNAVA15 with nPSV and nNAVA 
on VASd, EAdipeak, pressurization rate and arterial blood gases (ABGs).
Methods Fourteen patients undergoing noninvasive ventilation 
because of acute respiratory failure underwent three randomized 
30-minute trials: nPSV (inspiratory support above positive end-
expiratory pressure (PEEP) ≥8  cmH2O, fastest rate of pressurization); 
nNAVA (NAVA level to achieve a comparable EAdipeak as during nPSV); 
nNAVA15 (NAVA level at 15 cmH2O/μV and the maximum inspiratory 
airway pressure (Paw) set at the value corresponding to PEEP + 
inspiratory support during nPSV). Oxygen inspiratory fraction and PEEP 
remained unmodifi ed throughout the study period. The last minute of 
each trial was analyzed. Paw-time products of the initial 200 ms from 
the onset of ventilator pressurization (PTP200), of the initial 300 and 
500  ms from the onset of the EAdi swing indexed to the ideal PTP 
(PTP300i and PTP500i, respectively), and of the triggering area (PTPt) 
were computed. ABGs and VASd were assessed at the end of each trial.
Results nNAVA15 reduced VASd (3.0 (2.0; 3.0)), compared with both 
nPSV (5.0 (4.0; 5.2)) and nNAVA (4.0 (3.0; 5.0)) (P  <0.001), without 
aff ecting ABGs and EAdipeak. nNAVA15 improved PTP300i and 
PTP500i (42% (32.5; 46.5) and 63% (54; 68)%, respectively) compared 
with nPSV (25 (4; 33)% and 44 (23; 52)%, P  <0.001) and nNAVA (25 
(20; 34)% and 46 (33; 57)%, P  <0.001). PTP200 was lower in nNAVA 
(62 (46; 82) cmH2O*second) with respect to both nPSV (87 (77; 112) 
cmH2O*second) and nNAVA15 (85 (70; 127) cmH2O*second) (P = 0.001). 
PTPt was signifi cantly improved by both nNAVA (–00.9 (–3.2; –0.2) 
cmH2O*second) and nNAVA15 (–0.6 (–2.3; –0.2) cmH2O*second) as 
opposed to nPSV (–9.4 (–12.3; –5.9) cmH2O*second, P <0.001).
Conclusion Compared with nPSV and nNAVA, nNAVA15 through a mask 
reduces VASd, assuring an optimal pressurization rate and triggering 
performance, without aff ecting the breathing pattern, neural drive and 
ABGs.
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Introduction Noninvasive neurally adjusted ventilatory assist by helmet 
(hNAVA) was shown to improve, compared with pressure support 
ventilation by helmet (hPSV), patient–ventilator interaction and 
synchrony in patients with acute respiratory failure without aff ecting 
peak electrical activity of the diaphragm (EAdipeak) [1]. Recently, a 
new helmet is available, which improves pressurization during hPSV. 
We propose a new setting of hNAVA (hNAVA15) to achieve further 
improvement. We compare hPSV, hNAVA and hNAVA15, all delivered 
using the new helmet, with respect to patient’s dyspnea, assessed by 
a visual analogue scale (VASd), arterial blood gases (ABGs), EAdipeak, 
rate of ventilator pressurization and triggering performance.
Methods Fifteen patients underwent three randomized 30-minute 
trials: hPSV, set with an inspiratory support above positive end-
expiratory pressure (PEEP) ≥10 cmH2O and the fastest rate of 
pressurization; hNAVA, setting the NAVA level to achieve the same 
EAdipeak as during hPSV; hNAVA15 setting the NAVA level at 15 cmH2O/
μV and the maximum inspiratory airway pressure (Paw) at the value 
corresponding to PEEP + inspiratory support during nPSV. Oxygen 
inspiratory fraction and PEEP remained unmodifi ed throughout the 
study period. Paw-time products of the initial 200 ms from the onset of 
ventilator pressurization (PTP200), of the initial 500 ms from the onset 
of the EAdi swing indexed to the ideal PTPaw (PTP500i), and of the 
triggering area (PTPt) were computed. ABGs and VASd were assessed 
at the end of each trial.
Results hNAVA15 reduced the EAdipeak (10.2 (7.1; 16.2)  μV) with 
respect to both hPSV (16.9 (12.7; 19.8) μV, P <0.001) and hNAVA (15.3 
(10.7; 18.8) μV, P <0.001), while decreasing VASd (3.0 (3.0; 4.0) in hPSV, 
3.0 (2.0; 4.0) in hNAVA and 1.0 (1.0; 2.0) in hNAVA15; P <0.01). PTP200 
and PTP500i were improved by hNAVA15 (36 (28; 57) cmH2O*second 
and 40 (30; 47)%, respectively) compared with hPSV (31 (24; 45) 
cmH2O*second and 17 (9; 26)%, respectively) and hNAVA (23 (16; 30) 
cmH2O*second and 23 (17; 37)%, respectively) (P <0.01). PTPt was lower 
in hNAVA15 (2.9 (1.6; 4.4) cmH2O*second, P <0.01) compared with both 
hPSV and hNAVA, and lower in hNAVA (6.0 (2.7; 11.6) cmH2O*second), 
compared with hPSV (18.5 (11.2; 22.5) cmH2O*second, P <0.01). ABGs 
were no diff erent between trials.
Conclusion In comparison with hPSV and hNAVA, hNAVA15 
signifi cantly reduced EAdipeak and VASd, improving the pressurization 
and triggering performance, without aff ecting ABGs.
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Introduction Neurally adjusted ventilatory assist (NAVA) has so far 
been used in minimally sedated intensive care patients. NAVA has not 
been applied in patients in the operation room. The eff ect of diff erent 
sedatives/anesthetics on the electrical activity of the diaphragm (Edi) 
has not so far been studied. The aim of our study was to compare the 
eff ect of sevofl urane and propofol on the Edi signal and breathing 
pattern during sedation and anesthesia and also in combination with 
remifentanil.
Methods A randomized cross-over study comparing sevofl urane and 
propofol sedation and anesthesia in 10 juvenile pigs. Remifentanil 
0.1  μg/kg/minute was added after a period of anesthetic agent 
administration. The animals were ventilated with NAVA with fi xed level 
throughout the study. Respiratory variables were measured for the last 
5 minutes of each 15-minute exposure.
Results The Edi signal and spontaneous breathing were preserved 
with both anesthetics. The breathing variability, expressed as the 
coeffi  cient of variation (SD/mean) of the tidal volume (CVvt), was high 
with both drugs. CVvt was greater during with propofol than with 
sevofl urane (CVvt 32 vs. 18% during sedation and CVvt 23 vs. 14% 
during anesthesia). The frequency of sighs was higher with propofol 
both during sedation (29 vs. 12 sighs/hour) and anesthesia (21 vs. 1 
sighs/hour) than with sevofl urane.
Conclusion NAVA can be applied during propofol and sevofl urane 
anesthesia in pigs, with well-preserved Edi and spontaneous breathing. 
The natural variability is maintained with NAVA even during anesthesia.
In contrast to sevofl urane, propofol sedation and anesthesia is 
associated with a high frequency of sighs and post-sigh apneas, 
probably due to a centrally induced mechanism. Our data warrant 
studies of NAVA in humans undergoing anesthesia and surgery when 
neuromuscular blockade is not required.
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Introduction Protective mechanical ventilation has been associated 
with lower incidence of pulmonary and extrapulmonary complications 
in major surgery. The aim of the present study is evaluate whether 
adding an intensive alveolar recruitment protocol improves clinical 
outcomes and reduces healthcare utilization in patients undergoing 
cardiac surgery.
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Methods In this single-center, parallel-group trial, we randomly 
assigned adult patients presenting signals of defi cient gas exchange 
(PaO2/FIO2 <250 at a PEEP of 5 cmH2O) in the immediate postoperative 
period to either intensive alveolar recruitment or a standard protocol, 
both using low-tidal volume ventilation (6 ml/kg/ibw). Our hypothesis 
was that an aggressive alveolar recruitment protocol will be translated 
to better lung compliance, better gas exchange, fewer pulmonary 
complications and reduced length of hospital stay when compared 
with the control group.
Results A total of 320 patients were enrolled in the study, 163 patients 
in the standard protocol group and 157 in the intensive alveolar 
recruitment group. Patients of the interventional group presented a 
higher incidence of pneumonia than patients for the control group 
(5 (3.3%) vs. 19 (22%), P = 0.004). The length of the hospital stay was 
shorter among patients receiving intensive alveolar recruitment than 
among those receiving standard care (10.9 (9.9 to 11.9) vs. 12.4 days 
(11.3 to 13.6); P  = 0.045). There was no diff erence between groups 
according to extrapulmonary complications and mortality.
Conclusion In this trial, an intensive alveolar recruitment protocol 
associated with a protective mechanical ventilation strategy reduced 
pulmonary complication and length of hospital stay in patients 
undergoing cardiac surgery (NCT01502332).
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Introduction We used transthoracic endoscopy [1] to continuously 
record images of subpleural alveoli during recruitment manoeuvres 
and diff erent steady plateau pressures between the manoeuvres.
Methods We investigated two groups of 13 rats each. Animals were 
ventilated with ZEEP or PEEP of 5 mbar, FiO2 of 1.0 and tidal volume 
of 10 ml/kg. A double low-fl ow manoeuvre was designed, consisting 
of two consecutive low-fl ow manoeuvres with a peak pressure of 
30 mbar, interrupted by a 5-second plateau phase at diff erent pressures 
(2, 4, 8 and 12 mbar). Alveolar size at the peak pressures and during the 
plateau levels was analyzed from the recorded videos frame by frame. 
Therefore the alveolar outline of 10 alveoli was marked manually and 
the outlined area was calculated [2]. Compliance of tidal breaths before 
and after the manoeuvres was calculated using two-point compliance.
Results In both groups, analysis of the alveolar area revealed that 
alveolar size at the second peak of the manoeuvre did not diff er 
signifi cantly compared with the fi rst peak (100.97% in ZEEP group, 
102.37% in the PEEP group). During the plateau phases there was 
a slight increase in alveolar size at higher plateau pressures (slope 
of linear regression at plateau 4 mbar: 0.1 %/500 ms for ZEEP group, 
0.18%/500  ms for PEEP group; at plateau 8  mbar: 0.42%/500 ms for 
ZEEP group, 0.565%/500 ms for PEEP group). After the manoeuvres, 
compliance increased to 137.73% in the ZEEP group and 119.91% in 
the PEEP group.
Conclusion In the healthy lung, once recruited, alveoli stay stable in 
size over wide pressure ranges. Further recruitment manoeuvres do 
not lead to further increase of alveolar size, but increase of compliance. 
During plateau phases, alveolar size increases dependent on pressure. 
This leads to the assumption that recruitment is not only pressure 
dependent but also time dependent.
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Introduction Lung-protective mechanical ventilation requires positive 
end-expiratory pressure (PEEP) and tidal volume (VT) to be chosen with 
regard to the individual state of the lung. The shape of the intratidal 
compliance–volume profi les might refl ect the state of the lung 
(atelectatic, open, overdistended) and could therefore be classifi ed 
into shape categories that translate into PEEP suggestions [1]. Intratidal 
resistance–volume profi les might refl ect intratidal opening and 
collapse of the lung [2]. Using respiratory data from an animal study we 
suggest a classifi cation into resistance shape categories based on the 
slope of the R(V) profi les.
Methods Fifteen pigs with lavage-induced lung damage were 
ventilated at two PEEP levels (0 and 12 mbar) and three tidal volumes 
(8, 12 and 16  ml/kg bodyweight). Compliance (C(V)) and resistance 
(R(V)) profi les for each individual animal and ventilation setting were 
calculated from respiratory data using the gliding-SLICE method [3]. 
C(V) profi les were associated with one of the six suggested shape 
categories. The dependency of the mean R(V) slope of all animals on the 
ventilation setting was used as a basis for classifi cation into resistance 
shape categories. Resistance shape categories were compared with 
compliance shape categories for each individual animal to test whether 
similar PEEP suggestions result from both methods.
Results Small PEEP and VT were typically associated with increasing 
C(V), and decreasing C(V) corresponds to large PEEP and VT. A 
classifi cation of each C(V) profi le into one of six compliance shape 
categories was possible. The shapes of the R(V) profi les of individual 
animals were remarkably similar. The R(V) slope was typically largest for 
a PEEP and VT setting at which derecruitment was likely and smallest 
where overdistension was likely. Based on this a classifi cation scheme 
was defi ned: 10 <slope <21  mbar s/L2 (category 1, ‘increase PEEP’), 
slope ≥21 mbar s/L2 (category 2, ‘keep PEEP’) and slope ≤10 mbar s/L2 
(category 3, ‘decrease PEEP’). Comparison of resistance and compliance 
shape categories for single animals shows a good correlation.
Conclusion Resistance shape categories might provide additional 
guidance for PEEP setting. Combining compliance and resistance 
shape categories could improve lung-protective ventilation.
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Introduction A protective ventilatory strategy should prevent VILI, 
but in patients with larger nonaerated areas hyperinfl ation may occur 
during tidal ventilation even during a protective ventilatory strategy 
[1]. The gliding sign is used as a marker of pneumothorax and, in a 
study [2], to quantify preoperatively the degree of pleural adhesion 
in thoracic surgery patients. In our study we measured the variations 
of gliding (G) and static compliance (Cstat) according to incremental/
decremental variations of PEEP in patients with hypoxic respiratory 
failure.
Methods Ten patients with hypoxic respiratory failure (P/F <300) were 
ventilated in VCV (Vt of 7  ml/kg, FiO2 100%, RR 10/minute); keeping 
Vt constant, PEEP was gradually increased from ZEEP to 22  cmH2O, 
unless there was occurrence of hypotension or SpO2 <90% or Pplat 
>45  cmH2O or G no more visible, and then similarly reduced from 
22 cmH2O to ZEEP. The gliding was assessed at six points of intercostal 
Critical Care 2014, Volume 18 Suppl 1 
http://ccforum.com/supplements/18/S1
S97
spaces bilaterally and the movement of a hyperechoic point of pleura 
or a b-line was observed during tidal ventilation. For each step, 
the excursion of G during the inspiratory phase was measured and 
compared with the Cstat values. Statistical analysis was performed with 
the Pearson correlation coeffi  cient (PCC).
Results All patients completed the study without adverse events. In all 
patients we observed a reduction of G and Cstat at the increase of PEEP 
and specularly an increase of G and Cstat during the reduction of PEEP 
(Figure 1). In fi ve patients at the lower levels of PEEP (from 0 to 10) an 
increase of Cstat and G was observed. For all patients the PCC of Cstat 
and G and was >0.5 (P <0.03), ranging from 0.537 (P = 0.017) to 0.964 
(P <0.0001).
Conclusion The variations of G at diff erent levels of PEEP are consensual 
with those of Cstat. The study of G during tidal ventilation could help to 
identify hyperinfl ation in nondependent lung regions and to optimize 
lung-protective ventilatory strategies.
References
1. Terragni PP, et al.: Am J Respir Crit Care Med 2007, 175:160-166.
2. Masato S, et al.: Ann Thorac Surg 2005, 80:439-442.
P275
Protective ventilation reduces bacterial growth and lung injury in a 
porcine pneumonia model
J Sperber1, A Nyberg1, M Lipcsey2, A Larsson2, J Sjölin2, M Castegren1
1Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; 
2Uppsala University, Uppsala, Sweden
Critical Care 2014, 18(Suppl 1):P275 (doi: 10.1186/cc13465)
Introduction Bacterial pneumonia is a common indication for 
mechanical ventilation in the ICU. Ventilation with high positive end-
expiratory pressure (PEEP) and low tidal volume (VT) is recommended 
in patients with adult respiratory distress syndrome. This improves 
clinical outcome compared with ventilation with low PEEP and 
medium-high VT [1]. However, the eff ect of VT and PEEP on bacterial 
growth in lung tissue is not known. This study contrasted the eff ect of 
a protective ventilator protocol with a standard medium-high VT and 
lower PEEP protocol on lung bacterial growth, lung edema formation 
and lung injury. It was performed in a porcine model of intensive care 
with the frequently found pathogen Pseudomonas aeruginosa.
Methods Sixteen pigs were anesthetized and randomized to 
mechanical ventilation with two diff erent ventilator settings for 6 hours; 
Prot-V (PEEP 10 cmH2O, VT 6 ml/kg, n = 8) and Control (PEEP 5 cmH2O, 
VT 10 ml/kg, n = 8). At 0 hours, 1×1011 colony-forming units (cfu) of P. 
aeruginosa were instilled intratracheally. At the end of the experiment, 
six postmortem lung biopsies from predefi ned declivial locations were 
taken from each animal for cultures and weight measurements.
Results P. aeruginosa growth in lung tissue and wet to dry ratio were 
lower in the Prot-V group than in the Control group (P  <0.05 and 
P <0.05). PaO2/FiO2 was higher in the Prot-V group than in the Control 
group (P <0.05) (Table 1).
Conclusion Protective ventilation with low VT and higher PEEP reduces 
P. aeruginosa growth in lung tissue, lung edema formation and lung 
injury in contrast with medium-high VT and lower PEEP ventilation in 
this porcine pneumonia model.
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Introduction The purpose was to compare eff ects of PEEP on computed 
tomography (CT) and estimated ventilation/perfusion (V/Q) mismatch. 
Previously, an oxygenation-based method was shown more related to 
the CT-measured eff ect of PEEP than lung mechanics [1], indicating 
lung aeration is better quantifi ed using V/Q mismatch. Pulmonary 
shunt and low and high V/Q mismatch can be estimated from varying 
FIO2 and measuring ventilation and blood gas contents [2].
Methods Preliminary results in six ARDS patients. CT scans were 
taken in static conditions at PEEP 5, 45 and 15 to 20 cmH2O. V/Q was 
estimated at 5 and 15 to 20 cmH2O as: shunt, low V/Q as alveolar to lung 
capillary PO2 diff erence (ΔAcPO2), high V/Q as alveolar to lung capillary 
PCO2 diff erence (ΔAcPCO2) [2]. Nonaeration, poor aeration, and normal 
aeration plus hyperinfl ation were calculated from Hounsfi eld units. 
Aeration and V/Q were compared (Pearson, ρ).
Results PEEP improved V/Q in four patients, shunt reducing 7 to 42% with 
no/small increase in ΔAcPCO2. Two deteriorated, with large ΔAcPCO2 or 
shunt increase. No systematic changes in ΔAcPO2 were seen. Figure  1 
shows response to PEEP in two patients. Changes in nonaerated regions 
and shunt were correlated (ρ  = 0.94, P  = 0.002). No correlations were 
found between poorly aerated regions and ΔAcPO2 (ρ = –0.09, P = 0.84) 
or hyperinfl ated regions and ΔAcPCO2 (ρ = 0.07, P = 0.88).
Conclusion In these preliminary cases, changes in shunt and nonaerated 
tissue correlated well. However, results indicate poor agreement 
between changes in low and high V/Q and lung morphology.
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Introduction In data collected during the Third International Study on 
Mechanical Ventilation, we compared data from the Netherlands with 
a global cohort. We hypothesized that tidal volumes (Vt) were smaller 
and applied positive end-expiratory pressure (PEEP) was higher in the 
Netherlands, compared with the global cohort. We also compared use 
of non-invasive ventilation (NIV) and outcomes in both cohorts.
Methods A post-hoc analysis of a prospective observational study of 
patients receiving invasive mechanical ventilation was conducted in 
Figure 1 (abstract P274). PCC between mean G (cm) and mean Cstat at 
diff erent PEEP, in axis Pplat.
Table 1 (abstract P275). P. aeruginosa log mean, wet to dry ratio, and PaO2/
FiO2 at 5 hours
 P. aeruginosa (cfu/g) W/D PaO2/FiO2 at 5 hours (mmHg)
Prot-V 3.5 ± 0.7 1.7 ± 0.2 434 ± 62
Control 4.2 ± 0.7 2.7 ± 1.3 343 ± 61
Data presented as mean ± SD.
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494 ICUs around the world [1]. The Dutch cohort covered 196 patients 
and the global cohort 7,952.
Results Vt was 7.6  ml/kg predicted bodyweight in the Dutch cohort 
versus 8.0  ml/kg and the median applied PEEP was 8  cmH2O versus 
5.8 cmH2O (both P <0.01). In the subgroup of patients with ARDS, Vt 
ml/kg was 7.6 and applied PEEP 8.8 cmH2O in the Netherlands versus 
8.6  ml/kg (P  = 0.41) and 8.3  cmH2O worldwide. In the Netherlands 
7.1% of admitted patients received NIV as fi rst mode of mechanical 
ventilation versus 15% in the global cohort. In both cohorts 18% of 
patients were hypercapnic at ICU admission. Fewer patients in the 
Dutch cohort showed an ICU-acquired pneumonia (4.1 vs. 9.4%, P  = 
0.007) and sepsis (5.1 vs. 9.0%, P = 0.042), but more patients evolved 
delirium (16 vs. 5%, P <0.01).
Conclusion According to our hypothesis, Vt was smaller and applied 
PEEP was higher in the Dutch cohort. Patients in both cohorts received 
larger Vt than recommended in prevention of ARDS [2]. Hypercapnia is 
a main criterion for the use of NIV [3], which suggests that NIV could be 
used more often in the Netherlands. The lower incidence of delirium 
worldwide could be caused by diff erences in sedation or may be due to 
the used methods of screening.
References
1. Esteban et al.: Am J Respir Crit Care Med 2013, 188:220-230.
2. The Acute Respiratory Distress Syndrome Network: N Engl J Med 2000, 
342:1301-1308.
3. Brochard: Eur Respir J 2003, 22:31s-37s.
P278
Graphical user interface for visualization of a decision support 
system for PEEP titration
S Lozano-Zahonero, S Buehler, S Schumann, J Guttmann
University Medical Center Freiburg, Germany
Critical Care 2014, 18(Suppl 1):P278 (doi: 10.1186/cc13468)
Introduction The analysis of dynamic volume-dependent compliance 
provides the rationale basis for PEEP titration during mechanical 
ventilation. Due to its volume dependence, the compliance of the 
respiratory system is nonlinear within each single breath (intratidal), 
which is refl ected in the compliance–volume curve (CV curve). The 
shape of the CV curve is determined by the PEEP level. The mechanical 
stress for the mechanically ventilated lung is expected to be minimal 
when the lung is ventilated within the volume range of maximal 
compliance. We present a new graphical user interface (GUI) that 
supports the clinician to titrate the PEEP level by means of a shape 
category analysis of the CV curve.
Methods A decision support system in the form of a computer-based 
GUI was developed and tested using respiratory data obtained from 
patients of the University Medical Center Freiburg. The new clinician-
oriented approach provides a breath-by-breath visualization of the 
patient’s individual intratidal CV curve. The dynamic compliance was 
analyzed using the gliding-SLICE method [1]. The resulting intratidal 
CV curve was classifi ed into one of six shape categories according to 
the defi nition from Mols and colleagues [2]. The actual shape category 
of the CV curve indicates whether PEEP setting should be changed or 
whether the volume range of maximal compliance is reached.
Results The GUI provided a breath-by-breath visualization of the 
intratidal CV curve and the intuitive individual compliance shape 
category. Based on the compliance shape category, diff erent guidelines 
of PEEP titration were applied with the objective of ventilating the 
patient mechanically within the range of maximal compliance.
Conclusion The newly developed GUI allows a breath-by-breath 
visualization of the intratidal CV curve with high reliability. Automated 
classifi cation of the intratidal CV curve into compliance shape 
categories provides the rationale basis for patient-individual PEEP 
titration.
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Introduction The cyclic strain of lung tissue during mechanical 
ventilation compared with spontaneous breathing is associated 
with a largely increased mechanical load due to larger pressure 
amplitudes and higher acceleration forces. This additional load may 
change tissue mechanics and may lead to tissue damage. Although 
experimental mechanostimulation in vitro is a widely used method 
Figure 1 (abstract P276). Gas exchange and CT for patient improving (A) or worsening (B) with PEEP change.
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to analyse mechanical load on cells or tissue, in vitro experiments 
with ventilation-analogue stimulation are missing. In this work we 
compare for the fi rst time the changes of monolayer lung cells after 
ventilation-analogue stimulation with spontaneous-breathing 
analogue mechanostimulation. The aim of the study was to show time-
dependent diff erences in the induction of apoptosis due to mechanical 
overload, by fl uorescence microscopic observations.
Methods Alveolar epithelial cells (A549) were grown on RGD-coated, 
highly fl exible polydimethyl siloxane membranes. After becoming 
approximately 100% confl uent, cells were stained with Hoechst 
33342/TMRE/caspase-3 and caspase-7/PI and continuously observed 
by fl uorescence microscopy. The cells were stimulated either with 
ventilation-analogue or spontaneous-breathing analogue profi le [1]. 
For both settings the frequency was 0.25 Hz, the surface increase 20% 
and the cell monolayers were stimulated over a time period of 2 hours 
in the bioreactor [2].
Results The analysis of fl uorescence microscopic images showed 
the fi rst evidence of apoptosis induction after 40 minutes of 
ventilation-analogue stimulation. In contrast, apoptosis induction 
after spontaneous-breathing analogue stimulation occurred after 90 
minutes.
Conclusion The observation of cells during stimulation with continuous 
fl uorescence microscopic imaging allowed us to analyse the time-
dependent induction of apoptosis under the aspects of diff erent 
stimuli. We could prove our hypothesis that ventilation-analogue 
stimulation was worse for the cellular viability then spontaneous-
breathing analogue stimulation. In future, the direct optical tracking of 
cell damage should allow one to analyse other stimulation profi les as 
well, and thereby to improve the stimulation profi les and ultimately the 
ventilation profi le as well.
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Introduction Cyclic recruitment and derecruitment (R/D) of lung 
parenchyma during mechanical ventilation are responsible for 
atelectrauma. Theoretically, cyclic R/D can lead to varying degrees 
of pulmonary shunt fraction throughout the respiratory cycle. 
Measurements of dynamic pulmonary shunt fraction could help 
in assessing the degree of cylic R/D. However, common methods 
of measuring pulmonary shunt do not allow for dynamic serial 
measurements during one respiratory cycle. In this study, we measured 
serial dynamic pulmonary shunt fractions during one breathing cycle 
and investigated the eff ect of positive end-expiratory pressure (PEEP) 
on cyclic R/D in artifi cially ventilated pigs before and after saline 
washout induced acute lung injury.
Methods Pigs (n  = 10) were anesthetized and ventilated at a tidal 
volume of 8 ml/kg and two levels of PEEP (0 and 15 cmH2O – conditions: 
PEEP0; PEEP15). Hemodynamic, respiratory and multiple inert gas 
analysis by micropore membrane inlet mass spectrometery (MMIMS-
MIGET; Oscillogy, USA) measurements were taken at PEEP0 and PEEP15 
before and after saline washout. Retention of SF6, measured fi ve times 
during one breathing cycle, was taken as a refl ection of shunt fraction. 
MIGET sample acquisition was synchronized by electrical impedance 
tomography.
Results We observed dynamic changes in pulmonary shunt fraction, 
expressed as changes in SF6 retention, within all breathing cycles 
recorded, before and after induction of ALI. In healthy lungs at PEEP0 
there was a decrease in SF retention at the end of inspiration and a 
return to baseline levels during expiration. In contrast, SF6 retention 
increased at PEEP0 in ALI during inspiration and decreased during 
expiration. In healthy pigs ventilated with PEEP15 there was an increase 
in SF6 retention at the end of inspiration and a return to baseline during 
expiration similar to the changes observed in pigs with ALI at PEEP0. In 
ALI at PEEP15, shunt decreased throughout inspiration and returned to 
baseline levels during expiration.
Conclusion Serial dynamic pulmonary shunt measurements during 
mechanical ventilation showed distinct variations over the respiratory 
cycle in both healthy and injured lungs. Increasing PEEP from 0 to 
15 cmH2O altered the patterns of dynamic pulmonary shunt before 
and after ALI. Thus, serial assessment of dynamic pulmonary shunt 
fraction by SF6 retention with MMIMS-MIGET could prove useful for 
optimization of mechanical ventilation in healthy and injured lungs.
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Introduction We sought to determine in a swine model whether a 
novel echocardiography method, speckle tracking echocardiography 
(STE), could determine deterioration in right ventricle (RV) function 
induced by escalating levels of positive end-expiratory pressure (PEEP), 
and to compare STE with RV fractional area change (FAC). Acute cor 
pulmonale and hypotension can be induced by high levels of PEEP 
used in the management of acute respiratory distress syndrome [1]. 
Quantifying RV function by echocardiography can be challenging due 
to its shape and position. STE is a relatively new, feasible, sensitive, 
angle-independent method for describing cardiac deformation (strain) 
[2] and is particularly useful in analyzing RV function (RV free wall strain, 
RVfwS), as has been shown in pulmonary hypertension cohorts [3].
Methods Ten pigs, 40 to 90  kg, anaesthetized, fully mechanically 
ventilated at 6 to 8 mg/kg were subject to stepwise escalating levels of 
PEEP at 2-minute intervals (0, 5, 10, 15, 20, 25 and 30 cmH2O). RV images 
were obtained using intracardiac echocardiography (for optimal frame-
rate and endocardial defi nition) and were analyzed offl  ine for FAC and 
RVfwS (using Velocity Vector Imaging; Siemens).
Results Escalating levels of PEEP were strongly associated with 
signifi cant reductions in mean blood pressure (R2 = 0.8, P <0.0001), FAC 
(R2 = 0.8, P <0.0001) and RVfwS (R2 = 0.9, P <0.001). Paired t tests indicated 
signifi cant reductions in RVfwS with each step increase in PEEP. FAC 
only showed signifi cant deterioration at 15  cmH2O PEEP. Signifi cant 
hypotension (a decrease of more than 20  mmHg) occurred after 
10  cmH2O PEEP. RVfwS decreased by a larger extent and earlier than 
FAC and mean blood pressure with increasing levels of PEEP.
Conclusion RVfwS measured by STE is a sensitive method for 
determining RV dysfunction induced by PEEP. RVfwS displays a stronger 
association, greater deterioration and earlier reduction than FAC and 
mean blood pressure with escalating levels of PEEP. This potentially has 
interesting implications for the role of STE in managing PEEP levels in 
critically ill patients with acute lung injury.
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Introduction Airway pressure release ventilation (APRV) is a pressure-
limited, time-cycled mode of mechanical ventilation. It increases the 
cardiac index, resulting in improved organ perfusion, which is crucial 
in cardiogenic shock patients preventing organ failure secondary to 
inadequate perfusion [1]. The purpose of this study was to evaluate 
the eff ectiveness of APRV in restoring hemodynamic stability and 
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improving oxygenation in ventilated patients with cardiogenic shock 
and severe progressive hypoxemia.
Methods All cardiac and cardiac surgical patients with cardiogenic 
shock and ALI/ARDS admitted to our ICU were enrolled between 
January 2012 and September 2013. Data were collected on admission 
while the patients were on the conventional mode of ventilation and 
after 48  hours from switching to APRV. All enrolled patients were 
hemodynamically monitored with a pulmonary artery catheter and 
frequent echocardiography assessment. A retrospective analysis of 
these data was performed.
Results Completed datasets were obtained from 29 patients. The 
cardiac index was increased by 30% (P <0.013), serum lactate decreased 
by 37% (P  <0.001), central venous saturation increased by 42% 
(P  <0.001) and peak airway pressure decreased 19% (P  <0.001), with 
50% increase of mean airway pressure, hypoxemia improved within 
the fi rst few hours of alveolar recruitment with PaO2/FIO2 increased by 
23% (P <0.018), and there was less use of vasopressors, sedation and 
neuromuscular blockage over the course of APRV application.
Conclusion In our patient series, APRV signifi cantly improved 
oxygenation and allowed for spontaneous breathing and a reduction 
in peak airway pressures. Furthermore, this strategy improved 
hemodynamics and facilitated weaning from MV. Therefore, our data 
suggest that this ventilation modality has favorable results and appears 
to be an eff ective alternative for lung recruitment in patients with 
cardiogenic shock and acute lung injury during their course of stay in 
cardiac ICU [2].
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Introduction We developed an experimental model of VILI, ventilating 
piglets at a strain (TV/FRC) >2.5. It is possible that lung inhomogeneities 
act as stress raisers within the lung parenchyma, locally multiplying 
pressures. In a healthy lung the pleural surface, vessels and bronchi are 
detected as natural lung inhomogeneities. We studied the development 
of VILI with CT scan to determine where the fi rst lung lesion developed.
Methods Piglets were sedated, orotracheally intubated and 
instrumented with arterial and central venous catheter and urinary 
catheter. The whole study was performed in the animal CT scan facility, 
which was equipped as an ICU, and CT scan was performed every 
3 hours or if respiratory parameters (plateau/peak pressure) changed. 
We defi ned as new lesion lung regions the appearance of poorly 
infl ated/not infl ated lung regions not present in the previous CT scan 
image. We select the fi rst CT scan in which a relevant number of new 
lesions appeared (>15) and manually delineated the lesions; the lesions 
were classifi ed as close/not close to the pleural surface.
Results Six piglets were studied (22 ± 8 kg) that were ventilated with 
a TV of 750 ± 71 ml (41 ± 1 ml/kg) up to development of VILI, defi ned 
radiologically as infi ltrates present in all pulmonary fi elds at CT scan 
plus development of lung edema. In the fi rst CT scan where lesions 
appeared, a median of 28 lesions (IQ range 22 to 30) were present. Of 
these lesions, 18 (17 to 22) (72%) were located near the pleura and nine 
(6 to 11) (28%) near vessels/bronchi. See Figure 1.
Conclusion In an experimental model of VILI the fi rst lung lesions 
appear below the pleural surface. Mutiple nonmutually exclusive 
possible explanations are possible: the pleural surface acts as a stress 
raiser; the mechanical friction of the lung with the ribs at very high tidal 
volume leads to parenchimal injury; and the lung skeleton is a fan-like 
structure starting from the hilum and going to the pleural surface, 
leading to increased stress/strain of the subpleural regions.
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Introduction During mechanical ventilation some of the energy 
delivered to the respiratory system (RS) is dissipated within it, while 
some is recovered during expiration. The amount of unrecovered 
energy represents mechanical work done on the RS by the ventilator 
and may be related to the development of ventilatory-induced lung 
injury (VILI). The unrecovered energy is measured as the hysteresis area 
of the pressure–volume (PV) curve in static and dynamic conditions. 
We explored how and where the energy is dissipated inside the RS.
Methods In fi ve piglets (weight 21 ± 2 kg) under general anesthesia, 
we recorded PV curves to quantify dynamic dissipated energy (DE) 
at increasing tidal volume (TV) (150, 300, 450, 600, 750, 900) and at 
increasing respiratory rate (RR) (3, 6, 9, 12, 15). We then recorded PV 
curves for the same TV infl ated with a super-syringe (100 ml), to quantify 
static DE. We also quantifi ed airway DE connecting the postmortem 
isolated tracheobronchial tree to the ventilator and recording PV 
curves at the respiratory setting previously described.
Figure 1 (abstract P283).
Figure 1 (abstract P284). Relationship between fl ow (l/minute) and 
(dynamic–static) dissipated energy (J).
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Results Static DE(J) had a nonlinear relationship with the TV (ml/kg) 
applied: static DE  = 0.0031*TV1.5198, R2  = 0.96. Subtracting from the 
PV curve hysteresis area of a single breath (dynamic DE) the airway 
DE, the resulting curve overlapped static DE at every RR considered, 
suggesting that the amount of energy spent on the RS is equal to the 
static DE. Static DE can be estimated knowing fl ow (l/minute) and 
dynamic DE(J) since:
(dynamic–static)DE = 0.0014*[fl ow]2 – 0.0173*fl ow + 0.1387, R2 = 0.90 
(Figure 1).
Conclusion According to our data, the amount of energy that may be 
related to the development of VILI is static DE; it is a nonlinear function 
of TV and can be estimated knowing fl ow and dynamic DE.
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Introduction CT-scan quantitative analysis (qCT) represents the gold 
standard to assess lung aeration and recruitment in ARDS patients. 
Lung ultrasound (LUS) has been proposed as a bedside nonirradiating 
alternative to assess lung recruitability, identifying patients who may 
benefi t from higher PEEP levels. We compared the two methods in the 
assessment of PEEP-induced lung aeration changes.
Methods LUS and whole-lung CT scan were performed on ARDS 
sedated, paralyzed, mechanically ventilated patients at PEEP 5 and 
15  cmH2O. LUS was performed considering six areas for each lung, 
with a comprehensive scan of the intercostal spaces in each area. We 
assigned to each area a score of aeration [1]: 0 (normal lung), 1 (≥3 
noncoalescent B-lines), 2 (≥3 coalescent B-lines), 3 (consolidation). A 
cumulative LUS score (LUSS, ranging from 0 to 36 for the two lungs) 
was obtained as sum of all areas’ individual scores, each area’s score 
being the average of all pertaining LUS fi ndings. LUS recruiters upon 
PEEP increase from 5 to 15 cmH2O were defi ned by the switch of at least 
three areas to well aerated (area score 0). LUS-based assessment of lung 
aeration and lung recruitability was compared with qCT fi ndings.
Results We enrolled seven patients (six males, age 54.1  ±  22.2  years, 
BMI 24.2 ± 4.9 kg/m2, PaO2/FiO2 186 ± 78, tidal volume 445 ± 140 ml, RR 
14.5 ± 3.4 breaths/minute, PEEP 12.5 ± 3.3 cmH2O). In the 14 conditions 
evaluated, median LUSS was 19 (IQR 14 to 23); LUSS ≤19 (n  = 8) 
corresponded to 34 ± 13% of nonaerated tissue at qCT; LUSS >20 (n = 
6) to 48 ± 18% (P <0.05). A good linear correlation was found between 
reduction at LUS of consolidated areas (area score 3) versus reduction 
of qCT nonaerated volume (R2 = 0.66), and between reduction at LUS of 
poorly aerated areas (area score 1 to 2) versus reduction of qCT poorly 
aerated volume (R2  = 0.74). Change at LUS of at least three areas to 
well aerated (LUS recruiters, n = 4) corresponded to a qCT increase in 
well-aerated lung volume of 788 ± 262 g versus 431 ± 35 g in the LUS 
nonrecruiter group (n = 3) (P <0.05).
Conclusion These preliminary data suggest that LUS could be an 
accurate tool to assess lung aeration and recruitment at the bedside, 
avoiding the risks and workload related to the use of CT scan.
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Introduction Growing evidence suggests that, as long as the total lung 
capacity is not overcome, dynamic (that is, tidal volume, VT) is more 
injurious than static (that is, positive end-expiratory pressure, PEEP) 
lung deformation [1]. Because the lung behaves like a viscoelastic 
body [2], hysteresis may play a role in the development of ventilator-
induced lung injury. The aim of the study was to investigate the eff ects 
of increasing VT or PEEP on lung hysteresis.
Methods In eight healthy piglets we measured total hysteresis and 
the peak inspiratory pressure (Ppeak) while randomly increasing VT 
(with no PEEP) or PEEP (with fi xed VT). P1 was extrapolated from the 
drop in airway pressure during an end-inspiratory pause [3]. Hysteresis 
attributable to lung parenchyma was computed as: total hysteresis – 
((Ppeak – P1) × VT).
Results The main fi ndings are shown in Figure 1. P values refer to one-
way repeated-measures analysis of variance.
Conclusion Lung hysteresis increases with VT, but not with PEEP. 
Further studies are needed to prospectively evaluate the role of lung 
hysteresis in the pathogenesis of ventilator-induced lung injury.
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Figure 1 (abstract P286). Lung hysteresis as a function of VT (A) and PEEP (B). *P <0.05 versus VT 250 ml or PEEP 0 cmH2O (Holm–Sidak method).
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Introduction Mechanical ventilation (MV) aims to enhance blood 
oxygenation and to remove carbon dioxide. However, excessive 
hyperinfl ation by MV may cause lung injury.
Methods Eighteen cats (4  ±  1  kg) were anesthetized with propofol 
(loading dose of 6 mg/kg and constant rate infusion of 0.5  mg/kg/
minute) and neuromuscular blockade was achieved with rocuronium 
at 1 mg/kg/minute. Their lungs were initially mechanically ventilated 
in FiO2 of 40%, with peak inspiratory pressure (Ppeak) of 5 cmH2O for 
20 minutes, and then the Ppeak was increased by 5 cmH2O increments 
until 15 cmH2O every 5 minutes. Following that, Ppeak was decreased 
by 2  cmH2O every 5  minutes until reaching Ppeak of 5  cmH2O. The 
ventilator maintained the respiratory rate and inspiratory time at 
15  breaths/minute and 1 second, respectively. Between the Ppeak 
increments, we applied a 4-second pause for a 5-mm computed 
tomography (CT) scan of the thorax area. The radiographic attenuation 
(in Hounsfi eld units, HU) was classifi ed as over-insuffl  ation (1,000 to 
900  HU), normal insuffl  ation (900 to 500  HU) and atelectasic (500 to 
100 HU). We split the lungs into three proportional gravitational zones 
(I, II and III) from apex to base.
Results The three zones presented increased over-insuffl  ated areas and 
decreased areas with normal insuffl  ation with increasing Ppeak from 
5 to 15 cmH2O. At 5 cmH2O, the areas of over-insuffl  ation and normal 
insuffl  ation in zones I, II and III were 13% and 36%; 4% and 22%; and 
0.7% and 15%, respectively. At 15 cmH2O, the areas of over-insuffl  ation 
and normal insuffl  ation in zones I, II and III were 74% and 55%; 81% and 
57%; and 82% and 71%, respectively.
Conclusion The higher proportion of overly distended pulmonary 
areas in high Ppeak may increase the risk of lung injury. The lowest 
Ppeak (5 cmH2O) showed less potential to lung injury as it has higher 
areas of normal insuffl  ation and less areas of over-insuffl  ation in all 
gravitational zones.
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Introduction Activation of lymphocyte apoptosis while reducing the 
endogenous nitric oxide is a predictor of adverse outcome in newborns 
on mechanical ventilation [1]. With the aim to improve the results 
of treatment we studied the eff ect of inhalable nitric oxide on the 
immune system in newborns with respiratory diseases on mechanical 
ventilation [2].
Methods With the permission of the ethics committee in a controlled, 
randomized, blind clinical trial we included 27 newborns with respiratory 
diseases on mechanical ventilation. Randomization was performed by 
the method of envelopes. Group I (n = 17), patients receiving inhalation 
of nitric oxide at a concentration of 10 ppm for 24 hours controlling the 
level of methemoglobin (Pulmonox mini; Messer II NO Therapeutics, 
Austria). Group II (n  = 10) did not receive inhaled NO. At admission 
and at 3 to 5  days we studied subpopulations of lymphocytes by 
one-parameter immunophenotyping using reagents (Immunotech 
Beckman Coulter, USA): fi tz-labeled CD3, CD4, CD8, CD14, CD19, CD34, 
CD56, CD69, CD71, CD95 monoclonal antibody, the relative content of 
lymphocytes in early and late apoptosis using Annexin V+-labeled FITK 
and propidium iodide (PL+), labeled with PE (Saltag, USA), with results 
on the Beckman Coulter Epics XL cytometer (USA). The statistical power 
of the study was 80% (α ≤0.05).
Results In Group I relative to group II at 3 to 5 days we registered an 
increase in mature monocytes (CD14) – 23.1 ± 0.8% (P <0.05); reduction 
in the relative content of CD69 – 3.8 ± 0.21%, lymphocyte of apoptosis: 
(Annexin V–FITC+PI–)  – 7.12  ±  0.46% and (Annexin V–FITC+PI+)  – 
0.79  ±  0.07% (P  <0.001). The duration of mechanical ventilation was 
4.1  ±  1.4 days (P  <0.05). All patients survived. None of the patients 
showed clinical or laboratory evidence of adverse eff ects of inhaled 
nitric oxide. In Group II seven newborns died, and the duration of 
mechanical ventilation in survivors was 18 ± 3.4 days.
Conclusion Inhalable of nitric oxide activates monocyte–macrophage 
immunity, stabilizes the apoptosis of T-lymphocytes, and reduces 
mortality and duration of mechanical ventilation in newborns with 
respiratory diseases on mechanical ventilation.
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Introduction Sepsis-induced diaphragm dysfunction (SIDD) has 
been widely described in the literature as a condition aff ecting the 
diaphragm muscle characterized by contractility loss of function and 
associated with a high mortality, assessed at around 54% [1]. Previous 
studies have investigated the pathogenesis of ventilator-induced 
diaphragmatic dysfunction (VIDD), its lipid metabolic alterations [2] 
and microcirculatory function processes. This study was designed 
to investigate on diaphragm muscle the eff ects of LPS-induced 
endotoxemia in rabbits undergoing two diff erent modes of mechanical 
ventilation.
Methods A prospective randomized animal study in 25 invasively 
monitored and mechanically ventilated New Zealand White rabbits. 
The rabbits were randomized to control (n = 5), controlled mechanical 
ventilation (CMV) (n  = 5), pressure support ventilation (PSV) (n  = 5), 
or CMV or PSV with LPS-induced endotoxemia (CMV-LPS and PSV-
LPS respectively) (n  = 5 for each). The endotoxemia was induced 
by LPS injection in the CMV-LPS and PSV-LPS groups. Rabbits were 
anesthetized and ventilated for 24  hours, except for the control 
(30 minutes). A catheter able to detect the electrical activity of the 
diaphragm was placed to evaluate the diaphragm contractility at 
baseline and after 6, 12 and 24  hours. After 24  hours, we evaluated: 
the diaphragm microcirculation assessed by a sidestream dark-fi eld 
videomicroscopy; the mitochondria membrane potential; the lipid 
accumulation; and the diaphragm muscular fi ber structure.
Results In endotoxemic animals, after 24  hours, the diaphragm 
contractility and fi ber structure, the microcirculation, mitochondrial 
membrane potential and lipid accumulation were severely 
compromised, but not in the CMV and PSV groups. Moreover, a slight 
but signifi cant increase of lipid accumulation was observed in the CMV 
and PSV groups in comparison with control (P <0.05).
Conclusion In endotoxemic rabbits, the impaired microcirculation 
resulted in an increased lipid accumulation and in a disturbance of the 
mitochondria membrane potential and contractility of the diaphragm. 
No microvascular alterations have been observed in ventilated 
non-endotoxemic animals. Moreover, the diaphragm contractility 
dysfunction was more pronounced in endotoxemic animals.
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Introduction Limited evidence exists as to the value of high-frequency 
oscillatory ventilation (HFOV) for patients with H1N1 [1,2]. We describe 
a subgroup of patients, from a single UK centre, who received HFOV 
and had H1N1-positive virology.
Methods Local permissions for research were obtained. Patients with 
confi rmed H1N1 who underwent HFOV between 2008 and 2012 were 
included. Data collected retrospectively included demographics, 
diagnosis, illness severity and outcome measures.
Results We identifi ed 10 patients (Table  1) who received both HFOV 
and had confi rmed H1N1. Two patients were transferred to a tertiary 
centre to receive ECMO and both critical care and 6-month mortality 
were 40%.
Table 1 (abstract P290). Patient characteristics
Male (%) 60
Age (years) 39.4 ± 9.75
Mean APACHE II 19.5 ± 4.88
Pre-HFOV neuromuscular blockade infusion (%) 40
Pre-HFOV vasoactive drug infusion (%) 50
Mean pre-HFOV VT exp (ml/kg) 8.54 ± 2.68
Median P/F ratio (mmHg) 
 Pre HFOV 67.5
 0 hours 94.35
 4 hours 110.4
Conclusion This study adds to the literature on the use of HFOV in H1N1 
patients. We managed to replicate some of the existing evidence in 
respect to the population age [1,2] and the incidence of mortality. Whilst 
P/F ratios improved on initiation of HFOV, these patients subsequently 
had long critical care and hospital stays. There is uncertainty regarding 
the use of HFOV in ARDS, but it may be a valuable treatment for H1N1 
patients. The ventilation strategies employed and the subsequent 
consequences for H1N1 patients require further evaluation.
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Introduction The aim was to study EIT as a monitoring tool for tidal 
ventilation (TV) redistribution following switching patients from 
volume-controlled ventilation (VCV) to airway pressure release 
ventilation (APRV) in patients with severe ARDS.
Methods Six patients with severe ARDS having Pplat ≥30  cm were 
included in the study. Patients ventilated with the ARDSnet strategy 
were subjected to EIT analysis. Regional TV distribution was monitored 
by an EIT system (PulmoVista 500®; Dräger Medical GmbH, Lübeck, 
Germany), dividing the lung fi eld into four same-size regions of interest 
(ROIs): ventral right (ROI 1) and left (ROI 2) and dorsal right (ROI 3) and 
left (ROI 4). In step 1, patients ventilated with VCV as per the ARDSnet 
protocol were subjected to EIT analysis. In step 2, patients were 
switched to APRV. Ventilation parameters, arterial blood gas analysis 
and percentage of tidal ventilation distribution in the four ROIs were 
recorded at steps 1 and 2. Analyses were performed by paired t test.
Results Patients on VCV had P/F ratio of 79.5  ±  12.5 with PEEP of 
14.16  ±  1.32 There was a signifi cant improvement in P/F ratios 
on switching to APRV (126.16  ±  23.69, P  = 0.002) at 30 minutes of 
ventilation on APRV. There was a trend to decrease in FiO2 (0.82 ± 0.15 
vs. 0.68 ± 0.10, P = 0.068) and PCO2 (52.5 ± 6.15 vs. 45.00 ± 8.67, P = 
0.071) and increase in PaO2 (65.83 ± 14.53 vs. 84.83 ± 12.22, P = 0.056) 
at step 2. The proportional distribution of ventilation in the dorsal ROI 3 
and ROI 4 also improved on switching to APRV. TV in ROI 3 during VCV, 
12.76 ± 6.76%, improved to 24.58 ± 6.61% (P = 0.067). Similarly TV in 
ROI 4 during VCV, 24.58 ± 6.61%, improved to 26.6 ± 6.09% (P = 0.068). 
Due to small sample size, improvement in TV in dorsal ROIs was not 
statistically signifi cant. Upper panel of Figure 1 shows end-inspiratory 
and end-expiratory images of EIT on VCV with poor TV in dorsal ROI 3 
and ROI 4. Lower panel of fi gure shows two EIT images at Phigh = 30 cm 
showing improved TV in dorsal ROIs.
Conclusion EIT may help to identify patients with severe ARDS on VCV 
with a potential of increasing recruitment by tidal redistribution of 
ventilation with APRV.
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Introduction Mechanical ventilation aff ects systemic infl ammation 
where protective ventilation attenuates the response [1]. Plasma 
Figure 1 (abstract P291). EIT comparison of VCV and APRV.
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levels of cell-free DNA (cfDNA) increase and have prognostic value in 
sepsis [2]. In the present study, the eff ect of tidal volume and PEEP on 
arterial and transorgan levels of cfDNA was investigated in a porcine 
postoperative sepsis model.
Methods Two groups of anaesthetised pigs were ventilated with 
either protective ventilation (VT 6  ml/kg, PEEP 10  cmH2O; n  = 20) or 
controls (VT 10 ml/kg, PEEP 5 cmH2O; n = 10) for 7 hours. An artery, the 
hepatic vein, the portal vein and the jugular bulb were catheterized. 
Continuous endotoxin infusion at 0.25  μg/kg/hour for 5  hours was 
started after 2 hours of laparotomy that simulated a surgical procedure.
Results The group receiving protective ventilation showed lower levels 
of cfDNA in arterial blood compared with controls (P  = 0.02). Trans-
hepatic levels of cfDNA were higher compared with trans-splanchnic 
levels during the experiment (P = 0.02), but this eff ect was attenuated 
in the group receiving protective ventilation. No diff erence between 
the groups was detected in blood samples from the jugular bulb.
Conclusion In experimental postoperative sepsis, protective ventila tion 
suppresses arterial levels of cfDNA. The liver seems to be a signifi cant 
contributor to systemic cfDNA levels, an eff ect that is suppressed 
during protective ventilation.
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Introduction HFOV is a promising rescue therapy for refractory hypoxia 
in severe ARDS.
Methods This is a retrospective comparative study. We retrieved data 
for all patients with H1N1 infl uenza-related severe ARDS treated in the 
ICU during October 2009 to April 2013. Our ICU had only one HFOV 
machine during the pandemic. Patients were divided into two groups: 
HFOV group (received HFOV at fi rst eligibility) and conventional lung 
protective ventilation (CLPV) group (did not receive HFOV at fi rst 
eligibility due to nonavailability of HFOV). Eligibility criteria for rescue 
therapy by HFOV were: P/F ratio ≤100; PEEP needed above 12 cm; Pplat 
≥30  cm on CLPV. There was no selection or omission bias for HFOV 
application and HFOV was applied to the fi rst eligible patient. Patient 
demographic data, laboratory parameters, hemodynamic variables, 
and oxygenation and ventilator settings were recorded while on CLPV 
at fi rst HFOV eligibility in all patients.
Results The total of 43 patients who met the rescue therapy criteria 
were further grouped into the HFOV group (24 patients) and the 
CLPV group (19 patients) depending upon modality of ventilation 
received after satisfying fi rst-time HFOV eligibility criteria. Both groups 
were comparable for diff erences with Fisher’s t test for qualitative 
variables and ANOVA for quantitative variables (Table  1), except for 
higher mortality in the CLPV group (16/19 (84.4%) vs. 12/12 (50%), P = 
0.026). On logistic regression analysis to fi nd independent variables 
diff erentiating the two groups, mortality was higher in the CLPV group 
(P = 0.02, odds ratio (CI) 71.60 (1.85 to 2,766.59)) compared with the 
HFOV group.
Conclusion HFOV when applied as rescue therapy for refractory 
hypoxia due to severe ARDS caused by H1N1 infl uenza pneumonia is 
associated with better outcome compared with CLPV.
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Introduction Intratidal opening/closing is believed to be one of the 
main triggers of ventilator-induced lung injury; the application of 
higher PEEP united with the limitation of plateau pressure at 30 cmH2O 
may limit this phenomenon. We aim to evaluate the intratidal opening/
closing at diff erent PEEP levels and the amount of lung parenchyma 
that regains infl ation going from 30 (pressure limit of tidal ventilation) 
to 45 cmH2O.
Methods Patients with ARDS underwent whole-lung low-dose (60 mAs, 
120 kV) computed tomography at PEEP 5 cmH2O end expiration and 
end inspiration, PEEP 15  cmH2O end expiration and end inspiration, 
and airway pressure 30 and 45  cmH2O end inspiration. Quantitative 
analysis of CT data was performed and recruitability was defi ned as the 
fraction of lung parenchyma that regains infl ation going from 5 cmH2O 
end expiration to 45 cmH2O end inspiration. Patients were classifi ed as 
high recruiters (HR) and low recruiters (LR) according to the median 
lung recruitability (14% of lung parenchyma).
Results Eighteen patients (male 12, age 56.0  ±  18.6  years, BMI 
25.6  ±  5.2  kg/m2, PaO2/FiO2 166  ±  70, tidal volume 496  ±  84  ml, RR 
19  ±  7.4  breaths/minute, PEEP 11.4  ±  3.7  cmH2O) were enrolled. The 
fraction of lung parenchyma that could be recruited at plateau pressure 
above 30 cmH2O was highly variable with a median of 5% (IQ range 1 
to 17%) corresponding to a median 16% (IQ range 10 to 47%) of total 
lung recruitability. Indeed we observed a statistically relevant diff erence 
in lung recruitment between airway pressures of 30 and 45 cmH2O (P = 
0.016). With PEEP 5 cmH2O, median opening/closing was 129 g (IQ range 
124 to 145 g) in the HR group and 50 g (IQ range 24 to 76 g) in LR (P = 
0.006), corresponding to 8% of lung parenchyma (IQ range 6 to 8%) in HR 
and 4% (2 to 7%) in LR (P = 0.053). Increasing the PEEP level to 15 cmH2O, 
median opening/closing was 67 g (IQ range 24 to 95 g) in the HR group 
and 45 g (0 to 80 g) in the LR group (P = 0.512), corresponding to 3% (1 
to 5%) in HR and 3% (0 to 5%) in LR (P = 0.93). We observed a statistical 
diff erence between recruitments with PEEP 5 and PEEP 15 in the HR 
group (P = 0.013) but not in the LR group (P = 0.781).
Conclusion A highly variable and signifi cant fraction of lung 
parenchyma is always closed with tidal ventilation at 30 cmH2O plateau 
pressure, regardless of the PEEP level applied; this implies that sigh 
or periodic recruitment maneuvers may lead to opening and closing. 
Intratidal opening/closing was reduced but not abolished in all patients 
while ventilating at higher PEEP level (15 cmH2O).
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Introduction The importance of protective lung ventilation in reducing 
mortality in adult respiratory distress syndrome (ARDS) patients is well 
described [1]. However, suboptimal compliance with the recommended 
tidal volumes has been reported [2]. Therefore, we wished to assess our 
compliance in adhering to protective lung ventilation in patients with, 
or at risk of developing, ARDS.
Methods A retrospective review was done on all mechanically 
ventilated patients in the ICU of Tallaght Hospital over a 6-month 
period (February to July 2013). Hourly tidal volumes were recorded 
Table 1 (abstract P293).
Variable CLPV (n = 19) HFOV (n = 24) P value
Age 41.15  32.83  0.07
SOFA 4.95  4.62  0.41
Pplat 29.57  30.46  0.26
O.I. 38.88  35.70  0.54
P/F 70.63 76.79 0.50
PCO2 59.89  59.92  0.99
Death 16 12 0.02
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automatically in electronic charts. Compliance was assessed by 
calculating the total time patients with, or at risk of developing, ARDS 
were ventilated with tidal volumes <6 ml/kg, 6 to 8 ml/kg, and >8 ml/
kg during the fi rst 72 hours on mechanical ventilation. ARDS is defi ned 
as per the Berlin criteria [3]. Exclusion criteria were patients who did 
not receive invasive ventilation or who were ventilated for less than 
72 hours. We also assessed whether patients’ height was documented.
Results A total of 72 patients were ventilated for >72 hours. Of these 
patients (44 males, 28 females, mean age 65.5  years), ARDS criteria 
were met in 17 patients and 22 patients were determined to be at risk 
of developing ARDS. For patients with ARDS, the ventilated time with 
tidal volumes <6 ml/kg, 6 to 8 ml/kg, and >8 ml/kg was 25.3%, 31.7% 
and 43% respectively. For patients at risk of developing ARDS, the 
ventilated time with tidal volumes <6 ml/kg, 6 to 8 ml/kg, and >8 ml/
kg was 15.7%, 29.3%, 55%, respectively (Table 1). A total of 16 patients 
(nine who had ARDS) had no documentation of their height.
Table 1 (abstract P295).
Tidal volume With ARDS (%) At risk of ARDS (%)
<6 ml/kg 25.3 15.7
6 to 8 ml/kg 31.7 29.3
>8 ml/kg 43 55
Conclusion Compliance with protective lung ventilation in our ICU is 
suboptimal. This may be due to the lack of education and guidelines 
in the unit regarding protective lung ventilation. Moreover, accurate 
recording of patient height and determination of predicted body 
weight should be documented to facilitate accurate tidal volume 
calculation and protective lung ventilation.
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Introduction During mechanical ventilation the expiration occurs 
passively and is determined by the recoil forces of the respiratory 
system. In an experimental study in pigs we could fi nd that linearization 
of the expiratory fl ow via FLow-controlled EXpiration (FLEX) [1] is lung 
protective [2]. Utilizing electrical impedance tomography (EIT) we 
aimed at investigating the mechanisms underlying the lung-protective 
eff ects of FLEX.
Methods All experiments were approved by the local animal welfare 
committee. Twelve pigs with oleic acid-induced lung injury were 
ventilated in the volume-controlled mode (VCV). In six animals, 
expiratory fl ow was linearized via FLEX. PEEP was set to achieve similar 
mean airway pressure in the control group (n = 6) and in the FLEX group 
(n = 6). Using EIT, the local distribution of ventilation was measured and 
alveolar derecruitment during the no-fl ow phase in late expiration was 
quantifi ed.
Results During ventilation with FLEX the no-fl ow phase in late 
expiration was reduced by 50% compared with passive expiration. 
Derecruitment during the no-fl ow phase was clearly reduced by FLEX 
compared with VCV. Furthermore, intratidal ventilation was more 
homogeneously distributed during ventilation with FLEX compared 
with conventional passive expiration.
Conclusion In comparison with conventional VCV with passive 
expiration, the no-fl ow phase in late expiration is reduced and so is the 
time the lung persists on the lowest pressure level (PEEP) during the 
breath. The reduced low-pressure time is associated with reduced end-
tidal derecruitment. In a lung mechanically stabilized and recruited 
by sustained airway pressure throughout the expiration phase, the 
distribution of ventilation is more homogeneous. These mechanisms 
of alveolar recruitment maintenance can explain the lung-protective 
eff ects of FLEX.
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Introduction Numerous parameters have been suggested for the 
prediction of weaning from mechanical ventilation; however, these 
parameters have limited success in the prediction of weaning outcome. 
The aim of this study is to assess the success of minute peak fl ow rates 
(spontaneous peak inspiratory fl ow rate (SPIF) and spontaneous peak 
expiratory fl ow rate (SPEF)) measured during a spontaneous breathing 
trial (SBT) in the prediction of weaning outcome.
Methods Patients managed and receiving mechanical ventilation 
support for at least 24 hours in the medical and surgical ICUs of Erciyes 
University between March 2011 and May 2012 were included in the 
present study. Over 30 minutes, SPIF and SPEF values were measured 
during a SBT in patients spontaneously breathing by T tube. Patients 
who tolerated 30  minutes of SBT were extubated. Patients who did 
not need reintubation for 48 hours after extubation were considered 
successful weaning, while those needing reintubation were considered 
weaning failure.
Results The study was completed with 36 patients overall, being 11 
patients in failure and 25 patients in the success group. In both groups, 
areas under the curve (AUCs) were calculated for each minute via ROC 
analysis using minute SPIF and SPEF values measured during SBT. The 
maximum AUC was calculated at minute 23 for SPIF (0.564; 95% CI: 
0.363 to 0.764) and at minute 9 for SPEF (0.542; 95% CI: 0.316 to 0.376). 
Cutoff  values were determined for the minutes in which maximum AUC 
values for SPIF and SPEF were detected; and sensitivity and specifi city 
values were calculated. When the cutoff  value for SPIF was accepted as 
>26.7 l/minute at minute 23, sensitivity and specifi city was calculated 
as 72.0% and 28.0%, respectively. When the cutoff  value for SPEF was 
accepted as >24.7 l/minute at minute 9, sensitivity and specifi city were 
calculated as 63.6% and 48.8%, respectively.
Conclusion We think that minute SPIF measurement which has 
better sensitivity and minute SPEF measurement which has better 
specifi city compared with available traditional predictors [1] may be 
used as a potential bedside weaning predictor when evaluated in 
comprehensive studies.
Reference
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Introduction Lung ultrasound is increasingly becoming a diagnostic 
tool in the critical care setting. The B-line is an artifact that correlates 
with interstitial edema. Decreases in intrathoracic pressure during 
a spontaneous breathing trial (SBT) will augment venous return and 
impede left ventricular ejection, increasing intrathoracic blood volume. 
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Therefore, the presence of cardiovascular dysfunction can contribute to 
weaning failure (WF). A randomized trial concluded that bedside lung 
ultrasound could predict post-extubation distress through changes 
in aeration during a T-tube test; however, it could not screen patients 
before submission to a SBT [1]. We aim to assess the reliability of lung 
ultrasound as a predictor of weaning outcomes.
Methods We conducted a prospective, multicenter, observational study 
in two adult medical–surgical ICUs. Lung ultrasound was performed 
immediately before SBT. Three or more B-lines in a single view were 
called a B-pattern. B-predominance was defi ned as a B-pattern on at 
least one of the four anterior chest wall zones. All enrolled patients met 
eligibility criteria for ventilation liberation. Patients with tracheostomy 
were excluded.
Results During 2  years, 250 SBTs were analyzed. WF, defi ned as an 
inability to tolerate a T-tube trial during 30 to 120 minutes, occurred 
in 51 (20.4%). There was a higher prevalence of chronic obstructive 
pulmonary disease in the WF group as well as higher duration of 
mechanical ventilation. WF patients were also younger. Patients 
succeed at SBT and were extubated at fi rst time in 75.9% of cases. We 
observed a signifi cant association between B-predominance prior to 
submission to SBT and WF (OR = 1.99 (1.04 to 3.84)). For diagnosing WF, 
B-predominance showed 69% sensitivity, 48% specifi city, 25% positive 
predictive value, and 86% negative predictive value.
Conclusion The fi nding of B-predominance at bedside lung ultrasound 
performed before SBT predicts WF, although it shows low accuracy.
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Introduction Fluid balance (FB) has been associated with weaning and 
extubation failure, particularly of cardiac origin. Also, the increased 
right ventricular afterload, a feature common in chronic obstructive 
pulmonary disease (COPD) patients especially during a weaning test, 
may hinder diastolic fi lling of the left ventricle through a biventricular 
interdependence mechanism. We aimed to investigate the relationship 
of the FB in the 48 hours prior to a spontaneous breathing trial (SBT) 
and weaning outcomes in a subgroup of COPD patients admitted to a 
medical–surgical ICU.
Methods We conducted a 2-year prospective, multicenter, obser-
vational study in two adult medical–surgical ICUs. All enrolled 
patients met eligibility criteria for ventilation liberation. Patients with 
tracheostomy were excluded. We collected demographic, physiologic, 
48-hour FB (measured inputs minus outputs) and lung ultrasound 
fi ndings immediately before a SBT in 29 COPD patients. Our main 
outcome of interest was weaning failure (WF), defi ned as the inability 
to tolerate a T-tube trial during 30 to 120  minutes, in which case 
patients were not extubated.
Results Weaning success (WS) (n = 19) and WF (n = 10) patients were 
similar in relation to age, sex, APACHE II score, reason for mechanical 
ventilation (MV) and comorbidities. Mean duration of MV was 11 days. 
FB in the 48  hours prior to the SBT did not diff er between the WS 
and WF groups (1,091.11  ±  2,195.89  ml and 2,398.80  ±  1,533.15  ml, 
respectively). Nevertheless, comparing individuals with 48-hour 
FB above and under the cutoff  value of 0  ml according to weaning 
outcomes resulted in signifi cant association between positive FB and 
WF in COPD patients (odds ratio = 1.77 (1.24 to 2.53)). That cutoff  point 
was obtained on the ROC curve. See Figure 1.
Conclusion Positive FB in the 48  hours preceding the SBT predicted 
WF in COPD individuals. We recognized that no intervention was 
performed in order to accelerate the weaning process. Brain natriuretic 
peptide levels were not available.
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Introduction The rapid shallow breathing index (RSBI) is considered 
a good parameter to predict mechanical ventilator liberation. We 
hypothesized that the RSBI provides no benefi t when clinical readiness 
criteria are met.
Methods Adults with acute respiratory who required MV for more than 
24 hours, excluding COPD, were assessed daily as a liberation protocol 
(Figure 1). During the RSBI step, RSBI was recorded and blinded to the 
Figure 1 (abstract P299). Association between positive fl uid balance WF 
in COPD patients.
Figure 1 (abstract P300). Standard mechanical ventilator weaning 
protocol.
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researcher. The liberation process was continued regardless of the 
RSBI result. The primary outcome was the success rate of mechanical 
ventilator liberation with or without RSBI.
Results Analysis of 120 cases with clinical characteristics as presented 
in Table  1. There was no statistically signifi cant diff erence between 
using only clinical readiness and using clinical readiness and the RSBI 
(92% vs. 89%, P = 0.43).
Conclusion The inclusion of RSBI in our standard mechanical ventilator 
liberation protocol for patients who met the clinical readiness criteria 
did not signifi cantly increase the success rate of mechanical ventilator 
liberation.
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Introduction The purpose of this study is to prospectively evaluate the 
determinants of weaning outcome in a selected sample of ventilator-
dependent patients.
Methods After fulfi lling a set of inclusion/exclusion criteria, 46 patients 
treated in a single medical–surgical ICU were prospectively evaluated 
between October 2011 and January 2013. The study protocol 
followed the generic course of mechanical ventilatory support and its 
discontinuation. A period of CMV was followed by stepwise reduction 
in pressure support. The outcomes were recorded at the second and 
24th hour after the beginning of the PSV (8 cmH2O PS) spontaneous 
breathing trial (SBT). A short period of ZEEP breathing was introduced 
after the CMV as an additional respiratory stressor. A large number 
of parameters (including those derived via indirect calorimetry and 
esophageal balloon catheter) were analyzed. The following statistical 
methods were used: Student’s t test or its nonparametric alternatives 
for intergroup comparisons, repeated-measurements ANOVA for 
intragroup comparisons, cross-tabulation and Fisher’s exact test 
to compare categorical variables. Logistic regression analysis was 
conducted with regard to success/failure classifi cation.
Results Twenty-two (63.04% of all) patients successfully passed the 
2-hour SBT. Of them, fi ve failed the subsequent 24-hour SBT. Almost 
all of the latter (four out of fi ve) were ventilated due to chronic 
respiratory or cardiac diseases. The following parameters were 
signifi cantly diff erent between the groups of patients who successfully 
and unsuccessfully completed 2-hour SBT: pre-inclusion body weight; 
PEEPi (end-expiratory occlusion method), peak and mean airway 
pressures during CMV; PaO2, PaO2/FiO2 and oxygenation index during 
the SBT; respiratory rate, tidal volume, f/Vt, patient work of breathing 
(modifi ed Campbell method), total body oxygen consumption, 
respiratory quotient and energy expenditure during ZEEP and the SBT. 
The logistic regression model devised to predict the outcome of the 
2-hour SBT included the following parameters: type of artifi cial airway 
(tracheotomy vs. translaryngeal), oxygen consumption, f/Vt and energy 
expenditure during the SBT.
Conclusion The presence of serious respiratory and/or cardiac 
comorbidities might require longer duration of the SBT. In our study, 
respiratory load–muscle capacity balance and metabolic activity 
appear to play a major role in determining the weaning outcome. A 
short period of ZEEP breathing is safe and might have prognostic 
utility regarding the outcome of mechanical ventilatory support 
discontinuation.
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Introduction Pneumonia is the most frequent types of infection in 
cancer patients. The presence of multiresistant pathogens (MR) is 
often associated with inadequate antimicrobial therapy. The aims of 
this study were to describe the microbiology and outcomes of cancer 
patients with severe pneumonia requiring ICU admission.
Methods A secondary analysis of a prospective cohort study was 
performed from 2002 to 2011 at Instituto Nacional de Cancer and 
Hospital Sirio-Libanes, Brazil. Adult patients with a diagnosis of cancer 
with pneumonia (not acquired in the hospital setting) were evaluated 
at ICU admission. Demographic, clinical and laboratory data were 
collected during the fi rst day in the ICU, severity scores, comorbidities, 
performance status, cancer-related data, microbiologic identifi cation, 
empiric antibiotics and the adherence to treatment guidelines.
Results A total of 268 patients were enrolled: 187 (69.8%) patients with 
solid tumors and 81 (30.2%) patients with hematological malignancies. 
In total, 167 (62.3%) patients had septic shock, and ICU and hospital 
mortality rates were 45.5% and 67.9%. Microbiological confi rmation 
was present in 140 (52%) patients with 56% Gram-negative. The most 
frequent pathogens were methicillin-sensitive S.  aureus (36 (26%)), 
P. aeruginosa (35 (25%)) and S. pneumoniae (16 (12%)). Low incidence 
of MR (16 (11.4%)) was observed. Adequate antibiotic therapy based on 
microbiological identifi cation was prescribed in 120 (85.72%) patients. 
Adherence to ATS/IDSA guidelines was observed in 41 (15.3%) patients. 
There were no diff erences regarding ATS/IDSA guideline adherence 
(MR 3 (18.8%) vs. no MR 38 (15.1%), P = 0.719). We observed a trend 
towards higher hospital mortality in the MR patients (MR 14 (87.5%) 
vs. no MR 168 (66.7%), P = 0.101). In multivariate analysis, mechanical 
ventilation (OR 2.52 (1.19 to 5.32)), dialysis (3.86 (1.23 to 12.10)) and 
higher SAPS2 (OR per point 1.03 (1.01 to 1.05)) were associated 
with increased hospital mortality whereas successful noninvasive 
ventilation was associated with lower mortality (0.32 (0.13 to 0.77)). MR 
were forced into MV analysis but were not associated with outcomes.
Conclusion Severe pneumonia in cancer patients presents high 
hospital mortality, with particular clinical and microbiology features. 
Despite low adherence to ATS/IDSA guidelines, antibiotic therapy was 
adequate in most of patients following local guidelines based on local 
bacterial profi les. Further investigation is needed to clarify the impact 
of MRs in clinical outcomes of cancer patients with severe pneumonia.
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Introduction Ventilator-associated pneumonia (VAP) remains a leading 
cause of nosocomial infection in the ICU [1]. VAP is confi rmed by positive 
microbiology in approximately one-third of patients with suspected VAP 
[2], implying that there is scope to improve antibiotic stewardship. In a 
single-centre study, bronchoalveolar lavage fl uid (BALF) infl ammatory 
mediators (in particular interleukin-1 beta (IL-1β)) [3] and neutrophil 
proteases [4] demonstrated potential as biomarkers to exclude VAP. We 
aimed to validate these fi ndings in a multicentre study.
Methods We conducted a prospective, multicentre observational 
study of 167 patients with clinically suspected VAP from 12 ICUs across 
the UK. VAP was confi rmed by growth of a potential pathogen in BALF 
at >104 colony-forming units/ml. IL-1β, IL-8, matrix metalloproteinase-8 
(MMP-8), MMP-9 and human neutrophil elastase (HNE) were measured 
in BALF by cytometric bead array. IL-6, IL-8, MMP-8, MMP-9 and HNE 
were measured in serum. Patients were dichotomised into VAP and 
Table 1 (abstract P300).
Character CR CR + RSBI P value
Age 55.79 ± 19.6 56.62 ± 19.4 0.74
Male sex (%) 58.3 59.1 0.90
Success rate (%) 89.2 92.2 0.43
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non-VAP groups and receiver operating characteristics (ROC) curves 
were constructed for individual biomarkers and combinations of 
markers before optimum cutoff  points were determined.
Results A total of 150 patients had paired semi-quantitative culture 
and biomarker results. Fifty-three (35%) patients had VAP and 97 
(65%) patients formed the non-VAP group. All BALF biomarkers were 
signifi cantly higher in the VAP group (P <0.001). The area under the ROC 
curve for IL-1β was 0.81, for IL-8 was 0.736, for MMP-8 was 0.758, for 
MMP-9 was 0.785 and for HNE was 0.777. Using a cutoff  value of 17 pg/
ml, IL-1β had a sensitivity of 96.2%, a specifi city of 43.3%, a negative 
predictive value (NPV) of 95.5% and a post-test probability of 4.5% 
(95 CI: 1 to 16%). A combination of IL-1β and IL-8 excluded VAP with a 
sensitivity of 100%, a specifi city of 44.3% and a NPV of 1. There was no 
signifi cant diff erence in serum biomarkers between the VAP and non-
VAP groups.
Conclusion This study demonstrates that IL-1β eff ectively excludes 
VAP when validated in a multicentre study. The performance is further 
improved by the addition of IL-8, and the combination could form a 
rapid diagnostic assay to exclude VAP. Biomarker analysis appears to 
have the potential to improve antibiotic stewardship, and this concept 
should be formally tested in the setting of a randomised controlled 
trial.
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Introduction Ventilator-associated pneumonia (VAP) is a frequently 
occurring nosocomial infection in ICU patients and has been associated 
with increased morbidity, prolonged duration of ventilation and ICU stay 
and increased costs for healthcare. It was shown that early diagnosis of 
VAP and immediate initiation of appropriate antibiotics is associated 
with reduced morbidity and mortality. The aim of this study is to evaluate 
the potential ability of a screening test based on the clinical pulmonary 
infection score (CPIS) to identify and treat patients with VAP.
Methods All fi les belonging to patients between 18 and 80 years old 
admitted to the ICU and supported by mechanical ventilation for 
longer than 48  hours were evaluated retrospectively. Demographic 
data of the patients, the time of mechanical ventilation, duration of 
the ICU stay and results (survival or death) were recorded. The CPIS was 
calculated after 48 hours for the diagnosis of VAP. The patients with CPIS 
>5 intubated were evaluated VAP(+) and the others with CPIS ≤5 were 
thought VAP(–). The diagnosis of VAP was bacteriologically confi rmed 
with the culture of endotracheal aspirate. Statistical evaluations were 
done according to the results on the day of intubation and the results 
on days 2, 3, 5, 8 and 10 after intubation. Scores of APACHE II and CRP 
levels were also recorded on the same days.
Results The duration of mechanical ventilation and ratio of death 
were signifi cantly higher in the patients with VAP(+). CPIS levels in the 
patients with VAP(+) were signifi cantly higher than the patients with 
VAP(–) in the days after the diagnosis. CPIS levels were also higher in 
the patients with VAP(+) on the day of diagnosis. At the same day the 
parameters, which included the CPIS, body temperature, leukocyte 
number, tracheal secretions, PaO2/FiO2 levels and the presence of 
infi ltrates on the chest radiograph, were signifi cantly higher in VAP(+) 
patients (P <0.05). ROC curves were formed for CPIS scores to be used 
in diagnosis VAP and the cutoff  point had a sensitivity of 97.44% and a 
specifi city of 100% for diagnosing VAP.
Conclusion At the end of the study, it was concluded that using the 
CPIS for early diagnosis and treatment of VAP and thinking that the 
patients with CPIS >5 were VAP(+) are guiding factors to resolve the 
problems associated with VAP in ICU patients.
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Introduction To select the empirical antimicrobial treatment for 
patients with ventilator-associated pneumonia (VAP), the 2005 
American Thoracic Society/Infectious Disease of America (ATS/IDSA) 
guidelines classify patients according to time of onset and risk factors 
for potential multidrug-resistant pathogens (MDRPs). This study aimed 
to evaluate the eff ectiveness of microbial prediction and validate the 
adequacy of these guidelines for antibiotic strategy in VAP patients.
Methods We retrospectively analyzed 296 patients who received 
empiric antimicrobial treatment for VAP between January 2006 and 
December 2010 in 10 ICUs of Japanese tertiary hospitals. VAP was 
diagnosed according to CDC criteria. After assigning patients to the 
ATS/IDSA risk group (n = 250; late onset or risk factors for MDRPs) or 
non-risk group (n = 46; early onset without risk factors for MDRPs), we 
determined the accuracy of the guidelines for predicting pathogens 
and the impact of guideline adherence on patient outcome.
Results Median age and SOFA scores on ICU admission were 66 
(interquartile range: 50 to 77) years and 6 (4 to 8) years, respectively. 
Primary diagnosis on ICU admission was coma including post-cardiac 
arrest syndrome (31%), trauma (29.4%), and sepsis (9.8%). Prediction 
of MDRPs was signifi cantly higher in the risk group than in the nonrisk 
group (36.8% vs. 15.2%, P = 0.004). Guideline adherence was lower in the 
risk group (45.6% vs. 65.2%, P = 0.016). Treatment adequacy was greater 
with guideline adherence than with nonadherence (75.7% vs. 55.9%, 
P <0.01). Hospital mortality was not aff ected by guideline adherence 
(P = 0.70). Multivariate analysis revealed that the independent factors 
related to hospital mortality were adequate antimicrobial treatment 
(odds ratio: 0.53, 95% CI: 0.29 to 0.95; P  = 0.034), age (1.02, 1.00 to 
1.04; P  = 0.004), history of malignancy (8.59, 1.48 to 49.6; P  = 0.016), 
trauma (0.41, 0.2 to 0.87; P  = 0.02), acute kidney injury (5.54, 2.69 to 
11.4: P <0.001), and severe sepsis at VAP onset (2.7, 1.4 to 5.1; P = 0.002).
Conclusion The prediction of MDRPs using the 2005 ATS/IDSA 
guidelines was acceptable. To ensure adequate antimicrobial treatment, 
strict guideline adherence is required in the Japanese setting.
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Introduction While ventilator-associated pneumonia (VAP) can aff ect 
all patients ventilated for >2 days in an ICU, an issue during the last two 
decades has been identifi cation of a universally accepted defi nition. 
The Centers for Disease Control and Prevention (CDC) in Atlanta, GA, 
USA, have designed a new surveillance paradigm aiming to increase 
the objectivity of VAE diagnosis ranging from ventilator-associated 
condition (VAC), infective VAC to possible and probable VAP [1]. We 
assessed the feasibility and accessibility of the audit tool developed 
from the CDC guidelines as a marker of quality assurance.
Methods A prospective audit of patients admitted to University 
Hospital Lewisham ICU for intubation and ventilation was performed 
for September and October 2013. Recording of minimum PEEP and 
FiO2, minimum and maximum temperatures, WBC count, specimens 
sent, antibiotics administered and date of organisms found was 
performed on a daily basis. VAEs were recorded as per modifi ed CDC 
criteria (absence of quantitative microbiological testing) and compared 
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against a surrogate marker of clinically diagnosed VAEs based on 
information available to the clinician.
Results Forty patients were admitted with 29 fulfi lling inclusion 
criteria. Of n  = 29, mean age was 58 (SD 21) with a median number 
of 5 (2 to 29) ventilator-days. We recorded eight VAEs based on CDC 
criteria, one VAC, four IVAC and three VAPs. Clinical decision-making 
indicated seven VAEs, of which fi ve were VAPs. CDC and clinical criteria 
correlated in only fi ve of eight VAPs and clinical criteria alone would 
have indicated 40% more VAPs than CDC criteria. Median time to VAE 
trigger was 8 days (4 to 20), median number of ventilator-days if a CDC 
VAE triggered was 14 compared with 3 if no CDC VAE was triggered 
(P <0.01), and 11 compared with 3 (P <0.01) for clinical VAEs.
Conclusion While similar numbers of VAEs are triggered using CDC 
and clinical criteria, we noted a disparity in the VAP incidence. Four 
clinical VAPs were not triggered due to the hierarchical nature of the 
CDC criteria because the initial criterion of sustained minimum PEEP or 
FiO2 rise was not met despite clear clinical criteria based on increased 
infl ammatory markers, temperature spikes and new microbiology. We 
are therefore doubtful of the robustness of this tool in its current format 
as an accurate measure of quality assurance and agree with recent 
statements from the CDC [1] that modifi cations may be necessary.
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Introduction The introduction of the lung allocation score has 
resulted in a growing number of patients who are considered for 
lung transplantation (LTX) while being acutely decompensated. In the 
sickest of these patients, mechanical ventilation (MV) alone may not be 
suffi  cient to establish adequate gas exchange. Thus, diff erent modes 
of extracorporeal life support have come to the focus of interest in this 
setting.
Methods A retrospective analysis of 17 patients (male/female ratio: 
6/11; median age: 35 (range 16 to 63)) who underwent arteriovenous 
or venovenous interventional lung assist (iLA; Novalung, Germany) 
support as bridging to primary LTX (n = 11) or re-LTX (n = 6) between 
2005 and 2013.
Results The underlying diagnosis was bronchiolitis obliterans 
syndrome III in re-LTX patients (n = 6), cystic fi brosis (n = 5), idiopathic 
pulmonary fi brosis (n = 2), emphysema (n = 1), adult respiratory distress 
syndrome (n = 1), hemosiderosis (n = 1), and chronic obstructive lung 
disease (n = 1), respectively. The type of iLA was arteriovenous in 10 and 
venovenous (iLA active) in seven patients. The median bridging time 
was 14 (1 to 58) days. The type of transplantation was bilateral LTX (n = 
6), size-reduced bilateral LTX (n = 5), lobar bilateral LTX (n = 4), and right 
single LTX with contralateral pneumonectomy (n  = 1), respectively. 
Hypercapnia was eff ectively corrected in all patients within the fi rst 
12 hours of iLA therapy: PaCO2 levels declined from 145 (70 to 198) to 
60 (36 to 99) mmHg, P <0.0001. iLA was initiated during non-invasive 
ventilation in three patients, of whom one was intubated prior to LTX. 
All other patients (n = 14) were placed on iLA while on invasive MV. Of 
those, three patients were extubated and remained on iLA until LTX, 
one patient was weaned from iLA and remained on MV until LTX, and 
one patient was weaned from iLA and MV prior to LTX. Five patients 
were switched to extracorporeal membrane oxygenation (venovenous 
n  = 2, venoarterial n  = 3) after 5 (1 to 30) days on iLA support. One 
patient died prior to LTX due to septic multiorgan failure (SMOF). All 
others (n  = 16; 94%) were successfully transplanted. Of these, two 
patients died in the ICU due to SMOF. The remaining 14 patients (82%) 
survived to hospital discharge and were alive at a median follow-up of 
20 (1 to 63) months.
Conclusion In patients with life-threatening hypercapnia, bridging to 
LTX with iLA is feasible, and results in favorable short-term and long-
term outcome.
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Introduction The primary aim of this study was to identify in adult 
intensive care patients whether there was a diff erence in the acute 
physiological response when a patient is sat out into a chair compared 
with when a patient is placed in a chair position using an electric bed. 
The secondary aim of this study was to observe the functional outcome 
of these patients [1].
Methods The study was conducted in an adult tertiary referral ICU over 
a 3-month period. Patients that met predetermined inclusion/exclusion 
criteria were allocated to either sitting in a chair or sitting up in an 
electric bed. Heart rate, respiratory rate, tidal volume and mean arterial 
pressure were obtained for all patients when they were supine in bed, 
at 1 minute and at 1 hour in the new position. Arterial blood gases 
were obtained at 1 hour in their new position. A functional outcome 
measure known as the Chelsea Critical Care Physical Assessment Tool 
(CPAX) was also taken on the day of admission, on the day of sitting out, 
on the day of discharge from intensive care and at ward level. All data 
were analysed using Student’s t test.
Results Sixteen subjects were recruited for this study. There was a 
signifi cant increase in paO2 (13.6  ±  2.35  kPa, P  = 0.01) and decrease 
in paCO2 (4.82 ± 1.27 kPa, P = 0.02) in the chair group at 1 hour after 
sitting out in the chair when compared with baseline (10.9 ± 2.44 kPa; 
5.41 ± 1.32 kPa). Also there was a signifi cant increase in tidal volume in 
the chair group after 1 minute of sitting out (403 ± 118 ml) compared 
with baseline (314 ± 105 ml). There was no diff erence in the electric bed 
group for all physiological parameters. The chair group had a better 
CPAX score on discharge from intensive care (chair group 24; electric 
bed group 13) and on discharge from the hospital (chair group 39; 
electric bed group 16). There were no adverse cardiovascular responses 
to either position.
Conclusion Sitting suitable critically ill patients out into a chair is safe 
and can signifi cantly improve the arterial blood gas measurement and 
the tidal volume when compared with sitting a patient into the sitting 
position in an electric bed.
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Introduction Sputum is essential for the protection of the respiratory 
tract but also plays a signifi cant role in the pathophysiology of lung 
disease [1]. This is evident in critical care where high sputum loads 
contribute to respiratory failure [2]. The quantity of sputum produced 
by a patient can impact on key decisions such as weaning, extubation 
and discharge. We undertook a survey to establish whether there was 
a consensus on how we quantify sputum on our intensive therapy unit 
(ITU).
Methods We conducted a multidisciplinary team questionnaire of our 
28-bed tertiary ITU. Staff  were asked how they quantifi ed sputum load 
in intubated patients. They were also asked to rate statements on a 
fi ve-point scale pertaining to sputum characteristics. The results were 
analysed in Excel 2010.
Results One hundred members of staff  completed the sputum 
production in intensive therapy (SPIT) questionnaire (21% doctors, 
71% nurses, 8% physiotherapists). Sputum load was deemed to be 
important or essential by more than 95% of respondents when making 
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decisions to extubate or decanulate. The quantifi cation of sputum was 
inconsistent: 39% of respondents counted the frequency of suctioning, 
24% measured the quantity of sputum in the suction tubing, whereas 
25% used another method. An eff ective cough, consistency and colour 
were felt to be more important features of sputum than blood staining.
Conclusion Our results showed a very high level of agreement on 
the importance of knowing sputum load for decisions to extubate, 
decanulate or discharge from the ITU. In contrast, there was little 
consensus on how we should quantify sputum load in ventilated 
patients. This lack of standard approach may contribute to uncertainty 
in the clinical decision-making process. We have developed an objective 
sputum scoring system. Components identifi ed as important by our 
survey such as suction frequency, sputum consistency and colour 
are included. We have recognised the benefi ts of the standardised 
Bristol stool chart to facilitate communication and believe this can be 
achieved with sputum load in ventilated patients.
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Introduction Bilevel non-invasive ventilation (NIV) is an established 
therapy in chronic obstructive pulmonary disease (COPD) and 
cardiogenic pulmonary oedema but evidence for its use in other acute 
respiratory conditions is less robust. Reported ICU mortality after NIV 
treatment of pneumonia ranges between 18 and 33% [1,2], compared 
with 10% in exacerbations of COPD [3]. We aimed to study the 
outcomes of patients with acute respiratory failure of mixed aetiology 
treated with NIV in our critical care unit and compare fi ndings with 
those already published.
Methods Data were collected retrospectively on patients admitted 
to our critical care unit with acute respiratory failure requiring NIV 
over a 3-year period using the Metavision electronic patient record 
system. Patients with a primary surgical problem and those who 
received continuous positive airway pressure as a primary intervention 
were excluded. We recorded: primary respiratory diagnosis causing 
respiratory failure; patient demographics; serial arterial blood gas 
results; success of NIV as defi ned by the British Thoracic Society (BTS) 
[4]; and mortality statistics.
Results In total, 113 consecutive patients were identifi ed. Mean 
age was 64 and 50% (56/113) were male. The primary diagnosis was 
pneumonia in 55 patients and exacerbation of COPD in 40 patients. 
The overall mortality on critical care, in hospital and at 1 year was 19% 
(22/113), 34% (38/113) and 41% (46/113) respectively. Success of NIV as 
defi ned by BTS criteria (pH >7.3 or reduction in PaCO2 by 0.5 kPa) in the 
fi rst 6 hours was seen in 72% (80/111) of patients. In NIV responders, 
1-year mortality was 31% (25/80) compared with 65% (20/31) in 
nonresponders.
Conclusion NIV is used to treat acute respiratory failure due to a wide 
range of aetiologies in our unit with comparable mortality rates to large 
published series [1,2,5]. A successful response to NIV in the fi rst 6 hours 
is associated with a reduction in 1-year mortality when compared with 
nonresponders.
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Introduction We studied the eff ect of nasal high fl ow (NHF) for 
postoperative respiratory failure after extubation in our general 
surgical ICU. Recently some studies have reported that NHF improves 
oxygenation and reduces respiratory rate. However, the usefulness of 
NHF in the general surgical ICU has not been fully determined.
Methods A prospective observational study was conducted in our 
general surgical ICU to investigate the eff ect of NHF on respiratory 
parameters in patients with postoperative respiratory failure. Patients 
who were admitted to the ICU for postoperative respiratory failure 
(defi ned as oxygen saturation as measured by pulse oximetry <96% 
and/or respiratory rate>24 beats/minute while receiving more than 6 l/
minute oxygen through a facemask) were eligible in this study. Pre and 
1 and 6 hours after NHF treatment, we collected PaO2, PaCO2, respiratory 
rate, heart rate, and blood pressure. Data were presented with means 
and standard deviations. P <0.05 was considered statistically signifi cant.
Results Forty-two patients were treated using NHF in our ICU from 
February 2013 to November 2013. The mean age of the patients was 
62.8 ± 15.8 years, and the male:female ratio was 22:19. PaO2 values after 
1 and 6 hours of NHF (104 ± 34 mmHg, 107 ± 26 mmHg, respectively) 
were signifi cantly higher than that before NHF (89  ±  38  mmHg; 
P <0.02). The PaO2/FiO2 ratio was increased from 1 hour to 6 hours of 
NHF (from 218 ± 90 mmHg to 236 ± 86 mmHg, P <0.05). Respiratory 
rate after NHF (19.6 ± 4.7/minute) was signifi cantly lower than that at 
baseline (22.3 ± 4.8/minute; P = 0.0006), whereas PaCO2 after NHF was 
reduced compared with baseline (from 41 ± 7 mmHg to 39 ± 5 mmHg, 
P <0.02). Thirty-two (76%, success group) patients did not need other 
positive ventilation. On the other hand, 10 (24%, failure group) patients 
required non-invasive positive pressure ventilation or intubation. We 
compared the failure group with the success group. However, there 
were no signifi cant diff erences in vital signs, total bleeding, operative 
duration and preoperative respiratory function between the groups.
Conclusion In this study, NHF gradually improved oxygenation. 
Additionally, NHF reduces the respiratory rate and the value of PaCO2. 
This result might suggest that NHF decreased dead-space ventilation. 
There was no diff erence between the success group and the failure 
group. So we can use NHF as the fi rst choice for postoperative 
respiratory failure, but it is diffi  cult to predict success or failure.
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Introduction Inhalation injury is the primary determinant of 
mortality in major burned patients, particularly when associated with 
pneumonia. This study sought to describe the association between 
severity of inhalation injury on bronchoscopic examination and clinical 
course among fi re victims of Santa Maria, RS, Brazil. Two hundred and 
forty-two people were killed in the disaster.
Methods Eighteen patients with inhalation injury secondary to smoke 
and fi re exposure in an enclosed space admitted to Hospital de Clínicas 
de Porto Alegre were divided into groups according to the severity 
of injury as determined by bronchoscopic criteria: grade 1 (moderate 
edema and hyperemia), grade 2 (marked edema and hyperemia, with 
or without carbonaceous debris), or grade 3 (mucosal ulceration or 
necrosis). Duration of mechanical ventilation (MV), length of ICU stay, 
overall length of hospital stay, and PaO2/FiO2 ratio on days 1 and 3 were 
compared among these groups by means of ANOVA with Tukey’s post-
hoc correction.
Results Three patients had grade 1 injury, four had grade 2 injury, and 
11 had grade 3 injury. Seven patients developed ventilator-associated 
pneumonia. Mean duration of MV increased progressively in relation 
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to injury severity (grade 1: 2.7 ± 0.6 days vs. grade 2: 5.7 ± 2.1 days vs. 
grade 3: 13.0  ±  5.4  days; P  = 0.004), as did length of ICU stay (grade 
1: 4  days vs. grade 2: 7.2  ±  2.2  days vs. grade 3: 19.9  ±  7.7  days; P  = 
0.001) and overall length of hospital stay (grade 1: 5  days vs. grade 
2: 14.5 ± 5.0 days vs. grade 3: 63.4 ± 43.6 days; P = 0.025). There were 
no signifi cant diff erences in PaO2/FiO2 ratio between groups at day 1. 
However, as expected, diff erences in PaO2/FiO2 ratio were found on day 
3 (grade 1: 501 vs. grade 2: 424 ± 115 vs. grade 3: 318 ± 120; P = 0.049).
Conclusion In this cohort of patients with major burns, the severity 
of inhalation injury was associated with prolonged MV, length of ICU 
stay, and overall length of hospital stay, as well as with deterioration in 
oxygenation on day 3.
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Introduction Use of extracorporeal life support (ECLS) in trauma 
casualties is limited by concerns regarding hemorrhage, particularly in 
the presence of traumatic brain injury (TBI). We report usage of ECMO/
interventional lung assist (iLA) as salvage therapy in 13 trauma patients. 
A high-fl ow technique without anticoagulation was used in cases with 
coagulopathy or severe TBI.
Methods Data were collected from all adult trauma cases referred to one 
center for ECMO/iLA treatment due to severe hypoxemic respiratory 
failure. Thirteen consecutives cases are reported. The type of assistance 
was chosen based on a fl owchart. Type of study: therapeutic, level of 
evidence IV. We analyzed patient data, injury data, blood gases before 
connection, methods of assistance, coagulation study, complications, 
survival and neurological outcome.
Results Thirteen casualties had an average Injury Severity Score of 
50.3  ±  10.5 (age 27.7  ±  8.6  years, 69.2% male) and were supported 
9.9 ± 4.8 days on ECMO (n = 7) and 7.16 ± 5.9 days on iLA (n = 6). All 
suff ered severe chest injuries, including one cardiac perforation. Most 
were coagulopathic prior to initiation of ECMO/iLA support. Among 
the seven patients with TBI, four had active intracranial hemorrhage. 
Only 30% of the patients received continuous anticoagulation during 
the fi rst 24 hours of support without clotting of the system or diagnosis 
of a thromboembolic event. Complications directly related to support 
therapy were not lethal; these included hemorrhage from a cannulation 
site (n = 1), accidental removal of a cannula (n = 1) and pressure sores 
(n = 3). Deaths occurred due to septic (n = 3) and cardiogenic shock 
(n = 1). Survival rates were 57 and 83% on ECMO and iLA, respectively. 
Follow-up of survivors detected no neurological deterioration.
Conclusion ECMO/iLA therapy can be used as rescue therapy in adult 
trauma cases with severe hypoxemic respiratory failure, even in the 
presence of coagulopathy, bleeding and/or brain injury. The benefi ts 
of oxygenation and circulatory support must be weighed individually 
against the risk of hemorrhage. Further research should determine 
whether ECMO therapy also confers survival benefi t.
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Introduction Outcome is improved when patients with severe adult 
respiratory distress syndrome are transferred to an extracorporeal 
membrane oxygenation (ECMO)-capable unit [1]. Not all patients 
transferred require ECMO, and this service evaluation examines which 
techniques are utilised in patients who ultimately do not require ECMO.
Methods All patients transferred to the Severe Adult Respiratory 
Failure (SARF) unit between April 2012 and April 2013 for advanced 
respiratory care who did not require ECMO, identifi ed from the ECMO 
database, underwent retrospective notes’ review to identify the 
advanced respiratory techniques performed at the SARF unit and the 
base hospital.
Results Ten patients were admitted for advanced respiratory care 
who did not require ECMO. Eight patients had community-acquired 
pneumonia, one had an inhalational injury and one had a previously 
undiagnosed cardiac sarcoma. The techniques utilised in the SARF unit 
and base hospital are shown in Figure 1. Nine patients were discharged 
from the SARF unit alive (90%).
Conclusion A negative fl uid balance and targeting higher haemoglobin 
are more frequently achieved in a SARF unit. Further studies are 
required to fully elucidate the advanced respiratory care techniques 
undertaken at specialist SARF units.
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Introduction While complement protein defi ciencies are associated 
with severe and recurrent pulmonary infections, excessive complement 
activation plays a role in the pathogenesis of lung injury. We hypo-
thesized that inhibition of the complement system by repetitive 
treatment with nebulized plasma-derived human C1-esterase inhibitor 
(C1-INH) reduces pulmonary complement activation and subsequently 
attenuates lung injury and lung infl ammation in a model of severe 
Streptococcus pneumoniae pneumonia.
Methods Thirty-two male rats were intratracheally challenged with S. 
pneumoniae to induce pneumonia. Rats were repeatedly exposed to 
nebulized C1-INH or saline, 30 minutes before induction of pneumonia 
and every 6 hours thereafter. Rats were sacrifi ced 20 or 40 hours after 
inoculation to investigate early and late eff ects. BALF and lung tissue 
were obtained for measuring levels of complement activation (C4b/c in 
BALF), lung injury (total protein levels in BALF), and infl ammation (IL-6 
levels in lung tissue).
Results Pneumonia was characterized by bilateral macroscopic 
infi ltrates, bacterial outgrowth in the lung and clinical signs of illness. 
Pneumonia was associated with pulmonary complement activation. 
In rats treated with nebulized C1-INH, a functional fraction of C1-INH 
was detectable in BALF. However, C1-INH treatment did not aff ect 
Figure 1 (abstract P314). Frequency of interventions in the base hospital 
(BH) and SARF centre.
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pulmonary complement activation (Figure 1A), lung injury (Figure 1B) 
or infl ammation (Figure 1C).
Conclusion Severe S. pneumoniae pneumonia is associated with 
pulmonary complement activation in rats. Nebulized C1-INH treat-
ment, in an attempt to reduce pulmonary complement activation, 
neither aff ects pulmonary complement activation or lung injury and 
infl ammation.
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Introduction Management of acute respiratory diseases must avoid 
ventilator-induced lung injuries along with the rise of PaCO2 and 
respiratory acidosis [1]. Eff orts are made to fi nd devices assisting 
protective ventilation and able to remove arterial CO2 and correct 
acidosis [2]. An extracorporeal CO2 removal device driven by the widely 
used Prismafl ex® platform called PrismaLung® was tested in vivo.
Methods Five hypercapnic ventilated pigs were equipped with the 
PrismaLung® system designed to remove CO2 from the bloodstream 
through a decarboxylation membrane mounted on a renal replacement 
device without any hemofi lter. Experiments examined the potential for 
blood decarboxylation by gas-exchanger membrane with diff erent sets 
of parameters (blood fl ow rate: 200, 300 and 400 ml/minute, sweep gas 
fl ow: 2, 5, 10 and 50  l/minute, FiO2: 21 and 100%). Statistical analysis 
was performed with the Student t test.
Results The extracorporeal device allowed effi  cient CO2 removal 
rates at FiO2 1 (Figure 1) and 0.21 (Figure 2), ranging from 40 to 60 ml/
minute. Effi  ciency was increased with blood and sweep gas fl ows. 
Carbia and pH of animals were signifi cantly modifi ed after 10 minutes 
Figure 1 (abstract P315).
Figure 1 (abstract P316). CO2 removal rates at FiO2 1.
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of treatment. No signifi cant modifi cation of blood oxygenation was 
obtained with pure oxygen, allowing the use of ambient air as the 
sweep gas through the membrane. No side eff ects or fi lter clotting 
occurred during experiments.
Conclusion The device based on the Prismafl ex® platform effi  ciently 
removed CO2 from blood and decreased PaCO2 and acidosis of 
hypercapnic pigs. Benefi ts for patients with acute to chronic respiratory 
diseases need evaluation.
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Introduction Referral for ECMO has been demonstrated to reduce 
mortality in severe hypoxic respiratory failure [1-3]. The numbers of 
patients that undergo ECMO is still small and the service depends on 
timely referral from regional ICUs. There is evidence that intensivists’ 
views on the role of ECMO are mixed [4]. The purpose of this study is to 
determine whether there are variations in the geographical distribution 
of patients that receive ECMO.
Methods NHS England provided the home primary care trust (PCT) of 
all adult patients referred for ECMO for potentially reversible respiratory 
failure from 2008 to 2012. The referrals from each PCT were indexed 
to the population of each area to produce a referral rate per 1,000,000 
people.
Results See Figure  1. ECMO services have expanded rapidly in the 
last 5  years in England following the publication of evidence for its 
effi  cacy and concerns regarding an infl uenza pandemic. The referral 
rates for ECMO for severe hypoxic respiratory failure vary greatly 
around the country from 88 per 1,000,000 population in Leicester City 
to no referrals in 32 PCTs. Possible explanations could include: the 
distributions of swine fl u around the country, referring doctors’ beliefs 
about the effi  cacy of ECMO, local access to high-frequency oscillation 
ventilation and possible reluctance of teaching hospitals to refer to 
specialist centres. Further investigation to account for this variation 
appears indicated.
Conclusion The referral rates for ECMO vary greatly around the country.
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Introduction Using micro-computed tomography (MicroCT), we 
assessed the eff ectiveness of a cleaning closed-suctioning system (CSS) 
to remove secretions from the endotracheal tube (ETT) lumen. Biofi lm 
growing within the ETT, soon after intubation, increases the patient’s 
risk to develop ventilator-associated pneumonia, and new cleaning 
devices have been designed to keep the ETT clean from secretions [1].
Methods In a bench test, we injected a water-based gel into unused 
ETTs to evaluate MicroCT scan (SkyScan 1172; Bruker, Belgium) 
eff ectiveness to measure secretions. In six critically ill patients, a 
cleaning CSS (Airway Medix Closed Suction system; Biovo, Tel Aviv) 
was used three times a day to keep the ETT clean. After extubation, we 
measured ETT secretions volume by MicroCT scanning over a length 
of 20 cm from the ETT tip. We also collected ETTs from 11 patients 
treated with a standard CSS as controls, and evaluated ETT microbial 
colonization.
Results The volume of gel measured by MicroCT strongly correlated 
with the volume of injected gel (P  <0.001, R2  = 0.99). At extubation, 
a lower amount of secretions was measured in the ETTs treated 
with the cleaning CSS as compared with controls (0.031  ±  0.029 vs. 
0.350 ± 0.417 mm3, P = 0.028), corresponding to a smaller occupation 
of the cross-sectional area (average 0.3 ± 0.4 vs. 3.8 ± 4.5% respectively, 
P  = 0.030). Microbial colonization tended to be reduced in the ETTs 
treated with the cleaning CSS (total bacterial charge 1.3  ±  1.7 vs. 
3.6 ± 2.7 log(CFU/ml), P = 0.08).
Conclusion MicroCT scan showed high precision and accuracy in 
measuring the volume of secretions in bench tests and can thus 
be used to evaluate the eff ectiveness of actions or devices studied 
to reduce ETT biofi lm accumulation. In a small nonrandomized 
population of critically ill patients, the use of an ETT cleaning device 
appeared eff ective to reduce the volume of secretions present in the 
ETT at extubation.
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Introduction Today’s healthcare environment has forced providers 
to constantly evaluate the materials used, and to fi nd less expensive 
alternatives. Recently, low-cost endotracheal tubes (ETTs) have been 
introduced to the market. The aim of this study was to test these tubes 
(Portex AirCare and Cardinal Health ETT) compared with endotracheal 
tubes with known performance (Hi-Lo Covidient pre ISO standard and 
Taper-Guard Covidient, post ISO standard).
Methods We used the required test setups according to the ISO 
standard for cuff  sealing performance. The tubes were tested versus 
each other in size 7.0, 7.5 and 8.0 mm. Kink performance was done in 
the routine manner.
Figure 2 (abstract P316). CO2 removal rates at FiO2 0.21.
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Results The leak test showed that the Portex AirCare ETT leaked 
signifi cantly more compared with both the Hi-Lo (P  <0.05) or Taper-
Guard (P  <0.001) ETTs. The standard deviation leak rate for AirCare 
was large, suggesting varying seal performance between tubes from 
various lots. The kink test showed no diff erence among tubes.
Conclusion Although tubes look the same there may be diff erences in 
performance. This study demonstrated that the new cheaper ETTs had 
greater cuff  leak compared with the two tubes used for comparison. We 
can only speculate whether diff erences found in this study is a result 
of cost cutting. However, the great variability in sealing performance 
between ETTs of the same size from diff erent lots would indicate that 
manufacturing controls may be less stringent. Although we cannot 
demonstrate that the higher incidence of leak will result in adverse 
patient outcomes, one can surmise that the possibility exists. Thus, 
selection of endotracheal tubes should not be based on purchase 
price alone but should take into account documented performance in 
standardized tests.
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Tracheostomy in obese patients: the best tube choice issue
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Introduction Obesity is not an absolute contraindication for 
percutaneous tracheostomy (PDT). Video-endoscopy (video-FBS) and 
ultrasound (US) facilitate PDT techniques and reduce complications in 
obese patients (OPs) [1,2]. OPs may have a higher trachea–skin distance 
that makes it diffi  cult to place or to manage a tracheostomy tube (TT).
Figure 1 (abstract P317).
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Methods A retrospective review was performed using data in the 
last 5 years. All OPs were from the ICU of our university hospital. Only 
OPs who underwent a PDT were selected with BMI >30 kg/m2. All OPs 
needed prolonged mechanical ventilation. A total of 67 OPs were 
identifi ed, with 60 PDTs placed using the Ciaglia Blue Rhino (CBR) 
Introducer Kit and seven PDTs with the UniPerc PDT Kit. All PDTs were 
performed by dedicated staff  including residents. Valuation of clinical 
anatomical and physio-pathological features of the OPs and US scan 
of the neck came before the procedure. At the beginning of the 
procedure we placed a 5  mm ID orotracheal tube by tube exchange 
with video-FBS assistance, as already described [3]. An 8 to 9  mm ID 
wire-reinforced silicone tracheostomy tube (rTT) with adjustable 
fl ange was chosen instead of a standard PVC or silastic TT (sTT) in all 
OPs treated with CBR because of the anatomical particularities of OPs 
and because of external traction by the weight of the tubing attached 
to the TT. An extralong TT (eTT) was chosen because the pretracheal 
tissue was too thick for a regular-sized TT in 16 OPs with BMI >40 kg/m2 
treated with CBR. For three OPs treated with CBR we needed to change 
rTT to eTT because of tube dislodgement and subocclusion X-ray and 
video-FBS diagnosis. The UniPerc technique was chosen for OPs with 
BMI >40 kg/m2.
Results No major complications (aborting procedure, >50  ml bleed-
ing, TT misplacement, death) were observed. We had only minor 
complications (<50 ml bleeding: 3%; ring fracture: 2%; diffi  cult insertion: 
21% only with CBR rTT because of the step between the tip of the rTT and 
its introducer). UniPerc eTT placement has always been easy.
Conclusion In our experience, the data do not support what previous 
studies have shown suggesting increased risk of complication in OPs 
[1,2]. We know that the sTT could not be eff ective in OPs. The use of US, 
video-FBS assistance [3], and rTT with an adjustable fl ange allows a safe 
and eff ective adjustment to anatomical OP particularities, avoiding 
collected risks.
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Introduction High-fl ow oxygen therapy (HFOT) delivered through 
nasal cannulas can improve oxygenation as compared with low-fl ow 
oxygen devices. It has been shown that nasal HFOT can generate a 
positive airway pressure, which increases linearly with the gas fl ow rate. 
Data on the use of HFOT delivered through a tracheostomy are scarce. 
The aim of the present randomized, controlled, cross-over trial was to 
assess the eff ects of HFOT delivered through a tracheostomy on arterial 
blood gases and endotracheal pressure in critically ill patients.
Methods Tracheostomized patients underwent HFOT with three gas 
fl ow rates (10 l/minute, 30 l/minute and 50 l/minute), randomly applied 
for 20-minute periods. At the end of each period, arterial blood gases, 
respiratory rate, and endotracheal pressure (Ptrach) were measured. 
Ptrach was recorded over the last 3  minutes of each study period: 
the maximum expiratory pressure (MEPtrach) and mean expiratory 
pressure were measured and averaged for all respiratory cycles during 
1-minute recording with stable breathing. FiO2 was kept constant 
during the whole study.
Results Seventeen tracheostomized patients were enrolled (SAPS II 
52 ± 10, PaO2 96 ± 27 mmHg, PaCO2 33 ± 10 mmHg). Increasing the 
gas fl ow rate from 10 l/minute to 30 l/minute was associated with an 
increase in PaO2/FiO2 that did not improve further when 50  l/minute 
was used (259 ± 66, 317 ± 79, and 325 ± 76, respectively, P <0.001). The 
same trend was observed with PaO2 (89 ± 19 mmHg, 109 ± 26 mmHg, 
and 113  ±  29  mmHg, respectively, P  <0.001) and SaO2 (96  ±  3%, 
98  ±  2%, 98  ±  2%, respectively, P  <0.001). PaCO2 (32  ±  8  mmHg on 
average) and respiratory rate (27 ± 7 breaths/minute on average) did 
not change with diff erent gas fl ow rates. MEPtrach (0.96 ± 0.43 cmH2O, 
1.32  ±  0.4 cmH2O, and 1.89  ±  0.5 cmH2O at 10 l/minute, 30 l/minute 
and 50 l/minute, respectively, P <0.01) and mean expiratory pressure 
(0.54 ± 0.27 cmH2O, 0.91 ± 0.29 cmH2O, and 1.36 ± 0.35 cmH2O, at 10 l/
minute, 30  l/minute and 50  l/minute, respectively, P <0.01) increased 
with fl ow. Changes in PaO2/FiO2 were not correlated with changes in 
expiratory pressures.
Conclusion When HFOT is used through a tracheostomy at increasing 
gas fl ow rate, oxygenation increases up to 30  l/minute while CO2 
clearance and the respiratory rate do not vary. Tracheal expiratory 
pressure increases with fl ow, but changes are small and probably of 
limited clinical relevance. Changes in oxygenation are not related 
to the variations of tracheal expiratory pressure. HFOT through a 
tracheostomy has diff erent eff ects from when a nasal interface is used.
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Introduction The 4th National Audit project, conducted by the Royal 
College of Anaesthetists in 2011, reviewed major airway complications 
in the UK [1]. It highlighted tracheostomy tube displacement as a 
signifi cant risk in critical care patients. Prior to 2011, at the Royal London 
Hospital ICU, the Tracoe Twist (marketed by Kapitex) was primarily used 
as the default choice of tracheostomy tube. However, over a 5-year 
period, there were a signifi cant number of critical incidents related 
to tracheostomy tube displacement or blockage. On investigation of 
these incidents, root-cause analysis identifi ed inadequate length of 
the Tracoe Twist as a major contributing factor. As a consequence of 
this, there was also an increasing requirement for the use of adjustable 
fl ange tubes. This was particularly apparent in obese patients. Our 
objective was to develop a new tracheostomy tube that would reduce 
the number of incidents related to inadequate length. An additional 
aim was to maximise the inner diameter for a given external diameter, 
thus reducing airway resistance and potentially aiding weaning.
Methods We formed a consultation committee, consisting of 
consultants in critical care, a consultant surgeon and a consultant 
anaesthetist with a specialist interest in head and neck anaesthesia 
and tracheostomy care. We collaborated with the Kapitex design team 
to develop a new tracheostomy tube which addressed some of the 
perceived defi cits of existing devices.
Results We developed a prototype tracheostomy tube that had an 
increased length for a given internal diameter. We also increased 
the mobility to fl ange, in order to reduce pressure areas and assist 
with fi xation. A third modifi cation was to ensure a maximal internal 
diameter for a given external diameter. We piloted its use in 20 patients. 
No adverse events were observed and the clinical impression was that 
the increased length was benefi cial to the patients.
Conclusion Following the success of the pilot study, this new 
tracheostomy tube was developed and then marketed by Kapitex. This 
tube was named the Tracoe Twist Plus. We have now used this tube for 
2 years. We have since performed an extensive retrospective audit of 
tracheostomy usage and the eff ect of the introduction of the novel 
Tracoe Twist Plus, and the complication rate was reduced in terms of 
displacement and obstruction.
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Introduction Mechanical ventilation (MV) and inability to speak 
increases psycho-emotional distress [1]. Although not commonly used 
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in ICU patients, MV with a defl ated cuff  in patients with a tracheostomy 
can be provided safely and comfortably, by use of a BiPAP Vision®. Air 
leakage to the upper airway enables speech [2]. By adding a Passy-
Muir® speaking valve as second step, the quality of speech and cough 
will improve. The ability to speak provides an important improvement 
in communication.
Methods The aim of this study was to compare weaning from MV by 
gradually decreasing the level of support in cuff -defl ated ventilation 
with use of a BiPAP Vision® and a Passy Muir® speaking valve, or by 
trials of spontaneous breathing with use of a speaking valve, both for 
progressively longer periods of time. We examined the diff erences in 
the ability to speak, the duration of the weaning period, the occurrence 
of delirium and the frequency of tracheal suctioning. We performed a 
single-centre retrospective and prospective observational study in a 
22-bed mixed ICU during 1 year. Data were collected using the patient 
data management system. Baseline criteria were age, gender, APACHE 
IV score, ICU length of stay and duration of MV before placement of the 
tracheostomy.
Results Ten patients were included, fi ve in the BiPAP group and fi ve 
in the spontaneous group. There were no signifi cant diff erences in 
the baseline criteria. On the second day after tracheostomy, three 
out of fi ve patients in the BiPAP group were able to speak compared 
with one in the spontaneous method group. A diff erence in speaking 
ability remained until day 9 (see Figure 1). At fi rst time of speaking, the 
BiPAP group had higher PEEP level (10 vs. 7.5 cmH2O) and higher SOFA 
score (6.2 vs. 4.6) compared with the spontaneous group. There was 
no signifi cant diff erence in delirium, duration of weaning and tracheal 
suctioning between both groups.
Conclusion Cuff -defl ated MV in ICU patients enables speaking during 
ventilator dependence. With this technique the ability to speak 
started in an earlier phase of weaning compared with weaning with 
spontaneous breathing trials and a speaking valve.
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Introduction A double-lumen endotracheal tube (DLET; bilumen 
ventilation tube, PCT/IT2012/000154; Deas S.r.l., Italy) (Figure  1) has 
been developed to improve the safety of patients and procedural 
comfort during percutaneous tracheostomy (PT). The DLET is divided 
into an upper channel, for placement of a fi beroptic bronchoscope 
(FOB), and a lower channel exclusively dedicated to the patient’s 
ventilation. The aim of this study is to achieve an in vitro and an in vivo 
evaluation of PT performed with the DLET.
Methods The nonlinear constant of the Rohrer equation (K2) was 
calculated as resistive properties, during a continuous fl ow of 10 
to 90  l/minute, for a conventional endotracheal tube (ETT) with and 
without FOB (ETT size 7, 7.5, 8, 7f, 7.5f, 8f ), ventilation tube of TLT (F4 
and F5) and DLET. The variation of gas exchange (Δ) was measured with 
arterial blood gas samples obtained before and after the PT. During 
PT, all patients received sedation, analgesia, neuromuscular blocking 
and volume-controlled ventilation set with FiO2 100%, TV 500 ml, RR 
15 breaths/minute, PEEP 5 cmH2O.
Results In vitro evaluation showed that the DLET had the lowest K2 (7 = 
11.33; 7.5 = 8.74; 8 = 7.57; 7f = 6.13; 7.5f = 10.52; 8f = 12.28; F4 = 130.0; 
F5 = 11.12; DLET = 5.25 cmH2O/l/minute). During in vivo evaluation, PT 
was performed with the conventional ETT with FOB and DLET for fi ve 
patients in each group (age 69  ±  13 vs. 71  ±  16; SAPS II: 56  ±  14 vs. 
52 ± 20; GCS 3 vs. 4). Gas exchange before and after the procedure did 
not diff er between the groups, but the Δ values of pH, PaO2 and PaCO2 
measured before and after the procedure were, ETT+FOB versus DLET: 
ΔpH: –0.05 ± 0.05 versus 0.01 ± 0.02, P = 0.04; ΔPaO2: –112.6 ± 112.6 
versus 41.6 ± 25.3, P = 0.01; ΔPaCO2: 14.5 ± 10.8 versus 0.6 ± 1.1, P = 
0.02; ΔHCO3: 0.5 ± 2 versus –0.04 ± 0.3, P = 0.6.
Conclusion The DLET resulted in adequate airway patency and minimal 
obstruction due to the lower channel exclusively dedicated to patient’s 
ventilation. Gas exchange in PT with the DLET remained stable without 
any variation in oxygenation and carbon dioxide levels, although the 
same settings of mechanical ventilation.
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Introduction Respiratory weaning in ICUs can be a lengthy 
and expensive process [1], but may be facilitated by the use of 
tracheostomies. Discharging patients with tracheostomies to general 
wards improves ICU bed availability but raises potential patient safety 
issues. This is demonstrated by the increased mortality compared 
with patients decannulated before discharge from the ICU [2]. 
We investigated how often ICUs in the UK discharge patients with 
tracheostomies to wards, which wards these are and whether systems 
are in place to ensure adequate safety on discharge.
Methods We telephoned 217 ICUs in the UK. Nursing staff  answered 
a series of questions regarding the discharge of patients with 
tracheostomies to the wards and their follow-up.
Results We obtained information from 203 ICUs. A total of 201 units 
used tracheostomies for respiratory weaning. In total, 151 routinely 
discharged patients to wards with tracheostomies, 11 never did and 
Figure 1 (abstract P323). Number of patients able to speak.
Figure 1 (abstract P324). Point 1 just before vocal cord, point 2 
asymmetric elliptical cuff  just before the carena.
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39 did occasionally. Five discharged to the high dependency unit 
only, 60 to respiratory wards only, 70 to specialist wards and 15 to any 
or most wards. Eighty-fi ve out of 190 units discharged patients with 
tracheostomy cuff s both up and down, 72 discharged with the cuff  
down or cuffl  ess and 16 with the cuff  ‘usually down’. A total of 141 
hospitals had routine follow-up for tracheostomy patients from critical 
care outreach or other services. Critical care outreach was available 
24 hours a day in 65 hospitals.
Conclusion The vast majority of ICUs in the UK perform tracheostomies 
for respiratory weaning and many routinely discharge patients to the 
wards prior to decannulation. Routine follow-up is usually available, 
but cover may only be available during the day. Patients may go to 
a specialist ward with trained nurses but this is not always the case. 
Patients are often discharged to wards with their tracheostomy cuff  
up, raising major safety issues if their tracheostomy tubes block and 
nurses are not trained for such emergencies. Twenty-four hours a day 
critical care outreach cover may improve patient safety, but further 
research and the production of guidelines is needed to facilitate the 
safe discharge of patients with tracheostomies from ICU to the wards.
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Introduction Percutaneous dilatational tracheostomy (PDT) is the 
standard airway access in critically ill patients who require prolonged 
mechanical ventilation. However, patients with severe coagulopathy 
or thrombocytopenia might have an increased risk of periprocedural 
bleeding.
Methods We retrospectively reviewed the records of all patients who 
underwent PDT (using the Ciaglia technique with bronchoscopic 
guidance) on our cardiothoracic ICU between January 2004 
and February 2013. Patients were stratifi ed into two groups: no 
coagulopathy (group 1), and coagulopathy/thrombocytopenia defi ned 
as international normalized ratio >1.5, partial thromboplastin time >50 
seconds and/or platelet count <50 × 109/l (group 2).
Results From a total of 1,001 patients (46% male, mean age 68.1 years) 
that underwent PDT, we identifi ed 441 patients (44.1%) with a severe 
coagulopathy (group 2). There were no procedure-related deaths. 
Major procedure-related complications included a severe bleeding 
(requiring transfusion and/or surgery) in two patients in each group 
(one laceration of the brachiocephalic trunk, one venous bleeding, two 
bleedings from a thyroid vessel), injury of the membranous wall of the 
trachea in two patients in group 2 as well as a pneumothorax and a 
device failure in group 1. The incidence of moderate periprocedural 
bleeding was comparable between the two groups (n = 43 (9.75%) vs. 
n = 41 (7.3%), P = NS).
Conclusion Periprocedural bleeding complications during and after 
PDT are rare, even in patients with a severe coagulopathy, and thus PDT 
can be safely performed in these patients.
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Introduction Percutaneous tracheostomy has become an established 
procedure in airway management of critically ill patients. Repeat PDT is 
considered a (relative) contraindication as a result of distorted anatomy.
Methods A retrospective review of all repeat bedside percutaneous 
dilatational tracheostomies (Ciaglia technique with direct broncho-
scopic guidance) performed on our cardiothoracic critical care unit 
from January 2004 to February 2013 was conducted.
Results From a total of 1,001 patients undergoing PDT, we identifi ed 
36 patients with repeat PDT. Patients’ previous tracheostomies dated 
back between 5  days and 2.7  years (mean 122  days). Mean age was 
60.3  ±  14.3  years, 42% of patients were female. The mean time from 
intubation to PDT was 3.7 ± 3.9 days. There were no deaths associated 
with PDT but one major procedure-related complication: one patient 
suff ered from a periprocedural laceration of the brachiocephalic trunk. 
After emergency surgery and surgical tracheotomy (ST), the patient 
recovered completely. In all other patients, no conversion to ST, no 
loss of airway, no paratracheal insertion, and no accidental tracheal 
extubation was observed. No pneumothorax, pneumomediastinum, 
hypotension, hypoxemia, or arrhythmias were recorded. A mild 
bleeding was observed in 13 patients (36%). A moderate but not 
signifi cant bleeding was observed in only one patient (2.8%). A 
tracheal ring fracture occurred in six patients (16.7%). Fourteen 
patients (38.9%) could be weaned successfully from the respirator 
and the tracheostomy could be removed. Thirteen patients (36.1%) 
were transferred to another ICU with the tracheostomy in place. The 
functional and cosmetic outcomes of PDT were excellent.
Conclusion Repeat PDT is a safe procedure in experienced hands 
and should not be generally considered a contraindication. However, 
special attention should be paid to the anatomical situation with an 
increased risk of vascular complications.
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Introduction The tracheostomy is an ancient technique that more 
recently has developed a percutaneous technique. Percutaneous 
tracheostomies (PCT) have been shown to be safer and reduce infection, 
cost and other complications over surgical techniques [1-3]. Ventilator-
associated pneumonia (VAP) is a serious complication resulting from 
the use of endotracheal tubes (ETT) and tracheostomies. Changes in 
design of these tubes by the addition of a subglottic suction port have 
been shown to improve VAP rates in mechanically ventilated patients 
[4,5]. A large meta-analysis review showed that subglottic drainage 
reduced the number of days of mechanical ventilation required and 
reduced the number of days stayed on the ICU [4].
Methods We contacted all ICUs in the UK by telephone and spoke to 
the nurse-in-charge to ascertain their normal practice with regards to 
PCT and subglottic suction use.
Results We contacted a total of 246 general ICUs, 72% of which we 
received a response. The average number of beds per ICU from all 
units who responded was 11. Ninety-eight per cent of ICUs that we 
questioned did use PCT. For three units, the average bed number per 
unit was 11 and the other 2% of ICUs who did not use PCT had fi ve beds 
per unit on average. The proportion of ICUs that employed subglottic 
suction ports on their ETTs was 43% having on average 11 beds per 
unit, whilst the proportion of ICUs that did not employ subglottic 
suction ports was 57%, also with 11 beds per unit on average. 
Regarding PCT subglottic suction ports, 38% of ICUs did utilise these 
tubes whilst 62% did not. Of the group of ICUs that did use subglottic 
suction ports on their tracheostomy tubes, the average beds per unit 
was 12. Of the group of ICUs that did not use subglottic suction ports 
on their tracheostomy tubes, the average beds per unit was 10.
Conclusion Signifi cant diff erences in practise exist with PCT and 
subglottic suction ports on tubes. The size of the ICUs in these groups 
is variable. The larger units are more likely to use PCT over the smaller 
units. Regarding subglottic suction ports on ETT and tracheostomy 
tubes, the size of the ICU does not necessarily dictate their use. We 
propose that all ICUs review their policy on the use of PCT and subglottic 
suction-assisted tubes to help improve surgical complications, cost, 
VAP rates and ICU stays.
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Introduction Over 5,000 tracheostomies are performed in the UK per 
year [1]. The 4th National Audit Project identifi ed signifi cant morbidity 
and mortality associated with tracheostomy care [1]. The National 
Tracheostomy Safety Project (NTSP) 2013 manual highlighted the 
need for: local policy; an appropriate care environment; immediate 
availability of emergency equipment; trained staff  and local training 
programmes; and bed-head sign and emergency algorithms for 
tracheostomy patients [2]. Following these guidelines, we asked: how 
are adult tracheostomy patients managed post discharge from the 
intensive care/high dependence unit (ICU/HDU) throughout the UK?
Methods In November 2013, 200 adult ICU/HDUs throughout the UK 
were contacted to take part in a telephone survey. Data were collected 
on tracheostomy weaning, post-ICU/HDU care, safety guidelines, 
emergency protocols and training for clinicians and nurses.
Results Out of the 200 adult ICU/HDUs contacted, 134 took part in 
the survey. Out of these, 44% have a tracheostomy weaning protocol, 
69% initiate weaning whilst the patient is mechanically ventilated, and 
92% use a speaking valve in their weaning process. Also, 87% allow 
tracheostomy patients to have oral nutritional intake and in 59% of 
these the decision involves speech and language therapy. Post ICU/
HDU, 67% of units discharge to specialised wards, 22% to nonspecialised 
wards, 4% to dedicated step-down units and 6% do not step down 
their tracheostomy patients. A critical care outreach team reviews the 
patients in 73% of the hospitals surveyed. Furthermore, only 11% of 
the hospitals have a consultant lead tracheostomy ward round and 
17% have a tracheostomy multidisciplinary team (MDT). Also within 
these hospitals, 57% have their own tracheostomy safety guidelines 
and 70% have emergency tracheostomy management protocols. On 
the wards: 34% have tracheostomy bed-head information signs, 93% 
have emergency bed-side tracheostomy equipment, 89% have a 
tracheostomy training programme, and 50% have a MDT approach to 
decannulation.
Conclusion There is a wide variation in post-ICU/HDU management 
of tracheostomy patients throughout the UK. Although there are 
well established UK national guidelines for the management of 
tracheostomy patients, outside the ICU/HDU environment there is a 
lack of full implementation of the NTSP recommendations, increasing 
the risk of tracheostomy-related morbidity and mortality.
References
1. Cook TM, Woodall N, Frerk C (Eds): The Fourth National Audit Project of the 
Royal College of Anaesthetists and the Diffi  cult Airway Society: Major 
Complications of Airway Management in the UK. Report and Findings. London: 
Royal College of Anaesthetists; 2011.
2. National Tracheostomy Safety Project Manual 2013 [http://www.
tracheostomy.org.uk]
P330
Survey on the use of chlorhexidine and toothpaste as part of oral 
care in UK ICUs
I Kangesan1, F Millinchamp1, JV Williams1, LA Burrows2
1Royal United Hospital, Bath, UK; 2Frenchay Hospital, Bristol, UK
Critical Care 2014, 18(Suppl 1):P330 (doi: 10.1186/cc13520)
Introduction Ventilator-associated pneumonia (VAP) is the most 
common nosocomial infection among ventilated patients and 
is associated with increased mortality and morbidity [1]. Oral 
chlorhexidine has been used to decontaminate the airway in critically 
ill patients, as studies suggest a risk reduction in VAP [2]. Chlorhexidine 
reacts with soaps in toothpaste to form inactive insoluble salts [3]. A 
minimum delay of 30 minutes between tooth brushing and the sub-
sequent application of chlorhexidine is therefore recommended [4].
Methods A telephone questionnaire was conducted on all ICUs in the 
UK to assess current oral decontamination procedures with regards to 
chlorhexidine use and the timing of tooth brushing with toothpaste.
Results Sixty-fi ve per cent of ICUs in the UK responded to our survey 
(n = 157). Ninety-seven per cent (n = 152) used chlorhexidine and 96% 
(n = 150) used it as part of a ventilator care bundle. Forty-six per cent 
(n = 70) used a gel, 32% (n = 48) used a mouthwash and 23% (n = 34) 
used both preparations. The frequency of chlorhexidine application 
varied between ICUs; 15 (9.9%) applied 4-hourly, 91 (59.9%) 6-hourly, 
20 (13.2%) 8-hourly, 19 (12.5%) 12-hourly and seven (4.6%) applied at 
variable times. Ninety-seven per cent (n = 152) brushed patient’s teeth; 
86% (n = 130) used toothpaste, 3% (n = 5) used chlorhexidine gel and 
11% (n = 17) used both. Ninety-seven per cent (n = 147) of ICUs using 
chlorhexidine also brushed patient’s teeth with toothpaste. Forty-eight 
per cent (n  = 70) administered chlorhexidine within 30 minutes of 
toothpaste application (Table 1).
Conclusion Chlorhexidine is being used too soon after the application 
of toothpaste in 48% of ICUs in the UK. This results in attenuation of its 
eff ect and may remove its benefi cial risk reduction in VAP. Awareness of 
this interaction should be emphasised.
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Introduction We aimed to assess the eff ect of continuous drainage 
of subglottic secretion in the prevention of ventilator-associated 
pneumonia (VAP) in patients requiring prolonged mechanical 
ventilation for more than 48  hours in the ICU as a prospective, 
randomized, controlled study.
Methods Our study was performed with a document from the ethics 
committee and written informed consent from the relatives of patients 
between April 2011 and February 2012 in our 14-bed ICU. Fifty-four 
patients whose mechanical ventilation requirements were expected 
to be longer than 72 hours were included in our study. Patients were 
randomly divided into two groups. These were formed as the group 
using a conventional intubation tube (Group C) and the group using an 
intubation tube allowing aspiration of subglottic secretions (Group S). 
In Group S, continuous subglottic aspiration occurred under constant 
pressure with a special device. In both groups, the cuff  pressure was 
maintained at a constant pressure of 20 to 30 using a digital cuff  
pressure device [1].
Results In Group C, VAP was developed in 10 (35.7%) of 28 patients. 
In group S, VAP was developed in fi ve (21.7%) of 23 patients. In both 
groups when compared according to the development of VAP, no 
Table 1 (abstract P330). Timing diff erence between toothpaste and 
chlorhexidine (minutes)
Minutes Number of ICUs (%)
>30 74 (50.3%)
<30 32 (21.8%)
Nil 38 (25.9%)
Variable 3 (2.0%)
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statistically signifi cant diff erences were detected (P = 0.276). However, 
in the fi rst 5 days the development of VAP was signifi cantly higher in 
Group C (respectively, 4.3% vs. 25%, P = 0.046). The growth rate of VAP 
(VAP number/ventilator-day × 1,000) in Group C was 17.48, while in 
Group S it was 11.62. Between the groups there were no statistically 
signifi cant diff erence according to ICU mortality, length of ICU stay and 
length of hospital stay (P ≥0.05).
Conclusion This prospective randomized controlled study 
demonstrated that the incidence of VAP (especially early development 
of the VAP) with continuous aspiration of subglottic secretions 
without creating any undesirable clinical damage in the airways was 
signifi cantly reduced.
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Introduction Subglottic secretion drainage (SSD) has been shown 
to reduce the incidence of ventilator-associated pneumonia (VAP) 
[1]. We reviewed current UK practice and practicalities surrounding 
implementation of SSD using a survey.
Methods We constructed a survey of 10 questions using SurveyMonkey 
and circulated it via an email link to the Linkmen of the UK Intensive 
Care Society. Responses were received between August and November 
2013.
Results We had 77 responses. The majority were from doctors (88%) 
and the rest from nurses. Of respondents, 63% worked in district 
general hospitals, 28% in teaching hospitals and the rest in specialist 
units. Overall, 54% of respondents worked in units using SSD. From 
these responses, the types of patients receiving SSD are summarised in 
Table 1. One hundred per cent of units used intermittent SSD. Seventy-
one per cent of respondents reported that SSD tubes were stored only 
on their ICU, with 26% reporting availability in acute areas and the 
rest hospital wide. Twenty-eight per cent of respondents indicated 
it was unit policy to reintubate patients to facilitate SSD. More than 
90% of units had a ventilator care bundle and regularly measured cuff  
pressures. Overall, 83% of those surveyed thought SSD was benefi cial 
in the prevention of VAP.
Table 1 (abstract P332). SSD in specifi c patient groups (more than one per 
responder)
Patients Number
All  23
Tube >72 hours 6
Tracheostomy 13
Selected 7
Conclusion Despite specifi c recommendations from the UK Department 
of Health [2], only about one-half of respondents work in ICUs where 
SSD has been adopted. Most studies show benefi t in patients expected 
to be ventilated for greater than 72 hours [1], but most units used SSD 
in all intubated patients. The reintubation rate to facilitate SSD was also 
reasonably high, despite a lack of evidence to support this practice. In 
the vast majority of hospitals, SSD endotracheal tubes are stored only 
on the ICU and so the need for reintubation may result from a lack of 
available appropriate tubes at the point of fi rst intubation.
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Introduction Emulsifi ed perfl uorocarbons (PFC) are synthetic 
hydrocarbons that can carry 50 times more oxygen than human 
plasma. Their properties may be advantageous in applications 
requiring preservation of tissue viability in oxygen-deprived states, 
which makes them a potential candidate for combat and civilian pre-
hospital resuscitation. Our hypothesis was that an intravenous dose of 
PFC increases vital organ tissue oxygenation, improves survival and 
reduces or prevents the development of ventilator-associated ARDS. 
Here we report data from the second part (ARDS only) of a multiphase 
swine study to investigate the benefi ts of PFC in treating hemorrhagic 
shock and preventing ARDS.
Methods Anesthetized Yorkshire swine were randomized (n  = 6/
group) to receive a bolus of the PFC Oxycyte™ either 45 minutes before 
(PFC-B) or after (PFC-A) induction of ARDS or nothing as a control 
(NON). ARDS was induced via intravenous oleic acid infusion (time 0 
(T0)) over 30 minutes. Animals were monitored for physiological and 
hematological parameters. They were euthanized at T180 minutes and 
a full necropsy and histopathological analysis was performed.
Results Survival was 100% in the NON group, 80% in the PFC-A group 
and 20% in the PFC-B group. Mean arterial pressure (MAP) and mean 
pulmonary artery pressure (MPAP) were signifi cantly increased during 
infusion of PFC and during ARDS in the PFC-B group, while cardiac 
output (CO) was signifi cantly reduced. In the PFC-A group it was 
observed that MAP and MPAP increased and CO decreased during ARDS 
induction, but not during PFC infusion. Those changes were signifi cant 
in comparison with the NON group. Oxygen delivery and consumption 
in the PFC-A group were signifi cantly increased. Histopathological 
analysis is currently being performed. Interim analysis showed a trend 
to reduced alveolar damage in PFC-A animals.
Conclusion Administration of PFC before induction of ARDS was 
detrimental, while giving PFC after ARDS improved oxygen delivery and 
increased oxygen consumption. Although survival in this group was 
lower than in the NON control group (80% vs. 100%, not signifi cant), a 
reduction in alveolar damage was observed. This might improve long-
term outcome after ARDS. Based on these data we will continue to the 
fi nal phase of this project and evaluate the capacity of PFC to prevent 
ARDS in combination with HS.
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Introduction Venovenous extracorporeal membrane oxygenation (VV 
ECMO) is a treatment option for acute respiratory distress syndrome 
(ARDS) to minimize ventilator-induced lung injury including life-
threatening pneumothorax. The purpose of our study was to investigate 
the safety and effi  cacy of VV ECMO for preventing pneumothorax in 
ARDS patients who were complicated with emphysematous/cystic 
changes in the lung.
Methods We have retrospectively analyzed data of ARDS patients 
complicated with emphysematous/cystic changes in the lung who 
were admitted to our ICU from 2006 through 2012. We divided the 
subjects into two groups, patients treated with VV ECMO (ECMO group), 
and those treated only by conventional ventilator management (non-
ECMO group). Correlations between age, sex, underlying disease, PaO2/
FIO2 ratio on admission, duration of ICU stay, survival and incidence of 
pneumothorax were evaluated.
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Results Forty-one patients were included in this study (ECMO and non-
ECMO group, 21 and 20 patients, respectively). There were no signifi cant 
diff erences between ECMO and non-ECMO groups as regards age, sex, 
underlying disease, PaO2/FIO2 ratio, duration of ICU stay, and survival. 
In the ECMO group, the mean duration of ECMO use was 17 ± 13 days, 
and bleeding due to anticoagulation was observed in fi ve patients. The 
mean airway pressure in the ECMO group was signifi cantly lower than 
in the non-ECMO group (12  ±  6  cmH2O, 22  ±  6  cmH2O, respectively; 
P <0.0001). The incidence of pneumothorax was also signifi cantly lower 
in the ECMO group than the non-ECMO group (10%, 45%, respectively; 
P = 0.015). In Kaplan–Meier analysis, the proportion of pneumothorax-
free patients was signifi cantly higher in the ECMO group (P = 0.014). In 
multivariate analysis, conventional ventilator management, presence 
of interstitial pneumonia and the duration of intubation were the 
independent risk factors of pneumothorax (hazard ratio (HR), 18.0, P = 
0.010; HR 33.3, P = 0.025; HR 1.05, P = 0.041, respectively).
Conclusion Although the survival rate was not statistically diff erent, 
the use of ECMO for ARDS patients complicated with emphysematous/
cystic changes in the lung markedly reduced the incidence of 
pneumothorax.
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Introduction The underlying molecular mechanisms for the association 
between aging and a higher susceptibility to develop ARDS are poorly 
understood. The pulmonary renin–angiotensin system (RAS), with a 
lung-protective (angiotensin-converting enzyme (ACE)2–angiotensin 
(Ang)-1,7–Mas receptor) axis and a lung-injurious (ACE–Ang II–Ang II 
receptor (AT1)) axis, has been implicated in the pathogenesis of ARDS 
and changes with age. We hypothesized that injurious ventilation has 
an age-dependent eff ect on the pulmonary RAS in LPS-challenged rats 
that is associated with increased lung injury.
Methods Infant (~1/2 month), juvenile (~1 month), adult (~4 months) 
and older (~19 months) Wistar rats were challenged with intratracheal 
LPS and injurious ventilation using tidal volumes of 15 ml/kg for 4 hours. 
Lung injury was assessed by wet-to-dry ratio and changes in P/F ratio. 
Levels of infl ammatory mediators were measured in bronchoalveolar 
lavage fl uid; mRNA expression of key genes of the pulmonary RAS was 
determined in lung homogenates.
Results LPS-challenged and ventilated older rats showed higher 
mortality, larger change in wet-to-dry ratio and larger decline in 
P/F ratio, compared with other age groups. Increases in neutrophil 
infl ux and infl ammatory mediators were age dependent, with higher 
levels with increasing age. Compared with controls, ventilated LPS-
challenged rats showed a decrease in mRNA expression of ACE, ACE2, 
AT-1 and Mas receptor in all age groups, except for infants. The relative 
decrease in the mRNA expression of the Mas receptor was most 
extensive in older rats, thereby shifting the balance towards the lung 
injurious axis in this age group.
Conclusion The eff ects of injurious ventilation on lung injury are age 
dependent in a model of LPS-challenged rats, which is associated with 
a more pronounced imbalance of the pulmonary RAS at the expense of 
the lung-protective axis with increasing age.
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Introduction Acute lung injury (ALI) is characterized by an excessive 
infl ammatory response. Several recent clinical observations have 
shown that severe H1N1 infl uenza with ARDS is characterized by early 
secretion of Th17 (IL-6, IL-8, IL-9, IL-17) and Th1 (TNFα, IL-15, IL-12p70) 
cytokines [1,2]. However, the exact role of T-helper cells (Th) in the 
ALI model remains unknown. We hypothesized that there might be 
Th imbalance within the lung in the early phase of LPS-induced ALI. 
This study was to assess the role of lung Th polarization response in 
ALI mice.
Methods C57BL/6 mice were randomly divided into two groups: 
control group and ALI group. ALI animals received 2 mg/kg LPS. Lung 
wet weight/body weight (LW/BW) was recorded to assess lung injury. 
The pathological changes were examined under an optical microscope. 
The mRNA expression levels of T-bet, GATA-3 and RORγt were 
determined by quantitative real-time reverse transcriptase-polymerase 
chain reaction. Meanwhile, levels of IL-6, IFNγ, IL-4 and IL-17 in lung 
homogenates were assessed by enzyme-linked immunosorbent assay.
Results The increase in LW/BW was induced in ALI mice. Histologically, 
widespread alveolar wall thickening caused by edema, severe 
hemorrhage in the interstitium and alveolus, and marked and diff use 
interstitial infi ltration with infl ammatory cells were observed in the ALI 
group. Meanwhile, the levels of IL-6 in lung tissue were signifi cantly 
enhanced in the LPS-induced ALI mice. The mRNA expression of T-bet 
and RORγt was upregulated in ALI mice at 24  hours and 48  hours 
relative to normal mice (P  <0.05 vs. Con). There was no signifi cant 
diff erence in the expression of GATA-3 among groups at 24 hours and 
48 hours. Meanwhile, the levels of IFNγ, IL-17 and IL-6 in lung tissue were 
signifi cantly enhanced at 24  hours and 48  hours in the LPS-induced 
ALI mice. In addition, the levels of IL-4 in lung tissue were signifi cantly 
enhanced at 48 hours in the LPS-induced ALI mice. The expression of 
T-bet mRNA and RORγt mRNA had a strong correlation with the IL-6 
concentration. However, there was no signifi cant correlation of GATA-
3 with the IL-6 concentration. In addition, there was a signifi cant 
correlation of IFNγ, IL-4 and IL-17 with the IL-6 level in LPS-induced ALI 
at 24 hours and 48 hours.
Conclusion ALI provokes Th1 and Th17 polarization response. Th1 and 
Th17 may participate in the early infl ammatory response to ALI.
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Introduction Dendritic cells (DC) may play an important role in acute 
lung injury (ALI) [1]. CD80 is the crucial co-stimulatory molecule that 
is expressed on the surface of DCs. However, little is known about 
the expression of CD80. The purpose of this study was to observe the 
expression of CD80 on circulating, lung and splenic dendritic cells (DC) 
in ALI mice.
Methods Twelve C57BL/6 mice were randomly divided into two groups: 
control group and ALI group. Blood, lungs and spleens were harvested 
at 6  hours after LPS or PBS administration. The level of CD80 on DC 
was assessed by fl ow cytometry (FCM). The IL-6 level in the lung was 
measured by enzyme-linked immunosorbent assay. Lung wet weight/
body weight (LW/BW) was recorded to assess lung injury. Meanwhile, 
pathological changes were examined under an optical microscope.
Results LPS-ALI resulted in a signifi cant increase in lung W/D ratio. 
Histologically, widespread alveolar wall thickening caused by edema, 
severe hemorrhage in the interstitium and alveolus, and marked and 
diff use interstitial infi ltration with infl ammatory cells were observed 
in the ALI group. Meanwhile, the levels of IL-6 in lung tissue were 
signifi cantly enhanced in the LPS-induced ALI mice. FCM analysis 
showed that the level of CD80 on circulating DC in control group 
was (3.3  ±  1.5)%, CD80 expression on lung DC was (3.6  ±  1.2)%, 
and expression of CD80 on splenic DC was (9.0  ±  3.6)%, which was 
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signifi cantly higher than that on circulating DC and lung DC (P <0.05). 
In the ALI mouse, the level of CD80 on peripheral blood DC was 
(5.1 ± 2.1)%; the CD80 level on lung DC was (9.6 ± 2.50)%, which was 
signifi cantly higher than that on peripheral blood DC (P <0.05); and the 
level of CD80 on splenic DC was (25.2 ± 4.7)%, which was signifi cantly 
higher than CD80 levels on the peripheral blood and lung DC (P <0.05). 
The CD80 level on lung and splenic DC in ALI mice was signifi cantly 
higher than that on lung and splenic DC in control mice (P  <0.05 vs. 
Con).
Conclusion There is a dynamic characteristic in the expression of CD80 
on DC populations in normal and ALI mice. Elevated expression of 
CD80 on DC seems to play an important role in the pathogenesis of ALI.
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Introduction Two recent RCTs (OSCAR and OSCILLATE [1,2]) showed 
that high-frequency oscillatory ventilation (HFOV) had no positive 
impact on mortality. We present our experience over 5 years.
Methods Adult ARDS patients who received HFOV from 2008 to 2012 
were included. Demographics, illness severity and outcomes were 
collected retrospectively.
Results A total of 118 patients were included; 56.8% were male, mean 
age was 54.8  years. RRT use was 45% during admission. Vasoactive 
agent use and neuromuscular blockade infusion rate was 81.9 and 
29.7% pre HFOV respectively. The 28-day and 6-month mortality was 
61.9 and 70.3%. A total of 60.1% had less than 48 hours conventional 
ventilation (CV) pre HFOV. The 6-month mortality was 64.8% for this 
group. Patients who had over 48  hours CV pre HFOV had a 6-month 
mortality of 76.6%. See Table 1.
Conclusion Mortality rates were higher than in recent trials [1,2]. Our 
patients represent a more critically unwell group with lower PF ratios 
pre HFOV and high vasoactive and RRT use. HFOV may still have a role 
in the treatment of these very sick patients with treatment refractory to 
conventional ventilation.
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Introduction Losartan, an antagonist of angiotensin II (Ang II) type 
1 receptor, is a potential therapeutic drug for acute lung injury 
(ALI). Recent reports suggest that losartan inhibits T-helper (Th)-1 
immune response and ultimately attenuates infl ammation in several 
angiotensin II-mediated infl ammatory diseases [1,2]. However, the 
possible protective mechanisms of losartan in ALI remain poorly 
understood. This study was to assess the eff ect of losartan on the lung 
Th polarization response in ALI.
Methods C57BL/6 mice were randomly divided into three groups: 
control group, ALI group and ALI + losartan group. ALI animals 
received 2 mg/kg LPS; ALI + losartan animals received 2 mg/kg LPS and 
15 mg/kg losartan 30 minute before intratracheal injection of LPS. The 
pathological changes were examined under an optical microscope. The 
mRNA expression levels of T-bet, GATA-3 and RORγt were determined 
by quantitative real-time reverse transcriptase-polymerase chain 
reaction.
Results The increase in LW/BW induced by LPS was partly prevented 
by pretreated with losartan. Histologically, losartan eff ectively 
attenuated the LPS-induced lung hemorrhage, and leukocyte cell 
infi ltration in the interstitium and alveolus. Meanwhile, the levels of 
IL-6 in lung tissue were signifi cantly enhanced in the LPS-induced ALI 
mice. With pretreatment of ALI mice with losartan, the level of IL-6 in 
lungs markedly decreased. The mRNA expression of T-bet and RORγt 
was upregulated in ALI mice at 24  hours and 48  hours relative to 
normal mice (P  <0.05 vs. Con). There was no signifi cant diff erence in 
the expression of GATA-3 among groups at 24 hours and 48 hours. Of 
note, pretreatment of ALI mice with losartan resulted in signifi cantly 
reduced mRNA expression of T-bet at 24 hours and 48 hours and RORγt 
mRNA expression at 48 hours (P <0.05 vs. ALI). Meanwhile, the levels 
of IFNγ, IL-4, IL-17 and IL-6 in lung tissue were signifi cantly enhanced 
at 24  hours and 48  hours in the LPS-induced ALI mice. In addition, 
both IFNγ and IL-17 in lung tissue at 24 hours and 48 hours decreased 
signifi cantly in losartan-pretreated mice compared with the ALI mice. 
With pretreatment of ALI mice with losartan, the level of IL-4 in lungs 
was not changed.
Conclusion Ang II-induced Th1 and Th17 polarization response could 
upregulate infl ammatory response and induce lung injury, and losartan 
may be a promising substance for clinical use in LPS-induced ALI.
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Table 1 (abstract P338).
 OSCAR OSCILLATE
 Hull HFOV Control HFOV Control
Mean APACHE II 22.0 21.8 21.7 29 29
Mean Vt (ml/kg predicted) 8.6 8.7 8.3 7.2 7.1
PaO2:FiO2 (mmHg) 81.5 113 113 121 114
Vasoactive agents (%) 81.9 43.5 (day 1) 44.6 (day 1) 67 63
Hospital mortality (%) 66.1 50.1 48.4 46.9 35.2
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Introduction Venovenous ECMO is a therapeutic option in patients 
with severe ARDS. The dual-lumen catheter (Avalon Elite; Maquet 
Medical) off ers excellent oxygenation and decarboxylation through 
a single insertion site and facilitates patient mobilization as it avoids 
femoral access. As incorrect placement of the catheter might result in 
perforation and cardiac tamponade, fl uoroscopy guidance is advocated 
in the literature. Transporting an unstable patient for fl uoroscopy, 
however, can endanger the patient.
Methods We report a retrospective analysis of out-of-center ECMO 
implantation in patients with severe ARDS. Our center provides a 24/7 
service for out-of-hospital ECMO implantation with a team consisting 
of two intensive care physicians and a perfusionist. In all patients, ECMO 
therapy was initiated in a non-ECMO center prior to transportation to 
our hospital. Implantation of a dual-lumen catheter was fi rst choice in 
all patients and was guided echocardiographically.
Results Between January 2011 and November 2013, a total of 56 
patients (average age 53.3 years) underwent out-of-center venovenous 
ECMO implantation. In 52 cases (94.6%), a dual-lumen catheter could 
be implanted successfully using echocardiographic guidance. Either 
31  Fr (65.0%) or 27  Fr (35.0%) Avalon Elite catheters were employed. 
No patient developed any major or even fatal complications related to 
ECMO implantation. In three out of 56 patients, poor imaging quality or 
technical issues hampered the implantation of a dual-lumen catheter 
and a femoral approach had to be made. Concerning short-term 
survival, 81.0% of all patients could be dismissed from the ICU.
Conclusion Echocardiographic guidance for out-of-center Avalon Elite 
catheter implantation is a safe and effi  cient option when performed by 
an experienced team.
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Introduction The prevalence of viral respiratory infections in critically 
ill patients on the ICU and the diagnostic potential of tracheal aspirate 
sampling are unknown. For this study, the prevalence of respiratory 
viruses was investigated in intubated patients by simultaneous 
sampling of nasopharynx and tracheal aspirate.
Methods During March and April 2013, consecutive acutely admitted, 
intubated patients were included in three ICUs in the Netherlands, 
regardless of diagnosis at admission. Daily sampling of the nasopharynx 
(NP) with fl ocked swab and tracheal aspirate (TA) was performed until 
successful weaning from mechanical ventilation or death. Admission 
samples were tested via multiplex RT-PCR for infl uenza A and B, 
parainfl uenza, RSV, human metapneumovirus, bocavirus, coronavirus, 
rhinovirus, enterovirus, parechovirus and adenoviruses. Of the 
infl uenza-positive patients, subsequent daily samples were tested for 
infl uenza. Results of viral diagnostics performed by routine care were 
collected, and compared with results found in this study.
Results As part of an ongoing observational study (COURSE study), 128 
patients were included, of which 35 were virus-positive (27%). Of these, 
13 patients were positive in both NP and TA, eight only in NP, and 14 
only in TA. Thereby, 40% of the viruses would have been missed if only 
NP was performed in this study group. In eight out of 12 coronavirus-
positive patients, only the TA sample was virus-positive, with negative 
NP. In subsequent daily samples of infl uenza-positive patients, viral 
loads were higher in TA compared with NP, up to 2  log viral copies. 
Duration of positivity of infl uenza in daily samples was up to two 
times longer in TA samples than in NP samples. Of all 35 virus-positive 
patients, 10 had received viral diagnostics via routine care.
Conclusion The prevalence of respiratory viruses in this unselected 
patient population is high. Forty percent would have been missed if 
only NP was sampled. Thereby, TA sampling adds to the detection of 
respiratory viruses in critically ill patients. Accuracy and implications of 
these results needs to be investigated further.
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Introduction The increasing prevalence of infections by multi-resistant 
organisms (MDR) has increased over the last decades, with implications 
not only in the overall level of therapeutic success, but also in the 
selective pressure exerted by the use of broad-spectrum antibiotics to 
defeat increasingly resistant agents, thereby creating a vicious cycle 
[1,2]. The aim of this study is to describe risk factors associated with 
infection by MDR organisms among septic patients.
Methods A retrospective cohort study including all adult patients with 
microbiological documented sepsis, admitted to the emergency room 
of a tertiary care, university hospital between 1 July 2011 and 30 June 
2012.
Results During the study period, 162 patients were admitted to the 
emergency room with severe sepsis; 79 (49%) had microbiological 
documentation, and were included in this study. The mean (SD) age 
was 71 (15) years; 62% were men. Forty patients (51%) had an infection 
by a MDR organism. Risk factors associated with infection by a MDR 
organism were the presence of any comorbidity (OR = 3.542, P = 0.022), 
diabetes mellitus (OR  = 4.500, P  = 0.006), Karnofsky performance 
status (KPS) <70% (OR = 3.882, P = 0.005), the presence of modifi ers of 
etiology (OR = 5,040, P = 0.010), chronic wounds (OR = 5.371, P = 0.040), 
healthcare-associated infections (OR = 3.325, P = 0.026) and hospital-
acquired infections (OR  = 5.225, P  = 0.016). The multivariate model 
retained as independent variables associated with infection by a MDR 
organism: the presence of diabetes mellitus (adjusted OR = 4.1,95% CI: 
1.4 to 12.6) and the need for assistance in daily activities (KPS <70%, 
adjusted OR = 3.6, 95% CI: 1.3 to 9.7).
Conclusion The presence of diabetes and decreased functional 
capacity should be considered risk factors for infection by a MDR 
organism and should be taken into consideration in the empirical 
therapy prescription.
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Introduction The infection incidences from MDR strains in our ICU are 
in accordance with the results of respective studies in other ICUs of our 
country. Our aim is to identify potential risk factors for the development 
of MDR infection in ICU patients.
Methods The sample consisted of 882 patients, admitted to our ICU 
from 1 January 2010 until 30 June 2013. The factors studied were: 
age, gender, length of stay in the ICU, origin of patient (for example, 
home or transferred from another institution), APACHE II score, 
adjusted mortality score, previous colonization with MDR, prior use of 
antimicrobial agents, duration of ventilator use, immunosuppression, 
diabetes, hypoproteinemia and presence of central venous catheter 
(CVC). Bivariable analyses were conducted to determine the association 
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between potential risk factors and development of MDR infection. 
Categorical variables were compared using the Fisher test. Odds ratios 
(ORs) and 95% confi dence intervals (CIs) were calculated to evaluate the 
strength of any association. Continuous variables were compared using 
the Student t test or the Wilcoxon test where appropriate. Multivariable 
analysis was performed using multiple logistic regression. Variables 
with P <0.20 in bivariable analyses were considered for inclusion in a 
multivariable model.
Results Out of 882 patients, 135 (15.3%) developed MDR infection. The 
following factors showed statistical signifi cant diff erence (P  <<0.01): 
length of stay in the ICU, origin of patient, APACHE II score, previous 
colonization, previous use of carbapenems, duration of mechanical 
ventilation, immunosuppression, diabetes mellitus, hypoproteinemia 
and the presence of CVC. The multivariant analysis showed statistically 
signifi cant correlations for the following independent risk factors: 
previous use of carbapenems (OR = 632.64, P <<0.01), origin of patient 
(OR = 19.60, P = 0.014), presence of CVC (OR = 14.19, P = 0.015), previous 
colonization (OR = 4.71, P = 0.037) and duration of ventilator use (OR = 
1.10, P = 0.029).
Conclusion The analysis showed a very strong correlation between 
prior use of carbapenems and development of MDR infection. Other 
signifi cant factors are presence of CVC, origin of patient, previous 
colonization and duration of ventilator use. The identifi cation of 
the above factors and the eff ort for their restriction redound to the 
reduction of the MDR infections and, consequently, to the reduction 
of the morbidity and the mortality of the patients hospitalized in ICUs.
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Introduction Clostridium diffi  cile infection is becoming more common 
worldwide. Critically ill patients are at particularly high risk for this 
disease due to multiple risk factors in this population. Accurate 
diagnosis is essential for patient management, infection control and 
epidemiology. There are a variety of methods to detect the presence of 
toxigenic C. diffi  cile in stools [1,2]. The aim of this study was to evaluate 
the incidence of C. diffi  cile infection in our ICU. Laboratory results of 
C. diffi  cile toxin detection performed by the methods available in our 
institution are presented.
Methods During the last year, all stool specimens received in the 
microbiology department from patients hospitalized in the 30-bed, 
multidisciplinary ICU of a tertiary-care hospital were evaluated. 
Specimens were ordered by physicians in the presence of clinical 
features compatible with C. diffi  cile-associated infection. Each specimen 
was subjected to diagnostic tests for C. diffi  cile infection including toxin 
enzyme immunoassays for C. diffi  cile toxins A and B detection (DUO 
Toxin A&B; VEDA.LAB, France), and glutamate dehydrogenase (GDH) for 
cell wall antigen detection (C. DIFF Quik Chek Complete®; USA).
Results During the study period, 335 stool specimens were evaluated. 
Results obtained with the two-stage immunoassay tests are shown 
in Figure  1. All infected patients were treated with metronidazole or 
vancomycin. Following a course of therapy, 2% of the infected patients 
had recurrence or relapse. The crude mortality rate was 17%.
Conclusion GDH antigen was positive in 12% of the stool specimens 
received from ICU patients with suspected C. diffi  cile-associated 
infections. The majority of these specimens (51.4%) produce both C. 
diffi  cile toxins A and B, whereas toxin B is produced in 31.4% and toxin 
A in the remaining 17.2%.
References
1. Bobo LB, et al.: Chest 2011, 140:1643.
2. Cohen SH, et al.: Infect Control Clin Epidemiol 2010, 315:431.
P345
Retrospective observational analysis of the infective risk of arterial 
lines in a general ICU
M Wylie, M Clark
Victoria Hospital, Kirkcaldy, UK
Critical Care 2014, 18(Suppl 1):P345 (doi: 10.1186/cc13535)
Introduction This study aims to describe the infective morbidity of 
arterial line catheters in a general ICU.
Methods All ICU admissions for the year 2012 were listed on the 
WardWatcher database. All cases in which arterial line tip samples 
returned any growth were reviewed in conjunction with the medical, 
nursing and daily chart recordings. Data were collected on the 
organisms grown and antimicrobial sensitivities. A qualitative decision 
of clinical relevance was established based on necessitated change 
in patient management, signs of local site infection or evidence of 
bacteraemia with the same organism.
Results During 2012 there were 416 ICU admissions, representing 
a total of 2,440 ITU-days and 1,994 arterial line-days. A total of 48 
arterial line tips suspected of being infected were sent for culture. 
Figure 1 (abstract P344). Illustration of the tests performed for detection of C. diffi  cile.
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Thirty-seven arterial lines returned no growth (77.08%). Seven cultures 
grew organisms likely to be contaminants (14.58%). Four cultures 
grew signifi cant organisms (yield of 8.33%). There were two cases with 
documented clinical signs of catheter-related local infection (CRLI) at 
the arterial line puncture site. In one case of CRLI the primary source 
of infection was felt to be remote from the arterial line. The second 
represented a local infection with organisms that are typically skin 
commensals. Of the four cultures likely to represent invasive pathogens, 
three had clinical suspicion that the primary source was a site remote 
from the arterial line. In two of these cases this was confi rmed by 
growing the same organism at an alternative site more likely to be the 
source of infection.
Conclusion These results suggest that CRLI rates for arterial lines are 
low at 1.003 per 1,000 arterial line-days. However, there is a signifi cant 
bacterial colonisation rate of the arterial lines sampled. Three arterial 
lines (6.25%) grew organisms that could represent an important 
potential source of ongoing bacteraemia. There is evidence to suggest 
that the risk of infection and colonisation of arterial lines may be similar 
to that of central lines [1]. Further prospective work is needed to assess 
the impact of catheter care bundles on colonisation and infection rates 
of arterial lines in the ICU.
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Introduction Central venous catheters (CVCs) are essential for the 
delivery of medications and fl uids in the ICU patient; however, they 
carry a substantial infection risk. Evidence from a collaborative, cohort 
study suggests bundled interventions can provide a sustained decrease 
in infection [1].
Methods Since December 2009, data have been collected daily on 
the number of patients with one or more CVC. All positive blood 
cultures are reviewed monthly against predefi ned criteria to judge 
whether these are genuine bacteraemic episodes and thus classifi ed 
as laboratory-confi rmed bloodstream infections. A monthly rate for 
CR-BSI per 1,000 dwell-days is calculated from these data. Since July 
2010, a number of interventions aimed at reducing CR-BSI have been 
introduced to the ICU.
Results Data are presented on 15,644 CVC dwell-days over 47 months. 
Table 1 presents data for three full years and one part year* (January 
to November 2013). Despite an increase in bed-days per year, there 
has been a sustained reduction in infection rates and a reduction in 
dwell-days.
Table 1 (abstract P346). Catheter infection rates, APACHE score and 
bed-days 2010 to 2014
 Total  CR-BSI/   
 CVC CR-BSI 1,000 APACHE II Bed- Dwell-days/
Year dwell-days annually dwell-days (mean) days bed-days
2010 4,037 6 1.5 15.8 5,870 0.69
2011 3,942 2 0.5 16.3 5,967 0.66
2012 3,822 3 0.8 15.9 6,117 0.62
2013* 3,863 1 0.3 16.0 6,059 0.64
Conclusion CR-BSI rates of 1.5/1,000 dwell-days in the fi rst year were 
similar to the post-intervention rate of 1.4 in the Pronovost study [1]. 
Subsequent rates have reduced, suggesting we are outperforming 
the secular trend [2]. The proportion of dwell-days to bed-days was 
reduced, which may suggest a reduction in duration and/or quantity 
of CVC placements.
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Introduction The prediction for and the mortality of patients with 
candidemia are highly adverse. The aim of this study was to identify 
the risk factors for the development of candidemia in postoperative 
patients.
Methods From 1 July 2010 to 30 June 2013 all postoperative patients 
(n  = 588) admitted to the multivalent ICU of our hospital were 
enrolled in this study. We recorded the age, sex, length of stay in the 
ICU, APACHE II score upon admission to the ICU, adjusted mortality 
score, underlying conditions, recent operations, invasive therapeutic 
procedures and prior usage of antimicrobial agents. Initial bivariable 
statistical comparisons were conducted using the χ2 test for categorical 
data and the Student t test or Wilcoxon test for continuous data. 
Relative risks (RRs) and their 95% confi dence intervals (CIs) were 
calculated. Statistical signifi cance was set at P <0.05. To identify patient 
characteristics associated with candidemia we used multivariable 
logistic regression. In the multivariant analysis we also included the 
independent risk factors reported in recent medical literature. Results 
of the logistic regression analysis are reported as adjusted odds ratio 
(OR) with 95% CI.
Results Out of 588 patients, 30 (5.1%) developed candidemia 
(frequency: 12 per 1,000 days of hospitalization). The mortality 
of patients with candidemia was 66.7% (20/30). The monovariant 
analysis showed statistical signifi cant diff erence in the following 
factors: immunosuppression (P  = 0.0005), diabetes mellitus (P  = 
0.0005), hypoproteinemia (P = 0.0005), the presence of central venous 
catheter (P = 0.0005), the coexistence of bacteremia and the prior use 
of antimicrobial agents (P = 0.0005), length of stay in the ICU >5 days 
(P  = 0.004) and the type of intervention (P  = 0.001). As independent 
risk factors from the multivariant analysis were found the following: 
immunosuppression (exp(B)  = 218.37, 95% CI  = 11.76 to 4,053.72, 
P = 0.0005), hypoproteinemia (exp(B) = 25.69, 95% CI = 2.82 to 296.8, 
P  = 0.009), presence of central venous catheter (exp(B)  = 13.79, 95% 
CI  = 1.86 to 102.51, P  = 0.01) and the coexistence of bacteremia in 
combination with prior use of antimicrobial agents (exp(B)  = 404.94, 
95% CI = 11.61 to 14190.41, P = 0.001).
Conclusion Early candidemia identifi cation, prompt collaboration 
of intensivists with biopathologists and immediate initiation of the 
proper antifungal treatment is of great signifi cance. The concurrent 
understanding of the predisposing risk factors constitutes a signifi cant 
supportive tool for the prediction of such infections.
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Introduction The aim of our study was the analysis of the epidemiology 
of infections caused by ECO in Polish NICUs and their resistance to 
antibiotics, with particular reference to their impact on the safety of 
infants with very low birth weight, and their relationship to the care of 
women who are pregnant and in labour. The routes of transmission of 
ECO strains were also evaluated.
Methods Continuous prospective infection surveillance was conducted 
in 2009 to 2012 in fi ve NICUs and included 1,768 newborns whose birth 
weight was lower than 1,500 g.
Results The incidence of ECO infections was 5.4% and 2.0/1,000 patient-
days. The occurrence of ECO infections depended signifi cantly on the 
NICU and ranged from 3.9 to 17.9%. Multivariate analysis that took into 
account the combined eff ect of demographic data (gender, gestational 
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age and birth weight) and place of birth (NICUs, where the baby was 
born) showed that only the place of hospitalisation had a signifi cant 
eff ect on the ECO infection risk. The highest levels of resistance 
among all ECO isolates were observed against ampicillin (88.8%) and 
amoxicillin/clavulanic acid (62.2%). ECO isolates showed very diff erent 
pulsotypes and dominant epidemic clones were not detected. Cluster 
analysis based on PFGE of the 90 isolates showed 71 unique types, 
some of which were less than 70% similar, suggesting a genotypically 
variable population. Isolates that have identical pulsotypes usually 
were derived from the same patient (as in the case of 11 isolates) or 
were isolated from diff erent patients of the same NICU in the same 
period of time (in the case of seven isolates). The location of the NICU 
and the site of the isolation did not appear to have a correlation in the 
cluster analysis
Conclusion Unfortunately, the presented data indicate that antibiotic 
prophylaxis in the presence of symptoms such as chorioamnionitis 
and PROM did not help to reduce the risk of ECO infection in the group 
of examined infants. In addition, multivariate analysis demonstrated 
only one signifi cant risk factor for ECO infection among infants with 
a birth weight <1,500 g; that is, the impact of the NICU. Epidemiology 
of ECO infections clearly indicated that observed cases of infections 
have no connection with the horizontal transmission (thus no proof of 
a link between the observed ECO infections with possible negligence 
in hand hygiene or excessive congestion on NICUs). This is confi rmed 
by the fact that no epidemic clones were observed (DEC-2011/01/D/
N27/00104).
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Introduction Healthcare-associated infections (HAI) in ICU patients are 
related to intubation, mechanical ventilation, and central venous and/
or urinary catheters. The incidence of HAI is too high, and antibiotic 
strategies suff er from resistance to the common classes of antibacterial 
agents [1].
Methods A complex program including staff  teaching on the basic 
approaches of hand hygiene, microbiological passport of the ICU 
departments, and detection of the sources of the pathogens polluting 
the treatment area of the ICU was implemented at the Lugansk Regional 
Clinical Hospital. The incidence of the HAI was studied in polytrauma 
patients in 1999 to 2003 (before the implementation of the program) 
and in 2008 to 2012 (after its implementation).
Results Before the implementation of the infection control program, the 
incidence of respiratory tract infections in polytrauma patients staying 
in ICUs was 57.4% of patients. Urinary infections occurred in 51.9% of 
patients. Surgical site infections were found in 32.8% of the patients. 
Combination of the infections was detected in 33.8% of patients. The 
incidence of the multiple-drug-resistant bacterial colonies was 5.8%.
In contrast, recent data obtained after the implementation of the 
program of the infection control showed that the respiratory infections 
occurred in 29.3% of the patients, catheter-related urinary tract 
infections were detected in 32.8%, and surgical site infections were 
detected in 8.6% of the polytrauma patients. On the other hand, the 
incidence of the multiple-drug-resistant bacterial colonies increased 
signifi cantly up to 14.2% (P  <0.001). Other types of HAI changed 
nonsignifi cantly.
Conclusion In the era of the total antibacterial resistance, the education 
strategies and organization approaches (for example, infection control, 
antibiotic susceptibility, hand hygiene, and so forth) become more 
potent and eff ective than pharmacology innovations. Polytrauma 
patients, as one of the most severe categories suff ering from the HAI, 
demand a high level of compliance of the infection control approaches 
from the side of doctors as well as staff  of and visitors to ICUs.
Reference
1. Nalapko Y, Peicheva O, Iegorov O, Nekrylov A: The dependence of infectious 
complications from the trauma severity. Intensive Care Med 2013, 39(Suppl. 
2):P.0791.
P350
Surveillance for nosocomial pathogens in our ICU
Y Kawano, H Ishikura, T Nishida, N Matusmoto, H Ohya, M Mizunuma, 
Y Nakamura, T Umemura
Fukuoka University Hospital, Fukuoka, Japan
Critical Care 2014, 18(Suppl 1):P350 (doi: 10.1186/cc13540)
Introduction The use of contact precautions is recommended to reduce 
the transmission of these pathogens. However, there is little research 
regarding the relationship between the rate of patients with culture-
positive fi ndings for Acinetobacter baumannii and the consumption of 
hand disinfectant. The objective of this study was therefore to evaluate 
trends in nosocomial bacterial detection, including A. baumannii, and 
the use of hand disinfectant in our ICU.
Methods A single-center, retrospective, observational study was 
carried out. The results of all cultures (sputum, urine, blood, and so 
forth) were used to examine trends in the detection of microbiology in 
our ICU over a 4-year period from April 2009 through March 2013. The 
rate of culture-positive patients, frequency of use of hand disinfectant 
and the antimicrobial use density (AUD) values were investigated for 
the described periods and compared between the early period group 
(April 2009 to March 2011) and the late period group (April 2011 to 
March 2013).
Results We encountered 3,302 patients in our ICU during this period. 
No patients with culture-positive fi ndings for multidrug-resistant 
A. baumannii were identifi ed in this study. The rates of patients 
with culture-positive fi ndings for multidrug-resistant Pseudomonas 
aeruginosa (0‰ vs. 0.05‰ per 1,000 patient-days, P  = 0.99) and P. 
aeruginosa (6.96‰ vs. 7.21‰ per 1,000 patient-days, P  = 0.7) were 
not signifi cantly diff erent between the early period group and the 
late period group. The rates of patients with culture-positive fi ndings 
for MRSA (6.96‰ vs. 8.94‰ per 1,000 patient-days, P  <0.05) and A. 
baumannii (4.98‰ vs. 6.51‰ per 1,000 patient-days, P  <0.05) were 
signifi cantly higher in the late period group than in the early period 
group. The frequency of use of hand disinfectant (99.5  ml/patient-
day vs. 85 ml/patient-day, P <0.05) was signifi cantly lower in the late 
period group. The AUD values for fl uoroquinolones (34 vs. 31.1 defi ned 
daily doses/1,000 bed-days, P = 0.69), third-generation cephalosporins 
(23.5 vs. 38.4 defi ned daily doses/1,000 bed-days, P  = 0.55) and 
glycopeptides (34.9 vs. 35.9 defi ned daily doses/1,000 bed-days, P  = 
0.66) were not signifi cantly diff erent between the early period group 
and the late period group. However, the AUD values for carbapenems 
were signifi cantly higher in the early period group (40.6 vs. 71.8 defi ned 
daily doses/1,000 bed-days, P < 0.05).
Conclusion Improving compliance with hand hygiene and appropriate 
use of carbapenems is important for decreasing the rate of patients 
with culture-positive fi ndings for MRSA and A. baumannii.
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Introduction Acinetobacter infections have increased and gained 
attention because of the organism’s prolonged environmental survival 
and propensity to develop antimicrobial drug resistance [1,2]. We 
performed a retrospective, matched cohort investigation at a tertiary 
care hospital in a tier II city hospital of India to examine morbidity 
and mortality outcome of patients with multidrug-resistant (MDR) 
Acinetobacter (AB) infection compared with patients with MDR non-
Acinetobacter (non-AB) infections.
Methods Patient records from the last 3 years from 2011 through 2013 
were studied (n = 104) to examine outcomes of hospitalized patients 
in terms of number of organ dysfunctions, ICU length of stay, hospital 
length of stay and mortality in patients infected with MDR AB infection 
compared with the patients with MDR non-AB infection.
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Results MDR AB-infected patients (n = 45, 43%) had greater number of 
organ dysfunctions, and higher mean lengths of hospital stay (8.4 days 
vs. 6.1 days) and ICU stay (5.3 days vs. 0.8 days) after the index day than 
MDR non-AB infection (n  = 59, 57%) (Table  1). In-hospital mortality 
rates for patients with MDR AB infections (42%) were higher than for 
MDR non-AB infection (10%). F critical = 3.934253.
Conclusion We demonstrated in patients infected with MDR strains 
of any organism that patients infected with Acinetobacter have 
greater number of organ dysfunction, longer lengths of stay in both 
the hospital and the ICU as well as increased mortality than patients 
infected with non-Acinetobacter infection when we controlled for 
severity of illness.
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Introduction Candida spp. are frequently recovered from endotracheal 
secretions in critically ill patients suspected of having ventilator-
associated pneumonia. Observational studies reported an association 
with worse clinical outcomes [1] but the eff ect of antifungal therapy in 
these patients remains unclear. We designed this pilot study to assess 
the feasibility of a larger trial and to evaluate infl ammatory profi les and 
clinical outcomes in these patients.
Methods We conducted a double-blind, placebo-controlled, multi-
center, pilot randomized trial of antifungal therapy in critically ill 
patients with a clinical suspicion of ventilator-associated pneumonia 
with positive airway secretion specimens for Candida spp. We also 
included an observational group without Candida spp. in their airway 
secretions. We measured the recruitment rate, infl ammatory profi les 
over time and clinical outcomes.
Results We recruited 60 patients into the randomized trial; 29 patients 
into the observational study. Recruitment was halted before the end 
of the study because of diffi  culty in recruiting patients. Markers of 
infl ammation and all clinical outcomes were comparable between 
placebo and antifungal treatment groups at baseline and overtime. At 
baseline, TNFα levels were higher in the VAP with Candida compared 
with the observational group (mean ± SD) (21.8 ± 23.1 vs. 12.4 ± 9.3 pg/
ml, P  = 0.02) and these patients had lower response to the LPS 
stimulation test (854.8 ± 855.2 vs. 1,559.4 ± 1,290.6 pg/ml, P = 0.01).
Conclusion Given the diffi  culty recruiting patients and the lack of 
signal in clinical or infl ammatory outcomes, this study does not provide 
evidence to support a larger trial examining the effi  cacy of empiric 
antifungal treatment in patients with a clinical suspicion of ventilator-
associated pneumonia and Candida in the endotracheal secretions. 
The presence of Candida in the lung may be associated with persistent 
infl ammation and immunosuppression.
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Introduction We analysed positive respiratory isolates for antibiotic 
resistance in our out-of-hospital cardiac arrest (OOHCA) population 
to establish adequacy of current empirical regimes. Pneumonia 
commonly complicates OOHCA, with studies suggesting a prevalence 
up to 48% [1].
Methods Patients admitted to the ICU between May 2007 and 
September 2013 who underwent therapeutic hypothermia post 
OOHCA were included in this study. Demographics and antibiotic 
resistance were collected from an electronic database.
Results A total of 160 patients were admitted to the ICU post OOHCA. 
In total, 37.5% (60/160) had no respiratory sample sent within 72 hours 
of admission and were excluded. Forty per cent (40/100) grew a 
clinically important isolate. Gram-negative bacteria (GNB) were most 
frequently isolated (42.5%, 17/40) followed by Gram-positive bacteria 
(32.5%, 13/40) and mixed bacterial growth (25%, 10/40). S. aureus (n = 
14) isolates were often resistant to penicillin (92.8%, 13/14 isolates 
tested) but maintained macrolide (erythromycin 92.8%, 13/14), 
clindamycin (92.8%, 13/14) and vancomycin (100%, 13/13) sensitivity, if 
tested. S. pneumoniae isolates (n = 8) maintained penicillin (87.5%, 7/8), 
levofl oxacin (100%, 6/6), erythromycin (87.5%, 7/8) and vancomycin 
(100%, 6/6) sensitivity. The most commonly isolated GNB, H. infl uenzae, 
maintained high-level sensitivity to amoxicillin (81.8%, 9/11) and co-
amoxiclav (90.9%, 10/11). Other isolated GNB, however, demonstrated 
variable resistance to co-amoxiclav (69.2%, 9/13). Isolates were 100% 
sensitive to pipericillin–tazobactam (17/17), amikacin (12/12) and 
meropenem (16/16). The British Thoracic Society suggests co-amoxiclav 
and clarithromycin for fi rst-line treatment of severe community-
acquired pneumonia [2]. Based on this, 77.5% (31/40) of our patients 
would have received adequate cover. If pipericillin–tazobactam 
replaced co-amoxiclav, 95% (38/40) of our patients would have been 
treated with appropriate antibiotics.
Conclusion Respiratory samples post OOHCA frequently grow 
potentially pathogenic bacteria but current antibiotic guidelines fail to 
provide adequate cover in this population.
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Introduction The purpose of this study was to describe the 
pharmacokinetics of antituberculosis drugs, isoniazid (INH), rifampicin 
(RIF) and pyrazinamide (PZA), in eight critically ill patients with 
tuberculosis and acute respiratory failure.
Methods We analyzed plasma concentrations of RIF, INH and PZA. 
Blood samples were obtained at steady state. Plasma concentrations 
were determined with HPLC. A population pharmacokinetic 
approach using a nonlinear mixed-eff ect model was implemented 
[1]. Interindividual variability in PK parameters was ascribed to an 
exponential model according to the equation: θj = θp × exp(nj), where 
θj is the estimate for a pharmacokinetic parameter in the jth patient, 
θp is the typical population PK parameter value (ka, CL/F, V/F), and n 
is a random variable from a normal distribution with zero mean and 
variance ω2. Residual variability was estimated using additive and 
additive-proportional error models; Cij = Cj + εadd and Cij = Cj(1 + εp) 
+ εadd, where Cij and Cj are observed–predicted concentrations for the 
Table 1 (abstract P351).
Outcome evaluated MDR AB  MDR non-AB P value F value
Mean length of stay  8.488889 6.101695 0.029299 4.886684
after index day
Mean ICU stay after  5.311111 0.864407 1.73×10–11 57.30083
index day
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jth patient at time i, respectively, and ε is the error, a random variable 
with a normal distribution with zero mean and variance σ2. Bayesian 
estimates were obtained and the pharmacokinetic parameters Cmax, 
Tmax and AUC0–24 hours were calculated.
Results Cmax of PZA was above the recommended concentration 
(>20  mg/l). For RIF the Cmax was below the recommended level 
(>8  mg/l), and the Cmax of INH was below the recommended levels 
(>3 mg/l). See Table 1.
Conclusion Large interindividual pharmacokinetic variability and 
concentrations below the recommended levels for RIF and ISO. We 
need to monitor drugs and to re-evaluate the doses.
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Introduction Staphylococcus epidermidis (SE) is the most often isolated 
species of coagulase-negative staphylococci, which are recognized as 
one of the main causes of ICU infections [1]. In this study we aimed 
to study the resistance profi le of SE clinical isolates against last-line 
antibiotics (vancomycin (VA), teicoplanin (TEC), linezolid (LZ) and 
daptomycin (DA)) for treating CNS infections, during an 8-year period.
Methods From January 2005 until December 2012 we examined 518 
nonduplicated SE isolates recovered from blood cultures of 421 patients 
hospitalized in a surgical ICU of our hospital. Species identifi cation 
and susceptibility testing were performed using the automated 
VITEK II system (Biomerieux). Additionally we used the E-test method 
(Biomerieux, ABI-Biodisk) in order to confi rm some isolation resistances 
against TEC and LZ found by the VITEK II system and to estimate the 
MIC levels of DA and VA. Mueller–Hinton agar adjusted to contain 
physiologic levels of free calcium ions (50  μg/ml) was used when 
testing DA susceptibility. Isolates with MIC >4  mg/l were considered 
resistant to TEC and LZ and those with MIC <1 mg/l and MIC <4 mg/l 
susceptible to DA and VA, respectively.
Results The percentage resistance rate of the examined SE isolates is 
shown in Table 1. Methicillin resistance was observed with an overall 
prevalence of approximately 84.6%. All of the resistant isolates to TEC 
and LZ were also resistant to methicillin. The MIC values of VA were 
lower than 2 mg/l (Table 1).
Conclusion The examined SE isolates present a scattered resistance 
to TEC and they show a remarkable continuing increase of resistance 
to LZ. These fi ndings enforced the necessity to take the appropriate 
measures in the ICU environment and during the clinical practice to 
limit the dissemination and the amplifi cation of these resistances. DA 
and VA possess an excellent in vitro activity against SE isolates and they 
could be very good alternative solutions for treating ICU infections 
caused by this species.
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Introduction Patient-to-patient transmission enables vancomycin-
resistant enterococci (VRE) outbreaks. Outbreak management is expensive 
and time consuming, and therefore the possibility of VRE eradication is 
desirable. Since vancomycin is scarcely absorbed in the gastrointestinal 
tract, treatment with vancomycin per os may result in very high 
gastrointestinal concentrations (many times the minimum inhibiting 
concentration (MIC)). The purpose of this study is to measure in vivo 
gastrointestinal concentrations of vancomycin in patients that are treated 
with a standard dose orally, and to investigate in vitro whether vancomycin 
is able to kill VRE at concentrations up to 2,000 times the MIC.
Methods The faecal vancomycin concentration was measured in eight 
patients who suff ered a Clostridium diffi  cile infection and were treated 
with 4×500 mg vancomycin orally per day. In vitro, a (1:2) dilution 
series of vancomycin (range 6,250 to 0.4 μg/ml) was created and 1 ml 
vancomycin solution was then added to 1 ml standardized inoculum. 
One vancomycin-susceptible enterococcus isolate (VSE, MIC  = 3  μg/
ml) and two VRE isolates (MIC = 16 μg/ml) were studied. After 1, 7 and 
14 days incubation at 35°C, growth was defi ned as macroscopic visible 
turbidity. To test for surviving bacteria, all inocula were cultured to 
sheep blood agar plates, which were read after 24-hour incubation at 
35°C. E-tests to measure MIC were performed on relevant samples. The 
in vitro experiment was performed twice.
Results The faecal vancomycin concentration in patients treated orally 
with vancomycin was 8,000 μg/ml on average. VSE growth at day 14 
was detected at up to 1.5 μg/ml vancomycin, whereas VRE growth was 
detected at up to 98 μg/ml. The MIC of these VRE species growing at 
98 μg/ml vancomycin was increased (≥256 μg/ml). For both VSE and 
VRE, surviving bacteria were detected at very high concentrations of 
vancomycin (>98 μg/ml): the MIC of these survivors was not increased.
Conclusion Oral treatment with vancomycin results in extremely high 
faecal concentrations. At these high concentrations, VRE bacteria 
are killed in vitro; however, a minority of the VRE is able to survive. 
Vancomycin thus seems unsuitable for eradication. However, high 
concentrations of vancomycin dramatically reduce the bacterial VRE 
load. Therefore oral treatment with vancomycin may help to terminate 
VRE outbreaks: a dramatic reduction in bacterial load of the colonised 
patient will minimise the risk of patient-to-patient transmission.
P357
Audit of bacteraemia management in a university hospital ICU
V De Santis, MG Gresoiu, A Peter, R Wilson, M Singer
University College London Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P357 (doi: 10.1186/cc13547)
Introduction The optimal duration of antibiotic treatment in critically 
ill patients remains a subject of debate. In our multidisciplinary ICU, a 
short course of antibiotic monotherapy (5 to 7 days) is generally used as 
Table 1 (abstract P354). Mean population parameters of antituberculosis 
drugs
Parameter RIF INH PZA
ka 0.459 3.58 1.41
CL/F 6.69 2.74 1.56
V/F 105 42.3 33.4
ωka 0.645 38.7 0.98
ωCL/F 0.391 65.6 0.23
ωV/F 0.469 46.8 0.38
ε 0.441 0.235 0.089
Table 1 (abstract P355).
 2005 2006 2007 2008 2009 2010 2011 2012
 (n = 77) (n = 76) (n = 79) (n = 89) (n = 92) (n = 93) (n = 46) (n = 59)
VA 0 0 0 0 0 0 0 0
TEC 1.3 2.6 0 0 0 1.1 0 0
LZ 0 0 1.4 1.2 6.8 12.6 23.1 27.1
DA Not Not Not 0 0 0 0 0
 tested tested tested
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a strategy to treat bacteraemia, unless specifi cally indicated otherwise 
(for example, endocarditis, osteomyelitis). We aimed to determine the 
impact of this strategy on antibiotic resistance patterns and patient 
outcomes compared with a similar exercise we conducted in 2000 [1].
Methods We conducted a retrospective study of all patients with 
bacteraemia or fungaemia (community-acquired, hospital-acquired, 
and ICU-acquired) treated in our university hospital ICU over a 6-month 
period (December 2012 to May 2013). We compared this against data 
from blood culture-positive patients admitted between February 
and July 2000. Information was collected on bacteraemia episodes, 
causative pathogens, antimicrobial resistance patterns, antibiotic use 
and duration, and patient outcomes. Notably, our ICU admits many 
immunosuppressed patients (for example, haemoncology).
Results Table 1 presents demographics and incidence of bacteraemia. 
Antimicrobial resistance remained low in the 2013 cohort with few 
multi-resistant Gram-negative organisms, few fungaemia episodes 
and a marked decrease in methicillin-resistant Staphylococcus 
aureus (MRSA) (Figure  1). The number of relapses and breakthrough 
bacteraemias remained low.
Conclusion A strategy of short-course antibiotic monotherapy is 
associated with low breakthrough and relapse rates and a low rate of 
antibiotic resistance.
Reference
1. Corona A, et al.: J Antimicrob Chemother 2004, 54:809-881.
Figure 1 (abstract P357). Microorganisms isolated in each bacteraemia group. Left panel, 2000; right panel, 2013. Top panel, community-acquired 
bacteraemia; Middle panel, hospital-acquired bacteraemia; lower panel, ICU-acquired bacteraemia. Shaded areas represent numbers of methicillin-resistant 
strains for S. aureus and coagulase-negative staphylococci; vancomycin-resistant strains for Enterococcus spp.; multidrug-resistant strains for Gram-negative 
pathogens; and fl uconazole-resistant strains for Candida spp.
Table 1 (abstract P357). Demographics and incidence of bacteraemia
Variable 2000 cohort 2013 cohort
Total ICU population 713 1,318
Patients with bacteraemia 91 87
Episodes of bacteraemia 102 113
 Community-acquired bacteraemia 13 37
 Hospital-acquired bacteraemia 28 39
 ICU-acquired bacteraemia 60 37
Hospital mortality 45% 32%
Monotherapy treatment (%); duration median (IQR)  
 Community-acquired bacteraemia 57%; 6 (5 to 6) 65% 5 (3 to 5)
 Hospital-acquired bacteraemia 78%; 6 (5 to 8) 63%; 5 (4 to 7)
 ICU-acquired bacteraemia 80%; 5 (5 to 7) 62%; 4 (3 to 6)
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Sepsis: impact of timely and appropriate empirical antibiotic 
therapy on mortality
L Serpa-Pinto, T Cardoso
Oporto Hospital Center, Oporto, Portugal
Critical Care 2014, 18(Suppl 1):P358 (doi: 10.1186/cc13548)
Introduction The administration of timely and appropriate antibiotic 
therapy is a well-known prognostic factor among severe sepsis 
patients [1-4]. The purpose of this study is to describe the magnitude 
of the impact of early and appropriate empirical antibiotic therapy on 
hospital mortality.
Methods A retrospective cohort study including all adult patients with 
sepsis admitted to the emergency room of a tertiary care, university 
hospital between 1 July 2011 and 30 June 2012.
Results A total of 1,219 patients were admitted to the emergency room 
during the study period, of which 162 (13%) had severe sepsis. Forty 
(25%) patients had withheld therapeutic decisions and were excluded 
from the current analysis; 20 additional patients transferred from other 
acute healthcare facilities were excluded due to missing or inaccurate 
data, leaving 102 patients to be included with a hospital mortality rate 
of 45%. The median time to antibiotics administration was 36 minutes 
(IQR 0 to 174), 59 (58%) patients had antibiotic administered within the 
fi rst hour after sepsis recognition; 60 (59%) had positive microbiology, 
74% with appropriate empiric antibiotic therapy. An association was 
found for hospital mortality with: heart failure (OR = 4.297; P = 0.037), 
decreased functional status (Karnofsky performance status <70%) 
(OR = 2.368; P = 0.034) and SOFA score (OR per point = 1.415; P <0.001). 
Two multivariate models with hospital mortality as the dependent 
variable were built using alternative severity scores: one with SAPS II 
that was retained in the fi nal model (adjusted OR  = 1.068, 95% CI  = 
1.020 to 1.119) along with heart failure (adjusted OR = 5.859, 95% CI = 
0.996 to 34.474); and another with SOFA score that was also retained 
in the fi nal model (adjusted OR = 1.659, 95% CI = 1.227 to 2.242) along 
with heart failure (adjusted OR = 12.636, 95% CI = 1.423 to 112.229).
Conclusion Contrarily to what has been described previously, early and 
appropriate empirical antibiotic therapy was not associated with better 
prognosis. The most probable explanation is the higher compliance 
found with the current recommendations, reinforcing the need for 
period audits and feedback to the team.
References
1. Dellinger RP, et al.: Crit Care Med 2008, 36:296-327.
2. Levy MM, et al.: Intensive Care Med 2010, 36:222-231.
3. Kumar A, et al.: Crit Care Med 2006, 34:1589-1596.
4. Kumar A, et al.: Chest 2009, 136:1237-1248.
P359
Safety and effi  cacy of amphotericin B inhalation for Candida spp. in 
the respiratory tract of critically ill patients
P Van der Geest, E Dieters, B Rijnders, J Groeneveld
Erasmus Medical Center, Rotterdam, the Netherlands
Critical Care 2014, 18(Suppl 1):P359 (doi: 10.1186/cc13549)
Introduction Candida spp. are increasingly isolated in the critically 
ill, but the clinical signifi cance hereof is hard to establish [1]. 
Candida spp. colonization has been suggested as a risk factor for 
ventilator-associated pneumonia (VAP) [2]. The effi  cacy and safety of 
inhalational amphotericin B (AB) is unknown [3]. The hypothesis was 
that inhalational AB deoxycholate is a safe and eff ective treatment for 
Candida spp. colonization of the respiratory tract and thereby prevents 
VAP and prolonged need for mechanical ventilation.
Methods All patients admitted to the ICU from December 2010 to 
2011 with positive Candida spp. cultures of the respiratory tract 
and requiring mechanical ventilation >48  hours were included. AB 
treatment was decided by attending intensivists. The colonization 
index was calculated to determine the eff ect of AB. The clinical 
pulmonary infection score (CPIS) and the lung injury score (LIS) were 
calculated to determine pulmonary eff ects of AB.
Results Fifty-fi ve of 181 patients had been treated with AB. The AB 
decreased indicators of Candida spp. load but increased the duration 
of mechanical ventilation as compared with nontreated patients, 
associated with a higher CPIS and LIS, even in those with similar degree 
and duration of colonization and thus probably Candida spp. load at 
baseline (P <0.001) (Figure 1). There was no diff erence in occurrence of 
VAP or mortality.
Conclusion AB deoxycholate treatment is eff ective for the treatment of 
Candida spp. colonization of the respiratory tract in critically ill patients. 
However, patients are mechanically ventilated for longer.
References
1. El-Ebiary et al.: Am J Respir Crit Care Med 1997, 156:583-590.
2. Azoulay E, et al.: Chest 2006, 129:110-117.
3. Knechtel SA, et al.: Expert Opin Drug Saf 2007, 6:523-532.
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Inhaled tobramycin for the treatment of nosocomial pneumonia in 
sepsis
A Kuzovlev, V Moroz, A Goloubev
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Critical Care 2014, 18(Suppl 1):P360 (doi: 10.1186/cc13550)
Introduction Nosocomial pneumonia (NP) is frequently caused by 
multiresistant Gram-negative bacteria. The inhaled antibiotics provide 
us with a new treatment modality for NP in sepsis. The aim of this study 
was to estimate the effi  cacy of inhaled tobramycin (IT) as an adjunct to 
systemic antibiotics in the treatment of NP in sepsis.
Methods Fifty ICU ventilated septic patients with NP were enrolled in 
the study (all male, 55.3 ± 7.3 years old; primary reason for ICU stay – 
intraabdominal infections (78%), mediastinitis (13%), other (9%)). 
Diagnosis of NP was made according to the standard clinical and CPIS 
criteria. Associations of multiresistant Gram-negative bacteria were 
detected in bronchoalveolar lavage (BAL) of all patients. Seventy-
two percent of bacteria were sensitive to tobramycin. Patients were 
randomized into two groups: IT (group 1, n  = 25), addition of IT to 
systemic antibiotics (carbapenems, aminoglycosides, protected 
penicillins); and no IT (group 2, n  = 25), shift of systemic antibiotics 
according to sensitivity. Groups were comparable in APACHE II and CPIS 
scores. IT (Bramitob) was administered 300 mg twice daily via nebulizer. 
The data were statistically analyzed by STATISTICA 7.0 (M, σ, Newman–
Keuls test; P <0.05).
Results Administration of IT as an adjunct to systemic antibiotics 
was associated with a decrease of systemic infl ammation and acute 
respiratory insuffi  ciency signs 2.3 ± 1.2 days after the treatment onset 
(vs. 6.3 ± 1.5 days in group 2, P = 0.03). The decrease of microbial titer 
to 103 to 104 CFU/ml was detected in both groups by days 5 to 7, but it 
Figure 1 (abstract P359). Duration of mechanical ventilation grouped by 
amphotericin B.
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was reliable in 80% of the patients of group 1 (P <0.02). It is noteworthy 
that 21% of group 1 patients were in vitro resistant to tobramycin, but 
it was clinically eff ective, probably due to a local superconcentration. 
Treatment with IT was associated with an increase of sensitivity of 
microbes to antibiotics they were prior resistant to (32% of patients). 
This is probably due to IT eff ects on biolayers. De-escalation of 
antibiotic therapy was possible in group 1 by day 5 in 42% of patients. 
The treatment with IT made it possible to wean 40% of patients by 
day 5.3  ±  1.8 after treatment cessation (vs. 35% and 11.2  ±  1.3 days 
in group  2, P  = 0.02). Hearing loss and tinnitus was detected only in 
three patients of group 1. There were no cases of bronchospasm. The 
mortality was 12% (n  = 3) in group  1 and 16% (n  = 4) in group  2 (P 
>0.05), and was not related to a progression of NP [1].
Conclusion Administration of IT as an adjunct to systemic antibiotics 
is effi  cient in treatment of NP caused by multiresistant Gram-negative 
bacteria in sepsis.
Reference
1. Moroz VV, et al.: Gen Reanimatol 2012, VIII:5-10.
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Introduction Appropriate antibiotic prophylaxis plays a crucial role 
in preventing sternal wound infection after cardiac surgery [1]. In 
institutions with high prevalence of methicillin-resistant Staphylococci 
species, vancomycin prophylaxis is recommended either as a 
monotherapy or as an adjuvant agent [2]. In our study, we assessed 
sternal wound infection rates before and after the introduction of a 
vancomycin prophylaxis protocol.
Methods Twenty-six of a total 227 consecutive cardiac surgical patients, 
between July and December 2012, developed sternal wound infection 
(Group A). All of the patients received a standard empirical antibiotic 
prophylaxis. From January to July 2013, 308 patients underwent 
cardiac surgery (Group B). In this group, we applied a more restricted 
antibiotic protocol, considering the resistance patterns and the results 
of microbiological tests of group  A. We also evaluated the results 
of MIC susceptibility testing of fi ve antibiotics: oxacillin, linezolide, 
daptomycin, teicoplanin and vancomycin. In the new protocol the fi rst 
vancomycin dose was given 1 hour before sternal incision followed by 
three additional doses (48 hours duration).
Results In group A, 26 patients (11.45%) developed sternal wound 
infection. Twenty out of 26 patients had staphylococcal infections 
characterized by high prevalence of oxacillin resistance while six 
patients had Gram-negative infections. In the vancomycin prophylaxis 
group (group B) we observed a signifi cant reduction in the incidence of 
sternal wound infection rate (P <0.01). Among 308 patients, six patients 
(1.94%) developed sternal wound infections, two of them caused by 
coagulase-negative oxacillin-resistant staphylococci while in four 
patients Gram-negative microorganisms were cultured. Mortality in 
infected patients was 0% in both groups.
Conclusion Appropriate antibiotic prophylaxis in cardiac surgery 
patients is of paramount importance in preventing sternal wound 
infections, resulting in dramatic reduction of postoperative morbidity 
and in signifi cant economic benefi ts.
References
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V Humphrey, M Clark
Victoria Hospital, Kirkcaldy, UK
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Introduction This study aimed to establish clinical utility of blood 
cultures taken surrounding ICU admission. Blood culture cost in terms 
of resources and false results is well established and unnecessary 
cultures can cause patient harm.
Methods All ICU admissions in 2011 were listed retrospectively. Notes 
were reviewed for those with blood cultures taken during, or within 
24 hours prior to or following, ICU admission. Data collected for positive 
blood cultures included organism, antimicrobial sensitivity, culture 
timing with respect to ICU admission and antibiotic therapy before and 
after positive blood culture. Qualitative decisions were made regarding 
clinical utility of each positive blood culture. Results were deemed 
useful if management changed  – starting, changing or stopping 
antibiotics or altering antibiotic duration. Confi rmatory results or those 
not altering treatment were not deemed useful. Statistical analysis was 
performed using the chi-squared test.
Results During 2011 and 2012, there were 450 ICU admissions. In total, 
698 blood cultures were taken during, or within 24  hours prior to or 
following, ICU admission. A total of 135 blood cultures were taken 
in the 24  hours prior to ICU admission. Of these, 26 grew signifi cant 
organisms (19.3%). Nine of these cultures were deemed clinically useful 
(6.7%). A total of 542 blood cultures were taken during ICU admission. 
Thirty-three of these yielded signifi cant results (6.1%) but only nine 
(1.7%) were deemed clinically useful. A total of 102 cultures were taken 
in the fi rst 24 hours of the ICU, of which 17 were positive (16.7%) and 
six were useful (5.9%). Fifty-three were taken over the next 24 hours, 
of which two were positive and two were useful (3.8%). Forty-four 
cultures were taken over the following 24  hours, of which two were 
positive (4.5%) and one was useful (2.3%). A total of 343 cultures were 
taken subsequent to this in the ICU, of which 12 were positive (3.5%) 
and three were deemed useful (0.9%). Of 22 blood cultures taken in 
the 24 hours post ICU, one was positive but deemed useful (4.5% yield).
Conclusion These results demonstrate overall low clinical utility of 
blood cultures but specifi cally that utility of ICU cultures is signifi cantly 
lower than pre ICU (1.7% vs. 6.7%; P = 0.0001). The yield of positive blood 
cultures and their clinical utility also decrease during ICU stay. This may 
refl ect appropriate empirical antibiotics and lower bacteraemia burden 
in later illness. Given the low clinical yield and a lack of established 
sensitive or specifi c triggers [1], we suggest further work in an ICU 
setting to maximise utility whilst minimising harm.
Reference
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Introduction The Surviving Sepsis Campaign (SSC) has developed 
guidelines to promote evidence-based management for patients with 
severe sepsis [1]. Improvements in bundle compliance have been 
demonstrated over time, but compliance remains below 40%. Sepsis 
has been studied in acute and critical care environments, but little 
research has focused on the management in level 1 wards. An initial 
audit of patients with sepsis who were referred to the GSTT critical care 
outreach team revealed very low overall compliance to the SSC 3-hour 
bundle. A novel quality improvement campaign was instituted with the 
aim of improving bundle compliance.
Methods A retrospective cohort study in a university hospital was 
performed. Patients on level 1 wards with severe sepsis registered in 
the adult critical care response team (CCRT) database in November 
2012 were identifi ed (Cohort A). Physiological observation, track 
and trigger scores, compliance with the 3-hour bundle elements 
(measured lactate, blood cultures before antibiotics, fl uid challenge, 
early antibiotics), antimicrobial stewardship and 28-day mortality 
were recorded. Following this, a quality improvement project was 
initiated: central to this was an electronic ‘SEPSIS’ order set, containing 
appropriate investigations and a step-by-step management guide for 
use on level 1 wards. A ‘viral’ print and social media campaign were also 
undertaken. Compliance to the SSC early care bundle was re-examined 
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in two cohorts of patients in July 2013; patients that were referred to 
the CCRT as before (Cohort B) and also patients who had the electronic 
order set activated (Cohort C).
Results The mean age of all patients studied (n = 79) was 66.5 years. 
Fifty-three per cent of the patients were male. Thirty-one per cent 
were in septic shock at the time of sepsis identifi cation. Overall SSC 
bundle compliance was 6.60% (Cohort A), 24% (Cohort B) and 45.5% 
(Cohort C). Improvements in other bundle parameters were also seen, 
including blood culture (54%, 72%, 91%), antibiotic administration 
(50%, 69%,76%) and fl uid administration in septic shock (50%, 42%, 
75%) in Cohort A, Cohort B and Cohort C respectively.
Conclusion Baseline compliance with the SSC 3-hour bundle on level 
1 wards was very low. An electronic sepsis order set was associated 
with marked improvement. Novel quality improvement methodology 
may be important to achieve optimal compliance with evidence-based 
guidelines and an electronic sepsis order set is recommended.
Reference
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Introduction Cardiorenal syndrome type 1 (CRS-1) refl ects an abrupt 
worsening in cardiac function leading to acute kidney injury (AKI). 
Acute cardiac conditions contributing to CRS-1 include acute heart 
failure (AHF), acute coronary syndrome (ACS) and cardiac surgery (CS). 
The objective of this study was to evaluate the epidemiology of AKI in 
CRS-1.
Methods This is a systematic review and meta-analysis. AKI defi ned by 
the RIFLE defi nition and its modifi cations AKIN and KDIGO is grouped 
as AKIRIFLE. Similarly, AKI defi ned by variations of worsening renal 
failure is grouped as AKIWRF. Incidence of AKI is reported by the 
diff erent defi nitions of AKI. In addition, we report on mortality and 
length of intensive care and hospital stay (LOSICU and LOShosp) for 
AKIRIFLE. Data are reported as percentage, risk ratio (RR), and mean 
diff erence (MD).
Results Our literature search yielded 316 potential papers, of which 
57 were included (20 papers on AHF, 15 ACS and 22 CS). A risk of bias 
analysis showed a low risk for selection bias in 55% of the studies and 
prospective data collection in 45%. AKIRIFLE was used in 33 studies 
(RIFLE in 22, AKIN in 14, KDIGO in four), AKIWRF, with six variants, in 
24 studies and use of RRT (AKIRRT) in 20 studies. The incidence of 
AKI in CRS-1 patients defi ned by AKIRIFLE and AKIWRF was similar 
(22.5%, respectively 22.4%, P = 0.401), and greater than AKIRRT (2.6%, 
both P  <0.001). AKIRIFLE occurred more frequently in AHF patients 
compared with ACS and CS patients (55.0% vs. 14.9% vs. 19.3%; P  = 
0.009 respectively P  = 0.001, P  = NS for ACS vs. CS). This was similar 
when defi ned by AKIWRF. AKIRRT was evenly distributed among CRS-
1 subtypes (AHF 4.3%, ACS, 1.7%, and CS 3.1%, P  = 0.611). Despite 
predominant low severity of AKIRIFLE (stage 1: 16.9%, stage 2: 3.7%, 
and stage 3: 3.6%), AKIRIFLE was associated with increased mortality 
(RR  = 5.4), LOSICU (MD 1.7 days), and LOShosp (MD 4.4 days), and 
increasing AKIRIFLE severity was associated with increase in these three 
outcomes in all CRS-1 patients as well as in the three subgroups. The 
impact of AKIRIFLE on mortality was greatest in CS patients (AHF RR = 
2.8, ACS RR = 3.5, and CS RR = 9.1). Not surprisingly, AKIWRF had similar 
impact on outcomes, but AKIRRT had greater impact compared with 
AKIRIFLE (mortality RR = 9.16, LOSICU MD = 10.6 days, and LOShosp, 
MD = 20.2 days).
Conclusion Almost one-quarter of patients with an acute cardiac 
condition had AKI, and RRT was used in approximately 3%. AKI was 
associated with signifi cant worse outcomes. AHF patients experienced 
the highest incidence of AKI, but the impact on mortality was greatest 
in CS patients.
P365
Early detection of postoperative acute kidney injury by Doppler 
renal resistive index in major lung and cardiac operations
M Arslantas, I Cinel, A Kararmaz
Marmara University Pendik Education and Research Hospital, Istanbul, Turkey
Critical Care 2014, 18(Suppl 1):P365 (doi: 10.1186/cc13555)
Introduction Lung and cardiac operations cause signifi cant changes in 
the fl uid balance, and thus have a high incidence of development of 
postoperative acute kidney injury (AKI). The renal resistive index (RRI) 
calculated by the pattern of the renal artery fl ow is an indicator of renal 
artery fl ow. In this research work, we aimed to evaluate the effi  ciency of 
the RRI on the early prediction of postoperative kidney injury in major 
lung and cardiac operations.
Methods Twenty-two patients who have undergone lung or cardiac 
surgery were included in the study. After the kidneys were localized by 
ultrasonography, the best regions of blood fl ow were detected using 
color Doppler and then the arterial waveforms of these regions were 
obtained and optimized by Doppler. The measurements taken from 
three diff erent regions were averaged. The RRI was calculated at the 
preoperative and postoperative fi rst and 24th hours respectively.
Results A signifi cant correlation was established between RRI and 
postoperative creatinine levels (P  <0.01). RRI values reached their 
highest point at the postoperative fi rst day whereas the creatinine 
levels reached their highest level at the postoperative third day. 
Although there was no correlation between postoperative creatinine 
level and duration of staying in hospital, a signifi cant relationship was 
detected between duration of staying in ICU and the creatinine levels 
(P <0.01). When the cases were divided into two groups as RRI is less 
(n = 13) and larger (n = 9) than 0.7, signifi cant diff erences were present 
with regard to age and creatinine levels.
Conclusion The RRI, which is used to evaluate renal arterial fl ow, is 
directly related with increasing renal vascular resistance in the case of 
AKI. The usefulness of RRI for prediction of AKI was shown both clinically 
following a renal allograft and experimentally in the acute tubular 
necrosis modeling [1,2]. Also in septic patients this was asserted, as RRI 
is a better marker than cystatin C, which is one of the popular markers 
of recent times for prediction of development of AKI [3]. Our results 
show that RRI could be a simple, non-invasive and useful technique for 
early diagnosis of AKI in patients undergoing major operations such as 
lung and cardiac surgeries.
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Introduction The renal resistive index (RI) measured by Doppler 
ultrasound refl ects the changes in renal microvascular resistance. It was 
recently shown that the RI measured at ICU admission was associated 
with development of AKI and with persistent AKI on day 3 after 
admission. The aim of this study was to investigate whether change of 
RI after the fi rst 24 ICU hours has an additional predictive value for the 
development of AKI.
Methods This non-interventional study included adult patients with 
sepsis admitted to a medical ICU. Patients with renal transplant and 
those in terminal renal failure were excluded. The RI was measured 
within 2 hours from admission and 24 ± 2 hours after ICU admission. 
Occurrence of AKI within the fi rst 5  days was classifi ed according 
to the AKI Network criteria. There was no intervention guide by RI 
measurements, nor were the results known to the attending physicians.
Results There were 52 patients included in the study. At admission, 
eight patients had AKI stage 2 or 3 and it was persistent in fi ve patients 
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on day 3. Within the fi rst 5 days a total of 17 patients had AKI stage 2 or 
3. The RI at admission was associated with APACHE II score, hypotension 
at admission, baseline serum lactate and history of type II diabetes 
treated with insulin. Patients who developed AKI stage 2 or 3 had 
signifi cantly higher RI on admission (0.79 vs. 0.67, P = 0.021). A cutoff  
value of 0.72 best diff erentiated patients with AKI 2 or 3. Raise of RI by 
≥0.05 during the fi rst 24 hours was associated with the development of 
AKI stage 2 or 3 (P = 0.034). Patients with persistent AKI on day 3 had 
higher RI values on admission, and those who recovered lowered their 
RIs by >0.05. In multivariate analysis, admission RI and raise of RI by 
≥0.05 were independently associated with development of AKI stage 2 
or 3 and ICU mortality. Best sensitivity for AKI was achieved when both 
criteria were used: elevated RI at admission (>0.72) and raise of RI by 
≥0.05 at 24 hours post admission.
Conclusion The renal RI measured at admission and its dynamics after 
the fi rst 24 ICU hours are predictive of the development of AKI and ICU 
mortality. Further studies are needed to confi rm these results.
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Introduction We assessed the eff ect of fl uid balance (FB) on acute 
kidney injury (AKI) classifi cation/prognosis in cardiac surgical patients 
by comparing patients classifi ed with AKI, before and after adjusting the 
creatinine (used to classify AKI) for FB. Fluid accumulation is associated 
with negative outcomes including development of AKI in critically ill 
patients [1]. Cardiac surgical patients commonly receive large volumes 
of fl uid postoperatively and could be at risk for the harmful eff ects of 
fl uid accumulation. Furthermore, fl uid accumulation may infl uence 
serum creatinine concentration and mask AKI [2].
Methods We performed a retrospective analysis of prospectively 
collected data on all cardiac surgical patients admitted to St Vincent’s 
Hospital ICU, Melbourne, Australia from 1 July 2004 to 30 June 2012. 
AKI Network creatinine criteria were used to classify AKI in the usual 
method and then using FB-adjusted creatinine (FB at 18 hours and an 
assumption that total body water is 60% of weight involved). FB (total 
i.v. input minus (total urine output + chest drain losses)) was calculated 
for 18  hours post surgery as most patients were in the ICU for this 
period.
Results Patients classifi ed with AKI increased from 27.7% to 37.2% 
(n = 2,171) after adjusting creatinine for FB. Patients were categorised 
into four groups based on presence or absence of AKI before and after 
adjustment for FB: group A, no AKI before or after adjustment for FB; 
group B, no AKI before/AKI after; group C, AKI before/no AKI after; and 
group D, AKI before and after. Group B (n  = 209) had an in-hospital 
mortality rate similar to patients in group D (n = 599) (3.4% vs. 4.3%, 
P = 0.53) and greater than those in group A (n = 1,333) (3.4% vs. 1.6%, 
P = 0.07). Group B also had an ICU mortality rate similar to patients in 
group D (2.9% vs. 2.7%, P = 0.88) and signifi cantly greater than those 
in group A (2.9% vs. 0.7%, P = 0.003). The need for renal replacement 
therapy (RRT) in group B was also high as for patients in group D (7.7% 
vs. 12.4%, P = 0.06) and was signifi cantly greater than those in group 
A (7.7% vs. 1.6%, P <0.001). Thus, hospital and ICU mortality and use 
of RRT in patients classifi ed with AKI only after adjustment for FB were 
similar to patients with AKI before and after adjustment for FB and were 
notably higher than those of patients without AKI.
Conclusion Lack of adjustment for FB post cardiac surgery may mask 
the presence of AKI that is associated with increased risk for death and 
RRT, which could hinder optimal treatment.
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Introduction Acute kidney injury (AKI) complicates over 50% of ICU 
admissions and is associated with signifi cantly increased mortality, 
length of stay, and costs across a broad spectrum of conditions [1].
Methods We performed a single-centre, retrospective analysis of 
AKI diagnosis in patients with ICU admissions of 5 days or more who 
survived to hospital discharge between 2009 and 2011. We examined 
the relationship between hospital length of stay, AKI diagnosis, 
demographics and clinical characteristics in a multivariable Cox-hazard 
analysis.
Results We identifi ed 700 cases, with a 66% incidence of AKI. The 
AKI was associated with older age, greater initial illness severity and 
longer ICU and hospital length of stay in univariate analysis (Table 1). 
In Cox-hazard analysis, only AKI category and ICU length of stay were 
signifi cantly associated with lower probability of discharge over 
time (Figure  1). AKI-1 was associated with a hazard ratio for hospital 
discharge of 0.66 (0.55 to 0.79), AKI-2 with 0.55 (0.42 to 0.71) and AKI-3 
with 0.54 (0.44 to 0.66).
Table 1 (abstract P368). Patient characteristics by AKI
 No AKI AKI P value
Age 46 (32 to 60) 51 (37 to 64) <0.001
SAPS-2 35 (27 to 42) 41 (32 to 49) <0.001
ICU LOS 8 (6 to 12) 12 (7 to 18) <0.001
Hospital LOS 27 (17 to 42) 41 (28 to 72) <0.001
Data presented as median (IQR).
Conclusion AKI was a signifi cant predictor of remaining in hospital at 
all levels of AKI severity even after allowing for longer ICU stay. Even 
mild AKI is associated with extended recovery from critical illness and 
healthcare costs even after ICU discharge.
Reference
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Figure 1 (abstract P368). Cox-hazard prediction of AKI class on 
hospitalization (ICU LOS fi xed at median).
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Introduction Perioperative AKI is a signifi cant factor determining 
morbidity/mortality in surgical patients. We sought to determine 
the prevalence and risk factors of early AKI (within 72 hours of ICU 
admission) in nonsepsis, noncardiac surgical patients admitted to the 
general surgical ICU.
Methods This prospective observational study was done in 600 
nonsepsis, noncardiac surgical patients admitted to the 14-bed general 
surgical ICU of Siriraj Hospital. The following data were collected: 
patient demographic data, ASA, comorbidity, type and urgency 
of surgery, type of anesthesia, preoperative and the fi rst 72 hours 
laboratory data, amount of bleeding, type/amount of fl uid and blood 
replacement, average intraoperative and the fi rst 72 hours MAP, and 
severity score. Outcome as ventilator-hours, ICU length of stay and ICU 
mortality were also determined. Risk factors were identifi ed by multiple 
logistic regression. AKI was defi ned and classifi ed according to the 
AKIN criteria using adjusted serum creatinine (Cr) [1].
Results In total, 41.7% of the study patients developed AKI (AKIN-I 
31.0%, AKIN-II 10%, AKIN-III 4.8%) and 4.8% received RRT. The following 
factors were diff erent between AKI and non-AKI patients: baseline 
expected GFR <60 ml/minute/1.73 m2, baseline serum Cr and baseline 
serum albumin, major abdominal surgery, vascular surgery, combined 
regional and general anesthesia, APACHE II score, receiving 6% 130/0.4 
hydroxyethyl starch (HES) >20  ml/kg/day, 4% gelatin >20  ml/kg/day, 
crystalloid >30 ml/kg/day and positive fl uid balance in the fi rst 48 hours. 
Multiple logistic regression showed that independent risk factors of AKI 
included: baseline eGFR <60 ml/minute/1.73 m2 (OR = 1.53; 95% CI, 1.08 
to 1.27, P = 0.02), baseline serum albumin <2 mg/dl (OR = 1.75; 95% 
CI, 1.01 to 3.06, P = 0.049), admitting hemoglobin <8 g/dl (OR = 2.41; 
95% CI, 1.14 to 5.11, P = 0.02), receiving 6% 130/0.4 HES >20 ml/kg/day 
(OR = 2.02; 95% CI, 1.09 to 3.76, P = 0.03), receiving crystalloid >30 ml/
kg/day (OR = 3.15; 95% CI, 1.53 to 6.48, P = 0.01), vascular surgery (OR = 
1.67; 95% CI, 1.05 to 2.64, P = 0.03), and major abdominal surgery (OR = 
1.68; 95% CI, 1.11 to 2.55, P = 0.01). AKI patients had higher ventilator-
hours (P = 0.02) and ICU length of stay (P = 0.04).
Conclusion The prevalence of early AKI in nonsepsis, noncardiac 
patients admitted to the general surgical ICU was 41.7%. Surgical 
patients with risk factors should be carefully cared for to prevent the 
development of AKI. Receiving 6% 130/0.4 HES >20  ml/kg/day and 
crystalloid >30 ml/kg/day increased the risk of early AKI in nonsepsis, 
noncardiac surgical patients.
Reference
1. Macedo E, et al.: Crit Care 2010, 14:R82.
P370
Impact of kidney function calculation formulae on predicting early 
adverse renal events in cardiac surgery
M Sileli, F Ampatzidou, S Tsagkaropoulos, K Diplaris, C Koutsogiannidis, 
G Drosos
General Hospital ‘G. Papanikolaou’, Thessaloniki, Greece
Critical Care 2014, 18(Suppl 1):P370 (doi: 10.1186/cc13560)
Introduction The Cockcroft–Gault (CG) equation and the four-variable 
Modifi cation of Diet in Renal Disease (MDRD) formula are the most 
commonly used methods to provide estimation of kidney function. The 
newly developed Mayo Clinic quadratic equation (MCQE) is another 
alternative. The scope of this study is to investigate the prognostic 
value of the above algorithms as prediction models for development 
of acute renal injury (AKI) and early renal dialysis (RD) in cardiac surgery 
patients during the postoperative ICU stay.
Methods A retrospective single-centre study of 528 consecutive 
patients admitted to the ICU, who underwent elective cardiac surgery 
under extracorporeal circulation from July 2012 to November 2013. 
Patients undergoing urgent or emergent surgery were excluded prior 
to the study. Preoperative estimation of renal function was obtained 
using CG, MDRD and MCQE equations. The predictive capacity of these 
formulae was tested and compared in relation to AKI and RD incidence 
by constructing receiver operating characteristic curves for each of the 
models.
Results The mean age of the cohort was 64.7 ± 0.45 years and the mean 
value of estimated kidney function from MCQE, MRDR and CG formulae 
was 83.7  ±  1.03  ml/minute/1.73  m2, 69.03  ±  0.82  ml/minute/1.73  m2 
and 75.3 ± 1.18 ml/minute/1.73 m2 respectively. AKI was identifi ed in 75 
(14.2%) patients, whereas early RD was necessary in 16 (3%) patients. 
All of the three variables showed a good predictive value for estimating 
AKI and RD after cardiac surgery. The area under the curve values for 
the early RD group was 0.887, 0.867 and 0.804, respectively and for the 
AKI group was 0.701, 0.651 and 0.691, respectively.
Conclusion On the basis of our fi ndings, all of the above algorithms 
seem to be accurate in predicting AKI and RD incidence in the early ICU 
postoperative period after elective cardiac surgery. Nevertheless, the 
MCQE equation more accurately classifi ed individuals compared with 
MDRD and CG formulae. Our results extend knowledge from previous 
studies [1,2]. Further investigations should be performed to determine 
whether these costless formulae could be used as an additional 
validated predictor in this group of patients and hence whether they 
could be incorporated into clinical practice.
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Introduction Fluid therapy is a cornerstone in the management of 
patients with evolving acute kidney injury (AKI). Despite the wide 
availability of advanced hemodynamic monitoring to guide therapy, 
there are few data on how to manage hemodynamics optimally once 
early AKI has occurred. Our aim was to investigate the association 
between cumulative fl uid balance (FB)/fl uid administration and 
outcome (progression to AKI III and hospital mortality) in critically ill 
patients with early AKI, and its interaction with other hemodynamic 
parameters.
Methods A retrospective analysis (2-year period) of all patients 
admitted to an adult ICU with AKI (defi ned by KDIGO criteria) who had 
hemodynamic monitoring within 12  hours of AKI I. We recorded FB, 
urinary output (UO), fl uid administered and hemodynamic parameters 
including mean arterial pressure (MAP) on the day of AKI I and in the 
following 72  hours. Logistic regression was employed to determine 
independent predictors of outcome.
Results A total of 210 patients (median age 70  years; 138 male) had 
hemodynamic monitoring within 12  hours of AKI I. In total, 41.5% 
progressed to AKI III and 43.3% died. Patients with fl uid overload 
after the diagnosis of AKI I (FB >1  l/day; n = 85) had a higher rate of 
progression to AKI III (63.5 vs. 23.3%, respectively; P  <0.001) and in-
hospital mortality (43.5 vs. 24.8%, respectively; P  = 0.004) compared 
with patients with FB <1  l/day. There was no diff erence in the 
other parameters (demographics, comorbidities, severity scores, 
hemodynamic parameters on day of AKI I, vasopressor use), with the 
exception of MAP on the day of AKI I (71 vs. 74  mmHg, respectively; 
P = 0.01). In multivariate analysis after adjustment for demographics, 
severity scores, comorbidities and hemodynamic parameters on 
the day of AKI I, a higher FB was associated with an increased risk 
of progression to AKI III and death (odds ratio (OR) per each 1  l/day 
increase 2.8; P <0.001) and death (OR 1.6; P = 0.001). Similarly, a higher 
amount of fl uid administered was associated with an increased risk of 
AKI progression (OR per each 1 l/day increase 1.8; P = 0.011), even with 
adjustment for UO. There were no signifi cant interactions between 
the risk of progression/death and other hemodynamic parameters. 
With the exception of MAP, improvements in other hemodynamic 
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parameters in the days after AKI I diagnosis did not have a signifi cant 
impact on outcome.
Conclusion In critically ill patients with early AKI, a positive fl uid 
balance, induced by excessive fl uid administration, is associated with 
an increased risk of AKI progression and death.
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Introduction Postoperative acute kidney injury (AKI) is an important 
cause of mortality and morbidity among surgical patients. Less is 
known about the occurrence of AKI after operations for gynecologic 
malignancies. The aim of this study was to determine the incidence of 
AKI in patients who underwent surgery for gynecologic malignancies 
and to compare patients with and without postoperative AKI.
Methods A total of 1,000 patients were enrolled retrospectively from 
January 2007 through March 2013. Patients under 18 years of age, 
those with chronic kidney disease and patients who died within the 
fi rst week after surgery were excluded. AKI was defi ned according to 
the KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury. 
Perioperative variables of patients were collected from medical charts.
Results The mean age was 55.4  ±  12.4  years. The incidence of 
postoperative AKI was 8.8%, stage 1 occurred in 5.9%, stage 2 in 
2.4% and stage 3 in 0.5% of the patients. Patients who had AKI 
were signifi cantly older (57.9  ±  12.8 vs. 55.1  ±  12.3  years, P  = 0.046), 
had higher body mass index (30.1  ±  7.1 vs. 28.6  ±  6.4, P  = 0.031), 
higher preoperative C-reactive protein (CRP) levels (157.8  ±  121.5 
vs. 76.6  ±  81.1  mg/dl, P  = 0.037) and more frequently had history of 
distant organ metastasis (13.3 vs. 7.8%, P = 0.022) when compared with 
those who did not have AKI. When compared with patients who did 
not develop AKI postoperatively, longer operation times (149.1 ± 62.5 
vs. 123.8  ±  56.6  minutes, P  = 0.001), intraoperative usage of higher 
amounts of erythrocyte suspension (279.5 ± 616.7 vs. 128.3 ± 296.1 ml, 
P = 0.001) and fresh frozen plasma (165.9 ± 284.8 vs. 94.1 ± 185.9 ml, P = 
0.001) were seen in those who developed AKI.
Conclusion Our results demonstrate that AKI occurs in 8.8% of the 
patients following surgery for gynecologic malignancies. Patients 
who had AKI were older, had higher body mass index with higher 
preoperative CRP levels, more frequent distant organ metastasis 
and longer operation times and higher amounts of blood transfused 
intraoperatively.
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Introduction Acute kidney injury (AKI) is a signifi cant complication 
following cardiac surgery associated with an increase in morbidity, 
hospital stay and mortality. Although the estimated incidence of 
AKI following cardiac surgery is 30%, few studies have identifi ed the 
incidence of AKI following cardiac surgery as defi ned by the Kidney 
Disease: Improving Global Outcomes (KDIGO) group [1]. We conducted 
a prospective observational study at our institution to identify the 
incidence and staging of AKI according to the KDIGO defi nition. We also 
aim to identify the factors that predispose adult patients to developing 
AKI post cardiac surgery.
Methods A prospective analysis was performed on 103 adult patients 
admitted to ICU post-cardiac surgery from September to October 2013. 
Data for perioperative risk factors and renal biochemical markers were 
collected up to the sixth postoperative day and are expressed as mean 
(SD).
Results Ordered logistic regression was used to analyse the data. Thirty-
three per cent of cardiac surgery patients at our institution developed 
AKI. Factors such as poor left ventricular (LV) function, low preoperative 
haematocrit and low preoperative glomerular fi ltration rate (GFR) were 
signifi cant risk factors (P = 0.03, P = 0.04 and P <0.01 respectively) for 
developing postoperative AKI following cardiac surgery. See Table 1.
Conclusion Our results suggest that we should focus on LV function 
and GFR as predictors for developing AKI following cardiac surgery. 
Strategies to increase preoperative haematocrit should be investigated 
to reduce in the incidence and severity of postoperative AKI.
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Introduction Critically ill patients cared for in ICUs often require 
radiological investigation using iodinated contrast agents. Contrast-
induced nephropathy (CIN)  – a form of acute kidney injury (AKI)  – is 
a complication following the use of such contrast. Although CIN has 
been thoroughly studied in some populations (for example, those 
undergoing coronary angiography), it has not been investigated in 
large numbers of ICU patients [1].
Methods We conducted a single-centre retrospective review of the 
electronic patient records of general adult ICU patients who received 
iodinated contrast over a 3-year period (2009 to 2011). Our review 
identifi ed evidence of CIN or AKI post scan (assessed using CIN and 
KDIGO criteria); and clinical outcomes post scan (renal replacement 
therapy (RRT), ICU length of stay, mortality). Patients were excluded 
if: they had received pre-scan RRT; they did not have pre/post-scan 
creatinine measurements. Univariate analyses investigated the 
relationship between CIN or AKI and ICU outcomes (use of RRT post 
scan, ICU mortality and ICU length of stay), using chi-squared tests for 
categorical outcomes and nonparametric tests for continuous outcomes.
Results A total of 479 scans involving 331 patients were included. In 
total, 303 (63%) scans involved males, median age 61 (IQR 46 to 71) 
years, 119 (25%) diabetic, with median pre-scan eGFR of 85 (38 to 113) 
ml/minute/1.73  m2. Scans occurred a median of 2.9 (0.8 to 8.8) days 
from admission. A total of 266 (56%) scans were associated with CIN 
(grade 0, n = 167; grade 1, n = 39; grade 2, n = 60). Clinical outcomes 
were signifi cantly worse in patients developing higher grades of CIN 
(increased use of RRT post scan, P = 0.02; increased ICU length of stay, 
P  = 0.04; increased ICU mortality, P  = 0.01). Ninety-fi ve (20%) scans 
were associated with AKI (stage 1, n  = 45; stage 2, n  = 13; stage 3, 
n  = 37). Clinical outcomes were again signifi cantly worse in patients 
developing AKI (increased use of RRT post scan, P <0.001; increased ICU 
mortality P = 0.01).
Conclusion Renal impairment/injury is common in adult ICU patients 
undergoing investigations using iodinated contrast and the incidence 
varies depending upon the classifi cation used. Whichever classifi cation 
is used, patients developing CIN/AKI following contrast administration 
have poorer clinical outcomes than patients who do not.
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Table 1 (abstract P373). Results
Age (years) 66 (13.8)
Male 69
Female  34
No AKI 69
KDIGO 1 22
KDIGO 2 6
KDIGO 3 6
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Introduction Animal research suggests that acute kidney injury (AKI) 
is an infl ammatory condition [1]. Our aim was to describe the immune 
phenotype in human AKI.
Methods We enrolled patients with: AKI grade II/III (defi ned by KDIGO 
criteria) and systemic infl ammatory response syndrome (SIRS) without 
sepsis; SIRS without AKI; and AKI II/III without SIRS. A healthy control 
population was used for baseline comparison. Serial blood samples 
were taken on days 0, 2 and 7. Cells were separated using Percoll 
gradients and phenotyped using fl ow cytometry.
Results The results from 24 day 0 samples identifi ed statistically 
signifi cant diff erences between SIRS, AKI, AKI + SIRS and healthy controls 
amongst: CD8+ cytotoxic T cells, CD45–CD25+++ regulatory T cells, and 
CD45–CD25++ cytokine secreting non-T-regulatory cells (Table  1). The 
percentage of CD69-positive neutrophils was signifi cantly increased 
across all three groups relative to controls, with little variation between 
AKI, SIRS and AKI + SIRS patients.
Table 1 (abstract P375).
 AKI + SIRS AKI no SIRS SIRS alone Control
% CD8+ cytotoxic T cells 23.3 16.7 11.6 31.1
% Fr. II T-regulatory cells 4.1 2.7 1.6 1.2
% Fr. III cytokine T cell 11.5 21.2 13.9 8.0
% CD69+ neutrophils 83.9 69.7 65.5 7.35
Conclusion Human AKI is associated with a proinfl ammatory 
phenotype.
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Introduction Critically ill patients cared for in ICUs often require 
radiological investigation using iodinated contrast agents. Contrast-
induced nephropathy (CIN)  – a form of acute kidney injury (AKI)  – is 
a complication following the use of such contrast. Although CIN has 
been thoroughly studied in some populations (for example, those 
undergoing coronary angiography), it has not been investigated in 
large numbers of ICU patients [1].
Methods We conducted a single-centre retrospective review of the 
electronic patient records of general adult ICU patients who received 
iodinated contrast over a 3-year period (2009 to 2011). Our review 
identifi ed: patient demographics; ICU admission details (specialty, time 
of admission, elective/emergency admission); physiological status 
pre scan (evidence of shock, eGFR, urine output); volume of iodinated 
contrast; and evidence of CIN or AKI post scan (assessed using CIN 
and KDIGO criteria). Patients were excluded if they had pre-scan renal 
replacement therapy. Analyses investigated the risk factors for CIN or 
AKI using chi-squared tests for categorical variables and nonparametric 
tests for continuous variables (as no continuous variable was normally 
distributed, even with log transformation).
Results In total, 479 scans involving 331 patients were included. A total 
of 266 (56%) scans were associated with CIN. Signifi cant risk factors for 
the development of CIN included male gender (P = 0.02), reduced pre-
scan GFR (P <0.001), and decreasing time from admission to scan (P = 
0.03). Ninety-fi ve (20%) scans were associated with the development 
of AKI. Signifi cant risk factors for AKI again included male gender (P = 
0.009), reduced pre-scan eGFR (P  <0.001), and decreasing time from 
admission to scan (P = 0.003), but also included emergency admission 
to ICU (P  = 0.03), pre-scan shock (P  <0.001), and pre-scan oliguria 
(P <0.001).
Conclusion Male gender, reduced pre-scan eGFR and decreasing time 
from admission to scan are risk factors for the development of both CIN 
and AKI. The association with time from admission to scan may refl ect 
inadequate patient optimisation prior to contrast administration; this 
hypothesis is supported by the risk factors signifi cantly associated with 
AKI alone (emergency admission to ICU and pre-scan shock). Given the 
adverse clinical outcomes associated with the development of CIN/AKI, 
these fi ndings necessitate a review of current practice.
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Introduction Approximately 50% of acute kidney injury (AKI) is 
associated with sepsis. Neutrophil gelatinase-associated lipocalin 
(NGAL) and cystatin C are the two most widely used biomarkers for 
AKI. However, these two markers are also aff ected by the systemic 
infl ammatory response, and their diagnostic value in sepsis-induced 
AKI is disputed [1,2]. Unlike clinical AKI, animal models can be used 
to explore single etiology. The purpose of this study is to examine the 
relationship between infl ammatory mediators and biomarkers for AKI 
in a sepsis model in rats.
Methods Sepsis was induced by cecal ligation and puncture (CLP) in 
60 adult SD rats and then observed for AKI and survival. Blood and 
urine samples were collected at baseline, and 18, 22, and 48 hours after 
CLP. AKI severity was assessed by RIFLE criteria (creatinine only). The 
associations between plasma IL-6 and plasma NGAL, plasma cystatin 
C, urine NGAL and urine cystatin C were analyzed. The area under the 
receiver-operator characteristic curves (AUC) was used to evaluate the 
diagnostic capability between severe AKI (RIFLE-I or RIFLE-F) and no AKI 
(includes RIFLE-R) for diff erent biomarkers.
Results The changes of plasma NGAL, plasma cystatin C, urine NGAL 
and urine cystatin C with time were similar to the changes of plasma 
IL-6. However, only plasma NGAL levels were closely correlated with 
levels of plasma IL-6 (R2 = 0.36, P <0.05). The analysis for plasma cystatin 
C, urine NGAL and urine cystatin C at 22 hours for severe AKI showed 
AUCs of 0.78, 0.71 and 0.75 respectively (all P <0.05), and the AUC for 
plasma NGAL was 0.62 (P = 0.11). There were no signifi cant diff erences 
in plasma NGAL at 22 hours between severe AKI and no AKI (2,143.32 
vs. 2,077.02 U/ml, P = 0.21).
Conclusion In this animal model of CLP sepsis, plasma NGAL levels 
were aff ected by the systemic infl ammatory response, and did not 
discriminate for AKI. Urine NGAL, plasma cystatin C and urine cystatin C 
were able to diff erentiate severe AKI from no AKI in CLP sepsis.
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Introduction Acute kidney injury (AKI) remains a common complication 
after cardiopulmonary bypass (CPB) and can be diagnosed by 
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serum creatinine [1]. However, serum creatinine is an insensitive and 
nonspecifi c biomarker [2]. This study was designed to investigate 
whether a correlation exists between urinary oxygen tension (UOT) 
and early markers of AKI. The aim was to evaluate whether UOT could 
provide warning signs of an insuffi  cient renal oxygen supply, which can 
lead to postoperative AKI.
Methods Fourteen subjects undergoing cardiac surgery with CPB were 
included in this prospective clinical pilot study. UOT was measured 
perioperatively in all patients, both in the operating room (before, 
during and after CPB) and in the ICU. Biomarkers of AKI in blood 
and urine were measured preoperatively and postoperatively at 3, 
6, 12 and 24  hours after the initiation of CPB. These included serum 
creatinine and the early urinary biomarkers kidney injury molecule-1 
(KIM-1), neutrophil gelatinase-associated lipocalin (NGAL) and cystatin 
C. Student’s t tests and Mann–Whitney tests were used to compare 
continuous variables.
Results There was a signifi cant decrease in UOT between the start 
of CPB (138.44  ±  22.19  mmHg) and the lowest UOT during CPB 
(107.70 ± 23.28 mmHg) (P = 0.001). Dividing the subjects into two groups 
according to the Acute Kidney Injury Network (AKIN) classifi cation, no 
signifi cant diff erences were found in mean UOTs between the group 
of patients with a normal kidney function (n = 7) and the group with 
AKIN stage 1 or 2 (n = 7). For KIM-1, a signifi cant diff erence between the 
two groups was found at 3 hours (P = 0.041) after the initiation of CPB. 
Further, for NGAL a signifi cant increase in biomarker concentrations 
compared with the preoperative value was observed in the group with 
an AKIN stage 1 or 2 at all diff erent postoperative time points (3 hours 
(P = 0.013), 6 hours (P = 0.003), 12 hours (P = 0.009) and 24 hours (P = 
0.003)). On the contrary, there were no signifi cant increased urinary 
NGAL levels measured in the group with the normal kidney function.
Conclusion This pilot study was not able to demonstrate any 
association between perioperatively measured UOT and markers of 
postoperative AKI. Additional laboratory and clinical studies will be 
necessary to further defi ne the relationship between the UOT and new 
biomarkers of AKI.
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Introduction Acute kidney injury (AKI) in surgical critically ill patients 
is an independent risk factor for early mortality. Two novel urine 
biomarkers, insulin-like growth factor-binding protein 7 (IGFBP7) and 
tissue inhibitor of metalloproteinases-2 (TIMP-2), may help to detect 
clinically silent episodes of AKI in the golden hours prior to irreversible 
damage of the kidney. We evaluated the early predictive value of these 
biomarkers for AKI, moderate and severe AKI, early requirement of 
renal replacement therapy (RRT), and ICU mortality, with a cutoff  value 
of IGFBP7/TIMP-2 >0.3.
Methods Four to six hours after admission to the surgical ICU, urine 
biomarkers were prospectively evaluated in all patients with present 
exposures and susceptibilities for AKI according to the KDIGO 
recommendation. The incidence and severity of AKI (KDIGO 2012) 
and requirement of RRT were assessed over 48 hours after admission. 
In addition, ICU mortality and variables such a norepinephrine dose, 
mean arterial pressure, hemoglobin level, cumulative fl uid balance and 
urine production were noted at the time of biomarker evaluation (4 to 
6 hours) and for the fi rst 24 hours after admission.
Results A total of 120 patients were included in the study. The area under 
the curve (AUC) for IGFBP7/TIMP2 >0.3 was 0.83 for early detection of 
AKI, 0.86 for moderate and severe AKI, 0.86 for RRT in the fi rst 48 hours 
after admission and 0.86 for ICU mortality. Patients with IGFBP7/
TIMP-2 >0.3 had a higher risk (odds ratio 11.7) for development of AKI 
compared with patients with IGFBP7/TIMP-2 ≤0.3. The norepinephrine 
dose, mean arterial pressure, fl uid balance and urine output in the fi rst 
6 hours after admission were signifi cantly diff erent for patients with 
low and high risk for AKI. The negative predictive value (NPV) of 0.41 for 
urine output <1 ml/kg/hour over the fi rst 6 hours after admission was 
signifi cantly lower if compared with NPV of 0.86 for GFBP7/TIMP-2 ≤0.3 
for exclusion of AKI. Similarly NPV of urine output <1 ml/kg/hour of 0.89 
for moderate and severe AKI (stage 2 and 3) was lower than the NPV of 
1.00 for GFBP7/TIMP-2 ≤0.3.
Conclusion The novel urine biomarkers IGFBP7 and TIMP-2 enable early 
risk stratifi cation of surgical ICU patients at risk for development of AKI. 
The predictive values of biomarkers were better for early prediction 
than clinical parameters such as urine output within the fi rst 6 hours 
after admission to ICU.
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Introduction We recently reported a 728-patient multicenter study 
(Sapphire) where a biomarker combination of tissue inhibitor of 
metalloproteinases-2 (TIMP-2) and insulin-like growth factor binding 
protein 7 (IGFBP7) were validated for risk stratifi cation for moderate or 
severe acute kidney injury (AKI) KDIGO stage 2 and 3 [1].
Methods We subsequently selected two clinical cutoff  values for the 
TIMP2 × IGFBP7 combination from the Sapphire dataset, one (0.3) 
with high sensitivity (89%) (specifi city = 50%) and one (2.0) with high 
specifi city (95%) (sensitivity = 42%) for the development of AKI KDIGO 
stage 2 and 3 within 12 hours of study enrolment. We examined the 
timing of change in TIMP2 × IGFBP7 relative to change in creatinine 
using the sign test.
Results TIMP2 × IGFBP7 results were available for 178 patients who 
developed AKI stage 2 or 3. The median TIMP2  × IGFBP7 result was 
signifi cantly greater than the cutoff  value of 0.3 from 24 hours before to 
24 hours after AKI 2 or 3 (P <0.01) (Figure 1). Conversely, median serum 
creatinine was not diff erent from baseline prior to development of AKI 
2 or 3.
Conclusion The TIMP2 × IGFBP7 biomarker combination identifi es 
patients who ultimately develop moderate or severe AKI 24  hours 
earlier than serum creatinine.
Reference
1. Kashani K, et al.: Discovery and validation of cell cycle arrest biomarkers in 
human acute kidney injury. Crit Care 2013, 17:R25.
Figure 1 (abstract P380). NC, Nephrocheck (TIMP2 × IGFBP7); Cr, 
creatinine.
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Introduction Diffi  culties in prediction and early identifi cation of acute 
kidney injury (AKI) have hindered the ability to develop preventive 
and therapeutic measures for this syndrome. We tested the hypothesis 
that a urine test measuring insulin-like growth factor-binding protein 
7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2), both 
inducers of G1 cell cycle arrest, a key mechanism implicated in AKI, 
could predict AKI in cardiac surgery patients.
Methods We studied 50 patients at high risk for AKI undergoing cardiac 
surgery with cardiopulmonary bypass. Serial urine samples were 
analyzed for [TIMP-2] × [IGFBP7] concentrations. The primary outcome 
measure was AKI as defi ned by international consensus criteria 
following surgery. Furthermore, we investigated whether urine [TIMP-
2] × [IGFBP7] could predict renal recovery from AKI prior to hospital 
discharge.
Results Twenty-six patients (52%) developed AKI. Diagnosis based on 
serum creatinine and/or oliguria did not occur until 1 to 3 days after 
cardiopulmonary bypass. In contrast, urine concentration of [TIMP-2] × 
[IGFBP7] rose from a mean of 0.49 (0.24) at baseline to 1.51 (0.57) 4 hours 
after cardiopulmonary bypass in patients who developed AKI. The 
maximum urinary [TIMP-2]  × [IGFBP7] concentration achieved in the 
fi rst 24 hours following surgery (composite time point) demonstrated 
an area under the receiver-operating characteristic curve of 0.84. 
Sensitivity was 0.92, and specifi city was 0.81 for a cutoff  value of 0.50. 
The decline in urinary [TIMP-2]  × [IGFBP7] values was the strongest 
predictor for renal recovery.
Conclusion Urinary [TIMP-2]  × [IGFBP7] serves as a sensitive and 
specifi c biomarker to predict AKI early after cardiac surgery and to 
predict renal recovery.
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Introduction Patients with AKI have a high morbidity and mortality. 
Diagnosis of AKI may be improved by examination of the urinary 
sediment with microscopy and by measurement of urine albumin. 
A urine microscopy score (UMS; 0 to 4  points) of renal tubular 
epithelial cells and granular casts has previously been developed to 
aid diagnosis. We have devised a urine albumin:creatinine ratio score 
(ACRS; 0 to 4 points) and have combined this with the UMS with the aim 
of stratifying the risk of developing future AKI or worsening AKI (UMS-
ACRS; 0 to 8 points). The aims were to compare UMS-ACRS in critically 
ill patients with and without AKI at ICU admission, and to determine 
whether a high UMS-ACRS can predict if critically ill patients develop 
AKI or worsening AKI.
Methods Investigators were blinded to diagnosis prior to urine 
collection. Microscopy was performed on centrifuged urine obtained 
from 227 consecutive critically ill patients in a general ICU on day 1 
of admission. Five photographs were taken and the mean UMS was 
calculated. An independent reviewer scored the photographs. The urine 
albumin:creatinine ratio was calculated and the ACRS determined. The 
UMS was then combined with the ACRS.
Results Mean UMS-ACRS ± SD was higher (2.66 ± 1.57) in patients with 
AKI on ICU admission (n = 106) compared with those without AKI (mean 
UMS-ACRS  = 2.40  ±  1.03; n  = 120), unpaired t test P  = 0.14. Patients 
who developed AKI or worsening AKI (n  = 58) had a mean score of 
2.79  ±  1.21 versus 2.30  ±  1.14 in those who never developed AKI or 
improved (n = 150), P = 0.006. UMS-ACRS score >2 on admission had a 
sensitivity of 0.89 for identifying progressive AKI. UMS-ACRS score of 5 
to 8 on admission had a positive predictive value for worsening AKI of 
60%, a negative predictive value of 69% and a likelihood ratio 3.1 for 
developing AKI or worsening AKI.
Conclusion The mean UMS-ACRS is higher in patients with AKI. 
Combining UMS with ACRS improves prediction and stratifi cation of 
which patients will develop AKI, or progressive AKI, after ICU admission.
Clinical implications are that urine microscopy and ACR calculation 
are safe, inexpensive, non-invasive and may improve prediction of AKI 
in critically ill patients, potentially leading to earlier intervention and 
improved outcomes.
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Introduction Computed tomography with contrast medium is a 
common diagnostic tool in emergency and critical medicine. Contrast-
induced nephropathy (CIN) is one of the leading causes of hospital-
acquired acute kidney injury. Focus on renal tubule protection may be 
a hope to improve the eff ectiveness of current strategies.
Methods We used HK-2 human renal proximal tubule cells to evaluate 
the therapeutic potential of resveratrol, a polyphenol phytoalexin 
Figure 1 (abstract P383). Immunostaining of cytoplasmic DNA 
fragmentation in HK-2 cells.
Figure 2 (abstract P383). Upregulated survivin expression by resveratrol.
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produced naturally by several plants, for contrast ioxitalamate-induced 
toxicity in vitro. Cytotoxicity was determined by MTT assay. Patterns 
of cell death were observed by fl ow cytometry. Cytoplasmic DNA 
fragmentation was examined by ELISA. Western blots were used to 
analyze the expression of related proteins.
Results In a 48-hour administration, ioxitalamate elicited cytotoxicity 
on HK-2 cells. Annexin V+ cells were signifi cantly increased after 30 mg/
ml ioxitalamate exposure. A decrease in bcl-2 expression explained 
the ioxitalamate-induced apoptosis. Co-treatment with resveratrol 
ameliorated the cytotoxicity induced by ioxitalamate. Resveratrol at 
12.5 μM decreased ioxitalamate-induced DNA fragmentation through 
upregulated expression of survivin. See Figures 1 and 2.
Conclusion Resveratrol ameliorated apoptosis induced by contrast 
medium ioxitalamate in human renal proximal tubule cells. 
Investigations using animal models will be conducted in the future.
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Introduction To date, there are no known methods for preventing 
acute kidney injury after cardiac surgery. Increasing evidence suggests 
that erythropoietin (EPO) has renal anti-apoptotic and tissue protective 
eff ects [1], and in animal models a single high dose of EPO has been 
shown to ameliorate reperfusion injury after ischemia [2]. However, 
recent human studies have shown confl icting results. We aimed to 
study the eff ect of a single high dose of EPO preoperatively on renal 
function after coronary artery bypass grafting (CABG) in patients with 
preoperative impaired renal function.
Methods This single-centre, randomized, double-blind, placebo-
controlled study included 75 patients scheduled for CABG with 
preexisting renal impairment (estimated glomerular fi ltration rate 
based on p-cystatin C <60 ml/minute and >15 ml/minute). The patients 
either received a single high dose of EPO (400  IU/kg) or placebo 
preoperatively. The primary endpoint was renal protection evaluated 
by p-cystatin C at the third postoperative day compared with the 
preoperative values. Incidence of acute kidney injury and other renal 
biomarker changes were among secondary endpoints.
Results There was no signifi cant diff erence on the third postoperative 
day for p-cystatin C levels (2.1  ±  0.8  mg/l for the study group and 
1.9 ± 0.5 mg/l for the control group, P = 0.51). There were no signifi cant 
diff erences in other renal biomarkers or measures between the groups 
(p-NGAL, p-creatinine, p-urea, and estimated glomerular fi ltration 
rate). There were no other diff erences in outcome variables between 
the groups.
Conclusion Intravenous administration of a single high dose (400 IU/
kg) of EPO did not have a renal protective eff ect in patients with 
reduced kidney function undergoing coronary artery bypass surgery.
References
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Introduction The aim of this study is to quantify the impact of using 
eGFR instead of measured creatinine clearance (Clcr) on the evaluation 
of recovery from acute kidney injury (AKI).
Methods From a large RCT’s database [1] we excluded patients with 
end-stage renal disease and kidney transplants. In the remaining 4,560 
patients, 1,296 (28%) developed AKI (KDIGO criteria). After exclusion of 
ICU nonsurvivors (n = 229), patients on dialysis at ICU discharge (n = 
77) and patients for whom Clcr on the last day of ICU was not available 
(n  = 206), 784 patients were included in this analysis. We compared 
eGFR (MDRD equation) with measured Clcr (based on 24-hour urine 
collection and corrected for BSA) at ICU discharge for patient groups 
with diff erent ICU stays. We also evaluated the impact of using the two 
GFR measurements on the estimation of complete recovery relative to 
baseline eGFR. Parameters were compared with the paired t test and 
McNemar’s test.
Results Amongst the 784 patients with AKI, 456 (58%) reached stage 1, 
143 (18%) stage 2 and 185 (24%) stage 3. Mean ± SD Clcr and eGFR at ICU 
discharge were respectively 54.5 ± 28 and 76 ± 55 ml/minute/1.73 m2 
(P <0.0001). eGFR was not signifi cantly diff erent from Clcr in patients 
with ICU stay <7 days. In patients with ICU stay between 8 and 14 days, 
eGFR was signifi cantly higher than Clcr (79 ± 51 vs. 48.5 ± 20, P <0.0001) 
and the diff erence increased even further in patients with ICU stay 
over 14  days (102  ±  70 vs. 42.6  ±  20, P  <0.0001). The percentage of 
patients with complete recovery diff ered signifi cantly when evaluated 
by eGFR (35.3%) or Clcr (28.7%) (P = 0.007). In patients with ICU stay 
>14 days, this diff erence increased to 56.4% by eGFR versus 14.1% by 
Clcr (P <0.0001).
Conclusion Estimated GFR at ICU discharge is signifi cantly higher than 
the measured Clcr in patients with prolonged ICU stay. This diff erence 
can be explained by loss of muscle mass with decreased creatinine 
production and results in an important overestimation of recovery.
Reference
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Introduction Data on recovery of AKI are mainly limited to persistent 
dialysis dependency in patients with dialysis-requiring AKI. The aim of 
this analysis is to evaluate recovery from diff erent stages of AKI.
Methods In a large database (n  = 4,640) of a previous RCT [1] we 
estimated renal recovery from AKI defi ned by KDIGO criteria (without 
urine output criteria). Patients with end-stage renal disease (n  = 
56), kidney transplantation (n  = 15) or incomplete data (n  = 9) were 
excluded. Patients were classifi ed according to their maximal AKI stage 
(AKImax) during the ICU stay. Recovery was evaluated by AKI stage 
at hospital discharge. Complete recovery was defi ned as the absence 
of AKI, partial recovery as persistent AKI with a decrease in AKI stage 
compared with AKImax and no recovery as persistence of AKImax or 
worsening of AKI after ICU discharge. A persistent 0.3 mg/dl increase of 
Screat was also considered as no or partial recovery.
Results A total of 1,296 patients (28%) developed AKI. AKImax was 
stage 1 in 580 (45%) (416 with >50% increase of Screat), stage 2 in 207 
(16%) and stage 3 in 509 (39%) (348 needing RRT). Mortality increased 
from 12 to 42% (P <0.0001), hospital stay increased from 21 (14 to 37) 
to 34 (17 to 63) days (P  <0.0001) and complete recovery in survivors 
decreased from 82 to 53% (P <0.0001) with increasing severity of AKI. 
In patients requiring RRT, 51% of survivors left the hospital without AKI 
whereas 16% remained dialysis dependent. Within the AKI 3 group, the 
need for RRT signifi cantly increased mortality (P = 0.0002), but did not 
aff ect complete recovery in survivors (51% vs. 58%, P = 0.16). Patients 
with a ‘0.3 mg/dl increase of serum creatinine only’ had a signifi cantly 
higher mortality than patients without AKI in the ICU (P = 0.0004). They 
also had a worse kidney outcome at hospital discharge (P = 0.006).
Conclusion Increasing severity of AKI according to the KDIGO criteria 
is associated with increased mortality and decreased recovery of 
kidney function. The need for RRT signifi cantly increases mortality but 
complete recovery in survivors of AKI 3 is not diff erent with or without 
RRT. The 0.3 mg/dl criterion proves valid with regard to mortality and 
kidney outcome.
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Introduction Acute kidney injury (AKI) is a serious complication 
following lung transplantation (LTx) [1-3]. We aimed to describe the 
incidence and outcomes associated with AKI following LTx.
Methods A retrospective population-based cohort study of all adult 
recipients of LTx at the University of Alberta between 1990 and 2011 
was performed. The primary outcome was AKI, defi ned and classifi ed 
according to the Kidney Disease: Improving Global Outcomes (KDIGO) 
criteria, in the fi rst seven postoperative days. Secondary outcomes 
included risk factors, utilization of renal replacement therapy (RRT), 
occurrence of postoperative complications, mortality and kidney 
recovery.
Results Of 445 LTx recipients included, AKI occurred in 306 (68.8%), 
with severity classifi ed as stage I in 38.9% (n = 173), stage II in 17.5% 
(n = 78) and stage III in 12.4% (n = 55). RRT was received by 36 (8.1%). 
Independent risk factors associated with AKI included longer duration 
of cardiopulmonary bypass (per minute, odds ratio (OR) 1.003; 95% 
CI, 1.001 to 1.006; P  = 0.02), and mechanical ventilation (per hour 
(log-transformed), OR 5.30; 95% CI, 3.04 to 9.24; P <0.001), and use of 
cyclosporine (OR 2.03; 95% CI, 1.13 to 3.64; P = 0.02). In-hospital and 
1-year mortality were signifi cantly higher in those with AKI compared 
with no AKI (7.2% vs. 0%, adjusted P = 0.001; 14.4% vs. 5.0%, adjusted P = 
0.02, respectively). At 3 months, those with AKI had greater sustained 
loss of kidney function compared with no AKI (estimated glomerular 
fi ltration rate (mean (SD)) 68.9 (25.7) vs. 75.3 (22.1) ml/minute/1.73 m2, 
P = 0.01).
Conclusion By the KDIGO defi nition, AKI occurred in two-thirds of 
patients following LTx. AKI portended greater risk of death and loss of 
kidney function.
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Introduction We assessed the impact of fl uid accumulation on the 
development of acute kidney injury (AKI) and need for continuous renal 
replacement therapy in cardiac surgical patients. Fluid accumulation 
has been associated with negative outcomes including development of 
AKI in critically ill patients [1-3]. As cardiac surgical patients commonly 
receive large volumes of i.v. fl uid within 24 hours of surgery, they could 
be at risk of the harmful eff ects of fl uid accumulation.
Methods We performed a retrospective analysis of prospectively 
collected data on all patients admitted after cardiac surgery to St 
Vincent’s Hospital ICU, Melbourne, Australia from 1 July 2004 to 30 
June 2012 (n = 3,207). The fl uid accumulation percentage (total urine 
and chest drain losses subtracted from total i.v. intake (l) /weight (kg) × 
100) was calculated for 18 hours post surgery as most patients were in 
the ICU for this period. Acute Kidney Injury Network (AKIN) creatinine 
criteria were used to classify AKI using creatinine adjusted for fl uid 
balance.
Results Renal replacement therapy was performed on 136 patients in 
this group (4.2%). The fl uid accumulation percentage was associated 
with an 8% increase in odds for AKI (OR (CI), 1.08 (1.04 to 1.12)), and 
a 13% increase in odds for requiring renal replacement therapy (1.13 
(1.05 to 1.21)) for each percent increase in fl uid accumulation (l/kg%) 
after cardiac surgery, after adjusting for variables including APACHE 
score, cardiac failure, type of surgery, and inotrope use in multivariate 
analysis.
Conclusion In this relatively homogeneous patient group undergoing 
cardiac surgery, postoperative percent fl uid accumulation at 18 hours 
was associated with AKI and need for renal replacement therapy. 
Whether there is residual confounding due to indication for fl uid use 
or unmeasured risk factors requires further investigation in controlled 
trials.
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Introduction Acute kidney injury (AKI) is increasingly common in 
critically ill patients and many patients with severe kidney injury require 
continuous renal replacement therapy (CRRT). However, little is known 
regarding the incidence rate and associated factors for developing 
chronic kidney disease after CRRT in AKI patients. This study aimed to 
investigate renal outcome and the factors associated with incomplete 
renal recovery in AKI patients who received CRRT.
Methods Between January 2011 and August 2013, 397 patients 
received CRRT in our ICU. Among them, patients who had normal renal 
function before AKI and were discharged without maintenance renal 
replacement therapy (RRT) were included in this study. We examined 
the incidence of incomplete renal recovery with estimated glomerular 
fi ltration rate (eGFR) <60 ml/minute/1.73 m2 during follow-up. Factors 
that increased risk of incomplete renal recovery after AKI were 
investigated with multiple logistic regression.
Results Forty-one AKI patients were discharged without further 
RRT and followed up for a mean of 7  months. Sixteen (39.0%) of 41 
patients incompletely recovered their renal function. Patients with 
incomplete renal recovery showed older age and longer duration of 
anuria compared with complete renal recovery patients (69.7 ± 7.0 vs. 
54.8  ±  16.9 years, P  = 0.002; 128.6  ±  192.1 vs. 26.9  ±  66.6 hours, P  = 
0.019). Multivariate analysis adjusting for sex, initial eGFR, hemoglobin 
level, diabetes mellitus and hypertension showed that old age and 
long duration of anuria were independent risk factors for incomplete 
renal recovery (OR = 1.143, 95% CI = 1.020 to 1.281, P = 0.021 and OR = 
1.011, 95% CI = 1.001 to 1.032, P = 0.038, respectively).
Conclusion The renal outcome of severe AKI requiring CRRT was 
poor even in patients with previous normal renal function. Long-term 
monitoring of renal function is needed especially in severe AKI patients 
with old age and long duration of anuria.
P390
Relation between preoperative use of diuretics and renal 
replacement therapy after cardiac surgery: a propensity score 
analysis
E Curiel-Balsera1, M Delange van der Kroft2, I Macias-Guarasa1, 
R Hinojosa Perez1, J Ravina-Sanz1, M Garcia-Delgado1, R Rivera-Fernandez1
1Carlos Haya University Hospital, Malaga, Spain; 2County Hospital of 
Axarquia, Velez Malaga, Spain
Critical Care 2014, 18(Suppl 1):P390 (doi: 10.1186/cc13580)
Introduction The aim was to evaluate the relation between 
preoperative use of diuretics and renal replacement therapy (RRT) in 
postoperative patients of cardiac surgery.
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Methods A prospective cohort of adult patients who underwent cardiac 
surgery in 11 institutions all over the Andalusia community from March 
2008 to July 2012 was included in the ARIAM adult cardiac surgery 
project. Diuretic users prior to the intervention were pair-matched to 
nonusers on the basis of a propensity score based on demographics, 
comorbidities, medication and surgical data. We analysed diff erences 
in RRT in both groups.
Results The total cohort was composed of 7,276 patients with 
63.91 ± 12.45 years and 61.1% male gender. Elective scheduled surgery 
was done in 85.9% of patients. Surgical risk assessed by the additive 
EuroSCORE was 5.86  ±  3.14 points and predicted mortality by the 
Logistic EuroSCORE was 8.10%. Mortality in the ICU was 7.6% and in-
hospital mortality was 10.1% (8.1% missing data). Prior to surgery, 
10.4% of patients had a creatinine level between 1.2 and 2  mg/dl, 
1.1% between 2 and 2.3 mg/dl, 0.8% between 2.3 and 3.5 mg/dl and 
0.3% above 3.5 mg/dl. In the nonmatched cohort, 180 patients (2.5%) 
needed RRT. RRT was needed in 3.5% of 3,771 patients with diuretics 
and in 1.4% of 3,505 patients not treated with them (P  <0.001); 2.61 
(1.87 to 3.65). After adjusting with logistic regression by additive 
EuroSCORE, SAPS 3, bypass time exceeding 120 minutes and prior renal 
dysfunction, the OR was 1.67 (1.15 to 2.45). When we analysed 3,426 
matched patients according to the propensity score, RRT was needed 
in 3% of 1,713 patients with diuretics and in 1.6% of 1,713 not treated 
with them (P <0.009), 1.85 (1.16 to 2.94).
Conclusion Preoperative use of diuretics is associated with an increased 
risk of need for RRT.
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Continuous renal replacement therapy (CVVHD) for acute kidney 
injury in critical care: incidence and outcome across South West Wales
K Brown, M Challis, A Mikhail
Morriston Hospital, Swansea, UK
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Introduction Renal replacement therapy in critical care is associated 
with increased mortality. It is not known for which patients RRT confers 
the most benefi t, or who will recover function and remain dialysis 
independent on a long-term basis.
Methods All ICU patients receiving CVVHD (diff usive haemodialysis) for 
AKI were analysed in a retrospective cohort study of mixed non/surgical 
patients at a tertiary renal centre over a 2-year period (December 
2011 to November 2013). Children <18 years, patients on intermittent 
haemodialysis or patients requiring plasma exchange were excluded 
from analysis.
Results A total of 2,297 patients were admitted to the ICU, of which 14% 
(319) required CRRT. Thirteen patients were excluded from analysis; n = 
306, of which 58% were male. Causes of AKI included sepsis (37%), 
surgery (13%, of which 82% were emergency procedures) and vascular 
events (9%). Mean values for patients requiring RRT versus all ICU 
patients: age (65 vs. 62.5 years), APACHE II score (21.2 vs. 14.8), length of 
stay (13 vs. 8.2 days). Forty-seven per cent of patients received incident 
dialysis <24 hours of admission, with mean fl ow rates of 31 ml/kg/hour 
(2 l) in 39%. Mortality at hospital discharge was 56% for RRT versus 20% 
in all ICU patients admitted over the same time period.
Conclusion The reported incidence of AKI in critical care ranges from 20 
to 50%, with the highest rates seen in sepsis [1]. Utilisation of CRRT for 
AKI is higher at our centre than the described 5% [2], potentially due to 
close collaboration between critical care and nephrology [3] or relatively 
lenient ICU admission criteria. Increasing mortality was seen with age, 
APACHE II score and delay in initiation of RRT. Prospective analysis is 
required to look at determining biomarkers for AKI and risk factors for 
mortality; dynamic monitoring of haemodynamic responders (MAP, 
vasopressor requirement <24 hours), percentage creatinine decrease 
[4], severity-of-illness scores and urine output. Results of current 
RCTs are awaited, which may provide more information on mode of 
clearance, fl ow rates and early versus standard initiation of RRT to more 
accurately prognose patients’ outcomes.
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Introduction The very elderly (>80 years) UK population is increasing 
and along with it there is an increased utilisation of critical care resources 
[1]. The use of chronological age as a bar to treatment is unethical, yet 
a discrepancy of opinion remains between the disinclined and the 
elderly advocate intensivist [2]. Acute kidney injury requiring dialysis 
is a frequent complication of critical illness and is associated with high 
morbidity and mortality. An increased risk is seen with age due to the 
high prevalence of risk factors and chronic kidney disease in the elderly 
[3].
Methods Very elderly patients admitted to our tertiary referral ITU were 
included in a 2-year (December 2011 to November 2013) retrospective 
cohort analysis. The outcome of those receiving RRT was reviewed.
Results There were 2,297 admissions to the ITU, of which 323 (14%) 
were classifi ed as very elderly with a mean APACHE II score of 17.3. RRT 
was utilised in 12.4% (n = 40) of the very elderly patients with a mean 
APACHE II score of 25. Forty-fi ve per cent of AKI was due to sepsis and 
25% due to emergency surgery. ITU very elderly patient mortality was 
30.1%, and in those who received RRT was 42% and 67% at ITU and 
hospital discharge respectively. Recovery of renal function was seen in 
19 patients at ITU discharge, of these 11 survived to hospital discharge. 
Two patients required ongoing IHD in the community.
Conclusion Current predictions estimate that the very elderly UK 
population will almost double by 2030 [4]. The biggest uptake in 
acceptance of chronic RRT has been in the elderly [5], where no 
diff erence has been shown in health-related quality of life from the 
general dialysis population [6]. Our experience suggests that RRT has 
a role in the critically ill elderly patient, with 33% surviving to hospital 
discharge. The challenge is identifying those most likely to benefi t from 
a cohort with multiple comorbidities, against the available resources, 
rising demand for critical care in an aging population and increasing 
expectations [7].
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hypophosphatemia using a phosphate-containing CRRT solution in 
the setting of regional citrate anticoagulation
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Introduction Phosphate depletion is a known issue during 
continuous renal replacement therapies (CRRT) with an incidence 
of hypophosphatemia up to 80% when standard CRRT solutions 
are used. The aim was to evaluate the eff ects on serum phosphate 
and phosphorus supplementation needs of a regional citrate 
anticoagulation (RCA) protocol for CRRT combining the use of citrate 
with a phosphate-containing CRRT solution.
Methods In critically ill heart surgery patients undergoing CRRT for 
acute kidney injury, we adopted RCA in a CVVH or CVVHDF modality 
combining a commercially available citrate solution (18 mmol/l) with a 
phosphate-containing CRRT solution as dialysate and/or replacement 
fl uid (HCO3
 – 30  mmol/l, phosphate 1.2). The prescribed CRRT dose, 
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corrected for predilution, was at least 25  ml/kg/hour with about 
50 to 60% of dialysis dose given as phosphate-containing solution. 
By convention, hypophosphatemia was defi ned as follows: mild 
(<0.81 mmol/l), moderate (<0.61 mmol/l) and severe (<0.32 mmol/l).
Results Forty-eight patients were treated with RCA-CRRT for at least 
72 hours (total running time 12,502 hours). Two-hundred and nineteen 
RCA-CVVH circuits were used with a mean fi lter life of 57.1 ± 41.7 hours 
(median 47, IQR 24 to 83). Acid–base status was adequately maintained 
without the need for additional interventions on RCA-CRRT parameters 
(pH 7.43 (7.40 to 7.47), bicarbonate 25.3 mmol/l (23.8 to 26.6), BE 0.9 
(–0.7 to 2.4); median (IQR)). Serum phosphate was steadily maintained 
in a narrow range throughout RCA-CRRT days (1.2  mmol/l (0.97 to 
1.45); median (IQR)). At some times during CRRT, only 10 out of 48 
patients (20.8%) received a low amount of phosphate supplementation 
(D-fructose-1,6-diphosphate 1.05  ±  2.04  g/day) for mild (n  = 7) to 
moderate (n  = 3) hypophosphatemia. In particular, considering all 
patients, only 33 out of 513 serum phosphorus determinations met the 
criteria for mild (n = 24) to moderate (n = 9) hypophosphatemia. Severe 
hypophosphatemia was never observed.
Conclusion The use of a phosphate-containing CRRT solution, 
accounting for about 50 to 60% of the CRRT dose in the setting of 
RCA-CVVH or RCA-CVVHDF, allowed one to prevent CRRT-induced 
phosphate depletion in most of the patients, minimizing the need for 
phosphate supplementation and maintaining phosphorus levels in a 
near-normal range throughout CRRT days.
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during continuous renal replacement therapy with citrate CVVHD: 
infl uence of treatment dose
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Introduction During continuous renal replacement therapy (CRRT), 
relevant losses of nutritional substrates, vitamins and trace elements 
due to diff usive transport and elimination via the fi lter may occur. We 
investigated the amount of these losses with regard to treatment dose 
during a 72-hour treatment period.
Methods Forty-one patients with CRRT were investigated. Patients 
were treated with a citrate CVVHD with diff erent standard doses 
resulting in a treatment dose range from 14 to 53 (median 27) ml/
kg/hour. Losses were calculated from substrate concentrations in the 
dialysate × (dialysate + ultrafi ltration) fl ow. During a 72-hour treatment 
period, each 24 hours were determined separately. Regression analysis 
was performed for the respective per-day losses related to treatment 
doses.
Results Regression analyses of ER for Ca2+, Mg2+, PO4
2–, zinc, folic acid 
and vitamin B12 are shown in Table 1 as the median and interquartile 
range.
Table 1 (abstract P394). ER elimination rates
Parameter Average daily ER Day 1 R2 Day 2 R2 Day 3 R2
Ca2+ (mmol/day) 97 (83 to 107) 0.2125 0.2448 0.2315
Mg2+ (mmol/day) 6 (3 to 9) 0.0247 0.0708 0.0733
PO4
2– (mmol/day) 53 (40 to 69) 0.003 0.0556 0.0012
Zinc (μmol/day) 46 (27 to 73) 0.005 0.0527 0.0502
Folic acid (nmol/day) 268 (180 to 388) 0.0935 0.0031 0.0353
Vitamin B12 (pmol/day) 2,060 (1,690 to 2,558) 0.0009 0.0092 0.0152
Conclusion Only Ca2+ showed a correlation of ER and treatment dose. 
Mg2+, PO4
2– zinc, folic acid and vitamin B12 were eliminated without a 
correlation to treatment dose.
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Evaluation of functional diff erences between two anticoagulation 
methods used in continuous renal replacement therapy in critical 
patients
V Goulão, E Lafuente, J Silva, M Fernandes, F Santos, A Ferreira
CHTS, Penafi el, Portugal
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Introduction The aim of this study is to analyze the functional 
alterations that may infl uence the fi nal result when using citrate versus 
heparin anticoagulation in critically ill patients [1].
Methods We performed a retrospective and analytical study including 
patients exclusively submitted to citrate or heparin through years 2011 
and 2012. Included were demographic data with SAPS II, SOFA, RIFLE 
scores and mortality rate. For functional analysis we consider the timing 
of the beginning, duration, loss of dose and loss of creatinine clearance. 
We analyzed dialitrauma, considering the variation of: potassium, total 
and ionized calcium, magnesium, sodium, phosphorus, pH, lactates, 
bicarbonate, platelets, albumin, creatinine and urea. Data are presented 
as the average and standard deviations. To access the infl uence of dose 
and clearance losses on mortality, we used logistic regression test.
Results The study included 44 patients in the citrate group versus 61 
in the heparin group. We found no statistical signifi cant diff erences for: 
age (P = 0.06); SAPS II (P = 0.28); SOFA (P = 0.19); the timing of beginning 
of the technique (P = 0.61), with 34.8% versus 47.5% of patients in R 
(RIFLE), 27.8% versus 18% in I (RIFLE) and 16% versus 21% in F (RIFLE); 
duration of the technique (P = 0.74) and length of stay. Although we 
noticed a greater loss of dose and absolute creatinine clearance in 
the citrate group, this had no statistical signifi cance (P = 0.18 and P = 
0.13). The mortality found for citrate and heparin groups was 60.4% 
and 39.4% respectively. The diff erences with statistical signifi cance 
related to dialitrauma emerged in K+ (P = 0.03), Ca2+ (P = 0.02), Na+ (P = 
0.004), platelets (P = 0.002), pH (P = 0.02) and bicarbonate (P = 0.0001). 
Logistic regression for mortality in the citrate versus heparin groups 
showed the following values: eff ective dose (ROC 0.435 vs. ROC 0.663), 
clearance (ROC 0.606 vs. ROC 0.663), SAPS II (ROC 0.482 vs. ROC 0.696), 
SOFA (ROC 0.713 vs. ROC 0.696) and RIFLE (ROC 0.695 vs. ROC 0.636).
Conclusion We may say that there are functional diff erences that must 
be taken into account. Despite not having statistical signifi cance on 
this sample, losses of dose and creatinine clearance showed a direct 
relation with mortality.
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Development of key performance indicators for renal replacement 
therapy in adult intensive care to guide safe and cost-eff ective 
therapy
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Introduction Renal replacement therapy (RRT) is common. We 
undertook to develop and report some key performance indicators 
(KPIs) to monitor our provision of this costly therapy. We utilised data 
already collected in an electronic clinical information system that 
records the care received by our patients. We reduced our prescribed 
RRT dose to 25 ml/kg/hour in December 2011 following an appraisal 
of the literature [1]. We assessed whether the KPIs informed us if our 
practice changed and such changes were sustained.
Methods We calculate the hourly effl  uent rate corrected for a patient’s 
predicted body weight, and the lifespan of haemofi lters. This takes less 
than 30 minutes each month. Statistical process control charts (SPCs) 
are used to assimilate the indicators over time.
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Results A total of 736 patients received RRT during the study. Prior to 
the dose change, the mean set and delivered doses were 39 and 31 ml/
kg/hour respectively. Thereafter the mean set and delivered doses were 
33 and 26  ml/kg/hour respectively. Whilst higher than our guideline 
dose, they are signifi cantly less than the doses prior to the change in 
practice (both P <0.001). The SPC indicates that the change in practice 
has been sustained. See Figure 1 and Table 1.
Conclusion The KPIs could be produced quickly and allowed monitoring 
of the reduction in RRT dosing, assuring us that it is in excess of 20 ml/
kg/hour. The KPIs did not require additional data collection processes. 
We are developing similar indicators for other organ systems, therapies 
and processes.
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Eff ectiveness of sub-albumin protein leakage membrane EMIC2 in 
post-cardiac surgery rhabdomyolysis
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Introduction A high postoperative serum myoglobin (MyG) 
concentration predicts the incidence of acute kidney injury (AKI) 
and need for renal replacement therapy (RRT), as reported in several 
surgical settings. The incidence of such events in the ICU is reported to 
be 2 to 5% of all causes of AKI [1], but can even worsen in the case of 
cardiac surgery (40.3%) [1]. MyG is a small protein (17.8 kDa) that can 
be removed with RRT, typically in convection cases. New-generation 
membranes, removing sub-albumin protein molecular weight solutes, 
can be used in diff usive treatments (CVVHD) with the advantage of 
limiting albumin loss and easily combining with citrate anticoagulation, 
pivotal for cardio-surgical settings. We assessed the eff ectiveness of 
EMIC2 with citrate anticoagulation in AKI prevention of post-cardiac 
surgical patients.
Methods This is a case series of eight patients (mean age 62.7 years, fi ve 
male, EuroSCORE log 15.61) in cardiac surgery on CPBP for 150 minutes 
Figure 1 (abstract P396). Delivered dose of RRT each month.
Table 1 (abstract P396). KPI for renal replacement therapy 2013
 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
AICU-RBH no. of patients on CVVHD 8 8 17 15 6 7 13 12 9 15 21
AICU-RBH no. of patient-days on CVVHD 61 73 98 86 65 85 44 77 112 119 137
AICU-RBH fi lter started 32 30 52 47 34 50 26 60 71 62 74
AICU-RBH hours of CVVHD 1,154 1,463 1,769 1,532 1,317 1,565 693 1,422 2,215 2,157 2,393
AICU-RBH estimated no bags 544 602 763 689 636 695 294 629 995 952 1,054
AICU-RBH fl uid cost (£) 4,994 5,526 7,004 6,325 5,838 6,380 2,699 5,774 9,134 8,739 9,676
AICU-RBH ml/kg/hour actual 39.90 28.17 29.10 30.53 33.93 31.52 31.25 29.90 30.40 32.55 32.36
AICU-RBH ml/kg/hour 24 hours 32.46 23.44 22.23 23.60 29.32 24.43 21.34 23.93 25.25 25.38 24.01
AICU-RBH percent on CVVHDF 0.79 0.84 0.75 0.67 0.84 0.77 0.66 0.77 0.82 0.76 0.73
AICU-RBH average fi lter life (hours) 36.06 48.77 34.02 32.60 38.74 31.30 26.65 23.70 31.20 34.79 32.34
AICU-RBH fi lter cost (£) 2,477 2,322 4,025 3,638 2,632 3,870 2,012 4,644 5,495 4,799 5,728
AICU-RBH effl  uent bags cost (£) 680 753 954 861 795 869 368 786 1,244 1,190 1,318
AICU-RBH total consumable (£) 3,157 3,075 4,979 4,499 3,427 4,739 2,380 5,430 6,739 5,989 7,045
AICU-RBH total cost CVVHD (£) 8,151 8,601 11,983 10,824 9,265 11,119 5,079 11,204 15,873 14,728 16,721
AICU-RBH average cost per patient (£) 1,019 1,075 705 722 1,544 1,588 391 934 1,764 982 796
AICU-RBH average cost per patient day (£) 134 118 122 126 143 131 115 146 142 124 122
Figure 1 (abstract P397).
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and mean aortic cross-clamping of 98  minutes (range 25 to 190). 
We measured MyG, procalcitonin (PCT), and creatinin (sCr) at ICU 
admission and, if serum MyG was higher than 600 mg/dl, the patient 
was treated with CVVHD-EMIC2–citrate anticoagulant within 12 hours 
of ICU admission for 72 hours and a dose of 2,000 ml/hour. Biochemical 
assays were obtained at 12, 24, and 72 hours and at ICU discharge.
Results The pretreatment MyG median value was 10,789  ng/ml; it 
signifi cantly reduced on average 92.8% during CVVHD (see Figure  1) 
and it remained low at ICU discharge (median value 114  ng/ml). sCr 
remained stable (average time value equal to 0.94  mg/dl) during 
CVVHD; PCT also decreased over time with a reduction rate equal to 
78% (from 5.35 ± 4.39 mg/dl to 1.23 ± 1.09 mg/dl at the end of CVVHD). 
Finally, six patients survived at 90 days.
Conclusion This small experience confi rms that serum MyG is likely 
to increase in post-cardiac surgical high-risk patients and suggests a 
benefi cial eff ect of CRRT treatments with EMIC2 membranes and citrate 
on serum MyG, potentially preventing AKI. Further larger assessment 
can be advised for confi rmation.
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Introduction Rhabdomyolysis is characterized by breakdown of striated 
muscle due to a great number of causes. Acute kidney injury (AKI) is a 
common complication as a consequence of high concentrations of 
circulating myoglobin (Mb). The AKI degree can vary but often requires 
dialysis, a condition which drastically worsens the ICU stay and prognosis. 
Since Mb overconcentration represents the cause of AKI, one of the 
therapy’s aims should be its removal to prevent further kidney damage 
and to allow faster renal recovery. Both intermittent hemodialysis and 
high-volume CVVHF are poorly eff ective in removing Mb, while small-
protein leakage membranes seem to be promising in this setting. The 
aim of our study was therefore to measure effi  cacy of Mb removal of a 
new high cutoff  membrane (EMIC2; Fresenius, cutoff  value 40 kDa) for 
continuous renal replacement therapies (CRRT) in the ICU setting.
Methods We report results of EMIC2-based treatments in seven 
patients (four male/three female) with diff erent causes of 
rhabdomyolysis (trauma, sepsis, limb ischemia). Five patients had 
classic dialysis indications (persistent anuria) while in two patients 
treatment was prophylactically started. CRRT were delivered in CVVHD 
mode with the EMIC2 dialyzer and with loco-regional trisodium–citrate 
anticoagulation. Mb plasma levels were assessed each 12 hours while 
the removal rate, total body and dialyzer clearances were estimated by 
kinetic modeling as previously described [1]. Clinical data were also 
collected and both global and renal patient survival was reported.
Results The median Mb value at CRRT start was 6,971  ng/ml (range 
4,679 to 48,011  ng/ml). CRRT were delivered with an average 
blood fl ow rate of 143  ±  45  ml/minute and a dialysate fl ow rate of 
2,134 ± 1,334 ml/hour. These operating conditions allowed one to stop 
treatment on average after 75 ± 47 hours (median 54 hours) with a Mb 
reduction of 82.2% (range 99.4 to 44.4%). Overall median Mb removal 
per treatment was 59 mg (range 33 to 279 mg) mainly due to the fi rst 
24 hours of treatment (54 mg, range 20 to 187 mg). Only two patients 
had residual renal function that was in one case measured to account 
for only 7.45 mg Mb removal during the entire treatment. Six patients 
survived and recovered renal function with no dialysis need at present 
follow-up. One patient died during the ICU stay.
Conclusion Our data measured high performance of the EMIC2 
membrane in Mb removal and confi rm theoretical models indicating 
that CRRT with a high cutoff  membrane can achieve major Mb removal 
within 24  hours with great superiority in comparison with all other 
available techniques.
Reference
1. Keil R, et al.: Comp Met Progr Biomed 2013, S0169:2607.
P399
Plasma fi ltration with dialysis (plasma diafi ltration) in critically ill 
patients with acute liver failure
Y Eguchi1, H Nakae2, T Furuya3, M Isono4, Y Kishi5, T Yoshioka6
1Shiga University of Medical Science, Shiga, Japan; 2Akita University School 
of Medicine, Akita, Japan; 3Akita Red Cross Hospital, Akita, Japan; 4Otsu 
Municipal Hospital, Shiga, Japan; 5Hikone Municipal Hospital, Hikone, Japan; 
6Nishi-Kyoto Hospital, Kyoto, Japan
Critical Care 2014, 18(Suppl 1):P399 (doi: 10.1186/cc13589)
Introduction Removing the middle molecular weight substances 
including cytokines and albumin-bound toxin could be eff ective 
for patients with acute liver failure (ALF). We have developed a new 
system, plasma fi ltration with dialysis (plasma diafi ltration (PDF)) [1,2], 
and assessed its effi  cacy in multicenter analysis.
Methods A subgroup analysis of an observational study conducted 
in the ICUs of six hospitals. In PDF, simple plasma exchange is 
performed using a selective membrane plasma separator (Evaxclio 
EC-2A; Kawasumi Chemical Inc., Tokyo Japan), which has a sieving 
coeffi  cient of 0.3 for albumin, while the dialysate fl ows outside the 
hollow fi bers. The fl ow rate of the blood, dialysate, substitute and 
additional substitute was 80 to 100 ml/minute, 600 ml/hour, and 0 to 
450  ml/hour according to the rate of water elimination and 150  ml/
hour, respectively. As the substitute from the additional fl uid line, 
we added 1,200 ml (150 ml/hour) of fresh frozen plasma followed by 
50 ml of 25% albumin considering the loss of albumin by diff usion. As 
an anticoagulant, nafamostat mesilate (Torii Pharmaceutical Co. Ltd, 
Tokyo, Japan) was used at a rate of 15 to 25 mg/hour.
Results A multicenter study was underway from October 2005 to 
August 2011. We performed PDF on 65 patients with ALF (severe sepsis, 
22; post operation, 15; fulminant hepatitis, 11; alcohol hepatitis, 3; graft 
versus host disease, 4; and others, 10). The serum total bilirubin, plasma 
PT-INR and the model for end-stage liver disease (MELD) score before 
the PDF procedure were 15.0 ± 8.15 mg/dl (average ± SD), 2.3 ± 1.5 and 
35.8 ± 9.3, respectively. PDF was performed as 9.2 ± 13.2 sessions per 
patient and the overall 28-day survival rate was 68.5%. According to the 
severity of the MELD score, we stratifi ed patients into three categories 
defi ned by the MELD score. The numbers of patients were 15 (23%) in 
score 20 to 29, 30 (46%) in score 30 to 39 and 19 (29%) in score over 40. 
The 28-day survival rates were 73.3%, 40% and 16%, respectively.
Conclusion PDF may be a useful blood purifi cation therapy for ALF, but 
PDF should be performed below a MELD score of 30.
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Introduction Acute liver failure (ALF) is a critical illness with high 
mortality. Plasma diafi ltration (PDF) is a blood purifi cation therapy 
in which simple plasma exchange is performed using a selective 
membrane plasma separator while the dialysate fl ows outside the 
hollow fi bers. While several studies demonstrated that PDF therapy is 
a useful blood purifi cation therapy for patients with ALF, PDF therapy 
is often diffi  cult to employ in ALF patients complicated with multiple 
organ failure, especially in those with unstable hemodynamics. 
Furthermore, it is likely to re-occur immediately after PDF therapy. We 
developed continuous PDF (CPDF) as a new concept in PDF therapy, 
and assessed its effi  cacy and safety in ALF patients compared with 
conventional plasma exchange (PE) plus continuous hemodiafi ltration 
(CHDF) therapy in this study.
Methods Ten ALF patients (gender: male/female = 6/4, age: 47 ± 14) 
employed CPDF therapy. The primary outcomes were altered liver 
function, measured by the model for end-stage liver disease (MELD) 
score, and total bilirubin and prothrombin time International 
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Normalized Ratio (PT-INR), 5  days after CPDF therapy. Secondary 
outcomes included Sequential Organ Failure Assessment (SOFA) 
scores, 5 days after CPDF therapy, and the survival rate 14 days after 
this therapy.
Results The MELD score (34.5 to 28.0; P = 0.005), total bilirubin (10.9 to 
7.25 mg/dl; P = 0.048), PT-INR (1.89 to 1.31; P = 0.084), and SOFA score 
(10.0 to 7.5; P <0.039) were improved 5 days after CPDF therapy. Nine 
patients were alive and one patient died due to acute pancreatitis, 
complicated by ALF. The effi  cacy of CPDF therapy for maintaining liver 
function and renal function was not inferior to PE plus CHDF therapy. 
Parameters of renal function such as the creatinine value were also 
improved 5  days after CPDF therapy. Circulation parameters such 
as mean arterial pressure and heart rate were maintained without 
inotropic and vasopressor support during the CPDF treatment 
period. The oxygenation index (PaO2/FiO2) as a measure of pulmonary 
function tended to increase after this treatment. We could employ this 
treatment without any adverse events, such as infections and unstable 
hemodynamics.
Conclusion In the present study, CPDF therapy safely supported liver 
function and generally improved the condition of critically ill patients 
with ALF.
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Introduction It has been demonstrated that blood purifi cation therapy 
performed by means of venovenous hemodialysis with high cutoff  
membranes (HCO-CVVHD) may modulate the host infl ammatory 
response in septic patients with acute kidney injury (AKI), potentially 
limiting organ dysfunction. Improvement in hemodynamics and 
respiratory function has been described during HCO-CVVHD treatment 
[1]. The Sepsis in Florence sTudy (SIFT) has been designed to evaluate 
changes in infl ammatory biomarkers and tissue oxygenation/perfusion 
indexes in septic ICU patients with AKI during HCO-CVVHD.
Methods Patients with microbiologically confi rmed severe sepsis/
septic shock and AKI (RIFLE criteria F or more) treated with HCO-
CVVHD, started within 12 hours from the diagnosis, were prospectively 
included in the study. The cumulative vasopressor index (CVI), 
C-reactive protein levels (CRP), serum lactate concentration (Lac) 
and central venous oxygen saturation (ScvO2) were measured before 
(T0h) and at 24 hours and 48 hours after HCO-CVVHD initiation. Data 
are expressed as the median (range). The Mann–Whitney U test was 
applied to detect diff erences in CVI, CRP, Lac and ScvO2 at the three 
time points (statistical signifi cance for P <0.05).
Results In 16 ICUs, a total of 16 patients (six cardiac surgery, four 
abdominal surgery and six medical) met the inclusion criteria and 
were enrolled in the study. A signifi cant reduction in CRP levels was 
observed over time: 263 (216 to 358) mg/dl at T0h to 153 (56 to 186) 
mg/dl at T48h (P  <0.05). ScvO2 signifi cantly increased from 45 (40 to 
55)% at T0h to 75 (68 to 77)% at T48h (P <0.05). Finally, serum lactate 
decreased from 5.1 (3.0 to 9.5) mmol/l at T0h to 1.6 (1.0 to 4.6) mmol/l 
at T48h (P <0.05). Conversely, CVI did not signifi cantly reduce over time 
(8.2 (4 to 9) at T0h vs. 4.5 (4 to 8) at T48h, P >0.05).
Conclusion Our preliminary data show that patients with sepsis-
related AKI may benefi t from early treatment with HCO-CVVHD. The 
modulation of proinfl ammatory and anti-infl ammatory mediators, 
as previously demonstrated [1], may improve microcirculation, tissue 
perfusion and cellular oxygenation. Although promising, our results 
must be confi rmed at the end of the study with larger observations. 
Finally, a subgroup analysis is absolutely mandatory in order to explore 
diff erent behaviors of tissue perfusion indexes in diff erent populations 
of patients.
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Introduction Little information is available regarding ciprofl oxacin 
pharmacokinetics and pharmacodynamics in sepsis patients receiving 
sustained low-effi  ciency dialysis (SLED). This study determined the 
pharmacokinetics and simulated pharmacodynamics of ciprofl oxacin 
in ICU patients during SLED.
Methods This study was a prospective evaluation of ciprofl oxacin 
pharmacokinetics in patients with sepsis and >18 years of age, urine 
output <200 ml/day and receiving SLED for at least 8 hours. Following 
informed consent, plasma samples were collected at baseline and 1, 
2, 4, and 8  hours after a ciprofl oxacin 400  mg dose i.v. during SLED 
and post-SLED therapy at the same times. Dialysate samples were 
collected at 4-hour intervals during SLED. Pharmacokinetic parameters 
were determined using WinNonlin and compared between the two 
periods. Simulated pharmacodynamic parameters were determined 
for Pseudomonas aeruginosa using MIC = 2.
Results A total of seven patients (four male, three female, age 56.9 ± 7.6, 
APACHE II 26.8 ± 2.4) were enrolled. Ciprofl oxacin was cleared relatively 
rapidly with a half-life of 6.9  hours and a Ke of 0.108/hour during 
SLED compared with 11.9 hours and 0.057/hour post-SLED (P <0.05). 
Simulated pharmacodynamics demonstrated inadequate coverage for 
P. aeruginosa during SLED with Cmax/MIC ratio 5.7 ± 1.2 and AUC/MIC 
77.5 ± 22.3.
Conclusion Ciprofl oxacin is rapidly cleared during SLED similar to 
clearance during normal renal function, which may result in adequate 
pharmacodynamic coverage for some pathogens.
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Introduction Antibiotic dosing for patients with acute renal failure 
receiving continuous renal replacement therapy (CRRT) is a clinical 
challenge. The aim of this study was to investigate the pharmacokinetics 
of meropenem (M) during CRRT.
Methods A prospective and multicenter study was conducted at seven 
hospitals. Fifteen critically ill patients undergoing either continuous 
venovenous hemofi ltration (CVVHF) or hemodiafi ltration (CVVHDF) 
were included. Serum and ultrafi ltrate (UF) levels of M were determined 
by liquid chromatography. Blood samples were drawn 24 hours after 
starting CRRT at 08:00 a.m., 09:00 a.m., 10:00 a.m., 01:00 p.m., 06:00 p.m., 
20:00 p.m. and 08:00 a.m. of the following day. CRRT clearance (Cl), total 
amount of M in the UF (MUF), percentage of the dose extracted by 
CRRT (EF) and the AUC (ng/hour/ml) were calculated.
Results Nine patients were treated with CVVHDF and six with CVVHF. 
M (0.5 to 2  g) was administered every 6 to 12  h by i.v. infusion over 
15 minutes. Data (mean and SD) concerning the dialysate fl ow rate (DF; 
ml/hour), blood fl ow rate (ml/minute) and the average UF rate (ml/
kg/hour) for CRRT techniques are shown in Table  1. Pharmacokinetic 
Table 1 (abstract P403). Parameters of CRRT techniques
 CVVHF (n = 6) CVVHDF (n = 9)
DF rate    964/94
Blood fl ow rate 190/33 187/29
UF rate  37.7/5.7 29.8/15.6
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parameters for M are depicted in Table 2. No diff erences in either EF or 
M Cl between the two CRRT techniques were observed.
Conclusion A signifi cant removal of M by CVVHF/CVVHDF was 
observed. Dose adjustment is necessary in critically ill patients 
receiving CRRT.
Acknowledgement Supported by EC 81/00469.
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Introduction Acute kidney injury (AKI) in the critically ill is an 
independent risk factor for adverse outcome [1]. Previously, it was 
suggested that high-volume haemofi ltration (HVHF) may confer a 
mortality benefi t and lead to a reduction in organ failure compared 
with standard ultrafi ltration rates (UF) [2]. This was not confi rmed by a 
recent investigation [3]. It has also not been determined whether ideal 
(IBW) or estimated/actual body weight (E/ABW) was used to calculate 
UF rates. We sought to determine what impact diff erent weight 
calculations have on delivered UF rates.
Methods A retrospective single-centre study in a tertiary referral 
institution. Continuous venovenous haemodiafi ltration (CVVHDF) 
was administered according to the patient’s IBW. The delivered UF 
rate was then calculated both for IBW and E/ABW. The latter was 
based on measurements obtained at the time of ICU admission. We 
compared the highest predilution, postdilution and dialysate volume 
administered each day according to the diff erent weight estimate 
measurements respectively. Student’s t tests and chi-square tests were 
used for statistical analysis (P <0.05).
Results Data from 33 patients receiving renal replacement therapy 
were analysed. Mean time (±  SD) of treatment interruption was 
1.4  ±  2.7  hours/day due to fi lter changes, transfers for CT scans and 
surgical procedures. Therefore, 94% of the prescribed dose was 
delivered. There was a mean of 2.3 fi ltration dose prescriptions 
per patient over the observation period (due to changing clinical 
conditions), with a total of 77 dose adaptations. Mean E/ABW was 
signifi cantly higher than calculated IBW (76.3  kg vs. 61.4  kg), and 
thus a diff erence of 14.9 kg (95% CI = 9.2 to 20.6 kg). This resulted in a 
signifi cant diff erence in mean fi ltration dose delivered of 33.1 ml/kg/
hour for E/ABW versus 39.7 ml/kg/hour for IBW respectively (P <0.001). 
As a consequence, in 29.6% (8/27) of cases where HVHDF (>35 ml/kg/
hour) was prescribed, standard volume haemodiafi ltration (SVHDF) 
(≤35 ml/kg/hour) was delivered. In 10% (5/50) of cases where SVHDF 
was prescribed, HVHDF was delivered (P <0.001).
Conclusion We conclude that the delivered UF rate in our cohort of 
patients diff ered signifi cantly depending on measured or calculated 
body weight. In almost one-third of cases where HVHDF was 
prescribed, SVHDF was delivered. As many interventions in the ICU are 
based on IBW and daily weighing of patients is not uniformly practiced, 
this makes comparison of data diffi  cult.
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Introduction Chronic kidney disease (CKD) is a risk factor for developing 
acute kidney injury (AKI) with need for renal replacement therapy 
(RRT). AKI-RRT is associated with important short-term mortality, and 
recent data showed there is also important increased risk for 1-year 
mortality. The aim of this study is to evaluate variables associated with 
1-year survival, and in particular the impact of baseline CKD in a cohort 
of AKI-RRT patients.
Methods A single-center observational study in a 50-bed ICU tertiary 
care hospital. During the study period August 2004 to December 
2012, all consecutive adult AKI-RRT patients were included. Data were 
retrieved from the electronic ICU patient fi le, the electronic hospital 
patient fi le and the electronic ICU-RRT database. Long-term outcome 
data were collected by a telephone survey.
Results During the 9-year study period, a total of 1,291 AKI-RRT patients 
were included. Short-term mortality at day 30 was 47.2%; mortality at 
1 year was 64.3%. Compared with nonsurvivors, 1-year survivors had 
similar age (65 vs. 67 years, P = 0.077), worse kidney function at baseline 
(eGFR 46 vs. 52 ml/minute/1.73 m2, P = 0.001; CKD stage ≥3 65% vs. 58%, 
P = 0.019), a greater proportion was male (69.0% vs. 63.2%, P = 0.048), 
and more were admitted to the cardiac surgery ICU (39% vs. 46%, P = 
0.012). They were less severely ill as illustrated by lower SAPS 2 score at 
ICU admission (52 vs. 69, P <0.001), and at the time of initiation of RRT, 
and a lower SOFA score (9 vs. 11; P <0.001). A smaller proportion was on 
mechanical ventilation (85.1% vs. 89.7%, P = 0.042) and on vasoactive 
drugs (45.7% vs. 63.9%, P <0.001). Survivors had earlier initiation of RRT 
(2 vs. 3 days, P = 0.034), and more frequently intermittent RRT was used 
(84.8% vs. 63.2%; P <0.001). When corrected for gender, age, severity of 
illness, and modality and timing of RRT, worse baseline kidney function, 
defi ned as CKD stage ≥3, remained associated with better 1-year 
survival (odds ratio 1.6, 95% CI: 1.1 to 2.2, P = 0.011).
Conclusion In ICU patients who had AKI-RRT, 1-year survival was 
associated with lower severity of illness. Surprisingly, worse kidney 
function or CKD stage ≥3 was also associated with long-term survival. 
This eff ect remained present after adjudication for relevant covariates.
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Introduction Acute kidney injury (AKI) treated with renal replacement 
therapy (RRT) in ICU patients is associated with high mortality, chronic 
kidney disease (CKD) (eGFR <60 ml/minute/1.73 m2, or CKD stage ≥3) 
and end-stage kidney disease (ESKD). Data on long-term outcomes 
vary among studies due to diff erences in age, CKD, severity of illness, 
RRT modality and timing of initiation of RRT. Long-term patient and 
kidney outcomes in AKI-RRT patients were evaluated in this study.
Methods A retrospective study of all consecutive treated AKI-RRT 
patients in a 50-bed ICU academic hospital from August 2004 to 
December 2012. Data were retrieved from the electronic ICU, RRT and 
hospital patient fi les. Long-term outcomes data were obtained by a 
telephone survey.
Results During the study period 1,291 ICU patients were treated 
with RRT for AKI. Mortality was 47.2% at day 30 and 57.2% at hospital 
discharge. Mortality in hospital survivors showed an important increase 
until 3-year follow-up, and a moderate increase later (1  year: 14.4%, 
2  years: 20%, 3  years: 35.7%, and 7  years: 39%). In-hospital survivors’ 
Scr and eGFR at baseline were comparable to 1-year follow-up (1.4 vs. 
Table 2 (abstract P403). Pharmacokinetic parameters for meropenem
 CVVHF  CVVHDF 
AUC  357/188 433/369
M dose (g/day) 1.7/0.4 2.2/1.4
MUF (mg) 338/104 625/499
EF (%) 28/13 30/26
M Cl (l/hour) 1.2/0.7 1.7/1.5
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1.4 mg/dl, P = 0.162, respectively 46 vs. 51 ml/minute/1.73 m2) and we 
observed an increase of CKD stage in 36.0% of patients, a decrease in 
36.3%, and stable CKD stage in 27.7%. A total 43.1% of patients with 
CKD stage <3 at baseline had an increase to CKD stage ≥3 at 1 year. 
A total 26.6% of patients with CKD stage ≥3 at baseline decreased to 
CKD stage <3. A total of 8.3% of hospital survivors developed ESKD. 
Patients with increase of CKD stage had similar age (67 vs. 64  years, 
P = 0.145), SAPS 2 (57 vs. 51, P = 0.858), and SOFA score (9 vs. 9, P = 
0.275) compared with patients with stable or decreased CKD stage. 
There were no diff erences in type of ICU, modality of RRT, or number of 
patients treated with vasopressors (44% vs. 47%, P = 0.617) or invasive 
ventilation (84% vs. 81%, P = 0.496). However, these patients were more 
probably male (76.9% vs. 65.6%, P = 0.042), had lower Scr at baseline 
(1.1 vs. 1.7  mg/dl, P  <0.001) and at ICU admission (1.7 vs. 2.4  mg/dl, 
P <0.001), and were started on RRT later (3 vs. 2 days, P = 0.008).
Conclusion The annual mortality in AKI-RRT hospital survivors is 
approximately 10% per year during the fi rst 3 years of follow-up. One-
third of patients had an increase of CKD stage at 1 year of follow-up 
and almost one-half of patients who had eGFR >60 ml/minute/1.73 m2 
developed CKD. Patients who had an increase of CKD had similar 
severity of illness, but lower Scr at baseline and at ICU admission, and 
had later initiation of RRT compared with patients who had stable or 
decreased CKD stage.
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Introduction Sepsis-induced immunosuppression has long been 
considered a factor in the late mortality of sepsis patients, but little 
is known about the immunity of immunocompetent cells and the 
eff ect of polymyxin B-immobilized fi ber hemoperfusion therapy (PMX-
DHP) on sepsis-induced immunosuppression. The present study was 
designed to evaluate the eff ect of PMX-DHP on recovery from sepsis-
related immunodefi ciency.
Methods Patients with septic shock who were treated with PMX-
DHP were enrolled in this study. Study 1: (1) numbers of peripheral 
lymphocytes and CD4+ T cells, especially regulatory T cells (Tregs), and 
serum cytokine levels were examined to evaluate the eff ects of PMX-
DHP in septic shock patients. (2) Peripheral blood mononuclear cells 
(PBMCs) in these patients were examined to evaluate infl ammatory 
cytokine production before and after PMX-DHP. The obtained PBMCs 
were stimulated with interleukin (IL)-2 and IL-12, anti-CD3 antibody, 
or lipopolysaccharide for 24  hours, and tumor necrosis factor alpha 
and interferon-gamma (IFNγ) production in the culture supernatants 
was measured using enzyme-linked immunosorbent assay. Study 2: 
whole blood from patients with sepsis was incubated with a polymyxin 
B-immobilized fi lter (cut into small sizes) for small animals for 2 hours 
(PMX group), or were treated with 200 μg polymyxin B for 2 hours (PLB 
group), or were not treated (sepsis group). IFNγ production by PBMCs 
was compared among the three groups.
Results Study 1: (1)  the number of CD4+ T cells was lower and the 
percentage of Tregs in CD4+ T cells was higher in septic shock patients 
compared with those without shock. A signifi cant increase in the 
number of CD4+ T cells, a signifi cant decrease in the percentage of Tregs 
in the CD4+ T-cell population, and a signifi cant decrease in serum IL-10 
levels were observed 24 hours after PMX-DHP in septic shock patients 
who survived compared with those who did not. (2)  IFNγ production 
by PBMCs was signifi cantly lower in patients with sepsis than in healthy 
volunteers. IFNγ production by IL-2-stimulated and IL-12-stimulated 
PBMCs signifi cantly increased after PMX-DHP therapy. Study 2: IFNγ 
production by PBMCs in patients with sepsis increased signifi cantly in 
the PMX and PLB groups compared with that in the sepsis group.
Conclusion PMX-DHP directly decreased the number and percentage 
of Tregs in peripheral blood circulating CD4+ T cells in patients with 
septic shock. PMX-DHP improved IFNγ production by natural killer 
(NK)/NKT cells in patients with septic shock. Therefore, PMX-DHP could 
improve sepsis-related immunosuppression.
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Introduction Endotoxin plays a crucial role in the pathogenesis of 
severe sepsis and septic shock (SS&SSh) [1]. The aim of this study 
is to analyze the impact of extracorporeal endotoxin removal with 
polymyxin B hemoperfusion (PMX-DHP) (Toraymyxin®).
Methods All patients admitted to our ICU between 1 April 2011 and 30 
June 2013 who developed SS&SSh and underwent endotoxin activity 
assay (EAA) measurement were retrospectively evaluated.
Results During the study period, EAA was dosed in 100 patients. Eighty-
one patients were aff ected by septic shock. The source of infection was 
identifi ed in 70.4% of cases (45% abdominal) and the percentage of 
microbiologically confi rmed episodes was 77% (81% Gram-negatives). 
The mortality rate was 49%. The mean EAA level was 0.66 ± 0.2, and in 
66% of patients the value was higher than 0.6. No signifi cant diff erences 
were found in terms of SAPS II (P  = 0.32) and SOFA score (P  = 0.67), 
according to EAA level (>/≤0.6). Patients with levels >0.6 presented a 
higher percentage of microbiologically confi rmed infections (84% vs. 
66%; P  = 0.09). Thirty-two of 66 patients with EAA >0.6 were treated 
with Toraymyxin®. No complications leading to treatment interruption 
were recorded and a relevant decrease of cardiovascular SOFA score 
and lactate levels were observed 72 hours after treatment (P  = 0.05 
and P = 0.06, respectively). Source control and Toraymyxin® treatment 
resulted as the only modifi able factors improving the ICU survival rate 
(Table 1).
Table 1 (abstract P408). Multivariate analysis for ICU mortality risk factors
  P value OR (95% CI)
SAPS II score 0.04 1.1 (1.01 to 1.1)
Septic shock 0.02 10.4 (1.5 to 71)
PMX-DHP 0.04 0.2 (0.1 to 0.9)
Source control 0.01 0.1 (0.03 to 0.5)
Conclusion EAA is a rapid and reliable method to identify patients 
who may be treated with polymyxin B hemoperfusion. Source control 
and extracorporeal endotoxin removal have appeared as two eff ective 
interventions that should be implemented in the early management of 
patients with SS&SSh.
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Introduction We previously demonstrated a signifi cant increase in 
the number of ventilator-free days and reduced the rate of delirium in 
ICU patients treated with the Awakening and Breathing Coordination, 
Delirium Monitoring and Early Mobility (ABCDE) bundle. This study 
investigated whether implementation of the ABCDE bundle was cost-
eff ective at an academic medical center.
Methods A post-hoc cost-eff ectiveness study was done following 
the before–after ABCDE bundle implementation study. The bundle 
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consisted of the following components: daily spontaneous awakening 
trials (SATs); daily spontaneous breathing trials coordinated with the 
SATs; delirium monitoring; and early mobility. The study’s primary 
endpoint was the cost-eff ectiveness of the ABCDE bundle in terms of 
the bundle’s cost to prevent 1 day of mechanical ventilation (MV) or 
1 day of delirium for all patients, as well as for a subgroup of non-MV 
patients. All cost-eff ectiveness ratios (CERs) were constructed from 
the hospital’s cost perspective. The economic analyses were carried 
out in two steps. First, the mean cost per patient per hospital stay 
and total costs in the pre-ABCDE and post-ABCDE bundle periods 
were compared. Next, CERs of each respective primary endpoint were 
computed as incremental costs of implementing the bundle to prevent 
1 day of MV and to prevent 1 day of delirium. P <0.05 was considered 
statistically signifi cant.
Results Data were analyzed from 146 and 150 patients in the pre-
ABCDE and post-ABCDE groups respectively. There were mean 
decreases of 0.59 MV days and 0.83 delirium days between the pre 
and post bundle implementation. The mean costs (per patient per 
ICU stay) of implementing the bundle components were signifi cantly 
higher in the post-ABCDE cohort versus the pre-ABCDE cohort ($191 
vs. $92, P <0.0001), with an additional increase in total costs ($8,930 vs. 
$8,624, P = 0.0233). Costs to prevent 1 day of MV and to prevent 1 day of 
delirium were $552 and $368 respectively. In the non-MV patients, the 
post-ABCDE bundle demonstrated fewer days of delirium than the pre-
ABCDE cohort (0.8 vs. 1.13 days, P <0.05) but had higher overall costs 
($5,417 vs. $4,546, P <0.05), resulting in a cost of $2,639 to prevent 1 day 
of delirium in a non-MV patient.
Conclusion Implementing the ABCDE bundle in adult ICU patients 
appears to be a feasible cost-eff ective strategy when considering costs 
of mechanical ventilation and ICU delirium.
P410
An assessment of long-term sleep quality using actigraphy in 
survivors of critical illness
K Solverson, C Doig
University of Calgary, Canada
Critical Care 2014, 18(Suppl 1):P410 (doi: 10.1186/cc13600)
Introduction Recent studies have suggested that critical illness 
survivors experience long-term sleep disruption [1,2]. The Actigraph 
device is a sleep watch that has been shown to have equivalent 
accuracy to polysomnography and previously used during critical 
illness to show sleep disruption [3]. Our objective was to assess patients 
long-term sleep quality using the Actigraph device.
Methods Study patients were selected from a 24-bed multidisciplinary 
ICU. Thirteen patients who were ≥18  years old, stayed longer than 
4 days in the ICU and did not have and acute brain injury were followed 
up at 2  months post hospital discharge. The Actigraph device was 
given to patients to take home and worn for 72  hours. Previously 
validated algorithms were used to analyze sleep and wake cycles [4]. 
Additionally, patient completed the Pittsburgh Sleep Quality Index 
(PQSI), as a measure of subjective sleep quality.
Results Sixty-two percent of patients at 2 months post hospital discharge 
reported poor sleep quality as per the PSQI. The Actigraph results 
showed patients’ average total sleep time was 6.15 hours, with a sleep 
effi  ciency of 78%. The mean time to fall asleep was 12 minutes. Patients 
had an average of 11 awakenings per night and were awake for an 
average of 7 minutes during the awakenings. There were no associations 
found between patients’ perceived sleep quality and total sleep, sleep 
effi  ciency or sleep disruptions. Patients’ severity of illness, as measured 
by the APACHE II score, was statistically associated with lower total sleep 
time (β = –12.6, P = 0.019), reduced sleep effi  ciency (β = –1.18, P = 0.042) 
and higher number of sleep disruptions (β = 0.64, P = 0.023). The number 
of days ventilated or ICU and hospital length of stay were not statistically 
associated with the Actigraph sleep parameters.
Conclusion Survivors of critical illness have high levels of sleep 
dysfunction as measured by actigraphy. Patients’ severity of illness 
while critically ill appears to increase the level of long-term sleep 
dysfunction experienced. There is discordance between objective and 
subjective measures of sleep quality, which has been shown previously 
[5]. Objective measures of sleep quality are needed on a larger number 
of patients to confi rm these fi ndings.
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Introduction Sleep deprivation is recognised as an important cause 
of morbidity after ICU admission, but most centres do not routinely 
assess their patients’ sleep. Considering the invasive nature and costs 
associated with objective sleep measurements, they are unsuitable 
for routine use. Subjective measurements off er an easy-to-use and 
economical alternative, the most well validated of which is the 
Richards–Campbell Sleep Questionnaire (RCSQ). This can be used 
to derive an accurate estimation of the sleep effi  ciency index (SEI), a 
well-validated measure of sleep. However, there are several concerns 
regarding patients reporting their sleep quality and quantity using 
these questionnaires [1]. Additionally, they cannot be used to assess 
sleep in sedated or delirious patients. It has been suggested that one 
way to bypass the drawbacks of patients assessing their own sleep 
would be to utilise nursing staff  [1]. Previous smaller scare studies 
have since agreed with this suggestion [2]. This study aimed to assess 
whether staff  were able to use the RCSQ to accurately assess their 
patients’ sleep.
Methods Fifty-nine patients consented to complete the RCSQ for each 
night of their ICU admission. Alongside this, the nurses who had cared 
for these patients were asked to assess their patients’ sleep using the 
RCSQ. These were then matched with their patients’ responses. The 
Bland–Altman method was applied to assess for agreement between 
patient and nurse SEIs in order to reveal whether nurses could 
accurately estimate their patients’ night sleep. Additionally, Cronbach’s 
alpha was derived to assess for internal consistency. Ethical approval 
was gained prior to the start of the study.
Results A total of 126 pairs or RCSQs were gathered. The mean diff erence 
between nurse and patient SEIs was –0.9, suggesting there is no 
signifi cant trend regarding nurses overestimating or underestimating 
patients’ SEIs. In total, 94.2% of nurses’ estimations fell within the limits 
of agreement. The variability of the diff erences was consistent across 
the range of averages. Cronbach’s alpha was 0.63 between nurse and 
patient scores, suggesting questionable reliability between the RCSQ 
pairs. See Figure 1.
Conclusion The data gathered here demonstrate that nurses are not 
able to accurately estimate their patients sleep using the RCSQ, and 
hence alternative methods of sleep monitoring should be developed 
for routine use.
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Introduction The accurate measure of sedation depth among 
mechanically ventilated ICU patients remains challenging. The Patient 
State Index (PSI) is a quantitative measure calculated using an algorithm 
derived from a simplifi ed four-channel EEG. The aim of this study was 
to examine the value of the PSI to assess the level of sedation, and to 
verify its accuracy in comparison with the quantitative spectral analysis 
derived from a standard 19-channel EEG.
Methods Using the SEDLine four-channel simplifi ed EEG system 
(Masimo Corporation, Irvine, CA, USA), which assessed depth of 
sedation through two frontal leads, we prospectively studied 
mechanically ventilated sedated ICU patients and examined whether 
the PSI was accurate to quantify the individual level of sedation. Pain 
stimuli were applied and changes in PSI were examined and compared 
with changes in electrical activity (% of delta power), measured by the 
frontal Fp2–Fp1 electrodes using a standard 19-channel EEG system 
(Viasys Neurocare, Madison, WI, USA). EEG recordings were performed 
simultaneously during 20 minutes, and the relationship between PSI 
and % of delta power was analyzed with the Pearson’s correlation 
coeffi  cient.
Results Ten consecutive patients (mean age 59  ±  12  years) were 
included. EEG recordings were performed on average 6  ±  6  days 
from ICU admission. Sedation consisted of propofol (seven patients), 
midazolam (two patients) or both (one patient). The median PSI was 
54 (range 10 to 97), indicating large individual variations in PSI values. 
In contrast, the median delta power was 86.3% (range 55.2 to 99.4), 
indicating a deep sedation level. Pain stimuli were associated with a 
signifi cant increase of PSI value from baseline 51 (range 16 to 96) to 
68 (42 to 95) (P = 0.009). However, we found no correlation between 
the PSI and the % delta power, both at baseline (R  = 0.32, P  = 0.37) 
and after pain stimulation (R = 0.17, P = 0.63). The % delta power from 
frontal electrodes (Fp2–Fp1) was well correlated with that obtained 
from posterior electrodes (P4–Pz; R = 0.42, P < 0.0001), and remained 
unchanged after pain stimulation, indeed confi rming a deep sedation 
level in our patient cohort.
Conclusion Using standard EEG in this small cohort of mechanically 
ventilated ICU patients, a deep sedation level was frequently observed. 
Our preliminary data suggest that simplifi ed EEG with the SedLine 
system is less accurate than the standard 19-channel EEG to assess the 
depth of sedation in the ICU setting.
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Introduction Pain is a common problem in mechanically ventilated 
patients and assessing pain in the sedated patient is diffi  cult, as patients 
are often unable to verbalise [1]. Behavioural pain assessment tools 
have been developed and validated for the assessment of pain in this 
patient group. A behavioural pain assessment tool was implemented 
as part of a wider ventilator-associated pneumonia (VAP) prevention 
programme within a large UK ICU.
Methods The Behavioural Pain Scale (BPS) [2] was selected and 
implemented into daily clinical practice supported by a tailored 
education programme and incorporation into the clinical information 
system (MetaVision). Questionnaires pre and post BPS implementation 
were used to assess nursing staff  opinions on pain assessment and 
opioid infusion titration. Four months of data were compared pre 
and post implementation, examining aspects of patient sedation and 
analgesia exposure and ventilated patient outcome parameters.
Results In the pre-implementation and post-implementation question-
naire (response rate of 38% and 37% respectively of nurses surveyed), 
nursing staff  reported they were signifi cantly more confi dent in titrating 
opioids after implementation (3 (2; 3) and 3 (3; 4) respectively; P <0.01), 
despite a lack of signifi cant diff erence in their reported confi dence to 
assess pain. Compliance was good, with a median daily documentation 
rate of 66% with the standard being once per 8-hour shift. Median 
BPS score rank was signifi cantly higher on patient movement (2 (1; 
2)) compared with at rest (1 (1; 2); P  <0.001) (1  = no pain, 2  = mild 
pain). No statistically signifi cant diff erence was seen in the length of 
stay, duration of mechanical ventilation, VAP rate or median sedation 
exposure. Pre-implementation median opioid administration when 
looking at morphine (mg) equivalence was 455.8 (203.1; 1,174.8), and 
post implementation the median increased to 620.3 (218.1; 1,502); 
however, this did not reach statistical signifi cance (P  = 0.235). There 
was no statistically signifi cant change in the prescribing of analgesic 
adjuncts. The sample size was underpowered to detect signifi cant 
diff erences.
Conclusion The BPS was successfully implemented into routine 
nursing practice and signifi cantly improved nurse confi dence in opioid 
infusion titration. Analgesic use was not signifi cantly diff erent between 
evaluation periods, but the results indicate that further education 
on anticipating pain and treating pain pre-emptively with timely 
administration of opioids is needed.
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Introduction In sepsis, sympathetic nerve activity is increased, which 
helps maintain arterial pressure in the face of nitric oxide-induced 
vasodilatation. Accordingly, we investigated the haemodynamic 
eff ects of the centrally acting α-adrenoceptor agonist clonidine in an 
ovine model of severe sepsis.
Methods A prospective interventional blinded crossover study in 
12 Merino ewes with cardiac and renal fl ow probes implanted to 
continuously measure cardiac output and renal blood fl ow. Arterial 
pressure was continuously monitored and blood and urine samples 
were taken. After 24  hours of control, sepsis was induced by an 
intravenous bolus and continuous infusion of live Escherichia coli 
for 32  hours. After 24  hours of sepsis, animals were randomly and 
blindly allocated to vehicle infusion or clonidine (1 μg/ml/kg/minute) 
for 8  hours. The E. coli infusion was then discontinued, gentamycin 
150 mg given i.m. and the animals were followed for 16 hours during 
recovery. The animals that survived were crossed over to the alternative 
treatment 2 weeks later.
Results Complete data were collected on eight animals/group, three 
animals died/group. Hyperdynamic sepsis with hypotension and 
acute kidney injury of similar degree developed in the two groups. 
Haemodynamic and renal eff ects of clonidine are shown in Figure 1.
Conclusion In ovine hyperdynamic sepsis, clonidine transiently 
increased urine output without aff ecting creatinine clearance.
P415
Off -label use of clonidine for sedation in Dutch ICUs
J Van der Valk, M Zeeman, M Arbouw, H Van den Oever
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Critical Care 2014, 18(Suppl 1):P415 (doi: 10.1186/cc13605)
Introduction Clonidine is an α2-agonist, licensed in most countries 
for treatment of hypertension. Other pharmacologic characteristics 
of α2-agonists are sedation, hypnosis, anxiolysis, sympatholysis, and 
analgesia [1]. Because of these central nervous eff ects, clonidine can 
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be used off -label to augment sedation and delirium treatment. To our 
knowledge there have been no publications evaluating the effi  cacy 
and safety of clonidine in ventilated critically ill adults. A survey in 
German ICUs showed that clonidine was used for sedation in 62% of 
units [2]. We undertook an enquiry to investigate the off -label use of 
clonidine in Dutch ICUs.
Methods An inventory was sent by email to 25 ICUs in the Netherlands, 
determined by the diffi  culty to identify a contact person.
Results The response rate was 56%. The results are summarized in 
Table  1. Clonidine was used in all 14 responding ICUs; in 36% this 
use was reported as often. Licensed use (for hypertension) was 50%. 
Indications for off -label use were: substance withdrawal (50%), delirium 
(71%), and sedation (29%). The route of administration was intravenous 
in all cases. Nine ICUs reported the use of a loading dose, irrespective 
of indication, varying from 10 to 150  μg, median 150  μg. Ten ICUs 
reported the use of continuous infusion, varying from 10 to 100  μg/
hour, median 50 μg/hour.
Conclusion Off -label use of clonidine for sedation and treatment of 
withdrawal symptoms and delirium was common practice in Dutch 
ICUs. There was a wide range of dosing regimens: infusion schedules 
varied 10-fold and loading doses 15-fold. Clinical studies are required 
to establish the safety and effi  cacy of clonidine in the ICU setting.
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Introduction Both propofol and dexmedetomidine decrease systemic 
blood pressure, heart rate, and cardiac output in a dose-dependent 
manner. The aim of this study was to compare their safety and effi  cacy 
for intravenous sedation during mechanical ventilation.
Methods Eighty-four patients with traumatic brain injury (Glasgow 
scale 7 to 8) entered the study, mean age 44 ± 13.37 years. All patients 
Figure 1 (abstract P414). Haemodynamic and renal eff ects of clonidine in established sepsis.
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underwent mechanical lung ventilation. Patients were divided into two 
groups depending on the type of intravenous sedation. In the fi rst group 
(n = 42), sedation was performed by intravenous propofol infusion at a 
dose of 4 to 12 mg/kg/hour. In patients of the second group (n = 42), 
sedation was carried out by intravenous infusion of dexmedetomidine 
at a dose of 0.2 to 1.4 mg/kg/hour. The level of sedation was assessed 
with bispectral index monitoring, targeting index 70. For comparison 
of methods we evaluated heart rate, blood pressure, SpO2 30, 90 and 
180 minutes after the start of sedation. Both groups were matched for 
sex, age and comorbidity.
Results Thirty minutes after the start of sedation in patients of the 
fi rst group, HR was 83  ±  11.31 beats/minute, blood pressure was 
127 ± 12.87/64 ± 8.54 mmHg, SpO2 was 97 ± 3.01%. In patients of the 
second group 30 minutes after the beginning of sedation, HR was 87 ± 
10.01 beats/minute, blood pressure was 131 ± 11.67/68 ± 8.19 mmHg, 
SpO2 was 97 ± 2.98%. After 90 minutes in the fi rst group of patients, we 
observed HR was 81  ±  6.27 beats/minute, blood pressure was 119  ± 
11.46/59  ± 4.29  mmHg, SpO2 was 98  ±  2.35%. In the second group, 
HR was 82 ± 7.31 beats/minute, blood pressure was 94 ± 13.62/55 ± 
7.81 mmHg, SpO2 was 97 ± 2.76%. In the fi rst group 180 minutes after 
the start of sedation, HR was 86 ± 6.19 beats/minute, blood pressure 
was 105 ± 10.34/54 ± 4.28 mmHg, SpO2 was 98 ± 1.32%. In the second 
group, HR was 75  ± 6.27  beats/minute, blood pressure was 92  ± 
12.54/51 ± 6.91 mmHg, SpO2 was 96 ± 2.91%.
Conclusion Using dexmedetomidine at a dose of 0.2 to 1.4 mg/kg/hour 
for intravenous sedation is safe in terms of hemodynamic stability and 
blood oxygenation for sedation during mechanical lung ventilation in 
traumatic brain injury patients.
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Introduction Septic shock is a status characterized by the simultaneous 
use of vasopressors and sedative drugs in critical care patients. Little 
is known about the possible interference of these drugs during shock 
status. We aimed to clarify how propofol could diff erently aff ect the 
preload dependency in an endotoxemic model in comparison with 
dexmedetomidine, by evaluation of the systemic vascular system and 
cardiac function.
Methods After animal preparation and under PiCCO monitoring 
(BL), endotoxemic shock was induced by an intravenous bolus of 
lipopolysaccharide (LPS, 055:B5) in ketamine-anesthetized rabbits. 
After fl uid resuscitation and norepinephrine infusion (SD0), animals 
were randomized to propofol (PROP, n = 8) or dexmedetomidine (DEX, 
n = 8) sedation, with two incremental doses (SD1 and SD2). The mean 
arterial pressure (MAP) and central vein pressure (CVP) were monitored. 
Pulse pressure variation (PPV) and stroke volume variation (SVV) were 
assessed to evaluate the preload dependency. Global end-diastolic 
volume, vascular resistances, mean systemic fi lling pressure, cardiac 
functional index and vascular resistances were assessed at each time 
point. Normality was assessed by the Kolmogorov–Smirnov test. Two-
way analysis of variance for repeated measures was applied, and the 
Student–Newmann–Keuls post-hoc test when indicated. P  <0.05 was 
considered signifi cant.
Results At the increasing dose of propofol, both PPV and SVV signifi -
cantly increased in SD1 versus SD0 (P  <0.01) and SD2 versus SD0 
(P <0.001), but only PPV in SD2 versus SD1 (P = 0.024). Dexmedetomidine 
infusion did not aff ect PPV and SVV. At SD1 and SD2, PPV and SVV were 
higher in PROP with respect to DEX (P  <0.001). Moreover, propofol 
infusion increased the heart rate and had no eff ects on cardiac 
contractility and vascular resistances. On the contrary, in the DEX group 
we recorded a signifi cant decrease in heart contractility and increment 
of vascular resistances at SD2. Nonetheless, both drugs aff ected the 
MAP, CVP, mean systemic fi lling pressure, global end-diastolic volume 
and venous return.
Conclusion In an endotoxemic shock model, after fl uid resuscitation 
and during norepinephrine infusion, propofol increased more PPV 
and SVV in comparison with dexmedetomidine. At high dosage 
the vascular resistances and heart contractility were infl uenced by 
dexmedetomidine, but not by propofol.
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Introduction This re-audit aims to test our strategy for monitoring 
patients on propofol sedation for prolonged periods. Propofol infusion 
syndrome (PRIS), once established, is diffi  cult to treat and currently 
there is limited guidance on how best to monitor for this potentially 
Table 1 (abstract P415). Indication and doses of clonidine used in Dutch ICUs
IC levela Clonidine use Indication Loading dose (μg) Continuous infusion dose (μg/hour)
3 Often Hypertension sedation ns ns
3 Often Hypertension withdrawal; hypertension delirium; sedation 40 to 120 10 to 80
3 Often Substance withdrawal; sedation 150 50
3 Often Substance withdrawal 75 to 150 50
3 Often Substance withdrawal; hypertension; delirium 10 40 to 100
3 Sometimes Delirium ns 30 to 100
3 Sometimes Hypertension; delirium 150 ns
3 Sometimes Substance withdrawal; delirium ns 40
2 Sometimes Substance withdrawal; delirium ns 20 to 50
2 Sometimes Hypertension; sedation 150 40
2 Sometimes Substance withdrawal; hypertension; delirium 150 12 to 25
1 Sometimes Hypertension; delirium 150 ns
1 Sometimes Delirium 50 50 to 100
1 Sometimes Delirium ns ns
ns, not specifi ed. aLevel of ICU care, with level 3 being the most advanced.
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life-threatening complication [1]. An audit done in 2011 highlighted 
that lipid profi le and electrocardiograms (ECGs) were rarely monitored. 
We recommended regular monitoring of these parameters when 
propofol sedation is used for over 3  days and that propofol-sparing 
agents are considered in these patients at risk of developing PRIS.
Methods In patients who required propofol sedation for 4 days or more, 
we prospectively monitored: frequency of performing lipid profi le and 
12-lead ECG; and frequency of co-administration of a propofol-sparing 
agent.
Results We collected data from 25 patients. The duration of propofol 
infusion was 4 to 15  days (mean 8.5  days). Mean propofol dose in 
the fi rst 4  days was 2.2  mg/kg/hour. Maximum daily propofol dose 
ranged from 2.1 to 3.8 mg/kg/hour. Lipid profi le was checked in 16/25 
(64%) patients (20% in 2011) whilst on propofol sedation. However, 
these were checked following 3  days continuous infusion in only 
three patients. The triglyceride level was ≥2.2  mmol/l (very high) on 
fi rst testing in 75% of patients. All patients had a 12-lead ECG done 
on admission. Seventeen of 25 (68%) had a further ECG performed 
whilst on continuous propofol infusion (45% in 2011). Additional ECGs 
were done in 13/17 patients (zero in 2011). ECG changes that we feel 
were attributable to propofol occurred in two patients, one of whom 
developed severe PRIS. Fourteen of 25 (56%) patients (55% in 2011) 
were on concomitant sedative agents. This included the patient who 
developed PRIS.
Conclusion Awareness of complications from prolonged propofol 
sedation is increasing amongst our clinicians. This is refl ected in the 
increased frequency of lipid profi le and ECG monitoring compared 
with 2011. However, we feel that more regular and routine monitoring 
is essential to aid early detection of this potentially fatal complication. 
We recommend that all patients at risk of developing PRIS should have 
these parameters monitored on a daily basis as standard.
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Introduction Increased intracranial pressure (ICP) may adversely aff ect 
sevofl urane anesthesia and the recovery period due to a disturbed 
cerebral blood fl ow. Eff ect of sevofl urane on cerebral hemodynamics 
remains controversial and depends on the extent of the initial value of 
ICP [1]. This study was designed to evaluate the safety of sevofl urane-
fentanyl anesthesia during major abdominal surgery in patients with 
increased ICP.
Methods A total of 124 ASA 3 patients, undergoing major abdominal 
surgery (duration 5.6 (4.1 to 6.4) hours), were divided into two 
groups: with normal ICP (≤12  mmHg) (N group, 70 patients) and 
with ICP >12  mmHg (H group, 54 patients). Initial ICP was evaluated 
by venous ophthalmodynamometry [2]. ICP, mean arterial pressure 
(MAP) and cerebral perfusion pressure (CPP) were assessed every hour 
of anesthesia. Time of recovery of consciousness after anesthesia, 
complications and length of stay in the ICU and in the hospital were 
also evaluated.
Results Initial ICP was 8 ± 3 mmHg in the N group and 15 ± 2 mmHg in 
the H group. During the anesthesia ICP increased in the H group with 
a total increase of 33% (from 15 ± 2 to 20 ± 3 mmHg (P <0.05)). In the 
N group ICP was stable without any signifi cant change. Decrease of 
MAP after induction of anesthesia was similar in the two groups and 
was stable during anesthesia. CPP was stable in the N group (above 
70 mmHg during the anesthesia), but in the H group CPP decreased 
signifi cantly (from 82 mmHg to 63 mmHg (P <0.05)). Time of recovery 
of consciousness in the H group was higher (32  ±  6  minutes vs. 
20  ±  4  minutes (P  <0.05)). The incidence of postoperative delirium 
was higher in the H group (22.2% vs. 12.8% in the N group (P <0.05)). 
There were no signifi cant diff erences between two groups in other 
complications. Total length of stay in the ICU and in the hospital was 
higher in the H group (6 ± 2 days vs. 4 ± 2 days (P <0.05) and 15 ± 3 days 
vs. 11 ± 2 days in N group (P <0.05)).
Conclusion Sevofl urane-fentanyl anesthesia in patients with increased 
ICP was characterized by a delayed recovery with a higher incidence of 
postoperative delirium and higher length of stay in the ICU and in the 
hospital. The main cause of this is a decrease of CPP in patients with 
high ICP due to low craniocerebral compliance.
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Introduction Sedation monitoring with the Bispectral Index (BIS) is 
uncommon during bronchoscopy but allows for a more objective 
measure of sedation; we hypothesized that higher BIS scores would 
correlate with lower patient satisfaction and that lower BIS scores (deep 
sedation) would result in better patient and physician satisfaction.
Methods Between October 2012 and August 2013, bronchoscopy 
using conscious (CS) or monitored anesthetic deep sedation (DS) was 
monitored with BIS. Medication administration and procedures were 
time-stamped. Sedation was administered blinded to BIS score. DS 
cases used propofol infusions, CS cases used bolus midazolam and 
fentanyl. Providers rated sedation satisfaction, cough, and the ability 
to perform the intended procedure using a 100  mm visual analog 
scale at the end of the procedure blind to BIS (0 unsatisfi ed to 100 
satisfi ed). Patients were surveyed at 1  hour and 24  hours regarding 
overall sedation, symptoms, and procedure recall (unpleasant recall 1, 
no recall 4). Group diff erences were considered statistically signifi cant 
at P <0.05.
Results Twenty-six procedures were monitored, 20 with CS and six 
endobronchial ultrasound procedures with DS. There was no diff erence 
with respect to age or gender. The mean doses of midazolam and 
fentanyl were 5 mg and 85 μg, respectively. BIS values were lower at all 
predefi ned points of the procedure for DS cases versus CS. Physicians 
were more satisfi ed with sedation and the lack of cough with DS, but 
there was no signifi cant diff erence in patient satisfaction between 
the two groups with regards to overall sedation, procedure-related 
symptoms or willingness to have repeat bronchoscopy. Patients with 
no recall had lower nadir BIS scores (46 vs. 71, P  = 0.03) and scores 
at procedure end (76 vs. 94, P = 0.04) compared with those with any 
recall. There was no diff erence in the doses of midazolam or fentanyl 
in CS cases despite statistically signifi cant diff erences in patient recall 
and BIS scores. Junior fellows scored greater satisfaction with sedation, 
were less bothered by cough and more often felt able to perform the 
intended procedure compared with senior fellows.
Conclusion Deep sedation resulted in greater physician satisfaction 
with procedural conditions as well as lower BIS scores but no signifi cant 
diff erence in patient satisfaction compared with conscious sedation. 
Patients with no recall of the procedure had lower BIS scores at the 
nadir and end of the procedure. BIS may be a novel tool to monitor 
procedural depth, allowing proceduralists to better monitor the narrow 
window between adequate sedation and dangerous oversedation.
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Introduction Critically ill paediatric patients supported on mechanical 
ventilation frequently receive analgesia and sedation. Iatrogenic 
withdrawal syndrome occurs with the abrupt discontinuation or 
too rapid weaning of opioids and benzodiazepines. We induce the 
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Withdrawal Assessment Tool-1 (WAT-1) [1] to evaluate children during 
weaning from analgesics and sedatives. The patient is diagnosed 
with withdrawal syndrome when the score is 3 or >3. We compared 
the subjects who ever had a score over 3 and those with lower scores 
and assessed the risk factors and outcome of withdrawal syndrome 
between two groups.
Methods A total of 932 patients were admitted to our PICU from 1 
October 2011 to 31 March 2013. Of these, 127 paediatric patients 
were supported on mechanical ventilation on the fi rst day in the PICU 
and received intravenous analgesics and sedatives. A retrospective 
review of a prospectively collected database. The statistical method 
was the Mann–Whitney U test, and P <0.05 was considered statistically 
signifi cant.
Results Twenty-eight patients were scored with the WAT-1 during 
weaning from the drugs. Median age was 14 months (1 to 73 months) 
and the most common reasons for ventilation were airway trouble 
and pneumonia. Eight of 28 were diagnosed withdrawal syndrome, 
20 were not. There were no signifi cant diff erences in age, body weight, 
cumulative morphine and benzodiazepine dose before weaning. In the 
withdrawal group, the lactate level, catecholamine index, Paediatric 
Index of Mortality 2 and heart rates were greater when they were 
admitted to hospital. Further, there are longer length of PICU stay and 
shorter ventilator-free days for patients with WAT-1 score >3. But all of 
them are alive at 28 days, so there is no diff erence in 28-day mortality.
Conclusion Our study suggest that severely ill paediatric patients 
tended to suff er from withdrawal syndrome and then resulted in short 
ventilator-free days and longer PICU stay. But there is no diff erence in 
mortality.
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Introduction Epidural analgesia on top of general anesthesia in cardiac 
surgery might improve relevant clinical outcomes but the incidence of 
epidural hematoma is under-reported.
Methods An international web-based, online, viral, anonymous survey, 
a systematic review of the literature, and a meta-analysis of randomized 
and matched studies were performed.
Results Nine epidural hematomas were identifi ed in 198 published 
manuscripts. The risk of epidural hematoma (9:13,429) calculated on all 
published evidence might be therefore estimated to be 1:1,492 (95% 
confi dence interval (CI)  = 1:2,857 to 1:833). Through an anonymous, 
web-based, viral, international survey, we identifi ed at least 16 further 
nonpublished epidural hematomas together with at least 72,400 
epidural analgesia catheters positioned in cardiac surgery in the last 
20 years. The risk of epidural hematoma (25:85,829) is therefore 1:3,436 
(95% CI = 1:2,325 to 1:5,076) including both published and unpublished 
data. Out of the 66 randomized and case-matched studies, 57 trials 
reported the incidence of all-cause mortality at the longest available 
follow-up with a signifi cant reduction in the epidural group (59/3,137 
(1.9%) in the epidural group vs. 108/3,246 (3.3%) in the control arm, RR 
0.64 (95% CI 0.48 to 0.85), P = 0.002, NNT = 69).
Conclusion Epidural analgesia on top of general anesthesia in cardiac 
surgery might reduce the incidence of all-cause mortality (NNT 69). 
The incidence of epidural hematoma in this setting is 1:3,436 (95% CI = 
1:2,325 to 1:5,076) including both published and unpublished data. In 
fact, we identifi ed at least 25 epidural hematomas that occurred so far 
from the following countries: Belgium (n = 1), Brazil (n = 1), France (n = 
1), Germany (n = 2), India (n = 2), Italy (n = 1), Japan (n = 2), Korea (n = 
1), Malaysia (n = 1), Norway (n = 2), Russia (n = 3), Sweden (n = 1), the UK 
(n = 3), and the USA (n = 4). Even if from the public health point of view 
the benefi ts seem to encourage the use of epidural analgesia in cardiac 
surgery with a possible reduction in perioperative mortality, this topic 
merits further investigation and the decision to insert the epidural 
catheter should be discussed with the patient considering both local 
experience and legal dispute in case of medical complications.
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Introduction The occurrence of delirium heralds a circumstance of 
higher risk of death, longer stay, higher cost, and greater likelihood 
of long-term brain dysfunction, and yet the majority of ICU patients 
worldwide do not get routinely monitored for delirium, thus obstructing 
timely prevention and management strategies. Determination of 
eff ective implementation strategies regarding screening, treatment 
and prevention of delirium is critical to address needed modifi cations 
in the culture of patient care in the ICU. The aim of this study was to 
summarize the effi  cacy of and the barriers to implementation of 
delirium management.
Methods We searched PubMed, Embase, PsychINFO, Cochrane and 
CINAHL for studies published between January 2000 and October 
2012, and included them when implementation strategies and their 
effi  cacy and/or potential barriers of implementation were described.
Results In all studies (n  = 34) multifaceted education strategies 
were used and combined (median: 5; IQR: 4 to 6). Positive results 
were reported for both process and clinical outcomes: adherence to 
delirium screening  – improvement after implementation compared 
with the before measurement, by 15 to 57%; only measured after 
implementation, between 84 and 92%; delirium knowledge (on 
a 10-point scale; improved from 6.1 and 6.2 before to 8.2 and 7.4 
respectively (P <0.001) after implementation); length of stay in the ICU 
(4.1 vs. 5.9 days; P = 0.21 and 6.3 to 5.35 days; P < 0.009) and hospital 
stay (12 days vs. 18 days; P = 0.036 and from 55 to 27 days; P <0.0001); 
and decreased mortality (29.4% vs. 22.9%; P  = 0.009; and OR  = 0.45; 
95% CI  = 0.22 to 0.92; P  = 0.03). The major barriers found impairing 
implementation concerned clinicians’ attitude and healthcare 
professionals’ knowledge.
Conclusion Implementation strategies used suggest a strong potential 
for multifaceted strategies to be able to aff ect both process and clinical 
outcomes. The majority of studies focused only on implementation 
of delirium screening. There is a knowledge defi cit regarding effi  cacy 
of well-prepared implementation of integral delirium management 
considering screening, prevention, and treatment preceded by 
analysis of barriers. Further research on the extent and contents of 
implementation interventions aimed at integral delirium management 
such as those described in the recent ABCDE bundle and PAD guideline 
are necessary.
P424
Eff ect of enteral and/or parenteral glutamine supplementation on 
mortality and morbidity in the critically ill
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Introduction In this study we aimed to compare the eff ectiveness 
of enteral, parenteral and combined enteral–parenteral glutamine 
supplementations in the nutrition of critical care patients.
Methods This is a single-center, randomized controlled clinical trial. 
During the 5-day study period, all patients received standard enteral 
nutrition product and were divided into three groups, including 
parenteral glutamine (Group I), enteral glutamine (Group II) and 
enteral + parenteral glutamine (Group III) supplementations. Blood 
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biochemistry, rates of infections, length of stay in the ICU and duration 
of mechanical ventilation were evaluated.
Results Sixty patients were included in this study. There was no 
statistically signifi cant diff erence for biochemical values between the 
diff erent feeding groups. Frequency of infections ranged as Group 
II >Group III >Group I and mortality as Group II = Group III >Group I. 
Length of stay in the ICU and duration of mechanical ventilation were 
signifi cantly longer in Group II than the others.
Conclusion Although mortality was not signifi cantly diff erent between 
groups, parenteral glutamine administration causes less stay of ICU 
and mechanical ventilation. This needs a more powerful randomized 
controlled study [1].
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Introduction Gastric residual volumes (GRVs) as measured at regular 
intervals are considered a marker of tolerance of enteral nutrition (EN). 
There is controversy surrounding this practice, however. The absolute 
value for the designated cutoff  value for GRVs varies widely in the 
literature. No prospective randomized control trials have suggested 
that their use improves patient outcomes in the ICU. It has also not been 
shown, therefore, that GRVs are an accurate predictor of aspiration or 
pneumonia. However, the use of GRVs as a guide to the continuation 
of EN can result in a reduction in the percentage of goal calories 
received by patients. Prior to February 2013, in our ICU the threshold 
of GRVs prior to withholding of EN was 200 ml. This tolerated volume 
was increased to 500 ml in February 2013, in compliance with recent 
guidelines. By increasing the acceptable GRVs to this level, the aim was 
to increase the percentage of goal calories received by patients via the 
enteral route.
Methods Following ethical approval, the practice of measuring 
GRVs and the subsequent management of EN was retrospectively 
reviewed over a 3-month period, September to December 2012, and 
prospectively reviewed over a 3-month period, September to December 
2013, following the change in practice. Recorded parameters included: 
length of ICU admission; admitting diagnosis; duration of EN; GRVs; 
prescribed calories; delivered calories via an enteral route; requirement 
for PN; duration of PN; and cost of total parenteral nutrition (TPN).
Results The change of practice in terms of GRVs and management 
of EN led to an increased percentage of prescribed calories that was 
delivered. There was a reduced requirement for PN and reduced cost of 
TPN also associated with this change in practice.
Conclusion Increasing the threshold of GRV prior to reducing or 
stopping EN can result in increased calories delivered to ICU patients 
and a reduced requirement for and cost of TPN.
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Introduction It has been established that early enteral nutrition 
in critically ill patients improves overall outcome and mortality. In 
our unit, feeding protocols were established based on the ESPEN 
recommendations and have been implemented for the last 2 years. 
The purpose of this study was to evaluate the compliance of our septic 
patients’ nutritional approach with our feeding protocols.
Methods A prospective study was done on a 24-bed mixed ICU over a 
period of 18 months. Eighty-three patients ≥18 years were included in 
the study. All patients were dependent on mechanical ventilation and 
met the CCM criteria for sepsis upon admission to the ICU. APACHE II 
score, SOFA score, weight, BMI and nutritional status were calculated. 
Patients were initiated for enteral feeding based on the established 
feeding protocol within 48 hours of admission. The feeding status of 
the patient was recorded on the start day (D0), day 3 (D3) and day 7 
(D7). Factors aff ecting the feeding process and its progression were 
also recorded
Results The patient mean age was 71.4 ± 12.2. LOS in the ICU was 9 to 
21 days. Based on BMI, 18% of the patients were malnourished upon 
admission. APACHE II was 26 ± 7.8 and SOFA was 9.2 ± 4.6. The mortality 
rate was 42.5%. Enteral nutrition started early in 64 (77.1%) of the 
patients (D0), on day 3 (D3) 29 (45.31%) patients met their caloric goals 
and on day 7 (D7) only 18 (28.1%) patients achieved their caloric goals. 
Discontinuation of enteral feeding was mainly due to procedures, 
whereas late start and/or decreased hourly intake were due to GI 
complications, GI intolerance, excessive diarrhoea and hemodynamic 
instability. There was no association between compliance with the 
feeding protocol and the LOS, nutritional status, severity or disease 
progression.
Conclusion Although the initiation of early enteral feeding seems 
adequate for a good number of septic patients on D0, is still far off  for a 
signifi cant percentage of those patients on D3 and is even worse on D7. 
The caloric goal achievements were better on D3 but very suboptimal 
on D7. There was no association, however, between nutritional status 
and compliance with the feeding protocols. It is therefore mandatory 
to follow daily the nutritional therapy of the septic patient and not rely 
only on the feeding protocols.
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Introduction Providing adequate feeding in cardiac surgery patients 
is gaining importance [1]. The aims were to assess the preoperative 
nutritional status, to compare postoperative energy needs with 
eff ectively delivered amounts, and to evaluate the impact of a dietitian 
on optimizing postoperative energy balances.
Methods A prospective interventional study in adult patients after 
elective CABG and/or heart valve surgery. The patients’ nutritional 
risk was determined by the NRS 2002 and the Malnutrition Universal 
Screening Tool (MUST) [2]. A dedicated dietitian managed and assisted 
the nutritional approach. For each patient, global energy intake 
(intentional and non-intentional) and balance (diff erence between 
energy target and global caloric intake) were calculated daily during 
and after ICU stay until hospital discharge. The Harris–Benedict 
equation was used to calculate daily energy requirements. When 
energy delivery did not reach 60% of calculated needs, a protocol-
driven nutritional intervention was initiated.
Results Two hundred patients were enrolled during a 10-month period, 
representing 2,690 study-days. Mean age was 67 ± 11 years. In total, 
42.5% of the patients had a NRS 2002 score >3 and were considered 
to be nutritionally at risk. MUST identifi ed a high, medium, or low risk 
in respectively 1%, 4% and 95% of subjects. Mean energy requirement 
was 2,046 ± 347 kcal and mean daily intake 1,452 ± 335 kcal. Sixty-two 
percent of the caloric need was met during the entire hospital stay. 
Nutritional intervention was necessary in 52% of cases: oral feeding 
supplementation for 546 study-days, enteral feeding: 401 days, 
parenteral feeding: 367 days. This reduced the mean cumulative caloric 
defi cit to 9,085 kcal.
Conclusion Close monitoring of caloric intake shouldered by interventions 
based on a predefi ned algorithm under supervision of a dedicated 
nutrition team restricts the caloric defi cit in cardiac surgery patients.
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Introduction Vitamins are essential micronutrients and depletions are 
reported for chronically ill patients. It is well known that the general 
nutrition status of the homeless is poor, especially for heavy alcoholics. 
But there were few data about the actual vitamin status of homeless 
patients. We want to evaluate the vitamin levels of homeless patients.
Methods This study was conducted at a single urban teaching hospital 
emergency department. We performed a retrospective chart review 
of blood vitamin B1, B12, B6 and C levels of homeless patients. These 
vitamins are a common supplement in our center and sometimes 
blood levels are drawn if the patient is drunk, needs i.v. hydration and 
has cachexic features.
Results During study periods, vitamin levels were checked for 156 
patients. The number of male patients was 146 (94%) and the mean 
age was 50 ± 10.2. Vitamin C levels were 15.8 ± 1.3 mg/l. For 84 patients, 
levels of vitamin C were decreased. For vitamin B1 (152 ± 7.2 nmol/l), 
vitamin B12 (725.5  ±  35.4  pg/ml), and vitamin B6 (50.3  ±  5.5  ng/ml), 
there were three, two and 23 patients below the reference ranges 
respectively. See Table 1.
Table 1 (abstract P428).
  Reference Lower than Higher than
 Mean (SD) range reference (%) reference 
(%)
Vitamin B1  158.1 (80.2) 59 to 213 3.1 13.8
Vitamin B12  741.5 (432.2) 200 to 950 2.7 22.6
Vitamin B6 51.9 (53.8) 20 to 202 23.1 1.9
Vitamin C  15.57 (13.4) 26.1 to 84.6 82.7 0
Conclusion The level of vitamin C was markedly decreased. 
Replacement of vitamin C should be considered for the homeless who 
visit the emergency department after alcohol ingestion.
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Introduction ICU patients often develop acid–base disorders. In 
clinical practice, there are several methods (for example, Henderson–
Hasselbalch) used to interpret acid–base data, but most of them 
provide little information and fail to identify the cause of the problem. 
Stewart’s approach which is based on physicochemical principles 
has growing popularity among clinicians in critical care. This method 
includes three independent variables that determine plasma pH 
(strong ion diff erence (SID), PCO2, and total weak acid concentration – 
mainly albumins and phosphate).
Methods The prospective analysis of arterial blood gases (ABG) was 
performed according to the Henderson–Hasselbalch approach and 
the Stewart method. The results were categorized into three groups 
according to the Henderson–Hasselbalch concept and the BE values: 
BE <–2, metabolic acidosis; BE between –2 and 2, normal values; BE >2, 
metabolic alkalosis. The aim of the study was to compare the effi  cacy 
of the traditional Henderson–Hasselbalch approach with acid–base 
disturbances with the Stewart concept in the population of critically 
ill septic patients.
Results The analysis included 990 arterial blood gases taken from 43 
consecutive septic patients admitted to the ICU. One hundred and 
ninety-three ABG results met the criteria of metabolic acidosis, 473 were 
categorized into the metabolic alkalosis group and 324 results were 
within the range value of BE according to the Henderson–Hasselbalch 
concept. In the metabolic acidosis group (BE <–2), 34.7% of the results 
had elevated lactate concentration, 100% revealed hypoalbuminemia, 
96.9% had Cl/Na ratio >0.75 revealing SID acidosis, while 42.5% met the 
criteria of SIG acidosis. In the normal range BE group, 21.3% revealed 
lactate concentration >2 mmol/l, 100% had hypoalbuminemia, 98.4% 
had Cl/Na ratio >0.75 revealing SID acidosis and hyperchloremia, while 
14.5% showed SIG acidosis. The analysis of the ABG with BE >2 group 
showed that 18.4% had elevated lactate concentration, 99.1% revealed 
hypoalbuminemia, 88.8% had Cl/Na ratio >0.75 (SID acidosis) and 4.6% 
showed SIG acidosis.
Conclusion In critically ill patients with the BE values <–2, with 
BE in the range of normal value and BE >2 we observed complex 
acid–base disturbances with coexistence of hyperchloremic 
acidosis, hyperlactatemia, SIG acidosis and alkalosis caused by 
hypoalbuminemia. The Stewart approach is more eff ective in detecting 
acid–base disturbances and quantifying individual components of 
acid–base abnormalities and provides a detailed insight into their 
pathogenesis.
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Introduction The renal system compensates respiratory disorders 
of acid–base equilibrium by modifying the urinary electrolyte 
composition [1]. Such a condition mainly involves changes in urinary 
ammonium excretion as a reaction to prolonged periods of acid–base 
disequilibrium, leaving the renal response to acute derangements 
unexplored. We aimed to determine the acute variations of urinary 
ammonium [NH4+]u, sodium [Na
+]u, potassium [K
+]u and chloride 
[Cl–]u concentrations following controlled minimal respiratory acid–
base imbalances, and to further investigate whether urinary anion 
gap ([AG]u = [Na
+]u + [K
+]u – [Cl
–]u) and sodium and chloride diff erence 
([Na+]u – [Cl
–]u) might unveil an early activation of the renal response.
Methods Patients admitted to the ICU after major surgery were 
enrolled, during intubation and sedation. Patients with chronic renal 
failure were excluded. A urinary catheter was connected to the quasi-
continuous urinary analyzer KING®, measuring [NH4+]u, [Na
+]u, [K
+]u and 
[Cl–]u over time. Based upon the arterial pH (pHa) at entrance, patients 
were randomly assigned to controlled hypoventilation (30% reduction 
of minute ventilation if pHa ≥7.40) or hyperventilation (30% increase 
of minute ventilation if pHa <7.40) for 2 hours. Samples for blood gas 
analysis were collected every 30 minutes.
Results Thirty patients were enrolled; 20 were hypoventilated, 
10 hyperventilated. At 2  hours from ventilation change, pHa was 
respectively decreased from 7.44 ± 0.02 to 7.34 ± 0.02 and increased 
from 7.37  ±  0.03 to 7.44  ±  0.02 (P  <0.001) in the two groups. Mean 
[NH4+]u rose by 2.6 ± 3.3 mEq/l in hypoventilated patients and fell by 
2.5 ± 2.4 mEq/l in the hyperventilated (P <0.001). No diff erence in mean 
[K+]u was observed at any time, while [Na
+]u and [Cl
–]u progressively 
decreased in both groups (P <0.05). [Na+]u was reduced by 48 ± 43 mEq/l 
during hypoventilation and by 32 ± 41 mEq/l during hyperventilation 
(P  = 0.14), while [Cl–]u decreased by 29  ±  69 and by 46  ±  66  mEq/l 
respectively (P = 0.93). Whereas [AG]u did not diff er between groups, 
[Na+]u  – [Cl
–]u variation of hyperventilated patients was greater than 
that of hypoventilated (17 ± 34 vs. –18 ± 54 mEq/l, P <0.05).
Conclusion During acute respiratory modifi cations, changes in urinary 
ammonium can be observed within the fi rst 2 hours even while 
maintaining arterial pH within a physiologic range. This response 
seems to be better associated with changes in the diff erence between 
urinary sodium and chloride rather than anion gap.
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Introduction Magnesium is the second most abundant intracellular 
cation and serves as a cofactor in more than 300 enzymatic reactions. 
Hypomagnesemia is a common electrolyte imbalance in critically ill 
patients; yet it is frequently overlooked. Previous studies highlighted 
the relationship between hypomagnesemia and mortality in these 
patients [1,2]. This study was carried out on patients admitted to the 
critical care unit and seeks to fi nd admission hypomagnesemia’s role as 
a 28-day mortality predictor in medical critically ill patients.
Methods This is a cohort prospective study with prognostic research 
recruiting 150 critically ill patients in a major tertiary hospital. Blood 
samples were collected for estimation of serum total magnesium on 
admission, and then the patients were followed over 28 days.
Results This study was conducted consecutively from April to July 2013. 
Most subjects were male (62%) with mean age 52.6 ± 15.93 years. The 
occurrence of sepsis (33.3%) and cardiac disturbances (24.7%) were the 
most common problems among patients. The mean MSOFA score for 
the hypomagnesemics was higher than the normal group (4.91 ± 4.19 
vs. 3.77  ±  3.52). Subgroup analysis in the MSOFA 0 to 7 group had 
signifi cant P = 0.015 (chi-square) and crude RR = 2.2 (95% CI = 1.19 to 
4.06). From survival analysis, the survival mean of hypomagnesemia 
patients was lower than the normal group (19.4 vs. 22.8 days), and so 
was the survival percentage (52.7% vs. 74.7%).
Conclusion There was a high prevalence of hypomagnesemia in 
medical critically ill patients and it was associated with a high mortality 
rate.
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Introduction Phosphate is essential for cell and bone function [1]. In 
critical illness, hypophosphatemia is common and practice is often 
to correct even mild derangement [2]. Its supplementation has 
signifi cant cost and risk including hypotension and hypocalcaemia. We 
investigated whether changing frequency of routine serum phosphate 
testing had eff ects on the detected incidence of abnormal plasma 
levels and prescription of phosphate.
Methods This was a service improvement project using observational, 
anonymous data. We collected data on serum phosphate levels in a 
33-bed ITU over two 6-month periods before and after introduction of 
a new testing regime (phases 1 and 2). In phase 1, phosphate levels 
were tested daily. In phase 2, phosphate levels were tested three times 
per week. Replacement was at clinical discretion. Pharmacy data on 
phosphate prescription were compared for both phases.
Results A total of 4,253 tests were performed in phase 1, and 3,641 
in phase 2  – a reduction of 612 (14.4%). The ICU workload was 
similar in both phases. There was no signifi cant diff erence in mean 
phosphate levels or detected incidence of abnormal phosphate levels 
in phase 1 versus phase 2. Mean level was 1.13 ± 0.40 mmol/l versus 
1.14 ± 0.43 mmol/l (P = 0.42). Severe hypophosphatemia (<0.4 mmol/l) 
was relatively uncommon: n = 18 in phase 1 (0.42% of tests) versus 19 
(0.52%), P = 0.42, in phase 2. Mild hypophosphatemia (0.4 to 0.7 mmol/l) 
was frequent, with 1,203 episodes (28.2% of tests) versus 1,088 (29.8%), 
P = 0.42. Hyperphosphatemia (>1.5 mmol/l) was also common in both 
phases with 608 detected episodes (14.3% of tests) versus 572 (15.7%), 
P = 0.49. Pharmacy data show phosphate replacement fell signifi cantly, 
from 687 prescriptions in phase 1 to 395 in phase 2, with drug cost-
savings estimated at £1,430.
Conclusion Reducing testing from daily to three times weekly was not 
associated with a signifi cant change in mean phosphate levels nor 
with detection of abnormally high/low phosphate levels. Daily testing, 
however, is associated with higher rates of phosphate prescription. It is 
known that there is signifi cant diurnal variation in serum phosphate [2] 
and we speculate that mild hypophosphataemia self-corrects without 
intervention. Treating mild hypophosphatemia may therefore not be 
indicated.
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Introduction Direct ion-selective electrode without dilution is the most 
eff ective method for determination of the concentration of the ionized 
fraction of sodium [1]. We tested the hypothesis that the diff erence 
between indirect and direct sodium assays would be related to the 
plasma albumin concentration or the total protein concentration.
Methods A retrospective observational study was conducted in which 
plasma sodium concentrations, from 101 paired venous and arterial 
samples from patients admitted to the ICU, were respectively analyzed on 
the arterial blood gas (ABG) analyzers (direct ion-selective electrode) and 
the central laboratory auto-analyzers (indirect ion-selective electrode). A 
paired t test was performed comparing the central laboratory and ABG 
measurements. Correlation and regression analysis were performed 
between total protein concentration, albumin and the diff erences 
between the central laboratory and ABG assays for sodium.
Results The central laboratory sodium measurement was, on average, 
1.46  mmol/l more than the ICU assay, limits of agreement 1.18 to 
1.74  mmol/l greater, P  <0.001. Bland–Altman analysis of the central 
laboratory result minus the ICU sodium measurement had limits 
of agreement of 1.3 to –4.2  mmol/l. The correlation between the 
assay diff erences and total protein concentration and albumin were 
respectively r = 0.24 (P = 0.01) and r = 0.20 (P = 0.04). The diff erence 
in plasma sodium concentration between the assays increased as 
the plasma concentration albumin or total protein concentration 
decreased (respectively: r2 = 0.04 and r2 = 0.06).
Conclusion The diff erence between indirect and direct sodium 
assays was found to be statistically related to the plasma albumin 
concentration and the total protein concentration. Although the 
relationship was found to be weak, the total protein concentration 
should be monitored when measuring sodium by indirect ion-selective 
electrode.
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Introduction Water–electrolyte disturbances are one of the most 
common complications of acute brain injury of various origins, 
threatening the life of the patient and requiring timely correction. In 
this work we studied the structure of water–electrolyte complications 
in patients in the neurological intensive care with acute brain injury.
Methods We analyzed 259 cases of water–electrolyte disturbances that 
developed in patients treated in the Department of Intensive Care of 
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Russian Polenov’s Neurosurgical Institute from 2001 to 2012. Patients 
were between 16 and 55 years old. A total of 142 patients were operated 
for brain tumor, 72 of them of basal–supratentorial localization; eight 
severe brain trauma; 62 of the hemorrhagic type of stroke, one herpes 
encephalitis. We excluded from this study the patients with heart and 
renal failure receiving diuretics. We measured BP, HR, CVP, hourly and 
daily urine output, level of K and Na in plasma, brain natriuretic peptide 
(BNP) one to four times a day, and levels of K and Na in urine in single 
and daily servings. All patients were receiving dexamethasone at a 
dose between 8 and 32  mg/day as an anti-edema therapy, and thus 
levels of ACTH and cortisol were not investigated.
Results Central diabetes insipidus (CDI) developed in 106 patients. 
Against the background of substitution therapy, we did not observe 
the development of complications, hypovolemia, hypernatremia, or 
hyperosmolality. Out of 48 cases of CSWS, in 12 cases the symptoms 
interleaved with the symptoms of CDI. For 24 patients, CSWS was 
complicated by depressed consciousness, for three patients by 
convulsions against the background of hypovolemia, hyponatremia, 
or hypo-osmolality. No correlation between BPN level and absence of 
CSWS symptoms was found.
Conclusion In patients with acute brain trauma we observed two 
syndromes causing water–electrolyte disturbance  – CDI and CSWS. 
CSWS generally is more severe than CDI. We could not determine 
a correlation between BPN level and the absence of presence of the 
CSWS symptoms.
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Introduction Both ACTH and cortisol are secreted in a diurnal rhythm. 
Underlying this is an ultradian rhythm of discrete pulses [1] as a result 
of the feedforward:feedback interactions between cortisol and ACTH 
[2]. These pulses are critical for normal function; pulsatile and constant 
infusions yield diff erent transcriptional responses [3] and patients on 
optimal (nonpulsatile) glucocorticoid replacement have twice the 
age-related mortality of the general population [4]. We have now 
characterised the ultradian rhythm and pituitary–adrenal interaction 
of patients undergoing coronary artery bypass grafting (CABG).
Methods Twenty male patients presenting for elective CABG (on-pump 
and off -pump) were recruited. Blood samples were taken for 24 hours 
from placement of the fi rst venous access. Cortisol was sampled 
every 10 minutes, ACTH was sampled every hour and cortisol binding 
globulin (CBG) was sampled at baseline, at the end of operation and at 
the end of the 24-hour period.
Results Cortisol and ACTH were pulsatile throughout the perioperative 
period and the cortisol–ACTH interaction persists (Figure  1). The 
sensitivity of this interaction (calculated by the ratio of cortisol to ACTH 
pulse amplitude) changed at about 8 hours post surgery such that the 
adrenal sensitivity to ACTH increased.
Conclusion Both cortisol and ACTH remain pulsatile during and 
after cardiac surgery and the pituitary–adrenal interaction persists, 
although the sensitivity of the adrenal glands changes throughout the 
perioperative period. Our study shows that endogenous glucocorticoid 
levels reach very high oscillating levels following cardiac surgery, which 
not only invalidate the interpretation of point measures of adrenal 
function to diagnose adrenal insuffi  ciency but also demonstrate that 
constant infusions of hydrocortisone are unphysiological.
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Introduction Endogenous melatonin is decreased in critically ill 
patients; oral supplementation could help them to cope with sleep 
disruption and sepsis. Among patients who took part in a trial on 
melatonin and need for sedation [1], some were studied with blood 
sampling to describe their melatonin blood values and the relationship 
with total antioxidant capacity (TAC) in plasma.
Methods Inclusion criteria: mechanical ventilation previewed at ICU 
admission >8 days and mortality predicted at ICU admission over 
13% (SAPS II >32 points). After the clinical run-in period of 48 hours, 
samplings were taken to measure baseline blood melatonin and TAC, 
beginning from the third ICU night and day (midnight and 02:00 p.m.). 
At 8:00 p.m. of the third ICU day, treatment with 3 mg + 3 mg melatonin 
(Group M) or placebo (Group P) began: each patient received two 
tablets per day, at 8:00 p.m. and midnight, until ICU discharge. Further 
samplings were taken during the early (fourth night and day) and the 
late (eighth night and day) treatment phases. Melatonin was measured 
through an ELISA essay; TAC was measured with a specifi c kit.
Results Sixty-four critically ill patients were enrolled. Endogenous 
melatonin was shown decreased in the run-in period and in the 
placebo group compared with healthy subjects. All patients reached 
satisfying pharmacological values with enteral administration: peak of 
blood melatonin value (pg/ml) was 2,514 (982 to 7,148) for the M group 
versus 20 (15 to 62) for the P group (P <0.001) during the fi rst treatment 
night, while maintaining signifi cant diff erences also during the 
daytime: 51 (23 to 180) M group versus 14 (11 to 24) P group (P = 0.001). 
The same trend was observed in the late treatment samples (eighth 
ICU day). Regarding TAC values (nmol Trolox equivalent/μl plasma), a 
signifi cant diff erence was highlighted during the night (107 (97 to 123) 
M group vs. 61 (42 to 89) P group, P <0.001), but not during the daytime 
(37 (30 to 69) M group vs. 28 (25 to 50) P group, P = 0.092). Correlation 
between melatonin and TAC: Spearman’s rho = 0.33 (P <0.001).
Conclusion Enteral administration of melatonin was adequate in 
the early phase of critically illness, with pharmacokinetics similar to 
published data [2]. The administration of melatonin seems to increase 
the TAC, with a possible meaningful role in critically ill patients.
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Introduction Many if not most critically ill patients are treated with 
insulin during their stay in the ICU [1]. Intensive monitoring of the blood 
glucose level is a prerequisite for effi  cient and safe insulin titrations 
Figure 1 (abstract P435).
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in these patients [2]. Current continuous glucose measurement 
techniques rely on subcutaneous glucose measurements [3] or 
measurements in blood [4]. We hypothesized that changes in volatile 
organic compound (VOC) concentrations in exhaled breath refl ect 
changes in the blood glucose level. Changes in VOC concentrations can 
be analyzed continuously using a so-called electronic nose (eNose) [5].
Our aim was to investigate exhaled breath analysis to predict changes 
in glucose levels in intubated ICU patients.
Methods Exhaled breath was analyzed in 15 intubated ICU patients 
who were monitored with a subcutaneous CGM device. eNose results 
were compared with subcutaneous glucose measurements and linear 
regression models were built, including subject-specifi c models, and 
whole-sample models. The models were validated using temporal 
validation by training the model on the fi rst 75% of measurements and 
prospectively testing on the last 25% of measurements. Performance 
of the models was measured using an R2 value, Clarke error grids (CEG) 
and rate-error grid analysis (R–EGA).
Results Changes in VOC concentrations were associated with changes 
in subcutaneous glucose levels. R2 performance had a mean value of 
0.67 (0.34 to 0.98) for subject-specifi c models, and a mean value of 
0.70 (0.52 to 0.96) for the model for the whole sample. However, when 
externally validating the model, the predictive performance dropped 
to a mean R2 of 0.19 (0.00 to 0.70) for subject-specifi c models, and 0.04 
for the model for the whole sample. Point accuracy in CEG was mostly 
good with >99% in zones A and B; trend accuracy, as visualized with 
R–EGA, was low.
Conclusion Exhaled breath prediction of glucose levels seems 
promising. However, performance of the current models is too low to 
be used in daily practice.
References
1. Schultz MJ, et al.: Intensive Care Med 2010, 26:173-174.
2. Preiser J-C, et al.: Intensive Care Med 2009, 35:1738-1748.
3. Kosiborod M, et al.: Crit Care 2013, 17(Suppl 2):462.
4. Schierenbeck F, et al.: Diabetes Technol Ther 2013, 15:26-31.
5. Röck F, et al.: Chem Rev 2008, 108:705-725.
P438
Evaluation of blood glucose control in ICU patients with Space 
GlucoseControl: a European study
J Blaha, on behalf of the SGC NIS Study Group
General University Hospital, Prague, Czech Republic
Critical Care 2014, 18(Suppl 1):P438 (doi: 10.1186/cc13628)
Introduction Regardless of the ongoing debate on optimum target 
ranges, glycaemia control (GC) remains an important therapeutic goal 
in critically ill patients. Dozens of diff erent insulin protocols for ICUs 
have been developed with diff erent complexity, eff ectiveness, blood 
glucose (BG) variability and safety. Although comparison of existing 
protocols is diffi  cult due to signifi cant diff erences in processes and 
outcome measures, computerized clinical decision support systems 
generally achieved better GC with consistently lower hypoglycaemia 
rates than that achieved with paper-based protocols [1]. The enhanced 
Model Predictive Control (eMPC) algorithm, developed by the CLINICIP 
group, is the eff ective clinically proven protocol, which has been 
successfully tested at multiple institutions on medical and surgical 
patients with diff erent nutritional protocols [2,3]. The eMPC models 
the behaviour of glucose and insulin in ICU patients with a variable 
sample interval based on the accuracy of the BG prediction. It has 
been integrated in the B.Braun Space GlucoseControl (SGC) system, 
which allows direct data communication between pumps and Space 
Control with the incorporated eMPC algorithm. Although SGC is 
already clinically used in dozens of ICUs worldwide, there are few only 
published experiences with its use [4].
Methods The primary objective of this multicentre European non-
interventional study was to evaluate the performance (effi  ciency) 
of SGC under routine conditions in adult ICU patients requiring BG 
control. The primary endpoint was the percentage of time within the 
target range, and secondary outcome measures were the frequency 
of hypoglycaemic episodes and BG measurement intervals. Patients in 
this trial were assigned to the target range 4.4 to 8.3 mmol/l. Nutritional 
management (enteral, parenteral or both) was carried out at the 
discretion of the each centre.
Results Seventeen centres from nine European countries included a 
total of 508 patients. During the study a total of 29,575 BG values were 
entered into the SGCs and the same number of recommendations 
were rendered. The mean time-in-target was 77.5  ±  20.9%. The 
mean proposed next measurement time was 2.0  ±  0.5  hours. Only 
four episodes of hypoglycaemia <2.2  mmol/l occurred (0.01% of 
measurements).
Conclusion SGC is a safe and very effi  cient system to control BG in ICU 
patients.
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Introduction Glycemic control in the ICU has been shown to reduce 
morbidity, mortality and length of stay. However, current methods of 
blood glucose (BG) monitoring are invasive, intermittent and labor-
intensive. Continuous glucose monitoring (CGM) has potential to 
improve safety/effi  cacy of BG control. The performance of a non-
invasive, transdermal CGM system (Symphony CGM; Echo Therapeutics, 
Philadelphia, PA, USA) was evaluated in post-surgical ICU patients.
Methods Adult surgical patients with planned ICU admission of 
≥24 hours at four medical centers were consented. Following admission 
to the ICU, the skin of an upper arm was cleaned and a 6 mm diameter 
site was prepared with controlled micro-abrasion using the Symphony 
CGM system. A transdermal CGM sensor containing glucose oxidase 
was applied. Following a 1-hour warm-up period, a calibration was 
performed. Blood samples were obtained from a radial artery catheter 
approximately every hour, centrifuged to plasma, and glucose was 
measured using a YSI 2300 STAT Plus Glucose Analyzer (reference BG). A 
maximum of 30 reference BG samples were collected for each patient. 
Samples were collected as frequently as every 15  minutes for trend 
analysis. CGM was prospectively calibrated every 4 hours. All treatment 
decisions were based on BG alone. Safety was assessed by visual 
inspection of the site using a dermatological scale following sensor 
removal. A study was defi ned as evaluable for CGM sessions >16 hours.
Results Thirty-two subjects completed the study. Additional subjects 
were not considered evaluable due to early discharge from the ICU, 
failure or early removal of the radial artery catheter, or administration 
of intravenous acetaminophen. The study cohort was 19% female, 28% 
diabetes, 56% cardiac surgery, with a mean age of 65 ± 13 years. Overall 
mean absolute relative diff erence between CGM and reference BG was 
12.5%. Continuous glucose error-grid analysis, which assesses point 
and trend accuracy, showed 98.2% of readings in the A zone (clinically 
accurate) and 1.2% in the B zone (benign errors). Glucose values ranged 
from 49 to 324 mg/dl. No device or study-related adverse events were 
reported.
Conclusion The Symphony CGM system demonstrated clinically 
relevant accuracy and excellent safety in a variety of patients and 
ICU environments. Future studies are needed to determine whether 
Symphony CGM can be used to direct therapy and improve BG control 
in this patient population.
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Introduction Intravenous insulin by infusion is commonly used 
for blood glucose control in the ICU and blood glucose is almost 
exclusively monitored by intermittent sampling. The rate of change 
in blood glucose concentration [BG] when the insulin infusion rate is 
changed is not known, and as a result the optimum time to measure 
[BG] after changing the infusion rate is unclear.
Methods Following institutional ethics approval and patient consent, 
using a GluCath Continuous Glucose Monitoring system sensor 
deployed via a radial artery catheter we studied the change in [BG] in 
response to a 1 unit/hour increase in the insulin infusion rate during 
the fi rst 48  hours after cardiac surgery. [BG] was recorded every 
10 seconds. Insulin was infused at a concentration of 1 unit/5 ml/hour 
via a volumetric pump. We recorded [BG] for 2  hours after changing 
the insulin infusion rate. Data aff ected by artifacts produced by blood 
draws and subsequent fl ushing of the arterial catheter were excluded 
and linear interpolation was used to estimate missing [BG] data.
Results There were fi ve episodes where the insulin infusion increased 
by 1 unit/hour. [BG] decreased modestly for 50  minutes, after which 
there was marked interpatient variability in subsequent [BG] trend 
(Figure 1). The median (range) change in BG (mmol/l) at 30 minutes: –0.5 
(–0.7/+0.1), 60  minutes: –0.1 (–0.7/+1.0), 90  minutes: –0.3 (–0.7/+0.6) 
and 120 minutes: –0.5(–1.2/+2.9).
Conclusion Within the fi rst hour the change in [BG] was consistent but 
beyond this time it was highly variable. Further studies are needed 
to understand the dynamics of [BG] in response to changes in insulin 
infusion rates, but these data suggest [BG] should be checked hourly 
until stable.
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Introduction The aim of this study was to determine the impact of 
preadmission or fi rst 24-hour blood glucose (BG) measurements in UK 
ICUs on mortality.
Methods The Intensive Care National Audit & Research Centre case-mix 
programme database on adult admissions to general, neuroscience 
and cardiothoracic critical care units was used for analysis. Within the 
database, the highest and lowest blood glucose (BG) values measured 
during the fi rst 24  hours from admission were recorded. BG control 
value was defi ned as BG (≥4.0 ≤9.9  mmol/l). Other BG levels were 
defi ned as: very low, ≤2.2 mmol/l (≤40 mg/dl); low, >2.2 ≤3.9 mmol/l 
(40 to 70 mg/dl); high, ≥10.0 <11.1 mmol/l (180 to 200 mg/dl); and very 
high, ≥11.1 mmol/l (200 mg/dl).
Results There was an increased incidence of mortality in those patients 
with at least one BG measure below 3.9 mmol/l (70 mg/dl) compared 
with those without (Table 1). There was a link between BG levels and 
LoS for surviving patients with the longest hospital stays (critical 
care and total hospital) experienced by those with BG levels below 
2.2 mmol/l (40 mg/dl).
Conclusion There is a strong association between BG levels during 
admission and mortality and LoS outcomes. Although it is not possible 
to make the link with causation from our dataset, we present results 
from the largest single dataset of critical care unit patients [1,2].
Acknowledgement Funding from Edwards Lifesciences.
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Introduction While there is ongoing discussion of the optimal range 
for glycemic control in hospital intensive care, recent publications from 
Mackenzie and colleagues [1] and Krinsley [2-4] suggest not only that 
mean BG should be considered, but also that glucose variability and 
complexity may be equally important. This has increased the need for 
continuous systems which can provide early warnings of hypoglycemia 
and eff ectively measure variability. GlySure Ltd has developed an 
intravascular glucose monitoring system to simplify the application of 
hospital protocols for tight glycemic control (TGC) at the point of care. 
Experience with the original research-based instrumentation [5] has 
now been incorporated into a combined pre-production monitor and 
Figure 1 (abstract P440). Blood glucose change after infusion change and after calibration.
Table 1 (abstract P441). Critical care outcomes
 Very    Very
Variable low Low Control High high
Number of patients 11,471 70,106 521,839 77,423 187,553
ICU mortality* (%) 55 31 13 18 26
ICU LOS* 7 6 4 5 6
*P <0.001.
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autocalibration unit. We have now completed a 34-patient trial using 
this device and present the data collected from this study.
Methods The study used GlySure sterile, single-use sensors and a 
5-lumen 9.5-Fr CVC device, allowing the fl uorescence optical-based 
sensor to be placed into the patient’s right internal jugular vein. The 
screen data were blinded to the bedside staff . Data from the monitor 
were later compared with sample measurement from the Yellow 
Springs (YSI) glucose analyzer. The data accuracy was measured using 
the mean absolute relative diff erence (MARD), an error calculation tool.
Results The device met the primary safety and eff ectiveness endpoints 
of the trial. The 456 sample values recorded by the monitor based 
on 8-hour calibrations were correlated with samples taken from the 
YSI and the MARD for the study was 9.40%. The analysis showed that 
89.23% of the data fell within the A zone of the Clark error grid, with the 
rest falling within the B zone.
Conclusion The results demonstrate a good correlation with the 
accepted standard of blood glucose determination in ICU practice. 
Early detection of glycemic excursions can provide carers with the 
opportunity for an early intervention and thus achieve the elusive 
target of TGC around the chosen target range.
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Introduction The aim of this study was to determine the safety and 
effi  cacy of treating patients using a novel intravenous continuous 
glucose monitoring (CGM) system (GlucoClear™; Edwards Lifesciences). 
The practical benefi t of controlling blood glucose in the critically ill 
remains contentious, largely because of the lack of tools to adequately 
measure and therefore manage levels in real time. A system that is able 
to provide instant, constantly calibrated, accurate values is a major 
bonus to ICU care and we report here the fi rst clinical use of a novel 
CGM system directly used to manage postoperative glycaemia.
Methods All consecutive consenting adult patients undergoing 
cardiac surgery involving cardiopulmonary bypass and requiring 
postoperative insulin (>98% of patients) were enrolled in the study with 
a target enrolment of 100. Blood glucose was measured via a dedicated 
peripheral intravenous catheter with values reported every 5 minutes. 
The primary outcome was the number of data points in the target 
glycaemic control range (4.4 to 8.0  mmol/l), using a dynamic insulin 
protocol. Secondary endpoints include mean glucose levels, time in 
range and number of hypoglycaemic and hyperglycaemic episodes.
Results For the fi rst 45 patients, mean age was 67.7 years (male 
52.8%), 54% had undergone valve surgery with or without CABG and 
the majority (67%) had no history of diabetes. The CGM sensor was 
typically sighted in the forearm or hand (90.5%) and was resited on 
7.5% occasions. Median monitoring time in the ICU was 28.4  hours. 
Mean glycaemic value was 6.8 mmol/l. From the possible 18,609 
glucose values (one per 5  minutes), 16,808 values were recorded 
(90.3%). Overall, 13,389/16,808 values (79.6%) were within the target 
range. No hypoglycaemic episodes (≤2.2  mmol/l) were recorded at 
any point. There were 219/16,808 values (1.3%) in the hyperglycaemic 
range (≥10.0 mmol/l).
Conclusion This new CGM system enabled signifi cantly improved 
glycaemic control despite the challenges of working with an entirely 
new system of glucose control in a unit with over 200 nurses. 
Performance notably improved with experience and also highlighted 
that even previously validated dynamic algorithms will need to be 
refi ned to maximise the benefi t of GGM. Overall, the evidence from 
the fi rst applied clinical use of this novel CGM showed that proper 
safe, tight glycaemic control can be achieved. Further investigations 
are required to demonstrate the reduction in morbidity and mortality 
using CGM, and we plan to embark on further studies to address this.
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Introduction The purpose of this study was to assess the relation 
between glycemic control and the severity of sepsis in a cohort of 
patients with vasopressor-dependent septic shock treated with 
corticosteroids [1,2].
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Methods In a prospective, controlled study, 134 patients with septic 
shock were randomized into three study groups: group A (n  = 43), 
200 mg/day hydrocortisone hemisuccinate in four daily doses; group 
B (n = 47), same dose of hydrocortisone hemisuccinate in continuous 
administration; group C (n  = 44), no hydrocortisone hemisuccinate. 
Patients with diabetes mellitus were excluded. The duration of 
hydrocortisone treatment was a maximum 7  days. The target blood 
glucose (BG) level was below 180 mg/dl. BG values were analyzed by 
calculating mean daily values, standard deviation (SD) of BG values 
as an index of glycemic variability, and insulin doses. The local ethics 
committee approved the study.
Results There were no diff erences between the three groups at the 
beginning of the study regarding demographic data and the clinical 
characteristics, including BG value. BG levels were strongly correlated 
with severity of septic shock estimated by APACHE II score (r = +0.241; 
P = 0.005) or Simplifi ed Acute Physiology Score II (r = 0.280; P = 0.001) – 
Pearson correlation. The risk of death is signifi cantly increased if SD of 
BG is more than 20 mg/dl (67.7% vs. 20.8%, P = 0.000). A total 94.4% of 
deceased patients in group A registered a SD of BG more than 20 mg/dl 
versus 89.5% in group B or 40% in group C (P = 0.006). In total, 53.5% of 
patients in group A needed insulin therapy versus 25.5% in group B or 
27.3% in group C. The dose was between 30.28 ± 6.65 UI/day in group 
A, 37.85 ± 11.95 UI/day in group B, and 14.28 ± 5.76 UI/day in group C 
(P >0.05).
Conclusion BG variability is highly associated with mortality compared 
with BG mean daily value or insulin dose. SD levels above 20 mg/dl 
were associated with a signifi cantly higher mortality rate relative to 
those with SD levels below 20 mg/dl.
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Introduction Blood glucose (BG) control in acute illness improves 
outcome. However, how to manage BG levels, or BG target, is not clearly 
elucidated. In this study, the BG target was suggested by the analysis of 
the relationship between BG profi le and the severity of the diseases.
Methods Ninety-six patients were studied. The following parameters 
were calculated during the fi rst week after ICU admission. (1) Maximum 
value of SOFA score (SOFAmax). (2)  Mean, standard deviation, 
maximum, minimum, and diff erence of BG levels (BGm, BGsd, BGmax, 
BGmin, BGd (BGmax – BGmin), respectively). BG levels were measured 
basically every 6  hours. (3)  Correlation between SOFAmax and BG 
parameters using two-dimensional (correlation coeffi  cient rt) and linear 
regression analysis (rl).
Results (1) Mortality of the patients with SOFAmax 0 to 3, 4 to 5, 6 to 7, 8 
to 9, and 10 or more were 0%, 14%, 23%, 40%, and 89%, respectively. (2) 
rt and rl (rt/rl) between SOFAmax and BG parameters: BGsd (0.49/0.36), 
BGmax (0.47/0.32), BGm (0.45/0.23), BGd (0.44/0.32), and BGmin 
(0.25/0.06). (3) BG ranges that indicate SOFAmax less than 5 calculated 
from the two-dimensional correlation curves between SOFAmax and 
BGsd, BGmax, BGm, and BGd were 35 ± 25, 250 ± 112, 150 ± 33, and 
156 ± 115 mg/dl, respectively.
Conclusion BG parameters except BGmin were two-dimensionally 
related to the severity. Therefore, a part of the severe patients seemed 
to have lower BG levels and lower BG variability. Targeting those BG 
parameters in early phase within the abovementioned levels was 
considered to link to better outcome.
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Introduction Because of its ability to block late INa [1], ranolazine is 
used as an antianginal agent for the treatment of chronic angina 
pectoris when angina is not adequately controlled by other agents 
[2]. Besides its cardiovascular eff ects, ranolazine improves diff erent 
neuronal functions, and thus its use has been proposed for the 
treatment of pain and epileptic disorders [3,4]. Since astrocytes are 
involved in neuronal infl ammatory processes, and autoimmune 
and neurodegenerative diseases [5], we have investigated the anti-
infl ammatory and antioxidant eff ects of ranolazine in primary cultured 
astrocytes.
Methods We incubated diff erentiated rat astrocytes in primary culture 
(10 days of culture) [5] for 24 hours with ranolazine (10–5, 10–6, 10–7 M). 
We measured the protein expression levels of PPARγ and Cu/Zn-SOD by 
western blot technique. Protective eff ect of ranolazine on cell viability 
was assayed using MTT conversion assay. Finally, to evaluate the eff ect 
of ranolazine on the IL-1β cytokine and TNFα mediators, we used the 
enzyme-linked immunosorbent assay technique.
Results Compared with control cells, treatment with ranolazine 
induced an increment of anti-infl ammatory PPARγ and reduced 
the proinfl ammatory mediators IL-1β and TNFα in primary cultured 
astrocytes. Ranolazine (10–6 M) also increased the expression of 
antioxidant protein Cu/Zn-SOD and caused a signifi cant increase in cell 
viability.
Conclusion Ranolazine decreases infl ammatory mediators IL-1β and 
TNFα, and increases anti-infl ammatory PPARγ as well as the antioxidant 
Cu/Zn-SOD in astrocytes in culture. These results suggest that 
ranolazine could be useful as a neuroprotective drug in pathologies 
inducing infl ammatory damage and oxidant processes.
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Introduction Tuberculous meningitis (TBM) is the least common 
extrapulmonary manifestation of tuberculosis. Although the UK 
incidence of TBM is relatively low, it carries a high mortality and 
morbidity [1]. Neurological deterioration continues to be an important 
reason for ICU admission [2]. Little is known about the outcomes for 
TBM patients requiring ICU admission. Our aim is to evaluate patient 
demographics, TBM clinical data, and the necessity for organ support, 
and whether this can be associated with outcome.
Methods A retrospective study at a tertiary centre of patients with TBM 
admitted to our ICU between 2000 and 2012. Data were retrieved on 
demographics, microbiology, radiology and pharmacological fi ndings 
and type and level of organ support. APACHE II and SOFA scores were 
calculated. Patients were stratifi ed into two groups: CSF PCR+ve and 
CSF PCR–ve.
Results Eight patients (six males:two females) were evaluated. Total 
mean age was 43.9  ±  8.09  years. A reduction in GCS was the main 
reason for ICU admission. All patients received ≥3 anti-TBM drugs 
and steroids. Two CSF PCR+ve patients had primary drug resistance 
to isoniazid. There was also a longer mean delay in the time of onset 
of anti-TBM treatment in CSF PCR+ve patients (4 ± 2.88 days). Higher 
APACHE II and SOFA scores on admission (mean  = 23, 8.5) were 
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associated with a positive CSF PCR result. Increased requirements for 
mechanical ventilation (100%), tracheostomy (50%), inotropes (75%), 
neurosurgical intervention (predominantly CSF drainage) (100%) and 
enteral feeding (50%) were all signifi cant for this group. Mortality and 
long-term neurological morbidity were substantially higher for PCR+ve 
patients (75% and 25%). In contrast, the majority of culture-negative 
patients survived (75%), and experienced good recoveries at follow-up. 
Overall mortality was 50%.
Conclusion This is the second documented case analysis of TBM and 
ICU admission in adult patients [1,2]. Findings show that poor outcomes 
are associated with positive CSF PCR results. Factors linked to poor 
outcomes include delays in initiating anti-TBM treatment, neurosurgical 
interventions, and an increased requirement for multiorgan support. 
Earlier drug susceptibility testing would be preferable particularly for 
patients with positive CSF PCR cultures. Given the potential severity 
of TBM, a high index of clinical suspicion remains critical towards 
optimizing outcomes.
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Introduction The aim was to evaluate the role of intrathecal lactate as 
an early predictor of spinal cord injury during thoracoabdominal aortic 
aneurysmectomy. Forty-four consecutive patients were scheduled to 
undergo thoracoabdominal aortic aneurysmectomy. Two patients 
had a type B dissecting aneurysm; all other 42 patients suff ered from 
degenerative aneurysm.
Methods During surgery, samples of cerebrospinal fl uid and 
arterial blood were simultaneously withdrawn to evaluate lactate 
concentration. Samples were collected at fi ve fi xed times during and 
after surgery: T1 (beginning of the intervention), T2 (15 minutes after 
aortic cross-clamping), T3 (just before unclamping), T4 (end of surgery), 
and T5 (4 hours after the end of surgery).
Results Mean lactate levels in cerebrospinal fl uid rose consistently 
from the beginning of the intervention steadily until after surgery (T1 = 
1.83  mmol/l, T2  = 2.10  mmol/l, T3  = 2.72  mmol/l, T4  = 3.70  mmol/l, 
T5 = 4.31 mmol/l). Seven patients developed spinal cord injury; two of 
them had delayed injury occurring 24 hours after the end of surgery; 
the remaining fi ve had early onset. In this group of fi ve patients, 
preoperative cerebrospinal fl uid lactate levels were signifi cantly 
(P  = 0.04) higher than those of the other 40 patients preoperatively 
(2.12 ± 0.35 vs. 1.79 ± 0.29 mmol/l).
Conclusion The preoperative cerebrospinal lactate concentration is 
elevated in patients who will develop early-onset spinal cord injury 
after thoracoabdominal aortic aneurysmectomy. This may allow a 
better stratifi cation of these patients, suggesting a more aggressive 
strategy of spinal cord function preservation and possibly guaranteeing 
them a better outcome.
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Introduction Spinal cord injuries aff ect 50 persons per million every 
year in North America [1], with over 50% occurring at the cervical 
level [2]. Cervical spinal cord injuries (CSI) are at particular risk for 
mechanical ventilation (MV), pulmonary complications and increased 
length of hospital stay. A few small cohort studies looked at predictors 
of MV [3-6], and to our knowledge there are no studies addressing 
factors associated with prolonged MV. The purpose of this study was 
to compare known clinical predictors of MV and determine predictors 
of prolonged MV.
Methods We conducted a retrospective chart review of consecutive 
CSI admitted between 1 January 2005 and 1 March 2009. We recorded 
data related to the injury, the duration of MV, respiratory complications, 
ICU and hospital length of stay and patients’ outcomes. A review of the 
literature identifi ed known predictors (ASIA level, ISS, level of injury, 
and so forth). Univariate and multivariate logistic regression were used 
to identify predictors of MV and prolonged MV.
Results Of the 208 patients, 82% were male and the mean age was 
51 years. Hospital mortality was 8.7%. Main causes of injury were 
motor vehicle accidents (39.7%) and falls (43.2%). Injuries below C4 
level represented 51.5% of the population. A complete loss of motor 
function (ASIA level A and B) was found in 34.9% of patients. The mean 
and median ISS score was 20.7. In total, 78 patients required MV (37.5%) 
and 30 patients required prolonged MV (14.4%). After multivariate 
analysis, four predictors of MV were identifi ed: pneumonia (OR = 52.83); 
ISS score >22 (OR  = 4.09); age (OR  = 1.02); level C1 to C4 (2.34); and 
two predictors of prolonged MV: ASIA score A and B (OR = 5.57) and 
pneumonia (OR = 8.76).
Conclusion In our study ISS, cervical level and age were associated with 
MV but not with the need for prolonged MV, whereas pneumonia was 
an independent risk factor for both. This is a potentially preventable 
risk factor where specifi c strategies can be applied to improve patients’ 
outcome.
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Introduction Multimodal neuromonitoring is a part of goal-
directed therapy in severe neurosurgical pathology that leads to 
better understanding and therefore accurate and timely correction 
of disturbances of cerebral perfusion. The aim of our study was to 
evaluate and compare microcirculation in the conjunctiva of the eye 
and sublingual mucosa in brain-dead patients and healthy volunteers. 
No studies to our knowledge with this purpose were performed 
previously. We hypothesized that direct videomicroscopic evaluation 
of conjunctival microcirculation is linked to cerebral blood fl ow.
Methods We evaluated microcirculation of the eye conjunctiva and 
sublingual mucosa of 10 brain-dead diagnosed patients and 10 
healthy volunteers. Brain-death diagnoses were certifi ed by cerebral 
angiography. Direct in vivo observation of the microcirculation 
was obtained with sidestream dark-fi eld imaging. Assessment 
of microcirculatory parameters of convective oxygen transport 
(microvascular fl ow index (MFI), proportion of perfused vessels (PPV)), 
and diff usion distance (perfused vessel density (PVD) and total vessel 
density (TVD)) was performed according to international criteria.
Results All brain-dead patients required vasopressor support to sustain 
perfusion of donor organs. The MFI of small vessels was signifi cantly 
lower in brain-dead patients in comparison with healthy controls in 
ocular conjunctiva (2.6 (2.4 to 2.8) vs. 3.0 (3.0 to 3.0), P = 0.03) and in 
sublingual mucosa (2.8 (2.6 to 2.9) vs. 3.0 (3.0 to 3.0), P  = 0.04). TVD 
and PVD of small vessels were signifi cantly lower in brain-dead patients 
in comparison with healthy controls in ocular conjunctiva (10.2 (5.2 
to 14.8) vs. 17.0 (15.4 to 27.2) mm/mm2, P = 0.023 and 5.2 (2.9 to 7.2) 
vs. 10.1 (8.5 to 16.7) l/mm, P = 0.023), but there was no diff erence in 
sublingual mucosa.
Conclusion We were able to identify a signifi cant reduction of capillary 
density in the eye conjunctiva but not in sublingual mucosa when 
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comparing microcirculation of brain-dead diagnosed patients and 
healthy volunteers. However, the presence of conjunctival fl ow in case 
of general cerebral fl ow is completely absent, making it diffi  cult to use 
conjunctival fl ow as a substitute for brain fl ow.
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Introduction After severe traumatic brain injury (TBI), episodes of 
elevated intracranial pressure (ICP) are associated with poor outcome. 
Previously we developed a model to predict increased ICP, 30 minutes 
in advance, using the dynamic characteristics of routinely monitored 
minute-by-minute ICP and mean arterial blood pressure (MAP) signals 
[1]. The model was developed using data from the Brain-IT database 
[2]. Here we present external validation results of this model, on a more 
recent cohort of adult TBI patients from the AVERT-IT project [3].
Methods A retrospective analysis of physiological data collected at the 
minute resolution, from 43 adult patients from the AVERT-IT project. A 
total of 67 episodes of ICP above 30 mmHg lasting at least 10 minutes 
were identifi ed in this cohort. Four-hour time series of ICP and MAP 
anteceding each episode by 30 minutes were analyzed. Additional time 
series not preceding elevated ICP episodes were used for validation.
Results Table  1 summarizes the main fi ndings. Performance of the 
model in the original study [1] is reproduced in the fi rst column. The 
model retains identical performance for all criteria in the cohort of 
more recent TBI patients of the AVERT-IT database.
Table 1 (abstract P453).
Database Brain-IT Avert-IT
AUROC 0.85 0.83
aBrier SS (%) 34 30
Cal large 0.00 0.01
Cal slope 0.99 1.03
Accuracy (%) 77 77
Conclusion The obtained external validation results, on a previously 
unseen cohort of adult TBI patients, confi rm the robustness of the 
model to accurately predict future increased ICP events 30 minutes 
in advance. The general applicability of the model is probably due to 
its sparseness, as it only uses two routinely monitored signals as input, 
namely ICP and MAP. These results are a large step forward in our work 
toward an early warning system for elevated ICP that can be used 
worldwide.
References
1. Guiza et al.: Crit Care Med 2013, 41:554.
2. [http://www.brainit.org]
3. [http://www.avert-it.org]
P454
New support system using a mobile device for diagnostic image 
display and treatment of acute stroke in Japanese depopulated 
areas
T Kageji1, H Oka1, F Obata2, K Tani3, H Bando2, R Tabata3, M Kohno3
1Tokushima University Hospital, Tokushima, Japan; 2Tokushima Prefectural 
Kaifu Hospital, Kaifu, Japan; 3The University of Tokushima Graduate School, 
Tokushima, Japan
Critical Care 2014, 18(Suppl 1):P454 (doi: 10.1186/cc13644)
Introduction Stroke is the main cause of deterioration of activity of 
daily living in Japan. The social problem in Japan is the diff erence in 
medical quality between the urban and depopulated areas. To improve 
the problem, telemedicine using a mobile device between general 
physicians and stroke specialists became important with the increasing 
demand for rapid and correct diagnosis for treatment of acute stroke. 
We developed a system for rapidly exchanging diagnostic images and 
clinical information in depopulated areas to develop the standard 
thrombolytic therapy using alteplase for acute ischemic stroke [1,2].
Methods A system was consisted of communicating patient data and 
imaging between the hospital system and participating staff  members 
in and out of the hospital using mobile devices. The system can transfer 
clinical data and large volumes of CT and MRI, and expert opinion in 
real time. We developed the system (k-support) in the Kaifu area, which 
is a typical depopulated area in Tokushima Prefecture, Japan, between 
the general physicians in Tokushima Prefectural Kaifu Hospital and 
specialists in stroke and cardiovascular disease at Tokushima University 
Hospital from February 2013.
Results The k-support system was managed in 102 emergency 
patients, 65 patients (64%) were classifi ed as neurological disease, 41 
(40%) as stroke, 11 (11%) as head injury, two (2%) as epilepsy. The detail 
of stroke was ischemia in 35 (34%), hemorrhage in four (4%) and SAH in 
two (2%). Two ischemic stroke patients were treated with intravenous 
thrombolysis of alteplase using the k-support system and a ‘drip-
and-ship’ paradigm. One patient using alteplase showed complete 
recanalization of the middle cerebral artery. The consultations resulted 
in hospitalization in 42%, transfer in 37% and return home in 20%.
Conclusion Before introduction of the k-support system, the standard 
thrombolytic therapy using alteplase for acute ischemic stroke could 
not operate in the Kaifu area due to the absence of stroke specialists 
and the long distance to a neighboring stroke center. The telemedicine 
system using a mobile device as the k-support system can be used 
anytime, anywhere and by anyone. This system can communicate 
with the doctors, between general physicians in depopulated areas 
and specialists in urban areas, and may become a useful tool for acute 
patient management in not only stroke but also other emergency 
diseases.
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Introduction In patients with aneurysmal subarachnoid hemorrhage 
(SAH), hypervolemic therapy may result in fl uid overload that may be 
associated with adverse clinical outcomes [1,2]. We hypothesized that 
a goal-directed transpulmonary thermodilution (TPT) monitoring 
protocol aiming for normovolemia may result in decreased fl uid intake 
while sustaining adequate volume status in poor-grade SAH patients.
Methods Following the introduction of the hemodynamic protocol 
in 2011, 26 consecutive patients with SAH were included until 
2013. Using TPT (PiCCO; Pulsion), cardiac output (CO), global end-
diastolic volume index (GEDVI) and extravascular lung water index 
(EVLWI) were determined. Fluid administration was targeted at 
fl uid unresponsiveness. Indications for start of the protocol were: 
hypotension (in spite of fl uids), pulmonary edema or cardiac stunning, 
daily fl uid balance ≤–1  l, cerebral ischemia (DCI) with progressive 
symptoms. Data were collected on fl uid intake and output up to 3 days 
before and 3 days after the start of TPT. We assessed the course of fl uid 
input and output and hemodynamic parameters before and after the 
start of the protocol with the generalized estimating equation.
Results Mean age was 55 ± 16, and median Glasgow Coma Scale on 
admission was 8 (IQR 6 to 13). TPT was started at a median of 1 day after 
ICU admission (IQR 0 to 4). DCI developed in 70% and the in-hospital 
death rate was 45%. Compared with days preceding the protocol (day 
–3 to –1), TPT (day 0 to 3) was associated with decreased fl uid intake 
(compared with day 3 as reference; day –1: +1.14 ± 0.31 l, P <0.001; day 
0: +0.68 ± 0.29 l, P = 0.019; day 1: +0.73 ± 0.31 l, P = 0.02), increased 
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fl uid output (day –2: –0.91 ± 0.46 l, P <0.05 compared with day 3), and 
consequently a strong decrease in fl uid balance (day –3: +2.10 ± 0.56 
l, P  <0.001; day –2: +2.66  ±  1.14 l, P  = 0.02; day –1: +1.41  ±  0.37 l, 
P <0.001). The decreased fl uid intake and fl uid balances did not result 
in decreased CO, GEDVI or EVLWI on days 1 to 3 compared with day 
0 (mean PCCI 3.5  l/minute/m2, mean GEDVI 761  ml/m2, mean EVLWI 
10.8 ml/kg).
Conclusion Our data suggest that in poor-grade SAH patients goal-
directed fl uid management with TPT is feasible to decrease intake and 
increase diuresis without adverse eff ects on cardiac output or preload 
parameters. Future research should assess the eff ect of such a protocol 
on clinical outcomes.
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Introduction The receptor for advanced glycation end products 
(RAGE) is a multiligand receptor of the immunoglobulin superfamily 
that has been implicated in multiple neuronal and infl ammatory stress 
processes. In the present study, we investigated changes in RAGE 
immunoreactivity and its protein levels in the gerbil hippocampus (CA1 
to 3 regions) after 5 minutes of transient global cerebral ischemia.
Methods The ischemic hippocampus was stained with cresyl violet 
(CV), NeuN (a neuron-specifi c soluble nuclear antigen) antibody and 
Fluro-Jade B (a marker for neuronal degeneration).
Results Five days after ischemia–reperfusion, delayed neuronal death 
occurred in the stratum pyramidale (SP) of the CA1 region. RAGE 
immunoreactivity was not detected in any regions of the CA1 to 3 
regions of the sham group. RAGE immunoreactivity was detected 
only in the CA1 region from 3  days post ischemia, and the RAGE 
immunoreactivity was newly expressed in astrocytes, not in neurons. In 
addition, the level of RAGE protein was highest at 5 days post ischemia. 
In brief, both the RAGE immunoreactivity and protein level were 
distinctively increased in astrocytes in the ischemic CA1 region from 
3 days after transient cerebral ischemia.
Conclusion These results indicate that the increase of RAGE expression 
in astrocytes at post ischemia may be related to the ischemia-induced 
activation of astrocytes in the ischemic CA1 region.
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Introduction The purpose of this study is to investigate the relationship 
between continuously monitored regional cerebral blood fl ow (CBF) 
and microdialysis values in severe subarachnoid hemorrhage and 
traumatic brain injury patients.
Methods Advanced multimodal neuromonitoring including measure-
ments of CBF (QFlow, Hemedex) and brain lactate, pyruvate, lactate/
pyruvate ratio, glycerol and glucose values using microdialysis 
(CMA600, microdialysis) were performed in 21 patients with severe 
subarachnoid hemorrhage (n = 17) and traumatic brain injury (n = 4). 
Thirteen of the patients were successfully discharged from the ICU 
while eight did not survive. Additional recorded parameters include 
PbrO2 (Licox, GMS) ICP, CPP, MABP, CVP, local brain temperature, body 
core temperature, PCO2, and blood glucose among others. The cerebral 
monitoring probes were inserted via a Bolt (ICP, PbrO2, microdialysis) 
and an additional burr hole (CBF). All probes were positioned in the 
penumbra and location was verifi ed by brain CT. The PbrO2 arm of this 
study and its signifi cance is still underway and will be announced later. 
Thirteen of the patients were successfully discharged from the ICU 
while eight did not survive.
Results The fi nal data are currently under statistical evaluation, which 
will be completed at the time of presentation. However, there is 
indication of a link between brain glucose levels and CBF values, but 
it is not clear as to the CBF–PbrO2 correlation that is the second part 
of this study under evaluation. This may be due to the fl uctuation of 
brain glucose because of brain ischemia, hyperemia, hypermetabolism 
or hypometabolism. So far we are able to establish a correlation of CBF 
and lactate/pyruvate ratio only in persistently low CBF values.
Conclusion This will be a fi nal report of a study in human patients 
with severe subarachnoid hemorrhage and traumatic brain injury. The 
results indicate correlations of varying signifi cance between the pooled 
data still under statistical analysis. We hope that the outcome of our 
study will be able to answer questions regarding the pathophysiology 
of severe brain injury and guide us in the titration of therapy, as it is 
needed by each individual patient [1-4].
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Introduction We present a method based on minute-by-minute ICP 
monitoring and outcome (GOS) to visualize in a clinically useful way 
the dynamic aspects of secondary injury.
Methods A retrospective analysis of data from 165 adult patients from 
the Brain-IT database [1]. A color-coded contour plot was made for the 
association between good outcome and the number of secondary 
insults of ICP during the ICU stay, as defi ned by continuous values of 
insult duration and thresholds.
Figure 1 (abstract P458).
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Results Figure  1 visualizes in blue the region associated with good 
outcome for continuous values of thresholds and durations of 
secondary insults. The thick black line indicates the transition towards 
the negative association region in red. A best-fi t exponential curve is 
superimposed. This clearly shows that insults below 20 mmHg of ICP 
can be detrimental if sustained for long periods. Alternatively, they can 
be tolerated for higher thresholds but only for shorter periods.
Conclusion Secondary injury is dynamic such that not only thresholds 
but also insult duration are relevant. The proposed visualization goes 
beyond the static 20  mmHg ICP threshold introduced in [2] and 
provides a more accurate representation that could help the clinician 
in identifying when the patient’s outcome could be making a turn for 
the worse.
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Introduction The objective of this research is the creation of an 
experimental model of intracranial hypertension (ICH) of the tumor 
etiology in white nonlinear rats.
Methods Work was executed in the neurophysiology laboratory on 
12 white nonlinear rats, weight 280 to 320  g, preselected according 
to criteria of bioethical rules. For modeling ICH in animals, standard 
anesthesia was carried out. A longitudinal section was spent in the 
projections of saggital suture from the frontal to occipital bone. The 
off ensive surgical stage anesthesia showed loss of palpebral and 
lingual refl exes. Further, according to the stereotactic atlas coordinates, 
a burr hole was performed, through which sterile two-component anti-
allergen and depyrogenized gel in the amount of 0.025 ml was applied 
into the fourth ventricle with an intracerebroventricular microinjector. 
The injector was at an angle of 12° in order to avoid injuring vessels, 
its distal end entering a depth 4.5 mm in the fourth ventricle, and was 
installed and documented in the burr hole for measuring intracranial 
pressure. Monitoring during operations included: respiration, heart 
rate, ECG, thermometry, and control of diuresis.
Results In all animals the heart rate decreased to an average of 
180 beats/minute during 90 minutes after the introduction of the 
intracerebroventricular two-component gel. Also there was a decrease 
in respiration rate by an average of <70  breaths/minute. Behavioral 
responses of animals were evaluated. The average intensity and the 
duration of such actions as shaking, friction, licking and carding 
decreased. Decline in grooming was possibly associated with breached 
central regulation in the brain of studied rats. Macroscopically in 
the preparation we observed a pronounced hyperemia of obtained 
materials, which may indirectly indicate the syndrome of ICH. Survival 
of the animals was: 3  days  – 100%, 7  days  – 100%, 14  days  – 92%, 
21 days – 83%.
Conclusion The main result of this work can be considered creation of 
a successful and workable model of ICH. The developed model is the 
testing ground to assess especially anesthesia protection in patients 
with the syndrome of ICH including tumor etiology and has no analogs.
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Introduction Several reports indicate the potential usefulness of 
monitoring brain metabolic parameters and their correlation with the 
system [1-4]. We want to establish diff erences and correlation in pCO2, 
lactate, serum sodium and C-reactive protein (CRP) between arterial 
and jugular venous bulb blood.
Methods An observational study. Between 1 January and 31 October 
2013 we included neurocritical patients (NCP) with multimodal 
neuromonitoring (MMN). Daily samples of arterial blood and venous 
jugular bulb blood were obtained for measuring pCO2, lactate, serum 
sodium and CRP.
Results There were 45 NCP, six (13%) with MMN (fi ve men). Mean age 
was 37 ± 11 years (35 to 61). Diagnostics: two TBI, two SAH, one stroke, 
one lupus encephalitis. APACHE II was 27  ±  6.5 (25 to 39). Glasgow 
Coma Scale at admission was 14 ± 4 (4 to 14). pCO2 (mmHg): arterial 
41  ±  6.3 versus jugular 45  ±  7.4 (r  = 0.7, P  = 0.007). Lactate (mg/dl): 
arterial 11 ± 5.6 versus jugular 13.5 ± 3.9 (r = 0.7, P = 0.9). Sodium (mEq/dl): 
Figure 1 (abstract P460).
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arterial 141 ± 4.5 versus 141 ± 4.4 (r = 0.8, P = 0.15). CRP (mg/dl): arterial 
8 ± 7.4 versus 17 ± 11.6 (r = 0.9, P <0.001). The correlation and trend 
curves are shown in Figure 1.
Conclusion A suitable correlation is observed for the arterial–jugular 
bulb in diff erent variables. There is a signifi cant diff erence in CRP and 
pCO2 values being persistently higher in the jugular, particularly for 
CRP. Studies are required to defi ne its interpretation and potential 
usefulness.
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Introduction After a subarachnoid hemorrhage (SAH), delayed 
cerebral ischemia (DCI) remains the principal cause of morbid 
mortality. F2-isoprotanes are recognized as biomarkers of DCI. These 
lipid metabolites, by fi xing the thromboxane and prostaglandin 
(TP) receptor, induce vasoconstriction and platelet aggregation. Our 
objective was to evaluate the effi  cacy of terutroban (TER), a TP receptor-
specifi c antagonist, in preventing DCI after SAH.
Methods Twenty rats were assigned to one of three groups: a double 
250  μl intracisternal injection (ICI) was realized with saline in the 
CONTROLS group (n = 6) or with autologous arterial blood in the SAH 
(n = 8) and SAH+TER (n = 6) groups. Treated animals received an oral 
administration of 30  mg/kg/day TER during 5  days following blood 
injection. Rats were evaluated using a functional isotope imaging 
technique (high-resolution microSPECT). Brain capture of three 99m 
technetium radiolabeled tracers was evaluated: HMPAO at day (D) 0, 2 
and 5 for cerebral perfusion quantifi cation, DTPA at D3 for blood–brain 
barrier (BBB) integrity study and annexin V-128 at D4 for apoptotic 
activity study. Radioactivity was measured in a predefi ned region of 
interest: cerebrum, cerebellum and brainstem. Statistical analysis: one-
way ANOVA followed by Student’s t test.
Results Brain HMPAO perfusion microSPECT (Figure  1) reveals a 
transient hypoperfusion after ICI (D2) and a lasting hypoperfusion in 
the SAH group. TER curtailed the SAH-induced decrease of the HMPAO 
uptake. TER also signifi cantly counteracted the SAH-induced increase 
of DTPA in the brainstem (SAH 2.6 ± 0.7 vs. SAH+TER 1.3 ± 0.1 ppm/
mm3; P  <0.05) and increase of annexin V-128 in the cerebrum (SAH 
1.2 ± 0.1 vs. SAH+TER 1 ± 0.06 ppm/mm3; P <0.05).
Conclusion We made the fi rst microSPECT scan description of a DCI 
rat model. After induction of SAH, TER improves cerebral perfusion, 
prevents BBB disruption in the brainstem and decreases apoptotic 
phenomenon in the cerebrum.
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predicting clinical vasospasm and delayed cerebral ischemia in 
patients with subarachnoid hemorrhage
F Di Corte, S Piff eri, L Capuano, S Magnoni, V Conte, F Ortolano, N Stocchetti
Fondazione IRCCS Cà Granda – Ospedale Maggiore Policlinico, Milan, Italy
Critical Care 2014, 18(Suppl 1):P462 (doi: 10.1186/cc13652)
Introduction Cerebral vasospasm (VSP) and delayed cerebral ischemia 
(DCI) play a central role in worsening the neurological outcome 
in patients with aneurismal subarachnoid hemorrhage (aSAH) [1]. 
Transcranial color-coded duplex sonography (TCCS) is a non-invasive 
tool to detect VSP and predict DCI, but its clinical utility is limited by 
low accuracy. Our aim was to perform a sensitivity/specifi city analysis 
of TCCS in predicting clinical VSP and DCI.
Methods Consecutive patients admitted to our ICU for aSAH were 
enrolled in the study. CBF-Vm and the pulsatility index (PI) were 
obtained by TCCS in both mean cerebral arteries (MCAs) at two 
scheduled time points, <3  days (T1) and 7 to 10  days (T10), and at 
least once every other day after bleeding. The highest Vm between 
left and right and the corresponding PI were chosen for analysis. All 
patients underwent brain MRI plus TOF-MRI angiography at T1 and 
T10 to assess radiologic VSP. Symptomatic VSP was defi ned as a new 
neurologic defi cit associated with radiological VSP. The occurrence of 
DCI was evaluated on DWI sequences. The C statistic (ROC curves) and 
nonparametric t test were used for analysis.
Results Forty-three consecutive patients were recruited. Thirty-seven 
patients had simultaneous TCCS measures and MRI (mean age 58 years, 
28% WFNS 4 to 5). Eleven patients (30%) developed symptomatic VSP 
and 26 (70%) did not (NVSP). Vm increased signifi cantly from T1 to T10 
in both groups (VS: P = 0.03, NVSP P = 0.01). The accuracy of TCCS at T10 
(Vm) for predicting vasospasm was described by an AUC of 0.86 (CI = 
0.74 to 0.98) and a cutoff  value >115 cm/seconds (90% sensitivity, 73% 
specifi city). Interestingly, a cutoff  value >168 cm/second corresponded 
to the best specifi city (92% specifi city), but low sensitivity (45%). The 
accuracy of PI for predicting VSP was lower (AUC 0.75). The accuracy of 
TCCS for predicting DCI was also poor (AUC 0.57). Considering larger 
DCI only (volume >2 ml), the accuracy was slightly increased (AUC 0.75).
Conclusion TCCS is useful to predict clinical VSP with good accuracy. 
The Vm cutoff  value >115 cm/second might be considered as a warning 
threshold, while higher values (>168 cm/second) identify high-risk 
patients. The accuracy of TCCS in predicting DCI is low, which indicates 
that mechanisms other than VSP are likely to play a role.
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Introduction The aim was to evaluate the prognostic importance of 
the MRI examination using Block Design fMRI in patients in a vegetative 
state (VS).
Methods Twenty-two patients corresponding to the international 
standards of VS underwent high-resolution MRI (T2 and T1, isomatrix 
with slice thickness 1.00 mm, T2 FLAIR FS, DWI, SWI) examination and 
Block Design fMRI (paradigm of passive speech). The patients were 
aged from 4 to 42  years. Causes of VS: TBI in 19 patients, hypoxia in 
three patients. By the time of the examination the patients were in VS 
from 1 to 4 months.
Figure 1 (abstract P461). HMPAO uptake at day 2 and day 5. *P <0.01 
versus day 0; #P <0.01 versus day 2; ‡P <0.01.
Critical Care 2014, Volume 18 Suppl 1 
http://ccforum.com/supplements/18/S1
S166
Results Wernicke’s area activation was observed in nine patients 
(eight patients with TBI, one with hypoxia). During the subsequent 
examination, which lasted from 3 to 12  months, seven patients with 
activated Wernicke’s area showed further consciousness expansion up 
to the minimal consciousness state (further consciousness expansion 
was seen in two patients). Two other patients with activated Wernicke’s 
area did not show any signs of consciousness. Two patients revealed 
signifi cant activity in the Broca’s area.
Conclusion According to the fi rst results of the study one can conclude 
that behind the outwardly similar clinical symptoms in patients in VS 
lies a diverse (due to the organization of brain functions) group of 
patients. fMRI enables one to reveal the fi rst signs of cognitive activity; 
that is, reveals the linguistic value of speech addressed to the patient 
which cannot be detected during routine neurological examination.
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Introduction A patient is declared brain dead (BD) when physicians 
determine permanent loss of brain functions. Unfortunately, criteria for 
defi ning BD vary across diff erent countries [1]. We therefore decide to 
survey BD diagnostic modalities in Europe in order to describe diff erences.
Methods A multiple-choice questionnaire was developed on an online 
platform [2]. Direct link was sent to national representatives of the 
European Society of Intensive Care Medicine and NeuroIntensive Care 
section’s members. Thirty-three countries were contacted. Answers were 
reviewed. In cases of discrepancies or missing data, participants were 
contacted for further clarifi cation. Descriptive statistics have been applied.
Results Twenty-eight participants returned the questionnaire (85%). 
Every country has either specifi c law (93%) or guidelines issued by the 
scientifi c society (89%). Clinical examination, essential to the diagnosis, 
is the only requirement in 50% of countries. Coma, apnea, absence 
of corneal and cough refl exes are always necessary. Blood pressure 
and electrolytes are checked in 64% as mandatory prerequisites. The 
apnea test is legally defi ned in 86% of countries. Eighty-two percent 
of countries require achievement of a target paCO2 level while the 
Netherlands’ law states target apnea duration. Number of physicians 
(median 2, range 1 to 4), number of clinical examinations (median 2, 
1 to 3), and minimum observation time (median 3 hours, 0 to 12) are 
variable requisites in diff erent countries. In 50% of nations, additional 
tests are required. Hypothermia (4%), anoxic injury (7%), inability 
to complete clinical examination (61%), toxic drug levels (57%), 
and inconclusive apnea test (54%) are legal indications to perform 
additional tests. Cerebral blood fl ow investigation is mandatory in 18% 
of countries, while it is either optional or used only in selected cases 
in 82%. Conventional angiography is still the preferred method (50%), 
followed by transcranial Doppler (43%), angioCT (39%), CT perfusion 
and angioMR (11%). EEG is always (21%) or optionally (14%) recorded. 
Russia and Croatia evaluate both EEG and cerebral blood fl ow (7%).
Conclusion There are still areas of uncertainty and disparities in 
brain death diagnosis in European countries. This predisposes to 
misdiagnosis and confusion both for clinicians and families. Measures 
to promote uniformity of brain death procedures and clinical practice 
are therefore desirable.
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Introduction After a patient is declared brain dead, the cessation or 
withdrawal of therapy in Japan is quite a diffi  cult operation because 
of the legal issues involved. Therapy is continued except in the case of 
donation of organs for transplantation from brain-dead patients until 
their cardiac arrest. Consequently, we may determine what the fi nal 
cause of death is in brain-dead patients. Our hypothesis is that brain-
dead patients ultimately die of cardiac failure.
Methods From January 2011 to December 2012, brain-dead 
adult patients in our ICU were investigated. The declaration of 
brain death is determined by clinical neurological examinations, 
electroencephalography, and the auditory brain-stem response test. 
Age, sex, primary diagnosis, Glasgow Coma Scale (GCS) on admission, 
the number of days from the diagnosis of brain death until cardiac 
arrest (days), the fi nal cause of cardiac arrest, urine volume for the 
last 24 hours (ml), serum potassium levels (mEq/l), PaO2 (mmHg) and 
PaCO2 (mmHg) on the last day were evaluated. Values are expressed 
as mean ± SD. Data were analyzed by Kruskal–Wallis test and Mann–
Whitney U test. P <0.05 was considered statistically signifi cant.
Results Of a total 1,221 patients admitted to our ICU, 37 patients (18 
men, 19 women, age 65  ±  20) were clinically diagnosed with brain 
death. Primary diagnoses were 18 post-cardiac arrest syndromes, 
14 cerebrovascular diseases, and four traumatic subarachnoid 
hemorrhages. GCS on admission was 4.5  ±  2.7 and days to cardiac 
arrest after diagnosed brain death was 8.6 ± 13.2. Urine volume for the 
last 24 hours was 997 ± 1,712 and serum potassium level was 4.8 ± 1.7. 
PaO2 and PaCO2 were 131.9  ±  80.6 and 48.9  ±  13.8, respectively. The 
fi nal causes of cardiac arrest were 20 cardiac failures, 11 renal failures 
and six respiratory failures, although with mechanical ventilator 
support. The fi nal cause of cardiac arrest due to respiratory failure had 
signifi cantly longer stay in the ICU and days after diagnosis of brain 
death than cardiac failure or renal failure (27.2 ± 22.6 days vs. 9.2 ± 10.0 
and 8.1 ± 4.6, P <0.05; 23.2 ± 24.0 vs. 6.0 ± 9.0 and 5.4 ± 5.2, P <0.05, 
respectively).
Conclusion There were signifi cantly longer days until fi nal cardiac arrest 
that was caused by respiratory failure than by cardiac failure or renal 
failure. Many diff erent observations in each case were shown, such as 
urine volume or potassium level on the last day. Not only cardiac failure 
but also other failures might lead to fi nal cardiac arrest.
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Introduction ICU-acquired weakness is a frequent complication of 
critical illness. It is unclear whether it is a marker or mediator of poor 
outcomes. We aimed to determine acute and long-term outcomes and 
costs of ICU-acquired weakness among long-stay (≥8 days) ICU patients 
and to assess the impact of recovery of weakness at ICU discharge.
Methods Data were prospectively collected during an RCT (Clinical 
trials.gov: NCT00512122) [1,2]. Impact of weakness (MRC sum <48) on 
outcomes and costs was analyzed with 1:1 propensity score-matching 
for baseline characteristics, illness severity and risk factor exposure 
prior to assessment. Among weak patients, impact of persisting 
weakness at ICU discharge on risk of death after 1 year was examined 
with multivariable Cox proportional-hazard analysis.
Results A total 227 of the 405 (56%) long-stay assessable ICU patients 
were weak; 122 weak patients were matched to 122 not-weak patients. 
As compared with matched not-weak patients, weak patients had 
a lower likelihood at any time for live weaning from mechanical 
ventilation (HR: 0.709 (0.548 to 0.918), P  = 0.009), live ICU (HR: 0.738 
(0.570 to 0.955), P = 0.021) and hospital discharge (HR: 0.682 (0.521 to 
0.893), P = 0.005). In-hospital costs/patient (+30.5%, €+5,443/patient, 
P = 0.04) and 1-year mortality (30.6% vs. 17.2%, P = 0.015) were also 
higher. The 105/227 (46%) weak patients not matchable to not-weak 
patients had even worse prognosis and higher costs. At any time 
within the fi rst year following ICU admission, compared with patients 
who recovered from weakness and adjusted for potential confounders, 
those with persistent weakness and MRC sum between 36 and 47 at 
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ICU discharge had a higher likelihood of death (HR: 1.937, 95% CI: 1.048 
to 3.581, P = 0.035). This likelihood of late death was even higher for 
those patients with a more severe degree of persistent weakness (MRC 
sum <36) (HR: 1.815, 95% CI: 3.693 to 7.514, P <0.001).
Conclusion Patients with ICU-acquired weakness had worse acute 
morbidity outcomes, consumed more resources and revealed higher 
mortality after 1 year than patients without weakness. Persistence of 
weakness at ICU discharge further increased late mortality.
Acknowledgement GH and HVM contributed equally to this study.
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Introduction An early diagnosis of ICU-acquired weakness (ICU-AW) 
is diffi  cult because disorders of consciousness preclude strength 
assessment [1]. Electrophysiological (EMG) studies may be an 
alternative approach [2]. In this study we investigated feasibility and 
diagnostic accuracy of EMG studies to diagnose ICU-AW in unconscious 
patients.
Methods Newly admitted unconscious ICU patients (RASS <–3), 
ventilated for ≥2 days, were included in this single-center prospective 
cohort study. EMG testing included ulnar (motor/sensory), peroneal 
(motor) and sural (sensory) studies. Myography was performed 
when coagulation was normal (dorsal interossei I/II, deltoid and 
tibial muscles). Reliability of results was checked by an experienced 
neurophysiologist, blinded for strength. Motor/sensory studies were 
abnormal if amplitudes were below the 2.5th percentile reference 
values [3]. Myography was abnormal if spontaneous abnormal activity 
was found in ≥1 muscles. Upon awakening, strength was assessed (ICU-
AW: average MRC <4 [1]), blinded for EMG. Feasibility was determined 
as the percentage of measurements that could be performed and 
were reliable. Diagnostic accuracy was analyzed using sensitivity and 
specifi city.
Results We included 35 patients (ICU-AW: 17). EMG testing was done 
on day 4 (IQR: 3 to 6). Feasibility was 94%, 89%, 77%, 34% and 31% 
for ulnar motor, peroneal motor, ulnar sensory, sural sensory and 
myography studies, respectively. Figure  1 displays amplitude values. 
Sensitivity/specifi city was 100%/0%, 100%/31%, 31%/100%, 50%/25% 
and 67%/38%, respectively.
Conclusion Feasibility of ulnar and peroneal studies was acceptable; 
feasibility of sural and myography studies was low. Diagnostic accuracy 
was low for all studies. This may be improved with new reference values.
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Introduction Cerebral near-infrared spectroscopy (NIRS) represents 
an exciting prospect for the non-invasive monitoring of cerebral 
tissue oxygenation in traumatic brain injury (TBI). Earlier attempts at 
clinical application of cerebral NIRS demonstrated that further work 
was needed [1]. The basic layout of the probe portion of these devices 
consists of a light source and a light detector, arranged at calculated 
distances and confi gurations in order to observe target tissue. We aim 
to determine which commercially available NIRS probe represents the 
most sensitive layout of sources/detectors for the greatest sensitivity in 
observing tissue oxygenation at the optimal depth for TBI.
Methods The optimal depth for grey matter target tissue (grey–white 
matter junction) was ascertained by reviewing a series of brain CT 
scans of patients who had sustained a TBI. Set (average) measurements 
were derived from these identifying the target depth of the grey 
matter strip from the point of probe placement. Currently there are 
fi ve commercially available cerebral NIRS systems. Table 1 presents the 
variety of confi gurations off ered by each device. Source detector layouts 
were modelled and simulated using the NIRFAST® computational light 
modelling software (developed at the University of Birmingham) [2]. 
The novel approach of this modelling system makes no extrapolated 
assumptions based on subtraction.
Figure 1 (abstract P467). Dotted lines represent 2.5th percentile 
reference values [3].
Figure 1 (abstract P468). Light scatter predictions of available systems/
probes illustrated.
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Results We reviewed 32 trauma series CT brain images and the 
average depth to grey matter was derived as 21.37 mm (range 16.59 
to 31.03  mm, SD 2.33) from the surface (Figure  1). The spectrum of 
sensitivity of the fi ve probes was modelled (Figure 2). As is apparent 
here, the FORE-SIGHT (CAS Medical, CT, USA) probe currently off ers the 
greatest sensitivity at our derived target depth.
Conclusion Based on the computational modelling of our work, 
the FORE-SIGHT NIRS device by CAS Medical source detector layout 
provides the greatest sensitivity at depth for the purposes of cortical 
monitoring in trauma. Variations in the layout have a signifi cant impact 
on the quality of signal detected.
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Introduction Traumatic axonal injury (TAI) is a major contributor to 
adverse outcomes following traumatic brain injury (TBI). Diff usion 
tensor imaging (DTI) is a magnetic resonance imaging technique, 
which provides a robust measure of white matter integrity in patients 
with TBI. Certain brain regions have been identifi ed as particularly 
susceptible to TAI by means of DTI. Few studies, however, have focused 
on describing the distribution of DTI abnormalities in individual TBI 
patients. The aim of this project was to conduct an exploratory analysis 
of the extent and distribution of axonal injury in TBI patients at a single-
subject level.
Methods Patients admitted to the ICU for severe TBI underwent brain 
MRI and DTI (32 directions, b = 1,000, voxel size 2 × 2 × 2 mm3) between 
2  weeks and 3  years after injury. For each individual patient, we 
enrolled fi ve age-and-sex-matched healthy volunteers who underwent 
the same DTI protocol and were used as controls (31 total). We used a 
region of interest (ROI) automated analysis [1] to quantify white matter 
integrity. The fractional anisotropy (FA) maps were segmented using a 
white matter parcellation map covering the entire brain. Our primary 
outcome was the normalized diff erence in FA between each patient 
and the controls. Abnormalities were defi ned as values that were more 
than 2 SD below the mean of the values for the matched controls for 
each ROI.
Results Twelve TBI patients with a median age of 30 years (range 20 to 
38) and a median GCS of 5 (range 5 to 7) were included. The majority of 
them had diff use axonal injury according to CT and conventional MRI. 
Analysis of individual ROIs revealed that all subjects had numerous 
abnormal ROIs, varying from 14 to 64 (median 21) out of 78 regions 
assessed. The most frequently altered regions were the frontal lobe, 
orbital–frontal regions, corpus callosum, internal capsules, superior 
and inferior longitudinal fasciculi, cingulum, cerebellar structures and 
corona radiata. Thalamus, hippocampus and occipital lobes were less 
frequently aff ected.
Conclusion The extent and distribution of TAI varies on a patient 
basis. These fi ndings highlight the need for standardized methods to 
precisely assess TAI in single subjects. Such single-subject methods will 
probably improve prognostic accuracy and may be useful in clinical 
trials.
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Introduction Traumatic brain injury is a major public health issue, 
which results in signifi cant mortality and long-term disability [1,2]. The 
Table 1 (abstract P468). Available source detector layouts
Probe  Wavelengths (nm)  Sources  Detectors  Spacing (mm) Peak depth sensitivity
Optiplex TX (ISS, IL, USA) 690, 830  4 1 30, 35, 40, 45 8
INVOS (Covidien, MA, USA) 730, 810 1 2 30, 40 8
EQUANOX (Nonin, MN, USA) 730, 810, 880  2 2 20, 40 7
FORE-SIGHT (CAS Medical, CT, USA) 690, 780, 805, 850  1 2 20, 50  10
NIRO-200NX (Hamamatasu, Japan) 735, 810, 850 1 2 19.2, 20  9
Figure 2 (abstract P468). CT measurements and sensitivities at depth.
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profound impact of TBI is not only felt by the individuals who suff er 
the injury but also their caregivers and society as a whole. In this study 
we observed the long-term outcome of patients with severe traumatic 
brain injury admitted to our intensive care.
Methods This study includes all patients (n  = 160) with severe head 
trauma (GCS <9) admitted to the ICU of the emergency department 
of a tertiary referral center (Careggi Teaching Hospital, Florence, Italy) 
from 2009 to 2012. All patients will undergo a clinical assessment 
after 1 year, which is routine post-intensive follow-up. As an objective 
index of ability to function after injury, the Glasgow Outcome Scale 
(GOS) will be used. The neurological evaluation to determine the 
outcome of patients by GOS is performed in two diff erent modes. All 
eligible patients 1 year after discharge from the ICU are contacted by 
telephone by a nurse of the intensive care staff  and invited to make a 
visit to the surgery follow-up, where a intensivist evaluates the patient 
and determines the GOS. For the patients who were still hospitalized at 
6 months in rehabilitation departments, GOS assessment is performed 
by a doctor of the structure and notifi ed by telephone.
Results The ICU and hospital mortality was respectively 33.7% (n  = 
54) and 36.9% (n = 59). The mortality at 1 year was 44.4% (n = 71). The 
results of the neurological follow-up at 1 year were: GOS 2: 5.6% (n = 9), 
GOS 3: 10% (n = 16), GOS 4: 13.1% (n = 21), GOS 5: 26.9% (n = 43).
Conclusion According to the other studies, our data confi rm that the 
severe traumatic brain injury is associated with a high mortality at 1 
year. One-half of the survivors have a diff erent level of disability.
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Introduction Recent studies have shown that 1,25-dihydroxyvitamin 
D3 (vitamin D) defi ciency may aff ect negatively the clinical course of 
traumatic brain injury (TBI) [1]. This problem becomes important with 
respect to the older patient considering a 50% prevalence of vitamin 
D defi ciency [2]. Data from the Third National Health and Nutrition 
Examination Survey [3] document more than 60% of Caucasians 
aff ected by D defi ciency [4] so that all patients with TBI of any age are 
theoretically at risk of unfavorable outcome [2]. The objective of this 
preliminary study was to determine whether low levels of vitamin D at 
admission to the ICU (<24 hours) could negatively aff ect neurological 
recovery of patients with TBI.
Methods We retrospectively analyzed the data of 46 patients aff ected 
by TBI (65% severe, 9.5% moderate, 28.5% moderate) both isolated or 
associated with other extracranial lesions. The sampling of vitamin D 
was carried out within 24 hours from ICU admission. We had registered 
GCS at the moment of presentation (GCS in) and at discharge (GCS 
out) and their diff erence (GCS diff ) compared with levels of vitamin D. 
Patients that died in the ICU were assigned a GCS out = 0. See Table 1.
Results Our data, according to other studies [5], confi rm the presence of 
a defi ciency of vitamin D (Table 1); however, they do not demonstrate a 
statistical signifi cance correlation at the univariate regression (R = 0.04; 
P = 0.786) between vitamin D level and outcome from the ICU. There 
was no correlation stratifying patients for age, for TBI class, for Injury 
Severity Score and for BMI.
Conclusion Vitamin D defi ciency is really prevalent in our TBI cases 
but does not seem to aff ect neurological recovery at ICU discharge; 
however, these preliminary results should be exposed to several 
criticisms and need to be confi rmed with prospective studies.
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Introduction Severe traumatic brain injury (TBI) is a major cause 
of death in people between 19 and 45  years old. Gastrointestinal 
dysfunction is the most common complication due to mucosal 
ischemia, motility disorders, and disruption of the gut barrier, with 
severe consequences: malnutrition, weight loss, and high risk of 
infections [1]. Therefore, maintaining the intestinal barrier function is 
a systematic engineering project. Selected new probiotics due to the 
capacity to bind and neutralize toxins, and to interfere with pathogen 
adherence, by immunomodulatory properties, mopping up the 
infection, could improve recovery of critically ill patients [2]. Our aim 
was to assess the eff ects of a new probiotic in an early enteral regimen 
on clinical outcome of severe TBI patients, in terms of VAP incidence, 
tolerance to enteral nutrition, duration of mechanical ventilation, and 
mortality rate.
Methods A prospective randomized 1-year study of 64 patients 19 
to 78 years old allocated to receive for 10 days either an early enteral 
diet plus a new probiotic (Bioent; Lactobacillus bulgaricus 10 trillion 
CFU/cp + activated charcoal) every 6  hours (Group A) or the same 
formula without probiotics (Group B). The diets were isocaloric and 
isonitrogenous, and there were no diff erences between groups in 
gender, age, and nutritional status. We assessed the VAP incidence, 
duration of mechanical ventilation, tolerance to enteral nutrition, 
length of ICU stay, duration of diarrhea episodes, and mortality rate. 
The ANOVA test and t test were carried out; P  <0.05 was considered 
signifi cant.
Results The infection rate was higher in group B, the duration of 
mechanical ventilation was shorter in group A, and the patients in 
group A received 91.7% of total caloric needs by an enteral route versus 
74.68% in group B. There is a signifi cant diff erence in the number of 
diarrhea episodes, and the ICU length of stay was signifi cantly lower 
in group A; there was no signifi cant diff erence in the mortality rate 
between groups. See Figure 1.
Conclusion Early administration of new probiotics to severe TBI patients 
could have benefi cial eff ects in terms of reduction of GI dysfunction, 
VAP incidence and length of ICU stay.
Table 1 (P471)
 TBI
Descriptive statistics  Isolated Associated P value
Dead 8.70% Percentage 22 78
Male 87% GCS in 4 ± 3 8 ± 5 0.043
Age 50 ± 21 GCS out 10 ± 4 10 ± 5 0.933
BMI 26.36 ± 4.14 GCS diff  6 ± 4 3 ± 6 0.151
ISS 29 ± 15 Vitamin D (ng/ml) 17 ± 8.5 17 ± 9.8 0.597
Vitamin D  73.90% Length of 12 ± 7 8 ± 9 0.261
defi ciency   stay ICU (days)
(<30 ng/ml)
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Introduction We investigated whether blood alcohol levels (BAL) had 
any impact on presentation and outcome in patients with traumatic 
brain injury (TBI).
Methods Forty-six patients with TBI requiring intubation between 
January 2000 and December 2012 were included. Patients were 
grouped into BAL-positive (>0.5‰; n = 24) and BAL-negative (<0.5‰; 
n  = 22). Physiological parameters and outcome (survival to hospital 
discharge (STHD)) and neurological outcomes (Glasgow Outcome 
Scale (GOS), Cerebral Performance Category (CPC) and Glasgow Coma 
Scale (GCS)) were analyzed. Diff erences between groups were analyzed 
using Student’s t test and results presented as mean ± SD.
Results There were no signifi cant diff erences in gender and age 
distributions between the BAL-negative and BAL-positive groups (73% 
vs. 88% male; P = 0.218; 53 ± 21 vs. 43 ± 17 years; P = 0.098). There were 
also no diff erences in initial systolic blood pressure (BP; 144  ±  30 vs. 
132 ± 37 mmHg; P = 0.241) and respiratory rate (RR; 13 ± 6 vs. 12 ± 7/
minute; P = 0.891) but BAL did aff ect the initial GCS score (7 ± 3 vs. 5 ± 2; 
P = 0.022). There was no eff ect on CPC (3.5 ± 1.9 vs. 2.8 ± 1.8; P = 0.185), 
GOS (2.4 ± 1.8 vs. 3.0 ± 1.7; P = 0.270), and GCS at discharge from the 
hospital (14 ± 2 vs. 14 ± 2; P = 0.801). There were also no diff erences in 
length of hospital stay (LOHS; 15 ± 23 vs. 23 ± 34; P = 0.372) and STHD 
(1.6 ± 0.5 vs. 1.3 ± 0.5; P = 0.083).
Conclusion BAL did not have a signifi cant eff ect on presenting 
physiological parameters such as systolic BP and RR. It did, however, 
aff ect the presenting GCS score, which was signifi cantly lower in the 
BAL-positive group. BAL did not seem to have an eff ect on functional 
outcome or mortality measured by STHD. No favorable neuroprotective 
or deleterious eff ect was observed, demonstrated by no signifi cant 
diff erences in CPC, GOS or GCS scores at discharge.
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Introduction The International Mission for Prognosis and Analysis of 
Clinical Trials (IMPACT) is currently the most robust prognostic model 
in patients with traumatic brain injury (TBI). No studies have compared 
this TBI-specifi c prediction model with general ICU models, such as the 
Acute Physiology and Chronic Health Evaluation II (APACHE II) [1,2]. This 
study investigates the performance and the correlation of the IMPACT 
and APACHE II models for long-term outcome prediction in patients 
with TBI.
Methods The study population consisted of TBI patients admitted to 
a designated ICU in southern Finland during a 4-year period (2009 
to 2012). The IMPACT and APACHE II performances were assessed by 
calculating discrimination (by area under the curve), calibration (by 
GiViTI calibration test and Hosmer–Lemeshow C statistic) and precision 
(by Brier score). Correlation between the IMPACT and APACHE II was 
tested by Spearman’s rho. Primary outcome was 6-month mortality.
Results Of the total 897 included patients, overall 6-month mortality 
was 22%. The IMPACT and APACHE II showed similar AUCs (0.81, 95% 
CI = 0.77 to 0.84; 0.80, 95% = CI 0.76 to 0.83) and Brier scores (0.134, 
0.135). Calibration tests revealed signifi cant (P  <0.05) deviations 
between observed and predicted risk for both models. A moderately 
strong, positive correlation between the IMPACT and the APACHE II 
Figure 1 (abstract P472).
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was noted (Spearman’s rho  = 0.566, P  <0.001). The IMPACT and the 
APACHE II were found to identify slightly diff erent groups of patients 
that eventually do not survive (Figure 1).
Conclusion The IMPACT and the APACHE II models showed equal 
performance for 6-month mortality prediction. A moderately strong, 
positive correlation, with some major discrepancies between the 
models, was found. Thus, features of both the IMPACT and APACHE II 
models are valuable for optimal outcome prediction in patients with 
TBI treated in the ICU.
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Introduction The Confusion Assessment Method for the ICU (CAM-
ICU) and the Intensive Care Delirium Screening Checklist (ICDSC) are 
recommended for routine delirium screening. However, literature 
about delirium assessment in traumatic brain injury (TBI) remains 
scarce. The aim of our study was to evaluate the validity and reliability 
of the CAM-ICU and the ICDSC for delirium assessment in patients with 
mild to moderate TBI.
Methods A prospective observational study of mild to moderate TBI 
adult patients in two critical care trauma centers. Patients underwent 
delirium assessment on days 3, 5 and 7 with the CAM-ICU and the 
ICDSC. Psychiatrists or neurointensivists evaluated delirium using the 
DSM-IV criteria for delirium. Assessments results were blinded and 
performed independently. Criterion validity of the CAM-ICU and the 
ICDSC were calculated from 2  × 2 frequency tables using standard 
defi nitions of sensitivity, specifi city, positive and negative predictive 
value, and overall accuracy. Because delirium was assessed repeatedly, 
estimates of 95% CIs for binary repeated data using generalized 
estimating equation in conjunction with the Huber–White estimator 
were performed. Inter-rater reliability for the CAM-ICU and ICDSC was 
assessed with the kappa coeffi  cient.
Results During an 8-month period, 61 patients (mean age 
56.4 ± 18.5 years, mean APACHE II score 11.4 ± 6.5, mean GCS 13 ± 2) 
were enrolled. The overall sensitivity and specifi city for CAM-ICU (62% 
and 74%, respectively) and ICDSC (64% and 79%, respectively) were 
similar. The overall kappa for inter-rater reliability for the CAM-ICU and 
ICDSC was 0.64 and 0.68, respectively. In subgroup analyses, the CAM-
ICU and ICDSC showed increased sensitivity and decreased specifi city 
in moderate TBI as well as deeper levels of sedation (RASS –2 to –3).
Conclusion Criterion validity and inter-rater reliability of the CAM-ICU 
and ICDSC were good. Severity of TBI and depth of sedation infl uence 
delirium assessments. Clinicians should be aware of those limitations 
before using these clinical tools in this population.
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Introduction The aim was to study the functional status at 1 year and 
after 3 years in ICU patients with traumatic brain injury (TBI).
Methods A prospective cohort study of patients with TBI admitted to 
Carlos Haya Hospital, Malaga, between 2004 and 2008.
Results We studied 531 patients, age 40.35  ±  19.75 years, APACHE II 
17.94  ±  6.97, GCS admission 7.53  ±  3.83 points. Cranial tomography 
at admission was: diff use injury type I (10.4%), diff use injury type 
II (28.1%), diff use injury type III (24.5%), diff use injury type IV (8.3%), 
evacuated mass lesion (22.6%), non-evacuated mass lesion (6.2%). 
Hospital mortality was 28.6%. One-year mortality was 171 (32.2%) 
(missing: 6.6%). After 3 years, mortality was 181(34.1%) (16.2% missing). 
We followed 496 patients for 1 year after admission (35 were missing) 
and assessed their functional status using the GOS. Thus, 22.7% were 
normal and 20% presented some limitations but were self-suffi  cient, 
representing 55.6% of those who survived hospital admission. A 
total of 57.3% presented bad evolution (died: 34.5%, vegetative: 3%, 
disabled not self-suffi  cient: 19.8%). After 3  years we followed 445 
patients and 86 (16.2%) were missing. Thus, 132 patients (29.7% of 445 
patients) were normal and 15.3% presented some limitations but were 
self-suffi  cient, representing 75.76% of those who survived hospital 
admission. Fifty-six percent of 445 patients presented bad evolution 
(died: 40.7%, vegetative: 2.2%, disabled not self-suffi  cient: 12.1%). Of 
445 patients studied after 3 years of admission 171 died, and of the 274 
who survived 198 (72.2%) were in a similar functional situation after 
1 year, 11 (4.01%) had worsened functional situation, of which 10 had 
died, and 65 (27.72%) had improved situation (P <0.001).
Conclusion This study shows that approximately 75% of the patients 
who survived after 3 years from admission to the ICU with traumatic 
brain injury presented good recovery with functional situation normal 
or with some limitations but self-suffi  cient. Between 1 and 3 years after 
admission, approximately 25% of patients improved their functional 
situation.
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Introduction Trauma is the fi fth principal cause of death in Singapore, 
with traumatic brain injury (TBI) being the leading specifi c subordinate 
cause [1].
Methods This 8-year retrospective review of patients with severe 
TBI admitted to the neuroICU (NICU) of the National Neuroscience 
Institute, Tan Tock Seng Hospital between 2004 and 2011 reports the 
Figure 1 (abstract P474). Area under the curve for the new models.
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demographic profi les of severe TBI in the local context, with implications 
in the management of severe TBI, particularly the utilisation of critical 
care resources.
Results A total of 780 patients were admitted with TBI during the 
study period, of which 365 patients (46.8%) sustained severe TBI. The 
majority (75.3%) of the severe TBI patients were male. There was a 
bimodal preponderance of severe TBI cases in young adults (age 21 
to 40) and older people (age >61). Motor vehicle accidents (48.8%) 
and falls from <2  m (35.1%) were the main mechanisms of injury. 
Invasive monitoring was frequently employed in these patients with 
severe TBI: arterial blood pressure monitoring in 298 patients (81.6%), 
central venous pressure monitoring in 219 patients (60.0%), and 
intracranial pressure monitoring in 173 patients (47.4%). The incidence 
of use of tiered therapy such as sedation, mild hyperventilation, 
osmotherapy with mannitol, cerebrospinal fl uid drainage, barbiturate 
coma and decompressive craniectomy to control ICP converged with 
international practices.
Conclusion Young adults and older people involved mainly in motor 
vehicle accidents and falls respectively were among the high-risk 
groups for severe TBI. Management of these patients goes beyond 
the ICU and involves, but is not limited to, social support, emotional 
motivation and community reintegration of these patients [2]. TBI 
among the high-risk groups is largely preventable. Public awareness 
and prevention programmes will go some way in reducing the 
incidence of TBI amongst the high-risk groups.
References
1. Ministry of Health 2012 Health Facts Singapore [http://www.moh.gov.sg/
content/moh_web/home/statistics/Health_Facts_Singapore/Principal_
Causes_of_Death.html]
2. Chua KS, et al.: A brief review of traumatic brain injury rehabilitation. Ann 
Acad Med Singapore 2007, 36:31-42.
P478
Outcome measures in randomized controlled trials of patients with 
severe traumatic brain injury: a systematic review
G Lalonde1, M Shemilt1, F Lauzier1, P Desjardins1, A Boutin1, L Moore1, 
D Fergusson2, R Zarychanski3, A Turgeon1
1Laval University, Quebec, Canada; 2OHRI, Ottawa, Canada; 3University of 
Manitoba, Winnipeg, Canada
Critical Care 2014, 18(Suppl 1):P478 (doi: 10.1186/cc13668)
Introduction Traumatic brain injury (TBI) is a major cause of death 
and long-term disability worldwide, and understanding its eff ect on 
health is critical. Although mortality has been a gold standard for years, 
functional scales and quality of life have been used as main outcome 
measures over the last decades due to their usefulness and aid in 
decision-making for medical teams, patients, and families. Despite 
this preference, no consensus exists for the most optimal outcome 
measure. We systematically reviewed outcome measures used in 
randomized controlled trials (RCTs) in patients with severe TBI admitted 
to an acute care hospital.
Methods We searched MEDLINE, EMBASE, Cochrane Central, BIOSIS and 
references of eligible trials. RCTs published over the last 7 years (2006 
to October 2013) in 18 selected journals (based on impact factor) were 
considered for inclusion. RCTs performed in adults with severe TBI (GCS 
≤8) were eligible. The primary endpoint was the outcome measures 
used in RCTs. The secondary outcomes were the timing of assessment 
and the methodological quality of trials using the Cochrane risk of 
bias assessment tool. Two independent reviewers selected trials and 
collected data using a standardized form.
Results From 5,602 citations retrieved after removal of duplicates, 36 
RCTs met eligibility criteria. The outcome measures most frequently 
used were neurophysiologic indices (n = 18, 50%), the Glasgow Outcome 
Scale (n  = 17, 47%), mainly at 6  months, nonspecifi c complications 
(n = 15, 42%), mortality (n = 12, 33%), and biomarkers (n = 10, 28%). 
Nine trials reported only physiologic indices and did not present any 
clinical or functional outcome measures. The methodological quality 
of included RCTs was heterogeneous. We observed a low risk of bias 
for sequence generation (n  = 29, 80%), allocation concealment (n  = 
20, 55%), complete data reporting (n  = 30, 83%), selective reporting 
(n = 36, 100%), and sample size (n = 21, 58%) but a high risk of bias for 
blinding (n = 20, 55%).
Conclusion Outcome measures used to evaluate the eff ect of 
intervention in RCTs performed in patients with severe TBI in acute 
care are heterogeneous. A signifi cant proportion of trials did not 
consider evaluating the functional status or other clinically meaningful 
outcomes, and very few trials assessed outcomes beyond 6 months. 
Thus, a signifi cant proportion of RCTs in patients with severe TBI are 
based on outcome measures not clinically useful to guide or change 
practice in this population.
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Introduction Severity of illness scoring systems is paramount for the 
evaluation of quality of care of critically ill and trauma patients [1-3]. 
The purpose of the present study was to evaluate the usefulness of 
the Acute Physiology and Chronic Health Evaluation II (APACHE II), 
Simplifi ed Acute Physiology Score II (SAPS II) and Sequential Organ 
Failure Assessment (SOFA) scores in predicting long-term outcome of 
patients with moderate-to-severe traumatic brain injury (TBI).
Methods A Finnish multicenter ICU database was screened for TBI 
patients admitted in 2003 to 2012. Logistic regression was used 
for customization of the APACHE II, SAPS II and SOFA for 6-month 
mortality prediction. An adjusted SOFA model, including age, and a 
reference model, including only age and Glasgow Coma Scale, were 
built for comparison. A randomized split-sample technique was used 
for internal validation and prognostic performance was determined by 
assessing discrimination, calibration and precision.
Results A total of 1,625 patients were included. Overall 6-month 
mortality was 33%. The APACHE II and SAPS II-based models showed 
good discrimination (area under the curve (AUC) 0.79, 95% confi dence 
interval (CI) = 0.75 to 0.82; and 0.80, 95% CI = 0.77 to 0.83), calibration 
(P  >0.05) and precision. The SOFA-based model showed poor 
discrimination (AUC 0.68, 95% CI  = 0.64 to 0.72) and precision but 
good calibration (P >0.05). The adjusted SOFA model displayed better 
discrimination (AUC 0.79, 95% CI = 0.76 to 0.82). The reference model 
showed comparable performance with all scoring system-based 
models regarding discrimination (AUC 0.77, 95% CI  = 0.74 to 0.80), 
precision and calibration. See Figures 1 and 2.
Conclusion A simple prognostic model, based only on age and GCS, 
displayed a fairly good prognostic performance in predicting 6-month 
mortality of ICU-treated patients with moderate-to-severe TBI. The 
use of more complex scoring systems added little to the prognostic 
performance.
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Introduction The aim was to study work activities after 3 years in 
patients admitted to the ICU with traumatic brain injury (TBI).
Methods A prospective cohort study in an ICU of a reference hospital. 
We studied ICU-admitted patients consecutively with TBI between 2004 
and 2008. We used validated scales including the Glasgow Outcome 
Scale (GOS) and the Project for the Epidemiological Analysis of Critical 
Care Patients Quality of Life questionnaire.
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Results We studied 531 patients, age 40.35  ±  19.75 years, APACHE II 
17.94 ± 6.97 points, Glasgow Coma Scale at admission 7.53 ± 3.83 points. 
Cranial tomography at admission was: diff use injury type I (10.4%), 
diff use injury type II (28.1%), diff use injury type III (24.5%), diff use 
injury type IV (8.3%), evacuated mass lesion (22.6%), non-evacuated 
mass lesion (6.2%). Hospital mortality was 28.6%, 171 (32.2%) patients 
died after 1  year (6.6% missing) and 181 (34.1%) died after 3  years 
(16.2% missing). Regarding work activities, after 1 year, 28.5% of 326 
patients evaluated have no diffi  culties with work, 4.6% have diffi  culties 
but work as before, 10.1% work only part-time or have changed to a 
job requiring minimum eff ort and 56.7% of patients do not work. After 
3 years, 41.2% of 238 patients evaluated have no diffi  culties with work, 
4.6% have diffi  culties but work as before, 12.6% work only part-time or 
have changed to a job requiring minimum eff ort and 41.6% of patients 
do not work. Evolution between 1 and 3 years by the McNemar test was 
statistically signifi cant (P <0.001). A total of 173 patients were in similar 
situation, only one had deteriorated and in 62 (26.05%) patients the 
evaluation of work activity had improved.
Conclusion After 1 year of admission from the ICU with TBI, more than 
50% of patients have diffi  culties with work. After 3 years the number of 
patients who work has increased although approximately 40% of the 
surviving patients do not work.
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Introduction Antiseizure prophylaxis is recommended for preventing 
only early post-traumatic seizures (PTS) in the guidelines for the 
management of severe traumatic brain injury (TBI) by the Brain Trauma 
Foundation. Phenytoin is recommended to reduce the incidence 
of early PTS prophylaxis. Early enteral nutrition has recently shown 
theoretical advantages for prevention of bacterial translocation to 
maintain normal turnover of gut mucosa and is commonly used for 
TBI patients. Our hypothesis is that the enteral administration of 
antiepileptic agents is also useful for early PTS.
Methods This retrospective observational study included all adult 
patients admitted to our tertiary academic medico-surgical ICU due to 
TBI from September 2011 to August 2012. Patients who have epilepsy 
as a past history were excluded. Clinical data were collected from 
electrical medical archives. The baseline characteristics collected were 
age, gender, diagnosis, antiepileptic agents, timing of start and adverse 
eff ects of those agents, and methods of administration.
Figure 1 (abstract P479). Calibration.
Figure 2 (abstract P479). Discrimination.
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Results Of 65 patients with TBI, 25 patients (18 men, seven women; 
mean age 56.7 ± 20.1) who were administered antiepileptic agents for 
PTS prophylaxis were studied. Fifteen cerebral contusions, 10 acute 
subdural hematomas, nine traumatic subarachnoid hemorrhages, 
two cerebral infarctions, two pneumocephalus and one traumatic 
intracerebral hemorrhage were shown in 25 patients. All patients 
were alive 28 days after the injury. Fourteen patients (56%) were 
intravenously administered (13 phenytoin and one phenobarbital), 
while 11 patients (44%) were administered with enteral feeding 
(four valproates, four carbamazepine and three zonisamides) as PTS 
prophylaxis. The average start day of PTS prophylaxis was 2.6  days 
after the injury by intravenous administration, and 2.2 days by enteral 
administration, respectively. Two patients with phenytoin showed 
hepatic dysfunction as an adverse eff ect and no patient showed early 
PTS both by intravenous and by enteral administrations.
Conclusion The present study has some limitations because it is a 
single-center retrospective analysis. However, enteral administration of 
antiepileptic agents could be useful for PTS prophylaxis. Considering 
cost, adverse eff ects and serum monitoring, there is a possibility of 
enteral administration of antiepileptic agents as an alternative to 
intravenous phenytoin.
P482
Simulation-based education for cardiopulmonary resuscitation and 
airway management protocols: a brief report of a systematic review 
and meta-analysis
A Cortegiani, V Russotto, A Naro, G Sanzo, G Grutta, SM Raineri, 
A Giarratano
University of Palermo, Italy
Critical Care 2014, 18(Suppl 1):P482 (doi: 10.1186/cc13672)
Introduction We aimed to summarize the effi  cacy of simulation-based 
education in cardiopulmonary resuscitation and airway management 
[1].
Methods We searched the MEDLINE, Scopus and EMBASE databases 
for all peer-reviewed articles enrolling physicians/medical students 
in a simulation of either cardiopulmonary resuscitation or airway 
management protocols compared with no intervention or traditional 
teaching methods. We categorized the outcomes of the studies into 
four groups: task success, process skill, time skill, knowledge. Task 
success was defi ned as evaluation of successful completion of the 
task, process skill as evaluation of the procedure, time skill as the 
time required to complete the task, and knowledge as the objective 
assessment of conceptual understanding. When studies investigated 
more than one outcome, we considered the primary outcome, the 
overall measure or the most clinically relevant outcome.
Results From 8,528 articles, we selected 24 studies (13 randomized 
controlled studies, eight pre–post studies, three case–control 
studies) involving 1,149 participants. Compared with no intervention 
or traditional teaching methods, simulation was associated with 
a signifi cant improvement from mild to moderate of all outcomes 
(Figure 1). Log of odds ratio for task success was 2.03 (0.46 to 3.59) in 
favor of simulation. Pooled eff ect size for process skill was 0.48 (0.11 to 
0.84), for time skill was 0.29 (0.13 to 0.73) and for knowledge was 0.41 
(0 to 0.84).
Conclusion Simulation is an eff ective educational method to improve 
performance of physicians/medical students in the application of 
protocols for cardiopulmonary resuscitation and airway management.
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Introduction High quality of chest compressions during cardio-
pulmonary resuscitation (CPR) is a critical determinant of outcome from 
out-of-hospital cardiac arrest (OHCA). Unfortunately, however, victims 
often do not receive adequate chest compression for various reasons, 
particularly during transportation. Recent studies have demonstrated 
the interruption time of chest compression using transthoracic 
impedance analysis, but more information is needed to evaluate the 
performance of CPR provided by ambulance crews and reveal reasons 
for hands off  chest during CPR.
Methods All ambulances of the Hiroshima City Fire Department are 
equipped with a specially designed transmission device (RVT-SD200; 
Sony) that transmits high-resolution visual images and patient vital 
data using video cameras and a bio-monitor. We analyzed video data 
of OHCA patients transported by ambulance from November 2012 
through December 2012, and evaluated the performance of CPR 
during transportation in accordance with the 2010 guidelines. The 
hands-off  time was calculated as the time without chest compressions 
divided by the total CPR time.
Results Thirty-two resuscitation episodes during transportation by 
ambulance were analyzed. Median CPR time per episode was 846 
seconds (range 126 to 1,833 seconds). In total, the fraction of time 
without chest compression was 19.5  ±  7.6% (mean  ±  SD). Reasons 
for interruption and its fraction of time in total hands-off  time were 
as follows: 36% accounted for rhythm analysis/pulse check, 31% for 
ventilation, 11% for setting up automated chest compression devices, 
8% for tracheal intubation/placement of supraglottic airway devices, 
4% for intravenous line placement/administration of adrenaline, 3% for 
rescuer change, and 7% for adjustment of patient position/correction 
of rescuer posture and others.
Conclusion The fraction of time without chest compression observed 
in this study was comparative with those found in other studies in spite 
of the diffi  cult situations, such as during transportation. Most frequent 
reasons for hands-off  time were rhythm analysis and ventilation even 
though the ambulance crews strictly adhered to the guidelines.
Figure 1 (abstract P482).
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Introduction Only a minority of patients suff ering out-of-hospital 
cardiac arrest receive any bystander cardiopulmonary resuscitation 
(CPR). Bystander CPR is associated with improved odds for survival. 
The PulsePoint smartphone application alerts users in the vicinity of 
a cardiac arrest to facilitate immediate citizen bystander resuscitation. 
Addressing implementation barriers may provide an opportunity 
to increase eff ectiveness of the application. PulsePoint is currently 
active in over 400 communities in the United States. Our objective 
was to identify modifi able barriers to optimal implementation of the 
PulsePoint smartphone application.
Methods We conducted a structured survey delivered via Survey 
Monkey optimized for mobile devices. All alerted PulsePoint users 
between 28 June 2012 and 1 November 2013 were sent an invitation 
to participate in the survey. Survey responses associated with test 
activations and emergency medical services (EMS) professionals on 
active duty were excluded from the analysis.
Results Of 4,827 survey requests sent, 995 responded and completed 
our survey (response rate 21%). Respondents identifi ed themselves 
as fi refi ghters (30%), paramedics (19%), EMTs (16%), nurses (4.4%), 
MDs (0.83%) and other professions (50%). Of those who received 
a PulsePoint alert, 23% (157/690) responded by making their way 
towards the location of the emergency. Of those who responded, 70% 
(110/157) arrived on scene. Most of those who did not arrive said they 
saw professional rescuers already on scene and turned back (52%, 
24/47). Of those who arrived on scene, only 34% (37/110) found a 
person unconscious and not breathing normally. The majority found 
a person on scene who was not suff ering cardiac arrest. Of those who 
arrived on scene prior to EMS and also found a cardiac arrest victim 
on scene who required resuscitation, 80% (8/10) performed bystander 
CPR.
Conclusion We observed a very high proportion of bystander CPR 
(80%) for victims of out-of-hospital cardiac arrest when PulsePoint 
users arrived before EMS. This suggests that optimized PulsePoint 
implementation may increase community bystander CPR rates. Alert 
specifi city for cardiac arrest may be too low (the cry wolf scenario) with 
current default activation criteria. Also, the current activation radius 
(0.5 mile) may be too large because EMS frequently arrive before the 
PulsePoint responder.
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Introduction An organized team response and trained nursing staff  in 
the emergency room critical patient area (ER-CPA) are the main factors 
to determine cardiopulmonary resuscitation (CPR) success rates. The 
objective was to evaluate outcomes in the emergency room after 
advanced life support (ALS) by reanimation teams, to improve nursing 
care, quality of resuscitation and survival.
Methods We included all adult patients receiving ALS in the ER-CPA 
during 1 year. Cases not allowed CPR are excluded. A retrospective 
design, multivariate with ALS performed, gender, age, cause of arrest, 
precedence, outcome and hospital derivation, and 100% of cases 
studied.
Results A total of 149 patients were attended in the ER-CPA with 
ALS maneuvers during the studied period (9.23% of a total 1,613). 
Thirty-four of them were nonheart-beating donors. The protocol was 
performed with 23 eff ective donors and 31 organs were obtained for 
transplant. Respiratory arrest (n  = 31) was the best outcome group, 
with 100% survival and in-hospital ICU transfer. The cardiac arrest (CA) 
group depended on cause of CA: cardiac arrhythmia (n = 12), survival 
50%; surgical etiology (nontraumatic), survival 50%, mean age 70; 
myocardial infarction (n = 12), survival 83%, mean age 61; sepsis (n = 
6), survival 67%, mean age 48; drugs overdose (n = 2), survival 100%; 
traumatic cardiac arrest (n = 15), 89% mortality, mean age 41; and CA 
with unknown etiology, survival 38%, mean age 68.
Conclusion Emergency room cardiac arrest arrivals are not correlated 
with ER-CPA total activity. Good survival rates are probably related to a 
special quick response protocol and trained teams. Outcomes research 
to detect potential improvement in nurse care is needed, and should 
be evidence guided. Worst results in survival rates must be detected as 
the main topics for nursing care development.
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Introduction Guidelines recommend to perform head computed 
tomography (CT) in nontraumatic cardiac arrest only if the patient 
remains unconscious after return of spontaneous circulation [1]. 
Nevertheless, in cardiac arrest due to neurological causes, head CT 
would dramatically change the therapeutic strategy in these patients 
[2]. The aim of this study is to present the experience of our ICU in 
nontraumatic out-of-hospital cardiac arrest (OHCA) patients and to 
demonstrate that neurological abnormalities can be the primary cause 
of cardiac arrest.
Methods We collected data for all patients with nontraumatic OHCA 
admitted to the ICU from 1  January 2012 to 31  December 2012. We 
recorded mean age, male-to-female ratio, cause of cardiac arrest and 
mortality in the ICU.
Results Thirty-four survive cardiac arrest patients were admitted to the 
ICU. Mean age was 66 years. The male-to-female ratio was 2:1. Sixteen 
patients died in the ICU. Head CT scans obtained in the immediate post-
arrest period found signifi cant abnormalities in four patients (three 
subarachnoid hemorrhage and one ischemic ictus) with immediate 
modifi cation of treatment.
Conclusion Head CT abnormalities can be found in cardiac arrest 
patients. Further investigations are necessary to evaluate the impact 
of cardiac arrest from neurological causes and to establish the role of 
neuroimaging in these patients.
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Introduction The ALERT algorithm, a simple and eff ective com-
pression-only telephone CPR (t-CPR) protocol, has been previously 
demonstrated to help bystanders initiate CPR. According to their 
worldwide availability, mobile phone communications may play 
an increasing role in emergency calls. Preliminary studies suggest 
that they might improve dispatcher’s understanding of the rescuer’s 
situation. However, there is currently no validated protocol for 
videoconference-assisted CPR (v-CPR). We initiated the present study 
to validate an original protocol of v-CPR based on the ALERT algorithm 
and to evaluate the potential benefi t of this assistance in comparison 
with classical t-CPR.
Methods We developed a strictly worded algorithm for v-CPR, adapted 
from the ALERT t-CPR protocol, with additional re-evaluation loops, 
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every 2 minutes. A total of 120 students without prior CPR training were 
recruited from upper secondary school, during regular class hours, 
and randomly assigned to the t-CPR group (n = 60) versus the v-CPR 
group (n = 60). The Resusci®Anne SkillReporter™ manikin was used to 
evaluate CPR performance. Data were transferred from the manikin 
into a computerized database using the Laerdal SkillReporting System 
V.2.2.1 software. Further analysis was based on audio-recordings and 
video-recordings. Primary outcome measures were the results of the 
Cardiff  evaluation test; the secondary measures were global scoring of 
a complete 7-minute period of CPR.
Results The mean chest compression rate increased signifi cantly in the 
v-CPR group as compared with t-CPR (110 ± 16 vs. 86 ± 28; P <0.0001), 
while depth remained constant (48  ±  13  mm vs. 47    ±  16  mm, P  = 
NS). Hand positioning was correct in 91.7% of cases with v-CPR, but 
only in 68% with t-CPR (P  = 0.001). The hands-off  period was almost 
nonexistent in the v-CPR group (0 vs. 7 seconds; P = 0.0016), but the 
median no-fl ow time was signifi cantly greater in the v-CPR group (146 
vs. 122  seconds, P  < 0.0001). As a consequence, global evaluation of 
CPR performance revealed a signifi cant improvement in v-CPR group 
score as compared with the t-CPR group (6 vs. 5, P < 0.001).
Conclusion Video-assisted CPR using this original algorithm allows 
bystanders to reach compression rates and depths close to international 
guidelines and to reduce hands-off  events during CPR.
P488
Initial anticoagulation strategy for extracorporeal cardiopulmonary 
resuscitation patients
Y Iwashita, M Matsuduki, M Yukimitsu, K Yokoyama, T Nakata, 
A Yamamoto, K Ishikura, H Imai
Mie University Hospital, Tsu, Mie, Japan
Critical Care 2014, 18(Suppl 1):P488 (doi: 10.1186/cc13678)
Introduction Extracorporeal cardiopulmonary resuscitation (ECPR) 
is increasingly being used in emergency and critical care medicine in 
Japan. Although a major complication of this procedure is bleeding, 
the optimal heparin dose and activated coagulation time (ACT) remain 
unknown.
Methods We retrospectively evaluated the initial heparin doses, ACT 
values, and complications of patients who received ECPR between 
February 2011 and November 2013 at the Emergency and Critical Care 
Center, Mie University Hospital, Japan.
Results ECPR was performed in 45 patients, and the ACT was evaluated 
in 32 patients. All patients were administered 3,000 U unfractionated 
heparin at the time of priming the circuit. Patients for whom 
cannulation took a longer time received an additional 2,000 to 3,000 U 
unfractionated heparin. The average heparin dose administered 
was 53.6  U/kg body weight. The average ACT was 231.3  seconds. In 
17 of the 32 patients, the ACT exceeded 200 seconds. Three patients 
experienced fatal bleeding in the chest wall, which could not be 
stabilized by conservative treatment. One patient developed a cerebral 
infarction. There were no signifi cant diff erences between the patients 
with fatal bleeding and those without fatal bleeding with regard to the 
heparin dose, ACT, and duration of CPR.
Conclusion According to the Extracorporeal Life Support Organization 
guidelines, the target ACT should be around 1.5  times the normal 
ACT. However, it is diffi  cult to obtain the normal ACT in emergency 
situations. Many of our patients’ ACTs exceeded 200  seconds, and 
three patients experienced fatal bleeding that was possibly due to 
chest compression. Post-cardiac arrest patients often experience 
coagulopathy due to either cardiac arrest or hypothermia therapy. 
Therefore, an anticoagulation protocol other than the pulmonary 
extracorporeal membrane oxygenation protocol is required for ECPR 
patients. We evaluated our anticoagulation protocol for ECPR and 
observed that our patients’ ACTs frequently exceeded the target value 
and some experienced fatal bleeding. The anticoagulation protocol for 
post-CPR patients may need to be reconsidered.
P489
Predictors of poor outcome in out-of-hospital cardiac arrest
JE Petrie, S Brett, R Stümpfl e
Hammersmith Hospital, London, UK
Critical Care 2014, 18(Suppl 1):P489 (doi: 10.1186/cc13679)
Introduction Out-of-hospital cardiac arrest (OOHCA) causes 60,000 UK 
and 300,000 US deaths each year. Survival to hospital discharge in the 
developed world has historically been 7 to 10% with obvious cognitive 
impairment in 10% of survivors. Primary percutaneous coronary 
intervention (PPCI) and targeted temperature management (TTM) (or 
at least hyperthermia avoidance) have been shown to improve survival 
in comatose patients post OOHCA. There is no reliable method to 
predict poor outcome on presentation. We aimed to identify factors 
associated with poor outcome in our single-centre regional referral 
OOHCA population.
Methods We performed a pragmatic single-centre retrospective 
review over 18  months commencing 1  January 2011 of all patients 
admitted to our regional OOHCA centre ICU following successful 
resuscitation from OOHCA. In keeping with guidelines, all patients 
were assessed for suitability for PPCI and TTM. A good outcome was 
defi ned by a Pittsburgh Cognitive Performance Category (CPC) score 
of 1 to 2 (independence, mild impairment) on hospital discharge. A 
poor outcome was defi ned as death or CPC 3 to 4 (moderate to severe 
impairment, coma) on hospital discharge. CPC scoring was determined 
Table 1 (abstract P489). Presenting features and outcome at hospital discharge of ICU OOHCA patients
 Good outcome (CPC 1 to 2) Poor outcome (dead or CPC 3 to 4) Total P value
Age 63.3 ± 16.8 63.6 ± 14.4 63.5 ± 14.7 NS
Male sex 21/26 (81%) 29/43 (67%) 50/69 (72%) NS
Arrest occurring 08:00 to 20:00 14/19 (74%) 16/36 (44%) 30/55 (55%) <0.05
VF/VT as initial rhythm 25/26 (96%) 25/43 (58%) 50/69 (72%) <0.001
Bystander CPR 12/26 (46%) 24/43 (56%) 36/69 (52%) NS
Time from collapse to ROSC (minutes) 18.3 ± 11 32.3 ± 26 27.1 ± 23 <0.05
Advanced airway management 14/24 (58%) 38/42 (90%) 52/66 (79%) <0.005
Cardiac cause 24/26 (92%) 30/43 (70%) 54/69 (78%) <0.05
Angiography 19/26 (73%) 23/43 (53%) 42/69 (61%) NS
Therapeutic hypothermia 24/26 (92%) 41/43 (95%) 64/69 (93%) NS
Presenting pH 7.21 ± 0.11 7.08 ± 0.18 7.13 ± 0.17 <0.01
Presenting base defi cit (mmol/l) –7.9 ± 6.2 –13.8 ± 5.9 –11.5 ± 6.7 <0.001
Presenting lactate (mmol/l) 4.3 ± 3.0 8.3 ± 4.5 6.8 ± 4.4 <0.0005
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from physiotherapy and occupational therapy assessments in the 
clinical notes. Continuous data were analysed using a two-tailed t test 
or Mann–Whitney U test, categorical data with a chi-squared test.
Results Sixty-nine patients were admitted to our ICU following 
successful resuscitation from OOHCA in the 18-month period. 
Presenting features and outcomes are shown in Table 1.
Conclusion Good outcome was associated with a shockable rhythm on 
presentation, cardiac cause, arrest occurring in daylight hours (08:00 
to 20:00) and shorter time between collapse and ROSC. Poor outcome 
was associated with placement of an advanced airway device, lower 
pH, higher base defi cit and higher lactate.
P490
Mean initial cerebral saturation and time to start advanced life 
support in out-of-hospital cardiac arrest: are they correlated?
C Genbrugge, C De Deyne, I Meex, F Jans, W Boer, J Dens
ZOL, Genk, Belgium
Critical Care 2014, 18(Suppl 1):P490 (doi: 10.1186/cc13680)
Introduction During advanced life support (ALS) it is still impossible to 
predict return of spontaneous circulation (ROSC) or outcome. Cerebral 
saturation (rSO2) measurements with near-infrared spectroscopy 
can be used in cardiac arrest circumstances and could play a role in 
predicting ROSC or neurologic outcome [1]. It is known that an initial 
rhythm of asystole and a long no/low-fl ow time has a worse outcome. 
We measured rSO2 during ALS in out-of hospital cardiac arrest (OHCA) 
patients and compared the mean rSO2 during the fi rst minute with the 
time between the emergency call (EC) and start of ALS.
Methods With IRB approval, rSO2 was prospectively measured between 
December 2011 and November 2013 in 51 OHCA cases with presumed 
cardiac cause during ALS. One sensor of the EQUANOX Advance was 
applied to the right side of the patient’s forehead when the medical 
emergency team arrived. The measurement was continued until death 
of the patient or arrival at the ICU. Survivors (S) are defi ned as sustained 
ROSC longer than 20  minutes. CPR data were collected using the 
Utstein CPR data registration. The Mann–Whitney test and Pearson chi-
square were utilized for comparison of S and nonsurvivors (NS) data. 
The Pearson test was used to examine correlation.
Results Of the 51 patients, 21 were S. Mean age was 70 years (± 15) in 
the S, of which 10 (48%) were male, and in the nonsurvivors (NS) mean 
age was 70 years (± 17) (P = 0.916) with 23 (77%) male patients (P = 
0.042). The initial rhythm was asystole in 11 S and in 20 NS (P =0.386), 
pulseless electrical activity in two S and NS (P  = 1), and ventricular 
fi brillation in eight S and six NS (P = 0.207). The arrest was witnessed 
in 15 NS and 16 S (P = 0.083). Lay rescuer BLS was performed in 17 NS 
and nine S (P = 0.4). A signifi cant diff erence in time of EC and start of 
ALS was observed between S (12 minutes; 8 to 15) and NS (14 minutes; 
12 to 17) (P = 0.03). Mean initial rSO2 was 34% (± 23) and 24% (± 12.5) 
in S and NS (P = 0.077). We observed a negative correlation between 
mean initial rSO2 and time between EC and ALS (correlation coeffi  cient 
–0.243; P = 0.041).
Conclusion A tendency towards higher mean initial rSO2 in S compared 
with NS was observed together with a negative correlation between 
mean initial rSO2 and time between the EC and start of ALS. Also a 
signifi cant diff erence in time between the EC and start of ALS between 
S and NS is observed. Larger studies are needed to confi rm the possible 
function of rSO2 as a surrogate for time between the EC and start of ALS.
Reference
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Predicting survival in patients admitted to intensive care 
following out-of-hospital cardiac arrest using the Prognosis After 
Resuscitation score
H Davies, A Loosely, S Dolling, R Eve
University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Critical Care 2014, 18(Suppl 1):P491 (doi: 10.1186/cc13681)
Introduction Out-of-hospital cardiac arrest (OHCA) has a poor 
prognosis even after successful resuscitation [1]. No scoring system 
has been fully validated for predicting survival following OHCA. The 
Prognosis After Resuscitation (PAR) score was developed from meta-
analysis in 1992. A score >5 (from seven variables) predicts nonsurvival 
following in-hospital cardiac arrest (IHCA) [2,3]. Porter and colleagues 
demonstrated that PAR >5 is a useful predictor of nonsurvival for 
combined IHCA/OHCA ICU admissions [4]. We aim to evaluate PAR 
application to adult ICU admissions at University Hospitals Bristol 
(UHB), UK following OHCA.
Methods The Innovian (Dräger) electronic clinical information database 
was searched retrospectively for all OHCA ICU admissions from 2010 to 
2012. Data were extracted using an electronic pro forma in Microsoft 
Excel. Missing/incomplete data were excluded. Survival was defi ned as 
survival to discharge from the acute hospital (UHB).
Results There were 247 admissions to the ICU following OHCA from 
2010 to 2012. Seven patients were excluded for missing/incomplete 
data. In total, 102 patients (42.5%) survived to discharge. PAR ranged 
from –2 to 18. Zero was the most frequent score. Only one of 15 
admissions with PAR >5 (PAR 13) survived. A total of 101 patients with 
PAR ≤5 survived (45%). Acute myocardial infarction was identifi ed as 
the precipitating event in 111 patients (46%).
Conclusion Only one of 240 OHCA patients admitted to the ICU over 
a 3-year period with PAR >5 survived until discharge. PAR scoring has 
been shown to be useful in helping decide the appropriateness of ICU 
admission for combined IHCA/OHCA. Our data support its use in isolated 
OHCA. PAR ≤5 appears to be poorly predictive of survival. However, 
PAR >5, combined with clinical evaluation, could help identify OHCA 
nonsurvivors and avoid ICU admissions that do not benefi t the patient.
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Post Arrest Consult Team: a knowledge translation strategy for 
post-cardiac arrest care
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Critical Care 2014, 18(Suppl 1):P492 (doi: 10.1186/cc13682)
Introduction Lack of standardized care contributes to low survival in 
admitted out-of-hospital cardiac arrest (OHCA) patients. The objective 
of our study was to implement a Post Arrest Consult Team (PACT) and 
improve the quality of care for admitted OHCA patients.
Methods We conducted a prospective cohort study with concurrent 
controls from February 2011 to February 2013 in a network of 29 
Toronto-area hospitals. The PACT was implemented in two hospitals 
and functioned as a consult service with a nurse and physician on-
call 24/7. Patients from other network hospitals acted as concurrent 
controls. The PACT focused on four key processes of care: targeted 
temperature management (TTM); coronary angiography; avoidance of 
premature withdrawal of life-sustaining therapy (WLST <72 hours) on 
the basis of neuroprognostication; and electrophysiology assessment. 
We included nontraumatic OHCA patients who were >18  years old, 
survived at least 6  hours, and were comatose. We excluded patients 
with do-not-resuscitate orders, intracranial or other severe bleeding. 
We used generalized linear mixed models to assess whether PACT 
implementation was associated with higher odds of achieving each of 
the four targeted processes of care while adjusting for secular trends 
unrelated to the intervention.
Results The primary analysis included 162 patients from two 
intervention hospitals and 892 from 27 control hospitals. Thirty-
two percent of the patients were female and the mean age was 
65.3 ± 16.5 years. Almost one-half (46%) of patients had a shockable 
initial cardiac arrest rhythm, 41% had bystander CPR, and 5% had an 
AED applied. PACT did not improve use of TTM (ratio of ORs  = 1.03, 
95% CI = 0.89 to 1.20), angiography for patients without ST-elevation 
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myocardial infarction (ratio of ORs  = 1.10, 95% CI  = 0.87 to 1.40), or 
electrophysiology assessment (ratio of ORs  = 1.06, 95% CI  = 0.81 to 
1.38) as compared with concurrent control hospitals. Patients in the 
intervention group were less likely to have life support withdrawn 
within 72 hours on the basis of neuroprognosis compared with patients 
in the concurrent control group (ratio of ORs = 0.62, 95% CI = 0.39 to 0.98).
Conclusion PACT was associated with reduced WLST <72 on the 
basis of neuroprognostication but did not improve other important 
post-cardiac arrest processes of care. Further work is underway to 
identify factors that infl uenced implementation. This will guide future 
consideration of the PACT model in other settings.
P493
One-year assessment of in-hospital cardiac arrest
M Ahmed, A Kochhar, O Rose
Univeristy Hospital Lewisham, London, UK
Critical Care 2014, 18(Suppl 1):P493 (doi: 10.1186/cc13683)
Introduction This retrospective audit evaluated adult patients who 
suff ered in-hospital cardiac arrest (IHCA) against the recent National 
Confi dential Enquiry into Patient Outcome and Death (NCEPOD) 
report [1]. It looked specifi cally at the recognition of the acutely 
unwell, the interventions made, the decisions taken from admission 
through to the post-arrest period and the outcomes following 
cardiopulmonary resuscitation (CPR). The audit aims to guide future 
improvements in preventing cardiac arrest and enhancing end-of-life 
care decision-making.
Methods Medical notes of adult patients suff ering IHCA, over a 1-year 
period, were identifi ed and data were collected using a validated 
NCEPOD audit tool. These data included patient demographics, initial 
clerking and consultant review, patient care during the 48 hours prior to 
cardiac arrest, the resuscitation status of the patient, the resuscitation 
attempt, the post-cardiac arrest care and survival to discharge rates.
Results Medical notes were available for assessment for 69 out of the 82 
patients that were identifi ed as having IHCA between 1 October 2011 
and 30 September 2012. The frequency of IHCA showed no correlation 
to day of the week or month. Initial clerking was incomplete in history-
taking (16% vs. 14% in NCEPOD) and in examination (46% vs. 24% in 
NCEPOD). The majority of patients were appropriately escalated in a 
timely fashion (94% vs. 82% in NCEPOD), but fi rst consultant review 
was delayed beyond 12  hours in 49% of cases (48% in NCEPOD). A 
total 81% of patients suff ered cardiac arrest 24 hours after admission 
(68% in NCEPOD). Warning signs for cardiac arrest were considered 
present in 59% of cases (75% in NCEPOD), with a signifi cant proportion 
going unrecognised (27%) despite multiple medical reviews. Out-of-
hours CPR attempts (68% vs. 59% in NCEPOD) seemed be associated 
with poorer survival. The survival to discharge rate after in-hospital 
cardiac arrest was 10.1%. This compares with 14.6% in the NCEPOD 
data and 20% in larger studies [2]. Ninety per cent of patients had no 
documentation of resuscitation status (78% in NCEPOD).
Conclusion The results from this audit highlight persistent defi ciencies 
in the care pathway for the acutely unwell patient. Improvement will be 
focused on earlier consultant review and better recognition of warning 
signs with appropriate action taken. Furthermore, earlier routine and 
senior clinician-led discussions on appropriate end-of-life care are vital.
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Endovascular hypothermia after cardiac arrest in a Chilean ICU
M Canitrot, S Ugarte
INDISA Clinic, Santiago, Chile
Critical Care 2014, 18(Suppl 1):P494 (doi: 10.1186/cc13684)
Introduction For more than a decade, mild hypothermia has been 
a standard for enhancing the neurological prognosis in comatose 
survivors of cardiac arrest (CA). Despite this, in our country there are 
still few centers that apply hypothermia post CA regularly. We describe 
a Chilean experience with endovascular hypothermia post CA, in three 
ICUs of the same university clinical center [1-3].
Methods A descriptive cohort study. All surviving comatose patients 
after CA were included, and underwent endovascular hypothermia 
management according to protocol. CoolGard™ internal cooling 
equipment was used. Variables: delay between CA and hypothermia 
(34°C), time in hypothermia, complications, ventilatory and hemo-
dynamic management. Main outcome measures: mortality and neuro-
logical follow-up to 6 months with Glasgow Outcome Score Extended 
(GOSE).
Results Twenty-seven patients were managed in the ICU post CA (18 
outpatients). Twenty-four were men (89%), mean age 33.5 ± 19 years 
(16 to 76). Delay was considered (time between CA and achieving 
target temperature of 34°C): median 10.5 ± 3.3 hours (3 to 18 hours). 
Hypothermic maintenance (from when it reaches 34°C until it returns 
to 36°C): 24 ± 18 hours (24 to 48 hours). Complications of hypothermia: 
fi ve hypokalemia (18.5%), three ventricular arrhythmias (11%), one 
vein thrombosis (3.7%). There were no deaths during hypothermia. 
Hospital mortality was two cases (7.4%). At 6  months it was three 
(11%). Neurological outcome at discharge and 6 months are shown in 
Figure 1. Good outcome (GOSE 5 to 8) occurred in 11 patients (40%) at 
discharge. Good outcome at 6 months occurred in 20 patients (74%).
Conclusion Our series shows a low mortality and a very good 
neurological outcome. There was no mortality or severe complications 
associated with endovascular hypothermia. It is a safe and feasible 
technique implemented in Latin American critical care units. Even the 
delay in achieving the objective of hypothermia is very long.
References
1. Kory et al.: Resuscitation 2011, 82:15-20.
2. Seder et al.: Crit Care Med 2009, 37:S211-S222.
3. Holzer et al.: N Engl J Med 2010, 363:1256-1264.
P495
Knowledge and use of therapeutic hypothermia in cardiac arrest 
victims among healthcare staff  in Greece
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Introduction Therapeutic hypothermia (TH) improves the neurologic 
outcome of patients who survive after cardiac arrest but suff er from 
severe secondary neurological damage [1]. In 2010, the use of TH after 
cardiac arrest was included in the ERC guidelines. The purpose of this 
study was to investigate the knowledge of the medical and nursing 
staff  on the implementation of TH in patients after cardiac arrest [2].
Methods Data were collected by an anonymous questionnaire 
designed for the purpose of research, addressed to medical and nursing 
staff  of Greek hospitals. The questionnaire consisted of questions about 
knowledge and behavior related to TH induction, target temperature 
and duration of cooling. Information about the potential barriers to 
implementation of TH was also collected.
Results We obtained 344 questionnaires from 16 hospitals. The 
population of the study was registered nurses (RN) (63.8%) and doctors 
Figure 1 (abstract P494).
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(36.2%). The majority of health staff  (81.5%) had never implemented 
TH. A total 45.8% of respondents stated that the main reasons for not 
using TH were the lack of information and training about the method, 
the lack of nursing staff , the lack of available cooling methods and the 
required time. The most common methods of application were cold 
packs and intravenous fl uids. Only 30.2% of the doctors and 5.5% of 
the nurses (P  <0.001) actually had the knowledge to implement TH, 
and this was demonstrated by correct answers. Of the respondents 
who answered that they did know the method, only 23.9% answered 
correctly; about the target temperature, the maintenance and 
rewarming phase. A total 59.1% of doctors, despite having attended 
the Advanced Cardiac Life Support seminar, were not able to answer 
correctly the knowledge questions. Continuous education of health 
professionals and the existence of a protocol were proposed by 65% 
of participants as the best way of increasing knowledge and adherence 
with ERC guidelines about TH.
Conclusion Therapeutic hypothermia is rarely used in Greek hospitals. 
The level of knowledge is mainly related to the lack of education and 
the lack of information about new techniques. Programs for continuing 
education are necessary for the use of new therapeutic techniques in 
the fi eld of health.
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Induced hypothermia of 33°C does not aff ect host response 
compared with maintaining 36°C
C Beurskens, J Horn, E Van Leeuwen, N Juff ermans
AMC, Amsterdam, the Netherlands
Critical Care 2014, 18(Suppl 1):P496 (doi: 10.1186/cc13686)
Introduction Induced hypothermia is applied in the ICU and in the 
operating theater to reduce ischemia–reperfusion injury. It is thought 
that induced hypothermia may hamper the immune response and 
therefore carry the risk of acquiring or aggravating an infection. We 
investigated the eff ect of hypothermia on host response by comparing 
survivors of cardiac arrest in which body temperature was kept at 
either 33°C or 36°C.
Methods As a substudy to the Target Temperature Management trial [1] 
in which cardiac arrest patients admitted to the ICU were randomized 
to maintaining either 33°C (n = 11) or 36°C (n = 9) for 24 hours, blood 
was drawn at the start and end of the target temperature phase as well 
as after reaching normotemperature. Host response was measured via 
monocyte human leukocyte antigen-DR (HLA-DR) expression and via 
whole blood stimulation with TLR ligands lipopolysaccharide (LPS) and 
lipoteicoic acid (LTA) for 24 hours. Plasma levels of interleukin (IL)-1β, 
IL-1RA, IL-6, IL-8, IL-10, tumor necrosis factor alpha (TNFα), macrophage 
infl ammatory proteins (MIP)-1, monocyte chemotactic protein (MCP)-
1 and soluble CD40 ligand levels were determined with ELISA or 
Luminex. Statistics were by unpaired Mann–Whitney U tests.
Results HLA-DR expression was decreased compared with healthy 
controls, without diff erences between 33°C and 36°C. Following whole 
blood stimulation with LPS, TNFα and IL-6 production was lower 
after cardiac arrest compared with healthy controls. The 33°C and 
36°C groups diff ered at baseline in TNFα levels after LPS whole blood 
stimulation. After 24  hours of temperature management, there was 
no diff erence in both TNFα and IL-6 production between the groups 
following TLR ligand stimulation. After cessation of temperature 
management only TNFα levels increased after LTA stimulation. Plasma 
levels of IL-1RA, IL-8 and IL-10 were decreased after cardiac arrest 
compared with healthy controls. In plasma levels of IL-1β, MIP-1 and 
soluble CD40 ligand there were no diff erences between the 33°C and 
36°C groups at all time points. Apart from baseline diff erences, there 
were no diff erences between 33°C and 36°C in plasma levels of IL-1RA, 
IL-8, IL-10 and MCP-1.
Conclusion Cardiac arrest induces a decrease in proinfl ammatory 
response. There were no diff erences in immune host response after 
24 hours of targeting body temperature at 33°C or 36°C. These results 
suggest that hypothermia does not alter host immune response.
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Derived electromyography is an accurate measure of shivering 
burden during targeted temperature management
T May, DS Seder, GF Fraser, BM McCrum, CF Hoover, RR Riker
Maine Medical Center, Portland, ME, USA
Critical Care 2014, 18(Suppl 1):P497 (doi: 10.1186/cc13687)
Introduction Shivering complicates targeted temperature manage-
ment (TTM) by increasing metabolism, oxygen consumption, 
rest ing energy expenditure, and carbon dioxide production and 
is associated with lower brain tissue oxygen levels; all of these 
may limit the eff ectiveness of TTM. However, the recognition and 
measurement of shivering are subjective and ill-defi ned. The Bedside 
Shivering Assessment Scale (BSAS) is the only validated tool to 
describe the intensity of shivering. We hypothesized that the derived 
electromyography (dEMG) value measured by the bispectral index 
monitor (BIS) would agree with energy expenditure due to shivering, 
compared with the BSAS.
Methods We measured continuous indirect calorimetry during a 2 
to 5  hour time span during targeted temperature management in 
12 patients being treated for hypoxic ischemic encephalopathy after 
cardiac arrest. Patients were excluded if seizing, requiring >FiO2 0.5, 
exhibiting early spasticity, or not shivering. The BSAS was measured 
every 15 minutes by a blinded observer and shivering was treated for 
a BSAS ≥1, as per institutional protocol. The association of dEMG and 
BSAS as a predictor of resting energy exposure (REE) was measured 
using linear regression and Pearson’s correlation.
Results The study population included 12 patients. Average age was 
54 years, nine patients were male, eight patients had a CPC of 1 to 3 on 
hospital discharge. There were a total of 182 measurements of BSAS, 
dEMG, and REE. There is improved correlation between REE and dEMG 
compared with REE and BSAS (0.24 (CI  = 0.10 to 0.37) vs. 0.10 (CI  = 
–0.04 to 0.24); P <0.001 vs. 0.14). Each increase in dEMG resulted in an 
increase of 14 kcal of energy expenditure (P = 0.003).
Conclusion Continuous dEMG power measured by Covidien BIS monitors 
is a more accurate and less subjective measure of shivering burden 
compared with the intermittent BSAS. Introducing dEMG into clinical 
practice may improve recognition of shivering, allow quantifi cation of 
the metabolic cost of shivering, and serve as a more reliable research tool 
for diagnostic and treatment strategies of shivering.
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Shivering during targeted temperature management after cardiac 
arrest: a physiologic description
T May, DS Seder, GF Fraser, CF Hoover, RR Riker, BM McCrum
Maine Medical Center, Portland, ME, USA
Critical Care 2014, 18(Suppl 1):P498 (doi: 10.1186/cc13688)
Introduction Targeted temperature management (TTM) is used to treat 
hypoxic ischemic encephalopathy (HIE), elevated intracranial pressure, 
status epilepticus, and other brain injuries. Shivering complicates TTM, 
and the associated energy burden and its response to treatment are 
poorly understood. We describe the pattern of shivering and response 
to neuromuscular blockade in a series of patients undergoing TTM 
after cardiac arrest using continuous indirect calorimetry.
Methods With IRB approval, we studied 16 patients undergoing 
TTM for HIE with continuous calorimetry during their treatment. 
The calorimeter measures inspired and expired oxygen and carbon 
dioxide, which are used in the Weir equation to calculate resting 
energy expenditure (REE). We excluded patients known to be actively 
seizing, requiring FiO2 >0.5, with early spasticity, or who did not shiver. 
All patients received counterwarming, moderate analgosedation, and 
bolused vecuronium in response to visible shivering, measured hourly 
by nurses using the Bedside Shivering Assessment Scale.
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Results Sixteen patients of average age 57 included 12 men. Twelve 
patients had CPC of 1 to 3 on hospital discharge. Sixteen shivering 
events were monitored with calorimetry among the 12 patients. The 
average rate of energy expenditure (without shivering) leading up to 
and following paralytic treatment was 1,425 kcal/hour (±  489  kcal/
hour) and 1,386  kcal/hour (±  235  kcal/hour). This was signifi cantly 
greater than the predicted basal energy expenditure (1,089  ±  222 
kcal; P = 0.007 and P <0.001). Time from a change in baseline energy 
expenditure to recognition and treatment of clinical shivering was 57 
(± 64) minutes, and from treatment with neuromuscular blockade to 
baseline energy expenditure was 30 (± 20) minutes. This accounts for 
a total diff erence of 15,223 kcal (± 10,997 kcal) before treatment and 
7,113  kcal (±  3,706 kcal) after treatment for each shivering episode 
compared with baseline (P = 0.01 and P = 0.003).
Conclusion The energy burden of shivering is underestimated by 
standard nutritional formulas in patients undergoing TTM after cardiac 
arrest. Subclinical shivering is associated with increased energy 
expenditure. Clinical recognition occurs long after the increase in 
metabolic activity, and persists for a signifi cant period of time after 
treatment. These fi ndings should infl uence how shivering is monitored 
and treated during TTM.
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Temperature management following cardiac arrest: introducing a 
protocol improves compliance with targets
P Creber, G Talling, M Oram
Cheltenham General Hospital, Cheltenham, UK
Critical Care 2014, 18(Suppl 1):P499 (doi: 10.1186/cc13689)
Introduction We audited the achievement of therapeutic hypothermia 
(TH) before and after the introduction of a cooling protocol. Instituting 
TH is recommended following the return of spontaneous circulation 
(ROSC) for many patients who survive a cardiac arrest [1,2]. The key 
intervention may be the avoidance of hyperthermia rather than 
cooling [3].
Methods We conducted a chart review of all patients admitted to the 
Department of Critical Care (DCC) at our hospital following cardiac arrest 
over 2 years in 2010 to 2012 (Group 1). We recorded compliance with key 
recommendations produced by the Royal College of Anaesthetists [4] 
although we defi ned post-ROSC hyperthermia as >37.2°C rather than 
>38°C. A TH protocol was designed and personnel in the emergency 
department and DCC educated as to its use. Recommended practice 
was the infusion of cold i.v. normal saline (1 to 2 l) followed by the use 
of an intravascular cooling device (Alsius CoolGard™). Data collection 
was then undertaken after introduction of the protocol for all patients 
admitted to the DCC following cardiac arrest in November 2012 to 2013 
(Group 2).
Results Forty-three patients were admitted in Group 1, 28 in Group 
2. Of these, 42% in both groups were following out-of-hospital 
(OOH) VF arrests. Cooling was attempted in 88% and 82% of OOH VF 
patients respectively. For patients with either in-hospital or non-VF/
VT cardiac arrests, the numbers cooled were 16% and 12.5%. Cooling 
initiation within 1  hour increased from 27 to 50%. Achievement of a 
target temperature of 32 to 34°C within 4 hours of ROSC was 55% and 
50% respectively. Target maintenance for 12 to 24  hours after ROSC 
increased 79% to 100%. Avoidance of hypothermia <31°C for 48 hours 
after ROSC improved 95% to 100%. Slow rewarming at 0.25 to 0.5°C/
hour to 37°C was achieved in 76% and 90%. Avoidance of temperature 
>37.2°C for 48 hours after ROSC increased 84 to 100%. Of the patients 
cooled, survival with good neurological outcome was achieved in 52% 
in Group 1 and 88% in Group 2.
Conclusion The institution of a temperature management protocol 
improved compliance with recommended goals, both in achieving 
hypothermia and in the avoidance of hyperthermia.
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Introduction Therapeutic hypothermia (TH) following out-of-hospital 
cardiac arrest (OHCA) improves neurological outcomes in such patients. 
During TH, neuromuscular blockade is used to control shivering in 
the patient. In our hospital, we use vecuronium as a neuromuscular 
blocker. However, occasionally, prolonged eff ects of vecuronium delay 
accurate evaluation of patients’ neurological function or extubation. 
Unfortunately, the factors involved in the prolonged eff ect of 
vecuronium in TH remain unclear.
Methods We conducted a retrospective cohort study of patients 
managed with TH following OHCA at our institution from April 2010 
to September 2013. We defi ned full-muscle reaction to train-of-four 
stimulation (TOF) as the end of eff ects of vecuronium. In this study, the 
time from the end of vecuronium administration to full-muscle reaction 
to TOF was evaluated as the outcome. We calculated the adjusted 
hazard ratio (HR) for the outcome using Cox regression analysis after 
adjustment for age, gender, albumin levels, estimated glomerular 
fi ltration rate, temperature at the end of vecuronium administration, 
and total amount of vecuronium per kilogram of body weight.
Results In total, 52 patients were evaluated in this study (86.5% male; 
average age, 55.2 years). The median time from the end of vecuronium 
administration to full-muscle reaction to TOF was 660  minutes 
(maximum: 10,363 minutes; minimum: 72  minutes). Blood albumin 
levels on admission decreased the time (adjusted HR: 2.31, 95% CI: 
1.073 to 5.004; P  <0.05). However, other factors had no signifi cant 
diff erence on the time. The amount of vecuronium per kilogram of 
weight had no signifi cant diff erences (adjusted HR: 1.073, 95% CI: 0.869 
to 1.325; P = 0.511).
Conclusion The time from the end of vecuronium administration to 
full-muscle reaction to TOF decreased in relation to blood albumin 
levels on admission. Other factors had no signifi cant diff erence on the 
outcome time. Taken together, the outcome time may be determined 
by albumin levels and not by the administered amount of vecuronium 
per kilogram of body weight. Based on this result, we suggest that 
blood albumin levels on admission should be taken into consideration 
for appropriate use of vecuronium in TH.
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Introduction Short-term neuropsychologic dysfunction (SND) is often 
observed during the postoperative period of open total arch repair 
(TAR) under deep hypothermic circulatory arrest (DHCA). We supposed 
that there might be a large consumption of high-energy phosphates 
during the rewarming period, and this might be associated with 
awakening and SND. Due to diffi  culty in measuring such high-energy 
phosphates at the bedside, we measured the serum phosphate 
concentration (P) as a substitute, and assessed its infl uence on 
awakening and postoperative SND.
Methods Twenty patients with a mean age of 68  ±  11 years who 
underwent open TAR under DHCA applied at a temperature of 20°C, 
with antegrade cerebral perfusion (ACP) or retrograde cerebral 
perfusion (RCP), were enrolled. Arterial blood gas lactate concentration 
(ALac), ScvO2, and P were measured at 2, 4, 6, and 10 hours after 
weaning from cardiopulmonary bypass (CPB). We also measured time 
to confi rm M6 on the Glasgow Coma Scale (GCS), and incidence of SND. 
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Occurrence of SND was defi ned as neurological disarrangement such 
as irritability, confusion, or delirium within 48 hours after operation.
Results Durations of CPB, aortic clamp, and circulatory arrest were 
194  ±  51, 136  ±  53, and 70  ±  17 minutes respectively. Nine patients 
underwent ACP (89  ±  26 minutes) and 11 patients underwent RCP 
(56 ± 25 minutes). Concentration of ALac, ScvO2, and P changed at 2, 4, 6, 
10 hours after CPB as follows: ALac 4.0 ± 1.9, 5.1 ± 2.6, 5.3 ± 3.3, 4.0 ± 2.8 
mmol/l, ScvO2 71 ± 6.7, 67 ± 10, 67 ± 9.7, 65 ± 11%, and P 2.9 ± 0.9, 
2.4 ± 0.7, 2.2 ± 1.0, 1.8 ± 0.8 mg/dl, respectively. Serum P recovered to 
2.6  ±  1.4 at 18 hours after CPB. The incidence of hypophosphatemia 
(<2.6 mg/dl) and SND in our series were 18/20 (90%) and 14/20(70%) 
respectively. There was a correlation between minimum P and time to 
confi rm M6 on the GCS (P = 0.508, Fisher r-to-z transformation), but no 
signifi cant correlation between SND. The mortality rate during the fi rst 
28 days was 5% (1/20).
Conclusion Serum phosphate decreased dramatically during 
the rewarming period after deep hypothermic circulatory arrest. 
There was a moderate correlation between minimum phosphate 
concentration and time to confi rm M6 on the GCS. Monitoring 
phosphate concentration might predict neurological recovery after 
deep hypothermic circulatory arrest.
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Introduction Therapeutic temperature modulation (TTM) is widely 
used in the care setting to improve outcomes of patients with traumatic 
brain injury (TBI). Through fever prevention, both oxygen utilization 
and caloric expenditure are reduced, so metabolic effi  ciency can be 
maximized [1]. However, patient cooling is not without consequences 
and shivering is experienced by more than 70% of patients achieving 
TTM. Because shivering triggers an increase in metabolic demand, 
causing additional oxygen consumption and the promotion of 
catabolism, its prevention is ideal [2]. We set out to review the data 
surrounding the anti-shivering component of a normothermia protocol 
in the surgical ICU (SICU) of one Minnesota hospital.
Methods A retrospective review was conducted looking at SICU 
patients managed with a normothermia protocol, with particular 
attention paid to the anti-shivering portion of the protocol. Serum 
magnesium (Mg) levels were assessed prior to initiation of TTM and 
Bedside Shivering Assessment Scale (BSAS) scores were collected.
Results Twenty patients receiving TTM for TBI were evaluated (March 
to October 2013). One-half of the patients maintained targeted BSAS 
scores <1 for the full duration of TTM (n = 10 of 20). Serum Mg levels 
at the initiation of TTM were observed to negatively correlate with the 
level of shivering, as indicated by the BSAS scoring system (P = 0.02). 
See Figure 1.
Conclusion The literature suggests the positive impact of TTM on 
patient outcomes can be maximized with shivering prevention [2]. 
Current SICU practices provide a similar Mg loading dose for all patients, 
regardless of baseline Mg levels. In our observed patients, achieving a 
baseline serum Mg level >2 was associated with lower shivering scores 
throughout the TTM course. This supports the hypothesis that serum 
Mg concentrations prior to TTM are important predictors of shivering 
reduction, and suggests that loading doses of Mg should be tailored to 
the individual patient to achieve such levels.
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